pmid,year,mesh,meshTreeNumber
23281597,2013-01-02T00:00:00,Analgesia,E03.091
23281597,2013-01-02T00:00:00,Anesthesia,E03.155
23281597,2013-01-02T00:00:00,Animals,B01.050
23281597,2013-01-02T00:00:00,"Pain, Postoperative",C23.550.767.700
23281597,2013-01-02T00:00:00,"Pain, Postoperative",C23.888.646.530
23281597,2013-01-02T00:00:00,Perioperative Care,E02.760.722
23281597,2013-01-02T00:00:00,Perioperative Care,E04.604
23281597,2013-01-02T00:00:00,Perioperative Care,N02.421.585.722
23281597,2013-01-02T00:00:00,Swine,B01.050.150.900.649.077.880
23281597,2013-01-02T00:00:00,"Swine, Miniature",B01.050.150.900.649.077.880.399.800
23283355,2013-01-02T00:00:00,Animals,B01.050
23283355,2013-01-02T00:00:00,Bayes Theorem,E05.318.740.600.200
23283355,2013-01-02T00:00:00,Bayes Theorem,N05.715.360.750.625.150
23283355,2013-01-02T00:00:00,Bayes Theorem,N06.850.520.830.600.200
23283355,2013-01-02T00:00:00,Cell Line,A11.251.210
23283355,2013-01-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23283355,2013-01-02T00:00:00,"Models, Biological",E05.599.395
23283355,2013-01-02T00:00:00,Peptide Fragments,D12.644.541
23283355,2013-01-02T00:00:00,Podocytes,A05.810.453.324.359.720
23283355,2013-01-02T00:00:00,Podocytes,A05.810.453.736.520.720
23283355,2013-01-02T00:00:00,Podocytes,A11.436.720
23283355,2013-01-02T00:00:00,Renin-Angiotensin System,G03.495.805
23283355,2013-01-02T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
23283355,2013-01-02T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
23284071,2013-01-02T00:00:00,Aged,M01.060.116.100
23284071,2013-01-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23284071,2013-01-02T00:00:00,Incidence,E05.318.308.985.525.375
23284071,2013-01-02T00:00:00,Incidence,L01.280.975.525.375
23284071,2013-01-02T00:00:00,Incidence,N01.224.935.597.500
23284071,2013-01-02T00:00:00,Incidence,N06.850.505.400.975.525.375
23284071,2013-01-02T00:00:00,Incidence,N06.850.520.308.985.525.375
23284071,2013-01-02T00:00:00,Risk Factors,E05.318.740.600.800.725
23284071,2013-01-02T00:00:00,Risk Factors,N05.715.350.200.700
23284071,2013-01-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23284071,2013-01-02T00:00:00,Risk Factors,N06.850.490.625.750
23284071,2013-01-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23284071,2013-01-02T00:00:00,Stroke,C10.228.140.300.775
23284071,2013-01-02T00:00:00,Stroke,C14.907.253.855
23290460,2013-01-02T00:00:00,Gastric Bypass,E02.065.062.249
23290460,2013-01-02T00:00:00,Gastric Bypass,E04.035.398.385
23290460,2013-01-02T00:00:00,Gastric Bypass,E04.062.249
23290460,2013-01-02T00:00:00,Gastric Bypass,E04.210.457.430
23290460,2013-01-02T00:00:00,Heart Transplantation,E04.100.376.475
23290460,2013-01-02T00:00:00,Heart Transplantation,E04.928.220.390
23290460,2013-01-02T00:00:00,Heart Transplantation,E04.936.450.475
23290460,2013-01-02T00:00:00,Heart-Assist Devices,E04.050.430
23290460,2013-01-02T00:00:00,Heart-Assist Devices,E07.695.300.300
23290460,2013-01-02T00:00:00,Heart-Assist Devices,E07.858.082.374.300
23290460,2013-01-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23290460,2013-01-02T00:00:00,Laparoscopy,E01.370.388.250.520
23290460,2013-01-02T00:00:00,Laparoscopy,E04.800.250.520
23290460,2013-01-02T00:00:00,Obesity,C18.654.726.500
23290460,2013-01-02T00:00:00,Obesity,C23.888.144.699.500
23290460,2013-01-02T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23290460,2013-01-02T00:00:00,Obesity,G07.100.100.160.120.699.500
23290460,2013-01-02T00:00:00,Young Adult,M01.060.116.815
23290934,2013-01-02T00:00:00,Animals,B01.050
23290934,2013-01-02T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
23290934,2013-01-02T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
23290934,2013-01-02T00:00:00,Dopamine,D02.092.211.215.311.342
23290934,2013-01-02T00:00:00,Dopamine,D02.092.311.342
23290934,2013-01-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.644.276.860.381.500
23290934,2013-01-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.467.860.381.500
23290934,2013-01-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D12.776.641.600.381.500
23290934,2013-01-02T00:00:00,Glial Cell Line-Derived Neurotrophic Factor,D23.529.850.381.500
23290934,2013-01-02T00:00:00,Motor Activity,F01.145.632
23290934,2013-01-02T00:00:00,Motor Activity,G11.427.590.530.698
23290934,2013-01-02T00:00:00,Oxidative Stress,G03.495.710
23290934,2013-01-02T00:00:00,Oxidative Stress,G07.700.830.750
23290934,2013-01-02T00:00:00,Recombinant Proteins,D12.776.828
23290934,2013-01-02T00:00:00,Substantia Nigra,A08.186.211.132.659.822.731
23290934,2013-01-02T00:00:00,Substantia Nigra,A08.186.211.653.822.731
23290934,2013-01-02T00:00:00,Superoxide Dismutase,D08.811.682.881
23290934,2013-01-02T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
23290934,2013-01-02T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
23288666,2013-01-03T00:00:00,Adult,M01.060.116
23288666,2013-01-03T00:00:00,Algorithms,G17.035
23288666,2013-01-03T00:00:00,Algorithms,L01.224.050
23288666,2013-01-03T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
23288666,2013-01-03T00:00:00,"Depressive Disorder, Major",F03.600.300.375
23288666,2013-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23288666,2013-01-03T00:00:00,Middle Aged,M01.060.116.630
23288666,2013-01-03T00:00:00,Psychiatric Status Rating Scales,F04.586
23288666,2013-01-03T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23288666,2013-01-03T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23288666,2013-01-03T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23288666,2013-01-03T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23288666,2013-01-03T00:00:00,Remission Induction,E02.860
23288666,2013-01-03T00:00:00,Sensitivity and Specificity,E05.318.740.872
23288666,2013-01-03T00:00:00,Sensitivity and Specificity,E05.318.780.800
23288666,2013-01-03T00:00:00,Sensitivity and Specificity,G17.800
23288666,2013-01-03T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23288666,2013-01-03T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23288666,2013-01-03T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23288666,2013-01-03T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23288666,2013-01-03T00:00:00,Treatment Outcome,E01.789.800
23288666,2013-01-03T00:00:00,Treatment Outcome,N04.761.559.590.800
23288666,2013-01-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23291424,2013-01-03T00:00:00,"Embolization, Therapeutic",E02.520.360
23291424,2013-01-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23291424,2013-01-03T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
23291424,2013-01-03T00:00:00,Intracranial Aneurysm,C14.907.055.635
23291424,2013-01-03T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
23291424,2013-01-03T00:00:00,Treatment Outcome,E01.789.800
23291424,2013-01-03T00:00:00,Treatment Outcome,N04.761.559.590.800
23291424,2013-01-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23301082,2013-01-03T00:00:00,Albumins,D12.776.034
23301082,2013-01-03T00:00:00,Animals,B01.050
23301082,2013-01-03T00:00:00,Cell Separation,E05.200.500.363
23301082,2013-01-03T00:00:00,Enzyme Inhibitors,D27.505.519.389
23301082,2013-01-03T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23301082,2013-01-03T00:00:00,Flow Cytometry,E05.200.500.386.350
23301082,2013-01-03T00:00:00,Inflammation,C23.550.470
23301082,2013-01-03T00:00:00,Kidney Glomerulus,A05.810.453.324.359
23301082,2013-01-03T00:00:00,Kidney Glomerulus,A05.810.453.736.520
23301082,2013-01-03T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
23301082,2013-01-03T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
23301082,2013-01-03T00:00:00,Lupus Nephritis,C17.300.480.680
23301082,2013-01-03T00:00:00,Lupus Nephritis,C20.111.590.560
23301082,2013-01-03T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
23301082,2013-01-03T00:00:00,Sphingolipids,D10.570.877
23301082,2013-01-03T00:00:00,Sphingolipids,D10.808
23301082,2013-01-03T00:00:00,Thromboxane B2,D10.251.355.255.100.825.810
23301082,2013-01-03T00:00:00,Thromboxane B2,D23.469.050.175.800.810
23287455,2013-01-04T00:00:00,Animals,B01.050
23287455,2013-01-04T00:00:00,Extracellular Matrix,A11.284.295.310
23287455,2013-01-04T00:00:00,Fibrosis,C23.550.355
23287455,2013-01-04T00:00:00,Heart Failure,C14.280.434
23287455,2013-01-04T00:00:00,Hemodynamics,G09.330.190.400
23287455,2013-01-04T00:00:00,Hemodynamics,G09.330.380
23287455,2013-01-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23287455,2013-01-04T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23287455,2013-01-04T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23287455,2013-01-04T00:00:00,Myocardium,A02.633.580
23287455,2013-01-04T00:00:00,Myocardium,A07.541.704
23287455,2013-01-04T00:00:00,Myocardium,A10.690.552.750
23287455,2013-01-04T00:00:00,Signal Transduction,G02.111.087.800
23287455,2013-01-04T00:00:00,Signal Transduction,G02.149.115.800
23287455,2013-01-04T00:00:00,Signal Transduction,G04.299.880
23287455,2013-01-04T00:00:00,Substrate Specificity,G02.111.835
23287455,2013-01-04T00:00:00,Ventricular Remodeling,C23.300.985
23287455,2013-01-04T00:00:00,Ventricular Remodeling,G09.330.190.962.975
23292563,2013-01-05T00:00:00,Aged,M01.060.116.100
23292563,2013-01-05T00:00:00,Angiography,E01.370.350.700.060
23292563,2013-01-05T00:00:00,Angiography,E01.370.370.050
23292563,2013-01-05T00:00:00,Colonic Diseases,C06.405.469.158
23292563,2013-01-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23292563,2013-01-05T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
23292563,2013-01-05T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
23292563,2013-01-05T00:00:00,Laparoscopy,E01.370.388.250.520
23292563,2013-01-05T00:00:00,Laparoscopy,E04.800.250.520
23299104,2013-01-07T00:00:00,Aged,M01.060.116.100
23299104,2013-01-07T00:00:00,Brain Ischemia,C10.228.140.300.150
23299104,2013-01-07T00:00:00,Brain Ischemia,C14.907.253.092
23299104,2013-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23299104,2013-01-07T00:00:00,Middle Aged,M01.060.116.630
23299104,2013-01-07T00:00:00,Stroke,C10.228.140.300.775
23299104,2013-01-07T00:00:00,Stroke,C14.907.253.855
23299104,2013-01-07T00:00:00,Thrombolytic Therapy,E02.319.913
23299104,2013-01-07T00:00:00,Treatment Outcome,E01.789.800
23299104,2013-01-07T00:00:00,Treatment Outcome,N04.761.559.590.800
23299104,2013-01-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23305825,2013-01-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23305825,2013-01-07T00:00:00,Liver Cirrhosis,C06.552.630
23305825,2013-01-07T00:00:00,Wound Healing,G16.100.856.891
23308122,2013-01-07T00:00:00,Animals,B01.050
23308122,2013-01-07T00:00:00,Mammaplasty,E02.218.565
23308122,2013-01-07T00:00:00,Mammaplasty,E04.680.500
23308122,2013-01-07T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
23308122,2013-01-07T00:00:00,Obesity,C18.654.726.500
23308122,2013-01-07T00:00:00,Obesity,C23.888.144.699.500
23308122,2013-01-07T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23308122,2013-01-07T00:00:00,Obesity,G07.100.100.160.120.699.500
23308122,2013-01-07T00:00:00,Surgical Flaps,A10.850.710
23308122,2013-01-07T00:00:00,Surgical Flaps,E07.862.710
23140227,2013-01-08T00:00:00,Animals,B01.050
23140227,2013-01-08T00:00:00,Biocompatible Materials,D25.130
23140227,2013-01-08T00:00:00,Biocompatible Materials,D27.720.102.130
23140227,2013-01-08T00:00:00,Biocompatible Materials,J01.637.051.130
23140227,2013-01-08T00:00:00,Cell Differentiation,G04.299.151
23140227,2013-01-08T00:00:00,Cell Survival,G04.299.316
23140227,2013-01-08T00:00:00,DNA,D13.444.308
23140227,2013-01-08T00:00:00,Extracellular Matrix,A11.284.295.310
23140227,2013-01-08T00:00:00,Glycosaminoglycans,D09.698.373
23140227,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23140227,2013-01-08T00:00:00,Hydrogel,D02.033.455.250.700.485
23140227,2013-01-08T00:00:00,Hydrogel,D05.750.741.485
23140227,2013-01-08T00:00:00,Hydrogel,D25.720.741.485
23140227,2013-01-08T00:00:00,Hydrogel,D26.255.165.320.375.375
23140227,2013-01-08T00:00:00,Hydrogel,J01.637.051.720.741.485
23140227,2013-01-08T00:00:00,Materials Testing,E05.570
23140227,2013-01-08T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23140227,2013-01-08T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23140227,2013-01-08T00:00:00,"RNA, Messenger",D13.444.735.544
23140227,2013-01-08T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23140227,2013-01-08T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23140227,2013-01-08T00:00:00,Regeneration,G16.100.856
23140227,2013-01-08T00:00:00,Stem Cells,A11.872
23140227,2013-01-08T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
23140227,2013-01-08T00:00:00,Tissue Scaffolds,E07.206.627
23140227,2013-01-08T00:00:00,Tissue Scaffolds,E07.695.825
23140227,2013-01-08T00:00:00,Water,D01.455.900
23140227,2013-01-08T00:00:00,Water,D01.650.550.925
23296454,2013-01-08T00:00:00,African Americans,M01.686.508.100.100
23296454,2013-01-08T00:00:00,African Americans,M01.686.754.100
23296454,2013-01-08T00:00:00,Age Factors,N05.715.350.075
23296454,2013-01-08T00:00:00,Age Factors,N06.850.490.250
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
23296454,2013-01-08T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
23296454,2013-01-08T00:00:00,European Continental Ancestry Group,M01.686.508.400
23296454,2013-01-08T00:00:00,Health Status Disparities,I01.240.425.675
23296454,2013-01-08T00:00:00,Health Status Disparities,N01.224.425.437
23296454,2013-01-08T00:00:00,Health Status Disparities,N06.850.505.400.425.675
23296454,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23296454,2013-01-08T00:00:00,Incidence,E05.318.308.985.525.375
23296454,2013-01-08T00:00:00,Incidence,L01.280.975.525.375
23296454,2013-01-08T00:00:00,Incidence,N01.224.935.597.500
23296454,2013-01-08T00:00:00,Incidence,N06.850.505.400.975.525.375
23296454,2013-01-08T00:00:00,Incidence,N06.850.520.308.985.525.375
23296454,2013-01-08T00:00:00,Middle Aged,M01.060.116.630
23296454,2013-01-08T00:00:00,South Carolina,Z01.107.567.875.075.662
23296454,2013-01-08T00:00:00,South Carolina,Z01.107.567.875.750.700
23298181,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23298181,2013-01-08T00:00:00,Post-Dural Puncture Headache,C10.228.140.546.699.124
23298181,2013-01-08T00:00:00,Spinal Puncture,E01.370.376.700
23298181,2013-01-08T00:00:00,Spinal Puncture,E01.450.230.700
23298181,2013-01-08T00:00:00,Spinal Puncture,E01.450.865.632.700
23298181,2013-01-08T00:00:00,Young Adult,M01.060.116.815
23298188,2013-01-08T00:00:00,Age Factors,N05.715.350.075
23298188,2013-01-08T00:00:00,Age Factors,N06.850.490.250
23298188,2013-01-08T00:00:00,Alcohol Drinking,F01.145.317.269
23298188,2013-01-08T00:00:00,Animals,B01.050
23298188,2013-01-08T00:00:00,"Behavior, Animal",F01.145.113
23298188,2013-01-08T00:00:00,Central Nervous System Depressants,D27.505.696.277
23298188,2013-01-08T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
23298188,2013-01-08T00:00:00,Ethanol,D02.033.375
23298713,2013-01-08T00:00:00,Adult,M01.060.116
23298713,2013-01-08T00:00:00,Aged,M01.060.116.100
23298713,2013-01-08T00:00:00,Attention,F02.830.104.214
23298713,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23298713,2013-01-08T00:00:00,Middle Aged,M01.060.116.630
23298713,2013-01-08T00:00:00,Neuropsychological Tests,F04.711.513
23298713,2013-01-08T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23303389,2013-01-08T00:00:00,Adult,M01.060.116
23303389,2013-01-08T00:00:00,Antimalarials,D27.505.954.122.250.100.085
23303389,2013-01-08T00:00:00,Case-Control Studies,E05.318.760.500.500
23303389,2013-01-08T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23303389,2013-01-08T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23303389,2013-01-08T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
23303389,2013-01-08T00:00:00,Cyclophosphamide,D02.705.670.243
23303389,2013-01-08T00:00:00,Glucocorticoids,D06.472.040.543
23303389,2013-01-08T00:00:00,Glucocorticoids,D27.505.696.399.472.488
23303389,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23303389,2013-01-08T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23303389,2013-01-08T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23303389,2013-01-08T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23303389,2013-01-08T00:00:00,Middle Aged,M01.060.116.630
23303389,2013-01-08T00:00:00,Risk Factors,E05.318.740.600.800.725
23303389,2013-01-08T00:00:00,Risk Factors,N05.715.350.200.700
23303389,2013-01-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23303389,2013-01-08T00:00:00,Risk Factors,N06.850.490.625.750
23303389,2013-01-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23303389,2013-01-08T00:00:00,Young Adult,M01.060.116.815
23305649,2013-01-08T00:00:00,Adult,M01.060.116
23305649,2013-01-08T00:00:00,Aged,M01.060.116.100
23305649,2013-01-08T00:00:00,Attitude to Health,F01.100.150
23305649,2013-01-08T00:00:00,Attitude to Health,N05.300.150
23305649,2013-01-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23305649,2013-01-08T00:00:00,Internet,L01.224.230.110.500
23305649,2013-01-08T00:00:00,Kidney Transplantation,E02.870.500
23305649,2013-01-08T00:00:00,Kidney Transplantation,E04.936.450.485
23305649,2013-01-08T00:00:00,Kidney Transplantation,E04.950.774.400
23305649,2013-01-08T00:00:00,Middle Aged,M01.060.116.630
23305649,2013-01-08T00:00:00,Patient Compliance,F01.145.488.500
23305649,2013-01-08T00:00:00,Patient Compliance,N05.300.150.600.600
23305649,2013-01-08T00:00:00,Questionnaires,E05.318.308.750
23305649,2013-01-08T00:00:00,Questionnaires,L01.280.800
23305649,2013-01-08T00:00:00,Questionnaires,N05.715.360.300.695
23305649,2013-01-08T00:00:00,Questionnaires,N06.850.520.308.750
23305649,2013-01-08T00:00:00,Telemedicine,H02.403.840
23305649,2013-01-08T00:00:00,Telemedicine,L01.178.847.652
23305649,2013-01-08T00:00:00,Telemedicine,N04.590.374.800
23281651,2013-01-09T00:00:00,Animals,B01.050
23281651,2013-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23281651,2013-01-09T00:00:00,Luminescence,G01.201.875.770.578.665
23281651,2013-01-09T00:00:00,Luminescence,G01.590.540.665
23281651,2013-01-09T00:00:00,Nanocapsules,D26.255.260.575
23281651,2013-01-09T00:00:00,Nanocapsules,D27.720.280.260.575
23281651,2013-01-09T00:00:00,Nanocapsules,E02.319.300.380.575
23281651,2013-01-09T00:00:00,Nanocapsules,J01.637.512.600.575
23281651,2013-01-09T00:00:00,Optical Processes,G01.590.770
23281651,2013-01-09T00:00:00,Optical Processes,G01.595.640
23281651,2013-01-09T00:00:00,Photons,G01.201.875.770.578.782
23281651,2013-01-09T00:00:00,Photons,G01.249.705
23281651,2013-01-09T00:00:00,Photons,G01.590.540.782
23281651,2013-01-09T00:00:00,X-Rays,G01.201.875.750.918
23303956,2013-01-09T00:00:00,Animals,B01.050
23303956,2013-01-09T00:00:00,Biological Markers,D23.101
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",E05.245.380
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23303956,2013-01-09T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23303956,2013-01-09T00:00:00,Electric Stimulation,E05.723.402
23303956,2013-01-09T00:00:00,Limbic System,A08.186.211.464
23303956,2013-01-09T00:00:00,Neuronal Plasticity,G11.561.600.635
23303956,2013-01-09T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23303956,2013-01-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23303956,2013-01-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23303956,2013-01-09T00:00:00,Synapses,A08.850
23303956,2013-01-09T00:00:00,Synapses,A11.284.149.165.420.780
23303956,2013-01-09T00:00:00,Toluene,D02.455.426.559.389.832
23303956,2013-01-09T00:00:00,Tyrosine 3-Monooxygenase,D08.811.682.690.708.923
23303956,2013-01-09T00:00:00,Tyrosine 3-Monooxygenase,D12.776.556.579.374.925
23303956,2013-01-09T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
23303956,2013-01-09T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
23395283,2013-01-09T00:00:00,Algorithms,G17.035
23395283,2013-01-09T00:00:00,Algorithms,L01.224.050
23395283,2013-01-09T00:00:00,Computer Simulation,L01.224.160
23395283,2013-01-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23395283,2013-01-09T00:00:00,Image Enhancement,E01.370.350.600.350
23395283,2013-01-09T00:00:00,Image Enhancement,L01.224.308.380
23395283,2013-01-09T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
23395283,2013-01-09T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
23395283,2013-01-09T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
23395283,2013-01-09T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23395283,2013-01-09T00:00:00,"Microscopy, Confocal",E05.595.395
23395283,2013-01-09T00:00:00,"Models, Biological",E05.599.395
23395283,2013-01-09T00:00:00,"Pattern Recognition, Automated",L01.725
23395283,2013-01-09T00:00:00,Sensitivity and Specificity,E05.318.740.872
23395283,2013-01-09T00:00:00,Sensitivity and Specificity,E05.318.780.800
23395283,2013-01-09T00:00:00,Sensitivity and Specificity,G17.800
23395283,2013-01-09T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23395283,2013-01-09T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23395283,2013-01-09T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23395283,2013-01-09T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23307036,2013-01-10T00:00:00,Health Resources,N03.349.340
23307036,2013-01-10T00:00:00,Health Resources,N05.300.420
23307036,2013-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23307036,2013-01-10T00:00:00,Middle Aged,M01.060.116.630
23307036,2013-01-10T00:00:00,Motivation,F01.658
23307036,2013-01-10T00:00:00,Motivation,F01.752.543.500.750
23307036,2013-01-10T00:00:00,Neoplasms,C04
23307036,2013-01-10T00:00:00,Quality of Life,I01.800
23307036,2013-01-10T00:00:00,Quality of Life,K01.752.400.750
23307036,2013-01-10T00:00:00,Smoking,F01.145.466.753
23307036,2013-01-10T00:00:00,Smoking Cessation,F01.145.940.700
23314242,2013-01-10T00:00:00,Dietary Supplements,J02.500.456
23314242,2013-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23314242,2013-01-10T00:00:00,"Infant, Newborn",M01.060.703.520
23314242,2013-01-10T00:00:00,Pregnancy,G08.686.785.760.769
23314242,2013-01-10T00:00:00,Pregnancy Complications,C13.703
23314242,2013-01-10T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23314242,2013-01-10T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23314242,2013-01-10T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23314242,2013-01-10T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23314242,2013-01-10T00:00:00,Vitamin D,D04.808.812.768
23314242,2013-01-10T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23325143,2013-01-10T00:00:00,Adolescent,M01.060.057
23325143,2013-01-10T00:00:00,African Americans,M01.686.508.100.100
23325143,2013-01-10T00:00:00,African Americans,M01.686.754.100
23325143,2013-01-10T00:00:00,Blood Pressure,E01.370.600.875.249
23325143,2013-01-10T00:00:00,Blood Pressure,G09.330.380.076
23325143,2013-01-10T00:00:00,DNA Methylation,G02.111.087.029.538.161
23325143,2013-01-10T00:00:00,DNA Methylation,G02.111.087.218
23325143,2013-01-10T00:00:00,DNA Methylation,G02.149.115.029.538.161
23325143,2013-01-10T00:00:00,DNA Methylation,G02.149.115.218
23325143,2013-01-10T00:00:00,DNA Methylation,G03.495.130.538.161
23325143,2013-01-10T00:00:00,DNA Methylation,G05.355.190
23325143,2013-01-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23325143,2013-01-10T00:00:00,Hypertension,C14.907.489
23325143,2013-01-10T00:00:00,Inflammation,C23.550.470
23325143,2013-01-10T00:00:00,Leukocytes,A11.118.637
23325143,2013-01-10T00:00:00,Leukocytes,A15.145.229.637
23325143,2013-01-10T00:00:00,Leukocytes,A15.382.490
23325143,2013-01-10T00:00:00,Young Adult,M01.060.116.815
23312977,2013-01-11T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
23312977,2013-01-11T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
23312977,2013-01-11T00:00:00,Biological Markers,D23.101
23312977,2013-01-11T00:00:00,Case-Control Studies,E05.318.760.500.500
23312977,2013-01-11T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23312977,2013-01-11T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23312977,2013-01-11T00:00:00,"Diagnosis, Differential",E01.171
23312977,2013-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23312977,2013-01-11T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23312977,2013-01-11T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23312977,2013-01-11T00:00:00,MicroRNAs,D13.150.650.319
23312977,2013-01-11T00:00:00,MicroRNAs,D13.444.735.150.319
23312977,2013-01-11T00:00:00,MicroRNAs,D13.444.735.790.099
23312977,2013-01-11T00:00:00,Risk Factors,E05.318.740.600.800.725
23312977,2013-01-11T00:00:00,Risk Factors,N05.715.350.200.700
23312977,2013-01-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23312977,2013-01-11T00:00:00,Risk Factors,N06.850.490.625.750
23312977,2013-01-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23312977,2013-01-11T00:00:00,Sensitivity and Specificity,E05.318.740.872
23312977,2013-01-11T00:00:00,Sensitivity and Specificity,E05.318.780.800
23312977,2013-01-11T00:00:00,Sensitivity and Specificity,G17.800
23312977,2013-01-11T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23312977,2013-01-11T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23312977,2013-01-11T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23312977,2013-01-11T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23312977,2013-01-11T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
23314219,2013-01-11T00:00:00,Action Potentials,G04.580.100
23314219,2013-01-11T00:00:00,Action Potentials,G07.265.750.100
23314219,2013-01-11T00:00:00,Action Potentials,G11.561.570.100
23314219,2013-01-11T00:00:00,Animals,B01.050
23314219,2013-01-11T00:00:00,Drug Interactions,G07.690.812.240
23314219,2013-01-11T00:00:00,Drug Interactions,G07.700.680.240
23314219,2013-01-11T00:00:00,Ethanol,D02.033.375
23314219,2013-01-11T00:00:00,Neurons,A08.663
23314219,2013-01-11T00:00:00,Neurons,A11.671
23314219,2013-01-11T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23314219,2013-01-11T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
23314219,2013-01-11T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
23314221,2013-01-11T00:00:00,Adolescent,M01.060.057
23314221,2013-01-11T00:00:00,Adult,M01.060.116
23314221,2013-01-11T00:00:00,Analgesia,E03.091
23314221,2013-01-11T00:00:00,Brain,A08.186.211
23314221,2013-01-11T00:00:00,Brain Mapping,E01.370.350.086
23314221,2013-01-11T00:00:00,Brain Mapping,E01.370.376.149
23314221,2013-01-11T00:00:00,Brain Mapping,E05.132
23314221,2013-01-11T00:00:00,Cross-Over Studies,E05.318.780.150
23314221,2013-01-11T00:00:00,Cross-Over Studies,N05.715.360.780.150
23314221,2013-01-11T00:00:00,Cross-Over Studies,N06.850.520.445.150
23314221,2013-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23314221,2013-01-11T00:00:00,Middle Aged,M01.060.116.630
23314221,2013-01-11T00:00:00,Narcotic Antagonists,D27.505.696.543
23314221,2013-01-11T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
23314221,2013-01-11T00:00:00,Narcotic Antagonists,D27.505.954.427.550
23314221,2013-01-11T00:00:00,Pain,C10.597.617
23314221,2013-01-11T00:00:00,Pain,C23.888.592.612
23314221,2013-01-11T00:00:00,Pain,C23.888.646
23314221,2013-01-11T00:00:00,Pain,F02.830.816.444
23314221,2013-01-11T00:00:00,Pain,G11.561.600.810.444
23314221,2013-01-11T00:00:00,Pain Measurement,E01.370.376.550.600
23314221,2013-01-11T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23314221,2013-01-11T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
23314221,2013-01-11T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
23315939,2013-01-11T00:00:00,Animals,B01.050
23315939,2013-01-11T00:00:00,Arrestins,D12.776.306.090
23315939,2013-01-11T00:00:00,Arrestins,D12.776.543.090
23315939,2013-01-11T00:00:00,Bone and Bones,A02.835.232
23315939,2013-01-11T00:00:00,Bone and Bones,A10.165.265
23315939,2013-01-11T00:00:00,Cell Movement,G04.299.283
23315939,2013-01-11T00:00:00,Cell Movement,G07.700.560.500.180
23315939,2013-01-11T00:00:00,Cell Proliferation,G04.299.233.750
23315939,2013-01-11T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23315939,2013-01-11T00:00:00,Cell Survival,G04.299.316
23315939,2013-01-11T00:00:00,Osteoblasts,A11.329.629
23315939,2013-01-11T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
23315939,2013-01-11T00:00:00,Osteogenesis,G11.427.590.560.100.729
23315939,2013-01-11T00:00:00,Parathyroid Hormone,D06.472.699.590
23315939,2013-01-11T00:00:00,Parathyroid Hormone,D12.644.548.587
23315939,2013-01-11T00:00:00,Peptide Fragments,D12.644.541
23315939,2013-01-11T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
23318275,2013-01-11T00:00:00,ATP-Binding Cassette Transporters,D12.776.157.530.100
23318275,2013-01-11T00:00:00,ATP-Binding Cassette Transporters,D12.776.395.550.020
23318275,2013-01-11T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.550.192
23318275,2013-01-11T00:00:00,ATP-Binding Cassette Transporters,D12.776.543.585.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C10.228.140.163.100.680.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C10.314.400.250
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C10.597.606.643.455.124
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C16.320.322.500.124
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C16.320.400.525.124
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C16.320.565.189.680.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C16.320.565.663.112
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C18.452.132.100.680.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C18.452.648.189.680.100
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C18.452.648.663.112
23318275,2013-01-11T00:00:00,Adrenoleukodystrophy,C19.053.500.270
23318275,2013-01-11T00:00:00,Animals,B01.050
23318275,2013-01-11T00:00:00,Astrocytes,A08.637.200
23318275,2013-01-11T00:00:00,Astrocytes,A11.650.200
23318275,2013-01-11T00:00:00,Child,M01.060.406
23318275,2013-01-11T00:00:00,Fibroblasts,A11.329.228
23318275,2013-01-11T00:00:00,Fibroblasts,A11.872.228
23318275,2013-01-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23318275,2013-01-11T00:00:00,Inflammation,C23.550.470
23318275,2013-01-11T00:00:00,NF-kappa B,D12.776.260.600
23318275,2013-01-11T00:00:00,NF-kappa B,D12.776.660.600
23318275,2013-01-11T00:00:00,NF-kappa B,D12.776.930.600
23326546,2013-01-11T00:00:00,Alleles,G05.360.340.024.340.030
23326546,2013-01-11T00:00:00,Animals,B01.050
23326546,2013-01-11T00:00:00,HIV-1,B04.820.650.589.650.350.400
23326546,2013-01-11T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
23326546,2013-01-11T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
23326546,2013-01-11T00:00:00,Malaria,C03.752.530
23326546,2013-01-11T00:00:00,Pregnancy,G08.686.785.760.769
23229778,2013-01-14T00:00:00,African Continental Ancestry Group,M01.686.508.100
23229778,2013-01-14T00:00:00,Aged,M01.060.116.100
23229778,2013-01-14T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23229778,2013-01-14T00:00:00,Blood Pressure,E01.370.600.875.249
23229778,2013-01-14T00:00:00,Blood Pressure,G09.330.380.076
23229778,2013-01-14T00:00:00,European Continental Ancestry Group,M01.686.508.400
23229778,2013-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23229778,2013-01-14T00:00:00,Hypertension,C14.907.489
23229778,2013-01-14T00:00:00,Incidence,E05.318.308.985.525.375
23229778,2013-01-14T00:00:00,Incidence,L01.280.975.525.375
23229778,2013-01-14T00:00:00,Incidence,N01.224.935.597.500
23229778,2013-01-14T00:00:00,Incidence,N06.850.505.400.975.525.375
23229778,2013-01-14T00:00:00,Incidence,N06.850.520.308.985.525.375
23229778,2013-01-14T00:00:00,Middle Aged,M01.060.116.630
23229778,2013-01-14T00:00:00,Prevalence,E05.318.308.985.525.750
23229778,2013-01-14T00:00:00,Prevalence,L01.280.975.525.750
23229778,2013-01-14T00:00:00,Prevalence,N01.224.935.597.750
23229778,2013-01-14T00:00:00,Prevalence,N06.850.505.400.975.525.750
23229778,2013-01-14T00:00:00,Prevalence,N06.850.520.308.985.525.750
23229778,2013-01-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23229778,2013-01-14T00:00:00,Risk Factors,N05.715.350.200.700
23229778,2013-01-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23229778,2013-01-14T00:00:00,Risk Factors,N06.850.490.625.750
23229778,2013-01-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23229778,2013-01-14T00:00:00,Stroke,C10.228.140.300.775
23229778,2013-01-14T00:00:00,Stroke,C14.907.253.855
23229778,2013-01-14T00:00:00,United States,Z01.107.567.875
23319662,2013-01-14T00:00:00,Contrast Media,D27.720.259
23319662,2013-01-14T00:00:00,Diagnostic Imaging,E01.370.350
23319662,2013-01-14T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
23319662,2013-01-14T00:00:00,Glomerular Filtration Rate,G08.852.357
23319662,2013-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23319662,2013-01-14T00:00:00,Kidney Diseases,C12.777.419
23319662,2013-01-14T00:00:00,Kidney Diseases,C13.351.968.419
23341932,2013-01-14T00:00:00,Adult,M01.060.116
23341932,2013-01-14T00:00:00,Child,M01.060.406
23341932,2013-01-14T00:00:00,"Child, Preschool",M01.060.406.448
23341932,2013-01-14T00:00:00,Demography,I01.240
23341932,2013-01-14T00:00:00,Demography,N01.224
23341932,2013-01-14T00:00:00,Demography,N06.850.505.400
23341932,2013-01-14T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
23341932,2013-01-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23341932,2013-01-14T00:00:00,Infant,M01.060.703
23341932,2013-01-14T00:00:00,Middle Aged,M01.060.116.630
23341932,2013-01-14T00:00:00,Perfusion,E05.680
23341932,2013-01-14T00:00:00,Seizures,C10.228.140.490.631
23341932,2013-01-14T00:00:00,Seizures,C10.597.742
23341932,2013-01-14T00:00:00,Seizures,C23.888.592.742
23341932,2013-01-14T00:00:00,Technetium Tc 99m Exametazime,D01.632.825.562
23341932,2013-01-14T00:00:00,Technetium Tc 99m Exametazime,D02.092.570.665.810
23341932,2013-01-14T00:00:00,Technetium Tc 99m Exametazime,D02.691.825.562
23341932,2013-01-14T00:00:00,Young Adult,M01.060.116.815
23342106,2013-01-14T00:00:00,Animals,B01.050
23342106,2013-01-14T00:00:00,Embryonic Development,G07.700.320.500.325.180
23342106,2013-01-14T00:00:00,Embryonic Development,G08.686.785.760.170.104
23342106,2013-01-14T00:00:00,Heart,A07.541
23072722,2013-01-15T00:00:00,Animals,B01.050
23072722,2013-01-15T00:00:00,Cell Proliferation,G04.299.233.750
23072722,2013-01-15T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23072722,2013-01-15T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23072722,2013-01-15T00:00:00,DNA Methylation,G02.111.087.029.538.161
23072722,2013-01-15T00:00:00,DNA Methylation,G02.111.087.218
23072722,2013-01-15T00:00:00,DNA Methylation,G02.149.115.029.538.161
23072722,2013-01-15T00:00:00,DNA Methylation,G02.149.115.218
23072722,2013-01-15T00:00:00,DNA Methylation,G03.495.130.538.161
23072722,2013-01-15T00:00:00,DNA Methylation,G05.355.190
23072722,2013-01-15T00:00:00,Gene Expression Profiling,E05.393.332
23072722,2013-01-15T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23072722,2013-01-15T00:00:00,Histone Demethylases,D08.811.682.662.582.475
23072722,2013-01-15T00:00:00,Histones,D12.776.660.470
23072722,2013-01-15T00:00:00,Histones,D12.776.664.469
23072722,2013-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23072722,2013-01-15T00:00:00,Lysine,D12.125.068.555
23072722,2013-01-15T00:00:00,Lysine,D12.125.095.647
23072722,2013-01-15T00:00:00,Lysine,D12.125.142.497
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
23072722,2013-01-15T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
23072722,2013-01-15T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
23072722,2013-01-15T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
23072722,2013-01-15T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
23072722,2013-01-15T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
23319003,2013-01-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23319003,2013-01-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
23319003,2013-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23319003,2013-01-15T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23322627,2013-01-15T00:00:00,Age Factors,N05.715.350.075
23322627,2013-01-15T00:00:00,Age Factors,N06.850.490.250
23322627,2013-01-15T00:00:00,Aged,M01.060.116.100
23322627,2013-01-15T00:00:00,Biological Markers,D23.101
23322627,2013-01-15T00:00:00,C-Reactive Protein,D12.776.034.145
23322627,2013-01-15T00:00:00,C-Reactive Protein,D12.776.124.050.120
23322627,2013-01-15T00:00:00,C-Reactive Protein,D12.776.124.486.157
23322627,2013-01-15T00:00:00,Hearing Loss,C09.218.458.341
23322627,2013-01-15T00:00:00,Hearing Loss,C10.597.751.418.341
23322627,2013-01-15T00:00:00,Hearing Loss,C23.888.592.763.393.341
23322627,2013-01-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23322627,2013-01-15T00:00:00,Lipids,D10
23322627,2013-01-15T00:00:00,Middle Aged,M01.060.116.630
23322627,2013-01-15T00:00:00,Risk Factors,E05.318.740.600.800.725
23322627,2013-01-15T00:00:00,Risk Factors,N05.715.350.200.700
23322627,2013-01-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23322627,2013-01-15T00:00:00,Risk Factors,N06.850.490.625.750
23322627,2013-01-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23151037,2013-01-16T00:00:00,Animals,B01.050
23151037,2013-01-16T00:00:00,Biocompatible Materials,D25.130
23151037,2013-01-16T00:00:00,Biocompatible Materials,D27.720.102.130
23151037,2013-01-16T00:00:00,Biocompatible Materials,J01.637.051.130
23151037,2013-01-16T00:00:00,Collagen,D05.750.078.280
23151037,2013-01-16T00:00:00,Collagen,D12.776.860.300.250
23151037,2013-01-16T00:00:00,Coronary Vessels,A07.231.114.269
23151037,2013-01-16T00:00:00,Coronary Vessels,A07.231.908.194
23151037,2013-01-16T00:00:00,Elastin,D05.750.078.421
23151037,2013-01-16T00:00:00,Elastin,D12.776.860.300.350
23151037,2013-01-16T00:00:00,Extracellular Matrix,A11.284.295.310
23151037,2013-01-16T00:00:00,Fibronectins,D12.776.377.715.390
23151037,2013-01-16T00:00:00,Fibronectins,D12.776.395.550.350
23151037,2013-01-16T00:00:00,Fibronectins,D12.776.543.550.350
23151037,2013-01-16T00:00:00,Fibronectins,D12.776.860.300.450
23151037,2013-01-16T00:00:00,Materials Testing,E05.570
23151037,2013-01-16T00:00:00,Myocardium,A02.633.580
23151037,2013-01-16T00:00:00,Myocardium,A07.541.704
23151037,2013-01-16T00:00:00,Myocardium,A10.690.552.750
23151037,2013-01-16T00:00:00,Porosity,G01.374.710
23151037,2013-01-16T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23151037,2013-01-16T00:00:00,Tissue Scaffolds,E07.206.627
23151037,2013-01-16T00:00:00,Tissue Scaffolds,E07.695.825
23151037,2013-01-16T00:00:00,Vascular Patency,G09.330.920
23324604,2013-01-16T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
23324604,2013-01-16T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
23324604,2013-01-16T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
23324604,2013-01-16T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
23324604,2013-01-16T00:00:00,Apoptosis,G04.299.139.160
23324604,2013-01-16T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23324604,2013-01-16T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23324604,2013-01-16T00:00:00,Cell Proliferation,G04.299.233.750
23324604,2013-01-16T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23324604,2013-01-16T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23324604,2013-01-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23324604,2013-01-16T00:00:00,Mouth Neoplasms,C04.588.443.591
23324604,2013-01-16T00:00:00,Mouth Neoplasms,C07.465.565
23324604,2013-01-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
23324604,2013-01-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
23324604,2013-01-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
23324604,2013-01-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
23324604,2013-01-16T00:00:00,RNA Stability,G02.111.780
23324604,2013-01-16T00:00:00,"RNA, Messenger",D13.444.735.544
23324604,2013-01-16T00:00:00,RNA-Binding Proteins,D12.776.157.725
23324604,2013-01-16T00:00:00,RNA-Binding Proteins,D12.776.664.962
23324604,2013-01-16T00:00:00,"Tumor Markers, Biological",D23.101.840
23324604,2013-01-16T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
23324604,2013-01-16T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
23332093,2013-01-17T00:00:00,Adolescent,M01.060.057
23332093,2013-01-17T00:00:00,Adult,M01.060.116
23332093,2013-01-17T00:00:00,Aged,M01.060.116.100
23332093,2013-01-17T00:00:00,Case-Control Studies,E05.318.760.500.500
23332093,2013-01-17T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23332093,2013-01-17T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23332093,2013-01-17T00:00:00,Child,M01.060.406
23332093,2013-01-17T00:00:00,"Child, Preschool",M01.060.406.448
23332093,2013-01-17T00:00:00,Continuity of Patient Care,N04.590.233.727.210
23332093,2013-01-17T00:00:00,Graft Rejection,G12.425.901.545.328
23332093,2013-01-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23332093,2013-01-17T00:00:00,Infant,M01.060.703
23332093,2013-01-17T00:00:00,Medication Errors,E02.319.529
23332093,2013-01-17T00:00:00,Medication Errors,N02.421.450.500
23332093,2013-01-17T00:00:00,Medication Therapy Management,N02.421.668.438
23332093,2013-01-17T00:00:00,Medication Therapy Management,N03.219.521.576.343.575.500.500
23332093,2013-01-17T00:00:00,Medication Therapy Management,N03.219.521.576.343.840.938.500
23332093,2013-01-17T00:00:00,Medication Therapy Management,N04.590.661
23332093,2013-01-17T00:00:00,Middle Aged,M01.060.116.630
23332093,2013-01-17T00:00:00,Organ Transplantation,E04.936.450
23332093,2013-01-17T00:00:00,Patient Discharge,E02.760.400.610
23332093,2013-01-17T00:00:00,Patient Discharge,N02.421.585.400.610
23332093,2013-01-17T00:00:00,Pharmacists,M01.526.485.780
23332093,2013-01-17T00:00:00,Pharmacists,N02.360.780
23332093,2013-01-17T00:00:00,Risk Factors,E05.318.740.600.800.725
23332093,2013-01-17T00:00:00,Risk Factors,N05.715.350.200.700
23332093,2013-01-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23332093,2013-01-17T00:00:00,Risk Factors,N06.850.490.625.750
23332093,2013-01-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23332093,2013-01-17T00:00:00,Young Adult,M01.060.116.815
23333292,2013-01-18T00:00:00,Adult,M01.060.116
23333292,2013-01-18T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
23333292,2013-01-18T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
23333292,2013-01-18T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
23333292,2013-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23333292,2013-01-18T00:00:00,Opioid-Related Disorders,C21.739.675
23333292,2013-01-18T00:00:00,Opioid-Related Disorders,F03.900.675
23333292,2013-01-18T00:00:00,Prescription Drugs,D26.670
23333292,2013-01-18T00:00:00,Treatment Outcome,E01.789.800
23333292,2013-01-18T00:00:00,Treatment Outcome,N04.761.559.590.800
23333292,2013-01-18T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23333292,2013-01-18T00:00:00,Young Adult,M01.060.116.815
23337619,2013-01-18T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
23337619,2013-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23337619,2013-01-18T00:00:00,Neural Pathways,A08.612
23337619,2013-01-18T00:00:00,Parkinson Disease,C10.228.140.079.862.500
23337619,2013-01-18T00:00:00,Parkinson Disease,C10.228.662.600.400
23337619,2013-01-18T00:00:00,Parkinson Disease,C10.574.812
23567407,2013-01-18T00:00:00,Dementia,C10.228.140.380
23567407,2013-01-18T00:00:00,Dementia,F03.087.400
23567407,2013-01-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23567407,2013-01-18T00:00:00,Methylphenidate,D02.241.223.601.600
23567407,2013-01-18T00:00:00,Methylphenidate,D03.383.621.460
23567407,2013-01-18T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23567407,2013-01-18T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23567407,2013-01-18T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23567407,2013-01-18T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23567407,2013-01-18T00:00:00,Research Design,E05.581.500
23567407,2013-01-18T00:00:00,Research Design,H01.770.644.728
23347720,2013-01-21T00:00:00,Anaphylaxis,C20.543.480.099
23347720,2013-01-21T00:00:00,Animals,B01.050
23347720,2013-01-21T00:00:00,Ant Venoms,D20.888.065.055
23347720,2013-01-21T00:00:00,Ant Venoms,D23.946.833.065.055
23347720,2013-01-21T00:00:00,Ants,B01.050.500.131.617.479.205
23347720,2013-01-21T00:00:00,"Child, Preschool",M01.060.406.448
23347720,2013-01-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23347720,2013-01-21T00:00:00,Insect Bites and Stings,C21.613.127.441
23347720,2013-01-21T00:00:00,Rhabdomyolysis,C05.651.807
23347720,2013-01-21T00:00:00,Syndrome,C23.550.288.500
23348236,2013-01-21T00:00:00,Adult,M01.060.116
23348236,2013-01-21T00:00:00,Aged,M01.060.116.100
23348236,2013-01-21T00:00:00,Ascites,C23.550.081
23348236,2013-01-21T00:00:00,Case-Control Studies,E05.318.760.500.500
23348236,2013-01-21T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23348236,2013-01-21T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23348236,2013-01-21T00:00:00,Hemorrhage,C23.550.414
23348236,2013-01-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23348236,2013-01-21T00:00:00,Liver Cirrhosis,C06.552.630
23348236,2013-01-21T00:00:00,Middle Aged,M01.060.116.630
23388370,2013-01-22T00:00:00,Adolescent,M01.060.057
23388370,2013-01-22T00:00:00,Adult,M01.060.116
23388370,2013-01-22T00:00:00,Bacteremia,C01.252.100
23388370,2013-01-22T00:00:00,Bacteremia,C01.539.757.100
23388370,2013-01-22T00:00:00,Bacteremia,C23.550.470.790.500.100
23388370,2013-01-22T00:00:00,"Catheterization, Central Venous",E02.148.167
23388370,2013-01-22T00:00:00,Child,M01.060.406
23388370,2013-01-22T00:00:00,"Child, Preschool",M01.060.406.448
23388370,2013-01-22T00:00:00,Cross Infection,C01.539.248
23388370,2013-01-22T00:00:00,Escherichia coli,B03.440.450.425.325.300
23388370,2013-01-22T00:00:00,Escherichia coli,B03.660.250.150.180.100
23388370,2013-01-22T00:00:00,Hospitalization,E02.760.400
23388370,2013-01-22T00:00:00,Hospitalization,N02.421.585.400
23388370,2013-01-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23388370,2013-01-22T00:00:00,Infant,M01.060.703
23388370,2013-01-22T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
23388370,2013-01-22T00:00:00,Young Adult,M01.060.116.815
23792498,2013-01-22T00:00:00,Adult,M01.060.116
23792498,2013-01-22T00:00:00,Calcium,D01.268.552.100
23792498,2013-01-22T00:00:00,Calcium,D01.552.539.288
23792498,2013-01-22T00:00:00,Calcium,D23.119.100
23792498,2013-01-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23792498,2013-01-22T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
23792498,2013-01-22T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
23792498,2013-01-22T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
23792498,2013-01-22T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
23792498,2013-01-22T00:00:00,Kidney Transplantation,E02.870.500
23792498,2013-01-22T00:00:00,Kidney Transplantation,E04.936.450.485
23792498,2013-01-22T00:00:00,Kidney Transplantation,E04.950.774.400
23792498,2013-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23792498,2013-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23792498,2013-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23792498,2013-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23792498,2013-01-22T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23344746,2013-01-24T00:00:00,Action Potentials,G04.580.100
23344746,2013-01-24T00:00:00,Action Potentials,G07.265.750.100
23344746,2013-01-24T00:00:00,Action Potentials,G11.561.570.100
23344746,2013-01-24T00:00:00,Aged,M01.060.116.100
23344746,2013-01-24T00:00:00,Calcium,D01.268.552.100
23344746,2013-01-24T00:00:00,Calcium,D01.552.539.288
23344746,2013-01-24T00:00:00,Calcium,D23.119.100
23344746,2013-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23344746,2013-01-24T00:00:00,Middle Aged,M01.060.116.630
23344746,2013-01-24T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
23344746,2013-01-24T00:00:00,Potassium,D01.268.549.550
23344746,2013-01-24T00:00:00,Potassium,D01.552.528.652
23344746,2013-01-24T00:00:00,Urinary Bladder,A05.810.890
23349315,2013-01-24T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
23349315,2013-01-24T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
23349315,2013-01-24T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
23349315,2013-01-24T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
23349315,2013-01-24T00:00:00,Animals,B01.050
23349315,2013-01-24T00:00:00,Apoptosis,G04.299.139.160
23349315,2013-01-24T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23349315,2013-01-24T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23349315,2013-01-24T00:00:00,Cell Movement,G04.299.283
23349315,2013-01-24T00:00:00,Cell Movement,G07.700.560.500.180
23349315,2013-01-24T00:00:00,Cell Proliferation,G04.299.233.750
23349315,2013-01-24T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23349315,2013-01-24T00:00:00,Chick Embryo,A13.350.150
23349315,2013-01-24T00:00:00,Chick Embryo,A16.331.200
23349315,2013-01-24T00:00:00,Chorioallantoic Membrane,A10.615.284.375
23349315,2013-01-24T00:00:00,Chorioallantoic Membrane,A13.350.575
23349315,2013-01-24T00:00:00,Chorioallantoic Membrane,A16.331.400
23349315,2013-01-24T00:00:00,Head and Neck Neoplasms,C04.588.443
23349315,2013-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23349315,2013-01-24T00:00:00,Interleukin-6,D12.644.276.374.465.506
23349315,2013-01-24T00:00:00,Interleukin-6,D12.776.467.374.465.506
23349315,2013-01-24T00:00:00,Interleukin-6,D23.529.374.465.506
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.205.360
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.252.445
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.300.480.525.700.350
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.205.360
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.252.445
23349315,2013-01-24T00:00:00,Matrix Metalloproteinase 9,D08.811.277.656.675.374.525.700.350
23349315,2013-01-24T00:00:00,Neoplasm Invasiveness,C04.697.645
23349315,2013-01-24T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23349315,2013-01-24T00:00:00,RNA Stability,G02.111.780
23349315,2013-01-24T00:00:00,"RNA, Messenger",D13.444.735.544
23349315,2013-01-24T00:00:00,Tissue Array Analysis,E05.196.630.570.850
23349315,2013-01-24T00:00:00,Tissue Array Analysis,E05.588.570.850
23349315,2013-01-24T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
23349315,2013-01-24T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
23349315,2013-01-24T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
23349315,2013-01-24T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
23359212,2013-01-24T00:00:00,Algorithms,G17.035
23359212,2013-01-24T00:00:00,Algorithms,L01.224.050
23359212,2013-01-24T00:00:00,Animals,B01.050
23359212,2013-01-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23347797,2013-01-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23347797,2013-01-25T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
23347797,2013-01-25T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
23347797,2013-01-25T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
23347797,2013-01-25T00:00:00,Infant,M01.060.703
23347797,2013-01-25T00:00:00,Myocardial Contraction,G09.330.190.541
23347797,2013-01-25T00:00:00,Myocardial Contraction,G11.427.590.540.570
23347797,2013-01-25T00:00:00,Treatment Outcome,E01.789.800
23347797,2013-01-25T00:00:00,Treatment Outcome,N04.761.559.590.800
23347797,2013-01-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23357406,2013-01-26T00:00:00,Calcium,D01.268.552.100
23357406,2013-01-26T00:00:00,Calcium,D01.552.539.288
23357406,2013-01-26T00:00:00,Calcium,D23.119.100
23357406,2013-01-26T00:00:00,Calcium Channels,D12.776.157.530.400.150
23357406,2013-01-26T00:00:00,Calcium Channels,D12.776.543.550.425.150
23357406,2013-01-26T00:00:00,Calcium Channels,D12.776.543.585.400.150
23357406,2013-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23357406,2013-01-26T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23357406,2013-01-26T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23357406,2013-01-26T00:00:00,"Myocytes, Cardiac",A11.620.500
23357406,2013-01-26T00:00:00,Recombinant Proteins,D12.776.828
23357553,2013-01-26T00:00:00,Ethanol,D02.033.375
23357553,2013-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23357553,2013-01-26T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
23357553,2013-01-26T00:00:00,Recombinant Proteins,D12.776.828
23357553,2013-01-26T00:00:00,Tyrosine,D12.125.072.050.875
23360767,2013-01-26T00:00:00,Aged,M01.060.116.100
23360767,2013-01-26T00:00:00,Antithrombins,D12.644.822.750.060
23360767,2013-01-26T00:00:00,Antithrombins,D12.644.861.060
23360767,2013-01-26T00:00:00,Antithrombins,D12.776.645.750.060
23360767,2013-01-26T00:00:00,Antithrombins,D12.776.872.060
23360767,2013-01-26T00:00:00,Benzimidazoles,D03.438.103
23360767,2013-01-26T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23360767,2013-01-26T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23360767,2013-01-26T00:00:00,"Defibrillators, Implantable",E07.695.175
23360767,2013-01-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23360767,2013-01-26T00:00:00,"Pacemaker, Artificial",E07.858.082.748
23360767,2013-01-26T00:00:00,beta-Alanine,D12.125.042.070
23411031,2013-01-27T00:00:00,Animals,B01.050
23411031,2013-01-27T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
23411031,2013-01-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23411031,2013-01-27T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23411031,2013-01-27T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23411031,2013-01-27T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
23351552,2013-01-28T00:00:00,Arrestins,D12.776.306.090
23351552,2013-01-28T00:00:00,Arrestins,D12.776.543.090
23351552,2013-01-28T00:00:00,Cell Line,A11.251.210
23351552,2013-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23351552,2013-01-28T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
23351552,2013-01-28T00:00:00,"Microscopy, Fluorescence",E05.595.458
23351552,2013-01-28T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.100.650.100
23351552,2013-01-28T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.750.600.100
23356818,2013-01-28T00:00:00,African Continental Ancestry Group,M01.686.508.100
23356818,2013-01-28T00:00:00,Aged,M01.060.116.100
23356818,2013-01-28T00:00:00,Atrial Fibrillation,C14.280.067.198
23356818,2013-01-28T00:00:00,Atrial Fibrillation,C23.550.073.198
23356818,2013-01-28T00:00:00,"Cardiac Pacing, Artificial",E02.145
23356818,2013-01-28T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23356818,2013-01-28T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23356818,2013-01-28T00:00:00,"Defibrillators, Implantable",E07.695.175
23356818,2013-01-28T00:00:00,Electric Countershock,E02.342.287
23356818,2013-01-28T00:00:00,Ethnic Groups,M01.686.754
23356818,2013-01-28T00:00:00,Ethnic Groups,N01.224.317
23356818,2013-01-28T00:00:00,European Continental Ancestry Group,M01.686.508.400
23356818,2013-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23356818,2013-01-28T00:00:00,Incidence,E05.318.308.985.525.375
23356818,2013-01-28T00:00:00,Incidence,L01.280.975.525.375
23356818,2013-01-28T00:00:00,Incidence,N01.224.935.597.500
23356818,2013-01-28T00:00:00,Incidence,N06.850.505.400.975.525.375
23356818,2013-01-28T00:00:00,Incidence,N06.850.520.308.985.525.375
23356818,2013-01-28T00:00:00,North America,Z01.107.567
23356818,2013-01-28T00:00:00,"Pacemaker, Artificial",E07.858.082.748
23356818,2013-01-28T00:00:00,Prevalence,E05.318.308.985.525.750
23356818,2013-01-28T00:00:00,Prevalence,L01.280.975.525.750
23356818,2013-01-28T00:00:00,Prevalence,N01.224.935.597.750
23356818,2013-01-28T00:00:00,Prevalence,N06.850.505.400.975.525.750
23356818,2013-01-28T00:00:00,Prevalence,N06.850.520.308.985.525.750
23356818,2013-01-28T00:00:00,Risk Factors,E05.318.740.600.800.725
23356818,2013-01-28T00:00:00,Risk Factors,N05.715.350.200.700
23356818,2013-01-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23356818,2013-01-28T00:00:00,Risk Factors,N06.850.490.625.750
23356818,2013-01-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23356818,2013-01-28T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
23359698,2013-01-28T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.033
23359698,2013-01-28T00:00:00,"Adrenal Hyperplasia, Congenital",C16.320.565.925.249
23359698,2013-01-28T00:00:00,"Adrenal Hyperplasia, Congenital",C18.452.648.925.249
23359698,2013-01-28T00:00:00,"Adrenal Hyperplasia, Congenital",C19.053.440
23359698,2013-01-28T00:00:00,Ethnic Groups,M01.686.754
23359698,2013-01-28T00:00:00,Ethnic Groups,N01.224.317
23359698,2013-01-28T00:00:00,Gene Deletion,G05.355.600.800.320
23359698,2013-01-28T00:00:00,Gene Deletion,G05.365.590.762.320
23359698,2013-01-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23359698,2013-01-28T00:00:00,"Models, Genetic",E05.599.395.397
23359698,2013-01-28T00:00:00,Mutation,G05.365.590
23359698,2013-01-28T00:00:00,New York,Z01.107.567.875.075.437
23359698,2013-01-28T00:00:00,New York,Z01.107.567.875.350.530
23359698,2013-01-28T00:00:00,New York,Z01.107.567.875.500.530
23359698,2013-01-28T00:00:00,Phenotype,G05.695
23359698,2013-01-28T00:00:00,Steroid 21-Hydroxylase,D08.244.453.915.760
23359698,2013-01-28T00:00:00,Steroid 21-Hydroxylase,D08.811.682.690.708.170.915.760
23359698,2013-01-28T00:00:00,Steroid 21-Hydroxylase,D08.811.682.690.708.783.760
23359698,2013-01-28T00:00:00,Steroid 21-Hydroxylase,D12.776.422.220.453.915.760
23356584,2013-01-29T00:00:00,Adolescent,M01.060.057
23356584,2013-01-29T00:00:00,Adult,M01.060.116
23356584,2013-01-29T00:00:00,Age Factors,N05.715.350.075
23356584,2013-01-29T00:00:00,Age Factors,N06.850.490.250
23356584,2013-01-29T00:00:00,"Bile Ducts, Intrahepatic",A03.159.183.158
23356584,2013-01-29T00:00:00,"Bile Ducts, Intrahepatic",A03.620.150
23356584,2013-01-29T00:00:00,Biological Markers,D23.101
23356584,2013-01-29T00:00:00,Cell Proliferation,G04.299.233.750
23356584,2013-01-29T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23356584,2013-01-29T00:00:00,Child,M01.060.406
23356584,2013-01-29T00:00:00,"Child, Preschool",M01.060.406.448
23356584,2013-01-29T00:00:00,Fatty Liver,C06.552.241
23356584,2013-01-29T00:00:00,Gastric Bypass,E02.065.062.249
23356584,2013-01-29T00:00:00,Gastric Bypass,E04.035.398.385
23356584,2013-01-29T00:00:00,Gastric Bypass,E04.062.249
23356584,2013-01-29T00:00:00,Gastric Bypass,E04.210.457.430
23356584,2013-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23356584,2013-01-29T00:00:00,Liver,A03.620
23356584,2013-01-29T00:00:00,Liver Cirrhosis,C06.552.630
23356584,2013-01-29T00:00:00,Risk Factors,E05.318.740.600.800.725
23356584,2013-01-29T00:00:00,Risk Factors,N05.715.350.200.700
23356584,2013-01-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23356584,2013-01-29T00:00:00,Risk Factors,N06.850.490.625.750
23356584,2013-01-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23356584,2013-01-29T00:00:00,Stem Cells,A11.872
23356584,2013-01-29T00:00:00,Treatment Outcome,E01.789.800
23356584,2013-01-29T00:00:00,Treatment Outcome,N04.761.559.590.800
23356584,2013-01-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23358790,2013-01-29T00:00:00,Disease-Free Survival,E01.789.200
23358790,2013-01-29T00:00:00,Disease-Free Survival,E05.318.740.998.300
23358790,2013-01-29T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
23358790,2013-01-29T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
23358790,2013-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23358790,2013-01-29T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23358790,2013-01-29T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23358790,2013-01-29T00:00:00,Prostatectomy,E04.950.774.860.625
23358790,2013-01-29T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23358790,2013-01-29T00:00:00,Prostatic Neoplasms,C12.294.260.750
23358790,2013-01-29T00:00:00,Prostatic Neoplasms,C12.294.565.625
23358790,2013-01-29T00:00:00,Prostatic Neoplasms,C12.758.409.750
23358790,2013-01-29T00:00:00,Risk Factors,E05.318.740.600.800.725
23358790,2013-01-29T00:00:00,Risk Factors,N05.715.350.200.700
23358790,2013-01-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23358790,2013-01-29T00:00:00,Risk Factors,N06.850.490.625.750
23358790,2013-01-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23358790,2013-01-29T00:00:00,Salvage Therapy,E02.186.800
23358790,2013-01-29T00:00:00,Salvage Therapy,E02.895
23358790,2013-01-29T00:00:00,Treatment Outcome,E01.789.800
23358790,2013-01-29T00:00:00,Treatment Outcome,N04.761.559.590.800
23358790,2013-01-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23358790,2013-01-29T00:00:00,Urinary Incontinence,C12.777.934.852
23358790,2013-01-29T00:00:00,Urinary Incontinence,C13.351.968.934.814
23358790,2013-01-29T00:00:00,Urinary Incontinence,C23.888.942.800
23360332,2013-01-29T00:00:00,Diffusion of Innovation,L01.143.320
23360332,2013-01-29T00:00:00,"Hospitals, Rural",N02.278.421.518
23360332,2013-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23360332,2013-01-29T00:00:00,"Medical Staff, Hospital",M01.526.485.630.490
23360332,2013-01-29T00:00:00,"Medical Staff, Hospital",M01.526.485.740.422
23360332,2013-01-29T00:00:00,"Medical Staff, Hospital",N02.360.630.490
23360332,2013-01-29T00:00:00,"Medical Staff, Hospital",N02.360.740.422
23360332,2013-01-29T00:00:00,Qualitative Research,H01.770.644.241.850
23360332,2013-01-29T00:00:00,Questionnaires,E05.318.308.750
23360332,2013-01-29T00:00:00,Questionnaires,L01.280.800
23360332,2013-01-29T00:00:00,Questionnaires,N05.715.360.300.695
23360332,2013-01-29T00:00:00,Questionnaires,N06.850.520.308.750
23360332,2013-01-29T00:00:00,South Carolina,Z01.107.567.875.075.662
23360332,2013-01-29T00:00:00,South Carolina,Z01.107.567.875.750.700
23360332,2013-01-29T00:00:00,Telemedicine,H02.403.840
23360332,2013-01-29T00:00:00,Telemedicine,L01.178.847.652
23360332,2013-01-29T00:00:00,Telemedicine,N04.590.374.800
23360446,2013-01-29T00:00:00,Animals,B01.050
23360446,2013-01-29T00:00:00,Central Nervous System Stimulants,D27.505.696.282
23360446,2013-01-29T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
23360446,2013-01-29T00:00:00,Cocaine,D02.145.074.722.388
23360446,2013-01-29T00:00:00,Cocaine,D03.132.889.354
23360446,2013-01-29T00:00:00,Cocaine,D03.605.869.388
23360446,2013-01-29T00:00:00,Cocaine,D04.075.080.875.099.722.388
23360446,2013-01-29T00:00:00,Dopamine,D02.092.211.215.311.342
23360446,2013-01-29T00:00:00,Dopamine,D02.092.311.342
23360446,2013-01-29T00:00:00,Gene Expression,G05.355.310
23360446,2013-01-29T00:00:00,Glutamic Acid,D12.125.067.750
23360446,2013-01-29T00:00:00,Glutamic Acid,D12.125.119.450
23360446,2013-01-29T00:00:00,Glutamic Acid,D12.125.427.300
23360446,2013-01-29T00:00:00,Locomotion,G07.700.560.500
23360446,2013-01-29T00:00:00,Locomotion,G11.427.590.530.568
23360446,2013-01-29T00:00:00,Neurons,A08.663
23360446,2013-01-29T00:00:00,Neurons,A11.671
23360446,2013-01-29T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23360446,2013-01-29T00:00:00,Protein Transport,G03.495.166.700
23360446,2013-01-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23360446,2013-01-29T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
23360446,2013-01-29T00:00:00,"Restraint, Physical",E02.085.700
23360446,2013-01-29T00:00:00,"Restraint, Physical",E05.472.760
23360446,2013-01-29T00:00:00,"Stress, Psychological",F01.145.126.990
23360446,2013-01-29T00:00:00,"Stress, Psychological",F02.830.900
23361518,2013-01-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23361518,2013-01-29T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23361518,2013-01-29T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23361518,2013-01-29T00:00:00,Parotid Gland,A03.556.500.760.464
23361518,2013-01-29T00:00:00,Parotid Gland,A10.336.779.464
23361518,2013-01-29T00:00:00,Parotid Gland,A14.549.760.464
23361518,2013-01-29T00:00:00,Parotid Neoplasms,C04.588.443.591.824.695
23361518,2013-01-29T00:00:00,Parotid Neoplasms,C07.465.565.824.695
23361518,2013-01-29T00:00:00,Parotid Neoplasms,C07.465.815.470.770
23361518,2013-01-29T00:00:00,Parotid Neoplasms,C07.465.815.718.589
23327468,2013-01-30T00:00:00,Cell Line,A11.251.210
23327468,2013-01-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23327468,2013-01-30T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
23327468,2013-01-30T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23327468,2013-01-30T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23327468,2013-01-30T00:00:00,Oxidative Stress,G03.495.710
23327468,2013-01-30T00:00:00,Oxidative Stress,G07.700.830.750
23327468,2013-01-30T00:00:00,Vitamin K,D02.455.426.559.847.638.721.374
23327468,2013-01-30T00:00:00,Vitamin K,D02.455.849.291.523.500
23327468,2013-01-30T00:00:00,Vitamin K,D04.615.638.721.374
23361338,2013-01-30T00:00:00,Adolescent,M01.060.057
23361338,2013-01-30T00:00:00,Adult,M01.060.116
23361338,2013-01-30T00:00:00,Breast Neoplasms,C04.588.180
23361338,2013-01-30T00:00:00,Breast Neoplasms,C17.800.090.500
23361338,2013-01-30T00:00:00,Dietary Supplements,J02.500.456
23361338,2013-01-30T00:00:00,Ethnic Groups,M01.686.754
23361338,2013-01-30T00:00:00,Ethnic Groups,N01.224.317
23361338,2013-01-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23361338,2013-01-30T00:00:00,Middle Aged,M01.060.116.630
23361338,2013-01-30T00:00:00,Risk Factors,E05.318.740.600.800.725
23361338,2013-01-30T00:00:00,Risk Factors,N05.715.350.200.700
23361338,2013-01-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23361338,2013-01-30T00:00:00,Risk Factors,N06.850.490.625.750
23361338,2013-01-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23361338,2013-01-30T00:00:00,Vitamin D,D04.808.812.768
23361338,2013-01-30T00:00:00,Young Adult,M01.060.116.815
23361932,2013-01-30T00:00:00,Animals,B01.050
23361932,2013-01-30T00:00:00,Chondrocytes,A11.329.171
23361932,2013-01-30T00:00:00,Disease Progression,C23.550.291.656
23361932,2013-01-30T00:00:00,Fibrosis,C23.550.355
23361932,2013-01-30T00:00:00,Hematoma,C23.550.414.838
23361932,2013-01-30T00:00:00,Hip Joint,A02.835.583.411
23361932,2013-01-30T00:00:00,"Muscle, Skeletal",A02.633.567
23361932,2013-01-30T00:00:00,"Muscle, Skeletal",A10.690.552.500
23361932,2013-01-30T00:00:00,"Ossification, Heterotopic",C23.550.751
23361932,2013-01-30T00:00:00,Rabbits,B01.050.150.900.649.521.700
23383213,2013-01-30T00:00:00,Alligators and Crocodiles,B01.050.150.900.833.100
23383213,2013-01-30T00:00:00,Animals,B01.050
23383213,2013-01-30T00:00:00,Rivers,G01.311.750
23383213,2013-01-30T00:00:00,Rivers,G16.500.275.280.500
23383213,2013-01-30T00:00:00,Rivers,N06.230.232.500
23370205,2013-01-31T00:00:00,Algorithms,G17.035
23370205,2013-01-31T00:00:00,Algorithms,L01.224.050
23370205,2013-01-31T00:00:00,American Heart Association,N03.540.630.780.110
23370205,2013-01-31T00:00:00,Disease Management,N04.590.607
23370205,2013-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23370205,2013-01-31T00:00:00,"Societies, Medical",N03.540.828.589
23370205,2013-01-31T00:00:00,Stroke,C10.228.140.300.775
23370205,2013-01-31T00:00:00,Stroke,C14.907.253.855
23370205,2013-01-31T00:00:00,United States,Z01.107.567.875
23371937,2013-01-31T00:00:00,Adult,M01.060.116
23371937,2013-01-31T00:00:00,Disease Management,N04.590.607
23371937,2013-01-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23371937,2013-01-31T00:00:00,Middle Aged,M01.060.116.630
23371937,2013-01-31T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
23371937,2013-01-31T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
23371937,2013-01-31T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
23371937,2013-01-31T00:00:00,Treatment Outcome,E01.789.800
23371937,2013-01-31T00:00:00,Treatment Outcome,N04.761.559.590.800
23371937,2013-01-31T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22647828,2013-02-01T00:00:00,Adult,M01.060.116
22647828,2013-02-01T00:00:00,Aged,M01.060.116.100
22647828,2013-02-01T00:00:00,Artifacts,E05.047
22647828,2013-02-01T00:00:00,Clinical Competence,I02.399.630.210
22647828,2013-02-01T00:00:00,Clinical Competence,N04.761.210
22647828,2013-02-01T00:00:00,Deglutition,G10.261.326.215
22647828,2013-02-01T00:00:00,Deglutition Disorders,C06.405.117.119
22647828,2013-02-01T00:00:00,Deglutition Disorders,C09.775.174
22647828,2013-02-01T00:00:00,Esophagus,A03.556.875.500
22647828,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22647828,2013-02-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
22647828,2013-02-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
22647828,2013-02-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
22647828,2013-02-01T00:00:00,Internship and Residency,I02.358.399.644
22647828,2013-02-01T00:00:00,Manometry,E05.559
22647828,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
22647828,2013-02-01T00:00:00,Pressure,G01.374.715
22878834,2013-02-01T00:00:00,Bronchoscopy,E01.370.386.105
22878834,2013-02-01T00:00:00,Bronchoscopy,E01.370.388.250.100
22878834,2013-02-01T00:00:00,Bronchoscopy,E04.800.250.100
22878834,2013-02-01T00:00:00,Bronchoscopy,E04.928.600.080
22878834,2013-02-01T00:00:00,Clinical Competence,I02.399.630.210
22878834,2013-02-01T00:00:00,Clinical Competence,N04.761.210
22878834,2013-02-01T00:00:00,Critical Care,E02.760.190
22878834,2013-02-01T00:00:00,Critical Care,N02.421.585.190
22878834,2013-02-01T00:00:00,Data Collection,E05.318.308
22878834,2013-02-01T00:00:00,Data Collection,L01.280
22878834,2013-02-01T00:00:00,Data Collection,N05.715.360.300
22878834,2013-02-01T00:00:00,Data Collection,N06.850.520.308
22878834,2013-02-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
22878834,2013-02-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
22878834,2013-02-01T00:00:00,Endosonography,E01.370.350.850.280
22878834,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22878834,2013-02-01T00:00:00,Patient Simulation,I02.903.525
22878834,2013-02-01T00:00:00,United States,Z01.107.567.875
22902607,2013-02-01T00:00:00,Anesthesiology,H02.403.066
22902607,2013-02-01T00:00:00,Computer Simulation,L01.224.160
22902607,2013-02-01T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
22902607,2013-02-01T00:00:00,Educational Measurement,I02.399
22902607,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22902607,2013-02-01T00:00:00,Internal Medicine,H02.403.429
22902607,2013-02-01T00:00:00,"Intubation, Intratracheal",E05.497.578
22902607,2013-02-01T00:00:00,Masks,E07.700.500
22902607,2013-02-01T00:00:00,Masks,J01.637.708.500
22902607,2013-02-01T00:00:00,"Medical Staff, Hospital",M01.526.485.630.490
22902607,2013-02-01T00:00:00,"Medical Staff, Hospital",M01.526.485.740.422
22902607,2013-02-01T00:00:00,"Medical Staff, Hospital",N02.360.630.490
22902607,2013-02-01T00:00:00,"Medical Staff, Hospital",N02.360.740.422
22902607,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
22902607,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23039284,2013-02-01T00:00:00,Animals,B01.050
23039284,2013-02-01T00:00:00,Autoimmunity,G12.450.192
23039284,2013-02-01T00:00:00,B-Lymphocytes,A11.063.438
23039284,2013-02-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
23039284,2013-02-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
23039284,2013-02-01T00:00:00,B-Lymphocytes,A15.382.032.438
23039284,2013-02-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
23039284,2013-02-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
23039284,2013-02-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
23039284,2013-02-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
23039284,2013-02-01T00:00:00,Disease Progression,C23.550.291.656
23039284,2013-02-01T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23039284,2013-02-01T00:00:00,Flow Cytometry,E05.200.500.386.350
23039284,2013-02-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23039284,2013-02-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23039284,2013-02-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23039284,2013-02-01T00:00:00,Quinazolines,D03.438.786
23138547,2013-02-01T00:00:00,Adult,M01.060.116
23138547,2013-02-01T00:00:00,Brain,A08.186.211
23138547,2013-02-01T00:00:00,Brain Injuries,C10.228.140.199
23138547,2013-02-01T00:00:00,Brain Injuries,C10.900.300.087
23138547,2013-02-01T00:00:00,Brain Injuries,C21.866.260.118
23138547,2013-02-01T00:00:00,Brain Injuries,C21.866.915.300.200
23138547,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23138547,2013-02-01T00:00:00,Intracranial Pressure,G11.561.170.505
23138547,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23138547,2013-02-01T00:00:00,"Monitoring, Physiologic",E01.370.520
23138547,2013-02-01T00:00:00,Oxygen,D01.268.185.550
23138547,2013-02-01T00:00:00,Oxygen,D01.362.670
23138547,2013-02-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
23138547,2013-02-01T00:00:00,Trauma Centers,N02.421.297.195.480
23138547,2013-02-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
23138547,2013-02-01T00:00:00,Treatment Outcome,E01.789.800
23138547,2013-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23138547,2013-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23138547,2013-02-01T00:00:00,Young Adult,M01.060.116.815
23178069,2013-02-01T00:00:00,Breast Feeding,G07.610.220.500.500
23178069,2013-02-01T00:00:00,Breast Feeding,G07.610.593.185
23178069,2013-02-01T00:00:00,Breast Feeding,G07.700.620.185
23178069,2013-02-01T00:00:00,Diet,E05.272
23178069,2013-02-01T00:00:00,Diet,G07.610.240
23178069,2013-02-01T00:00:00,Dietary Proteins,D12.776.256
23178069,2013-02-01T00:00:00,Dietary Proteins,J02.500.428
23178069,2013-02-01T00:00:00,Dietary Supplements,J02.500.456
23178069,2013-02-01T00:00:00,Energy Intake,G07.610.240.340
23178069,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23178069,2013-02-01T00:00:00,Infant,M01.060.703
23178069,2013-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
23178069,2013-02-01T00:00:00,Lactation,G08.686.702.500
23178069,2013-02-01T00:00:00,Lactation,G08.686.785.420
23178069,2013-02-01T00:00:00,"Milk, Human",A12.200.467
23178069,2013-02-01T00:00:00,"Milk, Human",J02.200.700.500
23178069,2013-02-01T00:00:00,"Milk, Human",J02.500.350.525.500
23222499,2013-02-01T00:00:00,Adolescent,M01.060.057
23222499,2013-02-01T00:00:00,Adult,M01.060.116
23222499,2013-02-01T00:00:00,African Americans,M01.686.508.100.100
23222499,2013-02-01T00:00:00,African Americans,M01.686.754.100
23222499,2013-02-01T00:00:00,Aged,M01.060.116.100
23222499,2013-02-01T00:00:00,Delivery of Health Care,N04.590.374
23222499,2013-02-01T00:00:00,Delivery of Health Care,N05.300
23222499,2013-02-01T00:00:00,Demography,I01.240
23222499,2013-02-01T00:00:00,Demography,N01.224
23222499,2013-02-01T00:00:00,Demography,N06.850.505.400
23222499,2013-02-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23222499,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23222499,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23222499,2013-02-01T00:00:00,Questionnaires,E05.318.308.750
23222499,2013-02-01T00:00:00,Questionnaires,L01.280.800
23222499,2013-02-01T00:00:00,Questionnaires,N05.715.360.300.695
23222499,2013-02-01T00:00:00,Questionnaires,N06.850.520.308.750
23222499,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23222499,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23222499,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23222499,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23222499,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23222499,2013-02-01T00:00:00,United States,Z01.107.567.875
23241566,2013-02-01T00:00:00,Blood Pressure,E01.370.600.875.249
23241566,2013-02-01T00:00:00,Blood Pressure,G09.330.380.076
23241566,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23241566,2013-02-01T00:00:00,Hypertension,C14.907.489
23241566,2013-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23241566,2013-02-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23241566,2013-02-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23241566,2013-02-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23241566,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23241566,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23241566,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23241566,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23241566,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23241566,2013-02-01T00:00:00,Stroke,C10.228.140.300.775
23241566,2013-02-01T00:00:00,Stroke,C14.907.253.855
23254556,2013-02-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23254556,2013-02-01T00:00:00,Clinical Trials as Topic,E05.337.250
23254556,2013-02-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23254556,2013-02-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23254556,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23254556,2013-02-01T00:00:00,Neuronal Plasticity,G11.561.600.635
23254556,2013-02-01T00:00:00,Recovery of Function,G16.757
23254556,2013-02-01T00:00:00,Stroke,C10.228.140.300.775
23254556,2013-02-01T00:00:00,Stroke,C14.907.253.855
23254556,2013-02-01T00:00:00,Treatment Outcome,E01.789.800
23254556,2013-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23254556,2013-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23300312,2013-02-01T00:00:00,Animals,B01.050
23300312,2013-02-01T00:00:00,Antioxidants,D27.505.519.217
23300312,2013-02-01T00:00:00,Antioxidants,D27.505.696.706.125
23300312,2013-02-01T00:00:00,Antioxidants,D27.720.799.047
23300312,2013-02-01T00:00:00,Chickens,B01.050.150.900.248.350.150
23300312,2013-02-01T00:00:00,Chickens,B01.050.150.900.248.617.192
23303356,2013-02-01T00:00:00,Aged,M01.060.116.100
23303356,2013-02-01T00:00:00,Health Behavior,F01.145.488
23303356,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23303356,2013-02-01T00:00:00,Hypertension,C14.907.489
23303356,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23329057,2013-02-01T00:00:00,Adenoidectomy,E04.580.068
23329057,2013-02-01T00:00:00,Continuous Positive Airway Pressure,E02.880.820.790.259
23329057,2013-02-01T00:00:00,Craniofacial Abnormalities,C05.660.207
23329057,2013-02-01T00:00:00,Craniofacial Abnormalities,C16.131.621.207
23329057,2013-02-01T00:00:00,Down Syndrome,C10.597.606.643.220
23329057,2013-02-01T00:00:00,Down Syndrome,C16.131.077.327
23329057,2013-02-01T00:00:00,Down Syndrome,C16.131.260.260
23329057,2013-02-01T00:00:00,Down Syndrome,C16.320.180.260
23329057,2013-02-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
23329057,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23329057,2013-02-01T00:00:00,Infant,M01.060.703
23329057,2013-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
23329057,2013-02-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23329057,2013-02-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23329057,2013-02-01T00:00:00,Polysomnography,E01.370.520.625
23329057,2013-02-01T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
23329057,2013-02-01T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
23329057,2013-02-01T00:00:00,Tonsillectomy,E04.580.848
23329057,2013-02-01T00:00:00,Tracheostomy,E04.579.935
23329057,2013-02-01T00:00:00,Tracheostomy,E04.580.900
23329057,2013-02-01T00:00:00,Tracheostomy,E04.928.780
23331442,2013-02-01T00:00:00,Aged,M01.060.116.100
23331442,2013-02-01T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
23331442,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23331442,2013-02-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
23331442,2013-02-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
23331442,2013-02-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
23331442,2013-02-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
23331442,2013-02-01T00:00:00,Renin-Angiotensin System,G03.495.805
23331442,2013-02-01T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
23332327,2013-02-01T00:00:00,Adult,M01.060.116
23332327,2013-02-01T00:00:00,African Americans,M01.686.508.100.100
23332327,2013-02-01T00:00:00,African Americans,M01.686.754.100
23332327,2013-02-01T00:00:00,Aged,M01.060.116.100
23332327,2013-02-01T00:00:00,Community-Based Participatory Research,N05.425.104
23332327,2013-02-01T00:00:00,Diet,E05.272
23332327,2013-02-01T00:00:00,Diet,G07.610.240
23332327,2013-02-01T00:00:00,Health Behavior,F01.145.488
23332327,2013-02-01T00:00:00,Health Promotion,N02.370
23332327,2013-02-01T00:00:00,Health Promotion,N02.421.726.507
23332327,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23332327,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23332327,2013-02-01T00:00:00,Motor Activity,F01.145.632
23332327,2013-02-01T00:00:00,Motor Activity,G11.427.590.530.698
23332327,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23332327,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23336644,2013-02-01T00:00:00,Cutaneous Fistula,C17.800.135
23336644,2013-02-01T00:00:00,Cutaneous Fistula,C23.300.575.150
23336644,2013-02-01T00:00:00,"Diagnosis, Differential",E01.171
23336644,2013-02-01T00:00:00,"Diverticulitis, Colonic",C06.405.469.158.587.500
23336644,2013-02-01T00:00:00,"Hernia, Inguinal",C23.300.707.374.875
23336644,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23336644,2013-02-01T00:00:00,Intestinal Fistula,C06.267.550
23336644,2013-02-01T00:00:00,Intestinal Fistula,C06.405.469.471
23336644,2013-02-01T00:00:00,Intestinal Fistula,C23.300.575.185.550
23336644,2013-02-01T00:00:00,Intestinal Perforation,C06.405.469.557
23336644,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23336899,2013-02-01T00:00:00,Clinical Competence,I02.399.630.210
23336899,2013-02-01T00:00:00,Clinical Competence,N04.761.210
23336899,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23336899,2013-02-01T00:00:00,Informed Consent,I01.880.604.473.650.718
23336899,2013-02-01T00:00:00,Informed Consent,I01.880.604.583.427
23336899,2013-02-01T00:00:00,Informed Consent,N03.706.437.650.312
23336899,2013-02-01T00:00:00,Informed Consent,N03.706.535.489
23336899,2013-02-01T00:00:00,"Specialties, Surgical",H02.403.810
23336901,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23336901,2013-02-01T00:00:00,Tissue Donors,M01.898
23345347,2013-02-01T00:00:00,Breast Neoplasms,C04.588.180
23345347,2013-02-01T00:00:00,Breast Neoplasms,C17.800.090.500
23345347,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23345347,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
23345347,2013-02-01T00:00:00,"Receptor, erbB-2",D23.101.840.642
23345347,2013-02-01T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
23345347,2013-02-01T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
23345347,2013-02-01T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
23345347,2013-02-01T00:00:00,"Tumor Markers, Biological",D23.101.840
23345347,2013-02-01T00:00:00,"Ultrasonography, Mammary",E01.370.350.850.860
23345347,2013-02-01T00:00:00,"Ultrasonography, Mammary",E01.370.378.850
23354237,2013-02-01T00:00:00,Adult,M01.060.116
23354237,2013-02-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23354237,2013-02-01T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
23354237,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23354237,2013-02-01T00:00:00,Intensive Care Units,N02.278.388.493
23354237,2013-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C01.539.248.500
23354237,2013-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.520.750.750
23354237,2013-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.381.677.800
23354237,2013-02-01T00:00:00,"Pneumonia, Ventilator-Associated",C08.730.610.750
23354237,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23354237,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23354237,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23354237,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23354237,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23360855,2013-02-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23360855,2013-02-01T00:00:00,Cross Infection,C01.539.248
23360855,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23360855,2013-02-01T00:00:00,Infant,M01.060.703
23360855,2013-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
23360855,2013-02-01T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
23360855,2013-02-01T00:00:00,"Intensive Care, Neonatal",E02.760.190.400.405
23360855,2013-02-01T00:00:00,"Intensive Care, Neonatal",N02.421.088.120.120
23360855,2013-02-01T00:00:00,"Intensive Care, Neonatal",N02.421.585.190.400.405
23360855,2013-02-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
23360855,2013-02-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
23360855,2013-02-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23360855,2013-02-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23360855,2013-02-01T00:00:00,Program Evaluation,E05.337.820
23360855,2013-02-01T00:00:00,Program Evaluation,N04.761.685
23360855,2013-02-01T00:00:00,Program Evaluation,N05.715.360.650
23373750,2013-02-01T00:00:00,Animals,B01.050
23373750,2013-02-01T00:00:00,Bone Screws,E07.695.130
23373750,2013-02-01T00:00:00,Bone Screws,E07.858.442.660.115
23373750,2013-02-01T00:00:00,Bone Screws,E07.858.690.650.115
23373750,2013-02-01T00:00:00,Bone and Bones,A02.835.232
23373750,2013-02-01T00:00:00,Bone and Bones,A10.165.265
23373750,2013-02-01T00:00:00,Equipment Failure,E05.325
23373750,2013-02-01T00:00:00,Weight-Bearing,G01.374.676.965
23373750,2013-02-01T00:00:00,Weight-Bearing,G01.595.540.965
23375850,2013-02-01T00:00:00,Animals,B01.050
23375850,2013-02-01T00:00:00,Cardiovascular Diseases,C14
23375850,2013-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23375850,2013-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23375850,2013-02-01T00:00:00,Diabetic Angiopathies,C14.907.320
23375850,2013-02-01T00:00:00,Diabetic Angiopathies,C19.246.099.500
23375850,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23375850,2013-02-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
23375850,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23375850,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23375850,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23375850,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23375850,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23378075,2013-02-01T00:00:00,Adolescent,M01.060.057
23378075,2013-02-01T00:00:00,Adult,M01.060.116
23378075,2013-02-01T00:00:00,Family Practice,H02.403.280
23378075,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23378075,2013-02-01T00:00:00,Internship and Residency,I02.358.399.644
23378075,2013-02-01T00:00:00,Papillomavirus Infections,C02.256.650
23378075,2013-02-01T00:00:00,Papillomavirus Infections,C02.928.725
23378075,2013-02-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
23378075,2013-02-01T00:00:00,Physician's Practice Patterns,N04.590.748
23378075,2013-02-01T00:00:00,Physician's Practice Patterns,N05.300.625
23378075,2013-02-01T00:00:00,Questionnaires,E05.318.308.750
23378075,2013-02-01T00:00:00,Questionnaires,L01.280.800
23378075,2013-02-01T00:00:00,Questionnaires,N05.715.360.300.695
23378075,2013-02-01T00:00:00,Questionnaires,N06.850.520.308.750
23378075,2013-02-01T00:00:00,Sex Factors,N05.715.350.675
23378075,2013-02-01T00:00:00,Sex Factors,N06.850.490.875
23378075,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23378075,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23378393,2013-02-01T00:00:00,Cadaver,C23.550.260.224
23378393,2013-02-01T00:00:00,Cleft Palate,C05.500.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C05.660.207.540.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C07.320.440.185
23378393,2013-02-01T00:00:00,Cleft Palate,C07.465.525.185
23378393,2013-02-01T00:00:00,Cleft Palate,C07.650.500.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C07.650.525.185
23378393,2013-02-01T00:00:00,Cleft Palate,C16.131.621.207.540.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C16.131.850.500.460.185
23378393,2013-02-01T00:00:00,Cleft Palate,C16.131.850.525.185
23378393,2013-02-01T00:00:00,Endosonography,E01.370.350.850.280
23378393,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23378431,2013-02-01T00:00:00,Brain Ischemia,C10.228.140.300.150
23378431,2013-02-01T00:00:00,Brain Ischemia,C14.907.253.092
23378431,2013-02-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23378431,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23378431,2013-02-01T00:00:00,Stroke,C10.228.140.300.775
23378431,2013-02-01T00:00:00,Stroke,C14.907.253.855
23378431,2013-02-01T00:00:00,Thrombectomy,E04.100.814.842
23378431,2013-02-01T00:00:00,Treatment Outcome,E01.789.800
23378431,2013-02-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23378431,2013-02-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23382526,2013-02-01T00:00:00,Crowns,E06.323.428.100
23382526,2013-02-01T00:00:00,Crowns,E06.323.528.250
23382526,2013-02-01T00:00:00,Crowns,E06.780.345.250
23382526,2013-02-01T00:00:00,Crowns,E06.780.345.737.100
23382526,2013-02-01T00:00:00,Crowns,E07.695.190.190.150
23382526,2013-02-01T00:00:00,"Education, Dental",I02.358.274
23382526,2013-02-01T00:00:00,Educational Measurement,I02.399
23382526,2013-02-01T00:00:00,Educational Technology,J01.897.280
23382526,2013-02-01T00:00:00,"Faculty, Dental",I02.463.273
23382526,2013-02-01T00:00:00,"Faculty, Dental",M01.526.339.273
23382526,2013-02-01T00:00:00,"Faculty, Dental",M01.526.485.360
23382526,2013-02-01T00:00:00,"Faculty, Dental",N02.360.360
23382526,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23382526,2013-02-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
23382526,2013-02-01T00:00:00,Software,L01.224.900
23382526,2013-02-01T00:00:00,User-Computer Interface,L01.224.900.910
23385174,2013-02-01T00:00:00,Aged,M01.060.116.100
23385174,2013-02-01T00:00:00,Aging,G07.700.320.124
23385174,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23385174,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23385174,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23385174,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23385174,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23385174,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23385174,2013-02-01T00:00:00,Skin,A17.815
23386592,2013-02-01T00:00:00,Adverse Drug Reaction Reporting Systems,E05.337.800.120
23386592,2013-02-01T00:00:00,Adverse Drug Reaction Reporting Systems,L01.453.270.120
23386592,2013-02-01T00:00:00,Adverse Drug Reaction Reporting Systems,N02.421.668.320.120
23386592,2013-02-01T00:00:00,Evidence-Based Medicine,H02.249.750
23386592,2013-02-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23386592,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23402449,2013-02-01T00:00:00,Depression,F01.145.126.350
23402449,2013-02-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23402449,2013-02-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23402449,2013-02-01T00:00:00,Health Care Costs,N03.219.151.400
23402449,2013-02-01T00:00:00,Health Care Costs,N05.300.375
23402449,2013-02-01T00:00:00,Health Expenditures,N03.219.151.450
23402449,2013-02-01T00:00:00,Health Expenditures,N05.300.385
23402449,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23402449,2013-02-01T00:00:00,Prevalence,E05.318.308.985.525.750
23402449,2013-02-01T00:00:00,Prevalence,L01.280.975.525.750
23402449,2013-02-01T00:00:00,Prevalence,N01.224.935.597.750
23402449,2013-02-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
23402449,2013-02-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
23402449,2013-02-01T00:00:00,Quality of Life,I01.800
23402449,2013-02-01T00:00:00,Quality of Life,K01.752.400.750
23404872,2013-02-01T00:00:00,Adult,M01.060.116
23404872,2013-02-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
23404872,2013-02-01T00:00:00,Body Mass Index,E05.041.124.125
23404872,2013-02-01T00:00:00,Body Mass Index,G07.100.100.125
23404872,2013-02-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
23404872,2013-02-01T00:00:00,Case-Control Studies,E05.318.760.500.500
23404872,2013-02-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23404872,2013-02-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23404872,2013-02-01T00:00:00,Continental Population Groups,M01.686.508
23404872,2013-02-01T00:00:00,Fetus,A16.378
23404872,2013-02-01T00:00:00,Folic Acid,D03.438.733.631.400
23404872,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23404872,2013-02-01T00:00:00,Infant,M01.060.703
23404872,2013-02-01T00:00:00,"Infant, Newborn",M01.060.703.520
23404872,2013-02-01T00:00:00,Neural Tube Defects,C10.500.680
23404872,2013-02-01T00:00:00,Neural Tube Defects,C16.131.666.680
23404872,2013-02-01T00:00:00,Obesity,C18.654.726.500
23404872,2013-02-01T00:00:00,Obesity,C23.888.144.699.500
23404872,2013-02-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23404872,2013-02-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23404872,2013-02-01T00:00:00,Pregnancy,G08.686.785.760.769
23404872,2013-02-01T00:00:00,Questionnaires,E05.318.308.750
23404872,2013-02-01T00:00:00,Questionnaires,L01.280.800
23404872,2013-02-01T00:00:00,Questionnaires,N05.715.360.300.695
23404872,2013-02-01T00:00:00,Questionnaires,N06.850.520.308.750
23404872,2013-02-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23404872,2013-02-01T00:00:00,Risk Factors,N05.715.350.200.700
23404872,2013-02-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23404872,2013-02-01T00:00:00,Risk Factors,N06.850.490.625.750
23404872,2013-02-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23404872,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23404872,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23414498,2013-02-01T00:00:00,"Feedback, Psychological",F01.058.288
23414498,2013-02-01T00:00:00,"Feedback, Psychological",F04.754.308
23414498,2013-02-01T00:00:00,"Feedback, Psychological",L01.143.283.425.624
23414498,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23414498,2013-02-01T00:00:00,Mental Disorders,F03
23414498,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23414498,2013-02-01T00:00:00,Motivation,F01.658
23414498,2013-02-01T00:00:00,Motivation,F01.752.543.500.750
23414498,2013-02-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
23414498,2013-02-01T00:00:00,Substance-Related Disorders,C21.739
23414498,2013-02-01T00:00:00,Substance-Related Disorders,F03.900
23414498,2013-02-01T00:00:00,Veterans,M01.930
23513557,2013-02-01T00:00:00,Aged,M01.060.116.100
23513557,2013-02-01T00:00:00,"Diagnosis, Differential",E01.171
23513557,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C04.557.337.428.565.750
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C04.557.337.428.580.125
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C15.604.515.560.550.750
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C15.604.515.560.575.125
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C20.683.515.528.565.750
23513557,2013-02-01T00:00:00,"Leukemia, Prolymphocytic, T-Cell",C20.683.515.528.582.125
23513557,2013-02-01T00:00:00,Skin Neoplasms,C04.588.805
23513557,2013-02-01T00:00:00,Skin Neoplasms,C17.800.882
23539894,2013-02-01T00:00:00,African Americans,M01.686.508.100.100
23539894,2013-02-01T00:00:00,African Americans,M01.686.754.100
23539894,2013-02-01T00:00:00,Aged,M01.060.116.100
23539894,2013-02-01T00:00:00,Attitude to Health,F01.100.150
23539894,2013-02-01T00:00:00,Attitude to Health,N05.300.150
23539894,2013-02-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23539894,2013-02-01T00:00:00,Clinical Trials as Topic,E05.337.250
23539894,2013-02-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23539894,2013-02-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23539894,2013-02-01T00:00:00,Cultural Diversity,I01.076.201.450.350
23539894,2013-02-01T00:00:00,Cultural Diversity,I01.880.143.450
23539894,2013-02-01T00:00:00,Health Status Disparities,I01.240.425.675
23539894,2013-02-01T00:00:00,Health Status Disparities,N01.224.425.437
23539894,2013-02-01T00:00:00,Health Status Disparities,N06.850.505.400.425.675
23539894,2013-02-01T00:00:00,Hispanic Americans,M01.686.754.441
23539894,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23539894,2013-02-01T00:00:00,Middle Aged,M01.060.116.630
23539894,2013-02-01T00:00:00,Qualitative Research,H01.770.644.241.850
23539894,2013-02-01T00:00:00,Research Subjects,M01.774
23539894,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23539894,2013-02-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23546427,2013-02-01T00:00:00,Child,M01.060.406
23546427,2013-02-01T00:00:00,"Embolization, Therapeutic",E02.520.360
23546427,2013-02-01T00:00:00,Fontan Procedure,E04.035.410.295
23546427,2013-02-01T00:00:00,Fontan Procedure,E04.100.376.410.295
23546427,2013-02-01T00:00:00,Fontan Procedure,E04.928.220.370.295
23546427,2013-02-01T00:00:00,Hemoptysis,C08.381.348
23546427,2013-02-01T00:00:00,Hemoptysis,C23.550.414.896
23546427,2013-02-01T00:00:00,Hemoptysis,C23.888.852.430
23546427,2013-02-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23546427,2013-02-01T00:00:00,Postoperative Complications,C23.550.767
23380591,2013-02-03T00:00:00,Algorithms,G17.035
23380591,2013-02-03T00:00:00,Algorithms,L01.224.050
23380591,2013-02-03T00:00:00,Binding Sites,G02.111.570.120
23380591,2013-02-03T00:00:00,Internet,L01.224.230.110.500
23380591,2013-02-03T00:00:00,Proteins,D12.776
23380591,2013-02-03T00:00:00,Software,L01.224.900
23380591,2013-02-03T00:00:00,Static Electricity,G01.201.249.820
23379292,2013-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23379292,2013-02-04T00:00:00,Middle Aged,M01.060.116.630
23391444,2013-02-04T00:00:00,Animals,B01.050
23391444,2013-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23391444,2013-02-04T00:00:00,"Hyperthermia, Induced",E02.565
23391444,2013-02-04T00:00:00,"Hyperthermia, Induced",E02.779.496
23391444,2013-02-04T00:00:00,Lipids,D10
23391444,2013-02-04T00:00:00,Liposomes,D25.479.517
23391444,2013-02-04T00:00:00,Liposomes,D26.255.260.517
23391444,2013-02-04T00:00:00,Liposomes,D27.720.280.260.517
23391444,2013-02-04T00:00:00,Liposomes,J01.637.051.479.517
23391444,2013-02-04T00:00:00,Liposomes,J01.637.087.500.517
23391444,2013-02-04T00:00:00,Nanoparticles,J01.637.512.600
23391444,2013-02-04T00:00:00,Skin Neoplasms,C04.588.805
23391444,2013-02-04T00:00:00,Skin Neoplasms,C17.800.882
23501140,2013-02-04T00:00:00,Adolescent,M01.060.057
23501140,2013-02-04T00:00:00,Adult,M01.060.116
23501140,2013-02-04T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
23501140,2013-02-04T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
23501140,2013-02-04T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
23501140,2013-02-04T00:00:00,Child,M01.060.406
23501140,2013-02-04T00:00:00,Dental Clinics,N02.278.192.250
23501140,2013-02-04T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23501140,2013-02-04T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23501140,2013-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23501140,2013-02-04T00:00:00,Internet,L01.224.230.110.500
23501140,2013-02-04T00:00:00,Middle Aged,M01.060.116.630
23501140,2013-02-04T00:00:00,Patient Education as Topic,I02.233.332.500
23501140,2013-02-04T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
23501140,2013-02-04T00:00:00,Patient Education as Topic,N02.421.726.407.680
23501140,2013-02-04T00:00:00,Pilot Projects,E05.318.760.750
23501140,2013-02-04T00:00:00,Pilot Projects,E05.337.737
23501140,2013-02-04T00:00:00,Pilot Projects,N05.715.360.775.625
23501140,2013-02-04T00:00:00,Pilot Projects,N06.850.520.450.720
23501140,2013-02-04T00:00:00,Refuse Disposal,N06.850.780.200.800.800.700
23501140,2013-02-04T00:00:00,Refuse Disposal,N06.850.860.510.900.600
23501140,2013-02-04T00:00:00,Young Adult,M01.060.116.815
23680343,2013-02-04T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
23680343,2013-02-04T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
23680343,2013-02-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23680343,2013-02-04T00:00:00,Pediatrics,H02.403.670
23680343,2013-02-04T00:00:00,United States,Z01.107.567.875
23380680,2013-02-05T00:00:00,Adult,M01.060.116
23380680,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23380680,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23380680,2013-02-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23380680,2013-02-05T00:00:00,Risk Factors,N05.715.350.200.700
23380680,2013-02-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23380680,2013-02-05T00:00:00,Risk Factors,N06.850.490.625.750
23380680,2013-02-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23380680,2013-02-05T00:00:00,Spinal Cord Injuries,C10.228.854.770
23380680,2013-02-05T00:00:00,Spinal Cord Injuries,C10.900.850
23380680,2013-02-05T00:00:00,Spinal Cord Injuries,C21.866.819
23380680,2013-02-05T00:00:00,United States,Z01.107.567.875
23381105,2013-02-05T00:00:00,Adult,M01.060.116
23381105,2013-02-05T00:00:00,Equipment Failure,E05.325
23381105,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23381105,2013-02-05T00:00:00,"Hypertension, Portal",C06.552.494
23381105,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23381105,2013-02-05T00:00:00,Polytetrafluoroethylene,D05.750.395.616
23381105,2013-02-05T00:00:00,Polytetrafluoroethylene,D25.720.395.616
23381105,2013-02-05T00:00:00,Polytetrafluoroethylene,J01.637.051.720.395.616
23381105,2013-02-05T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.035.760.795
23381105,2013-02-05T00:00:00,"Portasystemic Shunt, Transjugular Intrahepatic",E04.100.814.790.830
23381105,2013-02-05T00:00:00,Reoperation,E04.690
23381105,2013-02-05T00:00:00,Stents,E07.695.750
23381105,2013-02-05T00:00:00,Treatment Outcome,E01.789.800
23381105,2013-02-05T00:00:00,Treatment Outcome,N04.761.559.590.800
23381105,2013-02-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23386625,2013-02-05T00:00:00,Aged,M01.060.116.100
23386625,2013-02-05T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23386625,2013-02-05T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23386625,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23386625,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23386625,2013-02-05T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
23386625,2013-02-05T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
23386625,2013-02-05T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
23386625,2013-02-05T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
23386625,2013-02-05T00:00:00,United States,Z01.107.567.875
23391523,2013-02-05T00:00:00,Adolescent,M01.060.057
23391523,2013-02-05T00:00:00,Adult,M01.060.116
23391523,2013-02-05T00:00:00,Aged,M01.060.116.100
23391523,2013-02-05T00:00:00,Cause of Death,E05.318.308.985.550.250
23391523,2013-02-05T00:00:00,Cause of Death,L01.280.975.550.250
23391523,2013-02-05T00:00:00,Cause of Death,N01.224.935.698.100
23391523,2013-02-05T00:00:00,Cause of Death,N06.850.505.400.975.550.250
23391523,2013-02-05T00:00:00,Cause of Death,N06.850.520.308.985.550.250
23391523,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23391523,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23391523,2013-02-05T00:00:00,Patient Discharge,E02.760.400.610
23391523,2013-02-05T00:00:00,Patient Discharge,N02.421.585.400.610
23391523,2013-02-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23391523,2013-02-05T00:00:00,Risk Factors,N05.715.350.200.700
23391523,2013-02-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23391523,2013-02-05T00:00:00,Risk Factors,N06.850.490.625.750
23391523,2013-02-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23391523,2013-02-05T00:00:00,South Carolina,Z01.107.567.875.075.662
23391523,2013-02-05T00:00:00,South Carolina,Z01.107.567.875.750.700
23391523,2013-02-05T00:00:00,Spinal Cord Injuries,C10.228.854.770
23391523,2013-02-05T00:00:00,Spinal Cord Injuries,C10.900.850
23391523,2013-02-05T00:00:00,Spinal Cord Injuries,C21.866.819
23391592,2013-02-05T00:00:00,Adolescent,M01.060.057
23391592,2013-02-05T00:00:00,Adult,M01.060.116
23391592,2013-02-05T00:00:00,Aged,M01.060.116.100
23391592,2013-02-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23391592,2013-02-05T00:00:00,Kidney Transplantation,E02.870.500
23391592,2013-02-05T00:00:00,Kidney Transplantation,E04.936.450.485
23391592,2013-02-05T00:00:00,Kidney Transplantation,E04.950.774.400
23391592,2013-02-05T00:00:00,Middle Aged,M01.060.116.630
23391592,2013-02-05T00:00:00,Perioperative Care,E02.760.722
23391592,2013-02-05T00:00:00,Perioperative Care,E04.604
23391592,2013-02-05T00:00:00,Perioperative Care,N02.421.585.722
23391592,2013-02-05T00:00:00,Young Adult,M01.060.116.815
23383719,2013-02-06T00:00:00,Adolescent,M01.060.057
23383719,2013-02-06T00:00:00,Adult,M01.060.116
23383719,2013-02-06T00:00:00,Aged,M01.060.116.100
23383719,2013-02-06T00:00:00,Cardiovascular Diseases,C14
23383719,2013-02-06T00:00:00,Diabetes Complications,C19.246.099
23383719,2013-02-06T00:00:00,Diabetes Mellitus,C18.452.394.750
23383719,2013-02-06T00:00:00,Diabetes Mellitus,C19.246
23383719,2013-02-06T00:00:00,Graft Rejection,G12.425.901.545.328
23383719,2013-02-06T00:00:00,Graft Survival,G12.425.901.545.340
23383719,2013-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23383719,2013-02-06T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
23383719,2013-02-06T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
23383719,2013-02-06T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
23383719,2013-02-06T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
23383719,2013-02-06T00:00:00,Kidney Transplantation,E02.870.500
23383719,2013-02-06T00:00:00,Kidney Transplantation,E04.936.450.485
23383719,2013-02-06T00:00:00,Kidney Transplantation,E04.950.774.400
23383719,2013-02-06T00:00:00,Middle Aged,M01.060.116.630
23383719,2013-02-06T00:00:00,Risk Factors,E05.318.740.600.800.725
23383719,2013-02-06T00:00:00,Risk Factors,N05.715.350.200.700
23383719,2013-02-06T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23383719,2013-02-06T00:00:00,Risk Factors,N06.850.490.625.750
23383719,2013-02-06T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23383719,2013-02-06T00:00:00,Treatment Outcome,E01.789.800
23383719,2013-02-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23383719,2013-02-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23383719,2013-02-06T00:00:00,Young Adult,M01.060.116.815
23384283,2013-02-06T00:00:00,Academic Medical Centers,N02.278.020
23384283,2013-02-06T00:00:00,Equipment Failure,E05.325
23384283,2013-02-06T00:00:00,"Hospitals, Community",N02.278.421.306
23384283,2013-02-06T00:00:00,"Hospitals, Teaching",N02.278.020.300
23384283,2013-02-06T00:00:00,"Hospitals, Teaching",N02.278.421.639
23384283,2013-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23384283,2013-02-06T00:00:00,Operating Rooms,N02.278.388.700
23385198,2013-02-06T00:00:00,Animals,B01.050
23385198,2013-02-06T00:00:00,Antibodies,D12.776.124.486.485.114
23385198,2013-02-06T00:00:00,Antibodies,D12.776.124.790.651.114
23385198,2013-02-06T00:00:00,Antibodies,D12.776.377.715.548.114
23385198,2013-02-06T00:00:00,Antioxidants,D27.505.519.217
23385198,2013-02-06T00:00:00,Antioxidants,D27.505.696.706.125
23385198,2013-02-06T00:00:00,Antioxidants,D27.720.799.047
23385198,2013-02-06T00:00:00,Apoptosis,G04.299.139.160
23385198,2013-02-06T00:00:00,Biological Markers,D23.101
23385198,2013-02-06T00:00:00,Brain Infarction,C10.228.140.300.150.477
23385198,2013-02-06T00:00:00,Brain Infarction,C10.228.140.300.775.200
23385198,2013-02-06T00:00:00,Brain Infarction,C14.907.253.092.477
23385198,2013-02-06T00:00:00,Brain Infarction,C14.907.253.855.200
23385198,2013-02-06T00:00:00,Drug Delivery Systems,E02.319.300
23385198,2013-02-06T00:00:00,Hippocampus,A08.186.211.464.405
23385198,2013-02-06T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
23385198,2013-02-06T00:00:00,Nanoparticles,J01.637.512.600
23385198,2013-02-06T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
23385198,2013-02-06T00:00:00,Reperfusion Injury,C14.907.725
23385198,2013-02-06T00:00:00,Reperfusion Injury,C23.550.767.877
23385198,2013-02-06T00:00:00,Stroke,C10.228.140.300.775
23385198,2013-02-06T00:00:00,Stroke,C14.907.253.855
23385198,2013-02-06T00:00:00,Superoxide Dismutase,D08.811.682.881
23389824,2013-02-06T00:00:00,Adult,M01.060.116
23389824,2013-02-06T00:00:00,Aged,M01.060.116.100
23389824,2013-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23389824,2013-02-06T00:00:00,Middle Aged,M01.060.116.630
23389824,2013-02-06T00:00:00,Multiple Sclerosis,C10.114.375.500
23389824,2013-02-06T00:00:00,Multiple Sclerosis,C10.314.350.500
23389824,2013-02-06T00:00:00,Multiple Sclerosis,C20.111.258.250.500
23389824,2013-02-06T00:00:00,Quality of Life,I01.800
23389824,2013-02-06T00:00:00,Quality of Life,K01.752.400.750
23389824,2013-02-06T00:00:00,Spinal Cord Injuries,C10.228.854.770
23389824,2013-02-06T00:00:00,Spinal Cord Injuries,C10.900.850
23389824,2013-02-06T00:00:00,Spinal Cord Injuries,C21.866.819
23389824,2013-02-06T00:00:00,Treatment Outcome,E01.789.800
23389824,2013-02-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23389824,2013-02-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23389824,2013-02-06T00:00:00,"Urinary Bladder, Neurogenic",C10.597.900
23389824,2013-02-06T00:00:00,"Urinary Bladder, Neurogenic",C12.777.829.839
23389824,2013-02-06T00:00:00,"Urinary Bladder, Neurogenic",C13.351.968.829.760
23389824,2013-02-06T00:00:00,"Urinary Bladder, Neurogenic",C23.888.592.900
23389824,2013-02-06T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
23389824,2013-02-06T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
23389824,2013-02-06T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
23389824,2013-02-06T00:00:00,Urodynamics,G08.852.898
23390038,2013-02-06T00:00:00,Clinical Trials as Topic,E05.318.760.535
23390038,2013-02-06T00:00:00,Clinical Trials as Topic,E05.337.250
23390038,2013-02-06T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23390038,2013-02-06T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23390038,2013-02-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23390038,2013-02-06T00:00:00,Stroke,C10.228.140.300.775
23390038,2013-02-06T00:00:00,Stroke,C14.907.253.855
23390038,2013-02-06T00:00:00,Thrombolytic Therapy,E02.319.913
23390038,2013-02-06T00:00:00,Treatment Outcome,E01.789.800
23390038,2013-02-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23390038,2013-02-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23389755,2013-02-07T00:00:00,Adult,M01.060.116
23389755,2013-02-07T00:00:00,Alcohol Drinking,F01.145.317.269
23389755,2013-02-07T00:00:00,Alcoholism,C21.739.100.250
23389755,2013-02-07T00:00:00,Alcoholism,F03.900.100.350
23389755,2013-02-07T00:00:00,Amines,D02.092
23389755,2013-02-07T00:00:00,Brain,A08.186.211
23389755,2013-02-07T00:00:00,Cues,F02.463.425.234
23389755,2013-02-07T00:00:00,Cyclohexanecarboxylic Acids,D02.241.223.268
23389755,2013-02-07T00:00:00,Cyclohexanecarboxylic Acids,D02.455.426.392.368.367.218
23389755,2013-02-07T00:00:00,Excitatory Amino Acid Antagonists,D27.505.519.625.190.300
23389755,2013-02-07T00:00:00,Excitatory Amino Acid Antagonists,D27.505.696.577.190.300
23389755,2013-02-07T00:00:00,Flumazenil,D03.438.079.080.070.305
23389755,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23389755,2013-02-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23389755,2013-02-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23389755,2013-02-07T00:00:00,Middle Aged,M01.060.116.630
23389755,2013-02-07T00:00:00,Secondary Prevention,N02.421.726.825
23389755,2013-02-07T00:00:00,Secondary Prevention,N06.850.780.750
23389755,2013-02-07T00:00:00,Substance Withdrawal Syndrome,C21.739.835
23389755,2013-02-07T00:00:00,Substance Withdrawal Syndrome,F03.900.825
23389755,2013-02-07T00:00:00,Treatment Outcome,E01.789.800
23389755,2013-02-07T00:00:00,Treatment Outcome,N04.761.559.590.800
23389755,2013-02-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23389755,2013-02-07T00:00:00,gamma-Aminobutyric Acid,D02.241.081.160.050.350
23389755,2013-02-07T00:00:00,gamma-Aminobutyric Acid,D12.125.190.350
23390923,2013-02-07T00:00:00,Adult,M01.060.116
23390923,2013-02-07T00:00:00,Aged,M01.060.116.100
23390923,2013-02-07T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23390923,2013-02-07T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23390923,2013-02-07T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23390923,2013-02-07T00:00:00,Combined Modality Therapy,E02.186
23390923,2013-02-07T00:00:00,Disability Evaluation,E01.370.400
23390923,2013-02-07T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23390923,2013-02-07T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23390923,2013-02-07T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23390923,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23390923,2013-02-07T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
23390923,2013-02-07T00:00:00,Middle Aged,M01.060.116.630
23390923,2013-02-07T00:00:00,Stroke,C10.228.140.300.775
23390923,2013-02-07T00:00:00,Stroke,C14.907.253.855
23390923,2013-02-07T00:00:00,Thrombectomy,E04.100.814.842
23390923,2013-02-07T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23390923,2013-02-07T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23390923,2013-02-07T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23390923,2013-02-07T00:00:00,Tissue Plasminogen Activator,D23.119.970
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23390923,2013-02-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23390923,2013-02-07T00:00:00,Treatment Outcome,E01.789.800
23390923,2013-02-07T00:00:00,Treatment Outcome,N04.761.559.590.800
23390923,2013-02-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23390923,2013-02-07T00:00:00,Young Adult,M01.060.116.815
23393065,2013-02-07T00:00:00,Acclimatization,G07.700.062.133
23393065,2013-02-07T00:00:00,Acclimatization,G16.100.057.500.133
23393065,2013-02-07T00:00:00,Adult,M01.060.116
23393065,2013-02-07T00:00:00,Dexamethasone,D04.808.745.432.769.344
23393065,2013-02-07T00:00:00,Dexamethasone,D04.808.908.238
23393065,2013-02-07T00:00:00,Down-Regulation,G02.111.087.225
23393065,2013-02-07T00:00:00,Down-Regulation,G02.149.115.225
23393065,2013-02-07T00:00:00,Down-Regulation,G05.355.315.200
23393065,2013-02-07T00:00:00,Down-Regulation,G07.690.812.230
23393065,2013-02-07T00:00:00,Down-Regulation,G07.700.680.230
23393065,2013-02-07T00:00:00,Glucocorticoids,D06.472.040.543
23393065,2013-02-07T00:00:00,Glucocorticoids,D27.505.696.399.472.488
23393065,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23393065,2013-02-07T00:00:00,Treatment Outcome,E01.789.800
23393065,2013-02-07T00:00:00,Treatment Outcome,N04.761.559.590.800
23393065,2013-02-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23393212,2013-02-07T00:00:00,C-Reactive Protein,D12.776.034.145
23393212,2013-02-07T00:00:00,C-Reactive Protein,D12.776.124.050.120
23393212,2013-02-07T00:00:00,C-Reactive Protein,D12.776.124.486.157
23393212,2013-02-07T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
23393212,2013-02-07T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
23393212,2013-02-07T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
23393212,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23393212,2013-02-07T00:00:00,Pre-Eclampsia,C13.703.395.249
23393212,2013-02-07T00:00:00,Pregnancy,G08.686.785.760.769
23409016,2013-02-07T00:00:00,Apoptosis,G04.299.139.160
23409016,2013-02-07T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23409016,2013-02-07T00:00:00,Flow Cytometry,E05.200.500.386.350
23409016,2013-02-07T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
23409016,2013-02-07T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
23409016,2013-02-07T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
23409016,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23409016,2013-02-07T00:00:00,MicroRNAs,D13.150.650.319
23409016,2013-02-07T00:00:00,MicroRNAs,D13.444.735.150.319
23409016,2013-02-07T00:00:00,MicroRNAs,D13.444.735.790.099
23409016,2013-02-07T00:00:00,Photochemotherapy,E02.186.500
23409016,2013-02-07T00:00:00,Photochemotherapy,E02.319.685
23409016,2013-02-07T00:00:00,Photochemotherapy,E02.774.722
23409016,2013-02-07T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23409016,2013-02-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23409016,2013-02-07T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23409016,2013-02-07T00:00:00,Signal Transduction,G02.111.087.800
23409016,2013-02-07T00:00:00,Signal Transduction,G02.149.115.800
23409016,2013-02-07T00:00:00,Signal Transduction,G04.299.880
23409071,2013-02-07T00:00:00,Algorithms,G17.035
23409071,2013-02-07T00:00:00,Algorithms,L01.224.050
23409071,2013-02-07T00:00:00,Gene Expression,G05.355.310
23409071,2013-02-07T00:00:00,Gene Expression Profiling,E05.393.332
23409071,2013-02-07T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
23409071,2013-02-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23409071,2013-02-07T00:00:00,"Models, Theoretical",E05.599
23409071,2013-02-07T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
23409071,2013-02-07T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
23394477,2013-02-08T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23394477,2013-02-08T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23394477,2013-02-08T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23394477,2013-02-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23394477,2013-02-08T00:00:00,Stroke,C10.228.140.300.775
23394477,2013-02-08T00:00:00,Stroke,C14.907.253.855
23394477,2013-02-08T00:00:00,Thrombectomy,E04.100.814.842
23394477,2013-02-08T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23394477,2013-02-08T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23394477,2013-02-08T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23394477,2013-02-08T00:00:00,Tissue Plasminogen Activator,D23.119.970
23399642,2013-02-11T00:00:00,Actins,D05.750.078.730.250
23399642,2013-02-11T00:00:00,Actins,D12.776.210.500.100
23399642,2013-02-11T00:00:00,Actins,D12.776.220.525.255
23399642,2013-02-11T00:00:00,Breast Neoplasms,C04.588.180
23399642,2013-02-11T00:00:00,Breast Neoplasms,C17.800.090.500
23399642,2013-02-11T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
23399642,2013-02-11T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
23399642,2013-02-11T00:00:00,Cell Adhesion Molecules,D23.050.301.350
23399642,2013-02-11T00:00:00,Cell Proliferation,G04.299.233.750
23399642,2013-02-11T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23399642,2013-02-11T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
23399642,2013-02-11T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
23399642,2013-02-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23399642,2013-02-11T00:00:00,Neoplasm Invasiveness,C04.697.645
23399642,2013-02-11T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23481720,2013-02-11T00:00:00,Computer Simulation,L01.224.160
23481720,2013-02-11T00:00:00,Equipment Failure Analysis,E05.325.192
23481720,2013-02-11T00:00:00,Fiber Optic Technology,H01.671.617.249
23481720,2013-02-11T00:00:00,Hot Temperature,G01.906.595.543
23481720,2013-02-11T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
23481720,2013-02-11T00:00:00,Hot Temperature,G16.500.750.775.710.380
23481720,2013-02-11T00:00:00,Hot Temperature,N06.230.300.100.725.232
23481720,2013-02-11T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
23481720,2013-02-11T00:00:00,Light,G01.201.875.770.578
23481720,2013-02-11T00:00:00,Light,G01.590.540
23481720,2013-02-11T00:00:00,"Models, Theoretical",E05.599
23481720,2013-02-11T00:00:00,Nonlinear Dynamics,E05.599.850
23481720,2013-02-11T00:00:00,Nonlinear Dynamics,H01.548.675
23481720,2013-02-11T00:00:00,"Scattering, Radiation",E05.196.822
23481720,2013-02-11T00:00:00,"Scattering, Radiation",G01.595.861
23399055,2013-02-12T00:00:00,Animals,B01.050
23399055,2013-02-12T00:00:00,Down-Regulation,G02.111.087.225
23399055,2013-02-12T00:00:00,Down-Regulation,G02.149.115.225
23399055,2013-02-12T00:00:00,Down-Regulation,G05.355.315.200
23399055,2013-02-12T00:00:00,Down-Regulation,G07.690.812.230
23399055,2013-02-12T00:00:00,Down-Regulation,G07.700.680.230
23399055,2013-02-12T00:00:00,Lung Injury,C08.381.520
23399055,2013-02-12T00:00:00,Lung Injury,C21.866.891.554
23399055,2013-02-12T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23399055,2013-02-12T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23399055,2013-02-12T00:00:00,Pulmonary Surfactant-Associated Protein C,D12.776.543.717
23399055,2013-02-12T00:00:00,Pulmonary Surfactant-Associated Protein C,D12.776.816.750
23399055,2013-02-12T00:00:00,Pulmonary Surfactant-Associated Protein C,D12.776.823.186
23400317,2013-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23400317,2013-02-12T00:00:00,Telemedicine,H02.403.840
23400317,2013-02-12T00:00:00,Telemedicine,L01.178.847.652
23400317,2013-02-12T00:00:00,Telemedicine,N04.590.374.800
23410586,2013-02-12T00:00:00,Adult,M01.060.116
23410586,2013-02-12T00:00:00,Breast Neoplasms,C04.588.180
23410586,2013-02-12T00:00:00,Breast Neoplasms,C17.800.090.500
23410586,2013-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23410586,2013-02-12T00:00:00,Incidence,E05.318.308.985.525.375
23410586,2013-02-12T00:00:00,Incidence,L01.280.975.525.375
23410586,2013-02-12T00:00:00,Incidence,N01.224.935.597.500
23410586,2013-02-12T00:00:00,Incidence,N06.850.505.400.975.525.375
23410586,2013-02-12T00:00:00,Incidence,N06.850.520.308.985.525.375
23410586,2013-02-12T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23410586,2013-02-12T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23410586,2013-02-12T00:00:00,Neoplasms,C04
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C04.588.322.455
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C19.344.410
23410586,2013-02-12T00:00:00,Ovarian Neoplasms,C19.391.630.705
23410586,2013-02-12T00:00:00,United States,Z01.107.567.875
23415554,2013-02-12T00:00:00,Adolescent,M01.060.057
23415554,2013-02-12T00:00:00,Adult,M01.060.116
23415554,2013-02-12T00:00:00,Aged,M01.060.116.100
23415554,2013-02-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23415554,2013-02-12T00:00:00,Intensive Care Units,N02.278.388.493
23415554,2013-02-12T00:00:00,Middle Aged,M01.060.116.630
23415554,2013-02-12T00:00:00,"Surgical Procedures, Operative",E04
23415554,2013-02-12T00:00:00,Trauma Centers,N02.278.354.422.336.500
23415554,2013-02-12T00:00:00,Trauma Centers,N02.421.297.195.480
23415554,2013-02-12T00:00:00,Trauma Centers,N04.452.442.422.336.400
23415554,2013-02-12T00:00:00,Young Adult,M01.060.116.815
23404634,2013-02-13T00:00:00,Animals,B01.050
23404634,2013-02-13T00:00:00,Reproduction,G08.686.785.760
23404634,2013-02-13T00:00:00,Seasons,G01.910.645.661
23404634,2013-02-13T00:00:00,Seasons,G16.500.275.071.590
23404634,2013-02-13T00:00:00,Seasons,N06.230.300.100.250.525
23404634,2013-02-13T00:00:00,Spermatozoa,A05.360.490.890
23404634,2013-02-13T00:00:00,Spermatozoa,A11.497.760
23404634,2013-02-13T00:00:00,Testis,A05.360.444.849
23404634,2013-02-13T00:00:00,Testis,A05.360.576.782
23404634,2013-02-13T00:00:00,Testis,A06.407.312.782
23408511,2013-02-13T00:00:00,Binding Sites,G02.111.570.120
23408511,2013-02-13T00:00:00,Computational Biology,H01.158.273.180
23408511,2013-02-13T00:00:00,Creatine,D02.078.370.280
23408511,2013-02-13T00:00:00,Creatine,D12.125.373
23408511,2013-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23408511,2013-02-13T00:00:00,"Mutation, Missense",G05.365.590.650
23408671,2013-02-13T00:00:00,Anticoagulants,D27.505.954.502.119
23408671,2013-02-13T00:00:00,Antithrombins,D12.644.822.750.060
23408671,2013-02-13T00:00:00,Antithrombins,D12.644.861.060
23408671,2013-02-13T00:00:00,Antithrombins,D12.776.645.750.060
23408671,2013-02-13T00:00:00,Antithrombins,D12.776.872.060
23408671,2013-02-13T00:00:00,Cardiopulmonary Bypass,E04.292.413
23408671,2013-02-13T00:00:00,Drug Resistance,G07.690.320
23408671,2013-02-13T00:00:00,Heparin,D09.698.373.400
23408671,2013-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23418583,2013-02-13T00:00:00,Animals,B01.050
23418583,2013-02-13T00:00:00,"Animals, Newborn",B01.050.050.282
23418583,2013-02-13T00:00:00,Cell Membrane,A11.284.149
23418583,2013-02-13T00:00:00,Fluorescent Dyes,D27.720.233.348
23418583,2013-02-13T00:00:00,Fluorescent Dyes,D27.720.470.330.348
23418583,2013-02-13T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
23418583,2013-02-13T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23418583,2013-02-13T00:00:00,"Microscopy, Confocal",E05.595.395
23418583,2013-02-13T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
23418583,2013-02-13T00:00:00,"Microscopy, Fluorescence",E05.595.458
23418583,2013-02-13T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23418583,2013-02-13T00:00:00,Mitochondria,A11.284.835.626
23418583,2013-02-13T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23418583,2013-02-13T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23418583,2013-02-13T00:00:00,"Myocytes, Cardiac",A11.620.500
23418583,2013-02-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.228.854.139
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.562.250
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.574.950.050
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C10.668.460.250
23418589,2013-02-13T00:00:00,Amyotrophic Lateral Sclerosis,C18.452.845.800.050
23418589,2013-02-13T00:00:00,Animals,B01.050
23418589,2013-02-13T00:00:00,Gene Expression,G05.355.310
23418589,2013-02-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23418589,2013-02-13T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23418589,2013-02-13T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23418589,2013-02-13T00:00:00,Mutation,G05.365.590
23418589,2013-02-13T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
23418589,2013-02-13T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
23418589,2013-02-13T00:00:00,Neurons,A08.663
23418589,2013-02-13T00:00:00,Neurons,A11.671
23418589,2013-02-13T00:00:00,Superoxide Dismutase,D08.811.682.881
23415658,2013-02-14T00:00:00,Adult,M01.060.116
23415658,2013-02-14T00:00:00,C-Reactive Protein,D12.776.034.145
23415658,2013-02-14T00:00:00,C-Reactive Protein,D12.776.124.050.120
23415658,2013-02-14T00:00:00,C-Reactive Protein,D12.776.124.486.157
23415658,2013-02-14T00:00:00,Child,M01.060.406
23415658,2013-02-14T00:00:00,Child Abuse,I01.198.240.856.350.250
23415658,2013-02-14T00:00:00,Child Abuse,I01.880.735.900.350.250
23415658,2013-02-14T00:00:00,Child Abuse,I01.880.787.293.292
23415658,2013-02-14T00:00:00,Cytokines,D12.644.276.374
23415658,2013-02-14T00:00:00,Cytokines,D12.776.467.374
23415658,2013-02-14T00:00:00,Cytokines,D23.529.374
23415658,2013-02-14T00:00:00,"Depressive Disorder, Major",F03.600.300.375
23415658,2013-02-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23415658,2013-02-14T00:00:00,Life Change Events,F01.829.458.410
23415658,2013-02-14T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23415658,2013-02-14T00:00:00,"Stress, Psychological",F01.145.126.990
23415658,2013-02-14T00:00:00,"Stress, Psychological",F02.830.900
23415658,2013-02-14T00:00:00,Young Adult,M01.060.116.815
23410875,2013-02-15T00:00:00,Animals,B01.050
23410875,2013-02-15T00:00:00,Myocardial Infarction,C14.280.647.500
23410875,2013-02-15T00:00:00,Myocardial Infarction,C14.907.585.500
23410875,2013-02-15T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
23498287,2013-02-15T00:00:00,"History, 20th Century",K01.400.504.968
23498287,2013-02-15T00:00:00,United States,Z01.107.567.875
23417570,2013-02-16T00:00:00,Animals,B01.050
23417570,2013-02-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23417570,2013-02-16T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.300.480.525.300.500
23417570,2013-02-16T00:00:00,Matrix Metalloproteinase 14,D08.811.277.656.675.374.525.300.500
23417570,2013-02-16T00:00:00,Myocardium,A02.633.580
23417570,2013-02-16T00:00:00,Myocardium,A07.541.704
23417570,2013-02-16T00:00:00,Myocardium,A10.690.552.750
23417570,2013-02-16T00:00:00,Sex Characteristics,G08.686.815
23417570,2013-02-16T00:00:00,Ventricular Remodeling,C23.300.985
23417570,2013-02-16T00:00:00,Ventricular Remodeling,G09.330.190.962.975
23417743,2013-02-17T00:00:00,Apoptosis,G04.299.139.160
23417743,2013-02-17T00:00:00,Brain Neoplasms,C04.588.614.250.195
23417743,2013-02-17T00:00:00,Brain Neoplasms,C10.228.140.211
23417743,2013-02-17T00:00:00,Brain Neoplasms,C10.551.240.250
23417743,2013-02-17T00:00:00,Cell Proliferation,G04.299.233.750
23417743,2013-02-17T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23417743,2013-02-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23417743,2013-02-17T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23417743,2013-02-17T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23417743,2013-02-17T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
23417743,2013-02-17T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
23417743,2013-02-17T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
23417743,2013-02-17T00:00:00,Neurons,A08.663
23417743,2013-02-17T00:00:00,Neurons,A11.671
23417743,2013-02-17T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
23417743,2013-02-17T00:00:00,Telomerase,D12.776.157.725.500.921
23417743,2013-02-17T00:00:00,Telomerase,D12.776.664.962.500.921
23422879,2013-02-17T00:00:00,Animals,B01.050
23422879,2013-02-17T00:00:00,DNA Damage,C21.111
23422879,2013-02-17T00:00:00,DNA Damage,G05.355.180
23422879,2013-02-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23422879,2013-02-17T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23422879,2013-02-17T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23422879,2013-02-17T00:00:00,Neurodegenerative Diseases,C10.574
23422879,2013-02-17T00:00:00,Oxidative Stress,G03.495.710
23422879,2013-02-17T00:00:00,Oxidative Stress,G07.700.830.750
23428656,2013-02-18T00:00:00,"Adaptation, Physiological",G07.700.062
23428656,2013-02-18T00:00:00,"Adaptation, Physiological",G16.100.057.500
23428656,2013-02-18T00:00:00,Animals,B01.050
23428656,2013-02-18T00:00:00,Cocaine,D02.145.074.722.388
23428656,2013-02-18T00:00:00,Cocaine,D03.132.889.354
23428656,2013-02-18T00:00:00,Cocaine,D03.605.869.388
23428656,2013-02-18T00:00:00,Cocaine,D04.075.080.875.099.722.388
23428656,2013-02-18T00:00:00,Neural Pathways,A08.612
23428656,2013-02-18T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23428656,2013-02-18T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
23428656,2013-02-18T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
23428656,2013-02-18T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
23441136,2013-02-18T00:00:00,African Americans,M01.686.508.100.100
23441136,2013-02-18T00:00:00,African Americans,M01.686.754.100
23441136,2013-02-18T00:00:00,Alleles,G05.360.340.024.340.030
23441136,2013-02-18T00:00:00,Apoptosis,G04.299.139.160
23441136,2013-02-18T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
23441136,2013-02-18T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
23441136,2013-02-18T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
23441136,2013-02-18T00:00:00,DNA-Binding Proteins,D12.776.260
23441136,2013-02-18T00:00:00,European Continental Ancestry Group,M01.686.508.400
23441136,2013-02-18T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23441136,2013-02-18T00:00:00,Genetic Predisposition to Disease,G05.380.355
23441136,2013-02-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23441136,2013-02-18T00:00:00,Inflammation,C23.550.470
23441136,2013-02-18T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23441136,2013-02-18T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23441136,2013-02-18T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23422753,2013-02-19T00:00:00,Adolescent,M01.060.057
23422753,2013-02-19T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
23422753,2013-02-19T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
23422753,2013-02-19T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
23422753,2013-02-19T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
23422753,2013-02-19T00:00:00,Child,M01.060.406
23422753,2013-02-19T00:00:00,"Child, Preschool",M01.060.406.448
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.318.416.249
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.318.780.392
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.393.385.500
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.393.522.500
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23422753,2013-02-19T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23422753,2013-02-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23422753,2013-02-19T00:00:00,Membrane Proteins,D12.776.543
23422753,2013-02-19T00:00:00,Mutation,G05.365.590
23422753,2013-02-19T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23422753,2013-02-19T00:00:00,Risk Factors,E05.318.740.600.800.725
23422753,2013-02-19T00:00:00,Risk Factors,N05.715.350.200.700
23422753,2013-02-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23422753,2013-02-19T00:00:00,Risk Factors,N06.850.490.625.750
23422753,2013-02-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23422753,2013-02-19T00:00:00,Stroke,C10.228.140.300.775
23422753,2013-02-19T00:00:00,Stroke,C14.907.253.855
23161644,2013-02-20T00:00:00,Computer Simulation,L01.224.160
23161644,2013-02-20T00:00:00,Electromagnetic Fields,G01.201.260
23161644,2013-02-20T00:00:00,Electromagnetic Fields,G01.201.875.240
23161644,2013-02-20T00:00:00,Electrophoresis,E05.196.401
23161644,2013-02-20T00:00:00,Electrophoresis,E05.301.300
23161644,2013-02-20T00:00:00,Electrophoresis,G02.149.767.570
23161644,2013-02-20T00:00:00,Electrophoresis,G02.842.750.570
23161644,2013-02-20T00:00:00,Fluorescent Dyes,D27.720.233.348
23161644,2013-02-20T00:00:00,Fluorescent Dyes,D27.720.470.330.348
23161644,2013-02-20T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
23161644,2013-02-20T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
23161644,2013-02-20T00:00:00,Microfluidic Analytical Techniques,E05.588.465
23425628,2013-02-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425628,2013-02-20T00:00:00,Lung Neoplasms,C04.588.894.797.520
23425628,2013-02-20T00:00:00,Lung Neoplasms,C08.381.540
23425628,2013-02-20T00:00:00,Lung Neoplasms,C08.785.520
23425628,2013-02-20T00:00:00,Smoking,F01.145.466.753
23223274,2013-02-21T00:00:00,Polymers,D05.750
23223274,2013-02-21T00:00:00,Polymers,D25.720
23223274,2013-02-21T00:00:00,Polymers,J01.637.051.720
23223274,2013-02-21T00:00:00,Polypropylenes,D02.455.326.271.665.590
23223274,2013-02-21T00:00:00,Polypropylenes,D05.750.716.550
23223274,2013-02-21T00:00:00,Polypropylenes,D25.720.716.550
23223274,2013-02-21T00:00:00,Polypropylenes,J01.637.051.720.716.550
23425165,2013-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425165,2013-02-21T00:00:00,Lung Neoplasms,C04.588.894.797.520
23425165,2013-02-21T00:00:00,Lung Neoplasms,C08.381.540
23425165,2013-02-21T00:00:00,Lung Neoplasms,C08.785.520
23425165,2013-02-21T00:00:00,Mass Screening,E01.370.500
23425165,2013-02-21T00:00:00,Mass Screening,E05.318.308.250.580
23425165,2013-02-21T00:00:00,Mass Screening,N02.421.143.827.233.443
23425165,2013-02-21T00:00:00,Mass Screening,N02.421.726.233.443
23425165,2013-02-21T00:00:00,Mass Screening,N05.715.360.300.375.500
23425165,2013-02-21T00:00:00,Mass Screening,N06.850.520.308.250.580
23425165,2013-02-21T00:00:00,Mass Screening,N06.850.780.500
23425165,2013-02-21T00:00:00,Patient Selection,E05.581.500.653
23425165,2013-02-21T00:00:00,Patient Selection,N04.590.731
23425165,2013-02-21T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
23425165,2013-02-21T00:00:00,Risk Assessment,E05.318.740.600.800.715
23425165,2013-02-21T00:00:00,Risk Assessment,N04.452.871.715
23425165,2013-02-21T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23425165,2013-02-21T00:00:00,Risk Assessment,N06.850.505.715
23425165,2013-02-21T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23425165,2013-02-21T00:00:00,Risk Factors,E05.318.740.600.800.725
23425165,2013-02-21T00:00:00,Risk Factors,N05.715.350.200.700
23425165,2013-02-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23425165,2013-02-21T00:00:00,Risk Factors,N06.850.490.625.750
23425165,2013-02-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23425165,2013-02-21T00:00:00,Sensitivity and Specificity,E05.318.740.872
23425165,2013-02-21T00:00:00,Sensitivity and Specificity,E05.318.780.800
23425165,2013-02-21T00:00:00,Sensitivity and Specificity,G17.800
23425165,2013-02-21T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23425165,2013-02-21T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23425165,2013-02-21T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23425165,2013-02-21T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23425165,2013-02-21T00:00:00,Smoking,F01.145.466.753
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23425165,2013-02-21T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23434577,2013-02-21T00:00:00,Occupational Exposure,N06.850.460.350.600
23434577,2013-02-21T00:00:00,Oxidative Stress,G03.495.710
23434577,2013-02-21T00:00:00,Oxidative Stress,G07.700.830.750
23438514,2013-02-21T00:00:00,Animals,B01.050
23438514,2013-02-21T00:00:00,Cell Differentiation,G04.299.151
23438514,2013-02-21T00:00:00,Cell Survival,G04.299.316
23438514,2013-02-21T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
23438514,2013-02-21T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
23438514,2013-02-21T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
23438514,2013-02-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C10.228.140.163.100.435.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C10.314.400.500
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.189.435.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.398.641.803.585
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C16.320.565.595.554.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.132.100.435.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.584.687.803.585
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.189.435.825.590
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.398.641.803.585
23438514,2013-02-21T00:00:00,"Leukodystrophy, Globoid Cell",C18.452.648.595.554.825.590
23438514,2013-02-21T00:00:00,Lipid Metabolism,G03.495.520
23438514,2013-02-21T00:00:00,"Microscopy, Fluorescence",E01.370.350.515.458
23438514,2013-02-21T00:00:00,"Microscopy, Fluorescence",E05.595.458
23438514,2013-02-21T00:00:00,Oligodendroglia,A08.637.600
23438514,2013-02-21T00:00:00,Oligodendroglia,A11.650.600
23438514,2013-02-21T00:00:00,Psychosine,D02.033.100.700.700
23438514,2013-02-21T00:00:00,Psychosine,D02.092.063.700.700
23438514,2013-02-21T00:00:00,Psychosine,D09.400.410.420.806
23438514,2013-02-21T00:00:00,Psychosine,D10.390.470.806
23438514,2013-02-21T00:00:00,Psychosine,D10.570.877.360.806
23438514,2013-02-21T00:00:00,RNA Interference,G05.355.315.203.374.790
23438514,2013-02-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23394144,2013-02-22T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.077.099
23394144,2013-02-22T00:00:00,Angiogenesis Inhibitors,D27.505.696.377.450.100
23394144,2013-02-22T00:00:00,Angiogenesis Inhibitors,D27.505.954.248.025
23394144,2013-02-22T00:00:00,Animals,B01.050
23394144,2013-02-22T00:00:00,Cell Proliferation,G04.299.233.750
23394144,2013-02-22T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23394144,2013-02-22T00:00:00,Endothelial Cells,A11.436.275
23394144,2013-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23394144,2013-02-22T00:00:00,Hydrolyzable Tannins,D02.241.223.100.380.350.299
23394144,2013-02-22T00:00:00,Hydrolyzable Tannins,D02.241.511.390.350.299
23394144,2013-02-22T00:00:00,Hydrolyzable Tannins,D02.755.410.350.299
23394144,2013-02-22T00:00:00,Hydrolyzable Tannins,D05.750.078.937.214
23394144,2013-02-22T00:00:00,"Neovascularization, Pathologic",C23.550.589.500
23394144,2013-02-22T00:00:00,"Receptors, Peptide",D12.776.543.750.750
23402624,2013-02-22T00:00:00,Animals,B01.050
23402624,2013-02-22T00:00:00,Artificial Intelligence,L01.224.065
23402624,2013-02-22T00:00:00,Cell Line,A11.251.210
23402624,2013-02-22T00:00:00,Environment,G16.500.275
23402624,2013-02-22T00:00:00,Environment,N06.230
23402624,2013-02-22T00:00:00,Environmental Pollutants,D27.888.284
23402624,2013-02-22T00:00:00,"Models, Biological",E05.599.395
23432507,2013-02-22T00:00:00,Adult,M01.060.116
23432507,2013-02-22T00:00:00,Echocardiography,E01.370.350.850.220
23432507,2013-02-22T00:00:00,Echocardiography,E01.370.370.380.220
23432507,2013-02-22T00:00:00,Equipment Failure Analysis,E05.325.192
23432507,2013-02-22T00:00:00,Heart Valve Prosthesis,E07.695.310
23432507,2013-02-22T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
23432507,2013-02-22T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
23432507,2013-02-22T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
23432507,2013-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23432507,2013-02-22T00:00:00,Prosthesis Design,E05.320.550
23432507,2013-02-22T00:00:00,Prosthesis Design,E07.695.680
23432507,2013-02-22T00:00:00,Pulmonary Valve,A07.541.510.738
23432507,2013-02-22T00:00:00,Pulmonary Valve Insufficiency,C14.280.484.660
23432507,2013-02-22T00:00:00,Sensitivity and Specificity,E05.318.740.872
23432507,2013-02-22T00:00:00,Sensitivity and Specificity,E05.318.780.800
23432507,2013-02-22T00:00:00,Sensitivity and Specificity,G17.800
23432507,2013-02-22T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23432507,2013-02-22T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23432507,2013-02-22T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23432507,2013-02-22T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23432507,2013-02-22T00:00:00,Treatment Outcome,E01.789.800
23432507,2013-02-22T00:00:00,Treatment Outcome,N04.761.559.590.800
23432507,2013-02-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23432507,2013-02-22T00:00:00,United States,Z01.107.567.875
23432971,2013-02-22T00:00:00,Animals,B01.050
23432971,2013-02-22T00:00:00,Antineoplastic Agents,D27.505.954.248
23432971,2013-02-22T00:00:00,Enzyme Inhibitors,D27.505.519.389
23432971,2013-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23432971,2013-02-22T00:00:00,Neoplasms,C04
23432971,2013-02-22T00:00:00,Polyamines,D02.092.782
23435159,2013-02-22T00:00:00,Adult,M01.060.116
23435159,2013-02-22T00:00:00,Aged,M01.060.116.100
23435159,2013-02-22T00:00:00,Blood Glucose,D09.546.359.448.500
23435159,2013-02-22T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23435159,2013-02-22T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23435159,2013-02-22T00:00:00,Hospitalization,E02.760.400
23435159,2013-02-22T00:00:00,Hospitalization,N02.421.585.400
23435159,2013-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23435159,2013-02-22T00:00:00,Hypoglycemic Agents,D27.505.696.422
23435159,2013-02-22T00:00:00,Insulin,D06.472.699.587.740.625
23435159,2013-02-22T00:00:00,Insulin,D12.644.548.586.740.625
23435159,2013-02-22T00:00:00,Middle Aged,M01.060.116.630
23435159,2013-02-22T00:00:00,"Surgical Procedures, Operative",E04
23435159,2013-02-22T00:00:00,Treatment Outcome,E01.789.800
23435159,2013-02-22T00:00:00,Treatment Outcome,N04.761.559.590.800
23435159,2013-02-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23436914,2013-02-22T00:00:00,Adolescent,M01.060.057
23436914,2013-02-22T00:00:00,Age Factors,N05.715.350.075
23436914,2013-02-22T00:00:00,Age Factors,N06.850.490.250
23436914,2013-02-22T00:00:00,Atherosclerosis,C14.907.137.126.307
23436914,2013-02-22T00:00:00,Biological Markers,D23.101
23436914,2013-02-22T00:00:00,C-Reactive Protein,D12.776.034.145
23436914,2013-02-22T00:00:00,C-Reactive Protein,D12.776.124.050.120
23436914,2013-02-22T00:00:00,C-Reactive Protein,D12.776.124.486.157
23436914,2013-02-22T00:00:00,Carotid Arteries,A07.231.114.186
23436914,2013-02-22T00:00:00,"Cholesterol, LDL",D10.532.515.500
23436914,2013-02-22T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
23436914,2013-02-22T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
23436914,2013-02-22T00:00:00,Disease Progression,C23.550.291.656
23436914,2013-02-22T00:00:00,Heptanoic Acids,D10.251.450
23436914,2013-02-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23436914,2013-02-22T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
23436914,2013-02-22T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
23436914,2013-02-22T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
23436914,2013-02-22T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23436914,2013-02-22T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23436914,2013-02-22T00:00:00,Pyrroles,D03.383.129.578
23436914,2013-02-22T00:00:00,Treatment Outcome,E01.789.800
23436914,2013-02-22T00:00:00,Treatment Outcome,N04.761.559.590.800
23436914,2013-02-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23413239,2013-02-25T00:00:00,Carbon,D01.268.150
23413239,2013-02-25T00:00:00,Fluorescent Dyes,D27.720.233.348
23413239,2013-02-25T00:00:00,Fluorescent Dyes,D27.720.470.330.348
23413239,2013-02-25T00:00:00,Fluorescent Dyes,D27.720.470.410.505.500
23439434,2013-02-25T00:00:00,Aged,M01.060.116.100
23439434,2013-02-25T00:00:00,Cell Line,A11.251.210
23439434,2013-02-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23439434,2013-02-25T00:00:00,Middle Aged,M01.060.116.630
23439434,2013-02-25T00:00:00,Osteitis Deformans,C05.116.692
23439434,2013-02-25T00:00:00,RANK Ligand,D12.644.276.374.750.562
23439434,2013-02-25T00:00:00,RANK Ligand,D12.644.276.972.562
23439434,2013-02-25T00:00:00,RANK Ligand,D12.776.467.374.750.562
23439434,2013-02-25T00:00:00,RANK Ligand,D12.776.467.972.562
23439434,2013-02-25T00:00:00,RANK Ligand,D23.529.374.750.562
23439434,2013-02-25T00:00:00,RANK Ligand,D23.529.972.562
23439434,2013-02-25T00:00:00,Signal Transduction,G02.111.087.800
23439434,2013-02-25T00:00:00,Signal Transduction,G02.149.115.800
23439434,2013-02-25T00:00:00,Signal Transduction,G04.299.880
23443134,2013-02-26T00:00:00,Acetylgalactosamine,D09.067.342.356.050
23443134,2013-02-26T00:00:00,Amino Acid Sequence,G02.111.570.060
23443134,2013-02-26T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23443134,2013-02-26T00:00:00,Animals,B01.050
23443134,2013-02-26T00:00:00,Glycoproteins,D09.400.430
23443134,2013-02-26T00:00:00,Glycoproteins,D12.776.395
23443134,2013-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23443134,2013-02-26T00:00:00,Molecular Sequence Data,L01.453.245.667
23443134,2013-02-26T00:00:00,Osteoblasts,A11.329.629
23443134,2013-02-26T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
23443134,2013-02-26T00:00:00,Osteogenesis,G11.427.590.560.100.729
23443134,2013-02-26T00:00:00,Peptide Fragments,D12.644.541
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
23443134,2013-02-26T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
23443134,2013-02-26T00:00:00,Proteome,D12.776.817
23443134,2013-02-26T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
23443736,2013-02-26T00:00:00,Adolescent,M01.060.057
23443736,2013-02-26T00:00:00,Adult,M01.060.116
23443736,2013-02-26T00:00:00,Animals,B01.050
23443736,2013-02-26T00:00:00,Complement System Proteins,D12.776.124.486.274
23443736,2013-02-26T00:00:00,Cytokines,D12.644.276.374
23443736,2013-02-26T00:00:00,Cytokines,D12.776.467.374
23443736,2013-02-26T00:00:00,Cytokines,D23.529.374
23443736,2013-02-26T00:00:00,Heart,A07.541
23443736,2013-02-26T00:00:00,Heart Transplantation,E04.100.376.475
23443736,2013-02-26T00:00:00,Heart Transplantation,E04.928.220.390
23443736,2013-02-26T00:00:00,Heart Transplantation,E04.936.450.475
23443736,2013-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23443736,2013-02-26T00:00:00,Middle Aged,M01.060.116.630
23443736,2013-02-26T00:00:00,"Models, Animal",E05.598
23443736,2013-02-26T00:00:00,Myocardium,A02.633.580
23443736,2013-02-26T00:00:00,Myocardium,A07.541.704
23443736,2013-02-26T00:00:00,Myocardium,A10.690.552.750
23443736,2013-02-26T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
23443736,2013-02-26T00:00:00,Reperfusion Injury,C14.907.725
23443736,2013-02-26T00:00:00,Reperfusion Injury,C23.550.767.877
23443736,2013-02-26T00:00:00,Tissue Donors,M01.898
23443736,2013-02-26T00:00:00,Young Adult,M01.060.116.815
23468913,2013-02-26T00:00:00,Animals,B01.050
23468913,2013-02-26T00:00:00,Binding Sites,G02.111.570.120
23468913,2013-02-26T00:00:00,Cell Line,A11.251.210
23468913,2013-02-26T00:00:00,Endocardium,A07.541.207
23468913,2013-02-26T00:00:00,Extracellular Matrix Proteins,D12.776.860.300
23468913,2013-02-26T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
23468913,2013-02-26T00:00:00,Heart,A07.541
23468913,2013-02-26T00:00:00,Molecular Sequence Data,L01.453.245.667
23468913,2013-02-26T00:00:00,Myocardium,A02.633.580
23468913,2013-02-26T00:00:00,Myocardium,A07.541.704
23468913,2013-02-26T00:00:00,Myocardium,A10.690.552.750
23468913,2013-02-26T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23468913,2013-02-26T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23468913,2013-02-26T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23468913,2013-02-26T00:00:00,"Transcription, Genetic",G02.111.087.847
23468913,2013-02-26T00:00:00,"Transcription, Genetic",G02.149.115.847
23468913,2013-02-26T00:00:00,"Transcription, Genetic",G05.355.310.700
23468913,2013-02-26T00:00:00,Transcriptional Activation,G05.355.315.800
23485014,2013-02-26T00:00:00,Adult,M01.060.116
23485014,2013-02-26T00:00:00,"Behavior, Addictive",F01.145.527.100.120
23485014,2013-02-26T00:00:00,Cues,F02.463.425.234
23485014,2013-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23485014,2013-02-26T00:00:00,Middle Aged,M01.060.116.630
23485014,2013-02-26T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23485014,2013-02-26T00:00:00,Smoking Cessation,F01.145.940.700
23485014,2013-02-26T00:00:00,Tobacco Use Disorder,C21.739.912
23485014,2013-02-26T00:00:00,Tobacco Use Disorder,F03.900.912
23485014,2013-02-26T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
23485014,2013-02-26T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
23485770,2013-02-26T00:00:00,Adenocarcinoma,C04.557.470.200.025
23485770,2013-02-26T00:00:00,Adult,M01.060.116
23485770,2013-02-26T00:00:00,Aged,M01.060.116.100
23485770,2013-02-26T00:00:00,Endometrial Neoplasms,C04.588.945.418.948.585
23485770,2013-02-26T00:00:00,Endometrial Neoplasms,C13.351.500.852.762.200
23485770,2013-02-26T00:00:00,Endometrial Neoplasms,C13.351.937.418.875.200
23485770,2013-02-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23485770,2013-02-26T00:00:00,Middle Aged,M01.060.116.630
23485770,2013-02-26T00:00:00,Questionnaires,E05.318.308.750
23485770,2013-02-26T00:00:00,Questionnaires,L01.280.800
23485770,2013-02-26T00:00:00,Questionnaires,N05.715.360.300.695
23485770,2013-02-26T00:00:00,Questionnaires,N06.850.520.308.750
23485770,2013-02-26T00:00:00,Risk Factors,E05.318.740.600.800.725
23485770,2013-02-26T00:00:00,Risk Factors,N05.715.350.200.700
23485770,2013-02-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23485770,2013-02-26T00:00:00,Risk Factors,N06.850.490.625.750
23485770,2013-02-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23447019,2013-02-27T00:00:00,Animals,B01.050
23447019,2013-02-27T00:00:00,Autoimmunity,G12.450.192
23447019,2013-02-27T00:00:00,Dendritic Cells,A11.066.270
23447019,2013-02-27T00:00:00,Dendritic Cells,A11.436.270
23447019,2013-02-27T00:00:00,Dendritic Cells,A15.382.066.270
23447019,2013-02-27T00:00:00,Dendritic Cells,A15.382.812.260
23447019,2013-02-27T00:00:00,Disease Progression,C23.550.291.656
23447019,2013-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23447019,2013-02-27T00:00:00,Inflammation,C23.550.470
23447019,2013-02-27T00:00:00,Lymphocyte Activation,E01.450.495.482
23447019,2013-02-27T00:00:00,Lymphocyte Activation,E05.478.594.530
23447019,2013-02-27T00:00:00,Lymphocyte Activation,G12.425.747
23447019,2013-02-27T00:00:00,Lymphocyte Activation,G12.450.050.400.545
23447019,2013-02-27T00:00:00,Peptides,D12.644
23447019,2013-02-27T00:00:00,Phenotype,G05.695
23447019,2013-02-27T00:00:00,Skin,A17.815
23447019,2013-02-27T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
23447019,2013-02-27T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
23447019,2013-02-27T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
23447019,2013-02-27T00:00:00,"Transcription, Genetic",G02.111.087.847
23447019,2013-02-27T00:00:00,"Transcription, Genetic",G02.149.115.847
23447019,2013-02-27T00:00:00,"Transcription, Genetic",G05.355.310.700
23447019,2013-02-27T00:00:00,Vaccination,E02.095.465.425.400.530.890
23447019,2013-02-27T00:00:00,Vaccination,E05.478.550.600.890
23447019,2013-02-27T00:00:00,Vaccination,N02.421.726.758.310.890
23447019,2013-02-27T00:00:00,Vaccination,N06.850.780.200.425.900
23447019,2013-02-27T00:00:00,Vaccination,N06.850.780.680.310.890
23447019,2013-02-27T00:00:00,Vitiligo,C17.800.621.440.895
23511065,2013-02-27T00:00:00,Adult,M01.060.116
23511065,2013-02-27T00:00:00,Age Factors,N05.715.350.075
23511065,2013-02-27T00:00:00,Age Factors,N06.850.490.250
23511065,2013-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23511065,2013-02-27T00:00:00,Middle Aged,M01.060.116.630
23511065,2013-02-27T00:00:00,Patient Selection,E05.581.500.653
23511065,2013-02-27T00:00:00,Patient Selection,N04.590.731
23511065,2013-02-27T00:00:00,Questionnaires,E05.318.308.750
23511065,2013-02-27T00:00:00,Questionnaires,L01.280.800
23511065,2013-02-27T00:00:00,Questionnaires,N05.715.360.300.695
23511065,2013-02-27T00:00:00,Questionnaires,N06.850.520.308.750
23511065,2013-02-27T00:00:00,Research Subjects,M01.774
23511065,2013-02-27T00:00:00,Self Efficacy,F01.752.747.792.700
23511065,2013-02-27T00:00:00,Smoking,F01.145.466.753
23511065,2013-02-27T00:00:00,Smoking Cessation,F01.145.940.700
23511065,2013-02-27T00:00:00,Social Support,I01.880.656.600
23517721,2013-02-27T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
23517721,2013-02-27T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
23517721,2013-02-27T00:00:00,Antineoplastic Agents,D27.505.954.248
23517721,2013-02-27T00:00:00,Arachidonate 5-Lipoxygenase,D08.811.682.690.416.444.050.055
23517721,2013-02-27T00:00:00,Arachidonate 5-Lipoxygenase,D12.776.556.579.374.450.025.020
23517721,2013-02-27T00:00:00,Cell Proliferation,G04.299.233.750
23517721,2013-02-27T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23517721,2013-02-27T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23517721,2013-02-27T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
23517721,2013-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23517721,2013-02-27T00:00:00,Hyaluronic Acid,D09.698.373.475
23517721,2013-02-27T00:00:00,"Models, Molecular",E05.599.595
23517721,2013-02-27T00:00:00,Molecular Structure,G02.111.570
23517721,2013-02-27T00:00:00,Molecular Structure,G02.575
23517721,2013-02-27T00:00:00,Molecular Structure,G02.842.575
23517721,2013-02-27T00:00:00,Signal Transduction,G02.111.087.800
23517721,2013-02-27T00:00:00,Signal Transduction,G02.149.115.800
23517721,2013-02-27T00:00:00,Signal Transduction,G04.299.880
23730981,2013-02-27T00:00:00,Blood Pressure,E01.370.600.875.249
23730981,2013-02-27T00:00:00,Blood Pressure,G09.330.380.076
23730981,2013-02-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23730981,2013-02-27T00:00:00,Potassium,D01.268.549.550
23730981,2013-02-27T00:00:00,Potassium,D01.552.528.652
23448506,2013-02-28T00:00:00,Animals,B01.050
23448506,2013-02-28T00:00:00,Arrestin,D12.776.306.090.050
23448506,2013-02-28T00:00:00,Arrestin,D12.776.543.090.050
23448506,2013-02-28T00:00:00,Arrestin,D23.050.301.280
23448506,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23448506,2013-02-28T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
23448506,2013-02-28T00:00:00,Osteogenesis,G11.427.590.560.100.729
23448506,2013-02-28T00:00:00,Protein Conformation,G02.111.570.790.709
23448506,2013-02-28T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.100.650.100
23448506,2013-02-28T00:00:00,"Receptor, Parathyroid Hormone, Type 1",D12.776.543.750.750.600.100
23448506,2013-02-28T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
23448506,2013-02-28T00:00:00,Signal Transduction,G02.111.087.800
23448506,2013-02-28T00:00:00,Signal Transduction,G02.149.115.800
23448506,2013-02-28T00:00:00,Signal Transduction,G04.299.880
23453434,2013-02-28T00:00:00,Adolescent,M01.060.057
23453434,2013-02-28T00:00:00,Adult,M01.060.116
23453434,2013-02-28T00:00:00,Environmental Pollutants,D27.888.284
23453434,2013-02-28T00:00:00,Fetal Blood,A12.207.152.200
23453434,2013-02-28T00:00:00,Fetal Blood,A15.145.300
23453434,2013-02-28T00:00:00,Fetal Blood,A16.378.200
23453434,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23453434,2013-02-28T00:00:00,Maternal-Fetal Exchange,G08.686.785.760.769.455
23453434,2013-02-28T00:00:00,Middle Aged,M01.060.116.630
23453434,2013-02-28T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
23453434,2013-02-28T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
23453434,2013-02-28T00:00:00,Pregnancy,G08.686.785.760.769
23453434,2013-02-28T00:00:00,Questionnaires,E05.318.308.750
23453434,2013-02-28T00:00:00,Questionnaires,L01.280.800
23453434,2013-02-28T00:00:00,Questionnaires,N05.715.360.300.695
23453434,2013-02-28T00:00:00,Questionnaires,N06.850.520.308.750
23453434,2013-02-28T00:00:00,Young Adult,M01.060.116.815
23453771,2013-02-28T00:00:00,"Child, Preschool",M01.060.406.448
23453771,2013-02-28T00:00:00,Disease Progression,C23.550.291.656
23453771,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C04.588.149.721.656
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C04.588.364.659
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C05.116.231.754.659
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C11.319.457
23453771,2013-02-28T00:00:00,Orbital Neoplasms,C11.675.659
23453771,2013-02-28T00:00:00,Rhabdomyosarcoma,C04.557.450.590.550.660
23453771,2013-02-28T00:00:00,Rhabdomyosarcoma,C04.557.450.795.550.660
23468611,2013-02-28T00:00:00,Amino Acid Sequence,G02.111.570.060
23468611,2013-02-28T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23468611,2013-02-28T00:00:00,Animals,B01.050
23468611,2013-02-28T00:00:00,Computer Simulation,L01.224.160
23468611,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23468611,2013-02-28T00:00:00,Hydrogen Bonding,G02.149.767.620
23468611,2013-02-28T00:00:00,Hydrogen Bonding,G02.842.750.620
23468611,2013-02-28T00:00:00,"Models, Molecular",E05.599.595
23468611,2013-02-28T00:00:00,Molecular Sequence Data,L01.453.245.667
23468611,2013-02-28T00:00:00,Protein Conformation,G02.111.570.790.709
23468611,2013-02-28T00:00:00,Static Electricity,G01.201.249.820
23468661,2013-02-28T00:00:00,3' Untranslated Regions,D13.444.735.544.875.880
23468661,2013-02-28T00:00:00,3' Untranslated Regions,D13.444.735.790.878.880
23468661,2013-02-28T00:00:00,3' Untranslated Regions,G05.360.340.024.220.880.880
23468661,2013-02-28T00:00:00,3' Untranslated Regions,G05.360.340.024.340.137.910.880
23468661,2013-02-28T00:00:00,African Americans,M01.686.508.100.100
23468661,2013-02-28T00:00:00,African Americans,M01.686.754.100
23468661,2013-02-28T00:00:00,Alleles,G05.360.340.024.340.030
23468661,2013-02-28T00:00:00,European Continental Ancestry Group,M01.686.508.400
23468661,2013-02-28T00:00:00,Gene Expression Regulation,G05.355.315
23468661,2013-02-28T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23468661,2013-02-28T00:00:00,Genetic Predisposition to Disease,G05.380.355
23468661,2013-02-28T00:00:00,Hispanic Americans,M01.686.754.441
23468661,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23468661,2013-02-28T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23468661,2013-02-28T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23468661,2013-02-28T00:00:00,MicroRNAs,D13.150.650.319
23468661,2013-02-28T00:00:00,MicroRNAs,D13.444.735.150.319
23468661,2013-02-28T00:00:00,MicroRNAs,D13.444.735.790.099
23468661,2013-02-28T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23597335,2013-02-28T00:00:00,Aged,M01.060.116.100
23597335,2013-02-28T00:00:00,Caregivers,M01.085
23597335,2013-02-28T00:00:00,Caregivers,M01.526.485.200
23597335,2013-02-28T00:00:00,Caregivers,N02.360.200
23597335,2013-02-28T00:00:00,Dyspnea,C08.618.326
23597335,2013-02-28T00:00:00,Dyspnea,C23.888.852.371
23597335,2013-02-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23597335,2013-02-28T00:00:00,Middle Aged,M01.060.116.630
23597335,2013-02-28T00:00:00,Psychophysiologic Disorders,C23.888.592.700
23597335,2013-02-28T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
23597335,2013-02-28T00:00:00,Questionnaires,E05.318.308.750
23597335,2013-02-28T00:00:00,Questionnaires,L01.280.800
23597335,2013-02-28T00:00:00,Questionnaires,N05.715.360.300.695
23597335,2013-02-28T00:00:00,Questionnaires,N06.850.520.308.750
23597335,2013-02-28T00:00:00,Risk Factors,E05.318.740.600.800.725
23597335,2013-02-28T00:00:00,Risk Factors,N05.715.350.200.700
23597335,2013-02-28T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23597335,2013-02-28T00:00:00,Risk Factors,N06.850.490.625.750
23597335,2013-02-28T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23597335,2013-02-28T00:00:00,Social Perception,F02.463.593.752
23597335,2013-02-28T00:00:00,"Stress, Psychological",F01.145.126.990
23597335,2013-02-28T00:00:00,"Stress, Psychological",F02.830.900
23192532,2013-03-01T00:00:00,Computer Simulation,L01.224.160
23192532,2013-03-01T00:00:00,Electromagnetic Fields,G01.201.260
23192532,2013-03-01T00:00:00,Electromagnetic Fields,G01.201.875.240
23192532,2013-03-01T00:00:00,Electrophoresis,E05.196.401
23192532,2013-03-01T00:00:00,Electrophoresis,E05.301.300
23192532,2013-03-01T00:00:00,Electrophoresis,G02.149.767.570
23192532,2013-03-01T00:00:00,Electrophoresis,G02.842.750.570
23192532,2013-03-01T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
23192532,2013-03-01T00:00:00,Microfluidic Analytical Techniques,E05.588.465
23192532,2013-03-01T00:00:00,"Models, Theoretical",E05.599
23258773,2013-03-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
23258773,2013-03-01T00:00:00,Environmental Monitoring,N06.850.780.375
23258773,2013-03-01T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
23258773,2013-03-01T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
23258773,2013-03-01T00:00:00,Rivers,G01.311.750
23258773,2013-03-01T00:00:00,Rivers,G16.500.275.280.500
23258773,2013-03-01T00:00:00,Rivers,N06.230.232.500
23258773,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23258773,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23258773,2013-03-01T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23338772,2013-03-01T00:00:00,"Diagnosis, Differential",E01.171
23338772,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23359110,2013-03-01T00:00:00,Brain-Derived Neurotrophic Factor,D12.644.276.860.100
23359110,2013-03-01T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.467.860.100
23359110,2013-03-01T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.641.600.100
23359110,2013-03-01T00:00:00,Brain-Derived Neurotrophic Factor,D23.529.850.100
23359110,2013-03-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
23359110,2013-03-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
23359110,2013-03-01T00:00:00,Cocaine-Related Disorders,C21.739.300
23359110,2013-03-01T00:00:00,Cocaine-Related Disorders,F03.900.300
23359110,2013-03-01T00:00:00,DNA Methylation,G02.111.087.029.538.161
23359110,2013-03-01T00:00:00,DNA Methylation,G02.111.087.218
23359110,2013-03-01T00:00:00,DNA Methylation,G02.149.115.029.538.161
23359110,2013-03-01T00:00:00,DNA Methylation,G02.149.115.218
23359110,2013-03-01T00:00:00,DNA Methylation,G03.495.130.538.161
23359110,2013-03-01T00:00:00,DNA Methylation,G05.355.190
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.318.416.249
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.318.780.392
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.393.385.500
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.393.522.500
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23359110,2013-03-01T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23359110,2013-03-01T00:00:00,Histones,D12.776.660.470
23359110,2013-03-01T00:00:00,Histones,D12.776.664.469
23359110,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23359110,2013-03-01T00:00:00,MicroRNAs,D13.150.650.319
23359110,2013-03-01T00:00:00,MicroRNAs,D13.444.735.150.319
23359110,2013-03-01T00:00:00,MicroRNAs,D13.444.735.790.099
23359110,2013-03-01T00:00:00,Substance-Related Disorders,C21.739
23359110,2013-03-01T00:00:00,Substance-Related Disorders,F03.900
23359110,2013-03-01T00:00:00,"Transcription, Genetic",G02.111.087.847
23359110,2013-03-01T00:00:00,"Transcription, Genetic",G02.149.115.847
23359110,2013-03-01T00:00:00,"Transcription, Genetic",G05.355.310.700
23379433,2013-03-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
23379433,2013-03-01T00:00:00,Alleles,G05.360.340.024.340.030
23379433,2013-03-01T00:00:00,Breast Neoplasms,C04.588.180
23379433,2013-03-01T00:00:00,Breast Neoplasms,C17.800.090.500
23379433,2013-03-01T00:00:00,Continental Population Groups,M01.686.508
23379433,2013-03-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23379433,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23379433,2013-03-01T00:00:00,"Immunity, Humoral",G12.450.050.420
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
23379433,2013-03-01T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
23379433,2013-03-01T00:00:00,"Receptor, erbB-2",D23.101.840.642
23379433,2013-03-01T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
23379433,2013-03-01T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
23379433,2013-03-01T00:00:00,"Receptors, IgG",D23.101.100.110.695
23391867,2013-03-01T00:00:00,Fiber Optic Technology,H01.671.617.249
23391867,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23404842,2013-03-01T00:00:00,Adult,M01.060.116
23404842,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23404842,2013-03-01T00:00:00,Insulin Resistance,C18.452.394.968.500
23404842,2013-03-01T00:00:00,Insulin Resistance,G07.690.320.617
23404842,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23404842,2013-03-01T00:00:00,"Muscle, Skeletal",A02.633.567
23404842,2013-03-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
23404842,2013-03-01T00:00:00,Muscular Atrophy,C10.597.613.612
23404842,2013-03-01T00:00:00,Muscular Atrophy,C23.300.070.500
23404842,2013-03-01T00:00:00,Muscular Atrophy,C23.888.592.608.612
23404842,2013-03-01T00:00:00,Myogenin,D12.776.210.500.570.600
23404842,2013-03-01T00:00:00,Myogenin,D12.776.260.103.750.600
23404842,2013-03-01T00:00:00,Myogenin,D12.776.930.125.750.600
23404842,2013-03-01T00:00:00,Obesity,C18.654.726.500
23404842,2013-03-01T00:00:00,Obesity,C23.888.144.699.500
23404842,2013-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23404842,2013-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23404842,2013-03-01T00:00:00,RNA,D13.444.735
23404842,2013-03-01T00:00:00,Signal Transduction,G02.111.087.800
23404842,2013-03-01T00:00:00,Signal Transduction,G02.149.115.800
23404842,2013-03-01T00:00:00,Signal Transduction,G04.299.880
23404842,2013-03-01T00:00:00,Transcription Factors,D12.776.930
23404842,2013-03-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
23404842,2013-03-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
23404842,2013-03-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
23404842,2013-03-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
23404842,2013-03-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
23404842,2013-03-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
23404842,2013-03-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
23404842,2013-03-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
23404842,2013-03-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
23414497,2013-03-01T00:00:00,Adult,M01.060.116
23414497,2013-03-01T00:00:00,Cocaine-Related Disorders,C21.739.300
23414497,2013-03-01T00:00:00,Cocaine-Related Disorders,F03.900.300
23414497,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23414497,2013-03-01T00:00:00,Life Change Events,F01.829.458.410
23414497,2013-03-01T00:00:00,Opioid-Related Disorders,C21.739.675
23414497,2013-03-01T00:00:00,Opioid-Related Disorders,F03.900.675
23414497,2013-03-01T00:00:00,Prescription Drugs,D26.670
23414497,2013-03-01T00:00:00,Sex Offenses,I01.198.240.748
23414497,2013-03-01T00:00:00,"Stress, Psychological",F01.145.126.990
23414497,2013-03-01T00:00:00,"Stress, Psychological",F02.830.900
23414497,2013-03-01T00:00:00,Tobacco Use Disorder,C21.739.912
23414497,2013-03-01T00:00:00,Tobacco Use Disorder,F03.900.912
23414497,2013-03-01T00:00:00,Wounds and Injuries,C21.866
23415116,2013-03-01T00:00:00,Adolescent,M01.060.057
23415116,2013-03-01T00:00:00,Adult,M01.060.116
23415116,2013-03-01T00:00:00,Drug Delivery Systems,E02.319.300
23415116,2013-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23415116,2013-03-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23415116,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23415116,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23415116,2013-03-01T00:00:00,Nicotine,D03.132.760.570
23415116,2013-03-01T00:00:00,Nicotine,D03.383.725.518
23415116,2013-03-01T00:00:00,Smoking,F01.145.466.753
23415116,2013-03-01T00:00:00,Young Adult,M01.060.116.815
23421569,2013-03-01T00:00:00,Adult,M01.060.116
23421569,2013-03-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
23421569,2013-03-01T00:00:00,Benzazepines,D03.438.079
23421569,2013-03-01T00:00:00,Cues,F02.463.425.234
23421569,2013-03-01T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
23421569,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23421569,2013-03-01T00:00:00,Learning,F02.463.425
23421569,2013-03-01T00:00:00,Learning,F02.784.629.529
23421569,2013-03-01T00:00:00,Neural Pathways,A08.612
23421569,2013-03-01T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
23421569,2013-03-01T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
23421569,2013-03-01T00:00:00,Pilot Projects,E05.318.760.750
23421569,2013-03-01T00:00:00,Pilot Projects,E05.337.737
23421569,2013-03-01T00:00:00,Pilot Projects,N05.715.360.775.625
23421569,2013-03-01T00:00:00,Pilot Projects,N06.850.520.450.720
23421569,2013-03-01T00:00:00,Smoking,F01.145.466.753
23421569,2013-03-01T00:00:00,Smoking Cessation,F01.145.940.700
23421569,2013-03-01T00:00:00,Tobacco Use Disorder,C21.739.912
23421569,2013-03-01T00:00:00,Tobacco Use Disorder,F03.900.912
23422526,2013-03-01T00:00:00,Adolescent,M01.060.057
23422526,2013-03-01T00:00:00,Adult,M01.060.116
23422526,2013-03-01T00:00:00,Aged,M01.060.116.100
23422526,2013-03-01T00:00:00,Electroconvulsive Therapy,F04.570.200.583
23422526,2013-03-01T00:00:00,Electroconvulsive Therapy,F04.669.224.300
23422526,2013-03-01T00:00:00,Electroencephalography,E01.370.376.300
23422526,2013-03-01T00:00:00,Electroencephalography,E01.370.405.245
23422526,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23422526,2013-03-01T00:00:00,Length of Stay,E02.760.400.480
23422526,2013-03-01T00:00:00,Length of Stay,N02.421.585.400.480
23422526,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23422526,2013-03-01T00:00:00,Seizures,C10.228.140.490.631
23422526,2013-03-01T00:00:00,Seizures,C10.597.742
23422526,2013-03-01T00:00:00,Seizures,C23.888.592.742
23422526,2013-03-01T00:00:00,Treatment Outcome,E01.789.800
23422526,2013-03-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23422526,2013-03-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23422526,2013-03-01T00:00:00,Young Adult,M01.060.116.815
23425740,2013-03-01T00:00:00,Adult,M01.060.116
23425740,2013-03-01T00:00:00,"Hospitals, Community",N02.278.421.306
23425740,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425740,2013-03-01T00:00:00,Incidence,E05.318.308.985.525.375
23425740,2013-03-01T00:00:00,Incidence,L01.280.975.525.375
23425740,2013-03-01T00:00:00,Incidence,N01.224.935.597.500
23425740,2013-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23425740,2013-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23425740,2013-03-01T00:00:00,Patient Transfer,E02.760.400.630
23425740,2013-03-01T00:00:00,Patient Transfer,N02.421.585.400.630
23425740,2013-03-01T00:00:00,Radiation Dosage,E05.799.513
23425740,2013-03-01T00:00:00,Radiation Dosage,G01.201.875.740
23425740,2013-03-01T00:00:00,Radiation Dosage,N06.850.810.250
23425740,2013-03-01T00:00:00,Radiation Injuries,C21.866.733
23425740,2013-03-01T00:00:00,Radiation Injuries,N06.850.810.300.360
23425740,2013-03-01T00:00:00,Respiration,G09.772.770.755
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23425740,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23425740,2013-03-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
23425740,2013-03-01T00:00:00,Trauma Centers,N02.421.297.195.480
23425740,2013-03-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
23425740,2013-03-01T00:00:00,United States,Z01.107.567.875
23425740,2013-03-01T00:00:00,Unnecessary Procedures,N02.421.380.900
23425740,2013-03-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
23425740,2013-03-01T00:00:00,Wounds and Injuries,C21.866
23426240,2013-03-01T00:00:00,Child Abuse,I01.198.240.856.350.250
23426240,2013-03-01T00:00:00,Child Abuse,I01.880.735.900.350.250
23426240,2013-03-01T00:00:00,Child Abuse,I01.880.787.293.292
23426240,2013-03-01T00:00:00,"Child, Preschool",M01.060.406.448
23426240,2013-03-01T00:00:00,Craniocerebral Trauma,C10.900.300
23426240,2013-03-01T00:00:00,Craniocerebral Trauma,C21.866.260
23426240,2013-03-01T00:00:00,Craniocerebral Trauma,C21.866.915.300
23426240,2013-03-01T00:00:00,"Diagnosis, Differential",E01.171
23426240,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23426240,2013-03-01T00:00:00,Incidence,E05.318.308.985.525.375
23426240,2013-03-01T00:00:00,Incidence,L01.280.975.525.375
23426240,2013-03-01T00:00:00,Incidence,N01.224.935.597.500
23426240,2013-03-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23426240,2013-03-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23426240,2013-03-01T00:00:00,Infant,M01.060.703
23426240,2013-03-01T00:00:00,"Infant, Newborn",M01.060.703.520
23426240,2013-03-01T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
23426240,2013-03-01T00:00:00,Intracranial Hemorrhages,C14.907.253.573
23426240,2013-03-01T00:00:00,Intracranial Hemorrhages,C23.550.414.913
23426240,2013-03-01T00:00:00,Poisson Distribution,E05.318.740.994.750
23426240,2013-03-01T00:00:00,Poisson Distribution,G17.820.750
23426240,2013-03-01T00:00:00,Poisson Distribution,N05.715.360.750.750.620
23426240,2013-03-01T00:00:00,Poisson Distribution,N06.850.520.830.994.750
23426240,2013-03-01T00:00:00,Population Surveillance,E05.318.308.250.700
23426240,2013-03-01T00:00:00,Population Surveillance,N05.715.360.300.375.625
23426240,2013-03-01T00:00:00,Population Surveillance,N06.850.520.308.250.700
23426240,2013-03-01T00:00:00,Population Surveillance,N06.850.780.675
23426240,2013-03-01T00:00:00,Retinal Hemorrhage,C11.290.807
23426240,2013-03-01T00:00:00,Retinal Hemorrhage,C11.768.710
23426240,2013-03-01T00:00:00,Retinal Hemorrhage,C23.550.414.756.775
23426240,2013-03-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23426240,2013-03-01T00:00:00,Risk Factors,N05.715.350.200.700
23426240,2013-03-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23426240,2013-03-01T00:00:00,Risk Factors,N06.850.490.625.750
23426240,2013-03-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23426240,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23426240,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23434251,2013-03-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
23434251,2013-03-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
23434251,2013-03-01T00:00:00,Consumer Health Information,I02.233.332.186
23434251,2013-03-01T00:00:00,Consumer Health Information,N02.421.143.827.407.228
23434251,2013-03-01T00:00:00,Consumer Health Information,N02.421.726.407.228
23434251,2013-03-01T00:00:00,Decision Making,F02.463.785.373
23434251,2013-03-01T00:00:00,Delivery of Health Care,N04.590.374
23434251,2013-03-01T00:00:00,Delivery of Health Care,N05.300
23434251,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23434251,2013-03-01T00:00:00,"Specialties, Surgical",H02.403.810
23434251,2013-03-01T00:00:00,United States,Z01.107.567.875
23438517,2013-03-01T00:00:00,Career Choice,F02.463.785.373.346.400
23438517,2013-03-01T00:00:00,Hepacivirus,B04.450.410
23438517,2013-03-01T00:00:00,Hepacivirus,B04.820.250.475
23438517,2013-03-01T00:00:00,Hepacivirus,B04.909.777.310.475
23438517,2013-03-01T00:00:00,"Hepatitis C, Chronic",C02.440.440.120
23438517,2013-03-01T00:00:00,"Hepatitis C, Chronic",C02.782.350.350.120
23438517,2013-03-01T00:00:00,"Hepatitis C, Chronic",C06.552.380.350.120
23438517,2013-03-01T00:00:00,"Hepatitis C, Chronic",C06.552.380.705.440.120
23438517,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23438517,2013-03-01T00:00:00,Internship and Residency,I02.358.399.644
23438527,2013-03-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
23438527,2013-03-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
23438527,2013-03-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
23438527,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23438527,2013-03-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23438527,2013-03-01T00:00:00,Lung Neoplasms,C08.381.540
23438527,2013-03-01T00:00:00,Lung Neoplasms,C08.785.520
23438527,2013-03-01T00:00:00,Pneumonectomy,E04.928.600.600
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.840.830
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.950.830
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.840.830
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.950.830
23438527,2013-03-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.928.752.830
23448420,2013-03-01T00:00:00,Adult,M01.060.116
23448420,2013-03-01T00:00:00,African Americans,M01.686.508.100.100
23448420,2013-03-01T00:00:00,African Americans,M01.686.754.100
23448420,2013-03-01T00:00:00,Child,M01.060.406
23448420,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23448420,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23448420,2013-03-01T00:00:00,Patient Selection,E05.581.500.653
23448420,2013-03-01T00:00:00,Patient Selection,N04.590.731
23448420,2013-03-01T00:00:00,Research Design,E05.581.500
23448420,2013-03-01T00:00:00,Research Design,H01.770.644.728
23448420,2013-03-01T00:00:00,Rural Population,N01.600.725
23448420,2013-03-01T00:00:00,Smoking,F01.145.466.753
23448420,2013-03-01T00:00:00,United States,Z01.107.567.875
23448420,2013-03-01T00:00:00,Urban Population,N01.600.900
23448818,2013-03-01T00:00:00,Adult,M01.060.116
23448818,2013-03-01T00:00:00,Ambulatory Care,E02.760.106
23448818,2013-03-01T00:00:00,Ambulatory Care,N02.421.585.106
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,A12.207.152.846.500.203
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,D12.776.124.486.485.114.573.203
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,D12.776.124.790.651.114.573.203
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,D12.776.377.715.548.114.573.203
23448818,2013-03-01T00:00:00,Antilymphocyte Serum,D20.215.401.203
23448818,2013-03-01T00:00:00,Graft Rejection,G12.425.901.545.328
23448818,2013-03-01T00:00:00,Health Care Costs,N03.219.151.400
23448818,2013-03-01T00:00:00,Health Care Costs,N05.300.375
23448818,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23448818,2013-03-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23448818,2013-03-01T00:00:00,Kidney Transplantation,E02.870.500
23448818,2013-03-01T00:00:00,Kidney Transplantation,E04.936.450.485
23448818,2013-03-01T00:00:00,Kidney Transplantation,E04.950.774.400
23448818,2013-03-01T00:00:00,Length of Stay,E02.760.400.480
23448818,2013-03-01T00:00:00,Length of Stay,N02.421.585.400.480
23448818,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23448818,2013-03-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23448818,2013-03-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23448818,2013-03-01T00:00:00,Patient Readmission,E02.760.400.620
23448818,2013-03-01T00:00:00,Patient Readmission,N02.421.585.400.620
23448818,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23448818,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23449699,2013-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
23449699,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23449699,2013-03-01T00:00:00,Hyperprolactinemia,C10.228.140.617.738.250.450
23449699,2013-03-01T00:00:00,Hyperprolactinemia,C19.700.355.600
23449699,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23449699,2013-03-01T00:00:00,Risperidone,D03.383.742.698.685
23452479,2013-03-01T00:00:00,Computer-Assisted Instruction,I02.903.573.208
23452479,2013-03-01T00:00:00,Curriculum,I02.158
23452479,2013-03-01T00:00:00,Educational Measurement,I02.399
23452479,2013-03-01T00:00:00,Health Physics,H01.671.368
23452479,2013-03-01T00:00:00,Health Physics,H02.229.333
23452479,2013-03-01T00:00:00,Internship and Residency,I02.358.399.644
23452479,2013-03-01T00:00:00,Program Evaluation,E05.337.820
23452479,2013-03-01T00:00:00,Program Evaluation,N04.761.685
23452479,2013-03-01T00:00:00,Program Evaluation,N05.715.360.650
23452479,2013-03-01T00:00:00,Radiology,H02.403.740
23452479,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23452479,2013-03-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23455498,2013-03-01T00:00:00,Animals,B01.050
23455498,2013-03-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
23455498,2013-03-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
23455498,2013-03-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
23455498,2013-03-01T00:00:00,Interleukin-10,D12.644.276.374.465.510
23455498,2013-03-01T00:00:00,Interleukin-10,D12.776.467.374.465.510
23455498,2013-03-01T00:00:00,Interleukin-10,D23.529.374.465.510
23455498,2013-03-01T00:00:00,Macrophages,A11.329.372
23455498,2013-03-01T00:00:00,Macrophages,A11.627.482
23455498,2013-03-01T00:00:00,Macrophages,A11.733.397
23455498,2013-03-01T00:00:00,Macrophages,A15.382.680.397
23455498,2013-03-01T00:00:00,Macrophages,A15.382.812.522
23455498,2013-03-01T00:00:00,Pregnancy,G08.686.785.760.769
23455498,2013-03-01T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
23455498,2013-03-01T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
23455498,2013-03-01T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
23455498,2013-03-01T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
23455498,2013-03-01T00:00:00,Uterus,A05.360.319.679
23457180,2013-03-01T00:00:00,Acetylcysteine,D02.886.030.230.259
23457180,2013-03-01T00:00:00,Acetylcysteine,D12.125.166.230.259
23457180,2013-03-01T00:00:00,Age of Onset,N05.715.350.075.100
23457180,2013-03-01T00:00:00,Age of Onset,N06.850.490.250.100
23457180,2013-03-01T00:00:00,Animals,B01.050
23457180,2013-03-01T00:00:00,Basal Ganglia,A08.186.211.730.885.287.249
23457180,2013-03-01T00:00:00,"Behavior, Addictive",F01.145.527.100.120
23457180,2013-03-01T00:00:00,Bipolar Disorder,F03.600.150.150
23457180,2013-03-01T00:00:00,Brain-Derived Neurotrophic Factor,D12.644.276.860.100
23457180,2013-03-01T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.467.860.100
23457180,2013-03-01T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.641.600.100
23457180,2013-03-01T00:00:00,Brain-Derived Neurotrophic Factor,D23.529.850.100
23457180,2013-03-01T00:00:00,Cocaine,D02.145.074.722.388
23457180,2013-03-01T00:00:00,Cocaine,D03.132.889.354
23457180,2013-03-01T00:00:00,Cocaine,D03.605.869.388
23457180,2013-03-01T00:00:00,Cocaine,D04.075.080.875.099.722.388
23457180,2013-03-01T00:00:00,Cocaine-Related Disorders,C21.739.300
23457180,2013-03-01T00:00:00,Cocaine-Related Disorders,F03.900.300
23457180,2013-03-01T00:00:00,Disease Progression,C23.550.291.656
23457180,2013-03-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
23457180,2013-03-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
23457180,2013-03-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
23457180,2013-03-01T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
23457180,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23457180,2013-03-01T00:00:00,"Stress, Psychological",F01.145.126.990
23457180,2013-03-01T00:00:00,"Stress, Psychological",F02.830.900
23458289,2013-03-01T00:00:00,Animals,B01.050
23458289,2013-03-01T00:00:00,Chorioallantoic Membrane,A10.615.284.375
23458289,2013-03-01T00:00:00,Chorioallantoic Membrane,A13.350.575
23458289,2013-03-01T00:00:00,Chorioallantoic Membrane,A16.331.400
23458289,2013-03-01T00:00:00,Progesterone,D04.808.745.745.654.829
23458289,2013-03-01T00:00:00,Progesterone,D06.472.334.734.623
23458289,2013-03-01T00:00:00,Progesterone,D06.472.334.851.687.750
23458289,2013-03-01T00:00:00,"Receptors, Androgen",D12.776.260.698.750.150
23458289,2013-03-01T00:00:00,"Receptors, Androgen",D12.776.826.750.150
23458289,2013-03-01T00:00:00,"Receptors, Androgen",D12.776.930.669.750.150
23458289,2013-03-01T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
23458289,2013-03-01T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
23458289,2013-03-01T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
23458289,2013-03-01T00:00:00,Steroids,D04.808
23458289,2013-03-01T00:00:00,Turtles,B01.050.150.900.833.848
23460146,2013-03-01T00:00:00,Communication,F01.145.209
23460146,2013-03-01T00:00:00,Communication,L01.143
23460146,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23460146,2013-03-01T00:00:00,Lung Diseases,C08.381
23460146,2013-03-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23460146,2013-03-01T00:00:00,Physician-Patient Relations,N05.300.660.625
23460146,2013-03-01T00:00:00,Solitary Pulmonary Nodule,C04.588.894.797.520.966
23460146,2013-03-01T00:00:00,Solitary Pulmonary Nodule,C08.381.540.933
23460146,2013-03-01T00:00:00,Solitary Pulmonary Nodule,C08.381.884
23460146,2013-03-01T00:00:00,Solitary Pulmonary Nodule,C08.785.520.933
23460177,2013-03-01T00:00:00,Aircraft,J01.937.285.100
23460177,2013-03-01T00:00:00,Anoxia,C23.888.852.079
23460177,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23460177,2013-03-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
23460177,2013-03-01T00:00:00,Occupational Exposure,N06.850.460.350.600
23460177,2013-03-01T00:00:00,Travel,I03.883
23462139,2013-03-01T00:00:00,Academic Medical Centers,N02.278.020
23462139,2013-03-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
23462139,2013-03-01T00:00:00,Data Collection,E05.318.308
23462139,2013-03-01T00:00:00,Data Collection,L01.280
23462139,2013-03-01T00:00:00,Data Collection,N05.715.360.300
23462139,2013-03-01T00:00:00,Data Collection,N06.850.520.308
23462139,2013-03-01T00:00:00,"Efficiency, Organizational",N04.452.227
23462139,2013-03-01T00:00:00,Home Care Services,N02.421.143.524
23462139,2013-03-01T00:00:00,Home Care Services,N02.421.539.089
23462139,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23462139,2013-03-01T00:00:00,Information Systems,L01.700.508.300
23462139,2013-03-01T00:00:00,Organizational Innovation,N04.452.610
23462139,2013-03-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
23462139,2013-03-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
23462139,2013-03-01T00:00:00,Patient Satisfaction,N05.715.360.600
23462139,2013-03-01T00:00:00,"Pharmacy Service, Hospital",N02.278.354.422.603
23462139,2013-03-01T00:00:00,"Pharmacy Service, Hospital",N02.421.668.556
23462139,2013-03-01T00:00:00,"Pharmacy Service, Hospital",N04.452.442.422.603
23462139,2013-03-01T00:00:00,Professional Role,F01.829.316.616.625
23462139,2013-03-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
23462139,2013-03-01T00:00:00,Quality of Health Care,N04.761
23462139,2013-03-01T00:00:00,Quality of Health Care,N05.715
23466141,2013-03-01T00:00:00,Diabetic Ketoacidosis,C18.452.076.176.390
23466141,2013-03-01T00:00:00,Diabetic Ketoacidosis,C18.452.394.750.535
23466141,2013-03-01T00:00:00,Diabetic Ketoacidosis,C19.246.099.812
23466141,2013-03-01T00:00:00,Emergency Medicine,H02.403.250
23466141,2013-03-01T00:00:00,Fluid Therapy,E02.319.360
23466141,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23466141,2013-03-01T00:00:00,Hypercalcemia,C18.452.174.451
23466141,2013-03-01T00:00:00,Hypercalcemia,C18.452.950.340
23466141,2013-03-01T00:00:00,Hyperparathyroidism,C19.642.355
23466141,2013-03-01T00:00:00,Insulin,D06.472.699.587.740.625
23466141,2013-03-01T00:00:00,Insulin,D12.644.548.586.740.625
23466141,2013-03-01T00:00:00,North America,Z01.107.567
23466141,2013-03-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23466141,2013-03-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23466141,2013-03-01T00:00:00,Pregnancy,G08.686.785.760.769
23466141,2013-03-01T00:00:00,Pregnancy Complications,C13.703
23466141,2013-03-01T00:00:00,Thyroid Crisis,C19.874.397.685.905
23466141,2013-03-01T00:00:00,Thyroid Crisis,C19.874.902.905
23486380,2013-03-01T00:00:00,Actins,D05.750.078.730.250
23486380,2013-03-01T00:00:00,Actins,D12.776.210.500.100
23486380,2013-03-01T00:00:00,Actins,D12.776.220.525.255
23486380,2013-03-01T00:00:00,Adsorption,G02.149.047
23486380,2013-03-01T00:00:00,Adsorption,G02.149.767.029
23486380,2013-03-01T00:00:00,Adsorption,G02.842.750.029
23486380,2013-03-01T00:00:00,Alloys,D01.552.033
23486380,2013-03-01T00:00:00,Alloys,D25.058
23486380,2013-03-01T00:00:00,Alloys,J01.637.051.058
23486380,2013-03-01T00:00:00,Animals,B01.050
23486380,2013-03-01T00:00:00,Endothelial Cells,A11.436.275
23486380,2013-03-01T00:00:00,Fibrinogen,D12.776.124.050.250
23486380,2013-03-01T00:00:00,Fibrinogen,D12.776.124.125.500
23486380,2013-03-01T00:00:00,Fibrinogen,D12.776.811.300
23486380,2013-03-01T00:00:00,Fibrinogen,D23.119.490
23486380,2013-03-01T00:00:00,Graphite,D01.268.150.300
23486380,2013-03-01T00:00:00,Graphite,D01.578.300
23486380,2013-03-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23486380,2013-03-01T00:00:00,"Microscopy, Confocal",E05.595.395
23486380,2013-03-01T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
23486380,2013-03-01T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
23486380,2013-03-01T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
23486380,2013-03-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23486380,2013-03-01T00:00:00,Serum Albumin,D12.776.034.841
23486380,2013-03-01T00:00:00,Serum Albumin,D12.776.124.050.700
23486380,2013-03-01T00:00:00,Serum Albumin,D12.776.124.727
23486380,2013-03-01T00:00:00,"Spectrum Analysis, Raman",E05.196.822.860
23486380,2013-03-01T00:00:00,"Spectrum Analysis, Raman",E05.196.867.890
23486380,2013-03-01T00:00:00,Stents,E07.695.750
23527652,2013-03-01T00:00:00,Adult,M01.060.116
23527652,2013-03-01T00:00:00,Brain Mapping,E01.370.350.086
23527652,2013-03-01T00:00:00,Brain Mapping,E01.370.376.149
23527652,2013-03-01T00:00:00,Brain Mapping,E05.132
23527652,2013-03-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
23527652,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23527652,2013-03-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
23527652,2013-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23527652,2013-03-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23527652,2013-03-01T00:00:00,"Memory, Short-Term",F02.463.425.540.407
23527652,2013-03-01T00:00:00,"Models, Neurological",E05.599.395.642
23527652,2013-03-01T00:00:00,"Models, Theoretical",E05.599
23527652,2013-03-01T00:00:00,Oxygen,D01.268.185.550
23527652,2013-03-01T00:00:00,Oxygen,D01.362.670
23527652,2013-03-01T00:00:00,Photic Stimulation,E05.723.729
23527652,2013-03-01T00:00:00,Reaction Time,F02.830.650
23527652,2013-03-01T00:00:00,Reaction Time,F04.669.817
23527652,2013-03-01T00:00:00,Reaction Time,G11.561.677
23527652,2013-03-01T00:00:00,Young Adult,M01.060.116.815
23528021,2013-03-01T00:00:00,Asthma,C08.127.108
23528021,2013-03-01T00:00:00,Asthma,C08.381.495.108
23528021,2013-03-01T00:00:00,Asthma,C08.674.095
23528021,2013-03-01T00:00:00,Asthma,C20.543.480.680.095
23528021,2013-03-01T00:00:00,Bronchiectasis,C08.127.384
23528021,2013-03-01T00:00:00,Cough,C08.618.248
23528021,2013-03-01T00:00:00,Cough,C23.888.852.293
23528021,2013-03-01T00:00:00,Disease Progression,C23.550.291.656
23528021,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23528021,2013-03-01T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
23528021,2013-03-01T00:00:00,Respiratory Sounds,C23.888.852.779
23528021,2013-03-01T00:00:00,Respiratory Sounds,E01.370.386.720
23528021,2013-03-01T00:00:00,Respiratory Sounds,G09.772.775
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23528021,2013-03-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23528021,2013-03-01T00:00:00,alpha 1-Antitrypsin Deficiency,C17.300.050
23549217,2013-03-01T00:00:00,Endoscopy,E01.370.388.250
23549217,2013-03-01T00:00:00,Endoscopy,E04.800.250
23549217,2013-03-01T00:00:00,Famous Persons,K01.517.211.506
23549217,2013-03-01T00:00:00,Famous Persons,M01.228
23549217,2013-03-01T00:00:00,Gastroenterology,H02.403.429.405
23549217,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23549217,2013-03-01T00:00:00,Intelligence,F01.752.543
23549217,2013-03-01T00:00:00,Judgment,F02.463.785.626
23549217,2013-03-01T00:00:00,Narration,E05.318.308.502
23549217,2013-03-01T00:00:00,Narration,F01.145.209.459
23549217,2013-03-01T00:00:00,Narration,L01.280.660
23549217,2013-03-01T00:00:00,Narration,N05.715.360.300.480
23549217,2013-03-01T00:00:00,Narration,N06.850.520.308.502
23551410,2013-03-01T00:00:00,Adult,M01.060.116
23551410,2013-03-01T00:00:00,Age Factors,N05.715.350.075
23551410,2013-03-01T00:00:00,Age Factors,N06.850.490.250
23551410,2013-03-01T00:00:00,Aged,M01.060.116.100
23551410,2013-03-01T00:00:00,Alleles,G05.360.340.024.340.030
23551410,2013-03-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
23551410,2013-03-01T00:00:00,Body Mass Index,E05.041.124.125
23551410,2013-03-01T00:00:00,Body Mass Index,G07.100.100.125
23551410,2013-03-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
23551410,2013-03-01T00:00:00,Cardiovascular Diseases,C14
23551410,2013-03-01T00:00:00,Case-Control Studies,E05.318.760.500.500
23551410,2013-03-01T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23551410,2013-03-01T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23551410,2013-03-01T00:00:00,Executive Function,F02.463.217
23551410,2013-03-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23551410,2013-03-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
23551410,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23551410,2013-03-01T00:00:00,Middle Aged,M01.060.116.630
23551410,2013-03-01T00:00:00,Neuropsychological Tests,F04.711.513
23551410,2013-03-01T00:00:00,Obesity,C18.654.726.500
23551410,2013-03-01T00:00:00,Obesity,C23.888.144.699.500
23551410,2013-03-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23551410,2013-03-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23551410,2013-03-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23551410,2013-03-01T00:00:00,Proteins,D12.776
23551410,2013-03-01T00:00:00,Psychomotor Performance,F02.808
23551410,2013-03-01T00:00:00,Psychomotor Performance,G11.427.700
23551410,2013-03-01T00:00:00,Psychomotor Performance,G11.561.623
23571057,2013-03-01T00:00:00,Critical Care,E02.760.190
23571057,2013-03-01T00:00:00,Critical Care,N02.421.585.190
23571057,2013-03-01T00:00:00,Evidence-Based Medicine,H02.249.750
23571057,2013-03-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23571057,2013-03-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23571057,2013-03-01T00:00:00,Intensive Care Units,N02.278.388.493
23571057,2013-03-01T00:00:00,Point-of-Care Systems,N04.452.442.452.680
23571057,2013-03-01T00:00:00,Point-of-Care Systems,N04.452.515.360.652
23571057,2013-03-01T00:00:00,Point-of-Care Systems,N04.590.874
23571057,2013-03-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
23599957,2013-03-01T00:00:00,Animals,B01.050
23599957,2013-03-01T00:00:00,Endocrine Disruptors,D27.505.696.353
23599957,2013-03-01T00:00:00,Endocrine Disruptors,D27.888.284.295
23599957,2013-03-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
23599957,2013-03-01T00:00:00,Environmental Monitoring,N06.850.780.375
23456569,2013-03-02T00:00:00,Age Factors,N05.715.350.075
23456569,2013-03-02T00:00:00,Age Factors,N06.850.490.250
23456569,2013-03-02T00:00:00,Animals,B01.050
23456569,2013-03-02T00:00:00,Ceramides,D02.065.313
23456569,2013-03-02T00:00:00,Ceramides,D09.400.410.420.525.200
23456569,2013-03-02T00:00:00,Ceramides,D10.390.470.675.200
23456569,2013-03-02T00:00:00,Ceramides,D10.570.877.360.612.200
23456569,2013-03-02T00:00:00,Diastole,G09.330.190.541.295
23456569,2013-03-02T00:00:00,Diastole,G11.427.590.540.554.250
23456569,2013-03-02T00:00:00,Diastole,G11.427.590.540.570.295
23456569,2013-03-02T00:00:00,Myocardium,A02.633.580
23456569,2013-03-02T00:00:00,Myocardium,A07.541.704
23456569,2013-03-02T00:00:00,Myocardium,A10.690.552.750
23456569,2013-03-02T00:00:00,Nitric Oxide Synthase,D08.811.682.664.500.772
23456569,2013-03-02T00:00:00,Obesity,C18.654.726.500
23456569,2013-03-02T00:00:00,Obesity,C23.888.144.699.500
23456569,2013-03-02T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23456569,2013-03-02T00:00:00,Obesity,G07.100.100.160.120.699.500
23456569,2013-03-02T00:00:00,Oxidative Stress,G03.495.710
23456569,2013-03-02T00:00:00,Oxidative Stress,G07.700.830.750
23456569,2013-03-02T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23456569,2013-03-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23456569,2013-03-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23456569,2013-03-02T00:00:00,Superoxide Dismutase,D08.811.682.881
23456569,2013-03-02T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
23456569,2013-03-02T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
23456569,2013-03-02T00:00:00,Weight Loss,C23.888.144.243.963
23456569,2013-03-02T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23458363,2013-03-04T00:00:00,Adrenal Gland Diseases,C19.053
23458363,2013-03-04T00:00:00,Adrenal Glands,A06.407.071
23458363,2013-03-04T00:00:00,Adult,M01.060.116
23458363,2013-03-04T00:00:00,"Child, Preschool",M01.060.406.448
23458363,2013-03-04T00:00:00,Diagnostic Errors,E01.354
23458363,2013-03-04T00:00:00,Diagnostic Errors,N02.421.450.280
23458363,2013-03-04T00:00:00,Forensic Pathology,H02.403.330.300
23458363,2013-03-04T00:00:00,Forensic Pathology,H02.403.650.249
23458363,2013-03-04T00:00:00,Forensic Pathology,I01.198.780.937.460
23458363,2013-03-04T00:00:00,Hemorrhage,C23.550.414
23458363,2013-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23458363,2013-03-04T00:00:00,Middle Aged,M01.060.116.630
23458363,2013-03-04T00:00:00,Pseudomonas Infections,C01.252.400.739
23458363,2013-03-04T00:00:00,Pseudomonas aeruginosa,B03.440.400.425.625.625.100
23458363,2013-03-04T00:00:00,Pseudomonas aeruginosa,B03.660.250.580.590.050
23458363,2013-03-04T00:00:00,Sepsis,C01.539.757
23458363,2013-03-04T00:00:00,Sepsis,C23.550.470.790.500
23458363,2013-03-04T00:00:00,Streptococcal Infections,C01.252.410.890
23458363,2013-03-04T00:00:00,Waterhouse-Friderichsen Syndrome,C01.252.200.500.550.800
23458363,2013-03-04T00:00:00,Waterhouse-Friderichsen Syndrome,C01.252.400.625.549.449.800
23458363,2013-03-04T00:00:00,Waterhouse-Friderichsen Syndrome,C10.228.228.180.500.750.500
23458363,2013-03-04T00:00:00,Waterhouse-Friderichsen Syndrome,C10.228.228.507.280.505.904
23458363,2013-03-04T00:00:00,Waterhouse-Friderichsen Syndrome,C15.378.463.950
23458363,2013-03-04T00:00:00,Waterhouse-Friderichsen Syndrome,C19.053.500.740
23460709,2013-03-04T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
23460709,2013-03-04T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
23460709,2013-03-04T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
23460709,2013-03-04T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23460709,2013-03-04T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23460709,2013-03-04T00:00:00,Cisplatin,D01.210.375
23460709,2013-03-04T00:00:00,Cisplatin,D01.625.125
23460709,2013-03-04T00:00:00,Cisplatin,D01.710.100
23460709,2013-03-04T00:00:00,Disease-Free Survival,E01.789.200
23460709,2013-03-04T00:00:00,Disease-Free Survival,E05.318.740.998.300
23460709,2013-03-04T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
23460709,2013-03-04T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
23460709,2013-03-04T00:00:00,Exanthema,C17.800.257
23460709,2013-03-04T00:00:00,Head and Neck Neoplasms,C04.588.443
23460709,2013-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23460709,2013-03-04T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
23460709,2013-03-04T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
23460709,2013-03-04T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
23460709,2013-03-04T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
23460709,2013-03-04T00:00:00,Pain,C10.597.617
23460709,2013-03-04T00:00:00,Pain,C23.888.592.612
23460709,2013-03-04T00:00:00,Pain,C23.888.646
23460709,2013-03-04T00:00:00,Pain,F02.830.816.444
23460709,2013-03-04T00:00:00,Pain,G11.561.600.810.444
23460709,2013-03-04T00:00:00,Quinazolines,D03.438.786
23460709,2013-03-04T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
23460709,2013-03-04T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
23460709,2013-03-04T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
23460709,2013-03-04T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
23460709,2013-03-04T00:00:00,Remission Induction,E02.860
23460709,2013-03-04T00:00:00,Treatment Outcome,E01.789.800
23460709,2013-03-04T00:00:00,Treatment Outcome,N04.761.559.590.800
23460709,2013-03-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23510830,2013-03-04T00:00:00,Animals,B01.050
23510830,2013-03-04T00:00:00,Blood Glucose,D09.546.359.448.500
23510830,2013-03-04T00:00:00,Carrier Proteins,D12.776.157
23510830,2013-03-04T00:00:00,Cholesterol,D04.808.247.222.284
23510830,2013-03-04T00:00:00,Cholesterol,D04.808.247.808.197
23510830,2013-03-04T00:00:00,Cholesterol,D10.570.938.208
23510830,2013-03-04T00:00:00,Cholesterol,D10.851.208
23510830,2013-03-04T00:00:00,Fatty Liver,C06.552.241
23510830,2013-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23510830,2013-03-04T00:00:00,Inflammation,C23.550.470
23510830,2013-03-04T00:00:00,Insulin,D06.472.699.587.740.625
23510830,2013-03-04T00:00:00,Insulin,D12.644.548.586.740.625
23510830,2013-03-04T00:00:00,Liver,A03.620
23510830,2013-03-04T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23510830,2013-03-04T00:00:00,Metabolic Syndrome X,C18.452.625
23510830,2013-03-04T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23510830,2013-03-04T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23510830,2013-03-04T00:00:00,"Muscle, Skeletal",A02.633.567
23510830,2013-03-04T00:00:00,"Muscle, Skeletal",A10.690.552.500
23510830,2013-03-04T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23510830,2013-03-04T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23510830,2013-03-04T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23523988,2013-03-04T00:00:00,"Adaptation, Psychological",F01.058
23523988,2013-03-04T00:00:00,Adult,M01.060.116
23523988,2013-03-04T00:00:00,Alcohol Drinking,F01.145.317.269
23523988,2013-03-04T00:00:00,Anxiety,F01.470.132
23523988,2013-03-04T00:00:00,Anxiety Disorders,F03.080
23523988,2013-03-04T00:00:00,Combined Modality Therapy,E02.186
23523988,2013-03-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23523988,2013-03-04T00:00:00,Paroxetine,D03.383.621.600
23523988,2013-03-04T00:00:00,Phobic Disorders,F03.080.725
23460266,2013-03-05T00:00:00,Adult,M01.060.116
23460266,2013-03-05T00:00:00,Cocaine-Related Disorders,C21.739.300
23460266,2013-03-05T00:00:00,Cocaine-Related Disorders,F03.900.300
23460266,2013-03-05T00:00:00,Cues,F02.463.425.234
23460266,2013-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23462656,2013-03-05T00:00:00,Adolescent,M01.060.057
23462656,2013-03-05T00:00:00,Adult,M01.060.116
23462656,2013-03-05T00:00:00,Aged,M01.060.116.100
23462656,2013-03-05T00:00:00,Deglutition Disorders,C06.405.117.119
23462656,2013-03-05T00:00:00,Deglutition Disorders,C09.775.174
23462656,2013-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23462656,2013-03-05T00:00:00,Middle Aged,M01.060.116.630
23462656,2013-03-05T00:00:00,Quality of Life,I01.800
23462656,2013-03-05T00:00:00,Quality of Life,K01.752.400.750
23462656,2013-03-05T00:00:00,Questionnaires,E05.318.308.750
23462656,2013-03-05T00:00:00,Questionnaires,L01.280.800
23462656,2013-03-05T00:00:00,Questionnaires,N05.715.360.300.695
23462656,2013-03-05T00:00:00,Questionnaires,N06.850.520.308.750
23462656,2013-03-05T00:00:00,Thyroid Neoplasms,C04.588.322.894
23462656,2013-03-05T00:00:00,Thyroid Neoplasms,C04.588.443.915
23462656,2013-03-05T00:00:00,Thyroid Neoplasms,C19.344.894
23462656,2013-03-05T00:00:00,Thyroid Neoplasms,C19.874.788
23462656,2013-03-05T00:00:00,Young Adult,M01.060.116.815
23463546,2013-03-05T00:00:00,"Models, Chemical",E05.599.495
23463546,2013-03-05T00:00:00,Molecular Weight,G02.842.580
23463546,2013-03-05T00:00:00,Polymers,D05.750
23463546,2013-03-05T00:00:00,Polymers,D25.720
23463546,2013-03-05T00:00:00,Polymers,J01.637.051.720
23463546,2013-03-05T00:00:00,Proteins,D12.776
23465380,2013-03-05T00:00:00,Calcinosis,C18.452.174.130
23465380,2013-03-05T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23465380,2013-03-05T00:00:00,Coronary Angiography,E01.370.370.050.200
23465380,2013-03-05T00:00:00,Coronary Angiography,E01.370.370.380.200
23465380,2013-03-05T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23465380,2013-03-05T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23465380,2013-03-05T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23465380,2013-03-05T00:00:00,Coronary Vessel Anomalies,C14.240.400.210
23465380,2013-03-05T00:00:00,Coronary Vessel Anomalies,C14.280.400.210
23465380,2013-03-05T00:00:00,Coronary Vessel Anomalies,C16.131.240.400.210
23465380,2013-03-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23465380,2013-03-05T00:00:00,Middle Aged,M01.060.116.630
23465380,2013-03-05T00:00:00,Prevalence,E05.318.308.985.525.750
23465380,2013-03-05T00:00:00,Prevalence,L01.280.975.525.750
23465380,2013-03-05T00:00:00,Prevalence,N01.224.935.597.750
23465380,2013-03-05T00:00:00,Prevalence,N06.850.505.400.975.525.750
23465380,2013-03-05T00:00:00,Prevalence,N06.850.520.308.985.525.750
23465380,2013-03-05T00:00:00,Risk Assessment,E05.318.740.600.800.715
23465380,2013-03-05T00:00:00,Risk Assessment,N04.452.871.715
23465380,2013-03-05T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23465380,2013-03-05T00:00:00,Risk Assessment,N06.850.505.715
23465380,2013-03-05T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23465380,2013-03-05T00:00:00,Sensitivity and Specificity,E05.318.740.872
23465380,2013-03-05T00:00:00,Sensitivity and Specificity,E05.318.780.800
23465380,2013-03-05T00:00:00,Sensitivity and Specificity,G17.800
23465380,2013-03-05T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23465380,2013-03-05T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23465380,2013-03-05T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23465380,2013-03-05T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23465380,2013-03-05T00:00:00,South Carolina,Z01.107.567.875.075.662
23465380,2013-03-05T00:00:00,South Carolina,Z01.107.567.875.750.700
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23465380,2013-03-05T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23461423,2013-03-06T00:00:00,Animals,B01.050
23461423,2013-03-06T00:00:00,Cocaine,D02.145.074.722.388
23461423,2013-03-06T00:00:00,Cocaine,D03.132.889.354
23461423,2013-03-06T00:00:00,Cocaine,D03.605.869.388
23461423,2013-03-06T00:00:00,Cocaine,D04.075.080.875.099.722.388
23461423,2013-03-06T00:00:00,Cues,F02.463.425.234
23461423,2013-03-06T00:00:00,Cyclic AMP,D03.438.759.646.138.395
23461423,2013-03-06T00:00:00,Cyclic AMP,D13.695.462.200
23461423,2013-03-06T00:00:00,Cyclic AMP,D13.695.667.138.395
23461423,2013-03-06T00:00:00,Cyclic AMP,D13.695.827.068.395
23461423,2013-03-06T00:00:00,Cyclic AMP-Dependent Protein Kinases,D08.811.913.696.620.682.700.150.125
23461423,2013-03-06T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.644.360.200.125
23461423,2013-03-06T00:00:00,Cyclic AMP-Dependent Protein Kinases,D12.776.476.200.125
23461423,2013-03-06T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
23461423,2013-03-06T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
23461423,2013-03-06T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
23461423,2013-03-06T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
23461423,2013-03-06T00:00:00,Neuronal Plasticity,G11.561.600.635
23461423,2013-03-06T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23461423,2013-03-06T00:00:00,Phosphoproteins,D12.776.744
23461423,2013-03-06T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23461423,2013-03-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23461423,2013-03-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23461423,2013-03-06T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
23461423,2013-03-06T00:00:00,Self Administration,E02.319.890
23461423,2013-03-06T00:00:00,Self Administration,E02.900.890
23462880,2013-03-06T00:00:00,Clinical Trials as Topic,E05.318.760.535
23462880,2013-03-06T00:00:00,Clinical Trials as Topic,E05.337.250
23462880,2013-03-06T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23462880,2013-03-06T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23462880,2013-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23462880,2013-03-06T00:00:00,Spinal Cord Injuries,C10.228.854.770
23462880,2013-03-06T00:00:00,Spinal Cord Injuries,C10.900.850
23462880,2013-03-06T00:00:00,Spinal Cord Injuries,C21.866.819
23462880,2013-03-06T00:00:00,United States,Z01.107.567.875
23468226,2013-03-06T00:00:00,Adult,M01.060.116
23468226,2013-03-06T00:00:00,"Blood Loss, Surgical",C23.550.414.300
23468226,2013-03-06T00:00:00,"Blood Loss, Surgical",C23.550.505.300
23468226,2013-03-06T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23468226,2013-03-06T00:00:00,Factor VIIa,D08.811.277.656.300.760.300
23468226,2013-03-06T00:00:00,Factor VIIa,D08.811.277.656.959.350.300
23468226,2013-03-06T00:00:00,Factor VIIa,D12.776.124.125.325.300
23468226,2013-03-06T00:00:00,Factor VIIa,D23.119.325.300
23468226,2013-03-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23468226,2013-03-06T00:00:00,Length of Stay,E02.760.400.480
23468226,2013-03-06T00:00:00,Length of Stay,N02.421.585.400.480
23468226,2013-03-06T00:00:00,Liver Transplantation,E04.210.650
23468226,2013-03-06T00:00:00,Liver Transplantation,E04.936.450.490
23468226,2013-03-06T00:00:00,Liver Transplantation,E04.936.580.490
23468226,2013-03-06T00:00:00,Preoperative Care,E02.760.795
23468226,2013-03-06T00:00:00,Preoperative Care,E04.641
23468226,2013-03-06T00:00:00,Preoperative Care,N02.421.585.795
23468226,2013-03-06T00:00:00,Recombinant Proteins,D12.776.828
23468226,2013-03-06T00:00:00,Treatment Outcome,E01.789.800
23468226,2013-03-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23468226,2013-03-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23473317,2013-03-06T00:00:00,Animals,B01.050
23473317,2013-03-06T00:00:00,Cocaine,D02.145.074.722.388
23473317,2013-03-06T00:00:00,Cocaine,D03.132.889.354
23473317,2013-03-06T00:00:00,Cocaine,D03.605.869.388
23473317,2013-03-06T00:00:00,Cocaine,D04.075.080.875.099.722.388
23473317,2013-03-06T00:00:00,Cocaine-Related Disorders,C21.739.300
23473317,2013-03-06T00:00:00,Cocaine-Related Disorders,F03.900.300
23473317,2013-03-06T00:00:00,Cues,F02.463.425.234
23473317,2013-03-06T00:00:00,Environment,G16.500.275
23473317,2013-03-06T00:00:00,Environment,N06.230
23473317,2013-03-06T00:00:00,Glutamic Acid,D12.125.067.750
23473317,2013-03-06T00:00:00,Glutamic Acid,D12.125.119.450
23473317,2013-03-06T00:00:00,Glutamic Acid,D12.125.427.300
23473317,2013-03-06T00:00:00,Long-Term Potentiation,G11.561.600.635.350
23473317,2013-03-06T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23473317,2013-03-06T00:00:00,"Microscopy, Confocal",E05.595.395
23473317,2013-03-06T00:00:00,Motivation,F01.658
23473317,2013-03-06T00:00:00,Motivation,F01.752.543.500.750
23473317,2013-03-06T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23473317,2013-03-06T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23473317,2013-03-06T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23473317,2013-03-06T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
23473317,2013-03-06T00:00:00,Self Administration,E02.319.890
23473317,2013-03-06T00:00:00,Self Administration,E02.900.890
23473317,2013-03-06T00:00:00,Synaptic Transmission,G02.111.087.800.850
23473317,2013-03-06T00:00:00,Synaptic Transmission,G02.149.115.800.850
23473317,2013-03-06T00:00:00,Synaptic Transmission,G04.299.880.850
23473317,2013-03-06T00:00:00,Synaptic Transmission,G07.265.337.900
23473317,2013-03-06T00:00:00,Synaptic Transmission,G07.700.240.900
23473317,2013-03-06T00:00:00,Synaptic Transmission,G11.561.600.835
23473812,2013-03-06T00:00:00,Animals,B01.050
23473812,2013-03-06T00:00:00,"Animals, Newborn",B01.050.050.282
23473812,2013-03-06T00:00:00,Calcium,D01.268.552.100
23473812,2013-03-06T00:00:00,Calcium,D01.552.539.288
23473812,2013-03-06T00:00:00,Calcium,D23.119.100
23473812,2013-03-06T00:00:00,Calcium Channels,D12.776.157.530.400.150
23473812,2013-03-06T00:00:00,Calcium Channels,D12.776.543.550.425.150
23473812,2013-03-06T00:00:00,Calcium Channels,D12.776.543.585.400.150
23473812,2013-03-06T00:00:00,Carrier Proteins,D12.776.157
23473812,2013-03-06T00:00:00,Electric Stimulation,E05.723.402
23473812,2013-03-06T00:00:00,Gene Expression Regulation,G05.355.315
23473812,2013-03-06T00:00:00,Glutamic Acid,D12.125.067.750
23473812,2013-03-06T00:00:00,Glutamic Acid,D12.125.119.450
23473812,2013-03-06T00:00:00,Glutamic Acid,D12.125.427.300
23473812,2013-03-06T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23473812,2013-03-06T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23473812,2013-03-06T00:00:00,Mutation,G05.365.590
23473812,2013-03-06T00:00:00,Neurons,A08.663
23473812,2013-03-06T00:00:00,Neurons,A11.671
23473812,2013-03-06T00:00:00,Patch-Clamp Techniques,E05.200.500.800
23473812,2013-03-06T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23473812,2013-03-06T00:00:00,Probability,E05.318.740.600
23473812,2013-03-06T00:00:00,Probability,G17.680
23473812,2013-03-06T00:00:00,Probability,N05.715.360.750.625
23473812,2013-03-06T00:00:00,Probability,N06.850.520.830.600
23473812,2013-03-06T00:00:00,Quaternary Ammonium Compounds,D01.625.075
23473812,2013-03-06T00:00:00,Quaternary Ammonium Compounds,D02.092.877
23473812,2013-03-06T00:00:00,Quaternary Ammonium Compounds,D02.675.276
23473812,2013-03-06T00:00:00,Synapses,A08.850
23473812,2013-03-06T00:00:00,Synapses,A11.284.149.165.420.780
23473812,2013-03-06T00:00:00,Synaptosomes,A11.284.835.859
23465739,2013-03-07T00:00:00,Adolescent,M01.060.057
23465739,2013-03-07T00:00:00,Adult,M01.060.116
23465739,2013-03-07T00:00:00,Aged,M01.060.116.100
23465739,2013-03-07T00:00:00,Cervical Vertebrae,A02.835.232.834.151
23465739,2013-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23465739,2013-03-07T00:00:00,Middle Aged,M01.060.116.630
23465739,2013-03-07T00:00:00,Postoperative Care,E02.760.722.700
23465739,2013-03-07T00:00:00,Postoperative Care,E04.624
23465739,2013-03-07T00:00:00,Postoperative Care,N02.421.585.722.700
23465739,2013-03-07T00:00:00,Reoperation,E04.690
23465739,2013-03-07T00:00:00,Spinal Fusion,E04.555.100.700
23465739,2013-03-07T00:00:00,Treatment Outcome,E01.789.800
23465739,2013-03-07T00:00:00,Treatment Outcome,N04.761.559.590.800
23465739,2013-03-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23470244,2013-03-07T00:00:00,Adult,M01.060.116
23470244,2013-03-07T00:00:00,African Americans,M01.686.508.100.100
23470244,2013-03-07T00:00:00,African Americans,M01.686.754.100
23470244,2013-03-07T00:00:00,Genetic Research,H01.158.273.343.249
23470244,2013-03-07T00:00:00,Genetic Research,H01.770.644.145.350
23470244,2013-03-07T00:00:00,Genetic Testing,E01.370.427
23470244,2013-03-07T00:00:00,Genetic Testing,E05.393.435
23470244,2013-03-07T00:00:00,Genetic Testing,N02.421.143.827.233.221
23470244,2013-03-07T00:00:00,Genetic Testing,N02.421.308.430
23470244,2013-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23470244,2013-03-07T00:00:00,Middle Aged,M01.060.116.630
23470244,2013-03-07T00:00:00,Nurses,M01.526.485.650
23470244,2013-03-07T00:00:00,Nurses,N02.360.650
23470244,2013-03-07T00:00:00,United States,Z01.107.567.875
23471966,2013-03-07T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
23471966,2013-03-07T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
23471966,2013-03-07T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
23471966,2013-03-07T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
23471966,2013-03-07T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
23471966,2013-03-07T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
23471966,2013-03-07T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
23471966,2013-03-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23471966,2013-03-07T00:00:00,Liver Neoplasms,C04.588.274.623
23471966,2013-03-07T00:00:00,Liver Neoplasms,C06.301.623
23471966,2013-03-07T00:00:00,Liver Neoplasms,C06.552.697
23471966,2013-03-07T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23471966,2013-03-07T00:00:00,Mitochondria,A11.284.835.626
23471966,2013-03-07T00:00:00,Mitochondrial Proteins,D12.776.575
23471966,2013-03-07T00:00:00,Neoplasm Proteins,D12.776.624
23471966,2013-03-07T00:00:00,Piperazines,D03.383.606
23471966,2013-03-07T00:00:00,Tubulin,D05.750.078.734.800
23471966,2013-03-07T00:00:00,Tubulin,D12.776.220.600.800
23471966,2013-03-07T00:00:00,Tubulin,D12.776.641.920
23471966,2013-03-07T00:00:00,Voltage-Dependent Anion Channels,D12.776.157.530.400.500.520
23471966,2013-03-07T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.550.425.730.520
23471966,2013-03-07T00:00:00,Voltage-Dependent Anion Channels,D12.776.543.585.400.730.520
23473840,2013-03-07T00:00:00,Aging,G07.700.320.124
23473840,2013-03-07T00:00:00,Animals,B01.050
23473840,2013-03-07T00:00:00,Brain,A08.186.211
23473840,2013-03-07T00:00:00,Brain Chemistry,G02.111.100
23473840,2013-03-07T00:00:00,Brain Chemistry,G03.200
23473840,2013-03-07T00:00:00,Macaca mulatta,B01.050.150.900.649.801.400.112.199.120.510.550
23473840,2013-03-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23473840,2013-03-07T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23470564,2013-03-08T00:00:00,Animals,B01.050
23470564,2013-03-08T00:00:00,"Antimetabolites, Antineoplastic",D27.505.519.186.144
23470564,2013-03-08T00:00:00,"Antimetabolites, Antineoplastic",D27.505.954.248.144
23470564,2013-03-08T00:00:00,"Antimetabolites, Antineoplastic",D27.888.569.042.030
23470564,2013-03-08T00:00:00,Apoptosis,G04.299.139.160
23470564,2013-03-08T00:00:00,Combined Modality Therapy,E02.186
23470564,2013-03-08T00:00:00,Deoxycytidine,D03.383.742.680.245.500
23470564,2013-03-08T00:00:00,Deoxycytidine,D13.570.230.329
23470564,2013-03-08T00:00:00,Deoxycytidine,D13.570.685.245.500
23470564,2013-03-08T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
23470564,2013-03-08T00:00:00,Gene Transfer Techniques,E05.393.350
23470564,2013-03-08T00:00:00,"Genes, p53",G05.360.340.024.340.375.249.385
23470564,2013-03-08T00:00:00,"Genes, p53",G05.360.340.024.340.415.400.385
23470564,2013-03-08T00:00:00,Liver Neoplasms,C04.588.274.623
23470564,2013-03-08T00:00:00,Liver Neoplasms,C06.301.623
23470564,2013-03-08T00:00:00,Liver Neoplasms,C06.552.697
23470564,2013-03-08T00:00:00,Nanomedicine,H01.603.600
23470564,2013-03-08T00:00:00,Nanomedicine,J01.897.115.625
23470564,2013-03-08T00:00:00,Nanomedicine,J01.897.520.600.600
23470564,2013-03-08T00:00:00,Nanoparticles,J01.637.512.600
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C04.588.274.761
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C04.588.322.421
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C06.301.761
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C06.689.667
23470564,2013-03-08T00:00:00,Pancreatic Neoplasms,C19.344.421
23470564,2013-03-08T00:00:00,"Receptors, Transferrin",D12.776.157.905.500
23470564,2013-03-08T00:00:00,"Receptors, Transferrin",D12.776.543.750.850
23381505,2013-03-11T00:00:00,Health Status Disparities,I01.240.425.675
23381505,2013-03-11T00:00:00,Health Status Disparities,N01.224.425.437
23381505,2013-03-11T00:00:00,Health Status Disparities,N06.850.505.400.425.675
23381505,2013-03-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23381505,2013-03-11T00:00:00,Middle Aged,M01.060.116.630
23381505,2013-03-11T00:00:00,Nutrition Surveys,E05.318.308.250.600
23381505,2013-03-11T00:00:00,Nutrition Surveys,E05.318.308.585.550
23381505,2013-03-11T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
23381505,2013-03-11T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
23381505,2013-03-11T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
23381505,2013-03-11T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
23381505,2013-03-11T00:00:00,Population Dynamics,I01.240.600
23381505,2013-03-11T00:00:00,Population Dynamics,N01.224.625
23381505,2013-03-11T00:00:00,Population Dynamics,N06.850.505.400.700
23381505,2013-03-11T00:00:00,United States,Z01.107.567.875
23404122,2013-03-11T00:00:00,Animals,B01.050
23404122,2013-03-11T00:00:00,Astrocytes,A08.637.200
23404122,2013-03-11T00:00:00,Astrocytes,A11.650.200
23404122,2013-03-11T00:00:00,Cell Survival,G04.299.316
23404122,2013-03-11T00:00:00,Chronic Disease,C23.550.291.500
23404122,2013-03-11T00:00:00,Intraocular Pressure,G14.440
23404122,2013-03-11T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23404122,2013-03-11T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23404122,2013-03-11T00:00:00,Ocular Hypertension,C11.525
23404122,2013-03-11T00:00:00,Optic Disk,A08.800.800.120.680.660
23404122,2013-03-11T00:00:00,Optic Disk,A09.371.729.690
23404122,2013-03-11T00:00:00,Piperazines,D03.383.606
23404122,2013-03-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23404122,2013-03-11T00:00:00,Retina,A09.371.729
23404122,2013-03-11T00:00:00,Retinal Ganglion Cells,A08.663.650.850.875
23404122,2013-03-11T00:00:00,Retinal Ganglion Cells,A09.371.729.831.875
23404122,2013-03-11T00:00:00,Retinal Ganglion Cells,A11.671.650.850.875
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
23404122,2013-03-11T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
23404122,2013-03-11T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
23404122,2013-03-11T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
23404122,2013-03-11T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
23404122,2013-03-11T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
23479355,2013-03-11T00:00:00,"Antigens, Bacterial",D23.050.161
23479355,2013-03-11T00:00:00,Fluorescence Resonance Energy Transfer,E05.196.712.516.600.676.500
23479355,2013-03-11T00:00:00,Fluorescence Resonance Energy Transfer,G01.154.100.240.280
23479355,2013-03-11T00:00:00,Fluorescence Resonance Energy Transfer,G01.595.100.240.280
23479355,2013-03-11T00:00:00,Fluorescence Resonance Energy Transfer,G02.111.087.242.280
23479355,2013-03-11T00:00:00,Fluorescence Resonance Energy Transfer,G02.149.115.242.280
23479355,2013-03-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23479355,2013-03-11T00:00:00,Neoplasm Proteins,D12.776.624
23479355,2013-03-11T00:00:00,Pilot Projects,E05.318.760.750
23479355,2013-03-11T00:00:00,Pilot Projects,E05.337.737
23479355,2013-03-11T00:00:00,Pilot Projects,N05.715.360.775.625
23479355,2013-03-11T00:00:00,Pilot Projects,N06.850.520.450.720
23479355,2013-03-11T00:00:00,"Receptors, Cell Surface",D12.776.543.750
23479355,2013-03-11T00:00:00,Small Molecule Libraries,D27.720.470.765
23479355,2013-03-11T00:00:00,"Tumor Markers, Biological",D23.101.840
23482718,2013-03-11T00:00:00,Adult,M01.060.116
23482718,2013-03-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23482718,2013-03-11T00:00:00,Nicotine,D03.132.760.570
23482718,2013-03-11T00:00:00,Nicotine,D03.383.725.518
23482718,2013-03-11T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23482718,2013-03-11T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23482718,2013-03-11T00:00:00,Smoking Cessation,F01.145.940.700
23490883,2013-03-11T00:00:00,Action Potentials,G04.580.100
23490883,2013-03-11T00:00:00,Action Potentials,G07.265.750.100
23490883,2013-03-11T00:00:00,Action Potentials,G11.561.570.100
23490883,2013-03-11T00:00:00,Animals,B01.050
23490883,2013-03-11T00:00:00,Anti-Arrhythmia Agents,D27.505.954.411.097
23490883,2013-03-11T00:00:00,"Arrhythmias, Cardiac",C14.280.067
23490883,2013-03-11T00:00:00,"Arrhythmias, Cardiac",C23.550.073
23490883,2013-03-11T00:00:00,Connexin 43,D12.776.543.585.250.200
23490883,2013-03-11T00:00:00,Gap Junctions,A11.284.149.165.420.471
23490883,2013-03-11T00:00:00,Heart Conduction System,A07.541.409
23490883,2013-03-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23490883,2013-03-11T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23490883,2013-03-11T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23490883,2013-03-11T00:00:00,"Myocytes, Cardiac",A11.620.500
23490883,2013-03-11T00:00:00,Signal Transduction,G02.111.087.800
23490883,2013-03-11T00:00:00,Signal Transduction,G02.149.115.800
23490883,2013-03-11T00:00:00,Signal Transduction,G04.299.880
23478382,2013-03-12T00:00:00,Adolescent,M01.060.057
23478382,2013-03-12T00:00:00,Adult,M01.060.116
23478382,2013-03-12T00:00:00,Age Factors,N05.715.350.075
23478382,2013-03-12T00:00:00,Age Factors,N06.850.490.250
23478382,2013-03-12T00:00:00,Aged,M01.060.116.100
23478382,2013-03-12T00:00:00,Dilatation,E05.284
23478382,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23478382,2013-03-12T00:00:00,Laparoscopy,E01.370.388.250.520
23478382,2013-03-12T00:00:00,Laparoscopy,E04.800.250.520
23478382,2013-03-12T00:00:00,Manometry,E05.559
23478382,2013-03-12T00:00:00,Middle Aged,M01.060.116.630
23478382,2013-03-12T00:00:00,Risk Assessment,E05.318.740.600.800.715
23478382,2013-03-12T00:00:00,Risk Assessment,N04.452.871.715
23478382,2013-03-12T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23478382,2013-03-12T00:00:00,Risk Assessment,N06.850.505.715
23478382,2013-03-12T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23478382,2013-03-12T00:00:00,Sex Factors,N05.715.350.675
23478382,2013-03-12T00:00:00,Sex Factors,N06.850.490.875
23478382,2013-03-12T00:00:00,Treatment Outcome,E01.789.800
23478382,2013-03-12T00:00:00,Treatment Outcome,N04.761.559.590.800
23478382,2013-03-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23478382,2013-03-12T00:00:00,Young Adult,M01.060.116.815
23479544,2013-03-12T00:00:00,Adolescent,M01.060.057
23479544,2013-03-12T00:00:00,Adult,M01.060.116
23479544,2013-03-12T00:00:00,Aged,M01.060.116.100
23479544,2013-03-12T00:00:00,Auditory Perception,F02.463.593.071
23479544,2013-03-12T00:00:00,Hearing Loss,C09.218.458.341
23479544,2013-03-12T00:00:00,Hearing Loss,C10.597.751.418.341
23479544,2013-03-12T00:00:00,Hearing Loss,C23.888.592.763.393.341
23479544,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23479544,2013-03-12T00:00:00,Middle Aged,M01.060.116.630
23479544,2013-03-12T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
23479544,2013-03-12T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
23479544,2013-03-12T00:00:00,Noise,G01.595.907.567
23479544,2013-03-12T00:00:00,Noise,G16.500.275.600
23479544,2013-03-12T00:00:00,Noise,N06.230.400
23479544,2013-03-12T00:00:00,Noise,N06.850.460.610
23479544,2013-03-12T00:00:00,United States,Z01.107.567.875
23479544,2013-03-12T00:00:00,Young Adult,M01.060.116.815
23482476,2013-03-12T00:00:00,Adolescent,M01.060.057
23482476,2013-03-12T00:00:00,Adult,M01.060.116
23482476,2013-03-12T00:00:00,Age Factors,N05.715.350.075
23482476,2013-03-12T00:00:00,Age Factors,N06.850.490.250
23482476,2013-03-12T00:00:00,Aged,M01.060.116.100
23482476,2013-03-12T00:00:00,Child,M01.060.406
23482476,2013-03-12T00:00:00,Combined Modality Therapy,E02.186
23482476,2013-03-12T00:00:00,Disease-Free Survival,E01.789.200
23482476,2013-03-12T00:00:00,Disease-Free Survival,E05.318.740.998.300
23482476,2013-03-12T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
23482476,2013-03-12T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
23482476,2013-03-12T00:00:00,Head and Neck Neoplasms,C04.588.443
23482476,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23482476,2013-03-12T00:00:00,Incidence,E05.318.308.985.525.375
23482476,2013-03-12T00:00:00,Incidence,L01.280.975.525.375
23482476,2013-03-12T00:00:00,Incidence,N01.224.935.597.500
23482476,2013-03-12T00:00:00,Incidence,N06.850.505.400.975.525.375
23482476,2013-03-12T00:00:00,Incidence,N06.850.520.308.985.525.375
23482476,2013-03-12T00:00:00,Middle Aged,M01.060.116.630
23482476,2013-03-12T00:00:00,Plasmacytoma,C04.557.595.600
23482476,2013-03-12T00:00:00,Plasmacytoma,C20.683.515.880
23482476,2013-03-12T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
23482476,2013-03-12T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
23482476,2013-03-12T00:00:00,Sex Factors,N05.715.350.675
23482476,2013-03-12T00:00:00,Sex Factors,N06.850.490.875
23482476,2013-03-12T00:00:00,Treatment Outcome,E01.789.800
23482476,2013-03-12T00:00:00,Treatment Outcome,N04.761.559.590.800
23482476,2013-03-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23482476,2013-03-12T00:00:00,Young Adult,M01.060.116.815
23482514,2013-03-12T00:00:00,Adult,M01.060.116
23482514,2013-03-12T00:00:00,African Americans,M01.686.508.100.100
23482514,2013-03-12T00:00:00,African Americans,M01.686.754.100
23482514,2013-03-12T00:00:00,Aged,M01.060.116.100
23482514,2013-03-12T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23482514,2013-03-12T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23482514,2013-03-12T00:00:00,European Continental Ancestry Group,M01.686.508.400
23482514,2013-03-12T00:00:00,Health Expenditures,N03.219.151.450
23482514,2013-03-12T00:00:00,Health Expenditures,N05.300.385
23482514,2013-03-12T00:00:00,Health Services Accessibility,N04.590.374.350
23482514,2013-03-12T00:00:00,Health Services Accessibility,N05.300.430
23482514,2013-03-12T00:00:00,Healthcare Disparities,N04.590.374.380
23482514,2013-03-12T00:00:00,Healthcare Disparities,N05.300.493
23482514,2013-03-12T00:00:00,Hispanic Americans,M01.686.754.441
23482514,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23482514,2013-03-12T00:00:00,Middle Aged,M01.060.116.630
23482514,2013-03-12T00:00:00,Patient Education as Topic,I02.233.332.500
23482514,2013-03-12T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
23482514,2013-03-12T00:00:00,Patient Education as Topic,N02.421.726.407.680
23482514,2013-03-12T00:00:00,Questionnaires,E05.318.308.750
23482514,2013-03-12T00:00:00,Questionnaires,L01.280.800
23482514,2013-03-12T00:00:00,Questionnaires,N05.715.360.300.695
23482514,2013-03-12T00:00:00,Questionnaires,N06.850.520.308.750
23482514,2013-03-12T00:00:00,Rural Population,N01.600.725
23482514,2013-03-12T00:00:00,Self Care,E02.900
23482514,2013-03-12T00:00:00,Self Care,N02.421.784.680
23482514,2013-03-12T00:00:00,United States,Z01.107.567.875
23482514,2013-03-12T00:00:00,Urban Population,N01.600.900
23497257,2013-03-12T00:00:00,Adult,M01.060.116
23497257,2013-03-12T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
23497257,2013-03-12T00:00:00,"Antiretroviral Therapy, Highly Active",E02.319.310.075
23497257,2013-03-12T00:00:00,HIV Infections,C02.782.815.616.400
23497257,2013-03-12T00:00:00,HIV Infections,C02.800.801.400
23497257,2013-03-12T00:00:00,HIV Infections,C20.673.480
23497257,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23497257,2013-03-12T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23497257,2013-03-12T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23497257,2013-03-12T00:00:00,Questionnaires,E05.318.308.750
23497257,2013-03-12T00:00:00,Questionnaires,L01.280.800
23497257,2013-03-12T00:00:00,Questionnaires,N05.715.360.300.695
23497257,2013-03-12T00:00:00,Questionnaires,N06.850.520.308.750
23497257,2013-03-12T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23497257,2013-03-12T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23497257,2013-03-12T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23497257,2013-03-12T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23497462,2013-03-12T00:00:00,Attitude of Health Personnel,F01.100.050
23497462,2013-03-12T00:00:00,Attitude of Health Personnel,N05.300.100
23497462,2013-03-12T00:00:00,Career Choice,F02.463.785.373.346.400
23497462,2013-03-12T00:00:00,Diffusion of Innovation,L01.143.320
23497462,2013-03-12T00:00:00,Forecasting,I01.320
23497462,2013-03-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23497462,2013-03-12T00:00:00,Motivation,F01.658
23497462,2013-03-12T00:00:00,Motivation,F01.752.543.500.750
23489952,2013-03-13T00:00:00,Adult,M01.060.116
23489952,2013-03-13T00:00:00,Aged,M01.060.116.100
23489952,2013-03-13T00:00:00,Case-Control Studies,E05.318.760.500.500
23489952,2013-03-13T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23489952,2013-03-13T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23489952,2013-03-13T00:00:00,Electromyography,E01.370.405.255
23489952,2013-03-13T00:00:00,Electromyography,E01.370.530.255
23489952,2013-03-13T00:00:00,Exercise Test,E01.370.370.380.250
23489952,2013-03-13T00:00:00,Exercise Test,E01.370.386.700.250
23489952,2013-03-13T00:00:00,Exercise Test,E05.333.250
23489952,2013-03-13T00:00:00,"Gait Disorders, Neurologic",C10.597.404
23489952,2013-03-13T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
23489952,2013-03-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23489952,2013-03-13T00:00:00,Lower Extremity,A01.378.610
23489952,2013-03-13T00:00:00,Middle Aged,M01.060.116.630
23489952,2013-03-13T00:00:00,"Muscle, Skeletal",A02.633.567
23489952,2013-03-13T00:00:00,"Muscle, Skeletal",A10.690.552.500
23489952,2013-03-13T00:00:00,Paresis,C10.597.636
23489952,2013-03-13T00:00:00,Paresis,C23.888.592.643
23489952,2013-03-13T00:00:00,Psychomotor Performance,F02.808
23489952,2013-03-13T00:00:00,Psychomotor Performance,G11.427.700
23489952,2013-03-13T00:00:00,Psychomotor Performance,G11.561.623
23489952,2013-03-13T00:00:00,Recovery of Function,G16.757
23489952,2013-03-13T00:00:00,Stroke,C10.228.140.300.775
23489952,2013-03-13T00:00:00,Stroke,C14.907.253.855
23489952,2013-03-13T00:00:00,Treatment Outcome,E01.789.800
23489952,2013-03-13T00:00:00,Treatment Outcome,N04.761.559.590.800
23489952,2013-03-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23493370,2013-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23493370,2013-03-14T00:00:00,Smoking Cessation,F01.145.940.700
23493397,2013-03-14T00:00:00,Animals,B01.050
23493397,2013-03-14T00:00:00,Cell Line,A11.251.210
23493397,2013-03-14T00:00:00,"Complement Pathway, Alternative",G12.425.255.695
23493397,2013-03-14T00:00:00,Homeodomain Proteins,D12.776.260.400
23493397,2013-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23493397,2013-03-14T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
23493397,2013-03-14T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
23493397,2013-03-14T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
23493397,2013-03-14T00:00:00,Oxidative Stress,G03.495.710
23493397,2013-03-14T00:00:00,Oxidative Stress,G07.700.830.750
23493397,2013-03-14T00:00:00,Phospholipids,D10.570.755
23493397,2013-03-14T00:00:00,Phospholipids,D10.695
23493397,2013-03-14T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23493397,2013-03-14T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23495143,2013-03-14T00:00:00,Adolescent,M01.060.057
23495143,2013-03-14T00:00:00,Adult,M01.060.116
23495143,2013-03-14T00:00:00,Cyclonic Storms,G16.500.240.135.500
23495143,2013-03-14T00:00:00,"Depressive Disorder, Major",F03.600.300.375
23495143,2013-03-14T00:00:00,Disasters,N06.230.100
23495143,2013-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23495143,2013-03-14T00:00:00,Middle Aged,M01.060.116.630
23495143,2013-03-14T00:00:00,Panic Disorder,F03.080.700
23495143,2013-03-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23495143,2013-03-14T00:00:00,Risk Factors,N05.715.350.200.700
23495143,2013-03-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23495143,2013-03-14T00:00:00,Risk Factors,N06.850.490.625.750
23495143,2013-03-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23495143,2013-03-14T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23495143,2013-03-14T00:00:00,Young Adult,M01.060.116.815
23497788,2013-03-14T00:00:00,Adult,M01.060.116
23497788,2013-03-14T00:00:00,Aged,M01.060.116.100
23497788,2013-03-14T00:00:00,Brain,A08.186.211
23497788,2013-03-14T00:00:00,Cocaine,D02.145.074.722.388
23497788,2013-03-14T00:00:00,Cocaine,D03.132.889.354
23497788,2013-03-14T00:00:00,Cocaine,D03.605.869.388
23497788,2013-03-14T00:00:00,Cocaine,D04.075.080.875.099.722.388
23497788,2013-03-14T00:00:00,Cocaine-Related Disorders,C21.739.300
23497788,2013-03-14T00:00:00,Cocaine-Related Disorders,F03.900.300
23497788,2013-03-14T00:00:00,Cues,F02.463.425.234
23497788,2013-03-14T00:00:00,Cycloserine,D03.383.129.385.162
23497788,2013-03-14T00:00:00,Cycloserine,D03.383.129.462.600.162
23497788,2013-03-14T00:00:00,Cycloserine,D12.125.837.150
23497788,2013-03-14T00:00:00,"Data Interpretation, Statistical",E05.245.380
23497788,2013-03-14T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23497788,2013-03-14T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23497788,2013-03-14T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23497788,2013-03-14T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23497788,2013-03-14T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
23497788,2013-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23497788,2013-03-14T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
23497788,2013-03-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23497788,2013-03-14T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23497788,2013-03-14T00:00:00,Middle Aged,M01.060.116.630
23497788,2013-03-14T00:00:00,Oxygen,D01.268.185.550
23497788,2013-03-14T00:00:00,Oxygen,D01.362.670
23499621,2013-03-14T00:00:00,Aged,M01.060.116.100
23499621,2013-03-14T00:00:00,Heart Failure,C14.280.434
23499621,2013-03-14T00:00:00,Heart Ventricles,A07.541.560
23499621,2013-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23499621,2013-03-14T00:00:00,Stroke Volume,E01.370.370.380.150.700
23499621,2013-03-14T00:00:00,Stroke Volume,G09.330.380.124.882
23499621,2013-03-14T00:00:00,Treatment Outcome,E01.789.800
23499621,2013-03-14T00:00:00,Treatment Outcome,N04.761.559.590.800
23499621,2013-03-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23499621,2013-03-14T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
23516612,2013-03-14T00:00:00,Animals,B01.050
23516612,2013-03-14T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23516612,2013-03-14T00:00:00,Mitochondria,A11.284.835.626
23516612,2013-03-14T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
23516612,2013-03-14T00:00:00,Zebrafish Proteins,D12.776.325.500
23726754,2013-03-14T00:00:00,Adolescent,M01.060.057
23726754,2013-03-14T00:00:00,Child,M01.060.406
23726754,2013-03-14T00:00:00,"Child, Preschool",M01.060.406.448
23726754,2013-03-14T00:00:00,"Decision Support Systems, Clinical",L01.700.508.300.190
23726754,2013-03-14T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
23726754,2013-03-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23726754,2013-03-14T00:00:00,Infant,M01.060.703
23726754,2013-03-14T00:00:00,Pediatrics,H02.403.670
23500034,2013-03-15T00:00:00,Drainage,E02.309
23500034,2013-03-15T00:00:00,Drainage,E04.237
23500034,2013-03-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23500034,2013-03-15T00:00:00,"Monitoring, Physiologic",E01.370.520
23500034,2013-03-15T00:00:00,Pain Measurement,E01.370.376.550.600
23500034,2013-03-15T00:00:00,"Pain, Postoperative",C23.550.767.700
23500034,2013-03-15T00:00:00,"Pain, Postoperative",C23.888.646.530
23500034,2013-03-15T00:00:00,Prostatectomy,E04.950.774.860.625
23500034,2013-03-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
23500034,2013-03-15T00:00:00,Risk Assessment,N04.452.871.715
23500034,2013-03-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23500034,2013-03-15T00:00:00,Risk Assessment,N06.850.505.715
23500034,2013-03-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23500034,2013-03-15T00:00:00,Robotics,H01.671.293.643
23500034,2013-03-15T00:00:00,Robotics,J01.897.104.834
23500034,2013-03-15T00:00:00,Robotics,L01.224.065.630
23500034,2013-03-15T00:00:00,Treatment Outcome,E01.789.800
23500034,2013-03-15T00:00:00,Treatment Outcome,N04.761.559.590.800
23500034,2013-03-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23500034,2013-03-15T00:00:00,Urinary Catheterization,E01.370.390.820
23500034,2013-03-15T00:00:00,Urinary Catheterization,E02.148.947
23497456,2013-03-16T00:00:00,Animals,B01.050
23497456,2013-03-16T00:00:00,Antineoplastic Agents,D27.505.954.248
23497456,2013-03-16T00:00:00,Apoptosis,G04.299.139.160
23497456,2013-03-16T00:00:00,Cell Proliferation,G04.299.233.750
23497456,2013-03-16T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23497456,2013-03-16T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23497456,2013-03-16T00:00:00,Flow Cytometry,E05.200.500.386.350
23497456,2013-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23497456,2013-03-16T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
23497456,2013-03-16T00:00:00,MicroRNAs,D13.150.650.319
23497456,2013-03-16T00:00:00,MicroRNAs,D13.444.735.150.319
23497456,2013-03-16T00:00:00,MicroRNAs,D13.444.735.790.099
23497456,2013-03-16T00:00:00,"RNA, Messenger",D13.444.735.544
23510946,2013-03-16T00:00:00,Adult,M01.060.116
23510946,2013-03-16T00:00:00,"Diagnosis, Differential",E01.171
23510946,2013-03-16T00:00:00,Esophageal Perforation,C06.405.117.468
23510946,2013-03-16T00:00:00,Esophageal Perforation,C21.866.348
23510946,2013-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23510946,2013-03-16T00:00:00,Mycobacterium tuberculosis,B03.510.024.049.525.500.702
23510946,2013-03-16T00:00:00,Mycobacterium tuberculosis,B03.510.460.400.410.552.552.702
23510946,2013-03-16T00:00:00,"Tuberculosis, Gastrointestinal",C01.252.410.040.552.846.628
23510946,2013-03-16T00:00:00,"Tuberculosis, Gastrointestinal",C06.405.874
23518262,2013-03-16T00:00:00,Aged,M01.060.116.100
23518262,2013-03-16T00:00:00,Electroconvulsive Therapy,F04.570.200.583
23518262,2013-03-16T00:00:00,Electroconvulsive Therapy,F04.669.224.300
23518262,2013-03-16T00:00:00,Electrodes,E07.305.250
23518262,2013-03-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23518262,2013-03-16T00:00:00,Middle Aged,M01.060.116.630
23518262,2013-03-16T00:00:00,Neuropsychological Tests,F04.711.513
23518262,2013-03-16T00:00:00,Seizures,C10.228.140.490.631
23518262,2013-03-16T00:00:00,Seizures,C10.597.742
23518262,2013-03-16T00:00:00,Seizures,C23.888.592.742
23518262,2013-03-16T00:00:00,Treatment Outcome,E01.789.800
23518262,2013-03-16T00:00:00,Treatment Outcome,N04.761.559.590.800
23518262,2013-03-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23508045,2013-03-18T00:00:00,Adenoviridae,B04.280.030
23508045,2013-03-18T00:00:00,Adenoviridae,B04.909.204.097
23508045,2013-03-18T00:00:00,Animals,B01.050
23508045,2013-03-18T00:00:00,Apoptosis,G04.299.139.160
23508045,2013-03-18T00:00:00,Blood Pressure,E01.370.600.875.249
23508045,2013-03-18T00:00:00,Blood Pressure,G09.330.380.076
23508045,2013-03-18T00:00:00,Endothelial Cells,A11.436.275
23508045,2013-03-18T00:00:00,Fetal Blood,A12.207.152.200
23508045,2013-03-18T00:00:00,Fetal Blood,A15.145.300
23508045,2013-03-18T00:00:00,Fetal Blood,A16.378.200
23508045,2013-03-18T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
23508045,2013-03-18T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
23508045,2013-03-18T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
23508045,2013-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23508045,2013-03-18T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
23508045,2013-03-18T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
23508045,2013-03-18T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
23508045,2013-03-18T00:00:00,Myocardial Infarction,C14.280.647.500
23508045,2013-03-18T00:00:00,Myocardial Infarction,C14.907.585.500
23508045,2013-03-18T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
23508045,2013-03-18T00:00:00,Oxidative Stress,G03.495.710
23508045,2013-03-18T00:00:00,Oxidative Stress,G07.700.830.750
23508045,2013-03-18T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23508045,2013-03-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23508045,2013-03-18T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23508045,2013-03-18T00:00:00,Stem Cells,A11.872
23508045,2013-03-18T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
23508045,2013-03-18T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
23508045,2013-03-18T00:00:00,Tissue Kallikreins,D23.101.840.870
23508045,2013-03-18T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
23508045,2013-03-18T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
23508045,2013-03-18T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
23508921,2013-03-18T00:00:00,Adult,M01.060.116
23508921,2013-03-18T00:00:00,Anatomy,H01.158.100
23508921,2013-03-18T00:00:00,Auditory Perception,F02.463.593.071
23508921,2013-03-18T00:00:00,Computer-Assisted Instruction,I02.903.573.208
23508921,2013-03-18T00:00:00,Curriculum,I02.158
23508921,2013-03-18T00:00:00,"Education, Medical, Undergraduate",I02.358.399.450
23508921,2013-03-18T00:00:00,Educational Measurement,I02.399
23508921,2013-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23508921,2013-03-18T00:00:00,Learning,F02.463.425
23508921,2013-03-18T00:00:00,Learning,F02.784.629.529
23508921,2013-03-18T00:00:00,"Students, Dental",I02.851.686.519
23508921,2013-03-18T00:00:00,"Students, Dental",M01.848.769.519
23508921,2013-03-18T00:00:00,"Students, Medical",I02.851.686.602
23508921,2013-03-18T00:00:00,"Students, Medical",M01.848.769.602
23508921,2013-03-18T00:00:00,Teaching,I02.903
23508921,2013-03-18T00:00:00,Young Adult,M01.060.116.815
23509163,2013-03-18T00:00:00,Adolescent,M01.060.057
23509163,2013-03-18T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23509163,2013-03-18T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23509163,2013-03-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23509163,2013-03-18T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
23509163,2013-03-18T00:00:00,Parents,F01.829.263.500.320
23509163,2013-03-18T00:00:00,Parents,I01.880.225.500.340
23509163,2013-03-18T00:00:00,Parents,M01.620
23509163,2013-03-18T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
23509163,2013-03-18T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23509163,2013-03-18T00:00:00,Physician-Patient Relations,N05.300.660.625
23509163,2013-03-18T00:00:00,United States,Z01.107.567.875
23509163,2013-03-18T00:00:00,Vaccination,E02.095.465.425.400.530.890
23509163,2013-03-18T00:00:00,Vaccination,E05.478.550.600.890
23509163,2013-03-18T00:00:00,Vaccination,N02.421.726.758.310.890
23509163,2013-03-18T00:00:00,Vaccination,N06.850.780.200.425.900
23509163,2013-03-18T00:00:00,Vaccination,N06.850.780.680.310.890
23510021,2013-03-19T00:00:00,Adult,M01.060.116
23510021,2013-03-19T00:00:00,Aged,M01.060.116.100
23510021,2013-03-19T00:00:00,Algorithms,G17.035
23510021,2013-03-19T00:00:00,Algorithms,L01.224.050
23510021,2013-03-19T00:00:00,Device Removal,E04.199
23510021,2013-03-19T00:00:00,"Electrodes, Implanted",E07.305.250.319
23510021,2013-03-19T00:00:00,Equipment Failure,E05.325
23510021,2013-03-19T00:00:00,Heart Diseases,C14.280
23510021,2013-03-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23510021,2013-03-19T00:00:00,Middle Aged,M01.060.116.630
23510021,2013-03-19T00:00:00,Postoperative Complications,C23.550.767
23510021,2013-03-19T00:00:00,Prevalence,E05.318.308.985.525.750
23510021,2013-03-19T00:00:00,Prevalence,L01.280.975.525.750
23510021,2013-03-19T00:00:00,Prevalence,N01.224.935.597.750
23510021,2013-03-19T00:00:00,Prevalence,N06.850.505.400.975.525.750
23510021,2013-03-19T00:00:00,Prevalence,N06.850.520.308.985.525.750
23510021,2013-03-19T00:00:00,Risk Factors,E05.318.740.600.800.725
23510021,2013-03-19T00:00:00,Risk Factors,N05.715.350.200.700
23510021,2013-03-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23510021,2013-03-19T00:00:00,Risk Factors,N06.850.490.625.750
23510021,2013-03-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23510021,2013-03-19T00:00:00,Treatment Outcome,E01.789.800
23510021,2013-03-19T00:00:00,Treatment Outcome,N04.761.559.590.800
23510021,2013-03-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23510021,2013-03-19T00:00:00,Young Adult,M01.060.116.815
23512682,2013-03-20T00:00:00,Aged,M01.060.116.100
23512682,2013-03-20T00:00:00,Aging,G07.700.320.124
23512682,2013-03-20T00:00:00,Hearing Loss,C09.218.458.341
23512682,2013-03-20T00:00:00,Hearing Loss,C10.597.751.418.341
23512682,2013-03-20T00:00:00,Hearing Loss,C23.888.592.763.393.341
23512682,2013-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23512682,2013-03-20T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23512682,2013-03-20T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23512682,2013-03-20T00:00:00,Middle Aged,M01.060.116.630
23512682,2013-03-20T00:00:00,Sex Factors,N05.715.350.675
23512682,2013-03-20T00:00:00,Sex Factors,N06.850.490.875
23514730,2013-03-20T00:00:00,Adolescent,M01.060.057
23514730,2013-03-20T00:00:00,Adult,M01.060.116
23514730,2013-03-20T00:00:00,Albuminuria,C12.777.934.734.269
23514730,2013-03-20T00:00:00,Albuminuria,C13.351.968.934.734.269
23514730,2013-03-20T00:00:00,Albuminuria,C23.888.942.750.269
23514730,2013-03-20T00:00:00,Biological Markers,D23.101
23514730,2013-03-20T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
23514730,2013-03-20T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
23514730,2013-03-20T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
23514730,2013-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23514730,2013-03-20T00:00:00,Inflammation,C23.550.470
23514730,2013-03-20T00:00:00,Interleukin-6,D12.644.276.374.465.506
23514730,2013-03-20T00:00:00,Interleukin-6,D12.776.467.374.465.506
23514730,2013-03-20T00:00:00,Interleukin-6,D23.529.374.465.506
23514730,2013-03-20T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D12.776.543.750.073.750
23514730,2013-03-20T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D12.776.543.750.705.852.760.597
23514730,2013-03-20T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D23.050.301.264.035.908
23514730,2013-03-20T00:00:00,"Receptors, Tumor Necrosis Factor, Type I",D23.101.100.110.912
23514936,2013-03-20T00:00:00,Adult,M01.060.116
23514936,2013-03-20T00:00:00,African Americans,M01.686.508.100.100
23514936,2013-03-20T00:00:00,African Americans,M01.686.754.100
23514936,2013-03-20T00:00:00,Cyclonic Storms,G16.500.240.135.500
23514936,2013-03-20T00:00:00,Disasters,N06.230.100
23514936,2013-03-20T00:00:00,Ethnic Groups,M01.686.754
23514936,2013-03-20T00:00:00,Ethnic Groups,N01.224.317
23514936,2013-03-20T00:00:00,European Continental Ancestry Group,M01.686.508.400
23514936,2013-03-20T00:00:00,Health Services Accessibility,N04.590.374.350
23514936,2013-03-20T00:00:00,Health Services Accessibility,N05.300.430
23514936,2013-03-20T00:00:00,Hispanic Americans,M01.686.754.441
23514936,2013-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23514936,2013-03-20T00:00:00,Internet,L01.224.230.110.500
23514936,2013-03-20T00:00:00,Mental Health Services,F04.408
23514936,2013-03-20T00:00:00,Mental Health Services,N02.421.461
23514936,2013-03-20T00:00:00,Middle Aged,M01.060.116.630
23514936,2013-03-20T00:00:00,United States,Z01.107.567.875
23515265,2013-03-20T00:00:00,Blood Pressure,E01.370.600.875.249
23515265,2013-03-20T00:00:00,Blood Pressure,G09.330.380.076
23515265,2013-03-20T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23515265,2013-03-20T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23515265,2013-03-20T00:00:00,"Defibrillators, Implantable",E07.695.175
23515265,2013-03-20T00:00:00,Disease Progression,C23.550.291.656
23515265,2013-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23515265,2013-03-20T00:00:00,Middle Aged,M01.060.116.630
23515265,2013-03-20T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
23515265,2013-03-20T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
23515265,2013-03-20T00:00:00,Ventricular Pressure,G09.330.190.962.950
23515265,2013-03-20T00:00:00,Ventricular Pressure,G09.330.380.937
23515277,2013-03-20T00:00:00,Activities of Daily Living,E02.831.067
23515277,2013-03-20T00:00:00,Activities of Daily Living,I03.050
23515277,2013-03-20T00:00:00,Activities of Daily Living,N02.421.784.110
23515277,2013-03-20T00:00:00,Adult,M01.060.116
23515277,2013-03-20T00:00:00,Aged,M01.060.116.100
23515277,2013-03-20T00:00:00,Cardiac Output,E01.370.370.380.150
23515277,2013-03-20T00:00:00,Cardiac Output,G09.330.380.124
23515277,2013-03-20T00:00:00,Diastole,G09.330.190.541.295
23515277,2013-03-20T00:00:00,Diastole,G11.427.590.540.554.250
23515277,2013-03-20T00:00:00,Diastole,G11.427.590.540.570.295
23515277,2013-03-20T00:00:00,Exercise,G11.427.590.237
23515277,2013-03-20T00:00:00,Exercise,I03.350
23515277,2013-03-20T00:00:00,Exercise Tolerance,G11.427.680.270
23515277,2013-03-20T00:00:00,Heart Failure,C14.280.434
23515277,2013-03-20T00:00:00,Hemodynamics,G09.330.190.400
23515277,2013-03-20T00:00:00,Hemodynamics,G09.330.380
23515277,2013-03-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23515277,2013-03-20T00:00:00,Middle Aged,M01.060.116.630
23515277,2013-03-20T00:00:00,Stroke Volume,E01.370.370.380.150.700
23515277,2013-03-20T00:00:00,Stroke Volume,G09.330.380.124.882
23518004,2013-03-21T00:00:00,African Americans,M01.686.508.100.100
23518004,2013-03-21T00:00:00,African Americans,M01.686.754.100
23518004,2013-03-21T00:00:00,Aged,M01.060.116.100
23518004,2013-03-21T00:00:00,Continental Population Groups,M01.686.508
23518004,2013-03-21T00:00:00,European Continental Ancestry Group,M01.686.508.400
23518004,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23518004,2013-03-21T00:00:00,Middle Aged,M01.060.116.630
23518004,2013-03-21T00:00:00,Population Surveillance,E05.318.308.250.700
23518004,2013-03-21T00:00:00,Population Surveillance,N05.715.360.300.375.625
23518004,2013-03-21T00:00:00,Population Surveillance,N06.850.520.308.250.700
23518004,2013-03-21T00:00:00,Population Surveillance,N06.850.780.675
23518004,2013-03-21T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
23518004,2013-03-21T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23518004,2013-03-21T00:00:00,Risk Factors,E05.318.740.600.800.725
23518004,2013-03-21T00:00:00,Risk Factors,N05.715.350.200.700
23518004,2013-03-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23518004,2013-03-21T00:00:00,Risk Factors,N06.850.490.625.750
23518004,2013-03-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23518004,2013-03-21T00:00:00,Stroke,C10.228.140.300.775
23518004,2013-03-21T00:00:00,Stroke,C14.907.253.855
23519469,2013-03-21T00:00:00,Aldehyde Dehydrogenase,D08.811.682.657.163.249
23519469,2013-03-21T00:00:00,Apoptosis,G04.299.139.160
23519469,2013-03-21T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
23519469,2013-03-21T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
23519469,2013-03-21T00:00:00,Ceramides,D02.065.313
23519469,2013-03-21T00:00:00,Ceramides,D09.400.410.420.525.200
23519469,2013-03-21T00:00:00,Ceramides,D10.390.470.675.200
23519469,2013-03-21T00:00:00,Ceramides,D10.570.877.360.612.200
23519469,2013-03-21T00:00:00,Folic Acid,D03.438.733.631.400
23519469,2013-03-21T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23519469,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23519469,2013-03-21T00:00:00,Membrane Proteins,D12.776.543
23519469,2013-03-21T00:00:00,"Mutation, Missense",G05.365.590.650
23519469,2013-03-21T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
23519469,2013-03-21T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
23519469,2013-03-21T00:00:00,"Stress, Physiological",G07.700.830
23519469,2013-03-21T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
23519469,2013-03-21T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
23519469,2013-03-21T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
23519469,2013-03-21T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
23519612,2013-03-21T00:00:00,Alternative Splicing,G02.111.087.750.700.100
23519612,2013-03-21T00:00:00,Alternative Splicing,G02.149.115.750.700.100
23519612,2013-03-21T00:00:00,Alternative Splicing,G03.495.839.700.100
23519612,2013-03-21T00:00:00,Alternative Splicing,G05.355.315.700.700.100
23519612,2013-03-21T00:00:00,Animals,B01.050
23519612,2013-03-21T00:00:00,Cell Line,A11.251.210
23519612,2013-03-21T00:00:00,Cell Movement,G04.299.283
23519612,2013-03-21T00:00:00,Cell Movement,G07.700.560.500.180
23519612,2013-03-21T00:00:00,Fibronectins,D12.776.377.715.390
23519612,2013-03-21T00:00:00,Fibronectins,D12.776.395.550.350
23519612,2013-03-21T00:00:00,Fibronectins,D12.776.543.550.350
23519612,2013-03-21T00:00:00,Fibronectins,D12.776.860.300.450
23519612,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23519612,2013-03-21T00:00:00,Mutation,G05.365.590
23519612,2013-03-21T00:00:00,Proteasome Endopeptidase Complex,D05.500.562.500
23519612,2013-03-21T00:00:00,Proteasome Endopeptidase Complex,D08.811.277.656.918
23519612,2013-03-21T00:00:00,Proteasome Endopeptidase Complex,D08.811.600.730
23519612,2013-03-21T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23519612,2013-03-21T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
23519612,2013-03-21T00:00:00,"RNA, Messenger",D13.444.735.544
23519612,2013-03-21T00:00:00,RNA-Binding Proteins,D12.776.157.725
23519612,2013-03-21T00:00:00,RNA-Binding Proteins,D12.776.664.962
23523039,2013-03-21T00:00:00,Aortic Valve,A07.541.510.110
23523039,2013-03-21T00:00:00,Certification,N03.706.110.120
23523039,2013-03-21T00:00:00,Certification,N05.700.200.190
23523039,2013-03-21T00:00:00,Health Services Accessibility,N04.590.374.350
23523039,2013-03-21T00:00:00,Health Services Accessibility,N05.300.430
23523039,2013-03-21T00:00:00,Heart Valve Prosthesis,E07.695.310
23523039,2013-03-21T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
23523039,2013-03-21T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
23523039,2013-03-21T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
23523039,2013-03-21T00:00:00,Hospitals,N02.278.421
23523039,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23523039,2013-03-21T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
23523039,2013-03-21T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
23524188,2013-03-21T00:00:00,Animals,B01.050
23524188,2013-03-21T00:00:00,Cell Survival,G04.299.316
23524188,2013-03-21T00:00:00,Combined Modality Therapy,E02.186
23524188,2013-03-21T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
23524188,2013-03-21T00:00:00,Doxorubicin,D04.615.562.050.200.175
23524188,2013-03-21T00:00:00,Doxorubicin,D09.408.051.059.200.175
23524188,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23524188,2013-03-21T00:00:00,"Hyperthermia, Induced",E02.565
23524188,2013-03-21T00:00:00,"Hyperthermia, Induced",E02.779.496
23524188,2013-03-21T00:00:00,Liposomes,D25.479.517
23524188,2013-03-21T00:00:00,Liposomes,D26.255.260.517
23524188,2013-03-21T00:00:00,Liposomes,D27.720.280.260.517
23524188,2013-03-21T00:00:00,Liposomes,J01.637.051.479.517
23524188,2013-03-21T00:00:00,Liposomes,J01.637.087.500.517
23524188,2013-03-21T00:00:00,Melanoma,C04.557.465.625.650.510
23524188,2013-03-21T00:00:00,Melanoma,C04.557.580.625.650.510
23524188,2013-03-21T00:00:00,Melanoma,C04.557.665.510
23524188,2013-03-21T00:00:00,Treatment Outcome,E01.789.800
23524188,2013-03-21T00:00:00,Treatment Outcome,N04.761.559.590.800
23524188,2013-03-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23555291,2013-03-21T00:00:00,African Americans,M01.686.508.100.100
23555291,2013-03-21T00:00:00,African Americans,M01.686.754.100
23555291,2013-03-21T00:00:00,"Cholesterol, HDL",D10.532.432.400
23555291,2013-03-21T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
23555291,2013-03-21T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
23555291,2013-03-21T00:00:00,"Cholesterol, LDL",D10.532.515.500
23555291,2013-03-21T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
23555291,2013-03-21T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
23555291,2013-03-21T00:00:00,European Continental Ancestry Group,M01.686.508.400
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.318.416.249
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.318.780.392
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.393.385.500
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.393.522.500
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23555291,2013-03-21T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23555291,2013-03-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23555291,2013-03-21T00:00:00,"Lipoproteins, HDL",D10.532.432
23555291,2013-03-21T00:00:00,"Lipoproteins, HDL",D12.776.521.479
23555291,2013-03-21T00:00:00,"Lipoproteins, LDL",D10.532.515
23555291,2013-03-21T00:00:00,"Lipoproteins, LDL",D12.776.521.550
23529144,2013-03-22T00:00:00,Adult,M01.060.116
23529144,2013-03-22T00:00:00,Aged,M01.060.116.100
23529144,2013-03-22T00:00:00,Disability Evaluation,E01.370.400
23529144,2013-03-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23529144,2013-03-22T00:00:00,Middle Aged,M01.060.116.630
23529144,2013-03-22T00:00:00,Motor Activity,F01.145.632
23529144,2013-03-22T00:00:00,Motor Activity,G11.427.590.530.698
23529144,2013-03-22T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23529144,2013-03-22T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23529144,2013-03-22T00:00:00,Paresis,C10.597.636
23529144,2013-03-22T00:00:00,Paresis,C23.888.592.643
23529144,2013-03-22T00:00:00,Recovery of Function,G16.757
23529144,2013-03-22T00:00:00,Stroke,C10.228.140.300.775
23529144,2013-03-22T00:00:00,Stroke,C14.907.253.855
23529144,2013-03-22T00:00:00,Upper Extremity,A01.378.800
23533664,2013-03-22T00:00:00,Cell Aging,G04.299.119
23533664,2013-03-22T00:00:00,DNA Damage,C21.111
23533664,2013-03-22T00:00:00,DNA Damage,G05.355.180
23533664,2013-03-22T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23533664,2013-03-22T00:00:00,Flow Cytometry,E05.200.500.386.350
23533664,2013-03-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23533664,2013-03-22T00:00:00,Lung Neoplasms,C04.588.894.797.520
23533664,2013-03-22T00:00:00,Lung Neoplasms,C08.381.540
23533664,2013-03-22T00:00:00,Lung Neoplasms,C08.785.520
23533664,2013-03-22T00:00:00,Reactive Oxygen Species,D01.339.431
23533664,2013-03-22T00:00:00,Reactive Oxygen Species,D01.650.775
23533664,2013-03-22T00:00:00,Stilbenes,D02.455.426.559.389.150.700
23533674,2013-03-22T00:00:00,DNA Methylation,G02.111.087.029.538.161
23533674,2013-03-22T00:00:00,DNA Methylation,G02.111.087.218
23533674,2013-03-22T00:00:00,DNA Methylation,G02.149.115.029.538.161
23533674,2013-03-22T00:00:00,DNA Methylation,G02.149.115.218
23533674,2013-03-22T00:00:00,DNA Methylation,G03.495.130.538.161
23533674,2013-03-22T00:00:00,DNA Methylation,G05.355.190
23533674,2013-03-22T00:00:00,Histones,D12.776.660.470
23533674,2013-03-22T00:00:00,Histones,D12.776.664.469
23533674,2013-03-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C04.588.322.455
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C19.344.410
23533674,2013-03-22T00:00:00,Ovarian Neoplasms,C19.391.630.705
23533674,2013-03-22T00:00:00,RGS Proteins,D12.644.360.325.150.750
23533674,2013-03-22T00:00:00,RGS Proteins,D12.776.402.150.750
23533674,2013-03-22T00:00:00,RGS Proteins,D12.776.476.325.150.750
23525571,2013-03-23T00:00:00,Adult,M01.060.116
23525571,2013-03-23T00:00:00,Aged,M01.060.116.100
23525571,2013-03-23T00:00:00,"Embolization, Therapeutic",E02.520.360
23525571,2013-03-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23525571,2013-03-23T00:00:00,Middle Aged,M01.060.116.630
23525571,2013-03-23T00:00:00,Treatment Outcome,E01.789.800
23525571,2013-03-23T00:00:00,Treatment Outcome,N04.761.559.590.800
23525571,2013-03-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23522556,2013-03-24T00:00:00,Community Mental Health Services,F04.408.307
23522556,2013-03-24T00:00:00,Community Mental Health Services,N02.421.143.183
23522556,2013-03-24T00:00:00,Community Mental Health Services,N02.421.461.232
23522556,2013-03-24T00:00:00,Delivery of Health Care,N04.590.374
23522556,2013-03-24T00:00:00,Delivery of Health Care,N05.300
23522556,2013-03-24T00:00:00,Diffusion of Innovation,L01.143.320
23522556,2013-03-24T00:00:00,Health Policy,I01.880.604.825.608.400
23522556,2013-03-24T00:00:00,Health Policy,N03.706.825.608.428
23522556,2013-03-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531444,2013-03-24T00:00:00,ADAM Proteins,D08.811.277.656.675.374.102
23531444,2013-03-24T00:00:00,ADAM Proteins,D09.400.430.500
23531444,2013-03-24T00:00:00,ADAM Proteins,D12.776.395.033
23531444,2013-03-24T00:00:00,Actins,D05.750.078.730.250
23531444,2013-03-24T00:00:00,Actins,D12.776.210.500.100
23531444,2013-03-24T00:00:00,Actins,D12.776.220.525.255
23531444,2013-03-24T00:00:00,Animals,B01.050
23531444,2013-03-24T00:00:00,Aortic Valve,A07.541.510.110
23531444,2013-03-24T00:00:00,"Heart Defects, Congenital",C14.240.400
23531444,2013-03-24T00:00:00,"Heart Defects, Congenital",C14.280.400
23531444,2013-03-24T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23531444,2013-03-24T00:00:00,Signal Transduction,G02.111.087.800
23531444,2013-03-24T00:00:00,Signal Transduction,G02.149.115.800
23531444,2013-03-24T00:00:00,Signal Transduction,G04.299.880
23531444,2013-03-24T00:00:00,Versicans,D09.698.735.830.750
23531444,2013-03-24T00:00:00,Versicans,D12.776.395.650.750.750
23531444,2013-03-24T00:00:00,Versicans,D12.776.503.280.625
22936613,2013-03-25T00:00:00,Ablation Techniques,E04.014
22936613,2013-03-25T00:00:00,Adult,M01.060.116
22936613,2013-03-25T00:00:00,Age Factors,N05.715.350.075
22936613,2013-03-25T00:00:00,Age Factors,N06.850.490.250
22936613,2013-03-25T00:00:00,Aged,M01.060.116.100
22936613,2013-03-25T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
22936613,2013-03-25T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
22936613,2013-03-25T00:00:00,Ethanol,D02.033.375
22936613,2013-03-25T00:00:00,Hospital Mortality,E05.318.308.985.550.400
22936613,2013-03-25T00:00:00,Hospital Mortality,L01.280.975.550.400
22936613,2013-03-25T00:00:00,Hospital Mortality,N01.224.935.698.400
22936613,2013-03-25T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
22936613,2013-03-25T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
22936613,2013-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22936613,2013-03-25T00:00:00,Middle Aged,M01.060.116.630
22936613,2013-03-25T00:00:00,Patient Selection,E05.581.500.653
22936613,2013-03-25T00:00:00,Patient Selection,N04.590.731
22936613,2013-03-25T00:00:00,Recovery of Function,G16.757
22936613,2013-03-25T00:00:00,Risk Factors,E05.318.740.600.800.725
22936613,2013-03-25T00:00:00,Risk Factors,N05.715.350.200.700
22936613,2013-03-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22936613,2013-03-25T00:00:00,Risk Factors,N06.850.490.625.750
22936613,2013-03-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22936613,2013-03-25T00:00:00,Treatment Outcome,E01.789.800
22936613,2013-03-25T00:00:00,Treatment Outcome,N04.761.559.590.800
22936613,2013-03-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23526312,2013-03-25T00:00:00,Bayes Theorem,E05.318.740.600.200
23526312,2013-03-25T00:00:00,Bayes Theorem,N05.715.360.750.625.150
23526312,2013-03-25T00:00:00,Bayes Theorem,N06.850.520.830.600.200
23526312,2013-03-25T00:00:00,Computer Simulation,L01.224.160
23526312,2013-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23526312,2013-03-25T00:00:00,"Infant, Low Birth Weight",M01.060.703.520.460
23526312,2013-03-25T00:00:00,"Infant, Newborn",M01.060.703.520
23526312,2013-03-25T00:00:00,"Models, Statistical",E05.318.740.500
23526312,2013-03-25T00:00:00,"Models, Statistical",E05.599.835
23526312,2013-03-25T00:00:00,"Models, Statistical",N05.715.360.750.530
23526312,2013-03-25T00:00:00,"Models, Statistical",N06.850.520.830.500
23526312,2013-03-25T00:00:00,Pregnancy,G08.686.785.760.769
23526312,2013-03-25T00:00:00,South Carolina,Z01.107.567.875.075.662
23526312,2013-03-25T00:00:00,South Carolina,Z01.107.567.875.750.700
23526312,2013-03-25T00:00:00,Space-Time Clustering,E05.318.740.250.700
23526312,2013-03-25T00:00:00,Space-Time Clustering,N05.715.360.750.200.775
23526312,2013-03-25T00:00:00,Space-Time Clustering,N06.850.520.830.250.700
23530041,2013-03-25T00:00:00,Animals,B01.050
23530041,2013-03-25T00:00:00,Autophagy,G04.299.139.399
23530041,2013-03-25T00:00:00,Autophagy,G04.299.482.350.091
23530041,2013-03-25T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
23530041,2013-03-25T00:00:00,Cell Line,A11.251.210
23530041,2013-03-25T00:00:00,Cell Survival,G04.299.316
23530041,2013-03-25T00:00:00,Gene Expression,G05.355.310
23530041,2013-03-25T00:00:00,Heart Ventricles,A07.541.560
23530041,2013-03-25T00:00:00,Lipid Metabolism,G03.495.520
23530041,2013-03-25T00:00:00,"Muscle, Skeletal",A02.633.567
23530041,2013-03-25T00:00:00,"Muscle, Skeletal",A10.690.552.500
23530041,2013-03-25T00:00:00,Myocardium,A02.633.580
23530041,2013-03-25T00:00:00,Myocardium,A07.541.704
23530041,2013-03-25T00:00:00,Myocardium,A10.690.552.750
23530041,2013-03-25T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23530041,2013-03-25T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23530041,2013-03-25T00:00:00,"Myocytes, Cardiac",A11.620.500
23530041,2013-03-25T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23530041,2013-03-25T00:00:00,Sphingolipids,D10.570.877
23530041,2013-03-25T00:00:00,Sphingolipids,D10.808
23530041,2013-03-25T00:00:00,Sphingosine N-Acyltransferase,D08.811.913.050.712
23530041,2013-03-25T00:00:00,Substrate Specificity,G02.111.835
23530212,2013-03-25T00:00:00,Animals,B01.050
23530212,2013-03-25T00:00:00,Anoxia,C23.888.852.079
23530212,2013-03-25T00:00:00,Complement C3,D12.776.124.050.140
23530212,2013-03-25T00:00:00,Complement C3,D12.776.124.486.274.250
23530212,2013-03-25T00:00:00,Fibrosis,C23.550.355
23530212,2013-03-25T00:00:00,Graft Rejection,G12.425.901.545.328
23530212,2013-03-25T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23530212,2013-03-25T00:00:00,Microcirculation,G09.330.190.163.645
23530212,2013-03-25T00:00:00,Oxygen,D01.268.185.550
23530212,2013-03-25T00:00:00,Oxygen,D01.362.670
23530212,2013-03-25T00:00:00,Perfusion,E05.680
23530212,2013-03-25T00:00:00,Thrombin,D08.811.277.656.300.760.855
23530212,2013-03-25T00:00:00,Thrombin,D08.811.277.656.959.350.855
23530212,2013-03-25T00:00:00,Thrombin,D12.776.124.125.890
23530212,2013-03-25T00:00:00,Thrombin,D23.119.960
23536776,2013-03-25T00:00:00,Adenocarcinoma,C04.557.470.200.025
23536776,2013-03-25T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23536776,2013-03-25T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23536776,2013-03-25T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
23536776,2013-03-25T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
23536776,2013-03-25T00:00:00,Cell Adhesion Molecules,D23.050.301.350
23536776,2013-03-25T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23536776,2013-03-25T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23536776,2013-03-25T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23536776,2013-03-25T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23536776,2013-03-25T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23536776,2013-03-25T00:00:00,Data Mining,L01.470.625
23536776,2013-03-25T00:00:00,Data Mining,L01.700.508.280.199
23536776,2013-03-25T00:00:00,"Databases, Genetic",L01.470.750.750.325
23536776,2013-03-25T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
23536776,2013-03-25T00:00:00,Gene Expression,G05.355.310
23536776,2013-03-25T00:00:00,Gene Expression Profiling,E05.393.332
23536776,2013-03-25T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23536776,2013-03-25T00:00:00,Head and Neck Neoplasms,C04.588.443
23536776,2013-03-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23536776,2013-03-25T00:00:00,Inflammation,C23.550.470
23536776,2013-03-25T00:00:00,Neoplasms,C04
23536776,2013-03-25T00:00:00,"Tumor Markers, Biological",D23.101.840
23463900,2013-03-26T00:00:00,"Biodegradation, Environmental",N06.850.460.375.500
23463900,2013-03-26T00:00:00,"Biodegradation, Environmental",N06.850.860.510.900.299
23463900,2013-03-26T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
23463900,2013-03-26T00:00:00,Geologic Sediments,G01.311.500
23463900,2013-03-26T00:00:00,Geologic Sediments,G16.500.320
23463900,2013-03-26T00:00:00,Polychlorinated Biphenyls,D02.455.426.559.389.185.698
23463900,2013-03-26T00:00:00,Polychlorinated Biphenyls,D02.455.526.439.773
23463900,2013-03-26T00:00:00,Polymerase Chain Reaction,E05.393.620.500
23541069,2013-03-26T00:00:00,"Adaptation, Psychological",F01.058
23541069,2013-03-26T00:00:00,Adolescent,M01.060.057
23541069,2013-03-26T00:00:00,Child,M01.060.406
23541069,2013-03-26T00:00:00,Cognitive Therapy,F04.754.137.428
23541069,2013-03-26T00:00:00,Depression,F01.145.126.350
23541069,2013-03-26T00:00:00,Disability Evaluation,E01.370.400
23541069,2013-03-26T00:00:00,Fibromyalgia,C05.651.324
23541069,2013-03-26T00:00:00,Fibromyalgia,C05.799.321
23541069,2013-03-26T00:00:00,Fibromyalgia,C10.668.491.425
23541069,2013-03-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23541069,2013-03-26T00:00:00,Pain Measurement,E01.370.376.550.600
23541069,2013-03-26T00:00:00,Psychiatric Status Rating Scales,F04.586
23541069,2013-03-26T00:00:00,Questionnaires,E05.318.308.750
23541069,2013-03-26T00:00:00,Questionnaires,L01.280.800
23541069,2013-03-26T00:00:00,Questionnaires,N05.715.360.300.695
23541069,2013-03-26T00:00:00,Questionnaires,N06.850.520.308.750
23541069,2013-03-26T00:00:00,Treatment Outcome,E01.789.800
23541069,2013-03-26T00:00:00,Treatment Outcome,N04.761.559.590.800
23541069,2013-03-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23536133,2013-03-27T00:00:00,Albuminuria,C12.777.934.734.269
23536133,2013-03-27T00:00:00,Albuminuria,C13.351.968.934.734.269
23536133,2013-03-27T00:00:00,Albuminuria,C23.888.942.750.269
23536133,2013-03-27T00:00:00,Biological Markers,D23.101
23536133,2013-03-27T00:00:00,Creatinine,D03.383.129.308.207
23536133,2013-03-27T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23536133,2013-03-27T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23536133,2013-03-27T00:00:00,Diabetic Nephropathies,C12.777.419.192
23536133,2013-03-27T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
23536133,2013-03-27T00:00:00,Diabetic Nephropathies,C19.246.099.875
23536133,2013-03-27T00:00:00,Disease Progression,C23.550.291.656
23536133,2013-03-27T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
23536133,2013-03-27T00:00:00,Glomerular Filtration Rate,G08.852.357
23536133,2013-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23536133,2013-03-27T00:00:00,Kidney,A05.810.453
23536133,2013-03-27T00:00:00,Middle Aged,M01.060.116.630
23536133,2013-03-27T00:00:00,Proteomics,H01.158.201.843
23536133,2013-03-27T00:00:00,Proteomics,H01.158.273.180.350.700
23536133,2013-03-27T00:00:00,Proteomics,H01.158.273.343.350.700
23536133,2013-03-27T00:00:00,Proteomics,H01.181.122.738
23536133,2013-03-27T00:00:00,Risk Factors,E05.318.740.600.800.725
23536133,2013-03-27T00:00:00,Risk Factors,N05.715.350.200.700
23536133,2013-03-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23536133,2013-03-27T00:00:00,Risk Factors,N06.850.490.625.750
23536133,2013-03-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24321568,2013-03-27T00:00:00,Gastroplasty,E02.065.062.750
24321568,2013-03-27T00:00:00,Gastroplasty,E04.062.750
24321568,2013-03-27T00:00:00,Gastroplasty,E04.210.485
24321568,2013-03-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24321568,2013-03-27T00:00:00,Laparoscopy,E01.370.388.250.520
24321568,2013-03-27T00:00:00,Laparoscopy,E04.800.250.520
24321568,2013-03-27T00:00:00,"Monitoring, Physiologic",E01.370.520
24321568,2013-03-27T00:00:00,"Obesity, Morbid",C18.654.726.500.700
24321568,2013-03-27T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
24321568,2013-03-27T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
24321568,2013-03-27T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
23537390,2013-03-28T00:00:00,Animals,B01.050
23537390,2013-03-28T00:00:00,Cell Cycle Proteins,D12.776.167
23537390,2013-03-28T00:00:00,Cilia,A11.284.180.165
23537390,2013-03-28T00:00:00,Fishes,B01.050.150.900.493
23537390,2013-03-28T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
23537390,2013-03-28T00:00:00,Mutation,G05.365.590
23537390,2013-03-28T00:00:00,Phylogeny,G05.697
23537390,2013-03-28T00:00:00,Phylogeny,G16.100.275.605
23537390,2013-03-28T00:00:00,Phylogeny,L01.100.697
23537390,2013-03-28T00:00:00,Signal Transduction,G02.111.087.800
23537390,2013-03-28T00:00:00,Signal Transduction,G02.149.115.800
23537390,2013-03-28T00:00:00,Signal Transduction,G04.299.880
23537390,2013-03-28T00:00:00,Skull,A02.835.232.781
23539690,2013-03-28T00:00:00,Asthma,C08.127.108
23539690,2013-03-28T00:00:00,Asthma,C08.381.495.108
23539690,2013-03-28T00:00:00,Asthma,C08.674.095
23539690,2013-03-28T00:00:00,Asthma,C20.543.480.680.095
23539690,2013-03-28T00:00:00,Environment,G16.500.275
23539690,2013-03-28T00:00:00,Environment,N06.230
23539690,2013-03-28T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23539690,2013-03-28T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23539690,2013-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23539690,2013-03-28T00:00:00,Pediatrics,H02.403.670
23539690,2013-03-28T00:00:00,Physicians,M01.526.485.810
23539690,2013-03-28T00:00:00,Physicians,N02.360.810
23539690,2013-03-28T00:00:00,Questionnaires,E05.318.308.750
23539690,2013-03-28T00:00:00,Questionnaires,L01.280.800
23539690,2013-03-28T00:00:00,Questionnaires,N05.715.360.300.695
23539690,2013-03-28T00:00:00,Questionnaires,N06.850.520.308.750
23539690,2013-03-28T00:00:00,United States,Z01.107.567.875
23541868,2013-03-28T00:00:00,Adult,M01.060.116
23541868,2013-03-28T00:00:00,Aged,M01.060.116.100
23541868,2013-03-28T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
23541868,2013-03-28T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
23541868,2013-03-28T00:00:00,"Blood Loss, Surgical",C23.550.414.300
23541868,2013-03-28T00:00:00,"Blood Loss, Surgical",C23.550.505.300
23541868,2013-03-28T00:00:00,Blood Transfusion,E02.095.135
23541868,2013-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23541868,2013-03-28T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
23541868,2013-03-28T00:00:00,Middle Aged,M01.060.116.630
23542507,2013-03-28T00:00:00,Calcium,D01.268.552.100
23542507,2013-03-28T00:00:00,Calcium,D01.552.539.288
23542507,2013-03-28T00:00:00,Calcium,D23.119.100
23542507,2013-03-28T00:00:00,Dietary Supplements,J02.500.456
23542507,2013-03-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23542507,2013-03-28T00:00:00,Pregnancy,G08.686.785.760.769
23542507,2013-03-28T00:00:00,Vitamin D,D04.808.812.768
23542507,2013-03-28T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23543298,2013-03-30T00:00:00,Adult,M01.060.116
23543298,2013-03-30T00:00:00,Aged,M01.060.116.100
23543298,2013-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23543298,2013-03-30T00:00:00,Melanoma,C04.557.465.625.650.510
23543298,2013-03-30T00:00:00,Melanoma,C04.557.580.625.650.510
23543298,2013-03-30T00:00:00,Melanoma,C04.557.665.510
23543298,2013-03-30T00:00:00,Middle Aged,M01.060.116.630
23543298,2013-03-30T00:00:00,Reconstructive Surgical Procedures,E04.680
23543298,2013-03-30T00:00:00,Skin Neoplasms,C04.588.805
23543298,2013-03-30T00:00:00,Skin Neoplasms,C17.800.882
23543298,2013-03-30T00:00:00,Surgical Flaps,A10.850.710
23543298,2013-03-30T00:00:00,Surgical Flaps,E07.862.710
23543298,2013-03-30T00:00:00,Treatment Outcome,E01.789.800
23543298,2013-03-30T00:00:00,Treatment Outcome,N04.761.559.590.800
23543298,2013-03-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23543733,2013-03-30T00:00:00,Aged,M01.060.116.100
23543733,2013-03-30T00:00:00,Blister,C17.800.865.187
23543733,2013-03-30T00:00:00,Blister,C23.300.122
23543733,2013-03-30T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
23543733,2013-03-30T00:00:00,Carotid Artery Diseases,C14.907.253.123
23543733,2013-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23543733,2013-03-30T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
23543733,2013-03-30T00:00:00,Intracranial Aneurysm,C14.907.055.635
23543733,2013-03-30T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
23543733,2013-03-30T00:00:00,Middle Aged,M01.060.116.630
23543733,2013-03-30T00:00:00,Stents,E07.695.750
23543733,2013-03-30T00:00:00,Treatment Outcome,E01.789.800
23543733,2013-03-30T00:00:00,Treatment Outcome,N04.761.559.590.800
23543733,2013-03-30T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23624105,2013-03-30T00:00:00,Adult,M01.060.116
23624105,2013-03-30T00:00:00,Agriculture,J01.040
23624105,2013-03-30T00:00:00,Attitude to Health,F01.100.150
23624105,2013-03-30T00:00:00,Attitude to Health,N05.300.150
23624105,2013-03-30T00:00:00,Chronic Disease,C23.550.291.500
23624105,2013-03-30T00:00:00,Hispanic Americans,M01.686.754.441
23624105,2013-03-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23624105,2013-03-30T00:00:00,South Carolina,Z01.107.567.875.075.662
23624105,2013-03-30T00:00:00,South Carolina,Z01.107.567.875.750.700
23624105,2013-03-30T00:00:00,Telemedicine,H02.403.840
23624105,2013-03-30T00:00:00,Telemedicine,L01.178.847.652
23624105,2013-03-30T00:00:00,Telemedicine,N04.590.374.800
23624105,2013-03-30T00:00:00,Young Adult,M01.060.116.815
23097329,2013-04-01T00:00:00,Animals,B01.050
23097329,2013-04-01T00:00:00,Brain,A08.186.211
23097329,2013-04-01T00:00:00,Brain-Derived Neurotrophic Factor,D12.644.276.860.100
23097329,2013-04-01T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.467.860.100
23097329,2013-04-01T00:00:00,Brain-Derived Neurotrophic Factor,D12.776.641.600.100
23097329,2013-04-01T00:00:00,Brain-Derived Neurotrophic Factor,D23.529.850.100
23097329,2013-04-01T00:00:00,Cell Differentiation,G04.299.151
23097329,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23097329,2013-04-01T00:00:00,Huntington Disease,C10.228.140.079.545
23097329,2013-04-01T00:00:00,Huntington Disease,C10.228.140.380.278
23097329,2013-04-01T00:00:00,Huntington Disease,C10.228.662.262.249.750
23097329,2013-04-01T00:00:00,Huntington Disease,C10.574.500.497
23097329,2013-04-01T00:00:00,Huntington Disease,C16.320.400.430
23097329,2013-04-01T00:00:00,Huntington Disease,F03.087.250.400
23097329,2013-04-01T00:00:00,Huntington Disease,F03.087.400.390
23097329,2013-04-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23097329,2013-04-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23097329,2013-04-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23146924,2013-04-01T00:00:00,Adult,M01.060.116
23146924,2013-04-01T00:00:00,Aged,M01.060.116.100
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23146924,2013-04-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23146924,2013-04-01T00:00:00,"Diagnosis, Differential",E01.171
23146924,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C04.588.945.947.535
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C12.758.820.750
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C12.777.419.473
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C13.351.937.820.535
23146924,2013-04-01T00:00:00,Kidney Neoplasms,C13.351.968.419.473
23146924,2013-04-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23146924,2013-04-01T00:00:00,Lung Neoplasms,C08.381.540
23146924,2013-04-01T00:00:00,Lung Neoplasms,C08.785.520
23146924,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C06.301.761
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C06.689.667
23146924,2013-04-01T00:00:00,Pancreatic Neoplasms,C19.344.421
23146924,2013-04-01T00:00:00,Skin Neoplasms,C04.588.805
23146924,2013-04-01T00:00:00,Skin Neoplasms,C17.800.882
23299051,2013-04-01T00:00:00,Clinical Competence,I02.399.630.210
23299051,2013-04-01T00:00:00,Clinical Competence,N04.761.210
23299051,2013-04-01T00:00:00,Computer Simulation,L01.224.160
23299051,2013-04-01T00:00:00,Conscious Sedation,E03.250
23299051,2013-04-01T00:00:00,"Education, Medical",I02.358.399
23299051,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425984,2013-04-01T00:00:00,Academic Medical Centers,N02.278.020
23425984,2013-04-01T00:00:00,Biostatistics,E05.318.740.237
23425984,2013-04-01T00:00:00,Health Services Research,N03.349.380
23425984,2013-04-01T00:00:00,Health Services Research,N05.425
23425984,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23425984,2013-04-01T00:00:00,Professional Competence,I02.399.630
23425984,2013-04-01T00:00:00,Professional Role,F01.829.316.616.625
23434896,2013-04-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23434896,2013-04-01T00:00:00,"Drug Resistance, Microbial",G06.225
23434896,2013-04-01T00:00:00,"Drug Resistance, Microbial",G07.690.320.269
23434896,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23434896,2013-04-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23434896,2013-04-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23470779,2013-04-01T00:00:00,Adolescent,M01.060.057
23470779,2013-04-01T00:00:00,Adult,M01.060.116
23470779,2013-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
23470779,2013-04-01T00:00:00,Blood Pressure,G09.330.380.076
23470779,2013-04-01T00:00:00,Child,M01.060.406
23470779,2013-04-01T00:00:00,Continental Population Groups,M01.686.508
23470779,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23470779,2013-04-01T00:00:00,"Models, Genetic",E05.599.395.397
23470779,2013-04-01T00:00:00,Sex Factors,N05.715.350.675
23470779,2013-04-01T00:00:00,Sex Factors,N06.850.490.875
23470779,2013-04-01T00:00:00,Young Adult,M01.060.116.815
23474970,2013-04-01T00:00:00,Hepatic Encephalopathy,C06.552.308.500.356
23474970,2013-04-01T00:00:00,Hepatic Encephalopathy,C10.228.140.163.360
23474970,2013-04-01T00:00:00,Hepatic Encephalopathy,C18.452.132.360
23474970,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23474970,2013-04-01T00:00:00,Liver Cirrhosis,C06.552.630
23474970,2013-04-01T00:00:00,Mental Disorders,F03
23474970,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23474970,2013-04-01T00:00:00,Sepsis,C01.539.757
23474970,2013-04-01T00:00:00,Sepsis,C23.550.470.790.500
23487599,2013-04-01T00:00:00,African Americans,M01.686.508.100.100
23487599,2013-04-01T00:00:00,African Americans,M01.686.754.100
23487599,2013-04-01T00:00:00,Blood Pressure,E01.370.600.875.249
23487599,2013-04-01T00:00:00,Blood Pressure,G09.330.380.076
23487599,2013-04-01T00:00:00,Cholecalciferol,D04.808.247.222.159
23487599,2013-04-01T00:00:00,Cholecalciferol,D04.808.247.808.146
23487599,2013-04-01T00:00:00,Cholecalciferol,D04.808.812.768.196
23487599,2013-04-01T00:00:00,Cholecalciferol,D10.570.938.146
23487599,2013-04-01T00:00:00,Dietary Supplements,J02.500.456
23487599,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23487599,2013-04-01T00:00:00,Hypertension,C14.907.489
23487599,2013-04-01T00:00:00,Prevalence,E05.318.308.985.525.750
23487599,2013-04-01T00:00:00,Prevalence,L01.280.975.525.750
23487599,2013-04-01T00:00:00,Prevalence,N01.224.935.597.750
23487599,2013-04-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
23487599,2013-04-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
23487599,2013-04-01T00:00:00,Treatment Outcome,E01.789.800
23487599,2013-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23487599,2013-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23521451,2013-04-01T00:00:00,Contrast Media,D27.720.259
23521451,2013-04-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23521451,2013-04-01T00:00:00,Coronary Angiography,E01.370.370.050.200
23521451,2013-04-01T00:00:00,Coronary Angiography,E01.370.370.380.200
23521451,2013-04-01T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23521451,2013-04-01T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23521451,2013-04-01T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23521451,2013-04-01T00:00:00,Disease Progression,C23.550.291.656
23521451,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23521451,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23521451,2013-04-01T00:00:00,Regression Analysis,E05.318.740.750
23521451,2013-04-01T00:00:00,Regression Analysis,N05.715.360.750.695
23521451,2013-04-01T00:00:00,Regression Analysis,N06.850.520.830.750
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23521451,2013-04-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23522158,2013-04-01T00:00:00,Angioplasty,E02.148.050
23522158,2013-04-01T00:00:00,Angioplasty,E04.100.814.050
23522158,2013-04-01T00:00:00,Brain Ischemia,C10.228.140.300.150
23522158,2013-04-01T00:00:00,Brain Ischemia,C14.907.253.092
23522158,2013-04-01T00:00:00,Carotid Artery Diseases,C10.228.140.300.200
23522158,2013-04-01T00:00:00,Carotid Artery Diseases,C14.907.253.123
23522158,2013-04-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
23522158,2013-04-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
23522158,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23522158,2013-04-01T00:00:00,Intracranial Embolism,C10.228.140.300.525.400
23522158,2013-04-01T00:00:00,Intracranial Embolism,C14.907.253.566.300
23522158,2013-04-01T00:00:00,Intracranial Embolism,C14.907.355.590.213.300
23522158,2013-04-01T00:00:00,Intracranial Embolism,C14.907.355.830.850.213.300
23522158,2013-04-01T00:00:00,Perfusion,E05.680
23522158,2013-04-01T00:00:00,Stents,E07.695.750
23522158,2013-04-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
23522158,2013-04-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
23522158,2013-04-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
23522158,2013-04-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
23522226,2013-04-01T00:00:00,Heart Transplantation,E04.100.376.475
23522226,2013-04-01T00:00:00,Heart Transplantation,E04.928.220.390
23522226,2013-04-01T00:00:00,Heart Transplantation,E04.936.450.475
23522226,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23522226,2013-04-01T00:00:00,Tissue Donors,M01.898
23522226,2013-04-01T00:00:00,Tissue and Organ Procurement,N02.421.911
23522414,2013-04-01T00:00:00,Dysplastic Nevus Syndrome,C04.557.665.560.260
23522414,2013-04-01T00:00:00,Dysplastic Nevus Syndrome,C04.700.305
23522414,2013-04-01T00:00:00,Dysplastic Nevus Syndrome,C16.320.700.305
23522414,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23522414,2013-04-01T00:00:00,Skin Neoplasms,C04.588.805
23522414,2013-04-01T00:00:00,Skin Neoplasms,C17.800.882
23529880,2013-04-01T00:00:00,Adult,M01.060.116
23529880,2013-04-01T00:00:00,Aged,M01.060.116.100
23529880,2013-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23529880,2013-04-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23529880,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23529880,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23529880,2013-04-01T00:00:00,Mouth Neoplasms,C04.588.443.591
23529880,2013-04-01T00:00:00,Mouth Neoplasms,C07.465.565
23529880,2013-04-01T00:00:00,Oropharyngeal Neoplasms,C04.588.443.665.710.684
23529880,2013-04-01T00:00:00,Oropharyngeal Neoplasms,C07.550.745.671
23529880,2013-04-01T00:00:00,Oropharyngeal Neoplasms,C09.647.710.685
23529880,2013-04-01T00:00:00,Oropharyngeal Neoplasms,C09.775.549.685
23529880,2013-04-01T00:00:00,United States,Z01.107.567.875
23529880,2013-04-01T00:00:00,Young Adult,M01.060.116.815
23531954,2013-04-01T00:00:00,Diabetes Mellitus,C18.452.394.750
23531954,2013-04-01T00:00:00,Diabetes Mellitus,C19.246
23531954,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531954,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23531954,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23531957,2013-04-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23531957,2013-04-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23531957,2013-04-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
23531957,2013-04-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
23531957,2013-04-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
23531957,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531957,2013-04-01T00:00:00,Oral Health,N01.400.535
23531957,2013-04-01T00:00:00,Periodontal Diseases,C07.465.714
23531958,2013-04-01T00:00:00,Glucocorticoids,D06.472.040.543
23531958,2013-04-01T00:00:00,Glucocorticoids,D27.505.696.399.472.488
23531958,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531958,2013-04-01T00:00:00,Hyperglycemia,C18.452.394.952
23531958,2013-04-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
23531958,2013-04-01T00:00:00,Incidence,E05.318.308.985.525.375
23531958,2013-04-01T00:00:00,Incidence,L01.280.975.525.375
23531958,2013-04-01T00:00:00,Incidence,N01.224.935.597.500
23531958,2013-04-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23531958,2013-04-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23531960,2013-04-01T00:00:00,Anti-Obesity Agents,D27.505.954.427.140
23531960,2013-04-01T00:00:00,Benzazepines,D03.438.079
23531960,2013-04-01T00:00:00,Fructose,D09.546.359.250
23531960,2013-04-01T00:00:00,Fructose,D09.546.465.354
23531960,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531960,2013-04-01T00:00:00,Obesity,C18.654.726.500
23531960,2013-04-01T00:00:00,Obesity,C23.888.144.699.500
23531960,2013-04-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23531960,2013-04-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23531960,2013-04-01T00:00:00,Phentermine,D02.092.471.683.152.766
23531961,2013-04-01T00:00:00,Diabetes Mellitus,C18.452.394.750
23531961,2013-04-01T00:00:00,Diabetes Mellitus,C19.246
23531961,2013-04-01T00:00:00,Exercise,G11.427.590.237
23531961,2013-04-01T00:00:00,Exercise,I03.350
23531961,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531961,2013-04-01T00:00:00,Hypertension,C14.907.489
23531961,2013-04-01T00:00:00,Telemedicine,H02.403.840
23531961,2013-04-01T00:00:00,Telemedicine,L01.178.847.652
23531961,2013-04-01T00:00:00,Telemedicine,N04.590.374.800
23531961,2013-04-01T00:00:00,Weight Loss,C23.888.144.243.963
23531961,2013-04-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23531962,2013-04-01T00:00:00,Diabetes Mellitus,C18.452.394.750
23531962,2013-04-01T00:00:00,Diabetes Mellitus,C19.246
23531962,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23531962,2013-04-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23531962,2013-04-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23531962,2013-04-01T00:00:00,Primary Health Care,N04.590.233.727
23531962,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23531962,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23554039,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23554039,2013-04-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23554039,2013-04-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23554039,2013-04-01T00:00:00,Pregnancy,G08.686.785.760.769
23554039,2013-04-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
23554039,2013-04-01T00:00:00,Thrombocytopenia,C15.378.140.855
23554039,2013-04-01T00:00:00,Thrombotic Microangiopathies,C15.378.140.855.925
23554039,2013-04-01T00:00:00,Young Adult,M01.060.116.815
23558419,2013-04-01T00:00:00,Adult,M01.060.116
23558419,2013-04-01T00:00:00,Aged,M01.060.116.100
23558419,2013-04-01T00:00:00,Colonoscopy,E01.370.372.250.250.200
23558419,2013-04-01T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
23558419,2013-04-01T00:00:00,Colonoscopy,E04.210.240.250.160
23558419,2013-04-01T00:00:00,Colonoscopy,E04.800.250.250.250.160
23558419,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23558419,2013-04-01T00:00:00,Middle Aged,M01.060.116.630
23558419,2013-04-01T00:00:00,Pilot Projects,E05.318.760.750
23558419,2013-04-01T00:00:00,Pilot Projects,E05.337.737
23558419,2013-04-01T00:00:00,Pilot Projects,N05.715.360.775.625
23558419,2013-04-01T00:00:00,Pilot Projects,N06.850.520.450.720
23558419,2013-04-01T00:00:00,Poisson Distribution,E05.318.740.994.750
23558419,2013-04-01T00:00:00,Poisson Distribution,G17.820.750
23558419,2013-04-01T00:00:00,Poisson Distribution,N05.715.360.750.750.620
23558419,2013-04-01T00:00:00,Poisson Distribution,N06.850.520.830.994.750
23558419,2013-04-01T00:00:00,Questionnaires,E05.318.308.750
23558419,2013-04-01T00:00:00,Questionnaires,L01.280.800
23558419,2013-04-01T00:00:00,Questionnaires,N05.715.360.300.695
23558419,2013-04-01T00:00:00,Questionnaires,N06.850.520.308.750
23558419,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23558419,2013-04-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23569184,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23569184,2013-04-01T00:00:00,Neoplasms,C04
23569184,2013-04-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23569184,2013-04-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23569184,2013-04-01T00:00:00,Probability,E05.318.740.600
23569184,2013-04-01T00:00:00,Probability,G17.680
23569184,2013-04-01T00:00:00,Probability,N05.715.360.750.625
23569184,2013-04-01T00:00:00,Probability,N06.850.520.830.600
23572407,2013-04-01T00:00:00,Animals,B01.050
23572407,2013-04-01T00:00:00,"Chemistry, Pharmaceutical",H01.158.703.007
23572407,2013-04-01T00:00:00,"Chemistry, Pharmaceutical",H01.181.466
23572407,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23572407,2013-04-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23572407,2013-04-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23572407,2013-04-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23572407,2013-04-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23572407,2013-04-01T00:00:00,Smoking,F01.145.466.753
23572407,2013-04-01T00:00:00,Smoking Cessation,F01.145.940.700
23572407,2013-04-01T00:00:00,Treatment Outcome,E01.789.800
23572407,2013-04-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23572407,2013-04-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23575132,2013-04-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
23575132,2013-04-01T00:00:00,Escherichia coli,B03.440.450.425.325.300
23575132,2013-04-01T00:00:00,Escherichia coli,B03.660.250.150.180.100
23575132,2013-04-01T00:00:00,Food Contamination,N06.850.460.400
23575132,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23575132,2013-04-01T00:00:00,Infant,M01.060.703
23575132,2013-04-01T00:00:00,Infant Food,J02.500.525.500
23575132,2013-04-01T00:00:00,Temperature,G01.906.595
23575132,2013-04-01T00:00:00,Temperature,G16.500.275.063.725.710
23575132,2013-04-01T00:00:00,Temperature,G16.500.750.775.710
23575132,2013-04-01T00:00:00,Temperature,N06.230.150.450
23575132,2013-04-01T00:00:00,Temperature,N06.230.300.100.725.710
23581466,2013-04-01T00:00:00,Adenylate Cyclase Toxin,D08.811.520.650.200.040
23581466,2013-04-01T00:00:00,Adenylate Cyclase Toxin,D23.946.123.946.040
23581466,2013-04-01T00:00:00,Adenylate Cyclase Toxin,D23.946.896.980.040
23581466,2013-04-01T00:00:00,Amino Acid Sequence,G02.111.570.060
23581466,2013-04-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23581466,2013-04-01T00:00:00,Animals,B01.050
23581466,2013-04-01T00:00:00,Calcium,D01.268.552.100
23581466,2013-04-01T00:00:00,Calcium,D01.552.539.288
23581466,2013-04-01T00:00:00,Calcium,D23.119.100
23581466,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23581466,2013-04-01T00:00:00,"Models, Molecular",E05.599.595
23581466,2013-04-01T00:00:00,Peptides,D12.644
23581466,2013-04-01T00:00:00,Recombinant Fusion Proteins,D12.776.828.300
23691683,2013-04-01T00:00:00,General Surgery,H02.403.810.300
23691683,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23691683,2013-04-01T00:00:00,Leadership,F01.752.609
23691683,2013-04-01T00:00:00,United States,Z01.107.567.875
24014489,2013-04-01T00:00:00,Cultural Diversity,I01.076.201.450.350
24014489,2013-04-01T00:00:00,Cultural Diversity,I01.880.143.450
24014489,2013-04-01T00:00:00,"Education, Nursing",I02.358.462
24014489,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24014489,2013-04-01T00:00:00,Transcultural Nursing,H02.478.676.920
24340419,2013-04-01T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
24340419,2013-04-01T00:00:00,Clinical Competence,I02.399.630.210
24340419,2013-04-01T00:00:00,Clinical Competence,N04.761.210
24340419,2013-04-01T00:00:00,Computer Simulation,L01.224.160
24340419,2013-04-01T00:00:00,Curriculum,I02.158
24340419,2013-04-01T00:00:00,Educational Measurement,I02.399
24340419,2013-04-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24340419,2013-04-01T00:00:00,Internship and Residency,I02.358.399.644
24340419,2013-04-01T00:00:00,"Intubation, Intratracheal",E05.497.578
24340419,2013-04-01T00:00:00,Manikins,J01.897.280.500.545.129.400
24340419,2013-04-01T00:00:00,Manikins,L01.178.820.090.545.129.400
24340419,2013-04-01T00:00:00,Patient Simulation,I02.903.525
24340419,2013-04-01T00:00:00,Pediatrics,H02.403.670
23543207,2013-04-02T00:00:00,Animals,B01.050
23543207,2013-04-02T00:00:00,Brain Neoplasms,C04.588.614.250.195
23543207,2013-04-02T00:00:00,Brain Neoplasms,C10.228.140.211
23543207,2013-04-02T00:00:00,Brain Neoplasms,C10.551.240.250
23543207,2013-04-02T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
23543207,2013-04-02T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
23543207,2013-04-02T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
23543207,2013-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23543207,2013-04-02T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23543207,2013-04-02T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23543207,2013-04-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23543207,2013-04-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23543207,2013-04-02T00:00:00,Proto-Oncogene Proteins c-met,D08.811.913.696.620.682.725.400.075
23543207,2013-04-02T00:00:00,Proto-Oncogene Proteins c-met,D12.776.543.750.060.186
23543207,2013-04-02T00:00:00,Proto-Oncogene Proteins c-met,D12.776.543.750.750.400.100
23543207,2013-04-02T00:00:00,Proto-Oncogene Proteins c-met,D12.776.624.664.700.186
23543207,2013-04-02T00:00:00,Signal Transduction,G02.111.087.800
23543207,2013-04-02T00:00:00,Signal Transduction,G02.149.115.800
23543207,2013-04-02T00:00:00,Signal Transduction,G04.299.880
23548168,2013-04-02T00:00:00,Adult,M01.060.116
23548168,2013-04-02T00:00:00,Aged,M01.060.116.100
23548168,2013-04-02T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23548168,2013-04-02T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23548168,2013-04-02T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23548168,2013-04-02T00:00:00,Hospitalization,E02.760.400
23548168,2013-04-02T00:00:00,Hospitalization,N02.421.585.400
23548168,2013-04-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23548168,2013-04-02T00:00:00,Incidence,E05.318.308.985.525.375
23548168,2013-04-02T00:00:00,Incidence,L01.280.975.525.375
23548168,2013-04-02T00:00:00,Incidence,N01.224.935.597.500
23548168,2013-04-02T00:00:00,Incidence,N06.850.505.400.975.525.375
23548168,2013-04-02T00:00:00,Incidence,N06.850.520.308.985.525.375
23548168,2013-04-02T00:00:00,Middle Aged,M01.060.116.630
23548168,2013-04-02T00:00:00,Neuropsychological Tests,F04.711.513
23548168,2013-04-02T00:00:00,United States,Z01.107.567.875
23548168,2013-04-02T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
23548168,2013-04-02T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
23548168,2013-04-02T00:00:00,Veterans,M01.930
23551281,2013-04-03T00:00:00,Graft Rejection,G12.425.901.545.328
23551281,2013-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23551281,2013-04-03T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23551281,2013-04-03T00:00:00,Isoxazoles,D03.383.129.385
23551281,2013-04-03T00:00:00,Kidney Transplantation,E02.870.500
23551281,2013-04-03T00:00:00,Kidney Transplantation,E04.936.450.485
23551281,2013-04-03T00:00:00,Kidney Transplantation,E04.950.774.400
23553999,2013-04-03T00:00:00,Adult,M01.060.116
23553999,2013-04-03T00:00:00,Aged,M01.060.116.100
23553999,2013-04-03T00:00:00,Anti-Infective Agents,D27.505.954.122
23553999,2013-04-03T00:00:00,Hospitalization,E02.760.400
23553999,2013-04-03T00:00:00,Hospitalization,N02.421.585.400
23553999,2013-04-03T00:00:00,"Hospitals, Teaching",N02.278.020.300
23553999,2013-04-03T00:00:00,"Hospitals, Teaching",N02.278.421.639
23553999,2013-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23553999,2013-04-03T00:00:00,Middle Aged,M01.060.116.630
23553999,2013-04-03T00:00:00,Young Adult,M01.060.116.815
23562653,2013-04-03T00:00:00,Animals,B01.050
23562653,2013-04-03T00:00:00,Apoptosis,G04.299.139.160
23562653,2013-04-03T00:00:00,Cell Proliferation,G04.299.233.750
23562653,2013-04-03T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23562653,2013-04-03T00:00:00,Cell Survival,G04.299.316
23562653,2013-04-03T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23562653,2013-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23562653,2013-04-03T00:00:00,MicroRNAs,D13.150.650.319
23562653,2013-04-03T00:00:00,MicroRNAs,D13.444.735.150.319
23562653,2013-04-03T00:00:00,MicroRNAs,D13.444.735.790.099
23562653,2013-04-03T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
23562653,2013-04-03T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
23562653,2013-04-03T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
23562653,2013-04-03T00:00:00,Plasmids,G05.360.600
23562653,2013-04-03T00:00:00,Telomerase,D08.811.913.696.445.308.300.750.750
23562653,2013-04-03T00:00:00,Telomerase,D12.776.157.725.500.921
23562653,2013-04-03T00:00:00,Telomerase,D12.776.664.962.500.921
23719074,2013-04-03T00:00:00,Arthrography,E01.370.350.700.070
23719074,2013-04-03T00:00:00,Heart Diseases,C14.280
23719074,2013-04-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23719074,2013-04-03T00:00:00,Lung Diseases,C08.381
23719074,2013-04-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23719074,2013-04-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23719074,2013-04-03T00:00:00,"Scleroderma, Systemic",C17.300.799
23719074,2013-04-03T00:00:00,"Scleroderma, Systemic",C17.800.784
23719074,2013-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23719074,2013-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23719074,2013-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23719074,2013-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23719074,2013-04-03T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23719074,2013-04-03T00:00:00,Ultrasonography,E01.370.350.850
23553611,2013-04-04T00:00:00,Adult,M01.060.116
23553611,2013-04-04T00:00:00,Aged,M01.060.116.100
23553611,2013-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23553611,2013-04-04T00:00:00,Middle Aged,M01.060.116.630
23553611,2013-04-04T00:00:00,Neoplasms,C04
23553611,2013-04-04T00:00:00,Risk Factors,E05.318.740.600.800.725
23553611,2013-04-04T00:00:00,Risk Factors,N05.715.350.200.700
23553611,2013-04-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23553611,2013-04-04T00:00:00,Risk Factors,N06.850.490.625.750
23553611,2013-04-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23553611,2013-04-04T00:00:00,United States,Z01.107.567.875
23559082,2013-04-04T00:00:00,Adult,M01.060.116
23559082,2013-04-04T00:00:00,Calcium,D01.268.552.100
23559082,2013-04-04T00:00:00,Calcium,D01.552.539.288
23559082,2013-04-04T00:00:00,Calcium,D23.119.100
23559082,2013-04-04T00:00:00,Dietary Supplements,J02.500.456
23559082,2013-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23559082,2013-04-04T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23559082,2013-04-04T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23559082,2013-04-04T00:00:00,Parathyroid Hormone,D06.472.699.590
23559082,2013-04-04T00:00:00,Parathyroid Hormone,D12.644.548.587
23559082,2013-04-04T00:00:00,Pregnancy,G08.686.785.760.769
23559082,2013-04-04T00:00:00,Vitamin D,D04.808.812.768
23559082,2013-04-04T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23608249,2013-04-04T00:00:00,Aged,M01.060.116.100
23608249,2013-04-04T00:00:00,Biological Markers,D23.101
23608249,2013-04-04T00:00:00,Blood Glucose,D09.546.359.448.500
23608249,2013-04-04T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23608249,2013-04-04T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23608249,2013-04-04T00:00:00,Diabetic Angiopathies,C14.907.320
23608249,2013-04-04T00:00:00,Diabetic Angiopathies,C19.246.099.500
23608249,2013-04-04T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
23608249,2013-04-04T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
23608249,2013-04-04T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
23608249,2013-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23608249,2013-04-04T00:00:00,Hypoglycemic Agents,D27.505.696.422
23608249,2013-04-04T00:00:00,Incidence,E05.318.308.985.525.375
23608249,2013-04-04T00:00:00,Incidence,L01.280.975.525.375
23608249,2013-04-04T00:00:00,Incidence,N01.224.935.597.500
23608249,2013-04-04T00:00:00,Incidence,N06.850.505.400.975.525.375
23608249,2013-04-04T00:00:00,Incidence,N06.850.520.308.985.525.375
23608249,2013-04-04T00:00:00,Middle Aged,M01.060.116.630
23608249,2013-04-04T00:00:00,Risk Assessment,E05.318.740.600.800.715
23608249,2013-04-04T00:00:00,Risk Assessment,N04.452.871.715
23608249,2013-04-04T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23608249,2013-04-04T00:00:00,Risk Assessment,N06.850.505.715
23608249,2013-04-04T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23608249,2013-04-04T00:00:00,Risk Factors,E05.318.740.600.800.725
23608249,2013-04-04T00:00:00,Risk Factors,N05.715.350.200.700
23608249,2013-04-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23608249,2013-04-04T00:00:00,Risk Factors,N06.850.490.625.750
23608249,2013-04-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23608249,2013-04-04T00:00:00,United States,Z01.107.567.875
23608249,2013-04-04T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
23608249,2013-04-04T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
23608249,2013-04-04T00:00:00,Vitamin D,D04.808.812.768
23608249,2013-04-04T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23773650,2013-04-04T00:00:00,Adult,M01.060.116
23773650,2013-04-04T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
23773650,2013-04-04T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
23773650,2013-04-04T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
23773650,2013-04-04T00:00:00,Biological Markers,D23.101
23773650,2013-04-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23773650,2013-04-04T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23773650,2013-04-04T00:00:00,Lung,A04.411
23773650,2013-04-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23773650,2013-04-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23773650,2013-04-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23773650,2013-04-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23773650,2013-04-04T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23773650,2013-04-04T00:00:00,Treatment Outcome,E01.789.800
23773650,2013-04-04T00:00:00,Treatment Outcome,N04.761.559.590.800
23773650,2013-04-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23557538,2013-04-05T00:00:00,Adult,M01.060.116
23557538,2013-04-05T00:00:00,African Americans,M01.686.508.100.100
23557538,2013-04-05T00:00:00,African Americans,M01.686.754.100
23557538,2013-04-05T00:00:00,Aged,M01.060.116.100
23557538,2013-04-05T00:00:00,Chronic Periodontitis,C07.465.714.533.324
23557538,2013-04-05T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23557538,2013-04-05T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23557538,2013-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23557538,2013-04-05T00:00:00,Hypertension,C14.907.489
23557538,2013-04-05T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23557538,2013-04-05T00:00:00,Metabolic Syndrome X,C18.452.625
23557538,2013-04-05T00:00:00,Middle Aged,M01.060.116.630
23557538,2013-04-05T00:00:00,Obesity,C18.654.726.500
23557538,2013-04-05T00:00:00,Obesity,C23.888.144.699.500
23557538,2013-04-05T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23557538,2013-04-05T00:00:00,Obesity,G07.100.100.160.120.699.500
23557538,2013-04-05T00:00:00,Regression Analysis,E05.318.740.750
23557538,2013-04-05T00:00:00,Regression Analysis,N05.715.360.750.695
23557538,2013-04-05T00:00:00,Regression Analysis,N06.850.520.830.750
23557538,2013-04-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23557538,2013-04-05T00:00:00,Risk Factors,N05.715.350.200.700
23557538,2013-04-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23557538,2013-04-05T00:00:00,Risk Factors,N06.850.490.625.750
23557538,2013-04-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23557538,2013-04-05T00:00:00,United States,Z01.107.567.875
23559454,2013-04-05T00:00:00,Adult,M01.060.116
23559454,2013-04-05T00:00:00,Aged,M01.060.116.100
23559454,2013-04-05T00:00:00,Contrast Media,D27.720.259
23559454,2013-04-05T00:00:00,Decision Making,F02.463.785.373
23559454,2013-04-05T00:00:00,Deglutition Disorders,C06.405.117.119
23559454,2013-04-05T00:00:00,Deglutition Disorders,C09.775.174
23559454,2013-04-05T00:00:00,Fluoroscopy,E01.370.350.700.225
23559454,2013-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23559454,2013-04-05T00:00:00,Middle Aged,M01.060.116.630
23559454,2013-04-05T00:00:00,Radiation Dosage,E05.799.513
23559454,2013-04-05T00:00:00,Radiation Dosage,G01.201.875.740
23559454,2013-04-05T00:00:00,Radiation Dosage,N06.850.810.250
23562239,2013-04-05T00:00:00,Action Potentials,G04.580.100
23562239,2013-04-05T00:00:00,Action Potentials,G07.265.750.100
23562239,2013-04-05T00:00:00,Action Potentials,G11.561.570.100
23562239,2013-04-05T00:00:00,Animals,B01.050
23562239,2013-04-05T00:00:00,Anticonvulsants,D27.505.954.427.080
23562239,2013-04-05T00:00:00,Carbamates,D02.241.081.251
23562239,2013-04-05T00:00:00,Pain Measurement,E01.370.376.550.600
23562239,2013-04-05T00:00:00,Physical Stimulation,E05.723
23562239,2013-04-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23562239,2013-04-05T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23563576,2013-04-05T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
23563576,2013-04-05T00:00:00,Enalapril,D12.644.456.345.360
23563576,2013-04-05T00:00:00,Hospitalization,E02.760.400
23563576,2013-04-05T00:00:00,Hospitalization,N02.421.585.400
23563576,2013-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23563576,2013-04-05T00:00:00,Peptide Fragments,D12.644.541
23564257,2013-04-05T00:00:00,Adult,M01.060.116
23564257,2013-04-05T00:00:00,Carcinoma,C04.557.470.200
23564257,2013-04-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23564257,2013-04-05T00:00:00,Middle Aged,M01.060.116.630
23564257,2013-04-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23564257,2013-04-05T00:00:00,Risk Factors,N05.715.350.200.700
23564257,2013-04-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23564257,2013-04-05T00:00:00,Risk Factors,N06.850.490.625.750
23564257,2013-04-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23564257,2013-04-05T00:00:00,Sex Factors,N05.715.350.675
23564257,2013-04-05T00:00:00,Sex Factors,N06.850.490.875
23564257,2013-04-05T00:00:00,Thyroid Neoplasms,C04.588.322.894
23564257,2013-04-05T00:00:00,Thyroid Neoplasms,C04.588.443.915
23564257,2013-04-05T00:00:00,Thyroid Neoplasms,C19.344.894
23564257,2013-04-05T00:00:00,Thyroid Neoplasms,C19.874.788
23564179,2013-04-06T00:00:00,Adult,M01.060.116
23564179,2013-04-06T00:00:00,Anxiety,F01.470.132
23564179,2013-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23564179,2013-04-06T00:00:00,Hydrocortisone,D04.808.745.745.654.600
23564179,2013-04-06T00:00:00,Hydrocortisone,D06.472.040.585.353.476
23564179,2013-04-06T00:00:00,Hydrocortisone,D06.472.040.585.478.392
23564179,2013-04-06T00:00:00,Marijuana Abuse,C21.739.635
23564179,2013-04-06T00:00:00,Marijuana Abuse,F03.900.635
23564179,2013-04-06T00:00:00,Pilot Projects,E05.318.760.750
23564179,2013-04-06T00:00:00,Pilot Projects,E05.337.737
23564179,2013-04-06T00:00:00,Pilot Projects,N05.715.360.775.625
23564179,2013-04-06T00:00:00,Pilot Projects,N06.850.520.450.720
23564179,2013-04-06T00:00:00,Saliva,A12.200.666
23564179,2013-04-06T00:00:00,"Stress, Psychological",F01.145.126.990
23564179,2013-04-06T00:00:00,"Stress, Psychological",F02.830.900
23564179,2013-04-06T00:00:00,Young Adult,M01.060.116.815
23566636,2013-04-06T00:00:00,Adult,M01.060.116
23566636,2013-04-06T00:00:00,Aged,M01.060.116.100
23566636,2013-04-06T00:00:00,Brain Ischemia,C10.228.140.300.150
23566636,2013-04-06T00:00:00,Brain Ischemia,C14.907.253.092
23566636,2013-04-06T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
23566636,2013-04-06T00:00:00,Glomerular Filtration Rate,G08.852.357
23566636,2013-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23566636,2013-04-06T00:00:00,Middle Aged,M01.060.116.630
23566636,2013-04-06T00:00:00,Stroke,C10.228.140.300.775
23566636,2013-04-06T00:00:00,Stroke,C14.907.253.855
23566636,2013-04-06T00:00:00,Treatment Outcome,E01.789.800
23566636,2013-04-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23566636,2013-04-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23566774,2013-04-06T00:00:00,Adult,M01.060.116
23566774,2013-04-06T00:00:00,Alcohol Drinking,F01.145.317.269
23566774,2013-04-06T00:00:00,Alcoholism,C21.739.100.250
23566774,2013-04-06T00:00:00,Alcoholism,F03.900.100.350
23566774,2013-04-06T00:00:00,Cognitive Therapy,F04.754.137.428
23566774,2013-04-06T00:00:00,Combined Modality Therapy,E02.186
23566774,2013-04-06T00:00:00,"Data Interpretation, Statistical",E05.245.380
23566774,2013-04-06T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23566774,2013-04-06T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23566774,2013-04-06T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23566774,2013-04-06T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23566774,2013-04-06T00:00:00,Disease Progression,C23.550.291.656
23566774,2013-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23566774,2013-04-06T00:00:00,"Models, Statistical",E05.318.740.500
23566774,2013-04-06T00:00:00,"Models, Statistical",E05.599.835
23566774,2013-04-06T00:00:00,"Models, Statistical",N05.715.360.750.530
23566774,2013-04-06T00:00:00,"Models, Statistical",N06.850.520.830.500
23566774,2013-04-06T00:00:00,Naltrexone,D03.132.577.249.706.550
23566774,2013-04-06T00:00:00,Naltrexone,D03.549.686.750.550
23566774,2013-04-06T00:00:00,Naltrexone,D03.605.497.750.550
23566774,2013-04-06T00:00:00,Naltrexone,D04.615.723.795.706.550
23566774,2013-04-06T00:00:00,Narcotic Antagonists,D27.505.696.543
23566774,2013-04-06T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
23566774,2013-04-06T00:00:00,Narcotic Antagonists,D27.505.954.427.550
23566774,2013-04-06T00:00:00,Poisson Distribution,E05.318.740.994.750
23566774,2013-04-06T00:00:00,Poisson Distribution,G17.820.750
23566774,2013-04-06T00:00:00,Poisson Distribution,N05.715.360.750.750.620
23566774,2013-04-06T00:00:00,Poisson Distribution,N06.850.520.830.994.750
23566774,2013-04-06T00:00:00,Risk-Taking,F01.145.722
23566774,2013-04-06T00:00:00,Taurine,D02.455.326.146.100.850
23566774,2013-04-06T00:00:00,Taurine,D02.886.645.600.055.850
23566774,2013-04-06T00:00:00,Treatment Outcome,E01.789.800
23566774,2013-04-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23566774,2013-04-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23570621,2013-04-06T00:00:00,Bacterial Infections,C01.252
23570621,2013-04-06T00:00:00,Cost Savings,N03.219.151.160.200
23570621,2013-04-06T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
23570621,2013-04-06T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
23570621,2013-04-06T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
23570621,2013-04-06T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
23570621,2013-04-06T00:00:00,Evidence-Based Medicine,H02.249.750
23570621,2013-04-06T00:00:00,Evidence-Based Medicine,H02.403.200.400
23570621,2013-04-06T00:00:00,Gastroenterology,H02.403.429.405
23570621,2013-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23570621,2013-04-06T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23570621,2013-04-06T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23570621,2013-04-06T00:00:00,"Societies, Medical",N03.540.828.589
23570621,2013-04-06T00:00:00,United States,Z01.107.567.875
23570621,2013-04-06T00:00:00,Water,D01.455.900
23570621,2013-04-06T00:00:00,Water,D01.650.550.925
23571051,2013-04-06T00:00:00,African Americans,M01.686.508.100.100
23571051,2013-04-06T00:00:00,African Americans,M01.686.754.100
23571051,2013-04-06T00:00:00,Aged,M01.060.116.100
23571051,2013-04-06T00:00:00,Cardiovascular Agents,D27.505.954.411
23571051,2013-04-06T00:00:00,European Continental Ancestry Group,M01.686.508.400
23571051,2013-04-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23571051,2013-04-06T00:00:00,Incidence,E05.318.308.985.525.375
23571051,2013-04-06T00:00:00,Incidence,L01.280.975.525.375
23571051,2013-04-06T00:00:00,Incidence,N01.224.935.597.500
23571051,2013-04-06T00:00:00,Incidence,N06.850.505.400.975.525.375
23571051,2013-04-06T00:00:00,Incidence,N06.850.520.308.985.525.375
23571051,2013-04-06T00:00:00,Middle Aged,M01.060.116.630
23571051,2013-04-06T00:00:00,Primary Prevention,N02.421.726.758
23571051,2013-04-06T00:00:00,Primary Prevention,N06.850.780.680
23571051,2013-04-06T00:00:00,Risk Factors,E05.318.740.600.800.725
23571051,2013-04-06T00:00:00,Risk Factors,N05.715.350.200.700
23571051,2013-04-06T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23571051,2013-04-06T00:00:00,Risk Factors,N06.850.490.625.750
23571051,2013-04-06T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23571051,2013-04-06T00:00:00,Stroke,C10.228.140.300.775
23571051,2013-04-06T00:00:00,Stroke,C14.907.253.855
23571051,2013-04-06T00:00:00,United States,Z01.107.567.875
23563529,2013-04-07T00:00:00,Adult,M01.060.116
23563529,2013-04-07T00:00:00,Age Factors,N05.715.350.075
23563529,2013-04-07T00:00:00,Age Factors,N06.850.490.250
23563529,2013-04-07T00:00:00,Aged,M01.060.116.100
23563529,2013-04-07T00:00:00,Cyclonic Storms,G16.500.240.135.500
23563529,2013-04-07T00:00:00,Disasters,N06.230.100
23563529,2013-04-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23563529,2013-04-07T00:00:00,Mental Disorders,F03
23563529,2013-04-07T00:00:00,Middle Aged,M01.060.116.630
23563529,2013-04-07T00:00:00,Psychiatric Status Rating Scales,F04.586
23563529,2013-04-07T00:00:00,Quality of Life,I01.800
23563529,2013-04-07T00:00:00,Quality of Life,K01.752.400.750
23563529,2013-04-07T00:00:00,Questionnaires,E05.318.308.750
23563529,2013-04-07T00:00:00,Questionnaires,L01.280.800
23563529,2013-04-07T00:00:00,Questionnaires,N05.715.360.300.695
23563529,2013-04-07T00:00:00,Questionnaires,N06.850.520.308.750
23563529,2013-04-07T00:00:00,Sex Factors,N05.715.350.675
23563529,2013-04-07T00:00:00,Sex Factors,N06.850.490.875
23563529,2013-04-07T00:00:00,"Stress, Psychological",F01.145.126.990
23563529,2013-04-07T00:00:00,"Stress, Psychological",F02.830.900
23570694,2013-04-09T00:00:00,Biomedical Research,H01.770.644.145
23570694,2013-04-09T00:00:00,Evidence-Based Medicine,H02.249.750
23570694,2013-04-09T00:00:00,Evidence-Based Medicine,H02.403.200.400
23570694,2013-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23570694,2013-04-09T00:00:00,Medical Oncology,H02.403.429.515
23570694,2013-04-09T00:00:00,Neoplasms,C04
23570694,2013-04-09T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23570694,2013-04-09T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23570694,2013-04-09T00:00:00,Risk Assessment,E05.318.740.600.800.715
23570694,2013-04-09T00:00:00,Risk Assessment,N04.452.871.715
23570694,2013-04-09T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23570694,2013-04-09T00:00:00,Risk Assessment,N06.850.505.715
23570694,2013-04-09T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23570694,2013-04-09T00:00:00,Smoking,F01.145.466.753
23570694,2013-04-09T00:00:00,Smoking Cessation,F01.145.940.700
23570694,2013-04-09T00:00:00,United States,Z01.107.567.875
23572575,2013-04-09T00:00:00,Animals,B01.050
23572575,2013-04-09T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23572575,2013-04-09T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
23572575,2013-04-09T00:00:00,Fibroblasts,A11.329.228
23572575,2013-04-09T00:00:00,Fibroblasts,A11.872.228
23572575,2013-04-09T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
23572575,2013-04-09T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
23572575,2013-04-09T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
23572575,2013-04-09T00:00:00,Gastrointestinal Tract,A03.556
23572575,2013-04-09T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
23572575,2013-04-09T00:00:00,Homeostasis,G07.700.360
23572575,2013-04-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23572575,2013-04-09T00:00:00,Membrane Glycoproteins,D12.776.395.550
23572575,2013-04-09T00:00:00,Membrane Glycoproteins,D12.776.543.550
23572575,2013-04-09T00:00:00,Molecular Chaperones,D12.776.580
23572575,2013-04-09T00:00:00,Plasmids,G05.360.600
23576578,2013-04-10T00:00:00,Angiotensin II,D06.472.699.094.078
23576578,2013-04-10T00:00:00,Angiotensin II,D12.644.400.070.078
23576578,2013-04-10T00:00:00,Angiotensin II,D12.644.456.073.041
23576578,2013-04-10T00:00:00,Angiotensin II,D12.644.548.058.078
23576578,2013-04-10T00:00:00,Angiotensin II,D12.776.641.650.070.078
23576578,2013-04-10T00:00:00,Angiotensin II,D23.469.050.050.050
23576578,2013-04-10T00:00:00,Animals,B01.050
23576578,2013-04-10T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
23576578,2013-04-10T00:00:00,Arrestins,D12.776.306.090
23576578,2013-04-10T00:00:00,Arrestins,D12.776.543.090
23576578,2013-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23576578,2013-04-10T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
23576578,2013-04-10T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
23576578,2013-04-10T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
23576578,2013-04-10T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
23576578,2013-04-10T00:00:00,NF-kappa B,D12.776.260.600
23576578,2013-04-10T00:00:00,NF-kappa B,D12.776.660.600
23576578,2013-04-10T00:00:00,NF-kappa B,D12.776.930.600
23576578,2013-04-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23576578,2013-04-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23576578,2013-04-10T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
23576578,2013-04-10T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
23576578,2013-04-10T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
23576578,2013-04-10T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
23576770,2013-04-10T00:00:00,Adolescent,M01.060.057
23576770,2013-04-10T00:00:00,Adult,M01.060.116
23576770,2013-04-10T00:00:00,African Continental Ancestry Group,M01.686.508.100
23576770,2013-04-10T00:00:00,Automobile Driving,I03.125
23576770,2013-04-10T00:00:00,Blood Pressure,E01.370.600.875.249
23576770,2013-04-10T00:00:00,Blood Pressure,G09.330.380.076
23576770,2013-04-10T00:00:00,Child,M01.060.406
23576770,2013-04-10T00:00:00,Computer Simulation,L01.224.160
23576770,2013-04-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
23576770,2013-04-10T00:00:00,Hemodynamics,G09.330.190.400
23576770,2013-04-10T00:00:00,Hemodynamics,G09.330.380
23576770,2013-04-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23576770,2013-04-10T00:00:00,"Models, Genetic",E05.599.395.397
23576770,2013-04-10T00:00:00,"Stress, Psychological",F01.145.126.990
23576770,2013-04-10T00:00:00,"Stress, Psychological",F02.830.900
23576770,2013-04-10T00:00:00,Young Adult,M01.060.116.815
23677120,2013-04-10T00:00:00,Animals,B01.050
23677120,2013-04-10T00:00:00,External Fixators,E07.858.442.660.430
23677120,2013-04-10T00:00:00,External Fixators,E07.858.690.650.430
23677120,2013-04-10T00:00:00,Materials Testing,E05.570
23578677,2013-04-11T00:00:00,Adult,M01.060.116
23578677,2013-04-11T00:00:00,Algorithms,G17.035
23578677,2013-04-11T00:00:00,Algorithms,L01.224.050
23578677,2013-04-11T00:00:00,"Data Interpretation, Statistical",E05.245.380
23578677,2013-04-11T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23578677,2013-04-11T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23578677,2013-04-11T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23578677,2013-04-11T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23578677,2013-04-11T00:00:00,Diffusion Tensor Imaging,E01.370.350.500.150.500
23578677,2013-04-11T00:00:00,Diffusion Tensor Imaging,E01.370.376.224
23578677,2013-04-11T00:00:00,Diffusion Tensor Imaging,E05.278
23578677,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23578677,2013-04-11T00:00:00,Image Enhancement,E01.370.350.600.350
23578677,2013-04-11T00:00:00,Image Enhancement,L01.224.308.380
23578677,2013-04-11T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
23578677,2013-04-11T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
23578677,2013-04-11T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
23578677,2013-04-11T00:00:00,Multiple Sclerosis,C10.114.375.500
23578677,2013-04-11T00:00:00,Multiple Sclerosis,C10.314.350.500
23578677,2013-04-11T00:00:00,Multiple Sclerosis,C20.111.258.250.500
23578677,2013-04-11T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
23578677,2013-04-11T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
23578677,2013-04-11T00:00:00,Sensitivity and Specificity,E05.318.740.872
23578677,2013-04-11T00:00:00,Sensitivity and Specificity,E05.318.780.800
23578677,2013-04-11T00:00:00,Sensitivity and Specificity,G17.800
23578677,2013-04-11T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23578677,2013-04-11T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23578677,2013-04-11T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23578677,2013-04-11T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23578677,2013-04-11T00:00:00,Spinal Cord Injuries,C10.228.854.770
23578677,2013-04-11T00:00:00,Spinal Cord Injuries,C10.900.850
23578677,2013-04-11T00:00:00,Spinal Cord Injuries,C21.866.819
23578931,2013-04-11T00:00:00,Animals,B01.050
23578931,2013-04-11T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
23578931,2013-04-11T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
23578931,2013-04-11T00:00:00,Cell Movement,G04.299.283
23578931,2013-04-11T00:00:00,Cell Movement,G07.700.560.500.180
23578931,2013-04-11T00:00:00,Endothelial Cells,A11.436.275
23578931,2013-04-11T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
23578931,2013-04-11T00:00:00,Heart Valves,A07.541.510
23578931,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23578931,2013-04-11T00:00:00,MicroRNAs,D13.150.650.319
23578931,2013-04-11T00:00:00,MicroRNAs,D13.444.735.150.319
23578931,2013-04-11T00:00:00,MicroRNAs,D13.444.735.790.099
23578931,2013-04-11T00:00:00,RNA-Binding Proteins,D12.776.157.725
23578931,2013-04-11T00:00:00,RNA-Binding Proteins,D12.776.664.962
23578931,2013-04-11T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
23578931,2013-04-11T00:00:00,Zebrafish Proteins,D12.776.325.500
23579263,2013-04-11T00:00:00,Adult,M01.060.116
23579263,2013-04-11T00:00:00,Aged,M01.060.116.100
23579263,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23579263,2013-04-11T00:00:00,Middle Aged,M01.060.116.630
23579263,2013-04-11T00:00:00,"Phantoms, Imaging",E07.671
23579263,2013-04-11T00:00:00,Radiation Dosage,E05.799.513
23579263,2013-04-11T00:00:00,Radiation Dosage,G01.201.875.740
23579263,2013-04-11T00:00:00,Radiation Dosage,N06.850.810.250
23579263,2013-04-11T00:00:00,Radiometry,E05.799
23579263,2013-04-11T00:00:00,Risk Assessment,E05.318.740.600.800.715
23579263,2013-04-11T00:00:00,Risk Assessment,N04.452.871.715
23579263,2013-04-11T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23579263,2013-04-11T00:00:00,Risk Assessment,N06.850.505.715
23579263,2013-04-11T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23579263,2013-04-11T00:00:00,Sex Factors,N05.715.350.675
23579263,2013-04-11T00:00:00,Sex Factors,N06.850.490.875
23579263,2013-04-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23579263,2013-04-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23579263,2013-04-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23579263,2013-04-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23579263,2013-04-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23582231,2013-04-11T00:00:00,Environment,G16.500.275
23582231,2013-04-11T00:00:00,Environment,N06.230
23582231,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23582231,2013-04-11T00:00:00,South Carolina,Z01.107.567.875.075.662
23582231,2013-04-11T00:00:00,South Carolina,Z01.107.567.875.750.700
23582638,2013-04-11T00:00:00,Adenoviridae,B04.280.030
23582638,2013-04-11T00:00:00,Adenoviridae,B04.909.204.097
23582638,2013-04-11T00:00:00,Adult,M01.060.116
23582638,2013-04-11T00:00:00,Drug Carriers,D26.255.260
23582638,2013-04-11T00:00:00,Drug Carriers,D27.720.280.260
23582638,2013-04-11T00:00:00,Drug Carriers,E02.319.300.380
23582638,2013-04-11T00:00:00,Genetic Vectors,G05.360.337
23582638,2013-04-11T00:00:00,HIV Infections,C02.782.815.616.400
23582638,2013-04-11T00:00:00,HIV Infections,C02.800.801.400
23582638,2013-04-11T00:00:00,HIV Infections,C20.673.480
23582638,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23582638,2013-04-11T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
23582638,2013-04-11T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
23582638,2013-04-11T00:00:00,"Receptors, IgG",D23.101.100.110.695
23582638,2013-04-11T00:00:00,"Vaccines, Synthetic",D12.776.828.868
23582638,2013-04-11T00:00:00,"Vaccines, Synthetic",D20.215.894.865
23582638,2013-04-11T00:00:00,"Vaccines, Synthetic",D23.050.865
23583651,2013-04-11T00:00:00,"Adaptation, Physiological",G07.700.062
23583651,2013-04-11T00:00:00,"Adaptation, Physiological",G16.100.057.500
23583651,2013-04-11T00:00:00,Animals,B01.050
23583651,2013-04-11T00:00:00,Anoxia,C23.888.852.079
23583651,2013-04-11T00:00:00,Case-Control Studies,E05.318.760.500.500
23583651,2013-04-11T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23583651,2013-04-11T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23583651,2013-04-11T00:00:00,Chronic Disease,C23.550.291.500
23583651,2013-04-11T00:00:00,Disease Progression,C23.550.291.656
23583651,2013-04-11T00:00:00,Down-Regulation,G02.111.087.225
23583651,2013-04-11T00:00:00,Down-Regulation,G02.149.115.225
23583651,2013-04-11T00:00:00,Down-Regulation,G05.355.315.200
23583651,2013-04-11T00:00:00,Down-Regulation,G07.690.812.230
23583651,2013-04-11T00:00:00,Down-Regulation,G07.700.680.230
23583651,2013-04-11T00:00:00,Endothelial Cells,A11.436.275
23583651,2013-04-11T00:00:00,"Endothelium, Vascular",A07.231.330
23583651,2013-04-11T00:00:00,"Endothelium, Vascular",A10.272.491.355
23583651,2013-04-11T00:00:00,Gene Expression Regulation,G05.355.315
23583651,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23583651,2013-04-11T00:00:00,"Hypertension, Pulmonary",C08.381.423
23583651,2013-04-11T00:00:00,Lung,A04.411
23583651,2013-04-11T00:00:00,"RNA, Messenger",D13.444.735.544
23583651,2013-04-11T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23583651,2013-04-11T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23583651,2013-04-11T00:00:00,"Scleroderma, Systemic",C17.300.799
23583651,2013-04-11T00:00:00,"Scleroderma, Systemic",C17.800.784
24499406,2013-04-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24499406,2013-04-11T00:00:00,Stroke,C10.228.140.300.775
24499406,2013-04-11T00:00:00,Stroke,C14.907.253.855
23585425,2013-04-12T00:00:00,Animals,B01.050
23585425,2013-04-12T00:00:00,Carcinogens,D27.888.569.100
23585425,2013-04-12T00:00:00,Cell Proliferation,G04.299.233.750
23585425,2013-04-12T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23585425,2013-04-12T00:00:00,Chronic Disease,C23.550.291.500
23585425,2013-04-12T00:00:00,Colitis,C06.405.205.265
23585425,2013-04-12T00:00:00,Colitis,C06.405.469.158.188
23585425,2013-04-12T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23585425,2013-04-12T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23585425,2013-04-12T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23585425,2013-04-12T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23585425,2013-04-12T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23585425,2013-04-12T00:00:00,Diet,E05.272
23585425,2013-04-12T00:00:00,Diet,G07.610.240
23585425,2013-04-12T00:00:00,"RNA, Messenger",D13.444.735.544
23585425,2013-04-12T00:00:00,Retinoid X Receptor alpha,D12.776.260.698.701.500.500
23585425,2013-04-12T00:00:00,Retinoid X Receptor alpha,D12.776.826.701.500.500
23585425,2013-04-12T00:00:00,Retinoid X Receptor alpha,D12.776.930.669.701.500.500
23585425,2013-04-12T00:00:00,Transcription Factors,D12.776.930
23585425,2013-04-12T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23585456,2013-04-12T00:00:00,Animals,B01.050
23585456,2013-04-12T00:00:00,Hela Cells,A11.251.210.190.400
23585456,2013-04-12T00:00:00,Hela Cells,A11.251.860.180.400
23585456,2013-04-12T00:00:00,Hela Cells,A11.436.340
23585456,2013-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23585456,2013-04-12T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23585456,2013-04-12T00:00:00,Prostatic Neoplasms,C12.294.260.750
23585456,2013-04-12T00:00:00,Prostatic Neoplasms,C12.294.565.625
23585456,2013-04-12T00:00:00,Prostatic Neoplasms,C12.758.409.750
23585456,2013-04-12T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23585456,2013-04-12T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23585456,2013-04-12T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23585456,2013-04-12T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23585456,2013-04-12T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
23585456,2013-04-12T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
23585456,2013-04-12T00:00:00,Signal Transduction,G02.111.087.800
23585456,2013-04-12T00:00:00,Signal Transduction,G02.149.115.800
23585456,2013-04-12T00:00:00,Signal Transduction,G04.299.880
23587468,2013-04-12T00:00:00,Cardiac Output,E01.370.370.380.150
23587468,2013-04-12T00:00:00,Cardiac Output,G09.330.380.124
23587468,2013-04-12T00:00:00,Cardiac Surgical Procedures,E04.100.376
23587468,2013-04-12T00:00:00,Cardiac Surgical Procedures,E04.928.220
23587468,2013-04-12T00:00:00,Cardiopulmonary Bypass,E04.292.413
23587468,2013-04-12T00:00:00,Hospital Costs,N03.219.151.400.687
23587468,2013-04-12T00:00:00,Hospital Costs,N03.219.262.500
23587468,2013-04-12T00:00:00,Hospital Costs,N05.300.375.500
23587468,2013-04-12T00:00:00,Hospital Mortality,E05.318.308.985.550.400
23587468,2013-04-12T00:00:00,Hospital Mortality,L01.280.975.550.400
23587468,2013-04-12T00:00:00,Hospital Mortality,N01.224.935.698.400
23587468,2013-04-12T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
23587468,2013-04-12T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
23587468,2013-04-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23587468,2013-04-12T00:00:00,"Infant, Newborn",M01.060.703.520
23587468,2013-04-12T00:00:00,Intensive Care Units,N02.278.388.493
23587468,2013-04-12T00:00:00,Length of Stay,E02.760.400.480
23587468,2013-04-12T00:00:00,Length of Stay,N02.421.585.400.480
23587468,2013-04-12T00:00:00,Postoperative Complications,C23.550.767
23587468,2013-04-12T00:00:00,Research Design,E05.581.500
23587468,2013-04-12T00:00:00,Research Design,H01.770.644.728
23587468,2013-04-12T00:00:00,"Respiration, Artificial",E02.365.647.729
23587468,2013-04-12T00:00:00,"Respiration, Artificial",E02.880.820
23587468,2013-04-12T00:00:00,Treatment Outcome,E01.789.800
23587468,2013-04-12T00:00:00,Treatment Outcome,N04.761.559.590.800
23587468,2013-04-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23587964,2013-04-12T00:00:00,Biotechnology,H01.158.550
23587964,2013-04-12T00:00:00,Biotechnology,J01.897.120
23587964,2013-04-12T00:00:00,Carbon Dioxide,D01.200.200
23587964,2013-04-12T00:00:00,Carbon Dioxide,D01.362.150
23587964,2013-04-12T00:00:00,Carbon Dioxide,D01.650.550.200
23587964,2013-04-12T00:00:00,Methane,D02.455.326.146.571
23587489,2013-04-13T00:00:00,Adipocytes,A11.329.114
23587489,2013-04-13T00:00:00,Animals,B01.050
23587489,2013-04-13T00:00:00,Cell Differentiation,G04.299.151
23587489,2013-04-13T00:00:00,Cytokines,D12.644.276.374
23587489,2013-04-13T00:00:00,Cytokines,D12.776.467.374
23587489,2013-04-13T00:00:00,Cytokines,D23.529.374
23587489,2013-04-13T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
23587489,2013-04-13T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
23587489,2013-04-13T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
23591286,2013-04-13T00:00:00,Adult,M01.060.116
23591286,2013-04-13T00:00:00,Aged,M01.060.116.100
23591286,2013-04-13T00:00:00,Clinical Laboratory Techniques,E05.200
23591286,2013-04-13T00:00:00,Decision Support Techniques,E05.245
23591286,2013-04-13T00:00:00,Decision Support Techniques,L01.700.508.190
23591286,2013-04-13T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
23591286,2013-04-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23591286,2013-04-13T00:00:00,Liver Cirrhosis,C06.552.630
23591286,2013-04-13T00:00:00,Middle Aged,M01.060.116.630
23591286,2013-04-13T00:00:00,Risk Assessment,E05.318.740.600.800.715
23591286,2013-04-13T00:00:00,Risk Assessment,N04.452.871.715
23591286,2013-04-13T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23591286,2013-04-13T00:00:00,Risk Assessment,N06.850.505.715
23591286,2013-04-13T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23591286,2013-04-13T00:00:00,Sensitivity and Specificity,E05.318.740.872
23591286,2013-04-13T00:00:00,Sensitivity and Specificity,E05.318.780.800
23591286,2013-04-13T00:00:00,Sensitivity and Specificity,G17.800
23591286,2013-04-13T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23591286,2013-04-13T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23591286,2013-04-13T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23591286,2013-04-13T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24090470,2013-04-13T00:00:00,Canes,E07.858.442.250
24090470,2013-04-13T00:00:00,Data Collection,E05.318.308
24090470,2013-04-13T00:00:00,Data Collection,L01.280
24090470,2013-04-13T00:00:00,Data Collection,N05.715.360.300
24090470,2013-04-13T00:00:00,Data Collection,N06.850.520.308
24090470,2013-04-13T00:00:00,Fatigue,C23.888.369
24090470,2013-04-13T00:00:00,"Gait Disorders, Neurologic",C10.597.404
24090470,2013-04-13T00:00:00,"Gait Disorders, Neurologic",C23.888.592.413
24090470,2013-04-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24090470,2013-04-13T00:00:00,Middle Aged,M01.060.116.630
24090470,2013-04-13T00:00:00,Pain,C10.597.617
24090470,2013-04-13T00:00:00,Pain,C23.888.592.612
24090470,2013-04-13T00:00:00,Pain,C23.888.646
24090470,2013-04-13T00:00:00,Pain,F02.830.816.444
24090470,2013-04-13T00:00:00,Pain,G11.561.600.810.444
24090470,2013-04-13T00:00:00,Spinal Cord Injuries,C10.228.854.770
24090470,2013-04-13T00:00:00,Spinal Cord Injuries,C10.900.850
24090470,2013-04-13T00:00:00,Spinal Cord Injuries,C21.866.819
24090470,2013-04-13T00:00:00,Wheelchairs,E07.796.980
23583978,2013-04-14T00:00:00,African Americans,M01.686.508.100.100
23583978,2013-04-14T00:00:00,African Americans,M01.686.754.100
23583978,2013-04-14T00:00:00,Body Mass Index,E01.370.600.115.100.125
23583978,2013-04-14T00:00:00,Body Mass Index,E05.041.124.125
23583978,2013-04-14T00:00:00,Body Mass Index,G07.100.100.125
23583978,2013-04-14T00:00:00,Body Mass Index,N06.850.505.200.100.175
23583978,2013-04-14T00:00:00,Case-Control Studies,E05.318.760.500.500
23583978,2013-04-14T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23583978,2013-04-14T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23583978,2013-04-14T00:00:00,Genetic Loci,G05.360.340.024.380
23583978,2013-04-14T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23583978,2013-04-14T00:00:00,Genetic Predisposition to Disease,G05.380.355
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.318.416.249
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.318.780.392
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.393.385.500
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.393.522.500
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23583978,2013-04-14T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23583978,2013-04-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23583978,2013-04-14T00:00:00,Linkage Disequilibrium,G05.540.500
23583978,2013-04-14T00:00:00,Obesity,C18.654.726.500
23583978,2013-04-14T00:00:00,Obesity,C23.888.144.699.500
23583978,2013-04-14T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23583978,2013-04-14T00:00:00,Obesity,G07.100.100.160.120.699.500
23583978,2013-04-14T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23587946,2013-04-15T00:00:00,Amino Acid Sequence,G02.111.570.060
23587946,2013-04-15T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23587946,2013-04-15T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23587946,2013-04-15T00:00:00,Bacterial Proteins,D12.776.097
23587946,2013-04-15T00:00:00,Gonorrhea,C01.252.400.625.391
23587946,2013-04-15T00:00:00,Gonorrhea,C01.252.810.401
23587946,2013-04-15T00:00:00,Gonorrhea,C01.539.778.281.401
23587946,2013-04-15T00:00:00,Gonorrhea,C12.294.668.281.401
23587946,2013-04-15T00:00:00,Gonorrhea,C13.351.500.711.281.401
23587946,2013-04-15T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
23587946,2013-04-15T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
23587946,2013-04-15T00:00:00,Molecular Sequence Data,L01.453.245.667
23587946,2013-04-15T00:00:00,Mutation,G05.365.590
23587946,2013-04-15T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
23587946,2013-04-15T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
23587946,2013-04-15T00:00:00,Penicillin-Binding Proteins,D08.811.710
23587946,2013-04-15T00:00:00,Penicillin-Binding Proteins,D12.776.097.545
23587946,2013-04-15T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
23669539,2013-04-15T00:00:00,Animals,B01.050
23669539,2013-04-15T00:00:00,"Immunity, Innate",G12.450.575
23669539,2013-04-15T00:00:00,"Models, Statistical",E05.318.740.500
23669539,2013-04-15T00:00:00,"Models, Statistical",E05.599.835
23669539,2013-04-15T00:00:00,"Models, Statistical",N05.715.360.750.530
23669539,2013-04-15T00:00:00,"Models, Statistical",N06.850.520.830.500
23669539,2013-04-15T00:00:00,Phylogeny,G05.697
23669539,2013-04-15T00:00:00,Phylogeny,G16.100.275.605
23669539,2013-04-15T00:00:00,Phylogeny,L01.100.697
23669539,2013-04-15T00:00:00,Regression Analysis,E05.318.740.750
23669539,2013-04-15T00:00:00,Regression Analysis,N05.715.360.750.695
23669539,2013-04-15T00:00:00,Regression Analysis,N06.850.520.830.750
23591789,2013-04-16T00:00:00,Adolescent,M01.060.057
23591789,2013-04-16T00:00:00,Adult,M01.060.116
23591789,2013-04-16T00:00:00,Aminoglycosides,D09.408.051
23591789,2013-04-16T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
23591789,2013-04-16T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
23591789,2013-04-16T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
23591789,2013-04-16T00:00:00,Disease-Free Survival,E01.789.200
23591789,2013-04-16T00:00:00,Disease-Free Survival,E05.318.740.998.300
23591789,2013-04-16T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
23591789,2013-04-16T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
23591789,2013-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23591789,2013-04-16T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
23591789,2013-04-16T00:00:00,Middle Aged,M01.060.116.630
23602822,2013-04-16T00:00:00,Adolescent,M01.060.057
23602822,2013-04-16T00:00:00,Adult,M01.060.116
23602822,2013-04-16T00:00:00,Aged,M01.060.116.100
23602822,2013-04-16T00:00:00,Case-Control Studies,E05.318.760.500.500
23602822,2013-04-16T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23602822,2013-04-16T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23602822,2013-04-16T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
23602822,2013-04-16T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
23602822,2013-04-16T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
23602822,2013-04-16T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
23602822,2013-04-16T00:00:00,Gastrostomy,E04.210.496
23602822,2013-04-16T00:00:00,Gastrostomy,E04.579.408
23602822,2013-04-16T00:00:00,Hospital Mortality,E05.318.308.985.550.400
23602822,2013-04-16T00:00:00,Hospital Mortality,L01.280.975.550.400
23602822,2013-04-16T00:00:00,Hospital Mortality,N01.224.935.698.400
23602822,2013-04-16T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
23602822,2013-04-16T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
23602822,2013-04-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23602822,2013-04-16T00:00:00,Incidence,E05.318.308.985.525.375
23602822,2013-04-16T00:00:00,Incidence,L01.280.975.525.375
23602822,2013-04-16T00:00:00,Incidence,N01.224.935.597.500
23602822,2013-04-16T00:00:00,Incidence,N06.850.505.400.975.525.375
23602822,2013-04-16T00:00:00,Incidence,N06.850.520.308.985.525.375
23602822,2013-04-16T00:00:00,Middle Aged,M01.060.116.630
23602822,2013-04-16T00:00:00,Risk Factors,E05.318.740.600.800.725
23602822,2013-04-16T00:00:00,Risk Factors,N05.715.350.200.700
23602822,2013-04-16T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23602822,2013-04-16T00:00:00,Risk Factors,N06.850.490.625.750
23602822,2013-04-16T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23602822,2013-04-16T00:00:00,United States,Z01.107.567.875
23602822,2013-04-16T00:00:00,Young Adult,M01.060.116.815
23594790,2013-04-17T00:00:00,Aged,M01.060.116.100
23594790,2013-04-17T00:00:00,Breast Neoplasms,C04.588.180
23594790,2013-04-17T00:00:00,Breast Neoplasms,C17.800.090.500
23594790,2013-04-17T00:00:00,Case-Control Studies,E05.318.760.500.500
23594790,2013-04-17T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23594790,2013-04-17T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23594790,2013-04-17T00:00:00,Circadian Rhythm,G07.180.562.190
23594790,2013-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23594790,2013-04-17T00:00:00,Lighting,N06.230.150.410
23594790,2013-04-17T00:00:00,Lung Neoplasms,C04.588.894.797.520
23594790,2013-04-17T00:00:00,Lung Neoplasms,C08.381.540
23594790,2013-04-17T00:00:00,Lung Neoplasms,C08.785.520
23594790,2013-04-17T00:00:00,Middle Aged,M01.060.116.630
23594790,2013-04-17T00:00:00,Risk Factors,E05.318.740.600.800.725
23594790,2013-04-17T00:00:00,Risk Factors,N05.715.350.200.700
23594790,2013-04-17T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23594790,2013-04-17T00:00:00,Risk Factors,N06.850.490.625.750
23594790,2013-04-17T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23601293,2013-04-17T00:00:00,Aged,M01.060.116.100
23601293,2013-04-17T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23601293,2013-04-17T00:00:00,Coronary Angiography,E01.370.370.050.200
23601293,2013-04-17T00:00:00,Coronary Angiography,E01.370.370.380.200
23601293,2013-04-17T00:00:00,Coronary Stenosis,C14.280.647.250.285
23601293,2013-04-17T00:00:00,Coronary Stenosis,C14.907.585.250.285
23601293,2013-04-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23601293,2013-04-17T00:00:00,Middle Aged,M01.060.116.630
23601293,2013-04-17T00:00:00,Physicians,M01.526.485.810
23601293,2013-04-17T00:00:00,Physicians,N02.360.810
23601293,2013-04-17T00:00:00,Prevalence,E05.318.308.985.525.750
23601293,2013-04-17T00:00:00,Prevalence,L01.280.975.525.750
23601293,2013-04-17T00:00:00,Prevalence,N01.224.935.597.750
23601293,2013-04-17T00:00:00,Prevalence,N06.850.505.400.975.525.750
23601293,2013-04-17T00:00:00,Prevalence,N06.850.520.308.985.525.750
23601293,2013-04-17T00:00:00,Professional Competence,I02.399.630
23601293,2013-04-17T00:00:00,Sensitivity and Specificity,E05.318.740.872
23601293,2013-04-17T00:00:00,Sensitivity and Specificity,E05.318.780.800
23601293,2013-04-17T00:00:00,Sensitivity and Specificity,G17.800
23601293,2013-04-17T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23601293,2013-04-17T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23601293,2013-04-17T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23601293,2013-04-17T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23601293,2013-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23601293,2013-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23601293,2013-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23601293,2013-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23601293,2013-04-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23595605,2013-04-18T00:00:00,Aged,M01.060.116.100
23595605,2013-04-18T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
23595605,2013-04-18T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
23595605,2013-04-18T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
23595605,2013-04-18T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
23595605,2013-04-18T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
23595605,2013-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23595605,2013-04-18T00:00:00,Indium Radioisotopes,D01.496.749.460
23595605,2013-04-18T00:00:00,Lymph Nodes,A10.549.400
23595605,2013-04-18T00:00:00,Lymph Nodes,A15.382.520.604.412
23595605,2013-04-18T00:00:00,Middle Aged,M01.060.116.630
23595605,2013-04-18T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23595605,2013-04-18T00:00:00,Prostatic Neoplasms,C12.294.260.750
23595605,2013-04-18T00:00:00,Prostatic Neoplasms,C12.294.565.625
23595605,2013-04-18T00:00:00,Prostatic Neoplasms,C12.758.409.750
23595605,2013-04-18T00:00:00,Sensitivity and Specificity,E05.318.740.872
23595605,2013-04-18T00:00:00,Sensitivity and Specificity,E05.318.780.800
23595605,2013-04-18T00:00:00,Sensitivity and Specificity,G17.800
23595605,2013-04-18T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23595605,2013-04-18T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23595605,2013-04-18T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23595605,2013-04-18T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23595605,2013-04-18T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
23595605,2013-04-18T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
23595605,2013-04-18T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
23595605,2013-04-18T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
23595605,2013-04-18T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
23595605,2013-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23595605,2013-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23595605,2013-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23595605,2013-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23595605,2013-04-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23597371,2013-04-18T00:00:00,Biomedical Research,H01.770.644.145
23597371,2013-04-18T00:00:00,Cardiovascular Diseases,C14
23597371,2013-04-18T00:00:00,Evidence-Based Medicine,H02.249.750
23597371,2013-04-18T00:00:00,Evidence-Based Medicine,H02.403.200.400
23597371,2013-04-18T00:00:00,Health Policy,I01.880.604.825.608.400
23597371,2013-04-18T00:00:00,Health Policy,N03.706.825.608.428
23597371,2013-04-18T00:00:00,Health Promotion,N02.370
23597371,2013-04-18T00:00:00,Health Promotion,N02.421.726.507
23597371,2013-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23597371,2013-04-18T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
23597371,2013-04-18T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
23597371,2013-04-18T00:00:00,Risk Factors,E05.318.740.600.800.725
23597371,2013-04-18T00:00:00,Risk Factors,N05.715.350.200.700
23597371,2013-04-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23597371,2013-04-18T00:00:00,Risk Factors,N06.850.490.625.750
23597371,2013-04-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23597371,2013-04-18T00:00:00,Rural Population,N01.600.725
23597371,2013-04-18T00:00:00,United States,Z01.107.567.875
23598275,2013-04-18T00:00:00,Hospitalization,E02.760.400
23598275,2013-04-18T00:00:00,Hospitalization,N02.421.585.400
23598275,2013-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23598275,2013-04-18T00:00:00,Myocardial Infarction,C14.280.647.500
23598275,2013-04-18T00:00:00,Myocardial Infarction,C14.907.585.500
23602730,2013-04-18T00:00:00,Aged,M01.060.116.100
23602730,2013-04-18T00:00:00,Algorithms,G17.035
23602730,2013-04-18T00:00:00,Algorithms,L01.224.050
23602730,2013-04-18T00:00:00,Alzheimer Disease,C10.228.140.380.100
23602730,2013-04-18T00:00:00,Alzheimer Disease,C10.574.945.249
23602730,2013-04-18T00:00:00,Alzheimer Disease,F03.087.400.100
23602730,2013-04-18T00:00:00,Brain,A08.186.211
23602730,2013-04-18T00:00:00,"Data Interpretation, Statistical",E05.245.380
23602730,2013-04-18T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23602730,2013-04-18T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23602730,2013-04-18T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23602730,2013-04-18T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23602730,2013-04-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23602730,2013-04-18T00:00:00,Image Enhancement,E01.370.350.600.350
23602730,2013-04-18T00:00:00,Image Enhancement,L01.224.308.380
23602730,2013-04-18T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
23602730,2013-04-18T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
23602730,2013-04-18T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
23602730,2013-04-18T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
23602730,2013-04-18T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
23602730,2013-04-18T00:00:00,Normal Distribution,E05.318.740.994.500
23602730,2013-04-18T00:00:00,Normal Distribution,G17.820.500
23602730,2013-04-18T00:00:00,Normal Distribution,N05.715.360.750.750.565
23602730,2013-04-18T00:00:00,Normal Distribution,N06.850.520.830.994.500
23602730,2013-04-18T00:00:00,"Pattern Recognition, Automated",L01.725
23602730,2013-04-18T00:00:00,Sensitivity and Specificity,E05.318.740.872
23602730,2013-04-18T00:00:00,Sensitivity and Specificity,E05.318.780.800
23602730,2013-04-18T00:00:00,Sensitivity and Specificity,G17.800
23602730,2013-04-18T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23602730,2013-04-18T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23602730,2013-04-18T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23602730,2013-04-18T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23529201,2013-04-22T00:00:00,Adult,M01.060.116
23529201,2013-04-22T00:00:00,Depression,F01.145.126.350
23529201,2013-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23529201,2013-04-22T00:00:00,Internship and Residency,I02.358.399.644
23529201,2013-04-22T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
23529201,2013-04-22T00:00:00,Sleep,F02.830.855
23529201,2013-04-22T00:00:00,Sleep,G11.561.600.815
23529201,2013-04-22T00:00:00,Work Schedule Tolerance,I03.946.900
23529201,2013-04-22T00:00:00,Workload,N04.452.677.950
23601571,2013-04-22T00:00:00,Adolescent,M01.060.057
23601571,2013-04-22T00:00:00,Child,M01.060.406
23601571,2013-04-22T00:00:00,"Child, Preschool",M01.060.406.448
23601571,2013-04-22T00:00:00,Diet,E05.272
23601571,2013-04-22T00:00:00,Diet,G07.610.240
23601571,2013-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23601571,2013-04-22T00:00:00,Obesity,C18.654.726.500
23601571,2013-04-22T00:00:00,Obesity,C23.888.144.699.500
23601571,2013-04-22T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23601571,2013-04-22T00:00:00,Obesity,G07.100.100.160.120.699.500
23601571,2013-04-22T00:00:00,Risk Factors,E05.318.740.600.800.725
23601571,2013-04-22T00:00:00,Risk Factors,N05.715.350.200.700
23601571,2013-04-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23601571,2013-04-22T00:00:00,Risk Factors,N06.850.490.625.750
23601571,2013-04-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23601571,2013-04-22T00:00:00,Social Environment,I01.880.656
23608661,2013-04-22T00:00:00,American Heart Association,N03.540.630.780.110
23608661,2013-04-22T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23608661,2013-04-22T00:00:00,Blood Pressure,E01.370.600.875.249
23608661,2013-04-22T00:00:00,Blood Pressure,G09.330.380.076
23608661,2013-04-22T00:00:00,Disease Management,N04.590.607
23608661,2013-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23608661,2013-04-22T00:00:00,Hypertension,C14.907.489
23608661,2013-04-22T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23608661,2013-04-22T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23608661,2013-04-22T00:00:00,United States,Z01.107.567.875
23608858,2013-04-22T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23608858,2013-04-22T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23608858,2013-04-22T00:00:00,"Diagnosis, Differential",E01.171
23608858,2013-04-22T00:00:00,Diagnostic Imaging,E01.370.350
23608858,2013-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23608858,2013-04-22T00:00:00,Lung Neoplasms,C04.588.894.797.520
23608858,2013-04-22T00:00:00,Lung Neoplasms,C08.381.540
23608858,2013-04-22T00:00:00,Lung Neoplasms,C08.785.520
23608858,2013-04-22T00:00:00,Middle Aged,M01.060.116.630
23608858,2013-04-22T00:00:00,Pancreatic Neoplasms,C04.588.274.761
23608858,2013-04-22T00:00:00,Pancreatic Neoplasms,C04.588.322.421
23608858,2013-04-22T00:00:00,Pancreatic Neoplasms,C06.301.761
23608858,2013-04-22T00:00:00,Pancreatic Neoplasms,C06.689.667
23608858,2013-04-22T00:00:00,Pancreatic Neoplasms,C19.344.421
23619475,2013-04-22T00:00:00,Adult,M01.060.116
23619475,2013-04-22T00:00:00,African Americans,M01.686.508.100.100
23619475,2013-04-22T00:00:00,African Americans,M01.686.754.100
23619475,2013-04-22T00:00:00,Aged,M01.060.116.100
23619475,2013-04-22T00:00:00,Alleles,G05.360.340.024.340.030
23619475,2013-04-22T00:00:00,European Continental Ancestry Group,M01.686.508.400
23619475,2013-04-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23619475,2013-04-22T00:00:00,"Immunity, Humoral",G12.450.050.420
23619475,2013-04-22T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
23619475,2013-04-22T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
23619475,2013-04-22T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
23619475,2013-04-22T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
23619475,2013-04-22T00:00:00,Middle Aged,M01.060.116.630
23619475,2013-04-22T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23619475,2013-04-22T00:00:00,Prostatic Neoplasms,C12.294.260.750
23619475,2013-04-22T00:00:00,Prostatic Neoplasms,C12.294.565.625
23619475,2013-04-22T00:00:00,Prostatic Neoplasms,C12.758.409.750
23619475,2013-04-22T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
23619475,2013-04-22T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
23619475,2013-04-22T00:00:00,"Receptors, IgG",D23.101.100.110.695
23619475,2013-04-22T00:00:00,Young Adult,M01.060.116.815
23533145,2013-04-23T00:00:00,Case-Control Studies,E05.318.760.500.500
23533145,2013-04-23T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23533145,2013-04-23T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23533145,2013-04-23T00:00:00,Exosomes,A11.284.430.214.190.875.190.880.495
23533145,2013-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23533145,2013-04-23T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23533145,2013-04-23T00:00:00,Prostatic Neoplasms,C12.294.260.750
23533145,2013-04-23T00:00:00,Prostatic Neoplasms,C12.294.565.625
23533145,2013-04-23T00:00:00,Prostatic Neoplasms,C12.758.409.750
23533145,2013-04-23T00:00:00,Proteinuria,C12.777.934.734
23533145,2013-04-23T00:00:00,Proteinuria,C13.351.968.934.734
23533145,2013-04-23T00:00:00,Proteinuria,C23.888.942.750
23533145,2013-04-23T00:00:00,Proteome,D12.776.817
23613330,2013-04-23T00:00:00,Adult,M01.060.116
23613330,2013-04-23T00:00:00,Aged,M01.060.116.100
23613330,2013-04-23T00:00:00,Ankle Joint,A02.835.583.378.062
23613330,2013-04-23T00:00:00,"Fracture Fixation, Intramedullary",E04.555.300.300.300
23613330,2013-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23613330,2013-04-23T00:00:00,Joint Diseases,C05.550
23613330,2013-04-23T00:00:00,Middle Aged,M01.060.116.630
23613330,2013-04-23T00:00:00,Postoperative Complications,C23.550.767
23613330,2013-04-23T00:00:00,Quality of Life,I01.800
23613330,2013-04-23T00:00:00,Quality of Life,K01.752.400.750
24060251,2013-04-23T00:00:00,Adolescent,M01.060.057
24060251,2013-04-23T00:00:00,Adult,M01.060.116
24060251,2013-04-23T00:00:00,Delivery of Health Care,N04.590.374
24060251,2013-04-23T00:00:00,Delivery of Health Care,N05.300
24060251,2013-04-23T00:00:00,Health Expenditures,N03.219.151.450
24060251,2013-04-23T00:00:00,Health Expenditures,N05.300.385
24060251,2013-04-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24060251,2013-04-23T00:00:00,Middle Aged,M01.060.116.630
24060251,2013-04-23T00:00:00,Young Adult,M01.060.116.815
23616168,2013-04-24T00:00:00,Adolescent,M01.060.057
23616168,2013-04-24T00:00:00,Adult,M01.060.116
23616168,2013-04-24T00:00:00,African Continental Ancestry Group,M01.686.508.100
23616168,2013-04-24T00:00:00,Age of Onset,N05.715.350.075.100
23616168,2013-04-24T00:00:00,Age of Onset,N06.850.490.250.100
23616168,2013-04-24T00:00:00,Aged,M01.060.116.100
23616168,2013-04-24T00:00:00,European Continental Ancestry Group,M01.686.508.400
23616168,2013-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23616168,2013-04-24T00:00:00,Hypertension,C14.907.489
23616168,2013-04-24T00:00:00,Incidence,E05.318.308.985.525.375
23616168,2013-04-24T00:00:00,Incidence,L01.280.975.525.375
23616168,2013-04-24T00:00:00,Incidence,N01.224.935.597.500
23616168,2013-04-24T00:00:00,Incidence,N06.850.505.400.975.525.375
23616168,2013-04-24T00:00:00,Incidence,N06.850.520.308.985.525.375
23616168,2013-04-24T00:00:00,Middle Aged,M01.060.116.630
23616168,2013-04-24T00:00:00,Motor Activity,F01.145.632
23616168,2013-04-24T00:00:00,Motor Activity,G11.427.590.530.698
23616168,2013-04-24T00:00:00,Risk Factors,E05.318.740.600.800.725
23616168,2013-04-24T00:00:00,Risk Factors,N05.715.350.200.700
23616168,2013-04-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23616168,2013-04-24T00:00:00,Risk Factors,N06.850.490.625.750
23616168,2013-04-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23616168,2013-04-24T00:00:00,Stroke,C10.228.140.300.775
23616168,2013-04-24T00:00:00,Stroke,C14.907.253.855
23616168,2013-04-24T00:00:00,Young Adult,M01.060.116.815
23616555,2013-04-24T00:00:00,Animals,B01.050
23616555,2013-04-24T00:00:00,Avoidance Learning,F02.463.425.097
23616555,2013-04-24T00:00:00,Cocaine,D02.145.074.722.388
23616555,2013-04-24T00:00:00,Cocaine,D03.132.889.354
23616555,2013-04-24T00:00:00,Cocaine,D03.605.869.388
23616555,2013-04-24T00:00:00,Cocaine,D04.075.080.875.099.722.388
23616555,2013-04-24T00:00:00,Dopamine,D02.092.211.215.311.342
23616555,2013-04-24T00:00:00,Dopamine,D02.092.311.342
23616555,2013-04-24T00:00:00,Habenula,A08.186.211.464.200.360
23616555,2013-04-24T00:00:00,Habenula,A08.186.211.730.317.200.360
23616555,2013-04-24T00:00:00,Neural Pathways,A08.612
23616555,2013-04-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23616555,2013-04-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23616602,2013-04-24T00:00:00,Adult,M01.060.116
23616602,2013-04-24T00:00:00,American Heart Association,N03.540.630.780.110
23616602,2013-04-24T00:00:00,Forecasting,I01.320
23616602,2013-04-24T00:00:00,Heart Failure,C14.280.434
23616602,2013-04-24T00:00:00,Hospitalization,E02.760.400
23616602,2013-04-24T00:00:00,Hospitalization,N02.421.585.400
23616602,2013-04-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23616602,2013-04-24T00:00:00,Income,N01.824.417
23616602,2013-04-24T00:00:00,Patient Care Team,N04.590.715
23616602,2013-04-24T00:00:00,Prevalence,E05.318.308.985.525.750
23616602,2013-04-24T00:00:00,Prevalence,L01.280.975.525.750
23616602,2013-04-24T00:00:00,Prevalence,N01.224.935.597.750
23616602,2013-04-24T00:00:00,Prevalence,N06.850.505.400.975.525.750
23616602,2013-04-24T00:00:00,Prevalence,N06.850.520.308.985.525.750
23616602,2013-04-24T00:00:00,Risk Factors,E05.318.740.600.800.725
23616602,2013-04-24T00:00:00,Risk Factors,N05.715.350.200.700
23616602,2013-04-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23616602,2013-04-24T00:00:00,Risk Factors,N06.850.490.625.750
23616602,2013-04-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23616602,2013-04-24T00:00:00,Terminal Care,E02.760.905
23616602,2013-04-24T00:00:00,Terminal Care,N02.421.585.905
23616602,2013-04-24T00:00:00,United States,Z01.107.567.875
23683959,2013-04-24T00:00:00,Plutonium,D01.268.033.700
23683959,2013-04-24T00:00:00,Plutonium,D01.268.271.100.700
23683959,2013-04-24T00:00:00,Plutonium,D01.268.556.700
23683959,2013-04-24T00:00:00,Plutonium,D01.552.020.734
23683959,2013-04-24T00:00:00,Plutonium,D01.552.544.700
23683959,2013-04-24T00:00:00,Quartz,D01.578.750.600
23683959,2013-04-24T00:00:00,Quartz,D01.650.550.825.600
23683959,2013-04-24T00:00:00,Quartz,D01.837.725.600
23614708,2013-04-25T00:00:00,Adolescent,M01.060.057
23614708,2013-04-25T00:00:00,Child,M01.060.406
23614708,2013-04-25T00:00:00,Echocardiography,E01.370.350.850.220
23614708,2013-04-25T00:00:00,Echocardiography,E01.370.370.380.220
23614708,2013-04-25T00:00:00,Fontan Procedure,E04.035.410.295
23614708,2013-04-25T00:00:00,Fontan Procedure,E04.100.376.410.295
23614708,2013-04-25T00:00:00,Fontan Procedure,E04.928.220.370.295
23614708,2013-04-25T00:00:00,"Heart Defects, Congenital",C14.240.400
23614708,2013-04-25T00:00:00,"Heart Defects, Congenital",C14.280.400
23614708,2013-04-25T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23614708,2013-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23614708,2013-04-25T00:00:00,Incidence,E05.318.308.985.525.375
23614708,2013-04-25T00:00:00,Incidence,L01.280.975.525.375
23614708,2013-04-25T00:00:00,Incidence,N01.224.935.597.500
23614708,2013-04-25T00:00:00,Incidence,N06.850.505.400.975.525.375
23614708,2013-04-25T00:00:00,Incidence,N06.850.520.308.985.525.375
23614708,2013-04-25T00:00:00,Postoperative Complications,C23.550.767
23614708,2013-04-25T00:00:00,Risk Factors,E05.318.740.600.800.725
23614708,2013-04-25T00:00:00,Risk Factors,N05.715.350.200.700
23614708,2013-04-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23614708,2013-04-25T00:00:00,Risk Factors,N06.850.490.625.750
23614708,2013-04-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23614708,2013-04-25T00:00:00,Sensitivity and Specificity,E05.318.740.872
23614708,2013-04-25T00:00:00,Sensitivity and Specificity,E05.318.780.800
23614708,2013-04-25T00:00:00,Sensitivity and Specificity,G17.800
23614708,2013-04-25T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23614708,2013-04-25T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23614708,2013-04-25T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23614708,2013-04-25T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23614708,2013-04-25T00:00:00,Treatment Outcome,E01.789.800
23614708,2013-04-25T00:00:00,Treatment Outcome,N04.761.559.590.800
23614708,2013-04-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23614708,2013-04-25T00:00:00,United States,Z01.107.567.875
23615775,2013-04-25T00:00:00,Adult,M01.060.116
23615775,2013-04-25T00:00:00,Arthralgia,C05.550.091
23615775,2013-04-25T00:00:00,Arthralgia,C23.888.646.130
23615775,2013-04-25T00:00:00,Arthralgia,F02.830.816.444.350
23615775,2013-04-25T00:00:00,Arthralgia,G11.561.600.810.444.350
23615775,2013-04-25T00:00:00,"Diagnosis, Differential",E01.171
23615775,2013-04-25T00:00:00,Graft Rejection,G12.425.901.545.328
23615775,2013-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23615775,2013-04-25T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23615775,2013-04-25T00:00:00,Kidney Transplantation,E02.870.500
23615775,2013-04-25T00:00:00,Kidney Transplantation,E04.936.450.485
23615775,2013-04-25T00:00:00,Kidney Transplantation,E04.950.774.400
23615775,2013-04-25T00:00:00,Premedication,E02.319.703
23615775,2013-04-25T00:00:00,Syndrome,C23.550.288.500
23619274,2013-04-25T00:00:00,Chromosome Aberrations,C23.550.210
23619274,2013-04-25T00:00:00,Chromosome Aberrations,G05.365.590.175
23619274,2013-04-25T00:00:00,Genomics,H01.158.273.180.350
23619274,2013-04-25T00:00:00,Genomics,H01.158.273.343.350
23619274,2013-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23619274,2013-04-25T00:00:00,Neoplasms,C04
23619274,2013-04-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
23619274,2013-04-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
23619274,2013-04-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
23619274,2013-04-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
23619274,2013-04-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
23619274,2013-04-25T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
23619274,2013-04-25T00:00:00,Software,L01.224.900
23620002,2013-04-25T00:00:00,Glottis,A04.329.364
23620002,2013-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23620002,2013-04-25T00:00:00,Infant,M01.060.703
23620002,2013-04-25T00:00:00,Laryngomalacia,C05.182.310
23620002,2013-04-25T00:00:00,Laryngomalacia,C08.360.563
23620002,2013-04-25T00:00:00,Laryngomalacia,C09.400.563
23620002,2013-04-25T00:00:00,Laryngomalacia,C16.131.621.568
23620002,2013-04-25T00:00:00,Laryngomalacia,C17.300.182.310
23620002,2013-04-25T00:00:00,Otorhinolaryngologic Surgical Procedures,E04.580
23620002,2013-04-25T00:00:00,Postoperative Care,E02.760.722.700
23620002,2013-04-25T00:00:00,Postoperative Care,E04.624
23620002,2013-04-25T00:00:00,Postoperative Care,N02.421.585.722.700
23620002,2013-04-25T00:00:00,Reconstructive Surgical Procedures,E04.680
23620002,2013-04-25T00:00:00,Treatment Outcome,E01.789.800
23620002,2013-04-25T00:00:00,Treatment Outcome,N04.761.559.590.800
23620002,2013-04-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23620586,2013-04-25T00:00:00,Cell Cycle Proteins,D12.776.167
23620586,2013-04-25T00:00:00,Ceramides,D02.065.313
23620586,2013-04-25T00:00:00,Ceramides,D09.400.410.420.525.200
23620586,2013-04-25T00:00:00,Ceramides,D10.390.470.675.200
23620586,2013-04-25T00:00:00,Ceramides,D10.570.877.360.612.200
23620586,2013-04-25T00:00:00,Lipid Metabolism,G03.495.520
23620586,2013-04-25T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
23620586,2013-04-25T00:00:00,Protein Phosphatase 2,D12.644.360.583
23620586,2013-04-25T00:00:00,Protein Phosphatase 2,D12.776.476.561
23620586,2013-04-25T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
23620586,2013-04-25T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
23620586,2013-04-25T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
23620586,2013-04-25T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
23624160,2013-04-25T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
23624160,2013-04-25T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
23624160,2013-04-25T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23624160,2013-04-25T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23624160,2013-04-25T00:00:00,"Defibrillators, Implantable",E07.695.175
23624160,2013-04-25T00:00:00,Heart Failure,C14.280.434
23624160,2013-04-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23387998,2013-04-26T00:00:00,Micelles,D05.374
23387998,2013-04-26T00:00:00,Micelles,D26.255.560
23387998,2013-04-26T00:00:00,Micelles,D27.720.280.560
23387998,2013-04-26T00:00:00,Microfluidic Analytical Techniques,E05.196.630.465
23387998,2013-04-26T00:00:00,Microfluidic Analytical Techniques,E05.588.465
23387998,2013-04-26T00:00:00,Nanoparticles,J01.637.512.600
23387998,2013-04-26T00:00:00,Oxides,D01.248.497.158.685
23387998,2013-04-26T00:00:00,Oxides,D01.650.550
23387998,2013-04-26T00:00:00,Porosity,G01.374.710
23387998,2013-04-26T00:00:00,Silicon Dioxide,D01.578.750
23387998,2013-04-26T00:00:00,Silicon Dioxide,D01.650.550.825
23387998,2013-04-26T00:00:00,Silicon Dioxide,D01.837.725
23387998,2013-04-26T00:00:00,Surface Properties,G02.842.850
23622112,2013-04-26T00:00:00,Fruit,A18.024.500
23622112,2013-04-26T00:00:00,Fruit,J02.500.562
23622112,2013-04-26T00:00:00,Insulin,D06.472.699.587.740.625
23622112,2013-04-26T00:00:00,Insulin,D12.644.548.586.740.625
23622112,2013-04-26T00:00:00,Nanotechnology,H01.603
23622112,2013-04-26T00:00:00,Nanotechnology,J01.897.520.600
23622112,2013-04-26T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.712.726.676.700
23622112,2013-04-26T00:00:00,"Spectroscopy, Fourier Transform Infrared",E05.196.867.826.676.700
23622112,2013-04-26T00:00:00,Water,D01.455.900
23622112,2013-04-26T00:00:00,Water,D01.650.550.925
23731521,2013-04-26T00:00:00,Adult,M01.060.116
23731521,2013-04-26T00:00:00,Civil Defense,I01.451.227
23731521,2013-04-26T00:00:00,Clinical Competence,I02.399.630.210
23731521,2013-04-26T00:00:00,Clinical Competence,N04.761.210
23731521,2013-04-26T00:00:00,Competency-Based Education,I02.158.210
23731521,2013-04-26T00:00:00,Computer Simulation,L01.224.160
23731521,2013-04-26T00:00:00,Disaster Planning,N06.230.100.035
23731521,2013-04-26T00:00:00,Group Processes,F01.829.316
23731521,2013-04-26T00:00:00,Health Personnel,M01.526.485
23731521,2013-04-26T00:00:00,Health Personnel,N02.360
23731521,2013-04-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23731521,2013-04-26T00:00:00,Middle Aged,M01.060.116.630
23731521,2013-04-26T00:00:00,"Models, Educational",E05.599.545
23731521,2013-04-26T00:00:00,"Models, Educational",I02.903.302
23731521,2013-04-26T00:00:00,Patient Care Team,N04.590.715
23731521,2013-04-26T00:00:00,Patient Simulation,I02.903.525
23731521,2013-04-26T00:00:00,South Carolina,Z01.107.567.875.075.662
23731521,2013-04-26T00:00:00,South Carolina,Z01.107.567.875.750.700
23731521,2013-04-26T00:00:00,United States,Z01.107.567.875
23411743,2013-04-27T00:00:00,Adult,M01.060.116
23411743,2013-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23411743,2013-04-27T00:00:00,Insulin,D06.472.699.587.740.625
23411743,2013-04-27T00:00:00,Insulin,D12.644.548.586.740.625
23411743,2013-04-27T00:00:00,Islets of Langerhans Transplantation,E04.270.550
23411743,2013-04-27T00:00:00,Islets of Langerhans Transplantation,E04.936.225.375
23411743,2013-04-27T00:00:00,Middle Aged,M01.060.116.630
23411743,2013-04-27T00:00:00,"Pain, Intractable",C10.597.617.788
23411743,2013-04-27T00:00:00,"Pain, Intractable",C23.888.592.612.776
23411743,2013-04-27T00:00:00,"Pain, Intractable",C23.888.646.515
23411743,2013-04-27T00:00:00,Pancreatectomy,E04.210.752
23411743,2013-04-27T00:00:00,Pancreaticojejunostomy,E04.035.703
23411743,2013-04-27T00:00:00,Pancreaticojejunostomy,E04.210.762
23411743,2013-04-27T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
23411743,2013-04-27T00:00:00,Reoperation,E04.690
23411743,2013-04-27T00:00:00,Treatment Outcome,E01.789.800
23411743,2013-04-27T00:00:00,Treatment Outcome,N04.761.559.590.800
23411743,2013-04-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23624315,2013-04-27T00:00:00,Adult,M01.060.116
23624315,2013-04-27T00:00:00,Aged,M01.060.116.100
23624315,2013-04-27T00:00:00,Brain Ischemia,C10.228.140.300.150
23624315,2013-04-27T00:00:00,Brain Ischemia,C14.907.253.092
23624315,2013-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23624315,2013-04-27T00:00:00,Middle Aged,M01.060.116.630
23624315,2013-04-27T00:00:00,Stroke,C10.228.140.300.775
23624315,2013-04-27T00:00:00,Stroke,C14.907.253.855
23624315,2013-04-27T00:00:00,Thrombectomy,E04.100.814.842
23624315,2013-04-27T00:00:00,Treatment Outcome,E01.789.800
23624315,2013-04-27T00:00:00,Treatment Outcome,N04.761.559.590.800
23624315,2013-04-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23624776,2013-04-27T00:00:00,Animals,B01.050
23624776,2013-04-27T00:00:00,Cocaine,D02.145.074.722.388
23624776,2013-04-27T00:00:00,Cocaine,D03.132.889.354
23624776,2013-04-27T00:00:00,Cocaine,D03.605.869.388
23624776,2013-04-27T00:00:00,Cocaine,D04.075.080.875.099.722.388
23624776,2013-04-27T00:00:00,Gene Expression Regulation,G05.355.315
23624776,2013-04-27T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23624776,2013-04-27T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
23624776,2013-04-27T00:00:00,Protein Phosphatase 2,D12.644.360.583
23624776,2013-04-27T00:00:00,Protein Phosphatase 2,D12.776.476.561
23624776,2013-04-27T00:00:00,"Protein Tyrosine Phosphatases, Non-Receptor",D08.811.277.352.650.775.300
23624776,2013-04-27T00:00:00,"Protein Tyrosine Phosphatases, Non-Receptor",D12.644.360.585
23624776,2013-04-27T00:00:00,"Protein Tyrosine Phosphatases, Non-Receptor",D12.776.476.564
23624776,2013-04-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23624776,2013-04-27T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23624776,2013-04-27T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
23624776,2013-04-27T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
23624776,2013-04-27T00:00:00,Self Administration,E02.319.890
23624776,2013-04-27T00:00:00,Self Administration,E02.900.890
23628740,2013-04-27T00:00:00,Animals,B01.050
23628740,2013-04-27T00:00:00,Brain,A08.186.211
23628740,2013-04-27T00:00:00,Cocaine,D02.145.074.722.388
23628740,2013-04-27T00:00:00,Cocaine,D03.132.889.354
23628740,2013-04-27T00:00:00,Cocaine,D03.605.869.388
23628740,2013-04-27T00:00:00,Cocaine,D04.075.080.875.099.722.388
23628740,2013-04-27T00:00:00,Cocaine-Related Disorders,C21.739.300
23628740,2013-04-27T00:00:00,Cocaine-Related Disorders,F03.900.300
23628740,2013-04-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23628740,2013-04-27T00:00:00,Treatment Outcome,E01.789.800
23628740,2013-04-27T00:00:00,Treatment Outcome,N04.761.559.590.800
23628740,2013-04-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23624809,2013-04-28T00:00:00,Acoustic Stimulation,E02.037
23624809,2013-04-28T00:00:00,Acoustic Stimulation,E02.190.888.030
23624809,2013-04-28T00:00:00,Acoustic Stimulation,E05.723.136
23624809,2013-04-28T00:00:00,Adolescent,M01.060.057
23624809,2013-04-28T00:00:00,Adult,M01.060.116
23624809,2013-04-28T00:00:00,Carbon Monoxide,D01.200.250
23624809,2013-04-28T00:00:00,Carbon Monoxide,D01.362.200
23624809,2013-04-28T00:00:00,Carbon Monoxide,D01.650.550.250
23624809,2013-04-28T00:00:00,Electromyography,E01.370.405.255
23624809,2013-04-28T00:00:00,Electromyography,E01.370.530.255
23624809,2013-04-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23624809,2013-04-28T00:00:00,Inhibition (Psychology),F01.145.544
23624809,2013-04-28T00:00:00,Inhibition (Psychology),F02.463.425.475
23624809,2013-04-28T00:00:00,Inhibition (Psychology),F02.739.794.405
23624809,2013-04-28T00:00:00,Nicotine,D03.132.760.570
23624809,2013-04-28T00:00:00,Nicotine,D03.383.725.518
23624809,2013-04-28T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
23624809,2013-04-28T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
23624809,2013-04-28T00:00:00,Questionnaires,E05.318.308.750
23624809,2013-04-28T00:00:00,Questionnaires,L01.280.800
23624809,2013-04-28T00:00:00,Questionnaires,N05.715.360.300.695
23624809,2013-04-28T00:00:00,Questionnaires,N06.850.520.308.750
23624809,2013-04-28T00:00:00,Smoking,F01.145.466.753
23624809,2013-04-28T00:00:00,Young Adult,M01.060.116.815
23621545,2013-04-29T00:00:00,Adult,M01.060.116
23621545,2013-04-29T00:00:00,Aged,M01.060.116.100
23621545,2013-04-29T00:00:00,Esophageal Motility Disorders,C06.405.117.119.500
23621545,2013-04-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23621545,2013-04-29T00:00:00,Manometry,E05.559
23621545,2013-04-29T00:00:00,Middle Aged,M01.060.116.630
23639436,2013-04-29T00:00:00,Animals,B01.050
23639436,2013-04-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23639436,2013-04-29T00:00:00,Neuronal Plasticity,G11.561.600.635
23639436,2013-04-29T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23639436,2013-04-29T00:00:00,Substance-Related Disorders,C21.739
23639436,2013-04-29T00:00:00,Substance-Related Disorders,F03.900
23639436,2013-04-29T00:00:00,Synapses,A08.850
23639436,2013-04-29T00:00:00,Synapses,A11.284.149.165.420.780
23639596,2013-04-29T00:00:00,Aged,M01.060.116.100
23639596,2013-04-29T00:00:00,Gastrostomy,E04.210.496
23639596,2013-04-29T00:00:00,Gastrostomy,E04.579.408
23639596,2013-04-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23639605,2013-04-29T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
23639605,2013-04-29T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
23639605,2013-04-29T00:00:00,Guideline Adherence,N04.761.337
23639605,2013-04-29T00:00:00,Guideline Adherence,N05.715.360.395
23639605,2013-04-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23639605,2013-04-29T00:00:00,Liver Cirrhosis,C06.552.630
23639605,2013-04-29T00:00:00,Medication Adherence,F01.145.488.500.500
23639605,2013-04-29T00:00:00,Medication Adherence,N05.300.150.600.600.500
23639605,2013-04-29T00:00:00,Middle Aged,M01.060.116.630
23639605,2013-04-29T00:00:00,Treatment Outcome,E01.789.800
23639605,2013-04-29T00:00:00,Treatment Outcome,N04.761.559.590.800
23639605,2013-04-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23639635,2013-04-29T00:00:00,Aged,M01.060.116.100
23639635,2013-04-29T00:00:00,C-Reactive Protein,D12.776.034.145
23639635,2013-04-29T00:00:00,C-Reactive Protein,D12.776.124.050.120
23639635,2013-04-29T00:00:00,C-Reactive Protein,D12.776.124.486.157
23639635,2013-04-29T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23639635,2013-04-29T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23639635,2013-04-29T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23639635,2013-04-29T00:00:00,Gene Expression Regulation,G05.355.315
23639635,2013-04-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23639635,2013-04-29T00:00:00,Macrophages,A11.329.372
23639635,2013-04-29T00:00:00,Macrophages,A11.627.482
23639635,2013-04-29T00:00:00,Macrophages,A11.733.397
23639635,2013-04-29T00:00:00,Macrophages,A15.382.680.397
23639635,2013-04-29T00:00:00,Macrophages,A15.382.812.522
23639635,2013-04-29T00:00:00,Middle Aged,M01.060.116.630
23639635,2013-04-29T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
23639635,2013-04-29T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
23639635,2013-04-29T00:00:00,Tissue Kallikreins,D23.101.840.870
23639635,2013-04-29T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
23639635,2013-04-29T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
23639635,2013-04-29T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
24034653,2013-04-29T00:00:00,Adult,M01.060.116
24034653,2013-04-29T00:00:00,Aged,M01.060.116.100
24034653,2013-04-29T00:00:00,Aging,G07.700.320.124
24034653,2013-04-29T00:00:00,Albuminuria,C12.777.934.734.269
24034653,2013-04-29T00:00:00,Albuminuria,C13.351.968.934.734.269
24034653,2013-04-29T00:00:00,Albuminuria,C23.888.942.750.269
24034653,2013-04-29T00:00:00,Body Mass Index,E01.370.600.115.100.125
24034653,2013-04-29T00:00:00,Body Mass Index,E05.041.124.125
24034653,2013-04-29T00:00:00,Body Mass Index,G07.100.100.125
24034653,2013-04-29T00:00:00,Body Mass Index,N06.850.505.200.100.175
24034653,2013-04-29T00:00:00,Creatinine,D03.383.129.308.207
24034653,2013-04-29T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
24034653,2013-04-29T00:00:00,Glomerular Filtration Rate,G08.852.357
24034653,2013-04-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24034653,2013-04-29T00:00:00,Hypertension,C14.907.489
24034653,2013-04-29T00:00:00,Incidence,E05.318.308.985.525.375
24034653,2013-04-29T00:00:00,Incidence,L01.280.975.525.375
24034653,2013-04-29T00:00:00,Incidence,N01.224.935.597.500
24034653,2013-04-29T00:00:00,Incidence,N06.850.505.400.975.525.375
24034653,2013-04-29T00:00:00,Incidence,N06.850.520.308.985.525.375
24034653,2013-04-29T00:00:00,Kidney,A05.810.453
24034653,2013-04-29T00:00:00,Middle Aged,M01.060.116.630
24034653,2013-04-29T00:00:00,Pregnancy,G08.686.785.760.769
24034653,2013-04-29T00:00:00,Pregnancy Complications,C13.703
24034653,2013-04-29T00:00:00,Questionnaires,E05.318.308.750
24034653,2013-04-29T00:00:00,Questionnaires,L01.280.800
24034653,2013-04-29T00:00:00,Questionnaires,N05.715.360.300.695
24034653,2013-04-29T00:00:00,Questionnaires,N06.850.520.308.750
24034653,2013-04-29T00:00:00,Risk Factors,E05.318.740.600.800.725
24034653,2013-04-29T00:00:00,Risk Factors,N05.715.350.200.700
24034653,2013-04-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24034653,2013-04-29T00:00:00,Risk Factors,N06.850.490.625.750
24034653,2013-04-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23632451,2013-04-30T00:00:00,Adult,M01.060.116
23632451,2013-04-30T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23632451,2013-04-30T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23632451,2013-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23632451,2013-04-30T00:00:00,Middle Aged,M01.060.116.630
23632451,2013-04-30T00:00:00,Papillomavirus Infections,C02.256.650
23632451,2013-04-30T00:00:00,Papillomavirus Infections,C02.928.725
23632451,2013-04-30T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
23632451,2013-04-30T00:00:00,Patient Education as Topic,I02.233.332.500
23632451,2013-04-30T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
23632451,2013-04-30T00:00:00,Patient Education as Topic,N02.421.726.407.680
23632451,2013-04-30T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
23632451,2013-04-30T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
23632451,2013-04-30T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
23632451,2013-04-30T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
23632451,2013-04-30T00:00:00,Vaginal Smears,E01.370.378.900
23632451,2013-04-30T00:00:00,Vaginal Smears,E01.450.230.900
23632451,2013-04-30T00:00:00,Vaginal Smears,E01.450.865.900
23632451,2013-04-30T00:00:00,Young Adult,M01.060.116.815
23639716,2013-04-30T00:00:00,Aged,M01.060.116.100
23639716,2013-04-30T00:00:00,Body Mass Index,E01.370.600.115.100.125
23639716,2013-04-30T00:00:00,Body Mass Index,E05.041.124.125
23639716,2013-04-30T00:00:00,Body Mass Index,G07.100.100.125
23639716,2013-04-30T00:00:00,Body Mass Index,N06.850.505.200.100.175
23639716,2013-04-30T00:00:00,Geriatric Assessment,E05.318.308.225
23639716,2013-04-30T00:00:00,Geriatric Assessment,I01.240.425.350
23639716,2013-04-30T00:00:00,Geriatric Assessment,L01.280.360
23639716,2013-04-30T00:00:00,Geriatric Assessment,N01.224.425.350
23639716,2013-04-30T00:00:00,Geriatric Assessment,N05.715.360.300.360
23639716,2013-04-30T00:00:00,Geriatric Assessment,N06.850.505.400.425.350
23639716,2013-04-30T00:00:00,Geriatric Assessment,N06.850.520.308.225
23639716,2013-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23639716,2013-04-30T00:00:00,Nursing Homes,N02.278.825.610
23639716,2013-04-30T00:00:00,Risk Factors,E05.318.740.600.800.725
23639716,2013-04-30T00:00:00,Risk Factors,N05.715.350.200.700
23639716,2013-04-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23639716,2013-04-30T00:00:00,Risk Factors,N06.850.490.625.750
23639716,2013-04-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23639716,2013-04-30T00:00:00,Weight Loss,C23.888.144.243.963
23639716,2013-04-30T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23642506,2013-04-30T00:00:00,Aged,M01.060.116.100
23642506,2013-04-30T00:00:00,Body Mass Index,E01.370.600.115.100.125
23642506,2013-04-30T00:00:00,Body Mass Index,E05.041.124.125
23642506,2013-04-30T00:00:00,Body Mass Index,G07.100.100.125
23642506,2013-04-30T00:00:00,Body Mass Index,N06.850.505.200.100.175
23642506,2013-04-30T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23642506,2013-04-30T00:00:00,Coronary Angiography,E01.370.370.050.200
23642506,2013-04-30T00:00:00,Coronary Angiography,E01.370.370.380.200
23642506,2013-04-30T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23642506,2013-04-30T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23642506,2013-04-30T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23642506,2013-04-30T00:00:00,Coronary Stenosis,C14.280.647.250.285
23642506,2013-04-30T00:00:00,Coronary Stenosis,C14.907.585.250.285
23642506,2013-04-30T00:00:00,Coronary Vessels,A07.231.114.269
23642506,2013-04-30T00:00:00,Coronary Vessels,A07.231.908.194
23642506,2013-04-30T00:00:00,Heart Failure,C14.280.434
23642506,2013-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23642506,2013-04-30T00:00:00,Lipids,D10
23642506,2013-04-30T00:00:00,Middle Aged,M01.060.116.630
23642506,2013-04-30T00:00:00,Myocardial Infarction,C14.280.647.500
23642506,2013-04-30T00:00:00,Myocardial Infarction,C14.907.585.500
23642506,2013-04-30T00:00:00,Myocardial Ischemia,C14.280.647
23642506,2013-04-30T00:00:00,Myocardial Ischemia,C14.907.585
23642506,2013-04-30T00:00:00,Risk Factors,E05.318.740.600.800.725
23642506,2013-04-30T00:00:00,Risk Factors,N05.715.350.200.700
23642506,2013-04-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23642506,2013-04-30T00:00:00,Risk Factors,N06.850.490.625.750
23642506,2013-04-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23642506,2013-04-30T00:00:00,"Spectroscopy, Near-Infrared",E01.370.350.750
23642506,2013-04-30T00:00:00,"Spectroscopy, Near-Infrared",E05.196.867.851
23642567,2013-04-30T00:00:00,Adolescent,M01.060.057
23642567,2013-04-30T00:00:00,Adult,M01.060.116
23642567,2013-04-30T00:00:00,Aged,M01.060.116.100
23642567,2013-04-30T00:00:00,Child,M01.060.406
23642567,2013-04-30T00:00:00,"Child, Preschool",M01.060.406.448
23642567,2013-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23642567,2013-04-30T00:00:00,"Intestinal Diseases, Parasitic",C03.432
23642567,2013-04-30T00:00:00,"Intestinal Diseases, Parasitic",C06.405.469.452
23642567,2013-04-30T00:00:00,Middle Aged,M01.060.116.630
23642567,2013-04-30T00:00:00,Prevalence,E05.318.308.985.525.750
23642567,2013-04-30T00:00:00,Prevalence,L01.280.975.525.750
23642567,2013-04-30T00:00:00,Prevalence,N01.224.935.597.750
23642567,2013-04-30T00:00:00,Prevalence,N06.850.505.400.975.525.750
23642567,2013-04-30T00:00:00,Prevalence,N06.850.520.308.985.525.750
23642567,2013-04-30T00:00:00,Young Adult,M01.060.116.815
23646135,2013-04-30T00:00:00,Animals,B01.050
23646135,2013-04-30T00:00:00,Computational Biology,H01.158.273.180
23646135,2013-04-30T00:00:00,Genomics,H01.158.273.180.350
23646135,2013-04-30T00:00:00,Genomics,H01.158.273.343.350
23646135,2013-04-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23646135,2013-04-30T00:00:00,Internet,L01.224.230.110.500
23646135,2013-04-30T00:00:00,Semantics,L01.143.506.598.745
23646135,2013-04-30T00:00:00,Software,L01.224.900
23646135,2013-04-30T00:00:00,User-Computer Interface,L01.224.900.910
22990049,2013-05-01T00:00:00,Animals,B01.050
22990049,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22990049,2013-05-01T00:00:00,Parasitic Diseases,C03
22990049,2013-05-01T00:00:00,Pleura,A04.716
22990049,2013-05-01T00:00:00,Pleura,A10.615.789.736
22990049,2013-05-01T00:00:00,Pleural Diseases,C08.528
23090041,2013-05-01T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
23090041,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23090041,2013-05-01T00:00:00,Liver Cirrhosis,C06.552.630
23090041,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23090041,2013-05-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
23090041,2013-05-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
23090041,2013-05-01T00:00:00,Sensitivity and Specificity,G17.800
23090041,2013-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23090041,2013-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23090041,2013-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23090041,2013-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23117277,2013-05-01T00:00:00,Adult,M01.060.116
23117277,2013-05-01T00:00:00,Aged,M01.060.116.100
23117277,2013-05-01T00:00:00,Antifungal Agents,D27.505.954.122.136
23117277,2013-05-01T00:00:00,Hemoptysis,C08.381.348
23117277,2013-05-01T00:00:00,Hemoptysis,C23.550.414.896
23117277,2013-05-01T00:00:00,Hemoptysis,C23.888.852.430
23117277,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23117277,2013-05-01T00:00:00,Lung,A04.411
23117277,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23117277,2013-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23117277,2013-05-01T00:00:00,Risk Factors,N05.715.350.200.700
23117277,2013-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23117277,2013-05-01T00:00:00,Risk Factors,N06.850.490.625.750
23117277,2013-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23117277,2013-05-01T00:00:00,Secondary Prevention,N02.421.726.825
23117277,2013-05-01T00:00:00,Secondary Prevention,N06.850.780.750
23117277,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23117277,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23117277,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23139240,2013-05-01T00:00:00,Adolescent,M01.060.057
23139240,2013-05-01T00:00:00,Child,M01.060.406
23139240,2013-05-01T00:00:00,"Child, Preschool",M01.060.406.448
23139240,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23139240,2013-05-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
23139240,2013-05-01T00:00:00,Infant,M01.060.703
23139240,2013-05-01T00:00:00,Questionnaires,E05.318.308.750
23139240,2013-05-01T00:00:00,Questionnaires,L01.280.800
23139240,2013-05-01T00:00:00,Questionnaires,N05.715.360.300.695
23139240,2013-05-01T00:00:00,Questionnaires,N06.850.520.308.750
23187606,2013-05-01T00:00:00,Acoustic Stimulation,E02.037
23187606,2013-05-01T00:00:00,Acoustic Stimulation,E02.190.888.030
23187606,2013-05-01T00:00:00,Acoustic Stimulation,E05.723.136
23187606,2013-05-01T00:00:00,Adult,M01.060.116
23187606,2013-05-01T00:00:00,Age Factors,N05.715.350.075
23187606,2013-05-01T00:00:00,Age Factors,N06.850.490.250
23187606,2013-05-01T00:00:00,Aged,M01.060.116.100
23187606,2013-05-01T00:00:00,Auditory Perception,F02.463.593.071
23187606,2013-05-01T00:00:00,Auditory Threshold,F02.463.593.071.173
23187606,2013-05-01T00:00:00,Auditory Threshold,F02.463.593.710.190
23187606,2013-05-01T00:00:00,Circadian Rhythm,G07.180.562.190
23187606,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23187606,2013-05-01T00:00:00,Inhibition (Psychology),F01.145.544
23187606,2013-05-01T00:00:00,Inhibition (Psychology),F02.463.425.475
23187606,2013-05-01T00:00:00,Inhibition (Psychology),F02.739.794.405
23187606,2013-05-01T00:00:00,Noise,G01.595.907.567
23187606,2013-05-01T00:00:00,Noise,G16.500.275.600
23187606,2013-05-01T00:00:00,Noise,N06.230.400
23187606,2013-05-01T00:00:00,Noise,N06.850.460.610
23187606,2013-05-01T00:00:00,Speech Perception,F02.463.593.071.875
23241602,2013-05-01T00:00:00,Blood Chemical Analysis,E01.450.150.100
23241602,2013-05-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
23241602,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23241602,2013-05-01T00:00:00,Transferrin,D12.776.124.050.800
23241602,2013-05-01T00:00:00,Transferrin,D12.776.124.790.223.839
23241602,2013-05-01T00:00:00,Transferrin,D12.776.157.427.500
23241602,2013-05-01T00:00:00,Transferrin,D12.776.377.715.182.839
23241602,2013-05-01T00:00:00,Transferrin,D12.776.556.579.500
23328689,2013-05-01T00:00:00,Aged,M01.060.116.100
23328689,2013-05-01T00:00:00,Angioplasty,E02.148.050
23328689,2013-05-01T00:00:00,Angioplasty,E04.100.814.050
23328689,2013-05-01T00:00:00,Brain Ischemia,C10.228.140.300.150
23328689,2013-05-01T00:00:00,Brain Ischemia,C14.907.253.092
23328689,2013-05-01T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23328689,2013-05-01T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23328689,2013-05-01T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23328689,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23328689,2013-05-01T00:00:00,Incidence,E05.318.308.985.525.375
23328689,2013-05-01T00:00:00,Incidence,L01.280.975.525.375
23328689,2013-05-01T00:00:00,Incidence,N01.224.935.597.500
23328689,2013-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23328689,2013-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23328689,2013-05-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
23328689,2013-05-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
23328689,2013-05-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
23328689,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23328689,2013-05-01T00:00:00,Postoperative Complications,C23.550.767
23328689,2013-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
23328689,2013-05-01T00:00:00,Risk Assessment,N04.452.871.715
23328689,2013-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23328689,2013-05-01T00:00:00,Risk Assessment,N06.850.505.715
23328689,2013-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23328689,2013-05-01T00:00:00,Stents,E07.695.750
23328689,2013-05-01T00:00:00,Stroke,C10.228.140.300.775
23328689,2013-05-01T00:00:00,Stroke,C14.907.253.855
23328689,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23328689,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23328689,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23328689,2013-05-01T00:00:00,United States,Z01.107.567.875
23392271,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23392271,2013-05-01T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
23392271,2013-05-01T00:00:00,Intracranial Aneurysm,C14.907.055.635
23392271,2013-05-01T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
23429468,2013-05-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
23429468,2013-05-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
23429468,2013-05-01T00:00:00,Hepatic Encephalopathy,C06.552.308.500.356
23429468,2013-05-01T00:00:00,Hepatic Encephalopathy,C10.228.140.163.360
23429468,2013-05-01T00:00:00,Hepatic Encephalopathy,C18.452.132.360
23429468,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23493030,2013-05-01T00:00:00,Adult,M01.060.116
23493030,2013-05-01T00:00:00,African Americans,M01.686.508.100.100
23493030,2013-05-01T00:00:00,African Americans,M01.686.754.100
23493030,2013-05-01T00:00:00,Biological Markers,D23.101
23493030,2013-05-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23493030,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23493030,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23493030,2013-05-01T00:00:00,Questionnaires,E05.318.308.750
23493030,2013-05-01T00:00:00,Questionnaires,L01.280.800
23493030,2013-05-01T00:00:00,Questionnaires,N05.715.360.300.695
23493030,2013-05-01T00:00:00,Questionnaires,N06.850.520.308.750
23493030,2013-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23493030,2013-05-01T00:00:00,Risk Factors,N05.715.350.200.700
23493030,2013-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23493030,2013-05-01T00:00:00,Risk Factors,N06.850.490.625.750
23493030,2013-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23493030,2013-05-01T00:00:00,Uterine Neoplasms,C04.588.945.418.948
23493030,2013-05-01T00:00:00,Uterine Neoplasms,C13.351.500.852.762
23493030,2013-05-01T00:00:00,Uterine Neoplasms,C13.351.937.418.875
23493030,2013-05-01T00:00:00,Vitamin D,D04.808.812.768
23493030,2013-05-01T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23507919,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23507919,2013-05-01T00:00:00,Liver Cirrhosis,C06.552.630
23507919,2013-05-01T00:00:00,Liver Diseases,C06.552
23529191,2013-05-01T00:00:00,Attitude of Health Personnel,F01.100.050
23529191,2013-05-01T00:00:00,Attitude of Health Personnel,N05.300.100
23529191,2013-05-01T00:00:00,Clinical Competence,I02.399.630.210
23529191,2013-05-01T00:00:00,Clinical Competence,N04.761.210
23529191,2013-05-01T00:00:00,Data Collection,E05.318.308
23529191,2013-05-01T00:00:00,Data Collection,L01.280
23529191,2013-05-01T00:00:00,Data Collection,N05.715.360.300
23529191,2013-05-01T00:00:00,Data Collection,N06.850.520.308
23529191,2013-05-01T00:00:00,Directive Counseling,F02.784.176.279
23529191,2013-05-01T00:00:00,Directive Counseling,F04.408.413.349
23529191,2013-05-01T00:00:00,Directive Counseling,N02.421.461.363.349
23529191,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23529191,2013-05-01T00:00:00,Neoplasms,C04
23529191,2013-05-01T00:00:00,Physician's Practice Patterns,N04.590.748
23529191,2013-05-01T00:00:00,Physician's Practice Patterns,N05.300.625
23529191,2013-05-01T00:00:00,Smoking,F01.145.466.753
23529191,2013-05-01T00:00:00,Smoking Cessation,F01.145.940.700
23535341,2013-05-01T00:00:00,Adolescent,M01.060.057
23535341,2013-05-01T00:00:00,Adolescent Behavior,F01.145.022
23535341,2013-05-01T00:00:00,Child,M01.060.406
23535341,2013-05-01T00:00:00,Child Behavior,F01.145.179
23535341,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23560728,2013-05-01T00:00:00,Animals,B01.050
23560728,2013-05-01T00:00:00,Collagen Type I,D05.750.078.280.300.100
23560728,2013-05-01T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
23560728,2013-05-01T00:00:00,Gene Expression Regulation,G05.355.315
23560728,2013-05-01T00:00:00,Hepatic Stellate Cells,A11.561
23560728,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23570890,2013-05-01T00:00:00,Amino Acid Sequence,G02.111.570.060
23570890,2013-05-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
23570890,2013-05-01T00:00:00,Amyloid Precursor Protein Secretases,D08.811.277.656.300.032
23570890,2013-05-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.049.025.150
23570890,2013-05-01T00:00:00,Amyloid beta-Protein Precursor,D12.776.811.050
23570890,2013-05-01T00:00:00,Animals,B01.050
23570890,2013-05-01T00:00:00,Molecular Sequence Data,L01.453.245.667
23570890,2013-05-01T00:00:00,Mutation,G05.365.590
23570890,2013-05-01T00:00:00,Peptide Fragments,D12.644.541
23571364,2013-05-01T00:00:00,Adult,M01.060.116
23571364,2013-05-01T00:00:00,Aged,M01.060.116.100
23571364,2013-05-01T00:00:00,"Colony Count, Microbial",E05.200.875.220
23571364,2013-05-01T00:00:00,Copper,D01.268.556.195
23571364,2013-05-01T00:00:00,Copper,D01.268.956.170
23571364,2013-05-01T00:00:00,Copper,D01.552.544.195
23571364,2013-05-01T00:00:00,Cross Infection,C01.539.248
23571364,2013-05-01T00:00:00,Disinfectants,D27.505.954.122.425
23571364,2013-05-01T00:00:00,Disinfectants,D27.720.274
23571364,2013-05-01T00:00:00,Disinfection,N06.850.780.200.450.850.375
23571364,2013-05-01T00:00:00,Environmental Microbiology,H01.158.273.540.274
23571364,2013-05-01T00:00:00,Environmental Microbiology,N06.850.425
23571364,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23571364,2013-05-01T00:00:00,Incidence,E05.318.308.985.525.375
23571364,2013-05-01T00:00:00,Incidence,L01.280.975.525.375
23571364,2013-05-01T00:00:00,Incidence,N01.224.935.597.500
23571364,2013-05-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23571364,2013-05-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23571364,2013-05-01T00:00:00,Intensive Care Units,N02.278.388.493
23571364,2013-05-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.300.390.400.800.750.100.500
23571364,2013-05-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.100.750.750.100.500
23571364,2013-05-01T00:00:00,Methicillin-Resistant Staphylococcus aureus,B03.510.400.790.750.100.500
23571364,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23571364,2013-05-01T00:00:00,Staphylococcal Infections,C01.252.410.868
23571374,2013-05-01T00:00:00,Bacteria,B03
23571374,2013-05-01T00:00:00,Beds,E07.325.220
23571374,2013-05-01T00:00:00,Copper,D01.268.556.195
23571374,2013-05-01T00:00:00,Copper,D01.268.956.170
23571374,2013-05-01T00:00:00,Copper,D01.552.544.195
23571374,2013-05-01T00:00:00,Cross Infection,C01.539.248
23571374,2013-05-01T00:00:00,Disinfectants,D27.505.954.122.425
23571374,2013-05-01T00:00:00,Disinfectants,D27.720.274
23571374,2013-05-01T00:00:00,Disinfection,N06.850.780.200.450.850.375
23571374,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23571374,2013-05-01T00:00:00,Intensive Care Units,N02.278.388.493
23588226,2013-05-01T00:00:00,Adolescent,M01.060.057
23588226,2013-05-01T00:00:00,Adult,M01.060.116
23588226,2013-05-01T00:00:00,Aged,M01.060.116.100
23588226,2013-05-01T00:00:00,Depressive Disorder,F03.600.300
23588226,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23588226,2013-05-01T00:00:00,Inpatients,M01.643.470
23588226,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23588226,2013-05-01T00:00:00,Psychiatric Status Rating Scales,F04.586
23588226,2013-05-01T00:00:00,Psychotherapy,F04.754
23588226,2013-05-01T00:00:00,Young Adult,M01.060.116.815
23597825,2013-05-01T00:00:00,Health Status Disparities,I01.240.425.675
23597825,2013-05-01T00:00:00,Health Status Disparities,N01.224.425.437
23597825,2013-05-01T00:00:00,Health Status Disparities,N06.850.505.400.425.675
23597825,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23597825,2013-05-01T00:00:00,Smoking,F01.145.466.753
23611916,2013-05-01T00:00:00,"Abdomen, Acute",C23.888.646.100.200
23611916,2013-05-01T00:00:00,"Abdomen, Acute",C23.888.821.030.249
23611916,2013-05-01T00:00:00,Adolescent,M01.060.057
23611916,2013-05-01T00:00:00,Appendectomy,E04.210.078
23611916,2013-05-01T00:00:00,Appendicitis,C06.405.205.099
23611916,2013-05-01T00:00:00,Appendicitis,C06.405.469.110.207
23611916,2013-05-01T00:00:00,Child,M01.060.406
23611916,2013-05-01T00:00:00,"Child, Preschool",M01.060.406.448
23611916,2013-05-01T00:00:00,Critical Pathways,N04.590.233.624.625
23611916,2013-05-01T00:00:00,Critical Pathways,N04.590.275
23611916,2013-05-01T00:00:00,Diagnostic Errors,E01.354
23611916,2013-05-01T00:00:00,Diagnostic Errors,N02.421.450.280
23611916,2013-05-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
23611916,2013-05-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
23611916,2013-05-01T00:00:00,Emergency Medicine,H02.403.250
23611916,2013-05-01T00:00:00,Guideline Adherence,N04.761.337
23611916,2013-05-01T00:00:00,Guideline Adherence,N05.715.360.395
23611916,2013-05-01T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
23611916,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23611916,2013-05-01T00:00:00,Infant,M01.060.703
23611916,2013-05-01T00:00:00,"Infant, Newborn",M01.060.703.520
23611916,2013-05-01T00:00:00,Length of Stay,E02.760.400.480
23611916,2013-05-01T00:00:00,Length of Stay,N02.421.585.400.480
23611916,2013-05-01T00:00:00,Patient Care Team,N04.590.715
23611916,2013-05-01T00:00:00,Pediatrics,H02.403.670
23611916,2013-05-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23611916,2013-05-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23611916,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23611916,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23611916,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23611916,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23611916,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23611916,2013-05-01T00:00:00,Unnecessary Procedures,N02.421.380.900
23611916,2013-05-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
23617869,2013-05-01T00:00:00,Adult,M01.060.116
23617869,2013-05-01T00:00:00,Anxiety Disorders,F03.080
23617869,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23617869,2013-05-01T00:00:00,Mood Disorders,F03.600
23617869,2013-05-01T00:00:00,Opioid-Related Disorders,C21.739.675
23617869,2013-05-01T00:00:00,Opioid-Related Disorders,F03.900.675
23617869,2013-05-01T00:00:00,Pain Measurement,E01.370.376.550.600
23617869,2013-05-01T00:00:00,Psychiatric Status Rating Scales,F04.586
23617869,2013-05-01T00:00:00,Sleep,F02.830.855
23617869,2013-05-01T00:00:00,Sleep,G11.561.600.815
23620210,2013-05-01T00:00:00,Adult,M01.060.116
23620210,2013-05-01T00:00:00,Anti-HIV Agents,D27.505.954.122.388.077.088
23620210,2013-05-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23620210,2013-05-01T00:00:00,HIV Infections,C02.782.815.616.400
23620210,2013-05-01T00:00:00,HIV Infections,C02.800.801.400
23620210,2013-05-01T00:00:00,HIV Infections,C20.673.480
23620210,2013-05-01T00:00:00,Health Care Costs,N03.219.151.400
23620210,2013-05-01T00:00:00,Health Care Costs,N05.300.375
23620210,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23620210,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23620210,2013-05-01T00:00:00,"Models, Economic",E05.318.740.500.600
23620210,2013-05-01T00:00:00,"Models, Economic",E05.599.835.890
23620210,2013-05-01T00:00:00,"Models, Economic",N05.715.360.750.530.500
23620210,2013-05-01T00:00:00,"Models, Economic",N06.850.520.830.500.600
23620210,2013-05-01T00:00:00,Ritonavir,D02.886.675.653
23620210,2013-05-01T00:00:00,Ritonavir,D03.383.129.708.653
23620210,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23620210,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23620210,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23620210,2013-05-01T00:00:00,United States,Z01.107.567.875
23622926,2013-05-01T00:00:00,Adult,M01.060.116
23622926,2013-05-01T00:00:00,Anesthesiology,H02.403.066
23622926,2013-05-01T00:00:00,Cardiology,H02.403.429.163
23622926,2013-05-01T00:00:00,Echocardiography,E01.370.350.850.220
23622926,2013-05-01T00:00:00,Echocardiography,E01.370.370.380.220
23622926,2013-05-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
23622926,2013-05-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
23622926,2013-05-01T00:00:00,"Heart Defects, Congenital",C14.240.400
23622926,2013-05-01T00:00:00,"Heart Defects, Congenital",C14.280.400
23622926,2013-05-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23622926,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23622926,2013-05-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
23622926,2013-05-01T00:00:00,"Quality Assurance, Health Care",N05.700
23622926,2013-05-01T00:00:00,"Societies, Medical",N03.540.828.589
23622926,2013-05-01T00:00:00,Thoracic Injuries,C21.866.891
23622926,2013-05-01T00:00:00,United States,Z01.107.567.875
23632837,2013-05-01T00:00:00,"Abnormalities, Drug-Induced",C16.131.042
23632837,2013-05-01T00:00:00,Antidepressive Agents,D27.505.954.427.700.122
23632837,2013-05-01T00:00:00,Depressive Disorder,F03.600.300
23632837,2013-05-01T00:00:00,"Depressive Disorder, Major",F03.600.300.375
23632837,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23632837,2013-05-01T00:00:00,Pregnancy,G08.686.785.760.769
23632837,2013-05-01T00:00:00,Pregnancy Complications,C13.703
23632837,2013-05-01T00:00:00,Pregnancy Outcome,E01.789.700
23632837,2013-05-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
23632936,2013-05-01T00:00:00,Coroners and Medical Examiners,M01.526.485.230
23632936,2013-05-01T00:00:00,Coroners and Medical Examiners,N02.360.230
23632936,2013-05-01T00:00:00,Curriculum,I02.158
23632936,2013-05-01T00:00:00,Educational Measurement,I02.399
23632936,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23632936,2013-05-01T00:00:00,"Licensure, Medical",N03.706.110.510.410
23632936,2013-05-01T00:00:00,"Licensure, Medical",N05.700.200.450.500
23632936,2013-05-01T00:00:00,Psychiatry,F04.096.544
23632936,2013-05-01T00:00:00,Psychiatry,H02.403.690
23632936,2013-05-01T00:00:00,United States,Z01.107.567.875
23635568,2013-05-01T00:00:00,Appendectomy,E04.210.078
23635568,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23635568,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23635568,2013-05-01T00:00:00,Postoperative Complications,C23.550.767
23635576,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23635576,2013-05-01T00:00:00,Thoracic Surgery,H02.403.810.803
23635577,2013-05-01T00:00:00,"History, 20th Century",K01.400.504.968
23635577,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23635577,2013-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23635577,2013-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23635577,2013-05-01T00:00:00,Thoracic Surgery,H02.403.810.803
23635725,2013-05-01T00:00:00,Biomedical Research,H01.770.644.145
23635725,2013-05-01T00:00:00,Breast Neoplasms,C04.588.180
23635725,2013-05-01T00:00:00,Breast Neoplasms,C17.800.090.500
23635725,2013-05-01T00:00:00,"Contraceptive Agents, Female",D27.505.696.875.360.276
23635725,2013-05-01T00:00:00,"Contraceptive Agents, Female",D27.505.954.705.360.276
23635725,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23635725,2013-05-01T00:00:00,Pelvic Inflammatory Disease,C01.539.635.500
23635725,2013-05-01T00:00:00,Pelvic Inflammatory Disease,C13.351.500.056.750
23636742,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23636742,2013-05-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23636742,2013-05-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23636742,2013-05-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23636742,2013-05-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
23636742,2013-05-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
23636742,2013-05-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
23636742,2013-05-01T00:00:00,Ultrasonography,E01.370.350.850
23637325,2013-05-01T00:00:00,Adult,M01.060.116
23637325,2013-05-01T00:00:00,African Continental Ancestry Group,M01.686.508.100
23637325,2013-05-01T00:00:00,Alleles,G05.360.340.024.340.030
23637325,2013-05-01T00:00:00,Genetic Loci,G05.360.340.024.380
23637325,2013-05-01T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23637325,2013-05-01T00:00:00,Genetic Predisposition to Disease,G05.380.355
23637325,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23637325,2013-05-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23637325,2013-05-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23637325,2013-05-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23644638,2013-05-01T00:00:00,Activities of Daily Living,E02.831.067
23644638,2013-05-01T00:00:00,Activities of Daily Living,I03.050
23644638,2013-05-01T00:00:00,Activities of Daily Living,N02.421.784.110
23644638,2013-05-01T00:00:00,Adolescent,M01.060.057
23644638,2013-05-01T00:00:00,Adult,M01.060.116
23644638,2013-05-01T00:00:00,Aged,M01.060.116.100
23644638,2013-05-01T00:00:00,Arthritis,C05.550.114
23644638,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23644638,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23644638,2013-05-01T00:00:00,Prevalence,E05.318.308.985.525.750
23644638,2013-05-01T00:00:00,Prevalence,L01.280.975.525.750
23644638,2013-05-01T00:00:00,Prevalence,N01.224.935.597.750
23644638,2013-05-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
23644638,2013-05-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
23644638,2013-05-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23644638,2013-05-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23644638,2013-05-01T00:00:00,Young Adult,M01.060.116.815
23645725,2013-05-01T00:00:00,Adipocytes,A11.329.114
23645725,2013-05-01T00:00:00,Animals,B01.050
23645725,2013-05-01T00:00:00,Cytokines,D12.644.276.374
23645725,2013-05-01T00:00:00,Cytokines,D12.776.467.374
23645725,2013-05-01T00:00:00,Cytokines,D23.529.374
23645725,2013-05-01T00:00:00,Mouth Neoplasms,C04.588.443.591
23645725,2013-05-01T00:00:00,Mouth Neoplasms,C07.465.565
23648897,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23648897,2013-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23648897,2013-05-01T00:00:00,Lung Neoplasms,C08.381.540
23648897,2013-05-01T00:00:00,Lung Neoplasms,C08.785.520
23649439,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23649439,2013-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23649439,2013-05-01T00:00:00,Lung Neoplasms,C08.381.540
23649439,2013-05-01T00:00:00,Lung Neoplasms,C08.785.520
23649439,2013-05-01T00:00:00,"Neoplasms, Radiation-Induced",C04.682
23649439,2013-05-01T00:00:00,"Neoplasms, Radiation-Induced",C21.866.733.476
23649439,2013-05-01T00:00:00,Occupational Exposure,N06.850.460.350.600
23649439,2013-05-01T00:00:00,Prevalence,E05.318.308.985.525.750
23649439,2013-05-01T00:00:00,Prevalence,L01.280.975.525.750
23649439,2013-05-01T00:00:00,Prevalence,N01.224.935.597.750
23649439,2013-05-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
23649439,2013-05-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
23649439,2013-05-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23649439,2013-05-01T00:00:00,Risk Factors,N05.715.350.200.700
23649439,2013-05-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23649439,2013-05-01T00:00:00,Risk Factors,N06.850.490.625.750
23649439,2013-05-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23649439,2013-05-01T00:00:00,Smoking,F01.145.466.753
23649439,2013-05-01T00:00:00,"Tumor Markers, Biological",D23.101.840
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
23649440,2013-05-01T00:00:00,"Biopsy, Needle",E04.074.119
23649440,2013-05-01T00:00:00,Bronchoscopy,E01.370.386.105
23649440,2013-05-01T00:00:00,Bronchoscopy,E01.370.388.250.100
23649440,2013-05-01T00:00:00,Bronchoscopy,E04.800.250.100
23649440,2013-05-01T00:00:00,Bronchoscopy,E04.928.600.080
23649440,2013-05-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
23649440,2013-05-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
23649440,2013-05-01T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
23649440,2013-05-01T00:00:00,Endosonography,E01.370.350.850.280
23649440,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23649440,2013-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23649440,2013-05-01T00:00:00,Lung Neoplasms,C08.381.540
23649440,2013-05-01T00:00:00,Lung Neoplasms,C08.785.520
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
23649440,2013-05-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
23649440,2013-05-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
23649440,2013-05-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
23649440,2013-05-01T00:00:00,Sensitivity and Specificity,G17.800
23649440,2013-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23649440,2013-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23649440,2013-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23649440,2013-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23649440,2013-05-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23649453,2013-05-01T00:00:00,Advance Care Planning,N04.590.233.624.124
23649453,2013-05-01T00:00:00,Evidence-Based Medicine,H02.249.750
23649453,2013-05-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23649453,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23649453,2013-05-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23649453,2013-05-01T00:00:00,Lung Neoplasms,C08.381.540
23649453,2013-05-01T00:00:00,Lung Neoplasms,C08.785.520
23649453,2013-05-01T00:00:00,Palliative Care,E02.760.666
23649453,2013-05-01T00:00:00,Palliative Care,N02.421.585.666
23649453,2013-05-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23649453,2013-05-01T00:00:00,Physician-Patient Relations,N05.300.660.625
23649453,2013-05-01T00:00:00,Quality of Life,I01.800
23649453,2013-05-01T00:00:00,Quality of Life,K01.752.400.750
23649453,2013-05-01T00:00:00,"Stress, Psychological",F01.145.126.990
23649453,2013-05-01T00:00:00,"Stress, Psychological",F02.830.900
23649453,2013-05-01T00:00:00,Terminal Care,E02.760.905
23649453,2013-05-01T00:00:00,Terminal Care,N02.421.585.905
23652695,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23652695,2013-05-01T00:00:00,Pressure Ulcer,C17.800.893.665
23652695,2013-05-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
23652695,2013-05-01T00:00:00,Risk Assessment,N04.452.871.715
23652695,2013-05-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23652695,2013-05-01T00:00:00,Risk Assessment,N06.850.505.715
23652695,2013-05-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23652695,2013-05-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
23652695,2013-05-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
23652695,2013-05-01T00:00:00,Sensitivity and Specificity,G17.800
23652695,2013-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23652695,2013-05-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23652695,2013-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23652695,2013-05-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23667204,2013-05-01T00:00:00,Combined Modality Therapy,E02.186
23667204,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23667204,2013-05-01T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
23667204,2013-05-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
23667204,2013-05-01T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
23667204,2013-05-01T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
23667204,2013-05-01T00:00:00,"Receptor, erbB-2",D23.101.840.642
23667204,2013-05-01T00:00:00,Stomach Neoplasms,C04.588.274.476.767
23667204,2013-05-01T00:00:00,Stomach Neoplasms,C06.301.371.767
23667204,2013-05-01T00:00:00,Stomach Neoplasms,C06.405.249.767
23667204,2013-05-01T00:00:00,Stomach Neoplasms,C06.405.748.789
23682563,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23682563,2013-05-01T00:00:00,Neurodegenerative Diseases,C10.574
23682563,2013-05-01T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23682563,2013-05-01T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23682563,2013-05-01T00:00:00,Vitamin K,D02.455.426.559.847.638.721.374
23682563,2013-05-01T00:00:00,Vitamin K,D02.455.849.291.523.500
23682563,2013-05-01T00:00:00,Vitamin K,D04.615.638.721.374
23690385,2013-05-01T00:00:00,Health Services Accessibility,N04.590.374.350
23690385,2013-05-01T00:00:00,Health Services Accessibility,N05.300.430
23690385,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23690385,2013-05-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
23690385,2013-05-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
23690385,2013-05-01T00:00:00,Patient Care Team,N04.590.715
23690385,2013-05-01T00:00:00,Patient-Centered Care,N04.590.233.675
23690385,2013-05-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
23690385,2013-05-01T00:00:00,Patient-Centered Care,N04.590.720
23690385,2013-05-01T00:00:00,Primary Health Care,N04.590.233.727
23744479,2013-05-01T00:00:00,Cell Differentiation,G04.299.151
23744479,2013-05-01T00:00:00,Cell Movement,G04.299.283
23744479,2013-05-01T00:00:00,Cell Movement,G07.700.560.500.180
23744479,2013-05-01T00:00:00,Cell Proliferation,G04.299.233.750
23744479,2013-05-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23744479,2013-05-01T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
23744479,2013-05-01T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
23744479,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23744479,2013-05-01T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
23744479,2013-05-01T00:00:00,Neoplasms,C04
23759452,2013-05-01T00:00:00,Adult,M01.060.116
23759452,2013-05-01T00:00:00,Depression,F01.145.126.350
23759452,2013-05-01T00:00:00,"Hospitals, Psychiatric",N02.278.421.556.508
23759452,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23759452,2013-05-01T00:00:00,Inpatients,M01.643.470
23759452,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23759452,2013-05-01T00:00:00,Psychiatric Status Rating Scales,F04.586
23759452,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23759452,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23759452,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23809587,2013-05-01T00:00:00,Animals,B01.050
23809587,2013-05-01T00:00:00,Biocompatible Materials,D25.130
23809587,2013-05-01T00:00:00,Biocompatible Materials,D27.720.102.130
23809587,2013-05-01T00:00:00,Biocompatible Materials,J01.637.051.130
23809587,2013-05-01T00:00:00,Nerve Regeneration,G11.561.600.615
23809587,2013-05-01T00:00:00,Nerve Regeneration,G16.100.856.611
23809587,2013-05-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23809587,2013-05-01T00:00:00,Recovery of Function,G16.757
23809587,2013-05-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
23809587,2013-05-01T00:00:00,Spinal Cord Injuries,C10.900.850
23809587,2013-05-01T00:00:00,Spinal Cord Injuries,C21.866.819
23809590,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23809590,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23809590,2013-05-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
23809590,2013-05-01T00:00:00,Spinal Cord Injuries,C10.900.850
23809590,2013-05-01T00:00:00,Spinal Cord Injuries,C21.866.819
23809590,2013-05-01T00:00:00,Veterans,M01.930
23814796,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23814796,2013-05-01T00:00:00,Mental Disorders,F03
23814796,2013-05-01T00:00:00,Mental Health Services,F04.408
23814796,2013-05-01T00:00:00,Mental Health Services,N02.421.461
23814796,2013-05-01T00:00:00,Nurse's Role,F01.829.316.616.625.450
23814796,2013-05-01T00:00:00,Nurse's Role,N05.300.100.337
23841969,2013-05-01T00:00:00,Aged,M01.060.116.100
23841969,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23841969,2013-05-01T00:00:00,Middle Aged,M01.060.116.630
23841969,2013-05-01T00:00:00,Motor Activity,F01.145.632
23841969,2013-05-01T00:00:00,Motor Activity,G11.427.590.530.698
23841969,2013-05-01T00:00:00,Postural Balance,G11.427.690
23841969,2013-05-01T00:00:00,Postural Balance,G11.561.600.810.541.595
23841969,2013-05-01T00:00:00,Stroke,C10.228.140.300.775
23841969,2013-05-01T00:00:00,Stroke,C14.907.253.855
23841969,2013-05-01T00:00:00,Treatment Outcome,E01.789.800
23841969,2013-05-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23841969,2013-05-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23841969,2013-05-01T00:00:00,User-Computer Interface,L01.224.900.910
23841969,2013-05-01T00:00:00,Video Games,I03.450.642.693.930
23841969,2013-05-01T00:00:00,Video Games,L01.224.900.930
23889892,2013-05-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23889892,2013-05-01T00:00:00,Proteins,D12.776
23889892,2013-05-01T00:00:00,Protons,D01.248.497.300.459.700
23889892,2013-05-01T00:00:00,Protons,D01.435.550
23889892,2013-05-01T00:00:00,Protons,G01.249.765
23639812,2013-05-02T00:00:00,Animals,B01.050
23639812,2013-05-02T00:00:00,Endothelial Cells,A11.436.275
23639812,2013-05-02T00:00:00,Gene Expression Regulation,G05.355.315
23639812,2013-05-02T00:00:00,Hepatic Stellate Cells,A11.561
23639812,2013-05-02T00:00:00,Nitric Oxide,D01.339.387
23639812,2013-05-02T00:00:00,Nitric Oxide,D01.625.550.500
23639812,2013-05-02T00:00:00,Nitric Oxide,D01.625.700.500
23639812,2013-05-02T00:00:00,Nitric Oxide,D01.650.550.587.600
23639812,2013-05-02T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
23639812,2013-05-02T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23639812,2013-05-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23639812,2013-05-02T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23639812,2013-05-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23639812,2013-05-02T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23639812,2013-05-02T00:00:00,Signal Transduction,G02.111.087.800
23639812,2013-05-02T00:00:00,Signal Transduction,G02.149.115.800
23639812,2013-05-02T00:00:00,Signal Transduction,G04.299.880
23640795,2013-05-02T00:00:00,Adult,M01.060.116
23640795,2013-05-02T00:00:00,B-Lymphocytes,A11.063.438
23640795,2013-05-02T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
23640795,2013-05-02T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
23640795,2013-05-02T00:00:00,B-Lymphocytes,A15.382.032.438
23640795,2013-05-02T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
23640795,2013-05-02T00:00:00,Case-Control Studies,E05.318.760.500.500
23640795,2013-05-02T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23640795,2013-05-02T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23640795,2013-05-02T00:00:00,Chronic Disease,C23.550.291.500
23640795,2013-05-02T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23640795,2013-05-02T00:00:00,Flow Cytometry,E05.200.500.386.350
23640795,2013-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23640795,2013-05-02T00:00:00,Middle Aged,M01.060.116.630
23640795,2013-05-02T00:00:00,Nasal Mucosa,A04.531.520
23640795,2013-05-02T00:00:00,Nasal Mucosa,A04.760.600
23640795,2013-05-02T00:00:00,Nasal Mucosa,A10.615.550.760.600
23640795,2013-05-02T00:00:00,Nasal Polyps,C08.460.572
23640795,2013-05-02T00:00:00,Nasal Polyps,C09.603.557
23640795,2013-05-02T00:00:00,Nasal Polyps,C23.300.825.557
23640795,2013-05-02T00:00:00,Paranasal Sinuses,A04.531.621
23640795,2013-05-02T00:00:00,Rhinitis,C08.460.799
23640795,2013-05-02T00:00:00,Rhinitis,C08.730.674
23640795,2013-05-02T00:00:00,Rhinitis,C09.603.799
23640795,2013-05-02T00:00:00,Sinusitis,C08.460.692.752
23640795,2013-05-02T00:00:00,Sinusitis,C08.730.749
23640795,2013-05-02T00:00:00,Sinusitis,C09.603.692.752
23640986,2013-05-02T00:00:00,Adolescent,M01.060.057
23640986,2013-05-02T00:00:00,Adult,M01.060.116
23640986,2013-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23640986,2013-05-02T00:00:00,Middle Aged,M01.060.116.630
23640986,2013-05-02T00:00:00,Questionnaires,E05.318.308.750
23640986,2013-05-02T00:00:00,Questionnaires,L01.280.800
23640986,2013-05-02T00:00:00,Questionnaires,N05.715.360.300.695
23640986,2013-05-02T00:00:00,Questionnaires,N06.850.520.308.750
23640986,2013-05-02T00:00:00,Tobacco Industry,J01.576.919
23640986,2013-05-02T00:00:00,United States,Z01.107.567.875
23640986,2013-05-02T00:00:00,Young Adult,M01.060.116.815
23641006,2013-05-02T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
23641006,2013-05-02T00:00:00,Echocardiography,E01.370.350.850.220
23641006,2013-05-02T00:00:00,Echocardiography,E01.370.370.380.220
23641006,2013-05-02T00:00:00,Exercise Test,E01.370.370.380.250
23641006,2013-05-02T00:00:00,Exercise Test,E01.370.386.700.250
23641006,2013-05-02T00:00:00,Exercise Test,E05.333.250
23641006,2013-05-02T00:00:00,Exercise Tolerance,G11.427.680.270
23641006,2013-05-02T00:00:00,Heart Failure,C14.280.434
23641006,2013-05-02T00:00:00,Hospitalization,E02.760.400
23641006,2013-05-02T00:00:00,Hospitalization,N02.421.585.400
23641006,2013-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23641006,2013-05-02T00:00:00,Middle Aged,M01.060.116.630
23641006,2013-05-02T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
23641006,2013-05-02T00:00:00,Ventricular Remodeling,C23.300.985
23641006,2013-05-02T00:00:00,Ventricular Remodeling,G09.330.190.962.975
23641015,2013-05-02T00:00:00,Adolescent,M01.060.057
23641015,2013-05-02T00:00:00,Adult,M01.060.116
23641015,2013-05-02T00:00:00,Age Factors,N05.715.350.075
23641015,2013-05-02T00:00:00,Age Factors,N06.850.490.250
23641015,2013-05-02T00:00:00,Aged,M01.060.116.100
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C02.256.466.313.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C02.928.313.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C04.557.386.480.100
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C04.557.386.480.150.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C04.619.935.313.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C04.925.313.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C15.604.515.569.480.100
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C15.604.515.569.480.150.165
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C20.683.515.761.480.100
23641015,2013-05-02T00:00:00,Burkitt Lymphoma,C20.683.515.761.480.150.165
23641015,2013-05-02T00:00:00,Child,M01.060.406
23641015,2013-05-02T00:00:00,"Child, Preschool",M01.060.406.448
23641015,2013-05-02T00:00:00,Clinical Trials as Topic,E05.318.760.535
23641015,2013-05-02T00:00:00,Clinical Trials as Topic,E05.337.250
23641015,2013-05-02T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23641015,2013-05-02T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23641015,2013-05-02T00:00:00,Disease-Free Survival,E01.789.200
23641015,2013-05-02T00:00:00,Disease-Free Survival,E05.318.740.998.300
23641015,2013-05-02T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
23641015,2013-05-02T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
23641015,2013-05-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23641015,2013-05-02T00:00:00,Infant,M01.060.703
23641015,2013-05-02T00:00:00,"Infant, Newborn",M01.060.703.520
23641015,2013-05-02T00:00:00,Middle Aged,M01.060.116.630
23641015,2013-05-02T00:00:00,Risk Factors,E05.318.740.600.800.725
23641015,2013-05-02T00:00:00,Risk Factors,N05.715.350.200.700
23641015,2013-05-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23641015,2013-05-02T00:00:00,Risk Factors,N06.850.490.625.750
23641015,2013-05-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23641015,2013-05-02T00:00:00,United States,Z01.107.567.875
23644531,2013-05-03T00:00:00,Animals,B01.050
23644531,2013-05-03T00:00:00,Antineoplastic Agents,D27.505.954.248
23644531,2013-05-03T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
23644531,2013-05-03T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
23644531,2013-05-03T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
23644531,2013-05-03T00:00:00,Immunologic Memory,G12.450.050.500
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.644.276.374.440.893
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.644.276.374.480.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.644.276.718.550
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.776.467.374.440.893
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.776.467.374.480.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D12.776.467.718.550
23644531,2013-05-03T00:00:00,Interferon-gamma,D23.529.374.440.893
23644531,2013-05-03T00:00:00,Interferon-gamma,D23.529.374.480.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D23.529.374.480.615.350
23644531,2013-05-03T00:00:00,Interferon-gamma,D23.529.718.550
23644531,2013-05-03T00:00:00,Interleukin-15,D12.644.276.374.465.515
23644531,2013-05-03T00:00:00,Interleukin-15,D12.776.467.374.465.515
23644531,2013-05-03T00:00:00,Interleukin-15,D23.529.374.465.515
23644531,2013-05-03T00:00:00,Multiple Myeloma,C04.557.595.500
23644531,2013-05-03T00:00:00,Multiple Myeloma,C14.907.454.460
23644531,2013-05-03T00:00:00,Multiple Myeloma,C15.378.147.780.650
23644531,2013-05-03T00:00:00,Multiple Myeloma,C15.378.463.835.460
23644531,2013-05-03T00:00:00,Multiple Myeloma,C20.683.515.845
23644531,2013-05-03T00:00:00,Multiple Myeloma,C20.683.780.650
23644531,2013-05-03T00:00:00,Proteins,D12.776
23645529,2013-05-03T00:00:00,Aged,M01.060.116.100
23645529,2013-05-03T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23645529,2013-05-03T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23645529,2013-05-03T00:00:00,"Defibrillators, Implantable",E07.695.175
23645529,2013-05-03T00:00:00,Device Removal,E04.199
23645529,2013-05-03T00:00:00,Dilatation,E05.284
23645529,2013-05-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23645529,2013-05-03T00:00:00,"Lasers, Excimer",E07.632.490.244
23645529,2013-05-03T00:00:00,"Lasers, Excimer",E07.710.520.244
23645529,2013-05-03T00:00:00,Middle Aged,M01.060.116.630
23645529,2013-05-03T00:00:00,"Pacemaker, Artificial",E07.858.082.748
23645529,2013-05-03T00:00:00,"Radiography, Interventional",E01.370.350.700.725
23645529,2013-05-03T00:00:00,"Radiography, Interventional",E02.148.694
23645529,2013-05-03T00:00:00,"Radiography, Interventional",E04.800.780
23645529,2013-05-03T00:00:00,Treatment Outcome,E01.789.800
23645529,2013-05-03T00:00:00,Treatment Outcome,N04.761.559.590.800
23645529,2013-05-03T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23647651,2013-05-03T00:00:00,Adult,M01.060.116
23647651,2013-05-03T00:00:00,Electroencephalography,E01.370.376.300
23647651,2013-05-03T00:00:00,Electroencephalography,E01.370.405.245
23647651,2013-05-03T00:00:00,Hot Temperature,G01.906.595.543
23647651,2013-05-03T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
23647651,2013-05-03T00:00:00,Hot Temperature,G16.500.750.775.710.380
23647651,2013-05-03T00:00:00,Hot Temperature,N06.230.300.100.725.232
23647651,2013-05-03T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
23647651,2013-05-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23647651,2013-05-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23647651,2013-05-03T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23647651,2013-05-03T00:00:00,Movement,G07.700.560
23647651,2013-05-03T00:00:00,Movement,G11.427.590.530
23647651,2013-05-03T00:00:00,Pain Measurement,E01.370.376.550.600
23647651,2013-05-03T00:00:00,Pain Threshold,F02.463.593.710.560
23647651,2013-05-03T00:00:00,Pain Threshold,F02.830.816.444.700
23647651,2013-05-03T00:00:00,Pain Threshold,G11.561.600.810.444.700
23647651,2013-05-03T00:00:00,Pilot Projects,E05.318.760.750
23647651,2013-05-03T00:00:00,Pilot Projects,E05.337.737
23647651,2013-05-03T00:00:00,Pilot Projects,N05.715.360.775.625
23647651,2013-05-03T00:00:00,Pilot Projects,N06.850.520.450.720
23647651,2013-05-03T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23647651,2013-05-03T00:00:00,Temperature,G01.906.595
23647651,2013-05-03T00:00:00,Temperature,G16.500.275.063.725.710
23647651,2013-05-03T00:00:00,Temperature,G16.500.750.775.710
23647651,2013-05-03T00:00:00,Temperature,N06.230.150.450
23647651,2013-05-03T00:00:00,Temperature,N06.230.300.100.725.710
23647651,2013-05-03T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
23647651,2013-05-03T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
23647651,2013-05-03T00:00:00,Young Adult,M01.060.116.815
23662055,2013-05-03T00:00:00,Animals,B01.050
23662055,2013-05-03T00:00:00,Bronchoalveolar Lavage Fluid,E05.510.100.500
23662055,2013-05-03T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
23662055,2013-05-03T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
23662055,2013-05-03T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
23662055,2013-05-03T00:00:00,Graphite,D01.268.150.300
23662055,2013-05-03T00:00:00,Graphite,D01.578.300
23662055,2013-05-03T00:00:00,Nanostructures,J01.637.512
23662055,2013-05-03T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
23662055,2013-05-03T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
23651638,2013-05-06T00:00:00,Adolescent,M01.060.057
23651638,2013-05-06T00:00:00,Adult,M01.060.116
23651638,2013-05-06T00:00:00,Age Factors,N05.715.350.075
23651638,2013-05-06T00:00:00,Age Factors,N06.850.490.250
23651638,2013-05-06T00:00:00,Crime Victims,M01.135
23651638,2013-05-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23651638,2013-05-06T00:00:00,Rape,I01.198.240.748.640
23651638,2013-05-06T00:00:00,Social Support,I01.880.656.600
23651638,2013-05-06T00:00:00,Students,I02.233.748
23651638,2013-05-06T00:00:00,Students,I02.851
23651638,2013-05-06T00:00:00,Students,M01.848
23651638,2013-05-06T00:00:00,Substance-Related Disorders,C21.739
23651638,2013-05-06T00:00:00,Substance-Related Disorders,F03.900
23651638,2013-05-06T00:00:00,Truth Disclosure,F01.145.209.259.800
23651638,2013-05-06T00:00:00,Universities,I02.783.850
23651638,2013-05-06T00:00:00,Young Adult,M01.060.116.815
23652265,2013-05-07T00:00:00,American Heart Association,N03.540.630.780.110
23652265,2013-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23652265,2013-05-07T00:00:00,Stroke,C10.228.140.300.775
23652265,2013-05-07T00:00:00,Stroke,C14.907.253.855
23652265,2013-05-07T00:00:00,United States,Z01.107.567.875
23659756,2013-05-07T00:00:00,Aged,M01.060.116.100
23659756,2013-05-07T00:00:00,Anxiety Disorders,F03.080
23659756,2013-05-07T00:00:00,Health Surveys,E05.318.308.250
23659756,2013-05-07T00:00:00,Health Surveys,N05.715.360.300.375
23659756,2013-05-07T00:00:00,Health Surveys,N06.850.520.308.250
23659756,2013-05-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23659756,2013-05-07T00:00:00,Middle Aged,M01.060.116.630
23659756,2013-05-07T00:00:00,Motor Activity,F01.145.632
23659756,2013-05-07T00:00:00,Motor Activity,G11.427.590.530.698
23659756,2013-05-07T00:00:00,Prevalence,E05.318.308.985.525.750
23659756,2013-05-07T00:00:00,Prevalence,L01.280.975.525.750
23659756,2013-05-07T00:00:00,Prevalence,N01.224.935.597.750
23659756,2013-05-07T00:00:00,Prevalence,N06.850.505.400.975.525.750
23659756,2013-05-07T00:00:00,Prevalence,N06.850.520.308.985.525.750
23659756,2013-05-07T00:00:00,Primary Health Care,N04.590.233.727
23659756,2013-05-07T00:00:00,Psychiatric Status Rating Scales,F04.586
23659756,2013-05-07T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23659756,2013-05-07T00:00:00,United States,Z01.107.567.875
23659756,2013-05-07T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
23659756,2013-05-07T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
23659756,2013-05-07T00:00:00,Veterans,M01.930
23657125,2013-05-09T00:00:00,Heart Diseases,C14.280
23657125,2013-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23657125,2013-05-09T00:00:00,Hypertension,C14.907.489
23657125,2013-05-09T00:00:00,United States,Z01.107.567.875
23657125,2013-05-09T00:00:00,Vagus Nerve Stimulation,E02.342.900
23657125,2013-05-09T00:00:00,Vagus Nerve Stimulation,E02.779.468.900
23661707,2013-05-09T00:00:00,Angiotensin II,D06.472.699.094.078
23661707,2013-05-09T00:00:00,Angiotensin II,D12.644.400.070.078
23661707,2013-05-09T00:00:00,Angiotensin II,D12.644.456.073.041
23661707,2013-05-09T00:00:00,Angiotensin II,D12.644.548.058.078
23661707,2013-05-09T00:00:00,Angiotensin II,D12.776.641.650.070.078
23661707,2013-05-09T00:00:00,Angiotensin II,D23.469.050.050.050
23661707,2013-05-09T00:00:00,Animals,B01.050
23661707,2013-05-09T00:00:00,Arrestins,D12.776.306.090
23661707,2013-05-09T00:00:00,Arrestins,D12.776.543.090
23661707,2013-05-09T00:00:00,Calcium,D01.268.552.100
23661707,2013-05-09T00:00:00,Calcium,D01.552.539.288
23661707,2013-05-09T00:00:00,Calcium,D23.119.100
23661707,2013-05-09T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
23661707,2013-05-09T00:00:00,GTP-Binding Proteins,D12.776.157.325
23661707,2013-05-09T00:00:00,Hemodynamics,G09.330.190.400
23661707,2013-05-09T00:00:00,Hemodynamics,G09.330.380
23661707,2013-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23661707,2013-05-09T00:00:00,Kallikreins,D08.811.277.656.300.760.442
23661707,2013-05-09T00:00:00,Kallikreins,D08.811.277.656.959.350.442
23661707,2013-05-09T00:00:00,Kallikreins,D12.776.124.125.597
23661707,2013-05-09T00:00:00,Kallikreins,D23.119.597
23661707,2013-05-09T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
23661707,2013-05-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23661707,2013-05-09T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23661707,2013-05-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.100.047.625
23661707,2013-05-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.720.600.150.625
23661707,2013-05-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.130.750
23661707,2013-05-09T00:00:00,"Receptor, Angiotensin, Type 1",D12.776.543.750.750.555.150.750
23661707,2013-05-09T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.100.080.500
23661707,2013-05-09T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.720.600.220.500
23661707,2013-05-09T00:00:00,"Receptor, Bradykinin B2",D12.776.543.750.750.555.220.500
23661707,2013-05-09T00:00:00,Signal Transduction,G02.111.087.800
23661707,2013-05-09T00:00:00,Signal Transduction,G02.149.115.800
23661707,2013-05-09T00:00:00,Signal Transduction,G04.299.880
23665373,2013-05-09T00:00:00,Adipocytes,A11.329.114
23665373,2013-05-09T00:00:00,Arteries,A07.231.114
23665373,2013-05-09T00:00:00,Bariatric Surgery,E02.065.062
23665373,2013-05-09T00:00:00,Bariatric Surgery,E04.062
23665373,2013-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23665373,2013-05-09T00:00:00,Inflammation,C23.550.470
23665427,2013-05-09T00:00:00,Animals,B01.050
23665427,2013-05-09T00:00:00,Apoptosis,G04.299.139.160
23665427,2013-05-09T00:00:00,Calcium,D01.268.552.100
23665427,2013-05-09T00:00:00,Calcium,D01.552.539.288
23665427,2013-05-09T00:00:00,Calcium,D23.119.100
23665427,2013-05-09T00:00:00,Hepatocytes,A11.436.348
23665427,2013-05-09T00:00:00,Iron,D01.268.556.412
23665427,2013-05-09T00:00:00,Iron,D01.268.956.287
23665427,2013-05-09T00:00:00,Iron,D01.552.544.412
23665427,2013-05-09T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
23665427,2013-05-09T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
23665427,2013-05-09T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23665427,2013-05-09T00:00:00,Reactive Oxygen Species,D01.339.431
23665427,2013-05-09T00:00:00,Reactive Oxygen Species,D01.650.775
23665427,2013-05-09T00:00:00,Reperfusion Injury,C14.907.725
23665427,2013-05-09T00:00:00,Reperfusion Injury,C23.550.767.877
23711994,2013-05-09T00:00:00,Adult,M01.060.116
23711994,2013-05-09T00:00:00,Aged,M01.060.116.100
23711994,2013-05-09T00:00:00,Animals,B01.050
23711994,2013-05-09T00:00:00,"Cholesterol, HDL",D10.532.432.400
23711994,2013-05-09T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
23711994,2013-05-09T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
23711994,2013-05-09T00:00:00,"Cholesterol, LDL",D10.532.515.500
23711994,2013-05-09T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
23711994,2013-05-09T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
23711994,2013-05-09T00:00:00,Diet,E05.272
23711994,2013-05-09T00:00:00,Diet,G07.610.240
23711994,2013-05-09T00:00:00,Ethnic Groups,M01.686.754
23711994,2013-05-09T00:00:00,Ethnic Groups,N01.224.317
23711994,2013-05-09T00:00:00,Fishes,B01.050.150.900.493
23711994,2013-05-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23711994,2013-05-09T00:00:00,Meat,J02.500.600
23711994,2013-05-09T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23711994,2013-05-09T00:00:00,Metabolic Syndrome X,C18.452.625
23711994,2013-05-09T00:00:00,Middle Aged,M01.060.116.630
23711994,2013-05-09T00:00:00,Prevalence,E05.318.308.985.525.750
23711994,2013-05-09T00:00:00,Prevalence,L01.280.975.525.750
23711994,2013-05-09T00:00:00,Prevalence,N01.224.935.597.750
23711994,2013-05-09T00:00:00,Prevalence,N06.850.505.400.975.525.750
23711994,2013-05-09T00:00:00,Prevalence,N06.850.520.308.985.525.750
23711994,2013-05-09T00:00:00,Questionnaires,E05.318.308.750
23711994,2013-05-09T00:00:00,Questionnaires,L01.280.800
23711994,2013-05-09T00:00:00,Questionnaires,N05.715.360.300.695
23711994,2013-05-09T00:00:00,Questionnaires,N06.850.520.308.750
23711994,2013-05-09T00:00:00,United States,Z01.107.567.875
23586422,2013-05-10T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23586422,2013-05-10T00:00:00,Biofilms,G06.120
23586422,2013-05-10T00:00:00,"Colony Count, Microbial",E05.200.875.220
23586422,2013-05-10T00:00:00,Gold,D01.268.556.322
23586422,2013-05-10T00:00:00,Gold,D01.268.956.186
23586422,2013-05-10T00:00:00,Gold,D01.552.544.322
23586422,2013-05-10T00:00:00,Legionella pneumophila,B03.440.400.425.450.450.500
23586422,2013-05-10T00:00:00,Legionella pneumophila,B03.660.250.460.460.580
23586422,2013-05-10T00:00:00,Metal Nanoparticles,J01.637.512.600.500
23666671,2013-05-10T00:00:00,Action Potentials,G04.580.100
23666671,2013-05-10T00:00:00,Action Potentials,G07.265.750.100
23666671,2013-05-10T00:00:00,Action Potentials,G11.561.570.100
23666671,2013-05-10T00:00:00,Animals,B01.050
23666671,2013-05-10T00:00:00,Binding Sites,G02.111.570.120
23666671,2013-05-10T00:00:00,Calcium,D01.268.552.100
23666671,2013-05-10T00:00:00,Calcium,D01.552.539.288
23666671,2013-05-10T00:00:00,Calcium,D23.119.100
23666671,2013-05-10T00:00:00,Calcium Signaling,G02.111.087.800.800.100
23666671,2013-05-10T00:00:00,Calcium Signaling,G02.149.115.800.800.100
23666671,2013-05-10T00:00:00,Calcium Signaling,G03.495.166.500.100
23666671,2013-05-10T00:00:00,Calcium Signaling,G04.299.880.800.100
23666671,2013-05-10T00:00:00,Calmodulin,D12.644.360.381.249
23666671,2013-05-10T00:00:00,Calmodulin,D12.776.157.125.412.249
23666671,2013-05-10T00:00:00,Calmodulin,D12.776.476.387.249
23666671,2013-05-10T00:00:00,Cardiomegaly,C14.280.195
23666671,2013-05-10T00:00:00,Cardiomegaly,C23.300.775.250
23666671,2013-05-10T00:00:00,Heart Failure,C14.280.434
23666671,2013-05-10T00:00:00,"Mutation, Missense",G05.365.590.650
23666671,2013-05-10T00:00:00,Myocardial Contraction,G09.330.190.541
23666671,2013-05-10T00:00:00,Myocardial Contraction,G11.427.590.540.570
23666671,2013-05-10T00:00:00,"RNA, Messenger",D13.444.735.544
23666671,2013-05-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
23666671,2013-05-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
23666671,2013-05-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
23666671,2013-05-10T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
23666671,2013-05-10T00:00:00,S100 Proteins,D12.776.157.125.750
23666671,2013-05-10T00:00:00,S100 Proteins,D12.776.641.655
23666671,2013-05-10T00:00:00,"Transcription, Genetic",G02.111.087.847
23666671,2013-05-10T00:00:00,"Transcription, Genetic",G02.149.115.847
23666671,2013-05-10T00:00:00,"Transcription, Genetic",G05.355.310.700
23669473,2013-05-10T00:00:00,Abdominal Pain,C23.888.646.100
23669473,2013-05-10T00:00:00,Abdominal Pain,C23.888.821.030
23669473,2013-05-10T00:00:00,Aged,M01.060.116.100
23669473,2013-05-10T00:00:00,"Diagnosis, Differential",E01.171
23669473,2013-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23669473,2013-05-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23669473,2013-05-10T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23669473,2013-05-10T00:00:00,Middle Aged,M01.060.116.630
23669473,2013-05-10T00:00:00,Pancreatic Neoplasms,C04.588.274.761
23669473,2013-05-10T00:00:00,Pancreatic Neoplasms,C04.588.322.421
23669473,2013-05-10T00:00:00,Pancreatic Neoplasms,C06.301.761
23669473,2013-05-10T00:00:00,Pancreatic Neoplasms,C06.689.667
23669473,2013-05-10T00:00:00,Pancreatic Neoplasms,C19.344.421
23669473,2013-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23669473,2013-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23669473,2013-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23669473,2013-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23669473,2013-05-10T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23889711,2013-05-10T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23889711,2013-05-10T00:00:00,Blood Pressure,E01.370.600.875.249
23889711,2013-05-10T00:00:00,Blood Pressure,G09.330.380.076
23889711,2013-05-10T00:00:00,Cardiovascular Diseases,C14
23889711,2013-05-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23889711,2013-05-10T00:00:00,Hypertension,C14.907.489
23672780,2013-05-11T00:00:00,"Angioedemas, Hereditary",C14.907.079.500
23672780,2013-05-11T00:00:00,"Angioedemas, Hereditary",C16.320.078
23672780,2013-05-11T00:00:00,"Angioedemas, Hereditary",C17.800.862.945.066.500
23672780,2013-05-11T00:00:00,"Angioedemas, Hereditary",C20.543.480.904.066.500
23672780,2013-05-11T00:00:00,Bradykinin,D12.644.276.812.169
23672780,2013-05-11T00:00:00,Bradykinin,D12.644.400.090
23672780,2013-05-11T00:00:00,Bradykinin,D12.644.456.193
23672780,2013-05-11T00:00:00,Bradykinin,D12.776.467.812.169
23672780,2013-05-11T00:00:00,Bradykinin,D12.776.641.650.090
23672780,2013-05-11T00:00:00,Bradykinin,D23.469.050.375.110
23672780,2013-05-11T00:00:00,Bradykinin,D23.529.812.169
23672780,2013-05-11T00:00:00,Factor XII,D12.776.124.125.450
23672780,2013-05-11T00:00:00,Factor XII,D23.119.450
23672780,2013-05-11T00:00:00,HSP90 Heat-Shock Proteins,D12.776.580.216.380
23672780,2013-05-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23672780,2013-05-11T00:00:00,Kallikreins,D08.811.277.656.300.760.442
23672780,2013-05-11T00:00:00,Kallikreins,D08.811.277.656.959.350.442
23672780,2013-05-11T00:00:00,Kallikreins,D12.776.124.125.597
23672780,2013-05-11T00:00:00,Kallikreins,D23.119.597
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D12.644.276.812.654.350
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.124.125.635.480
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.467.812.654.350
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.811.420.350
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D23.119.630.480
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D23.469.050.375.425.350
23672780,2013-05-11T00:00:00,"Kininogen, High-Molecular-Weight",D23.529.812.654.350
23672780,2013-05-11T00:00:00,Prekallikrein,D08.811.277.656.300.760.442.725
23672780,2013-05-11T00:00:00,Prekallikrein,D08.811.277.656.959.350.442.725
23672780,2013-05-11T00:00:00,Prekallikrein,D12.776.124.125.597.712
23672780,2013-05-11T00:00:00,Prekallikrein,D23.119.597.712
23673367,2013-05-11T00:00:00,Animals,B01.050
23673367,2013-05-11T00:00:00,Cats,B01.050.150.900.649.147.354.250.125
23673367,2013-05-11T00:00:00,Multiprotein Complexes,D05.500
23673367,2013-05-11T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23673367,2013-05-11T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23673367,2013-05-11T00:00:00,"Myocytes, Cardiac",A11.620.500
23673367,2013-05-11T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23673367,2013-05-11T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23673367,2013-05-11T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23666756,2013-05-12T00:00:00,Breast Neoplasms,C04.588.180
23666756,2013-05-12T00:00:00,Breast Neoplasms,C17.800.090.500
23666756,2013-05-12T00:00:00,Cell Movement,G04.299.283
23666756,2013-05-12T00:00:00,Cell Movement,G07.700.560.500.180
23666756,2013-05-12T00:00:00,Cell Proliferation,G04.299.233.750
23666756,2013-05-12T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23666756,2013-05-12T00:00:00,Gene Expression,G05.355.310
23666756,2013-05-12T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23666756,2013-05-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23666756,2013-05-12T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
23666756,2013-05-12T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
23666756,2013-05-12T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
23666756,2013-05-12T00:00:00,Serpins,D12.644.822.750
23666756,2013-05-12T00:00:00,Serpins,D12.644.861
23666756,2013-05-12T00:00:00,Serpins,D12.776.645.750
23666756,2013-05-12T00:00:00,Serpins,D12.776.872
23666756,2013-05-12T00:00:00,Vascular Endothelial Growth Factor A,D12.644.276.100.800.200
23666756,2013-05-12T00:00:00,Vascular Endothelial Growth Factor A,D12.776.467.100.800.200
23666756,2013-05-12T00:00:00,Vascular Endothelial Growth Factor A,D23.529.100.800.200
23512844,2013-05-13T00:00:00,Adult,M01.060.116
23512844,2013-05-13T00:00:00,Hemochromatosis,C16.320.565.618.337
23512844,2013-05-13T00:00:00,Hemochromatosis,C18.452.565.500.480
23512844,2013-05-13T00:00:00,Hemochromatosis,C18.452.648.618.337
23512844,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23512844,2013-05-13T00:00:00,Iron,D01.268.556.412
23512844,2013-05-13T00:00:00,Iron,D01.268.956.287
23512844,2013-05-13T00:00:00,Iron,D01.552.544.412
23512844,2013-05-13T00:00:00,Iron Overload,C18.452.565.500
23512844,2013-05-13T00:00:00,Membrane Proteins,D12.776.543
23512844,2013-05-13T00:00:00,Mutation,G05.365.590
23512844,2013-05-13T00:00:00,Phenotype,G05.695
23665759,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23665759,2013-05-13T00:00:00,Prostatectomy,E04.950.774.860.625
23665759,2013-05-13T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23665759,2013-05-13T00:00:00,Prostatic Neoplasms,C12.294.260.750
23665759,2013-05-13T00:00:00,Prostatic Neoplasms,C12.294.565.625
23665759,2013-05-13T00:00:00,Prostatic Neoplasms,C12.758.409.750
23665759,2013-05-13T00:00:00,Urinary Incontinence,C12.777.934.852
23665759,2013-05-13T00:00:00,Urinary Incontinence,C13.351.968.934.814
23665759,2013-05-13T00:00:00,Urinary Incontinence,C23.888.942.800
23668668,2013-05-13T00:00:00,Adolescent,M01.060.057
23668668,2013-05-13T00:00:00,Adult,M01.060.116
23668668,2013-05-13T00:00:00,Caregivers,M01.085
23668668,2013-05-13T00:00:00,Caregivers,M01.526.485.200
23668668,2013-05-13T00:00:00,Caregivers,N02.360.200
23668668,2013-05-13T00:00:00,Disease Management,N04.590.607
23668668,2013-05-13T00:00:00,Family Therapy,F04.754.864.581.273
23668668,2013-05-13T00:00:00,Guideline Adherence,N04.761.337
23668668,2013-05-13T00:00:00,Guideline Adherence,N05.715.360.395
23668668,2013-05-13T00:00:00,Health Personnel,M01.526.485
23668668,2013-05-13T00:00:00,Health Personnel,N02.360
23668668,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23668668,2013-05-13T00:00:00,Juvenile Delinquency,I01.880.735.479
23668668,2013-05-13T00:00:00,Substance-Related Disorders,C21.739
23668668,2013-05-13T00:00:00,Substance-Related Disorders,F03.900
23670399,2013-05-13T00:00:00,Adolescent,M01.060.057
23670399,2013-05-13T00:00:00,Adult,M01.060.116
23670399,2013-05-13T00:00:00,Aged,M01.060.116.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E01.370.388.100.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E01.450.230.100.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E01.450.865.100.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E01.450.865.632.100
23670399,2013-05-13T00:00:00,"Biopsy, Needle",E04.074.119
23670399,2013-05-13T00:00:00,Combined Modality Therapy,E02.186
23670399,2013-05-13T00:00:00,Disease-Free Survival,E01.789.200
23670399,2013-05-13T00:00:00,Disease-Free Survival,E05.318.740.998.300
23670399,2013-05-13T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
23670399,2013-05-13T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
23670399,2013-05-13T00:00:00,Head and Neck Neoplasms,C04.588.443
23670399,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23670399,2013-05-13T00:00:00,Lymph Nodes,A10.549.400
23670399,2013-05-13T00:00:00,Lymph Nodes,A15.382.520.604.412
23670399,2013-05-13T00:00:00,Middle Aged,M01.060.116.630
23670399,2013-05-13T00:00:00,Neoplasm Invasiveness,C04.697.645
23670399,2013-05-13T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23670399,2013-05-13T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23670399,2013-05-13T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23670399,2013-05-13T00:00:00,Treatment Outcome,E01.789.800
23670399,2013-05-13T00:00:00,Treatment Outcome,N04.761.559.590.800
23670399,2013-05-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23670399,2013-05-13T00:00:00,Young Adult,M01.060.116.815
23670699,2013-05-13T00:00:00,Adult,M01.060.116
23670699,2013-05-13T00:00:00,Aged,M01.060.116.100
23670699,2013-05-13T00:00:00,Chronic Disease,C23.550.291.500
23670699,2013-05-13T00:00:00,Endoscopy,E01.370.388.250
23670699,2013-05-13T00:00:00,Endoscopy,E04.800.250
23670699,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23670699,2013-05-13T00:00:00,Middle Aged,M01.060.116.630
23670699,2013-05-13T00:00:00,Rhinitis,C08.460.799
23670699,2013-05-13T00:00:00,Rhinitis,C08.730.674
23670699,2013-05-13T00:00:00,Rhinitis,C09.603.799
23670699,2013-05-13T00:00:00,Sinusitis,C08.460.692.752
23670699,2013-05-13T00:00:00,Sinusitis,C08.730.749
23670699,2013-05-13T00:00:00,Sinusitis,C09.603.692.752
23670699,2013-05-13T00:00:00,Treatment Outcome,E01.789.800
23670699,2013-05-13T00:00:00,Treatment Outcome,N04.761.559.590.800
23670699,2013-05-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23670699,2013-05-13T00:00:00,Young Adult,M01.060.116.815
23670876,2013-05-13T00:00:00,Chronic Disease,C23.550.291.500
23670876,2013-05-13T00:00:00,Endoscopy,E01.370.388.250
23670876,2013-05-13T00:00:00,Endoscopy,E04.800.250
23670876,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23670876,2013-05-13T00:00:00,Middle Aged,M01.060.116.630
23670876,2013-05-13T00:00:00,Quality of Life,I01.800
23670876,2013-05-13T00:00:00,Quality of Life,K01.752.400.750
23670876,2013-05-13T00:00:00,Rhinitis,C08.460.799
23670876,2013-05-13T00:00:00,Rhinitis,C08.730.674
23670876,2013-05-13T00:00:00,Rhinitis,C09.603.799
23670876,2013-05-13T00:00:00,Sinusitis,C08.460.692.752
23670876,2013-05-13T00:00:00,Sinusitis,C08.730.749
23670876,2013-05-13T00:00:00,Sinusitis,C09.603.692.752
23670876,2013-05-13T00:00:00,Treatment Outcome,E01.789.800
23670876,2013-05-13T00:00:00,Treatment Outcome,N04.761.559.590.800
23670876,2013-05-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23671067,2013-05-13T00:00:00,Animals,B01.050
23671067,2013-05-13T00:00:00,Cues,F02.463.425.234
23671067,2013-05-13T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
23671067,2013-05-13T00:00:00,"Microscopy, Confocal",E05.595.395
23671067,2013-05-13T00:00:00,Neuronal Plasticity,G11.561.600.635
23671067,2013-05-13T00:00:00,Patch-Clamp Techniques,E05.200.500.800
23671067,2013-05-13T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23671067,2013-05-13T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23671067,2013-05-13T00:00:00,"Receptors, AMPA",D12.776.543.750.720.200.450.200
23671067,2013-05-13T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
23671067,2013-05-13T00:00:00,Self Administration,E02.319.890
23671067,2013-05-13T00:00:00,Self Administration,E02.900.890
23671067,2013-05-13T00:00:00,Synapses,A08.850
23671067,2013-05-13T00:00:00,Synapses,A11.284.149.165.420.780
23671067,2013-05-13T00:00:00,Tobacco Use Disorder,C21.739.912
23671067,2013-05-13T00:00:00,Tobacco Use Disorder,F03.900.912
23671277,2013-05-13T00:00:00,Animals,B01.050
23671277,2013-05-13T00:00:00,"Antigens, CD11a",D12.776.543.750.705.408.100.100
23671277,2013-05-13T00:00:00,"Antigens, CD11a",D23.050.301.264.035.111.024
23671277,2013-05-13T00:00:00,"Antigens, CD11a",D23.101.100.110.111.024
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.395.550.200.275.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.543.550.200.275.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.543.750.705.408.200.249
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.543.750.705.408.600.100.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D12.776.543.750.705.833.249.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.050.301.264.035.118
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.050.301.264.894.118
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.050.301.350.275.750
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.101.100.110.118
23671277,2013-05-13T00:00:00,"Antigens, CD18",D23.101.100.894.118
23671277,2013-05-13T00:00:00,Binding Sites,G02.111.570.120
23671277,2013-05-13T00:00:00,Cell Line,A11.251.210
23671277,2013-05-13T00:00:00,Cell Movement,G04.299.283
23671277,2013-05-13T00:00:00,Cell Movement,G07.700.560.500.180
23671277,2013-05-13T00:00:00,Cell Survival,G04.299.316
23671277,2013-05-13T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
23671277,2013-05-13T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23671277,2013-05-13T00:00:00,Flow Cytometry,E05.200.500.386.350
23671277,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23671277,2013-05-13T00:00:00,Membrane Glycoproteins,D12.776.395.550
23671277,2013-05-13T00:00:00,Membrane Glycoproteins,D12.776.543.550
23671277,2013-05-13T00:00:00,Molecular Chaperones,D12.776.580
23671277,2013-05-13T00:00:00,Neoplasms,C04
23671277,2013-05-13T00:00:00,Peptides,D12.644
23671277,2013-05-13T00:00:00,RNA Interference,G05.355.315.203.374.790
23716734,2013-05-13T00:00:00,"Education, Pharmacy",I02.358.525
23716734,2013-05-13T00:00:00,Guideline Adherence,N04.761.337
23716734,2013-05-13T00:00:00,Guideline Adherence,N05.715.360.395
23716734,2013-05-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23716734,2013-05-13T00:00:00,Periodicals as Topic,L01.178.682.829.678
23716734,2013-05-13T00:00:00,Research Design,E05.581.500
23716734,2013-05-13T00:00:00,Research Design,H01.770.644.728
23726523,2013-05-13T00:00:00,Animals,B01.050
23726523,2013-05-13T00:00:00,"Antigens, CD",D23.050.301.264.035
23726523,2013-05-13T00:00:00,"Antigens, CD",D23.101.100.110
23726523,2013-05-13T00:00:00,Body Weight,C23.888.144
23726523,2013-05-13T00:00:00,Body Weight,E01.370.600.115.100.160.120
23726523,2013-05-13T00:00:00,Body Weight,E05.041.124.160.750
23726523,2013-05-13T00:00:00,Body Weight,G07.100.100.160.120
23726523,2013-05-13T00:00:00,Body Weight,G07.700.320.249.314.120
23726523,2013-05-13T00:00:00,Chronic Disease,C23.550.291.500
23726523,2013-05-13T00:00:00,Colitis,C06.405.205.265
23726523,2013-05-13T00:00:00,Colitis,C06.405.469.158.188
23726523,2013-05-13T00:00:00,Down-Regulation,G02.111.087.225
23726523,2013-05-13T00:00:00,Down-Regulation,G02.149.115.225
23726523,2013-05-13T00:00:00,Down-Regulation,G05.355.315.200
23726523,2013-05-13T00:00:00,Down-Regulation,G07.690.812.230
23726523,2013-05-13T00:00:00,Down-Regulation,G07.700.680.230
23726523,2013-05-13T00:00:00,Insulin,D06.472.699.587.740.625
23726523,2013-05-13T00:00:00,Insulin,D12.644.548.586.740.625
23726523,2013-05-13T00:00:00,Interleukin-10,D12.644.276.374.465.510
23726523,2013-05-13T00:00:00,Interleukin-10,D12.776.467.374.465.510
23726523,2013-05-13T00:00:00,Interleukin-10,D23.529.374.465.510
23726523,2013-05-13T00:00:00,Intestinal Mucosa,A03.556.124.369
23726523,2013-05-13T00:00:00,Intestinal Mucosa,A10.615.550.444
23726523,2013-05-13T00:00:00,Polyethylene Glycols,D02.033.455.250.700
23726523,2013-05-13T00:00:00,Polyethylene Glycols,D05.750.741
23726523,2013-05-13T00:00:00,Polyethylene Glycols,D25.720.741
23726523,2013-05-13T00:00:00,Polyethylene Glycols,J01.637.051.720.741
23726523,2013-05-13T00:00:00,Recombinant Proteins,D12.776.828
23726523,2013-05-13T00:00:00,STAT1 Transcription Factor,D12.644.360.024.303.500.500
23726523,2013-05-13T00:00:00,STAT1 Transcription Factor,D12.644.360.024.342.100
23726523,2013-05-13T00:00:00,STAT1 Transcription Factor,D12.776.157.057.061.500.500
23726523,2013-05-13T00:00:00,STAT1 Transcription Factor,D12.776.157.057.186.100
23726523,2013-05-13T00:00:00,STAT1 Transcription Factor,D12.776.260.513.249.500
23726523,2013-05-13T00:00:00,STAT1 Transcription Factor,D12.776.476.024.387.500.500
23726523,2013-05-13T00:00:00,STAT1 Transcription Factor,D12.776.476.024.421.100
23726523,2013-05-13T00:00:00,STAT1 Transcription Factor,D12.776.930.354.249.500
23726523,2013-05-13T00:00:00,STAT1 Transcription Factor,D12.776.930.840.100
23726523,2013-05-13T00:00:00,Signal Transduction,G02.111.087.800
23726523,2013-05-13T00:00:00,Signal Transduction,G02.149.115.800
23726523,2013-05-13T00:00:00,Signal Transduction,G04.299.880
23726523,2013-05-13T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
23726523,2013-05-13T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
23726523,2013-05-13T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
23726523,2013-05-13T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
23726523,2013-05-13T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
23726523,2013-05-13T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
23726523,2013-05-13T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
23726523,2013-05-13T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
23726523,2013-05-13T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
23726523,2013-05-13T00:00:00,Transforming Growth Factor beta,D23.529.374.687
23726523,2013-05-13T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
23726523,2013-05-13T00:00:00,Transforming Growth Factor beta,D23.529.960.720
23751416,2013-05-13T00:00:00,Adsorption,G02.149.047
23751416,2013-05-13T00:00:00,Adsorption,G02.149.767.029
23751416,2013-05-13T00:00:00,Adsorption,G02.842.750.029
23751416,2013-05-13T00:00:00,Animals,B01.050
23751416,2013-05-13T00:00:00,Chickens,B01.050.150.900.248.350.150
23751416,2013-05-13T00:00:00,Chickens,B01.050.150.900.248.617.192
23751416,2013-05-13T00:00:00,Glass,J01.637.241.400
23751416,2013-05-13T00:00:00,Glass,J01.637.437
23751416,2013-05-13T00:00:00,Muramidase,D08.811.277.450.642
23751416,2013-05-13T00:00:00,Polyethylene,D02.455.326.271.665.550.500
23751416,2013-05-13T00:00:00,Polyethylene,D05.750.716.507.500
23751416,2013-05-13T00:00:00,Polyethylene,D25.720.716.507.500
23751416,2013-05-13T00:00:00,Polyethylene,J01.637.051.720.716.507.500
23751416,2013-05-13T00:00:00,Polymethyl Methacrylate,D02.241.081.069.800.550.500
23751416,2013-05-13T00:00:00,Polymethyl Methacrylate,D05.750.716.822.111.650.605.500
23751416,2013-05-13T00:00:00,Polymethyl Methacrylate,D25.720.716.822.111.650.605.500
23751416,2013-05-13T00:00:00,Polymethyl Methacrylate,J01.637.051.720.716.822.111.650.605.500
23751416,2013-05-13T00:00:00,Protein Conformation,G02.111.570.790.709
23751416,2013-05-13T00:00:00,Silicon Dioxide,D01.578.750
23751416,2013-05-13T00:00:00,Silicon Dioxide,D01.650.550.825
23751416,2013-05-13T00:00:00,Silicon Dioxide,D01.837.725
23751416,2013-05-13T00:00:00,Surface Properties,G02.842.850
23670294,2013-05-14T00:00:00,Animals,B01.050
23670294,2013-05-14T00:00:00,Antineoplastic Agents,D27.505.954.248
23670294,2013-05-14T00:00:00,Apoptosis,G04.299.139.160
23670294,2013-05-14T00:00:00,Disease Progression,C23.550.291.656
23670294,2013-05-14T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23670294,2013-05-14T00:00:00,Flow Cytometry,E05.200.500.386.350
23670294,2013-05-14T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
23670294,2013-05-14T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
23670294,2013-05-14T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
23670294,2013-05-14T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
23670294,2013-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23670294,2013-05-14T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
23670294,2013-05-14T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
23670294,2013-05-14T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23670294,2013-05-14T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23670294,2013-05-14T00:00:00,Stem Cells,A11.872
23670675,2013-05-14T00:00:00,Adult,M01.060.116
23670675,2013-05-14T00:00:00,Aged,M01.060.116.100
23670675,2013-05-14T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
23670675,2013-05-14T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
23670675,2013-05-14T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
23670675,2013-05-14T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
23670675,2013-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23670675,2013-05-14T00:00:00,Incidence,E05.318.308.985.525.375
23670675,2013-05-14T00:00:00,Incidence,L01.280.975.525.375
23670675,2013-05-14T00:00:00,Incidence,N01.224.935.597.500
23670675,2013-05-14T00:00:00,Incidence,N06.850.505.400.975.525.375
23670675,2013-05-14T00:00:00,Incidence,N06.850.520.308.985.525.375
23670675,2013-05-14T00:00:00,Middle Aged,M01.060.116.630
23670675,2013-05-14T00:00:00,"Obesity, Morbid",C18.654.726.500.700
23670675,2013-05-14T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
23670675,2013-05-14T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
23670675,2013-05-14T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
23670675,2013-05-14T00:00:00,Pulmonary Embolism,C08.381.746
23670675,2013-05-14T00:00:00,Pulmonary Embolism,C14.907.355.350.700
23670675,2013-05-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23670675,2013-05-14T00:00:00,Risk Factors,N05.715.350.200.700
23670675,2013-05-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23670675,2013-05-14T00:00:00,Risk Factors,N06.850.490.625.750
23670675,2013-05-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23670675,2013-05-14T00:00:00,Venous Thrombosis,C14.907.355.830.925
23671178,2013-05-14T00:00:00,Cooperative Behavior,F01.145.813.115
23671178,2013-05-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23671178,2013-05-14T00:00:00,Pilot Projects,E05.318.760.750
23671178,2013-05-14T00:00:00,Pilot Projects,E05.337.737
23671178,2013-05-14T00:00:00,Pilot Projects,N05.715.360.775.625
23671178,2013-05-14T00:00:00,Pilot Projects,N06.850.520.450.720
23671178,2013-05-14T00:00:00,Stroke,C10.228.140.300.775
23671178,2013-05-14T00:00:00,Stroke,C14.907.253.855
23671178,2013-05-14T00:00:00,Treatment Outcome,E01.789.800
23671178,2013-05-14T00:00:00,Treatment Outcome,N04.761.559.590.800
23671178,2013-05-14T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23677931,2013-05-15T00:00:00,Animals,B01.050
23677931,2013-05-15T00:00:00,Blood Pressure,E01.370.600.875.249
23677931,2013-05-15T00:00:00,Blood Pressure,G09.330.380.076
23677931,2013-05-15T00:00:00,Pregnancy,G08.686.785.760.769
23677931,2013-05-15T00:00:00,"Receptors, Angiotensin",D12.776.543.750.100.047
23677931,2013-05-15T00:00:00,"Receptors, Angiotensin",D12.776.543.750.720.600.150
23677931,2013-05-15T00:00:00,"Receptors, Angiotensin",D12.776.543.750.750.130
23677931,2013-05-15T00:00:00,"Receptors, Angiotensin",D12.776.543.750.750.555.150
23677931,2013-05-15T00:00:00,Vitamin D,D04.808.812.768
23677931,2013-05-15T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23678058,2013-05-15T00:00:00,Adolescent,M01.060.057
23678058,2013-05-15T00:00:00,Adult,M01.060.116
23678058,2013-05-15T00:00:00,Aged,M01.060.116.100
23678058,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23678058,2013-05-15T00:00:00,Middle Aged,M01.060.116.630
23678058,2013-05-15T00:00:00,Sensitivity and Specificity,E05.318.740.872
23678058,2013-05-15T00:00:00,Sensitivity and Specificity,E05.318.780.800
23678058,2013-05-15T00:00:00,Sensitivity and Specificity,G17.800
23678058,2013-05-15T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23678058,2013-05-15T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23678058,2013-05-15T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23678058,2013-05-15T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23678058,2013-05-15T00:00:00,Trichomonas Vaginitis,C03.752.890.633
23678058,2013-05-15T00:00:00,Trichomonas Vaginitis,C13.351.500.894.906.633
23678058,2013-05-15T00:00:00,Trichomonas vaginalis,B01.630.800.808.717
23678058,2013-05-15T00:00:00,Young Adult,M01.060.116.815
23683344,2013-05-15T00:00:00,Adult,M01.060.116
23683344,2013-05-15T00:00:00,"Behavior, Addictive",F01.145.527.100.120
23683344,2013-05-15T00:00:00,Cues,F02.463.425.234
23683344,2013-05-15T00:00:00,Gyrus Cinguli,A08.186.211.464.330
23683344,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23683344,2013-05-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23683344,2013-05-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23683344,2013-05-15T00:00:00,Middle Aged,M01.060.116.630
23683344,2013-05-15T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23683344,2013-05-15T00:00:00,Smoking Cessation,F01.145.940.700
23683790,2013-05-15T00:00:00,Adult,M01.060.116
23683790,2013-05-15T00:00:00,"Behavior, Addictive",F01.145.527.100.120
23683790,2013-05-15T00:00:00,Brain,A08.186.211
23683790,2013-05-15T00:00:00,Cocaine,D02.145.074.722.388
23683790,2013-05-15T00:00:00,Cocaine,D03.132.889.354
23683790,2013-05-15T00:00:00,Cocaine,D03.605.869.388
23683790,2013-05-15T00:00:00,Cocaine,D04.075.080.875.099.722.388
23683790,2013-05-15T00:00:00,Cues,F02.463.425.234
23683790,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23683790,2013-05-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23683790,2013-05-15T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23683790,2013-05-15T00:00:00,Middle Aged,M01.060.116.630
23683790,2013-05-15T00:00:00,Photic Stimulation,E05.723.729
23683790,2013-05-15T00:00:00,Psychomotor Performance,F02.808
23683790,2013-05-15T00:00:00,Psychomotor Performance,G11.427.700
23683790,2013-05-15T00:00:00,Psychomotor Performance,G11.561.623
23683961,2013-05-15T00:00:00,Child,M01.060.406
23683961,2013-05-15T00:00:00,"Child, Preschool",M01.060.406.448
23683961,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23683961,2013-05-15T00:00:00,Hypospadias,C12.294.494.400
23683961,2013-05-15T00:00:00,Hypospadias,C12.706.516
23683961,2013-05-15T00:00:00,Hypospadias,C13.351.875.466
23683961,2013-05-15T00:00:00,Hypospadias,C16.131.939.516
23683961,2013-05-15T00:00:00,Infant,M01.060.703
23683961,2013-05-15T00:00:00,Postoperative Complications,C23.550.767
23683961,2013-05-15T00:00:00,Risk Factors,E05.318.740.600.800.725
23683961,2013-05-15T00:00:00,Risk Factors,N05.715.350.200.700
23683961,2013-05-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23683961,2013-05-15T00:00:00,Risk Factors,N06.850.490.625.750
23683961,2013-05-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23683961,2013-05-15T00:00:00,Urethra,A05.360.444.492.726
23683961,2013-05-15T00:00:00,Urethra,A05.810.876
23939446,2013-05-15T00:00:00,Adult,M01.060.116
23939446,2013-05-15T00:00:00,"Diagnosis, Differential",E01.171
23939446,2013-05-15T00:00:00,Headache,C10.597.617.470
23939446,2013-05-15T00:00:00,Headache,C23.888.592.612.441
23939446,2013-05-15T00:00:00,Headache,C23.888.646.487
23939446,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23939446,2013-05-15T00:00:00,Migraine Disorders,C10.228.140.546.399.750
23952889,2013-05-15T00:00:00,Acetylcysteine,D02.886.030.230.259
23952889,2013-05-15T00:00:00,Acetylcysteine,D12.125.166.230.259
23952889,2013-05-15T00:00:00,Adult,M01.060.116
23952889,2013-05-15T00:00:00,Cocaine-Related Disorders,C21.739.300
23952889,2013-05-15T00:00:00,Cocaine-Related Disorders,F03.900.300
23952889,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23952889,2013-05-15T00:00:00,Psychiatric Status Rating Scales,F04.586
23952889,2013-05-15T00:00:00,Secondary Prevention,N02.421.726.825
23952889,2013-05-15T00:00:00,Secondary Prevention,N06.850.780.750
23952889,2013-05-15T00:00:00,Treatment Outcome,E01.789.800
23952889,2013-05-15T00:00:00,Treatment Outcome,N04.761.559.590.800
23952889,2013-05-15T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23952895,2013-05-15T00:00:00,Adult,M01.060.116
23952895,2013-05-15T00:00:00,Case-Control Studies,E05.318.760.500.500
23952895,2013-05-15T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23952895,2013-05-15T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23952895,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23952895,2013-05-15T00:00:00,"Interview, Psychological",F04.669.599
23952895,2013-05-15T00:00:00,Motivation,F01.658
23952895,2013-05-15T00:00:00,Motivation,F01.752.543.500.750
23952895,2013-05-15T00:00:00,Opioid-Related Disorders,C21.739.675
23952895,2013-05-15T00:00:00,Opioid-Related Disorders,F03.900.675
23952895,2013-05-15T00:00:00,Pain,C10.597.617
23952895,2013-05-15T00:00:00,Pain,C23.888.592.612
23952895,2013-05-15T00:00:00,Pain,C23.888.646
23952895,2013-05-15T00:00:00,Pain,F02.830.816.444
23952895,2013-05-15T00:00:00,Pain,G11.561.600.810.444
23952895,2013-05-15T00:00:00,Pain Measurement,E01.370.376.550.600
23993239,2013-05-15T00:00:00,Animals,B01.050
23993239,2013-05-15T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
23993239,2013-05-15T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
23993239,2013-05-15T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
23993239,2013-05-15T00:00:00,Disease Progression,C23.550.291.656
23993239,2013-05-15T00:00:00,Extracellular Matrix,A11.284.295.310
23993239,2013-05-15T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23993239,2013-05-15T00:00:00,Genetic Predisposition to Disease,G05.380.355
23993239,2013-05-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23993239,2013-05-15T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23993239,2013-05-15T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23993239,2013-05-15T00:00:00,Phenotype,G05.695
23993239,2013-05-15T00:00:00,Risk Factors,E05.318.740.600.800.725
23993239,2013-05-15T00:00:00,Risk Factors,N05.715.350.200.700
23993239,2013-05-15T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23993239,2013-05-15T00:00:00,Risk Factors,N06.850.490.625.750
23993239,2013-05-15T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
23993239,2013-05-15T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
23676111,2013-05-16T00:00:00,Carbon Dioxide,D01.200.200
23676111,2013-05-16T00:00:00,Carbon Dioxide,D01.362.150
23676111,2013-05-16T00:00:00,Carbon Dioxide,D01.650.550.200
23676111,2013-05-16T00:00:00,Electrochemical Techniques,E05.301
23676111,2013-05-16T00:00:00,Electrodes,E07.305.250
23676111,2013-05-16T00:00:00,Phylogeny,G05.697
23676111,2013-05-16T00:00:00,Phylogeny,G16.100.275.605
23676111,2013-05-16T00:00:00,Phylogeny,L01.100.697
23683497,2013-05-16T00:00:00,Apoptosis,G04.299.139.160
23683497,2013-05-16T00:00:00,Cell Aging,G04.299.119
23683497,2013-05-16T00:00:00,Cell Proliferation,G04.299.233.750
23683497,2013-05-16T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23683497,2013-05-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23683497,2013-05-16T00:00:00,Lung Neoplasms,C04.588.894.797.520
23683497,2013-05-16T00:00:00,Lung Neoplasms,C08.381.540
23683497,2013-05-16T00:00:00,Lung Neoplasms,C08.785.520
23683497,2013-05-16T00:00:00,Piperazines,D03.383.606
23683497,2013-05-16T00:00:00,Radiation-Sensitizing Agents,D27.505.696.750
23683497,2013-05-16T00:00:00,Signal Transduction,G02.111.087.800
23683497,2013-05-16T00:00:00,Signal Transduction,G02.149.115.800
23683497,2013-05-16T00:00:00,Signal Transduction,G04.299.880
23683497,2013-05-16T00:00:00,Tumor Suppressor Protein p53,D12.776.260.820
23683497,2013-05-16T00:00:00,Tumor Suppressor Protein p53,D12.776.624.776.775
23683497,2013-05-16T00:00:00,Tumor Suppressor Protein p53,D12.776.660.825
23683497,2013-05-16T00:00:00,Tumor Suppressor Protein p53,D12.776.744.845
23685099,2013-05-16T00:00:00,Aged,M01.060.116.100
23685099,2013-05-16T00:00:00,Amides,D02.065
23685099,2013-05-16T00:00:00,"Analgesia, Patient-Controlled",E03.091.120
23685099,2013-05-16T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
23685099,2013-05-16T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
23685099,2013-05-16T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
23685099,2013-05-16T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
23685099,2013-05-16T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
23685099,2013-05-16T00:00:00,Drug Delivery Systems,E02.319.300
23685099,2013-05-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23685099,2013-05-16T00:00:00,Hydromorphone,D03.132.577.249.547.547.450
23685099,2013-05-16T00:00:00,Hydromorphone,D03.549.686.575.547.500
23685099,2013-05-16T00:00:00,Hydromorphone,D03.605.497.575.547.500
23685099,2013-05-16T00:00:00,Hydromorphone,D04.615.723.795.547.547.450
23685099,2013-05-16T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
23685099,2013-05-16T00:00:00,Middle Aged,M01.060.116.630
23685099,2013-05-16T00:00:00,Pain Measurement,E01.370.376.550.600
23685099,2013-05-16T00:00:00,"Pain, Postoperative",C23.550.767.700
23685099,2013-05-16T00:00:00,"Pain, Postoperative",C23.888.646.530
23651061,2013-05-17T00:00:00,Animals,B01.050
23651061,2013-05-17T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
23651061,2013-05-17T00:00:00,Flow Cytometry,E05.200.500.386.350
23651061,2013-05-17T00:00:00,Microbodies,A11.284.430.214.190.500.585
23651061,2013-05-17T00:00:00,Microbodies,A11.284.430.214.190.875.190.190.755
23682710,2013-05-17T00:00:00,Adult,M01.060.116
23682710,2013-05-17T00:00:00,Animals,B01.050
23682710,2013-05-17T00:00:00,Autoimmune Diseases,C20.111
23682710,2013-05-17T00:00:00,Calcium Signaling,G02.111.087.800.800.100
23682710,2013-05-17T00:00:00,Calcium Signaling,G02.149.115.800.800.100
23682710,2013-05-17T00:00:00,Calcium Signaling,G03.495.166.500.100
23682710,2013-05-17T00:00:00,Calcium Signaling,G04.299.880.800.100
23682710,2013-05-17T00:00:00,Cardiovascular Diseases,C14
23682710,2013-05-17T00:00:00,Cognition Disorders,F03.087.250
23682710,2013-05-17T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23682710,2013-05-17T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23682710,2013-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23682710,2013-05-17T00:00:00,Immune System,A15.382
23682710,2013-05-17T00:00:00,Infant,M01.060.703
23682710,2013-05-17T00:00:00,Lactation,G08.686.702.500
23682710,2013-05-17T00:00:00,Lactation,G08.686.785.420
23682710,2013-05-17T00:00:00,Obesity,C18.654.726.500
23682710,2013-05-17T00:00:00,Obesity,C23.888.144.699.500
23682710,2013-05-17T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23682710,2013-05-17T00:00:00,Obesity,G07.100.100.160.120.699.500
23682710,2013-05-17T00:00:00,Pregnancy,G08.686.785.760.769
23682710,2013-05-17T00:00:00,"Pulmonary Disease, Chronic Obstructive",C08.381.495.389
23682710,2013-05-17T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23682710,2013-05-17T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23682710,2013-05-17T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23682710,2013-05-17T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23682710,2013-05-17T00:00:00,Vitamin D,D04.808.812.768
23682710,2013-05-17T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23684427,2013-05-17T00:00:00,Adult,M01.060.116
23684427,2013-05-17T00:00:00,Calcium,D01.268.552.100
23684427,2013-05-17T00:00:00,Calcium,D01.552.539.288
23684427,2013-05-17T00:00:00,Calcium,D23.119.100
23684427,2013-05-17T00:00:00,Calcium Signaling,G02.111.087.800.800.100
23684427,2013-05-17T00:00:00,Calcium Signaling,G02.149.115.800.800.100
23684427,2013-05-17T00:00:00,Calcium Signaling,G03.495.166.500.100
23684427,2013-05-17T00:00:00,Calcium Signaling,G04.299.880.800.100
23684427,2013-05-17T00:00:00,Catecholamines,D02.092.211.215.311
23684427,2013-05-17T00:00:00,Catecholamines,D02.092.311
23684427,2013-05-17T00:00:00,Cell Differentiation,G04.299.151
23684427,2013-05-17T00:00:00,Cell Line,A11.251.210
23684427,2013-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23684427,2013-05-17T00:00:00,"Myocytes, Cardiac",A07.541.704.570
23684427,2013-05-17T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
23684427,2013-05-17T00:00:00,"Myocytes, Cardiac",A11.620.500
23684427,2013-05-17T00:00:00,Patch-Clamp Techniques,E05.200.500.800
23684427,2013-05-17T00:00:00,Pluripotent Stem Cells,A11.872.700
23684427,2013-05-17T00:00:00,Point Mutation,G05.365.590.675
23684427,2013-05-17T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.157.530.400.150.800
23684427,2013-05-17T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.210.500.800
23684427,2013-05-17T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.550.425.150.800
23684427,2013-05-17T00:00:00,Ryanodine Receptor Calcium Release Channel,D12.776.543.585.400.150.800
23684427,2013-05-17T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
23684427,2013-05-17T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
23687123,2013-05-17T00:00:00,Adolescent,M01.060.057
23687123,2013-05-17T00:00:00,Adult,M01.060.116
23687123,2013-05-17T00:00:00,Brain,A08.186.211
23687123,2013-05-17T00:00:00,Carrier Proteins,D12.776.157
23687123,2013-05-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23687123,2013-05-17T00:00:00,Iron,D01.268.556.412
23687123,2013-05-17T00:00:00,Iron,D01.268.956.287
23687123,2013-05-17T00:00:00,Iron,D01.552.544.412
23687123,2013-05-17T00:00:00,Middle Aged,M01.060.116.630
23687123,2013-05-17T00:00:00,Mutation,G05.365.590
23687123,2013-05-17T00:00:00,Neurodegenerative Diseases,C10.574
23687123,2013-05-17T00:00:00,Young Adult,M01.060.116.815
23690418,2013-05-20T00:00:00,Adult,M01.060.116
23690418,2013-05-20T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
23690418,2013-05-20T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
23690418,2013-05-20T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
23690418,2013-05-20T00:00:00,Antineoplastic Agents,D27.505.954.248
23690418,2013-05-20T00:00:00,Antiviral Agents,D27.505.954.122.388
23690418,2013-05-20T00:00:00,Hepacivirus,B04.450.410
23690418,2013-05-20T00:00:00,Hepacivirus,B04.820.250.475
23690418,2013-05-20T00:00:00,Hepacivirus,B04.909.777.310.475
23690418,2013-05-20T00:00:00,"Hepatitis C, Chronic",C02.440.440.120
23690418,2013-05-20T00:00:00,"Hepatitis C, Chronic",C02.782.350.350.120
23690418,2013-05-20T00:00:00,"Hepatitis C, Chronic",C06.552.380.350.120
23690418,2013-05-20T00:00:00,"Hepatitis C, Chronic",C06.552.380.705.440.120
23690418,2013-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23690418,2013-05-20T00:00:00,Melanoma,C04.557.465.625.650.510
23690418,2013-05-20T00:00:00,Melanoma,C04.557.580.625.650.510
23690418,2013-05-20T00:00:00,Melanoma,C04.557.665.510
23690418,2013-05-20T00:00:00,Skin Neoplasms,C04.588.805
23690418,2013-05-20T00:00:00,Skin Neoplasms,C17.800.882
23690418,2013-05-20T00:00:00,Treatment Outcome,E01.789.800
23690418,2013-05-20T00:00:00,Treatment Outcome,N04.761.559.590.800
23690418,2013-05-20T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23690557,2013-05-20T00:00:00,Animals,B01.050
23690557,2013-05-20T00:00:00,Anoxia,C23.888.852.079
23690557,2013-05-20T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23690557,2013-05-20T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23696427,2013-05-20T00:00:00,Adult,M01.060.116
23696427,2013-05-20T00:00:00,Brain Injuries,C10.228.140.199
23696427,2013-05-20T00:00:00,Brain Injuries,C10.900.300.087
23696427,2013-05-20T00:00:00,Brain Injuries,C21.866.260.118
23696427,2013-05-20T00:00:00,Brain Injuries,C21.866.915.300.200
23696427,2013-05-20T00:00:00,Cognitive Therapy,F04.754.137.428
23696427,2013-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23696427,2013-05-20T00:00:00,Middle Aged,M01.060.116.630
23696427,2013-05-20T00:00:00,Psychiatric Status Rating Scales,F04.586
23696427,2013-05-20T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23696427,2013-05-20T00:00:00,Veterans,M01.930
23700431,2013-05-20T00:00:00,Adult,M01.060.116
23700431,2013-05-20T00:00:00,African Americans,M01.686.508.100.100
23700431,2013-05-20T00:00:00,African Americans,M01.686.754.100
23700431,2013-05-20T00:00:00,Case-Control Studies,E05.318.760.500.500
23700431,2013-05-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23700431,2013-05-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23700431,2013-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23700431,2013-05-20T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23700431,2013-05-20T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23700431,2013-05-20T00:00:00,Middle Aged,M01.060.116.630
23700431,2013-05-20T00:00:00,Vitamin D,D04.808.812.768
23700431,2013-05-20T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
23702490,2013-05-20T00:00:00,Adolescent,M01.060.057
23702490,2013-05-20T00:00:00,Adult,M01.060.116
23702490,2013-05-20T00:00:00,Aged,M01.060.116.100
23702490,2013-05-20T00:00:00,Alcoholism,C21.739.100.250
23702490,2013-05-20T00:00:00,Alcoholism,F03.900.100.350
23702490,2013-05-20T00:00:00,Health Surveys,E05.318.308.250
23702490,2013-05-20T00:00:00,Health Surveys,N05.715.360.300.375
23702490,2013-05-20T00:00:00,Health Surveys,N06.850.520.308.250
23702490,2013-05-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23702490,2013-05-20T00:00:00,Middle Aged,M01.060.116.630
23702490,2013-05-20T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23702490,2013-05-20T00:00:00,United States,Z01.107.567.875
23702490,2013-05-20T00:00:00,Young Adult,M01.060.116.815
23690229,2013-05-21T00:00:00,Calpain,D08.811.277.656.262.500.120
23690229,2013-05-21T00:00:00,Calpain,D08.811.277.656.300.200.120
23690229,2013-05-21T00:00:00,DNA,D13.444.308
23690229,2013-05-21T00:00:00,Ethanol,D02.033.375
23690229,2013-05-21T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
23690229,2013-05-21T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
23690229,2013-05-21T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
23690229,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23690229,2013-05-21T00:00:00,Motor Neurons,A08.663.655.500
23690229,2013-05-21T00:00:00,Motor Neurons,A11.671.655.500
23690229,2013-05-21T00:00:00,Spinal Cord,A08.186.854
23696453,2013-05-21T00:00:00,Adolescent,M01.060.057
23696453,2013-05-21T00:00:00,Adult,M01.060.116
23696453,2013-05-21T00:00:00,Animals,B01.050
23696453,2013-05-21T00:00:00,Genetic Variation,G05.365
23696453,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23696453,2013-05-21T00:00:00,"Mutation, Missense",G05.365.590.650
23696453,2013-05-21T00:00:00,Phenotype,G05.695
23696453,2013-05-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23697984,2013-05-21T00:00:00,Adenoviridae,B04.280.030
23697984,2013-05-21T00:00:00,Adenoviridae,B04.909.204.097
23697984,2013-05-21T00:00:00,Animals,B01.050
23697984,2013-05-21T00:00:00,Apoptosis,G04.299.139.160
23697984,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23697984,2013-05-21T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
23697984,2013-05-21T00:00:00,Myocardial Infarction,C14.280.647.500
23697984,2013-05-21T00:00:00,Myocardial Infarction,C14.907.585.500
23697984,2013-05-21T00:00:00,Myocardial Ischemia,C14.280.647
23697984,2013-05-21T00:00:00,Myocardial Ischemia,C14.907.585
23697984,2013-05-21T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
23697984,2013-05-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23697984,2013-05-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23697984,2013-05-21T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
23697984,2013-05-21T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
23697984,2013-05-21T00:00:00,Tissue Kallikreins,D23.101.840.870
23706256,2013-05-21T00:00:00,Adenocarcinoma,C04.557.470.200.025
23706256,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23706256,2013-05-21T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23706256,2013-05-21T00:00:00,Prostatic Neoplasms,C12.294.260.750
23706256,2013-05-21T00:00:00,Prostatic Neoplasms,C12.294.565.625
23706256,2013-05-21T00:00:00,Prostatic Neoplasms,C12.758.409.750
23706256,2013-05-21T00:00:00,Quality of Life,I01.800
23706256,2013-05-21T00:00:00,Quality of Life,K01.752.400.750
23706701,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23706701,2013-05-21T00:00:00,Infant,M01.060.703
23706701,2013-05-21T00:00:00,"Infant, Newborn",M01.060.703.520
23706701,2013-05-21T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
23706701,2013-05-21T00:00:00,"Lenses, Intraocular",E07.632.500.460
23706701,2013-05-21T00:00:00,"Lenses, Intraocular",E07.695.460
23706701,2013-05-21T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23706701,2013-05-21T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23706701,2013-05-21T00:00:00,"Refraction, Ocular",E01.370.380.850.700
23706701,2013-05-21T00:00:00,"Refraction, Ocular",G01.590.770.760
23706701,2013-05-21T00:00:00,"Refraction, Ocular",G01.595.640.760
23706701,2013-05-21T00:00:00,"Refraction, Ocular",G14.760
23706701,2013-05-21T00:00:00,Regression Analysis,E05.318.740.750
23706701,2013-05-21T00:00:00,Regression Analysis,N05.715.360.750.695
23706701,2013-05-21T00:00:00,Regression Analysis,N06.850.520.830.750
23769413,2013-05-21T00:00:00,"Depressive Disorder, Major",F03.600.300.375
23769413,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23769413,2013-05-21T00:00:00,Pain,C10.597.617
23769413,2013-05-21T00:00:00,Pain,C23.888.592.612
23769413,2013-05-21T00:00:00,Pain,C23.888.646
23769413,2013-05-21T00:00:00,Pain,F02.830.816.444
23769413,2013-05-21T00:00:00,Pain,G11.561.600.810.444
23769413,2013-05-21T00:00:00,Pain Measurement,E01.370.376.550.600
23769413,2013-05-21T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23769413,2013-05-21T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
23769413,2013-05-21T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
23787030,2013-05-21T00:00:00,Adult,M01.060.116
23787030,2013-05-21T00:00:00,Ambulatory Care,E02.760.106
23787030,2013-05-21T00:00:00,Ambulatory Care,N02.421.585.106
23787030,2013-05-21T00:00:00,Counseling,F02.784.176
23787030,2013-05-21T00:00:00,Counseling,F04.408.413
23787030,2013-05-21T00:00:00,Counseling,N02.421.143.303
23787030,2013-05-21T00:00:00,Counseling,N02.421.461.363
23787030,2013-05-21T00:00:00,HIV Infections,C02.782.815.616.400
23787030,2013-05-21T00:00:00,HIV Infections,C02.800.801.400
23787030,2013-05-21T00:00:00,HIV Infections,C20.673.480
23787030,2013-05-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23787030,2013-05-21T00:00:00,Mass Screening,E01.370.500
23787030,2013-05-21T00:00:00,Mass Screening,E05.318.308.250.580
23787030,2013-05-21T00:00:00,Mass Screening,N02.421.143.827.233.443
23787030,2013-05-21T00:00:00,Mass Screening,N02.421.726.233.443
23787030,2013-05-21T00:00:00,Mass Screening,N05.715.360.300.375.500
23787030,2013-05-21T00:00:00,Mass Screening,N06.850.520.308.250.580
23787030,2013-05-21T00:00:00,Mass Screening,N06.850.780.500
23787030,2013-05-21T00:00:00,Motivation,F01.658
23787030,2013-05-21T00:00:00,Motivation,F01.752.543.500.750
23787030,2013-05-21T00:00:00,Nicotine,D03.132.760.570
23787030,2013-05-21T00:00:00,Nicotine,D03.383.725.518
23787030,2013-05-21T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
23787030,2013-05-21T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
23787030,2013-05-21T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23787030,2013-05-21T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23787030,2013-05-21T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
23787030,2013-05-21T00:00:00,Pilot Projects,E05.318.760.750
23787030,2013-05-21T00:00:00,Pilot Projects,E05.337.737
23787030,2013-05-21T00:00:00,Pilot Projects,N05.715.360.775.625
23787030,2013-05-21T00:00:00,Pilot Projects,N06.850.520.450.720
23787030,2013-05-21T00:00:00,Referral and Consultation,N04.452.758.849
23787030,2013-05-21T00:00:00,Smoking,F01.145.466.753
23787030,2013-05-21T00:00:00,Smoking Cessation,F01.145.940.700
23697546,2013-05-22T00:00:00,American Heart Association,N03.540.630.780.110
23697546,2013-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23697546,2013-05-22T00:00:00,"Societies, Medical",N03.540.828.589
23697546,2013-05-22T00:00:00,Stroke,C10.228.140.300.775
23697546,2013-05-22T00:00:00,Stroke,C14.907.253.855
23697546,2013-05-22T00:00:00,United States,Z01.107.567.875
23766850,2013-05-22T00:00:00,Animals,B01.050
23766850,2013-05-22T00:00:00,Cardiotonic Agents,D27.505.954.411.222
23766850,2013-05-22T00:00:00,Cardiotonic Agents,D27.720.799.080
23766850,2013-05-22T00:00:00,Cattle,B01.050.150.900.649.077.380.271
23766850,2013-05-22T00:00:00,Coronary Circulation,G09.330.190.163.324
23766850,2013-05-22T00:00:00,Endothelial Cells,A11.436.275
23766850,2013-05-22T00:00:00,Glycine,D12.125.481
23766850,2013-05-22T00:00:00,Heart Ventricles,A07.541.560
23766850,2013-05-22T00:00:00,"Models, Cardiovascular",E05.599.395.161
23766850,2013-05-22T00:00:00,Myocardial Infarction,C14.280.647.500
23766850,2013-05-22T00:00:00,Myocardial Infarction,C14.907.585.500
23766850,2013-05-22T00:00:00,Myocardial Reperfusion Injury,C14.280.238.615
23766850,2013-05-22T00:00:00,Myocardial Reperfusion Injury,C14.280.647.625
23766850,2013-05-22T00:00:00,Myocardial Reperfusion Injury,C14.907.585.625
23766850,2013-05-22T00:00:00,Myocardial Reperfusion Injury,C14.907.725.600
23766850,2013-05-22T00:00:00,Myocardial Reperfusion Injury,C23.550.767.877.500
23766850,2013-05-22T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
23766850,2013-05-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23766850,2013-05-22T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23766850,2013-05-22T00:00:00,Reactive Oxygen Species,D01.339.431
23766850,2013-05-22T00:00:00,Reactive Oxygen Species,D01.650.775
23766850,2013-05-22T00:00:00,Superoxides,D01.248.497.158.685.750.850
23766850,2013-05-22T00:00:00,Superoxides,D01.339.431.374.850
23766850,2013-05-22T00:00:00,Superoxides,D01.339.431.750
23766850,2013-05-22T00:00:00,Superoxides,D01.650.550.750.800
23766850,2013-05-22T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
23774882,2013-05-22T00:00:00,Animals,B01.050
23774882,2013-05-22T00:00:00,Autophagy,G04.299.139.399
23774882,2013-05-22T00:00:00,Autophagy,G04.299.482.350.091
23774882,2013-05-22T00:00:00,Circadian Rhythm,G07.180.562.190
23774882,2013-05-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23774882,2013-05-22T00:00:00,Lipid Metabolism,G03.495.520
23774882,2013-05-22T00:00:00,Liver,A03.620
23774882,2013-05-22T00:00:00,Liver Diseases,C06.552
23774882,2013-05-22T00:00:00,"Models, Biological",E05.599.395
23710620,2013-05-26T00:00:00,Age Factors,N05.715.350.075
23710620,2013-05-26T00:00:00,Age Factors,N06.850.490.250
23710620,2013-05-26T00:00:00,Aging,G07.700.320.124
23710620,2013-05-26T00:00:00,Animals,B01.050
23710620,2013-05-26T00:00:00,Collagen Type I,D05.750.078.280.300.100
23710620,2013-05-26T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
23710620,2013-05-26T00:00:00,Cytokines,D12.644.276.374
23710620,2013-05-26T00:00:00,Cytokines,D12.776.467.374
23710620,2013-05-26T00:00:00,Cytokines,D23.529.374
23710620,2013-05-26T00:00:00,Drug-Induced Liver Injury,C06.552.195
23710620,2013-05-26T00:00:00,Drug-Induced Liver Injury,C21.613.260
23710620,2013-05-26T00:00:00,Fibronectins,D12.776.377.715.390
23710620,2013-05-26T00:00:00,Fibronectins,D12.776.395.550.350
23710620,2013-05-26T00:00:00,Fibronectins,D12.776.543.550.350
23710620,2013-05-26T00:00:00,Fibronectins,D12.776.860.300.450
23710620,2013-05-26T00:00:00,Liver,A03.620
23710620,2013-05-26T00:00:00,Lymphocyte Subsets,A11.118.637.555.567.550
23710620,2013-05-26T00:00:00,Lymphocyte Subsets,A15.145.229.637.555.567.550
23710620,2013-05-26T00:00:00,Lymphocyte Subsets,A15.382.490.555.567.550
23710620,2013-05-26T00:00:00,Macrophages,A11.329.372
23710620,2013-05-26T00:00:00,Macrophages,A11.627.482
23710620,2013-05-26T00:00:00,Macrophages,A11.733.397
23710620,2013-05-26T00:00:00,Macrophages,A15.382.680.397
23710620,2013-05-26T00:00:00,Macrophages,A15.382.812.522
23710620,2013-05-26T00:00:00,"RNA, Messenger",D13.444.735.544
23711965,2013-05-26T00:00:00,Arsenic Poisoning,C10.720.475.150
23711965,2013-05-26T00:00:00,Arsenic Poisoning,C21.613.097
23711965,2013-05-26T00:00:00,Environmental Exposure,N06.850.460.350
23711965,2013-05-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23711965,2013-05-26T00:00:00,Neoplasms,C04
23711965,2013-05-26T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23722075,2013-05-27T00:00:00,Adult,M01.060.116
23722075,2013-05-27T00:00:00,Aged,M01.060.116.100
23722075,2013-05-27T00:00:00,Early Detection of Cancer,E01.390.500
23722075,2013-05-27T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23722075,2013-05-27T00:00:00,Genetic Predisposition to Disease,G05.380.355
23722075,2013-05-27T00:00:00,Health Behavior,F01.145.488
23722075,2013-05-27T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23722075,2013-05-27T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23722075,2013-05-27T00:00:00,Health Services Accessibility,N04.590.374.350
23722075,2013-05-27T00:00:00,Health Services Accessibility,N05.300.430
23722075,2013-05-27T00:00:00,Health Surveys,E05.318.308.250
23722075,2013-05-27T00:00:00,Health Surveys,N05.715.360.300.375
23722075,2013-05-27T00:00:00,Health Surveys,N06.850.520.308.250
23722075,2013-05-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23722075,2013-05-27T00:00:00,Middle Aged,M01.060.116.630
23722075,2013-05-27T00:00:00,Population Surveillance,E05.318.308.250.700
23722075,2013-05-27T00:00:00,Population Surveillance,N05.715.360.300.375.625
23722075,2013-05-27T00:00:00,Population Surveillance,N06.850.520.308.250.700
23722075,2013-05-27T00:00:00,Population Surveillance,N06.850.780.675
23722075,2013-05-27T00:00:00,South Carolina,Z01.107.567.875.075.662
23722075,2013-05-27T00:00:00,South Carolina,Z01.107.567.875.750.700
23722075,2013-05-27T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
23722075,2013-05-27T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
23722075,2013-05-27T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
23722075,2013-05-27T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
23722075,2013-05-27T00:00:00,Vaginal Smears,E01.370.378.900
23722075,2013-05-27T00:00:00,Vaginal Smears,E01.450.230.900
23722075,2013-05-27T00:00:00,Vaginal Smears,E01.450.865.900
23714399,2013-05-28T00:00:00,Adolescent,M01.060.057
23714399,2013-05-28T00:00:00,Adult,M01.060.116
23714399,2013-05-28T00:00:00,Aged,M01.060.116.100
23714399,2013-05-28T00:00:00,Antineoplastic Agents,D27.505.954.248
23714399,2013-05-28T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
23714399,2013-05-28T00:00:00,Glomerular Filtration Rate,G08.852.357
23714399,2013-05-28T00:00:00,Graft Rejection,G12.425.901.545.328
23714399,2013-05-28T00:00:00,Graft Survival,G12.425.901.545.340
23714399,2013-05-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23714399,2013-05-28T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23714399,2013-05-28T00:00:00,Incidence,E05.318.308.985.525.375
23714399,2013-05-28T00:00:00,Incidence,L01.280.975.525.375
23714399,2013-05-28T00:00:00,Incidence,N01.224.935.597.500
23714399,2013-05-28T00:00:00,Incidence,N06.850.505.400.975.525.375
23714399,2013-05-28T00:00:00,Incidence,N06.850.520.308.985.525.375
23714399,2013-05-28T00:00:00,Kidney,A05.810.453
23714399,2013-05-28T00:00:00,Liver Transplantation,E04.210.650
23714399,2013-05-28T00:00:00,Liver Transplantation,E04.936.450.490
23714399,2013-05-28T00:00:00,Liver Transplantation,E04.936.580.490
23714399,2013-05-28T00:00:00,Middle Aged,M01.060.116.630
23714399,2013-05-28T00:00:00,North America,Z01.107.567
23714399,2013-05-28T00:00:00,Treatment Outcome,E01.789.800
23714399,2013-05-28T00:00:00,Treatment Outcome,N04.761.559.590.800
23714399,2013-05-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23714399,2013-05-28T00:00:00,Young Adult,M01.060.116.815
23716130,2013-05-29T00:00:00,Animals,B01.050
23716130,2013-05-29T00:00:00,Biological Markers,D23.101
23716130,2013-05-29T00:00:00,Fibrosis,C23.550.355
23716130,2013-05-29T00:00:00,Heart Failure,C14.280.434
23716130,2013-05-29T00:00:00,Hemodynamics,G09.330.190.400
23716130,2013-05-29T00:00:00,Hemodynamics,G09.330.380
23716130,2013-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23716130,2013-05-29T00:00:00,Myocardium,A02.633.580
23716130,2013-05-29T00:00:00,Myocardium,A07.541.704
23716130,2013-05-29T00:00:00,Myocardium,A10.690.552.750
23716130,2013-05-29T00:00:00,Stroke Volume,E01.370.370.380.150.700
23716130,2013-05-29T00:00:00,Stroke Volume,G09.330.380.124.882
23716130,2013-05-29T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
23716130,2013-05-29T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
23719932,2013-05-29T00:00:00,Adenocarcinoma,C04.557.470.200.025
23719932,2013-05-29T00:00:00,Adult,M01.060.116
23719932,2013-05-29T00:00:00,Aged,M01.060.116.100
23719932,2013-05-29T00:00:00,"Carcinoma, Signet Ring Cell",C04.557.470.200.025.415
23719932,2013-05-29T00:00:00,"Carcinoma, Signet Ring Cell",C04.557.470.590.415
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C04.588.443.353
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C06.301.371.205
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C06.405.117.430
23719932,2013-05-29T00:00:00,Esophageal Neoplasms,C06.405.249.205
23719932,2013-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23719932,2013-05-29T00:00:00,Middle Aged,M01.060.116.630
23719932,2013-05-29T00:00:00,United States,Z01.107.567.875
23720394,2013-05-29T00:00:00,Adult,M01.060.116
23720394,2013-05-29T00:00:00,Blood Transfusion,E02.095.135
23720394,2013-05-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23720394,2013-05-29T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
23720394,2013-05-29T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
23720394,2013-05-29T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
23720394,2013-05-29T00:00:00,Iron,D01.268.556.412
23720394,2013-05-29T00:00:00,Iron,D01.268.956.287
23720394,2013-05-29T00:00:00,Iron,D01.552.544.412
23720394,2013-05-29T00:00:00,Iron Overload,C18.452.565.500
23720394,2013-05-29T00:00:00,Liver,A03.620
23720394,2013-05-29T00:00:00,Liver Diseases,C06.552
23720394,2013-05-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23720394,2013-05-29T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23720394,2013-05-29T00:00:00,Middle Aged,M01.060.116.630
23720394,2013-05-29T00:00:00,Sensitivity and Specificity,E05.318.740.872
23720394,2013-05-29T00:00:00,Sensitivity and Specificity,E05.318.780.800
23720394,2013-05-29T00:00:00,Sensitivity and Specificity,G17.800
23720394,2013-05-29T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23720394,2013-05-29T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23720394,2013-05-29T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23720394,2013-05-29T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23734084,2013-05-29T00:00:00,Animals,B01.050
23734084,2013-05-29T00:00:00,Cone Opsins,D12.776.306.466.249
23734084,2013-05-29T00:00:00,Cone Opsins,D23.767.930.750.249
23734084,2013-05-29T00:00:00,"Models, Biological",E05.599.395
23734084,2013-05-29T00:00:00,Molecular Weight,G02.842.580
23734084,2013-05-29T00:00:00,Phenotype,G05.695
23734084,2013-05-29T00:00:00,Protein Transport,G03.495.166.700
23734084,2013-05-29T00:00:00,Retina,A09.371.729
23734084,2013-05-29T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23734084,2013-05-29T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23734084,2013-05-29T00:00:00,Retinaldehyde,D02.047.850
23734084,2013-05-29T00:00:00,Retinaldehyde,D02.455.326.271.665.202.495.690
23734084,2013-05-29T00:00:00,Retinaldehyde,D02.455.426.392.368.367.379.249.700.690
23734084,2013-05-29T00:00:00,Retinaldehyde,D02.455.849.131.495.690
23734084,2013-05-29T00:00:00,Retinaldehyde,D23.767.261.700.690
23734084,2013-05-29T00:00:00,Rhodopsin,D12.776.543.750.100.955
23734084,2013-05-29T00:00:00,Rhodopsin,D23.767.930.750.500.500
23721520,2013-05-31T00:00:00,Chronic Disease,C23.550.291.500
23721520,2013-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23721520,2013-05-31T00:00:00,Patient Education as Topic,I02.233.332.500
23721520,2013-05-31T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
23721520,2013-05-31T00:00:00,Patient Education as Topic,N02.421.726.407.680
23721520,2013-05-31T00:00:00,Risk Assessment,E05.318.740.600.800.715
23721520,2013-05-31T00:00:00,Risk Assessment,N04.452.871.715
23721520,2013-05-31T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23721520,2013-05-31T00:00:00,Risk Assessment,N06.850.505.715
23721520,2013-05-31T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23721520,2013-05-31T00:00:00,Risk Factors,E05.318.740.600.800.725
23721520,2013-05-31T00:00:00,Risk Factors,N05.715.350.200.700
23721520,2013-05-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23721520,2013-05-31T00:00:00,Risk Factors,N06.850.490.625.750
23721520,2013-05-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23721520,2013-05-31T00:00:00,Secondary Prevention,N02.421.726.825
23721520,2013-05-31T00:00:00,Secondary Prevention,N06.850.780.750
23721520,2013-05-31T00:00:00,Self Care,E02.900
23721520,2013-05-31T00:00:00,Self Care,N02.421.784.680
23721520,2013-05-31T00:00:00,Stroke,C10.228.140.300.775
23721520,2013-05-31T00:00:00,Stroke,C14.907.253.855
23722357,2013-05-31T00:00:00,Aged,M01.060.116.100
23722357,2013-05-31T00:00:00,Atrial Fibrillation,C14.280.067.198
23722357,2013-05-31T00:00:00,Atrial Fibrillation,C23.550.073.198
23722357,2013-05-31T00:00:00,Biological Markers,D23.101
23722357,2013-05-31T00:00:00,C-Reactive Protein,D12.776.034.145
23722357,2013-05-31T00:00:00,C-Reactive Protein,D12.776.124.050.120
23722357,2013-05-31T00:00:00,C-Reactive Protein,D12.776.124.486.157
23722357,2013-05-31T00:00:00,Electric Countershock,E02.342.287
23722357,2013-05-31T00:00:00,Fibrosis,C23.550.355
23722357,2013-05-31T00:00:00,Heart Atria,A07.541.358
23722357,2013-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23722357,2013-05-31T00:00:00,Matrix Metalloproteinases,D08.811.277.656.300.480.525
23722357,2013-05-31T00:00:00,Matrix Metalloproteinases,D08.811.277.656.675.374.525
23722357,2013-05-31T00:00:00,Middle Aged,M01.060.116.630
23722357,2013-05-31T00:00:00,Peptide Fragments,D12.644.541
23722357,2013-05-31T00:00:00,Risk Factors,E05.318.740.600.800.725
23722357,2013-05-31T00:00:00,Risk Factors,N05.715.350.200.700
23722357,2013-05-31T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23722357,2013-05-31T00:00:00,Risk Factors,N06.850.490.625.750
23722357,2013-05-31T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23722357,2013-05-31T00:00:00,Tissue Inhibitor of Metalloproteinases,D12.776.926
23722357,2013-05-31T00:00:00,Treatment Outcome,E01.789.800
23722357,2013-05-31T00:00:00,Treatment Outcome,N04.761.559.590.800
23722357,2013-05-31T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23725028,2013-05-31T00:00:00,Adult,M01.060.116
23725028,2013-05-31T00:00:00,Age Factors,N05.715.350.075
23725028,2013-05-31T00:00:00,Age Factors,N06.850.490.250
23725028,2013-05-31T00:00:00,Aged,M01.060.116.100
23725028,2013-05-31T00:00:00,Chronic Periodontitis,C07.465.714.533.324
23725028,2013-05-31T00:00:00,Evidence-Based Dentistry,H02.163.232
23725028,2013-05-31T00:00:00,Evidence-Based Dentistry,H02.249.500
23725028,2013-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23725028,2013-05-31T00:00:00,Middle Aged,M01.060.116.630
23725028,2013-05-31T00:00:00,Molar,A14.549.167.860.525
23725028,2013-05-31T00:00:00,Periodontal Pocket,C07.465.714.533.750
23725028,2013-05-31T00:00:00,Smoking,F01.145.466.753
23725028,2013-05-31T00:00:00,Young Adult,M01.060.116.815
23729216,2013-05-31T00:00:00,Animals,B01.050
23729216,2013-05-31T00:00:00,Drug Delivery Systems,E02.319.300
23729216,2013-05-31T00:00:00,Endoscopy,E01.370.388.250
23729216,2013-05-31T00:00:00,Endoscopy,E04.800.250
23729216,2013-05-31T00:00:00,Evidence-Based Medicine,H02.249.750
23729216,2013-05-31T00:00:00,Evidence-Based Medicine,H02.403.200.400
23729216,2013-05-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23729216,2013-05-31T00:00:00,Nasal Cavity,A04.531.449
23729216,2013-05-31T00:00:00,Paranasal Sinuses,A04.531.621
23729216,2013-05-31T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23729216,2013-05-31T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23741359,2013-05-31T00:00:00,Animals,B01.050
23741359,2013-05-31T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
23741359,2013-05-31T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
23741359,2013-05-31T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
23741359,2013-05-31T00:00:00,Antigen-Antibody Complex,D23.050.101
23741359,2013-05-31T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
23741359,2013-05-31T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
23741359,2013-05-31T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
23741359,2013-05-31T00:00:00,Calcium,D01.268.552.100
23741359,2013-05-31T00:00:00,Calcium,D01.552.539.288
23741359,2013-05-31T00:00:00,Calcium,D23.119.100
23741359,2013-05-31T00:00:00,Complement System Proteins,D12.776.124.486.274
23741359,2013-05-31T00:00:00,Enzyme Inhibitors,D27.505.519.389
23741359,2013-05-31T00:00:00,Gene Expression,G05.355.310
23741359,2013-05-31T00:00:00,Kidney Glomerulus,A05.810.453.324.359
23741359,2013-05-31T00:00:00,Kidney Glomerulus,A05.810.453.736.520
23741359,2013-05-31T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
23741359,2013-05-31T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
23741359,2013-05-31T00:00:00,Lupus Nephritis,C17.300.480.680
23741359,2013-05-31T00:00:00,Lupus Nephritis,C20.111.590.560
23741359,2013-05-31T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.157.520.555
23741359,2013-05-31T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.199.520.520.555
23741359,2013-05-31T00:00:00,"Mice, Inbred MRL lpr",B01.050.150.900.649.865.635.505.500.400.555
23741359,2013-05-31T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23741359,2013-05-31T00:00:00,Mitochondria,A11.284.835.626
23741359,2013-05-31T00:00:00,Nitric Oxide,D01.339.387
23741359,2013-05-31T00:00:00,Nitric Oxide,D01.625.550.500
23741359,2013-05-31T00:00:00,Nitric Oxide,D01.625.700.500
23741359,2013-05-31T00:00:00,Nitric Oxide,D01.650.550.587.600
23741359,2013-05-31T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
23741359,2013-05-31T00:00:00,Proteinuria,C12.777.934.734
23741359,2013-05-31T00:00:00,Proteinuria,C13.351.968.934.734
23741359,2013-05-31T00:00:00,Proteinuria,C23.888.942.750
23741359,2013-05-31T00:00:00,Reactive Oxygen Species,D01.339.431
23741359,2013-05-31T00:00:00,Reactive Oxygen Species,D01.650.775
22752411,2013-06-01T00:00:00,Adult,M01.060.116
22752411,2013-06-01T00:00:00,African Americans,M01.686.508.100.100
22752411,2013-06-01T00:00:00,African Americans,M01.686.754.100
22752411,2013-06-01T00:00:00,Curriculum,I02.158
22752411,2013-06-01T00:00:00,Disaster Planning,N06.230.100.035
22752411,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22752411,2013-06-01T00:00:00,Mental Health Services,F04.408
22752411,2013-06-01T00:00:00,Mental Health Services,N02.421.461
22752411,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
22752411,2013-06-01T00:00:00,North Carolina,Z01.107.567.875.075.475
22752411,2013-06-01T00:00:00,North Carolina,Z01.107.567.875.750.530
23011459,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23011459,2013-06-01T00:00:00,Suicide,F01.145.126.980.875
23011459,2013-06-01T00:00:00,Suicide,I01.880.735.856
23011459,2013-06-01T00:00:00,United States,Z01.107.567.875
23011459,2013-06-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
23011459,2013-06-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
23011459,2013-06-01T00:00:00,Veterans,M01.930
23288037,2013-06-01T00:00:00,Glucose,D09.546.359.448
23288037,2013-06-01T00:00:00,Heart Failure,C14.280.434
23288037,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23288037,2013-06-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
23288037,2013-06-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
23288037,2013-06-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
23288037,2013-06-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
23288037,2013-06-01T00:00:00,Pleural Effusion,C08.528.652
23288037,2013-06-01T00:00:00,Proteins,D12.776
23436272,2013-06-01T00:00:00,Adolescent,M01.060.057
23436272,2013-06-01T00:00:00,African Americans,M01.686.508.100.100
23436272,2013-06-01T00:00:00,African Americans,M01.686.754.100
23436272,2013-06-01T00:00:00,Alleles,G05.360.340.024.340.030
23436272,2013-06-01T00:00:00,Blood Pressure,E01.370.600.875.249
23436272,2013-06-01T00:00:00,Blood Pressure,G09.330.380.076
23436272,2013-06-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.370.140.100
23436272,2013-06-01T00:00:00,"Blood Pressure Monitoring, Ambulatory",E01.370.520.500.100
23436272,2013-06-01T00:00:00,Circadian Rhythm,G07.180.562.190
23436272,2013-06-01T00:00:00,Discrimination (Psychology),F02.463.593.257
23436272,2013-06-01T00:00:00,Endothelin-1,D12.644.276.400.225
23436272,2013-06-01T00:00:00,Endothelin-1,D12.776.467.400.225
23436272,2013-06-01T00:00:00,Endothelin-1,D23.529.400.225
23436272,2013-06-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23436272,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23436272,2013-06-01T00:00:00,Hypertension,C14.907.489
23436272,2013-06-01T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23436272,2013-06-01T00:00:00,Young Adult,M01.060.116.815
23449288,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23449288,2013-06-01T00:00:00,Quality of Life,I01.800
23449288,2013-06-01T00:00:00,Quality of Life,K01.752.400.750
23463423,2013-06-01T00:00:00,Adult,M01.060.116
23463423,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23463423,2013-06-01T00:00:00,Subarachnoid Hemorrhage,C10.228.140.300.535.800
23463423,2013-06-01T00:00:00,Subarachnoid Hemorrhage,C14.907.253.573.800
23463423,2013-06-01T00:00:00,Subarachnoid Hemorrhage,C23.550.414.913.850
23463423,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23463423,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23463423,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23463423,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23463423,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23495171,2013-06-01T00:00:00,Animals,B01.050
23495171,2013-06-01T00:00:00,Cell Proliferation,G04.299.233.750
23495171,2013-06-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23495171,2013-06-01T00:00:00,Cell Survival,G04.299.316
23495171,2013-06-01T00:00:00,Cytokines,D12.644.276.374
23495171,2013-06-01T00:00:00,Cytokines,D12.776.467.374
23495171,2013-06-01T00:00:00,Cytokines,D23.529.374
23495171,2013-06-01T00:00:00,Hematopoietic Stem Cells,A11.148.378
23495171,2013-06-01T00:00:00,Hematopoietic Stem Cells,A11.872.378
23495171,2013-06-01T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
23495171,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23495171,2013-06-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23495171,2013-06-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23495171,2013-06-01T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23495171,2013-06-01T00:00:00,Proto-Oncogene Proteins c-pim-1,D08.811.913.696.620.682.700.776
23495171,2013-06-01T00:00:00,Proto-Oncogene Proteins c-pim-1,D12.776.624.664.700.191
23564430,2013-06-01T00:00:00,Adult,M01.060.116
23564430,2013-06-01T00:00:00,African Americans,M01.686.508.100.100
23564430,2013-06-01T00:00:00,African Americans,M01.686.754.100
23564430,2013-06-01T00:00:00,Aged,M01.060.116.100
23564430,2013-06-01T00:00:00,Awareness,F02.463.188.150
23564430,2013-06-01T00:00:00,Guideline Adherence,N04.761.337
23564430,2013-06-01T00:00:00,Guideline Adherence,N05.715.360.395
23564430,2013-06-01T00:00:00,HIV Seropositivity,C02.782.815.616.400.500
23564430,2013-06-01T00:00:00,HIV Seropositivity,C02.800.801.400.500
23564430,2013-06-01T00:00:00,HIV Seropositivity,C20.673.480.500
23564430,2013-06-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23564430,2013-06-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23564430,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23564430,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23564430,2013-06-01T00:00:00,Papillomavirus Infections,C02.256.650
23564430,2013-06-01T00:00:00,Papillomavirus Infections,C02.928.725
23564430,2013-06-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
23564430,2013-06-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
23564430,2013-06-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
23564430,2013-06-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
23564430,2013-06-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
23564430,2013-06-01T00:00:00,Vaginal Smears,E01.370.378.900
23564430,2013-06-01T00:00:00,Vaginal Smears,E01.450.230.900
23564430,2013-06-01T00:00:00,Vaginal Smears,E01.450.865.900
23564430,2013-06-01T00:00:00,Young Adult,M01.060.116.815
23589182,2013-06-01T00:00:00,Cerebellum,A08.186.211.132.810.428.200
23589182,2013-06-01T00:00:00,Cerebellum,A08.186.211.865.428.200
23589182,2013-06-01T00:00:00,"Child, Preschool",M01.060.406.448
23589182,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23589182,2013-06-01T00:00:00,Intracranial Hypertension,C10.228.140.631
23589182,2013-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23589182,2013-06-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23589182,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23589182,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23589182,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23589182,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23589182,2013-06-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23640069,2013-06-01T00:00:00,Antineoplastic Agents,D27.505.954.248
23640069,2013-06-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23640069,2013-06-01T00:00:00,Clinical Trials as Topic,E05.337.250
23640069,2013-06-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23640069,2013-06-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23640069,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23640069,2013-06-01T00:00:00,"Leukemia, Myeloid, Acute",C04.557.337.539.550
23640069,2013-06-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23673393,2013-06-01T00:00:00,Adolescent,M01.060.057
23673393,2013-06-01T00:00:00,Adult,M01.060.116
23673393,2013-06-01T00:00:00,Breast Neoplasms,C04.588.180
23673393,2013-06-01T00:00:00,Breast Neoplasms,C17.800.090.500
23673393,2013-06-01T00:00:00,Guideline Adherence,N04.761.337
23673393,2013-06-01T00:00:00,Guideline Adherence,N05.715.360.395
23673393,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23673393,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23673393,2013-06-01T00:00:00,North Carolina,Z01.107.567.875.075.475
23673393,2013-06-01T00:00:00,North Carolina,Z01.107.567.875.750.530
23673393,2013-06-01T00:00:00,Patient-Centered Care,N04.590.233.675
23673393,2013-06-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
23673393,2013-06-01T00:00:00,Patient-Centered Care,N04.590.720
23673393,2013-06-01T00:00:00,United States,Z01.107.567.875
23673685,2013-06-01T00:00:00,Adult,M01.060.116
23673685,2013-06-01T00:00:00,Device Removal,E04.199
23673685,2013-06-01T00:00:00,Gastroplasty,E02.065.062.750
23673685,2013-06-01T00:00:00,Gastroplasty,E04.062.750
23673685,2013-06-01T00:00:00,Gastroplasty,E04.210.485
23673685,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23673685,2013-06-01T00:00:00,Incidence,E05.318.308.985.525.375
23673685,2013-06-01T00:00:00,Incidence,L01.280.975.525.375
23673685,2013-06-01T00:00:00,Incidence,N01.224.935.597.500
23673685,2013-06-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23673685,2013-06-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23673685,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23673685,2013-06-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
23673685,2013-06-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
23673685,2013-06-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
23673685,2013-06-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
23673685,2013-06-01T00:00:00,Postoperative Complications,C23.550.767
23673685,2013-06-01T00:00:00,Prevalence,E05.318.308.985.525.750
23673685,2013-06-01T00:00:00,Prevalence,L01.280.975.525.750
23673685,2013-06-01T00:00:00,Prevalence,N01.224.935.597.750
23673685,2013-06-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
23673685,2013-06-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
23673685,2013-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23673685,2013-06-01T00:00:00,Risk Factors,N05.715.350.200.700
23673685,2013-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23673685,2013-06-01T00:00:00,Risk Factors,N06.850.490.625.750
23673685,2013-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23673685,2013-06-01T00:00:00,Weight Loss,C23.888.144.243.963
23673685,2013-06-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23677878,2013-06-01T00:00:00,Animals,B01.050
23677878,2013-06-01T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
23677878,2013-06-01T00:00:00,"Gene Expression Regulation, Developmental",G05.355.315.310
23677878,2013-06-01T00:00:00,"Genes, Homeobox",G05.360.340.024.340.230.500
23677878,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23677878,2013-06-01T00:00:00,NF-kappa B,D12.776.260.600
23677878,2013-06-01T00:00:00,NF-kappa B,D12.776.660.600
23677878,2013-06-01T00:00:00,NF-kappa B,D12.776.930.600
23677878,2013-06-01T00:00:00,Phenotype,G05.695
23680774,2013-06-01T00:00:00,Animals,B01.050
23680774,2013-06-01T00:00:00,Liver,A03.620
23680774,2013-06-01T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
23680774,2013-06-01T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
23680774,2013-06-01T00:00:00,Reperfusion Injury,C14.907.725
23680774,2013-06-01T00:00:00,Reperfusion Injury,C23.550.767.877
23687070,2013-06-01T00:00:00,Alkynes,D02.455.326.397
23687070,2013-06-01T00:00:00,Azides,D01.625.100
23687070,2013-06-01T00:00:00,Azides,D02.159
23687070,2013-06-01T00:00:00,Carbohydrates,D09
23687070,2013-06-01T00:00:00,"Chromatography, High Pressure Liquid",E05.196.181.400.300
23687070,2013-06-01T00:00:00,Glycoproteins,D09.400.430
23687070,2013-06-01T00:00:00,Glycoproteins,D12.776.395
23687070,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23687070,2013-06-01T00:00:00,Stromal Cells,A11.329.830
23687070,2013-06-01T00:00:00,Tandem Mass Spectrometry,E05.196.566.880
23694883,2013-06-01T00:00:00,Adolescent,M01.060.057
23694883,2013-06-01T00:00:00,Adult,M01.060.116
23694883,2013-06-01T00:00:00,Aged,M01.060.116.100
23694883,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23694883,2013-06-01T00:00:00,Intensive Care Units,N02.278.388.493
23694883,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23694883,2013-06-01T00:00:00,Patient Discharge,E02.760.400.610
23694883,2013-06-01T00:00:00,Patient Discharge,N02.421.585.400.610
23694883,2013-06-01T00:00:00,Patient Readmission,E02.760.400.620
23694883,2013-06-01T00:00:00,Patient Readmission,N02.421.585.400.620
23694883,2013-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23694883,2013-06-01T00:00:00,Risk Factors,N05.715.350.200.700
23694883,2013-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23694883,2013-06-01T00:00:00,Risk Factors,N06.850.490.625.750
23694883,2013-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23694883,2013-06-01T00:00:00,Sex Factors,N05.715.350.675
23694883,2013-06-01T00:00:00,Sex Factors,N06.850.490.875
23694883,2013-06-01T00:00:00,Wounds and Injuries,C21.866
23694883,2013-06-01T00:00:00,Young Adult,M01.060.116.815
23706430,2013-06-01T00:00:00,Adult,M01.060.116
23706430,2013-06-01T00:00:00,"Anastomosis, Surgical",E04.035
23706430,2013-06-01T00:00:00,Clinical Competence,I02.399.630.210
23706430,2013-06-01T00:00:00,Clinical Competence,N04.761.210
23706430,2013-06-01T00:00:00,Computer Simulation,L01.224.160
23706430,2013-06-01T00:00:00,Coronary Vessels,A07.231.114.269
23706430,2013-06-01T00:00:00,Coronary Vessels,A07.231.908.194
23706430,2013-06-01T00:00:00,"Education, Medical, Graduate",I02.358.337.350
23706430,2013-06-01T00:00:00,"Education, Medical, Graduate",I02.358.399.350
23706430,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23706430,2013-06-01T00:00:00,Internship and Residency,I02.358.399.644
23706430,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23706430,2013-06-01T00:00:00,Needs Assessment,I02.594
23706430,2013-06-01T00:00:00,Needs Assessment,N03.349.380.565
23706430,2013-06-01T00:00:00,Needs Assessment,N05.300.537
23706430,2013-06-01T00:00:00,Questionnaires,E05.318.308.750
23706430,2013-06-01T00:00:00,Questionnaires,L01.280.800
23706430,2013-06-01T00:00:00,Questionnaires,N05.715.360.300.695
23706430,2013-06-01T00:00:00,Questionnaires,N06.850.520.308.750
23706430,2013-06-01T00:00:00,"Societies, Medical",N03.540.828.589
23706430,2013-06-01T00:00:00,Thoracic Surgical Procedures,E04.928
23706430,2013-06-01T00:00:00,United States,Z01.107.567.875
23706430,2013-06-01T00:00:00,Video Recording,L01.240.960
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase III as Topic",E05.318.760.535.220
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase III as Topic",E05.337.250.220
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase III as Topic",N05.715.360.775.235.220
23709704,2013-06-01T00:00:00,"Clinical Trials, Phase III as Topic",N06.850.520.450.535.220
23709704,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23709704,2013-06-01T00:00:00,Research Design,E05.581.500
23709704,2013-06-01T00:00:00,Research Design,H01.770.644.728
23709704,2013-06-01T00:00:00,Stroke,C10.228.140.300.775
23709704,2013-06-01T00:00:00,Stroke,C14.907.253.855
23709704,2013-06-01T00:00:00,Treatment Outcome,E01.789.800
23709704,2013-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23709704,2013-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23709726,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23709726,2013-06-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
23709726,2013-06-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
23709726,2013-06-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
23709726,2013-06-01T00:00:00,Neurosurgical Procedures,E04.525
23709726,2013-06-01T00:00:00,Research Design,E05.581.500
23709726,2013-06-01T00:00:00,Research Design,H01.770.644.728
23709726,2013-06-01T00:00:00,Secondary Prevention,N02.421.726.825
23709726,2013-06-01T00:00:00,Secondary Prevention,N06.850.780.750
23709726,2013-06-01T00:00:00,Stents,E07.695.750
23709726,2013-06-01T00:00:00,Stroke,C10.228.140.300.775
23709726,2013-06-01T00:00:00,Stroke,C14.907.253.855
23709726,2013-06-01T00:00:00,Treatment Outcome,E01.789.800
23709726,2013-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23709726,2013-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23709726,2013-06-01T00:00:00,Vascular Surgical Procedures,E04.100.814
23728920,2013-06-01T00:00:00,Adolescent,M01.060.057
23728920,2013-06-01T00:00:00,Adult,M01.060.116
23728920,2013-06-01T00:00:00,Aged,M01.060.116.100
23728920,2013-06-01T00:00:00,Child,M01.060.406
23728920,2013-06-01T00:00:00,Head and Neck Neoplasms,C04.588.443
23728920,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23728920,2013-06-01T00:00:00,Middle Aged,M01.060.116.630
23728920,2013-06-01T00:00:00,"Radiotherapy, Adjuvant",E02.186.775
23728920,2013-06-01T00:00:00,"Radiotherapy, Adjuvant",E02.815.600
23728920,2013-06-01T00:00:00,Young Adult,M01.060.116.815
23736180,2013-06-01T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
23736180,2013-06-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23736180,2013-06-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23736180,2013-06-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23736180,2013-06-01T00:00:00,Hospitalization,E02.760.400
23736180,2013-06-01T00:00:00,Hospitalization,N02.421.585.400
23736180,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23736180,2013-06-01T00:00:00,Information Dissemination,F01.145.209.364
23736180,2013-06-01T00:00:00,Information Dissemination,L01.143.443
23736180,2013-06-01T00:00:00,United States,Z01.107.567.875
23736180,2013-06-01T00:00:00,Unnecessary Procedures,N02.421.380.900
23736180,2013-06-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
23738699,2013-06-01T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
23738699,2013-06-01T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
23738699,2013-06-01T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
23738699,2013-06-01T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
23738699,2013-06-01T00:00:00,Cell Survival,G04.299.316
23738699,2013-06-01T00:00:00,Hot Temperature,G01.906.595.543
23738699,2013-06-01T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
23738699,2013-06-01T00:00:00,Hot Temperature,G16.500.750.775.710.380
23738699,2013-06-01T00:00:00,Hot Temperature,N06.230.300.100.725.232
23738699,2013-06-01T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
23738699,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23738699,2013-06-01T00:00:00,"Hyperthermia, Induced",E02.565
23738699,2013-06-01T00:00:00,"Hyperthermia, Induced",E02.779.496
23738699,2013-06-01T00:00:00,Liver Neoplasms,C04.588.274.623
23738699,2013-06-01T00:00:00,Liver Neoplasms,C06.301.623
23738699,2013-06-01T00:00:00,Liver Neoplasms,C06.552.697
23738699,2013-06-01T00:00:00,"Models, Biological",E05.599.395
23805571,2013-06-01T00:00:00,Animals,B01.050
23805571,2013-06-01T00:00:00,Vitamin D,D04.808.812.768
23839176,2013-06-01T00:00:00,Adolescent,M01.060.057
23839176,2013-06-01T00:00:00,Adult,M01.060.116
23839176,2013-06-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23839176,2013-06-01T00:00:00,Child,M01.060.406
23839176,2013-06-01T00:00:00,Dermatologic Agents,D27.505.954.444
23839176,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23839176,2013-06-01T00:00:00,Inflammation,C23.550.470
23839176,2013-06-01T00:00:00,Treatment Outcome,E01.789.800
23839176,2013-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23839176,2013-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23839176,2013-06-01T00:00:00,Young Adult,M01.060.116.815
23845640,2013-06-01T00:00:00,Adolescent,M01.060.057
23845640,2013-06-01T00:00:00,Age Factors,N05.715.350.075
23845640,2013-06-01T00:00:00,Age Factors,N06.850.490.250
23845640,2013-06-01T00:00:00,"Catheterization, Central Venous",E02.148.167
23845640,2013-06-01T00:00:00,Child,M01.060.406
23845640,2013-06-01T00:00:00,Combined Modality Therapy,E02.186
23845640,2013-06-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23845640,2013-06-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23845640,2013-06-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23845640,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23845640,2013-06-01T00:00:00,Incidence,E05.318.308.985.525.375
23845640,2013-06-01T00:00:00,Incidence,L01.280.975.525.375
23845640,2013-06-01T00:00:00,Incidence,N01.224.935.597.500
23845640,2013-06-01T00:00:00,Incidence,N06.850.505.400.975.525.375
23845640,2013-06-01T00:00:00,Incidence,N06.850.520.308.985.525.375
23845640,2013-06-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23845640,2013-06-01T00:00:00,Risk Factors,N05.715.350.200.700
23845640,2013-06-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23845640,2013-06-01T00:00:00,Risk Factors,N06.850.490.625.750
23845640,2013-06-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23845640,2013-06-01T00:00:00,Treatment Outcome,E01.789.800
23845640,2013-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23845640,2013-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23845640,2013-06-01T00:00:00,Venous Thromboembolism,C14.907.355.590.700
23845640,2013-06-01T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
23845640,2013-06-01T00:00:00,Wounds and Injuries,C21.866
23845645,2013-06-01T00:00:00,Adolescent,M01.060.057
23845645,2013-06-01T00:00:00,Cardiopulmonary Bypass,E04.292.413
23845645,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23845645,2013-06-01T00:00:00,Liver,A03.620
23845645,2013-06-01T00:00:00,Multiple Trauma,C21.866.640
23845645,2013-06-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
23930384,2013-06-01T00:00:00,Adolescent,M01.060.057
23930384,2013-06-01T00:00:00,Equipment Failure Analysis,E05.325.192
23930384,2013-06-01T00:00:00,Extracorporeal Circulation,E04.292
23930384,2013-06-01T00:00:00,Heart Transplantation,E04.100.376.475
23930384,2013-06-01T00:00:00,Heart Transplantation,E04.928.220.390
23930384,2013-06-01T00:00:00,Heart Transplantation,E04.936.450.475
23930384,2013-06-01T00:00:00,Heart-Assist Devices,E04.050.430
23930384,2013-06-01T00:00:00,Heart-Assist Devices,E07.695.300.300
23930384,2013-06-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
23930384,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23930384,2013-06-01T00:00:00,Magnetics,H01.671.493
23930384,2013-06-01T00:00:00,Pediatrics,H02.403.670
23930384,2013-06-01T00:00:00,Treatment Outcome,E01.789.800
23930384,2013-06-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23930384,2013-06-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23930384,2013-06-01T00:00:00,"Ventricular Dysfunction, Right",C14.280.945.910
24015481,2013-06-01T00:00:00,Animals,B01.050
24015481,2013-06-01T00:00:00,Cartilage,A02.165
24015481,2013-06-01T00:00:00,Cartilage,A10.165.382
24015481,2013-06-01T00:00:00,Computer Simulation,L01.224.160
24015481,2013-06-01T00:00:00,Finite Element Analysis,E05.355
24015481,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24015481,2013-06-01T00:00:00,"Models, Biological",E05.599.395
24015481,2013-06-01T00:00:00,Regeneration,G16.100.856
24016180,2013-06-01T00:00:00,14-3-3 Proteins,D12.644.360.024.313
24016180,2013-06-01T00:00:00,14-3-3 Proteins,D12.776.157.057.126
24016180,2013-06-01T00:00:00,14-3-3 Proteins,D12.776.476.024.406
24016180,2013-06-01T00:00:00,Animals,B01.050
24016180,2013-06-01T00:00:00,Biological Markers,D23.101
24016180,2013-06-01T00:00:00,Central Nervous System Viral Diseases,C02.182
24016180,2013-06-01T00:00:00,Central Nervous System Viral Diseases,C10.228.228.210
24016180,2013-06-01T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
24016180,2013-06-01T00:00:00,Nerve Tissue Proteins,D12.776.641
24016180,2013-06-01T00:00:00,"RNA, Viral",D13.444.735.828
24016180,2013-06-01T00:00:00,Simian Acquired Immunodeficiency Syndrome,C02.782.815.616.850
24016180,2013-06-01T00:00:00,Simian Acquired Immunodeficiency Syndrome,C02.839.850
24016180,2013-06-01T00:00:00,Simian Acquired Immunodeficiency Syndrome,C22.735.500.850
24902392,2013-06-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
24902392,2013-06-01T00:00:00,Antibiotic Prophylaxis,E02.319.162.150
24902392,2013-06-01T00:00:00,Antibiotic Prophylaxis,E02.319.703.150
24902392,2013-06-01T00:00:00,"Drug Resistance, Microbial",G06.225
24902392,2013-06-01T00:00:00,"Drug Resistance, Microbial",G07.690.320.269
24902392,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24902395,2013-06-01T00:00:00,Disaster Planning,N06.230.100.035
24902395,2013-06-01T00:00:00,Emergency Medical Services,N02.421.297
24902395,2013-06-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24902395,2013-06-01T00:00:00,South Carolina,Z01.107.567.875.075.662
24902395,2013-06-01T00:00:00,South Carolina,Z01.107.567.875.750.700
24902395,2013-06-01T00:00:00,United States,Z01.107.567.875
23743354,2013-06-03T00:00:00,Animals,B01.050
23743354,2013-06-03T00:00:00,"Antigens, CD147",D12.776.395.550.045
23743354,2013-06-03T00:00:00,"Antigens, CD147",D12.776.543.550.188
23743354,2013-06-03T00:00:00,"Antigens, CD147",D23.050.285.040
23743354,2013-06-03T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
23743354,2013-06-03T00:00:00,"Antigens, CD147",D23.101.100.110.247
23743354,2013-06-03T00:00:00,Cell Movement,G04.299.283
23743354,2013-06-03T00:00:00,Cell Movement,G07.700.560.500.180
23743354,2013-06-03T00:00:00,Disease Progression,C23.550.291.656
23743354,2013-06-03T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
23743354,2013-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23743354,2013-06-03T00:00:00,Neoplasm Invasiveness,C04.697.645
23743354,2013-06-03T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23743354,2013-06-03T00:00:00,Signal Transduction,G02.111.087.800
23743354,2013-06-03T00:00:00,Signal Transduction,G02.149.115.800
23743354,2013-06-03T00:00:00,Signal Transduction,G04.299.880
23862054,2013-06-03T00:00:00,Adult,M01.060.116
23862054,2013-06-03T00:00:00,Body Image,F02.463.593.112
23862054,2013-06-03T00:00:00,Body Mass Index,E01.370.600.115.100.125
23862054,2013-06-03T00:00:00,Body Mass Index,E05.041.124.125
23862054,2013-06-03T00:00:00,Body Mass Index,G07.100.100.125
23862054,2013-06-03T00:00:00,Body Mass Index,N06.850.505.200.100.175
23862054,2013-06-03T00:00:00,Body Weight,C23.888.144
23862054,2013-06-03T00:00:00,Body Weight,E01.370.600.115.100.160.120
23862054,2013-06-03T00:00:00,Body Weight,E05.041.124.160.750
23862054,2013-06-03T00:00:00,Body Weight,G07.100.100.160.120
23862054,2013-06-03T00:00:00,Body Weight,G07.700.320.249.314.120
23862054,2013-06-03T00:00:00,Feeding Behavior,F01.145.113.547
23862054,2013-06-03T00:00:00,Feeding Behavior,F01.145.407
23862054,2013-06-03T00:00:00,Health Behavior,F01.145.488
23862054,2013-06-03T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23862054,2013-06-03T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23862054,2013-06-03T00:00:00,Health Status,I01.240.425
23862054,2013-06-03T00:00:00,Health Status,N01.224.425
23862054,2013-06-03T00:00:00,Health Status,N06.850.505.400.425
23862054,2013-06-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23862054,2013-06-03T00:00:00,Middle Aged,M01.060.116.630
23862054,2013-06-03T00:00:00,Obesity,C18.654.726.500
23862054,2013-06-03T00:00:00,Obesity,C23.888.144.699.500
23862054,2013-06-03T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23862054,2013-06-03T00:00:00,Obesity,G07.100.100.160.120.699.500
23733490,2013-06-04T00:00:00,Algorithms,G17.035
23733490,2013-06-04T00:00:00,Algorithms,L01.224.050
23733490,2013-06-04T00:00:00,Animals,B01.050
23733490,2013-06-04T00:00:00,Cattle,B01.050.150.900.649.077.380.271
23733490,2013-06-04T00:00:00,Mitochondrial Proteins,D12.776.575
23733490,2013-06-04T00:00:00,"Models, Molecular",E05.599.595
23733490,2013-06-04T00:00:00,Software,L01.224.900
23733490,2013-06-04T00:00:00,Static Electricity,G01.201.249.820
23733544,2013-06-04T00:00:00,Animals,B01.050
23733544,2013-06-04T00:00:00,Biological Markers,D23.101
23733544,2013-06-04T00:00:00,Genetic Testing,E01.370.427
23733544,2013-06-04T00:00:00,Genetic Testing,E05.393.435
23733544,2013-06-04T00:00:00,Genetic Testing,N02.421.143.827.233.221
23733544,2013-06-04T00:00:00,Genetic Testing,N02.421.308.430
23733544,2013-06-04T00:00:00,Heart Diseases,C14.280
23733544,2013-06-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23733544,2013-06-04T00:00:00,Mass Screening,E01.370.500
23733544,2013-06-04T00:00:00,Mass Screening,E05.318.308.250.580
23733544,2013-06-04T00:00:00,Mass Screening,N02.421.143.827.233.443
23733544,2013-06-04T00:00:00,Mass Screening,N02.421.726.233.443
23733544,2013-06-04T00:00:00,Mass Screening,N05.715.360.300.375.500
23733544,2013-06-04T00:00:00,Mass Screening,N06.850.520.308.250.580
23733544,2013-06-04T00:00:00,Mass Screening,N06.850.780.500
23736306,2013-06-05T00:00:00,Adolescent,M01.060.057
23736306,2013-06-05T00:00:00,Blood Glucose,D09.546.359.448.500
23736306,2013-06-05T00:00:00,Blood Pressure,E01.370.600.875.249
23736306,2013-06-05T00:00:00,Blood Pressure,G09.330.380.076
23736306,2013-06-05T00:00:00,Child,M01.060.406
23736306,2013-06-05T00:00:00,"Cholesterol, HDL",D10.532.432.400
23736306,2013-06-05T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
23736306,2013-06-05T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
23736306,2013-06-05T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23736306,2013-06-05T00:00:00,Genetic Predisposition to Disease,G05.380.355
23736306,2013-06-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23736306,2013-06-05T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23736306,2013-06-05T00:00:00,Metabolic Syndrome X,C18.452.625
23736306,2013-06-05T00:00:00,Mexican Americans,M01.686.754.441.500
23736306,2013-06-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23736306,2013-06-05T00:00:00,Risk Factors,N05.715.350.200.700
23736306,2013-06-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23736306,2013-06-05T00:00:00,Risk Factors,N06.850.490.625.750
23736306,2013-06-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23738693,2013-06-05T00:00:00,Arabidopsis,B01.650.388.100.157.100
23738693,2013-06-05T00:00:00,Gene Expression Profiling,E05.393.332
23738693,2013-06-05T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
23738693,2013-06-05T00:00:00,"Genes, Plant",G05.360.340.024.340.393
23738693,2013-06-05T00:00:00,"Genes, Plant",G05.360.340.365.500
23739791,2013-06-05T00:00:00,Animals,B01.050
23739791,2013-06-05T00:00:00,Cattle,B01.050.150.900.649.077.380.271
23739791,2013-06-05T00:00:00,Cattle Diseases,C22.196
23739791,2013-06-05T00:00:00,Testis,A05.360.444.849
23739791,2013-06-05T00:00:00,Testis,A05.360.576.782
23739791,2013-06-05T00:00:00,Testis,A06.407.312.782
23740184,2013-06-06T00:00:00,Aged,M01.060.116.100
23740184,2013-06-06T00:00:00,Animals,B01.050
23740184,2013-06-06T00:00:00,Artificial Intelligence,L01.224.065
23740184,2013-06-06T00:00:00,Auditory Threshold,F02.463.593.071.173
23740184,2013-06-06T00:00:00,Auditory Threshold,F02.463.593.710.190
23740184,2013-06-06T00:00:00,"Hearing Loss, Noise-Induced",C09.218.458.341.887.460
23740184,2013-06-06T00:00:00,"Hearing Loss, Noise-Induced",C10.597.751.418.341.887.460
23740184,2013-06-06T00:00:00,"Hearing Loss, Noise-Induced",C23.888.592.763.393.341.887.460
23740184,2013-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23740184,2013-06-06T00:00:00,Middle Aged,M01.060.116.630
23740184,2013-06-06T00:00:00,Phenotype,G05.695
23740184,2013-06-06T00:00:00,Presbycusis,C09.218.458.341.887.772
23740184,2013-06-06T00:00:00,Presbycusis,C10.597.751.418.341.887.772
23740184,2013-06-06T00:00:00,Presbycusis,C23.888.592.763.393.341.887.772
23740367,2013-06-06T00:00:00,Aged,M01.060.116.100
23740367,2013-06-06T00:00:00,Computer Simulation,L01.224.160
23740367,2013-06-06T00:00:00,Electromyography,E01.370.405.255
23740367,2013-06-06T00:00:00,Electromyography,E01.370.530.255
23740367,2013-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23740367,2013-06-06T00:00:00,Leg,A01.378.610.500
23740367,2013-06-06T00:00:00,"Models, Neurological",E05.599.395.642
23740367,2013-06-06T00:00:00,Muscle Contraction,G11.427.590.540
23740367,2013-06-06T00:00:00,"Muscle, Skeletal",A02.633.567
23740367,2013-06-06T00:00:00,"Muscle, Skeletal",A10.690.552.500
23740367,2013-06-06T00:00:00,Walking,G11.427.590.530.568.900
23740367,2013-06-06T00:00:00,Walking,G11.427.590.530.698.940
23740367,2013-06-06T00:00:00,Walking,I03.450.642.845.940
23746937,2013-06-06T00:00:00,Biocompatible Materials,D25.130
23746937,2013-06-06T00:00:00,Biocompatible Materials,D27.720.102.130
23746937,2013-06-06T00:00:00,Biocompatible Materials,J01.637.051.130
23746937,2013-06-06T00:00:00,Drug Delivery Systems,E02.319.300
23746937,2013-06-06T00:00:00,Extracellular Matrix,A11.284.295.310
23746937,2013-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23746937,2013-06-06T00:00:00,Myocardial Infarction,C14.280.647.500
23746937,2013-06-06T00:00:00,Myocardial Infarction,C14.907.585.500
23746937,2013-06-06T00:00:00,Ventricular Remodeling,C23.300.985
23746937,2013-06-06T00:00:00,Ventricular Remodeling,G09.330.190.962.975
23747986,2013-06-06T00:00:00,Adult,M01.060.116
23747986,2013-06-06T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23747986,2013-06-06T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23747986,2013-06-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23747986,2013-06-06T00:00:00,Informed Consent,I01.880.604.473.650.718
23747986,2013-06-06T00:00:00,Informed Consent,I01.880.604.583.427
23747986,2013-06-06T00:00:00,Informed Consent,N03.706.437.650.312
23747986,2013-06-06T00:00:00,Informed Consent,N03.706.535.489
23747986,2013-06-06T00:00:00,Middle Aged,M01.060.116.630
23747986,2013-06-06T00:00:00,Patient Preference,N04.452.822.360.600.500
23747986,2013-06-06T00:00:00,Patient Preference,N05.300.150.600.630.500
23747986,2013-06-06T00:00:00,Pilot Projects,E05.318.760.750
23747986,2013-06-06T00:00:00,Pilot Projects,E05.337.737
23747986,2013-06-06T00:00:00,Pilot Projects,N05.715.360.775.625
23747986,2013-06-06T00:00:00,Pilot Projects,N06.850.520.450.720
23747986,2013-06-06T00:00:00,Research Design,E05.581.500
23747986,2013-06-06T00:00:00,Research Design,H01.770.644.728
23747986,2013-06-06T00:00:00,Research Subjects,M01.774
23747986,2013-06-06T00:00:00,Videotape Recording,J01.897.280.500.846.734
23747986,2013-06-06T00:00:00,Videotape Recording,J01.897.280.500.898.840
23747986,2013-06-06T00:00:00,Videotape Recording,L01.178.590.875.840
23747986,2013-06-06T00:00:00,Videotape Recording,L01.178.820.090.846.734
23747986,2013-06-06T00:00:00,Videotape Recording,L01.178.820.090.898.840
23747986,2013-06-06T00:00:00,Videotape Recording,L01.240.940.840
23747986,2013-06-06T00:00:00,Videotape Recording,L01.240.960.880
23620303,2013-06-07T00:00:00,Toluene,D02.455.426.559.389.832
23742695,2013-06-07T00:00:00,Chronic Periodontitis,C07.465.714.533.324
23742695,2013-06-07T00:00:00,Gingival Recession,C07.465.714.258.447
23742695,2013-06-07T00:00:00,Gingival Recession,C07.465.714.354.625
23742695,2013-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23742695,2013-06-07T00:00:00,Lymphocytes,A11.118.637.555.567
23742695,2013-06-07T00:00:00,Lymphocytes,A15.145.229.637.555.567
23742695,2013-06-07T00:00:00,Lymphocytes,A15.382.490.555.567
23742695,2013-06-07T00:00:00,Macrophages,A11.329.372
23742695,2013-06-07T00:00:00,Macrophages,A11.627.482
23742695,2013-06-07T00:00:00,Macrophages,A11.733.397
23742695,2013-06-07T00:00:00,Macrophages,A15.382.680.397
23742695,2013-06-07T00:00:00,Macrophages,A15.382.812.522
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
23742695,2013-06-07T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
23742695,2013-06-07T00:00:00,Periodontal Pocket,C07.465.714.533.750
23742695,2013-06-07T00:00:00,Porphyromonas gingivalis,B03.140.094.625.515
23742695,2013-06-07T00:00:00,Porphyromonas gingivalis,B03.440.425.410.194.625.515
23742695,2013-06-07T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
23742695,2013-06-07T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
23742695,2013-06-07T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
23742695,2013-06-07T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
23742986,2013-06-07T00:00:00,Animals,B01.050
23742986,2013-06-07T00:00:00,Cell Differentiation,G04.299.151
23742986,2013-06-07T00:00:00,Cell Movement,G04.299.283
23742986,2013-06-07T00:00:00,Cell Movement,G07.700.560.500.180
23742986,2013-06-07T00:00:00,Chick Embryo,A13.350.150
23742986,2013-06-07T00:00:00,Chick Embryo,A16.331.200
23742986,2013-06-07T00:00:00,Gene Expression,G05.355.310
23742986,2013-06-07T00:00:00,Heart Valves,A07.541.510
23742986,2013-06-07T00:00:00,Morphogenesis,G07.700.320.500
23743980,2013-06-07T00:00:00,Adult,M01.060.116
23743980,2013-06-07T00:00:00,Aged,M01.060.116.100
23743980,2013-06-07T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23743980,2013-06-07T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23743980,2013-06-07T00:00:00,Head and Neck Neoplasms,C04.588.443
23743980,2013-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23743980,2013-06-07T00:00:00,Middle Aged,M01.060.116.630
23743980,2013-06-07T00:00:00,Weight Loss,C23.888.144.243.963
23743980,2013-06-07T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23749868,2013-06-07T00:00:00,Aged,M01.060.116.100
23749868,2013-06-07T00:00:00,Case-Control Studies,E05.318.760.500.500
23749868,2013-06-07T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23749868,2013-06-07T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23749868,2013-06-07T00:00:00,Ceramides,D02.065.313
23749868,2013-06-07T00:00:00,Ceramides,D09.400.410.420.525.200
23749868,2013-06-07T00:00:00,Ceramides,D10.390.470.675.200
23749868,2013-06-07T00:00:00,Ceramides,D10.570.877.360.612.200
23749868,2013-06-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23749868,2013-06-07T00:00:00,Lung Neoplasms,C04.588.894.797.520
23749868,2013-06-07T00:00:00,Lung Neoplasms,C08.381.540
23749868,2013-06-07T00:00:00,Lung Neoplasms,C08.785.520
23749868,2013-06-07T00:00:00,Lysophospholipids,D10.570.755.375.760.550
23749868,2013-06-07T00:00:00,Middle Aged,M01.060.116.630
23749868,2013-06-07T00:00:00,Sphingolipids,D10.570.877
23749868,2013-06-07T00:00:00,Sphingolipids,D10.808
23749868,2013-06-07T00:00:00,Sphingosine,D02.033.100.700
23749868,2013-06-07T00:00:00,Sphingosine,D02.033.455.843
23749868,2013-06-07T00:00:00,Sphingosine,D02.092.063.700
23749868,2013-06-07T00:00:00,"Tumor Markers, Biological",D23.101.840
23754846,2013-06-10T00:00:00,Animals,B01.050
23754846,2013-06-10T00:00:00,Elastin,D05.750.078.421
23754846,2013-06-10T00:00:00,Elastin,D12.776.860.300.350
23754846,2013-06-10T00:00:00,Glucose,D09.546.359.448
23754846,2013-06-10T00:00:00,"Muscle, Smooth, Vascular",A02.633.570.491
23754846,2013-06-10T00:00:00,"Muscle, Smooth, Vascular",A07.231.491
23754846,2013-06-10T00:00:00,"Muscle, Smooth, Vascular",A10.690.467.491
23754846,2013-06-10T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
23754846,2013-06-10T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
23754846,2013-06-10T00:00:00,Osteogenesis,G11.427.590.560.100.729
23754846,2013-06-10T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23754846,2013-06-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23754846,2013-06-10T00:00:00,Signal Transduction,G02.111.087.800
23754846,2013-06-10T00:00:00,Signal Transduction,G02.149.115.800
23754846,2013-06-10T00:00:00,Signal Transduction,G04.299.880
23754846,2013-06-10T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
23754846,2013-06-10T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
23754846,2013-06-10T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
23754846,2013-06-10T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
23754846,2013-06-10T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
23754846,2013-06-10T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
23754846,2013-06-10T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
23754846,2013-06-10T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
23754846,2013-06-10T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
23757370,2013-06-10T00:00:00,Adolescent,M01.060.057
23757370,2013-06-10T00:00:00,Adult,M01.060.116
23757370,2013-06-10T00:00:00,Aged,M01.060.116.100
23757370,2013-06-10T00:00:00,Clinical Trials as Topic,E05.318.760.535
23757370,2013-06-10T00:00:00,Clinical Trials as Topic,E05.337.250
23757370,2013-06-10T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23757370,2013-06-10T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23757370,2013-06-10T00:00:00,"Computers, Handheld",L01.224.230.260.550.500
23757370,2013-06-10T00:00:00,Documentation,L01.453.245
23757370,2013-06-10T00:00:00,Hospitals,N02.278.421
23757370,2013-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23757370,2013-06-10T00:00:00,Information Management,L01.399
23757370,2013-06-10T00:00:00,Informed Consent,I01.880.604.473.650.718
23757370,2013-06-10T00:00:00,Informed Consent,I01.880.604.583.427
23757370,2013-06-10T00:00:00,Informed Consent,N03.706.437.650.312
23757370,2013-06-10T00:00:00,Informed Consent,N03.706.535.489
23757370,2013-06-10T00:00:00,"Medical Records Systems, Computerized",E05.318.308.940.968.625
23757370,2013-06-10T00:00:00,"Medical Records Systems, Computerized",L01.280.900.968.775
23757370,2013-06-10T00:00:00,"Medical Records Systems, Computerized",L01.700.508.300.695
23757370,2013-06-10T00:00:00,"Medical Records Systems, Computerized",N04.452.859.564.650
23757370,2013-06-10T00:00:00,"Medical Records Systems, Computerized",N05.715.360.300.715.500.530
23757370,2013-06-10T00:00:00,"Medical Records Systems, Computerized",N06.850.520.308.940.968.625
23757370,2013-06-10T00:00:00,Middle Aged,M01.060.116.630
23757370,2013-06-10T00:00:00,Paper,J01.576.154.600
23757370,2013-06-10T00:00:00,Paper,J01.637.650
23757370,2013-06-10T00:00:00,Patient Selection,E05.581.500.653
23757370,2013-06-10T00:00:00,Patient Selection,N04.590.731
23757370,2013-06-10T00:00:00,Questionnaires,E05.318.308.750
23757370,2013-06-10T00:00:00,Questionnaires,L01.280.800
23757370,2013-06-10T00:00:00,Questionnaires,N05.715.360.300.695
23757370,2013-06-10T00:00:00,Questionnaires,N06.850.520.308.750
23757370,2013-06-10T00:00:00,Software,L01.224.900
23757370,2013-06-10T00:00:00,South Carolina,Z01.107.567.875.075.662
23757370,2013-06-10T00:00:00,South Carolina,Z01.107.567.875.750.700
23757370,2013-06-10T00:00:00,User-Computer Interface,L01.224.900.910
23757370,2013-06-10T00:00:00,Young Adult,M01.060.116.815
23759513,2013-06-10T00:00:00,Animals,B01.050
23759513,2013-06-10T00:00:00,Central Nervous System,A08.186
23759513,2013-06-10T00:00:00,Cytokines,D12.644.276.374
23759513,2013-06-10T00:00:00,Cytokines,D12.776.467.374
23759513,2013-06-10T00:00:00,Cytokines,D23.529.374
23759513,2013-06-10T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
23759513,2013-06-10T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
23759513,2013-06-10T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
23759513,2013-06-10T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
23759513,2013-06-10T00:00:00,Neuroglia,A08.637
23759513,2013-06-10T00:00:00,Neuroglia,A11.650
23759513,2013-06-10T00:00:00,Oligodendroglia,A08.637.600
23759513,2013-06-10T00:00:00,Oligodendroglia,A11.650.600
23759513,2013-06-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23759513,2013-06-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23759513,2013-06-10T00:00:00,Reactive Oxygen Species,D01.339.431
23759513,2013-06-10T00:00:00,Reactive Oxygen Species,D01.650.775
23759513,2013-06-10T00:00:00,Signal Transduction,G02.111.087.800
23759513,2013-06-10T00:00:00,Signal Transduction,G02.149.115.800
23759513,2013-06-10T00:00:00,Signal Transduction,G04.299.880
23762279,2013-06-10T00:00:00,Adult,M01.060.116
23762279,2013-06-10T00:00:00,Birth Weight,C23.888.144.186
23762279,2013-06-10T00:00:00,Birth Weight,E01.370.600.115.100.160.120.186
23762279,2013-06-10T00:00:00,Birth Weight,E05.041.124.160.750.149
23762279,2013-06-10T00:00:00,Birth Weight,G07.100.100.160.120.186
23762279,2013-06-10T00:00:00,Birth Weight,G07.700.320.249.314.120.186
23762279,2013-06-10T00:00:00,Continental Population Groups,M01.686.508
23762279,2013-06-10T00:00:00,"Diabetes, Gestational",C13.703.170
23762279,2013-06-10T00:00:00,"Diabetes, Gestational",C18.452.394.750.448
23762279,2013-06-10T00:00:00,"Diabetes, Gestational",C19.246.200
23762279,2013-06-10T00:00:00,Ethnic Groups,M01.686.754
23762279,2013-06-10T00:00:00,Ethnic Groups,N01.224.317
23762279,2013-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23762279,2013-06-10T00:00:00,"Infant, Newborn",M01.060.703.520
23762279,2013-06-10T00:00:00,Obesity,C18.654.726.500
23762279,2013-06-10T00:00:00,Obesity,C23.888.144.699.500
23762279,2013-06-10T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23762279,2013-06-10T00:00:00,Obesity,G07.100.100.160.120.699.500
23762279,2013-06-10T00:00:00,Pregnancy,G08.686.785.760.769
23762279,2013-06-10T00:00:00,Pregnancy Complications,C13.703
23762279,2013-06-10T00:00:00,South Carolina,Z01.107.567.875.075.662
23762279,2013-06-10T00:00:00,South Carolina,Z01.107.567.875.750.700
23762279,2013-06-10T00:00:00,Weight Gain,C23.888.144.243.926
23762279,2013-06-10T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
23764363,2013-06-10T00:00:00,Adult,M01.060.116
23764363,2013-06-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23764363,2013-06-10T00:00:00,Middle Aged,M01.060.116.630
23764363,2013-06-10T00:00:00,Multiple Sclerosis,C10.114.375.500
23764363,2013-06-10T00:00:00,Multiple Sclerosis,C10.314.350.500
23764363,2013-06-10T00:00:00,Multiple Sclerosis,C20.111.258.250.500
23764363,2013-06-10T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23764363,2013-06-10T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23764363,2013-06-10T00:00:00,Questionnaires,E05.318.308.750
23764363,2013-06-10T00:00:00,Questionnaires,L01.280.800
23764363,2013-06-10T00:00:00,Questionnaires,N05.715.360.300.695
23764363,2013-06-10T00:00:00,Questionnaires,N06.850.520.308.750
23764363,2013-06-10T00:00:00,Young Adult,M01.060.116.815
23754639,2013-06-11T00:00:00,Animals,B01.050
23754639,2013-06-11T00:00:00,Apoptosis,G04.299.139.160
23754639,2013-06-11T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
23754639,2013-06-11T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
23754639,2013-06-11T00:00:00,Brain Neoplasms,C04.588.614.250.195
23754639,2013-06-11T00:00:00,Brain Neoplasms,C10.228.140.211
23754639,2013-06-11T00:00:00,Brain Neoplasms,C10.551.240.250
23754639,2013-06-11T00:00:00,Disease Progression,C23.550.291.656
23754639,2013-06-11T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23754639,2013-06-11T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
23754639,2013-06-11T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
23754639,2013-06-11T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
23754639,2013-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23754639,2013-06-11T00:00:00,Liver,A03.620
23758715,2013-06-11T00:00:00,Adult,M01.060.116
23758715,2013-06-11T00:00:00,Developing Countries,I01.615.500.300
23758715,2013-06-11T00:00:00,Diet,E05.272
23758715,2013-06-11T00:00:00,Diet,G07.610.240
23758715,2013-06-11T00:00:00,Fetal Blood,A12.207.152.200
23758715,2013-06-11T00:00:00,Fetal Blood,A15.145.300
23758715,2013-06-11T00:00:00,Fetal Blood,A16.378.200
23758715,2013-06-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23758715,2013-06-11T00:00:00,Nutrition Surveys,E05.318.308.250.600
23758715,2013-06-11T00:00:00,Nutrition Surveys,E05.318.308.585.550
23758715,2013-06-11T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
23758715,2013-06-11T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
23758715,2013-06-11T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
23758715,2013-06-11T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
23758715,2013-06-11T00:00:00,Pregnancy,G08.686.785.760.769
23758715,2013-06-11T00:00:00,Questionnaires,E05.318.308.750
23758715,2013-06-11T00:00:00,Questionnaires,L01.280.800
23758715,2013-06-11T00:00:00,Questionnaires,N05.715.360.300.695
23758715,2013-06-11T00:00:00,Questionnaires,N06.850.520.308.750
23758715,2013-06-11T00:00:00,Selenium,D01.268.185.850
23758715,2013-06-11T00:00:00,Selenium,D01.578.700
23758715,2013-06-11T00:00:00,Young Adult,M01.060.116.815
23696608,2013-06-12T00:00:00,Animals,B01.050
23696608,2013-06-12T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
23696608,2013-06-12T00:00:00,Reperfusion Injury,C14.907.725
23696608,2013-06-12T00:00:00,Reperfusion Injury,C23.550.767.877
23696608,2013-06-12T00:00:00,Retina,A09.371.729
23696608,2013-06-12T00:00:00,Retinal Degeneration,C11.768.585
23696608,2013-06-12T00:00:00,Retinal Ganglion Cells,A08.663.650.850.875
23696608,2013-06-12T00:00:00,Retinal Ganglion Cells,A09.371.729.831.875
23696608,2013-06-12T00:00:00,Retinal Ganglion Cells,A11.671.650.850.875
23756689,2013-06-12T00:00:00,Brain Ischemia,C10.228.140.300.150
23756689,2013-06-12T00:00:00,Brain Ischemia,C14.907.253.092
23756689,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23756689,2013-06-12T00:00:00,Mesenchymal Stem Cell Transplantation,E04.936.225.687.625
23756689,2013-06-12T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
23756689,2013-06-12T00:00:00,Recovery of Function,G16.757
23756689,2013-06-12T00:00:00,Stroke,C10.228.140.300.775
23756689,2013-06-12T00:00:00,Stroke,C14.907.253.855
23760299,2013-06-12T00:00:00,Animals,B01.050
23760299,2013-06-12T00:00:00,Butterflies,B01.050.500.131.617.561.200
23760299,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23761402,2013-06-12T00:00:00,Animals,B01.050
23761402,2013-06-12T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.238.100
23761402,2013-06-12T00:00:00,"Cardiomyopathy, Hypertrophic",C14.280.484.150.070.160
23761402,2013-06-12T00:00:00,Glutathione,D12.644.456.448
23761402,2013-06-12T00:00:00,Homeostasis,G07.700.360
23761402,2013-06-12T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23761402,2013-06-12T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23761402,2013-06-12T00:00:00,NF-E2-Related Factor 2,D12.776.260.108.737
23761402,2013-06-12T00:00:00,NF-E2-Related Factor 2,D12.776.930.127.737
23761402,2013-06-12T00:00:00,"Stress, Physiological",G07.700.830
23761702,2013-06-12T00:00:00,Adolescent,M01.060.057
23761702,2013-06-12T00:00:00,Case-Control Studies,E05.318.760.500.500
23761702,2013-06-12T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23761702,2013-06-12T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23761702,2013-06-12T00:00:00,Child,M01.060.406
23761702,2013-06-12T00:00:00,"Child, Preschool",M01.060.406.448
23761702,2013-06-12T00:00:00,Electromyography,E01.370.405.255
23761702,2013-06-12T00:00:00,Electromyography,E01.370.530.255
23761702,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23761702,2013-06-12T00:00:00,Locomotion,G07.700.560.500
23761702,2013-06-12T00:00:00,Locomotion,G11.427.590.530.568
23761702,2013-06-12T00:00:00,"Muscle, Skeletal",A02.633.567
23761702,2013-06-12T00:00:00,"Muscle, Skeletal",A10.690.552.500
23761702,2013-06-12T00:00:00,Spinal Cord Injuries,C10.228.854.770
23761702,2013-06-12T00:00:00,Spinal Cord Injuries,C10.900.850
23761702,2013-06-12T00:00:00,Spinal Cord Injuries,C21.866.819
23764194,2013-06-12T00:00:00,Animals,B01.050
23764194,2013-06-12T00:00:00,Central Nervous System Stimulants,D27.505.696.282
23764194,2013-06-12T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
23764194,2013-06-12T00:00:00,Estrous Cycle,G08.686.195
23764194,2013-06-12T00:00:00,Methamphetamine,D02.092.471.683.152.619
23764194,2013-06-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23764194,2013-06-12T00:00:00,Reinforcement (Psychology),F02.463.425.770
23764194,2013-06-12T00:00:00,Self Administration,E02.319.890
23764194,2013-06-12T00:00:00,Self Administration,E02.900.890
23764194,2013-06-12T00:00:00,Sex Characteristics,G08.686.815
23768938,2013-06-12T00:00:00,Adolescent,M01.060.057
23768938,2013-06-12T00:00:00,Adult,M01.060.116
23768938,2013-06-12T00:00:00,Anxiety,F01.470.132
23768938,2013-06-12T00:00:00,Child,M01.060.406
23768938,2013-06-12T00:00:00,Child Abuse,I01.198.240.856.350.250
23768938,2013-06-12T00:00:00,Child Abuse,I01.880.735.900.350.250
23768938,2013-06-12T00:00:00,Child Abuse,I01.880.787.293.292
23768938,2013-06-12T00:00:00,Child Welfare,I01.880.787.293
23768938,2013-06-12T00:00:00,Depression,F01.145.126.350
23768938,2013-06-12T00:00:00,Family Therapy,F04.754.864.581.273
23768938,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23768938,2013-06-12T00:00:00,Intervention Studies,E05.318.760.565
23768938,2013-06-12T00:00:00,Intervention Studies,N05.715.360.775.390
23768938,2013-06-12T00:00:00,Intervention Studies,N06.850.520.450.565
23768938,2013-06-12T00:00:00,Parents,F01.829.263.500.320
23768938,2013-06-12T00:00:00,Parents,I01.880.225.500.340
23768938,2013-06-12T00:00:00,Parents,M01.620
23768938,2013-06-12T00:00:00,Pilot Projects,E05.318.760.750
23768938,2013-06-12T00:00:00,Pilot Projects,E05.337.737
23768938,2013-06-12T00:00:00,Pilot Projects,N05.715.360.775.625
23768938,2013-06-12T00:00:00,Pilot Projects,N06.850.520.450.720
23788812,2013-06-12T00:00:00,Career Choice,F02.463.785.373.346.400
23788812,2013-06-12T00:00:00,Curriculum,I02.158
23788812,2013-06-12T00:00:00,Faculty,I02.463
23788812,2013-06-12T00:00:00,Faculty,M01.526.339
23788812,2013-06-12T00:00:00,Feedback,L01.143.283.425
23788812,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23788812,2013-06-12T00:00:00,"Internship, Nonmedical",I02.358.750
23788812,2013-06-12T00:00:00,Program Development,N04.452.760
23788812,2013-06-12T00:00:00,Program Evaluation,E05.337.820
23788812,2013-06-12T00:00:00,Program Evaluation,N04.761.685
23788812,2013-06-12T00:00:00,Program Evaluation,N05.715.360.650
23788812,2013-06-12T00:00:00,"Schools, Pharmacy",I02.783.660.694
23788812,2013-06-12T00:00:00,Teaching,I02.903
23943931,2013-06-12T00:00:00,Attitude of Health Personnel,F01.100.050
23943931,2013-06-12T00:00:00,Attitude of Health Personnel,N05.300.100
23943931,2013-06-12T00:00:00,Clinical Competence,I02.399.630.210
23943931,2013-06-12T00:00:00,Clinical Competence,N04.761.210
23943931,2013-06-12T00:00:00,Cooperative Behavior,F01.145.813.115
23943931,2013-06-12T00:00:00,Diffusion of Innovation,L01.143.320
23943931,2013-06-12T00:00:00,Forecasting,I01.320
23943931,2013-06-12T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23943931,2013-06-12T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23943931,2013-06-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23943931,2013-06-12T00:00:00,Interdisciplinary Communication,F01.145.209.381
23943931,2013-06-12T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
23943931,2013-06-12T00:00:00,Interdisciplinary Communication,L01.143.474
23943931,2013-06-12T00:00:00,Motivation,F01.658
23943931,2013-06-12T00:00:00,Motivation,F01.752.543.500.750
23943931,2013-06-12T00:00:00,Patient Care Team,N04.590.715
23943931,2013-06-12T00:00:00,Pharmaceutical Services,N02.421.668
23943931,2013-06-12T00:00:00,Professional-Patient Relations,F01.829.401.650
23943931,2013-06-12T00:00:00,Professional-Patient Relations,N05.300.660
23943931,2013-06-12T00:00:00,Workload,N04.452.677.950
23764502,2013-06-13T00:00:00,Glycoproteins,D09.400.430
23764502,2013-06-13T00:00:00,Glycoproteins,D12.776.395
23764502,2013-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23764502,2013-06-13T00:00:00,Kallikreins,D08.811.277.656.300.760.442
23764502,2013-06-13T00:00:00,Kallikreins,D08.811.277.656.959.350.442
23764502,2013-06-13T00:00:00,Kallikreins,D12.776.124.125.597
23764502,2013-06-13T00:00:00,Kallikreins,D23.119.597
23764502,2013-06-13T00:00:00,Polysaccharides,D09.698
23764502,2013-06-13T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
23764502,2013-06-13T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
23764502,2013-06-13T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
23764502,2013-06-13T00:00:00,Prostate-Specific Antigen,D23.050.285.625
23764502,2013-06-13T00:00:00,Prostate-Specific Antigen,D23.101.840.625
23764502,2013-06-13T00:00:00,Proteomics,H01.158.201.843
23764502,2013-06-13T00:00:00,Proteomics,H01.158.273.180.350.700
23764502,2013-06-13T00:00:00,Proteomics,H01.158.273.343.350.700
23764502,2013-06-13T00:00:00,Proteomics,H01.181.122.738
23764722,2013-06-13T00:00:00,Aged,M01.060.116.100
23764722,2013-06-13T00:00:00,Algorithms,G17.035
23764722,2013-06-13T00:00:00,Algorithms,L01.224.050
23764722,2013-06-13T00:00:00,Alzheimer Disease,C10.228.140.380.100
23764722,2013-06-13T00:00:00,Alzheimer Disease,C10.574.945.249
23764722,2013-06-13T00:00:00,Alzheimer Disease,F03.087.400.100
23764722,2013-06-13T00:00:00,Diffusion Tensor Imaging,E01.370.350.500.150.500
23764722,2013-06-13T00:00:00,Diffusion Tensor Imaging,E01.370.376.224
23764722,2013-06-13T00:00:00,Diffusion Tensor Imaging,E05.278
23764722,2013-06-13T00:00:00,Disease Progression,C23.550.291.656
23764722,2013-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23764722,2013-06-13T00:00:00,Image Enhancement,E01.370.350.600.350
23764722,2013-06-13T00:00:00,Image Enhancement,L01.224.308.380
23764722,2013-06-13T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
23764722,2013-06-13T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
23764722,2013-06-13T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
23764722,2013-06-13T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
23764722,2013-06-13T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
23764722,2013-06-13T00:00:00,Sensitivity and Specificity,E05.318.740.872
23764722,2013-06-13T00:00:00,Sensitivity and Specificity,E05.318.780.800
23764722,2013-06-13T00:00:00,Sensitivity and Specificity,G17.800
23764722,2013-06-13T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23764722,2013-06-13T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23764722,2013-06-13T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23764722,2013-06-13T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23764885,2013-06-13T00:00:00,Aged,M01.060.116.100
23764885,2013-06-13T00:00:00,Exercise Test,E01.370.370.380.250
23764885,2013-06-13T00:00:00,Exercise Test,E01.370.386.700.250
23764885,2013-06-13T00:00:00,Exercise Test,E05.333.250
23764885,2013-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23764885,2013-06-13T00:00:00,Middle Aged,M01.060.116.630
23764885,2013-06-13T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23764885,2013-06-13T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23764885,2013-06-13T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23764885,2013-06-13T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23764885,2013-06-13T00:00:00,Stroke,C10.228.140.300.775
23764885,2013-06-13T00:00:00,Stroke,C14.907.253.855
23764885,2013-06-13T00:00:00,Walking,G11.427.590.530.568.900
23764885,2013-06-13T00:00:00,Walking,G11.427.590.530.698.940
23764885,2013-06-13T00:00:00,Walking,I03.450.642.845.940
23766515,2013-06-13T00:00:00,Animals,B01.050
23766515,2013-06-13T00:00:00,Cell Line,A11.251.210
23766515,2013-06-13T00:00:00,Diet,E05.272
23766515,2013-06-13T00:00:00,Diet,G07.610.240
23766515,2013-06-13T00:00:00,Interleukin-6,D12.644.276.374.465.506
23766515,2013-06-13T00:00:00,Interleukin-6,D12.776.467.374.465.506
23766515,2013-06-13T00:00:00,Interleukin-6,D23.529.374.465.506
23766515,2013-06-13T00:00:00,"Muscle, Skeletal",A02.633.567
23766515,2013-06-13T00:00:00,"Muscle, Skeletal",A10.690.552.500
23766515,2013-06-13T00:00:00,Obesity,C18.654.726.500
23766515,2013-06-13T00:00:00,Obesity,C23.888.144.699.500
23766515,2013-06-13T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23766515,2013-06-13T00:00:00,Obesity,G07.100.100.160.120.699.500
23766515,2013-06-13T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
23766515,2013-06-13T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23766515,2013-06-13T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23766515,2013-06-13T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23766515,2013-06-13T00:00:00,Signal Transduction,G02.111.087.800
23766515,2013-06-13T00:00:00,Signal Transduction,G02.149.115.800
23766515,2013-06-13T00:00:00,Signal Transduction,G04.299.880
23792567,2013-06-13T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
23792567,2013-06-13T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
23792567,2013-06-13T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
23792567,2013-06-13T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
23792567,2013-06-13T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
23792567,2013-06-13T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
23792567,2013-06-13T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
23792567,2013-06-13T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
23792567,2013-06-13T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
23792567,2013-06-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23792567,2013-06-13T00:00:00,Middle Aged,M01.060.116.630
23792567,2013-06-13T00:00:00,Mutation,G05.365.590
23792567,2013-06-13T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.374.750.625
23792567,2013-06-13T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.644.276.972.625
23792567,2013-06-13T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.374.750.625
23792567,2013-06-13T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D12.776.467.972.625
23792567,2013-06-13T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.374.750.625
23792567,2013-06-13T00:00:00,TNF-Related Apoptosis-Inducing Ligand,D23.529.972.625
23763289,2013-06-14T00:00:00,Adult,M01.060.116
23763289,2013-06-14T00:00:00,Aged,M01.060.116.100
23763289,2013-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23763289,2013-06-14T00:00:00,Immunosuppression,E02.095.465.425.450
23763289,2013-06-14T00:00:00,Immunosuppression,E05.478.610
23763289,2013-06-14T00:00:00,Kidney,A05.810.453
23763289,2013-06-14T00:00:00,Kidney Diseases,C12.777.419
23763289,2013-06-14T00:00:00,Kidney Diseases,C13.351.968.419
23763289,2013-06-14T00:00:00,Kidney Transplantation,E02.870.500
23763289,2013-06-14T00:00:00,Kidney Transplantation,E04.936.450.485
23763289,2013-06-14T00:00:00,Kidney Transplantation,E04.950.774.400
23763289,2013-06-14T00:00:00,Middle Aged,M01.060.116.630
23763289,2013-06-14T00:00:00,Pancreas Transplantation,E04.210.725
23763289,2013-06-14T00:00:00,Pancreas Transplantation,E04.936.450.650
23763289,2013-06-14T00:00:00,Postoperative Complications,C23.550.767
23765951,2013-06-14T00:00:00,Adolescent,M01.060.057
23765951,2013-06-14T00:00:00,Adult,M01.060.116
23765951,2013-06-14T00:00:00,Aged,M01.060.116.100
23765951,2013-06-14T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23765951,2013-06-14T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23765951,2013-06-14T00:00:00,Child,M01.060.406
23765951,2013-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23765951,2013-06-14T00:00:00,Middle Aged,M01.060.116.630
23799087,2013-06-14T00:00:00,Artificial Intelligence,L01.224.065
23799087,2013-06-14T00:00:00,Binding Sites,G02.111.570.120
23799087,2013-06-14T00:00:00,DNA-Binding Proteins,D12.776.260
23799087,2013-06-14T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
23799087,2013-06-14T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
23799087,2013-06-14T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
23799087,2013-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23799087,2013-06-14T00:00:00,"Models, Biological",E05.599.395
23799087,2013-06-14T00:00:00,"Mutation, Missense",G05.365.590.650
23799087,2013-06-14T00:00:00,Phenotype,G05.695
23899425,2013-06-14T00:00:00,Adult,M01.060.116
23899425,2013-06-14T00:00:00,Aged,M01.060.116.100
23899425,2013-06-14T00:00:00,Alcohol-Related Disorders,C21.739.100
23899425,2013-06-14T00:00:00,Alcohol-Related Disorders,F03.900.100
23899425,2013-06-14T00:00:00,Attitude of Health Personnel,F01.100.050
23899425,2013-06-14T00:00:00,Attitude of Health Personnel,N05.300.100
23899425,2013-06-14T00:00:00,Communication,F01.145.209
23899425,2013-06-14T00:00:00,Communication,L01.143
23899425,2013-06-14T00:00:00,Cross-Over Studies,E05.318.780.150
23899425,2013-06-14T00:00:00,Cross-Over Studies,N05.715.360.780.150
23899425,2013-06-14T00:00:00,Cross-Over Studies,N06.850.520.445.150
23899425,2013-06-14T00:00:00,Decision Making,F02.463.785.373
23899425,2013-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23899425,2013-06-14T00:00:00,Middle Aged,M01.060.116.630
23899425,2013-06-14T00:00:00,Patient Care Team,N04.590.715
23899425,2013-06-14T00:00:00,Primary Health Care,N04.590.233.727
23899425,2013-06-14T00:00:00,Questionnaires,E05.318.308.750
23899425,2013-06-14T00:00:00,Questionnaires,L01.280.800
23899425,2013-06-14T00:00:00,Questionnaires,N05.715.360.300.695
23899425,2013-06-14T00:00:00,Questionnaires,N06.850.520.308.750
23899425,2013-06-14T00:00:00,"Stress, Psychological",F01.145.126.990
23899425,2013-06-14T00:00:00,"Stress, Psychological",F02.830.900
23905826,2013-06-14T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
23905826,2013-06-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23905826,2013-06-14T00:00:00,Infant,M01.060.703
23905826,2013-06-14T00:00:00,"Infant, Newborn",M01.060.703.520
23905826,2013-06-14T00:00:00,Laryngomalacia,C05.182.310
23905826,2013-06-14T00:00:00,Laryngomalacia,C08.360.563
23905826,2013-06-14T00:00:00,Laryngomalacia,C09.400.563
23905826,2013-06-14T00:00:00,Laryngomalacia,C16.131.621.568
23905826,2013-06-14T00:00:00,Laryngomalacia,C17.300.182.310
23905826,2013-06-14T00:00:00,Laryngoscopy,E01.370.386.460
23905826,2013-06-14T00:00:00,Laryngoscopy,E01.370.388.250.525
23905826,2013-06-14T00:00:00,Laryngoscopy,E04.580.373
23905826,2013-06-14T00:00:00,Laryngoscopy,E04.800.250.525
23905826,2013-06-14T00:00:00,Respiratory Sounds,C23.888.852.779
23905826,2013-06-14T00:00:00,Respiratory Sounds,E01.370.386.720
23905826,2013-06-14T00:00:00,Respiratory Sounds,G09.772.775
23905826,2013-06-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23905826,2013-06-14T00:00:00,Risk Factors,N05.715.350.200.700
23905826,2013-06-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23905826,2013-06-14T00:00:00,Risk Factors,N06.850.490.625.750
23905826,2013-06-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23778303,2013-06-15T00:00:00,Adult,M01.060.116
23778303,2013-06-15T00:00:00,Aged,M01.060.116.100
23778303,2013-06-15T00:00:00,Cyclonic Storms,G16.500.240.135.500
23778303,2013-06-15T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
23778303,2013-06-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23778303,2013-06-15T00:00:00,Middle Aged,M01.060.116.630
23778303,2013-06-15T00:00:00,Panic Disorder,F03.080.700
23778303,2013-06-15T00:00:00,Questionnaires,E05.318.308.750
23778303,2013-06-15T00:00:00,Questionnaires,L01.280.800
23778303,2013-06-15T00:00:00,Questionnaires,N05.715.360.300.695
23778303,2013-06-15T00:00:00,Questionnaires,N06.850.520.308.750
23774438,2013-06-17T00:00:00,Animals,B01.050
23774438,2013-06-17T00:00:00,Dendritic Cells,A11.066.270
23774438,2013-06-17T00:00:00,Dendritic Cells,A11.436.270
23774438,2013-06-17T00:00:00,Dendritic Cells,A15.382.066.270
23774438,2013-06-17T00:00:00,Dendritic Cells,A15.382.812.260
23774438,2013-06-17T00:00:00,Hemorrhage,C23.550.414
23774438,2013-06-17T00:00:00,Herpesviridae Infections,C02.256.466
23774438,2013-06-17T00:00:00,Inflammation,C23.550.470
23774438,2013-06-17T00:00:00,Interferon-gamma,D12.644.276.374.440.893
23774438,2013-06-17T00:00:00,Interferon-gamma,D12.644.276.374.480.350
23774438,2013-06-17T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
23774438,2013-06-17T00:00:00,Interferon-gamma,D12.644.276.718.550
23774438,2013-06-17T00:00:00,Interferon-gamma,D12.776.467.374.440.893
23774438,2013-06-17T00:00:00,Interferon-gamma,D12.776.467.374.480.350
23774438,2013-06-17T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
23774438,2013-06-17T00:00:00,Interferon-gamma,D12.776.467.718.550
23774438,2013-06-17T00:00:00,Interferon-gamma,D23.529.374.440.893
23774438,2013-06-17T00:00:00,Interferon-gamma,D23.529.374.480.350
23774438,2013-06-17T00:00:00,Interferon-gamma,D23.529.374.480.615.350
23774438,2013-06-17T00:00:00,Interferon-gamma,D23.529.718.550
23774438,2013-06-17T00:00:00,Macrophages,A11.329.372
23774438,2013-06-17T00:00:00,Macrophages,A11.627.482
23774438,2013-06-17T00:00:00,Macrophages,A11.733.397
23774438,2013-06-17T00:00:00,Macrophages,A15.382.680.397
23774438,2013-06-17T00:00:00,Macrophages,A15.382.812.522
23774438,2013-06-17T00:00:00,Membrane Proteins,D12.776.543
23774438,2013-06-17T00:00:00,Myxoma virus,B04.280.650.160.500.550
23774438,2013-06-17T00:00:00,Myxoma virus,B04.909.204.210.600.550
23774438,2013-06-17T00:00:00,Myxoma virus,B04.909.204.783.160.500.550
23774438,2013-06-17T00:00:00,Myxoma virus,B04.909.574.204.600.550
23774438,2013-06-17T00:00:00,Neuropeptides,D12.644.400
23774438,2013-06-17T00:00:00,Neuropeptides,D12.776.641.650
23774438,2013-06-17T00:00:00,Serpins,D12.644.822.750
23774438,2013-06-17T00:00:00,Serpins,D12.644.861
23774438,2013-06-17T00:00:00,Serpins,D12.776.645.750
23774438,2013-06-17T00:00:00,Serpins,D12.776.872
23774438,2013-06-17T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23774438,2013-06-17T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23774438,2013-06-17T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23774438,2013-06-17T00:00:00,Tissue Plasminogen Activator,D23.119.970
23774628,2013-06-17T00:00:00,Body Image,F02.463.593.112
23774628,2013-06-17T00:00:00,Exercise Therapy,E02.779.483
23774628,2013-06-17T00:00:00,Exercise Therapy,E02.831.387
23774628,2013-06-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23774628,2013-06-17T00:00:00,Mental Processes,F02.463
23774628,2013-06-17T00:00:00,Middle Aged,M01.060.116.630
23774628,2013-06-17T00:00:00,Neuronal Plasticity,G11.561.600.635
23774628,2013-06-17T00:00:00,Physical Endurance,G11.427.680
23774628,2013-06-17T00:00:00,Physical Endurance,I03.450.642.845.054.600
23774628,2013-06-17T00:00:00,Qualitative Research,H01.770.644.241.850
23774628,2013-06-17T00:00:00,Recovery of Function,G16.757
23774628,2013-06-17T00:00:00,Self Concept,F01.752.747.792
23774628,2013-06-17T00:00:00,Spinal Cord Injuries,C10.228.854.770
23774628,2013-06-17T00:00:00,Spinal Cord Injuries,C10.900.850
23774628,2013-06-17T00:00:00,Spinal Cord Injuries,C21.866.819
23774628,2013-06-17T00:00:00,Walking,G11.427.590.530.568.900
23774628,2013-06-17T00:00:00,Walking,G11.427.590.530.698.940
23774628,2013-06-17T00:00:00,Walking,I03.450.642.845.940
23773363,2013-06-18T00:00:00,Albumins,D12.776.034
23773363,2013-06-18T00:00:00,Alleles,G05.360.340.024.340.030
23773363,2013-06-18T00:00:00,Animals,B01.050
23773363,2013-06-18T00:00:00,Azacitidine,D02.145.150
23773363,2013-06-18T00:00:00,Azacitidine,D03.383.742.680.245.217
23773363,2013-06-18T00:00:00,Azacitidine,D13.570.685.245.217
23773363,2013-06-18T00:00:00,Azacitidine,D13.570.800.286.300
23773363,2013-06-18T00:00:00,Gene Expression Regulation,G05.355.315
23773363,2013-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23773363,2013-06-18T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
23773363,2013-06-18T00:00:00,Membrane Proteins,D12.776.543
23773363,2013-06-18T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23773363,2013-06-18T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23773363,2013-06-18T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23773363,2013-06-18T00:00:00,Protein Transport,G03.495.166.700
23773363,2013-06-18T00:00:00,"Receptors, Cell Surface",D12.776.543.750
23993826,2013-06-18T00:00:00,Bronchoscopy,E01.370.386.105
23993826,2013-06-18T00:00:00,Bronchoscopy,E01.370.388.250.100
23993826,2013-06-18T00:00:00,Bronchoscopy,E04.800.250.100
23993826,2013-06-18T00:00:00,Bronchoscopy,E04.928.600.080
23993826,2013-06-18T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23993826,2013-06-18T00:00:00,Endosonography,E01.370.350.850.280
23993826,2013-06-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23993826,2013-06-18T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
23993826,2013-06-18T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
23993826,2013-06-18T00:00:00,Pulmonary Medicine,H02.403.429.675
23993826,2013-06-18T00:00:00,Quality of Life,I01.800
23993826,2013-06-18T00:00:00,Quality of Life,K01.752.400.750
23993826,2013-06-18T00:00:00,"Ultrasonography, Interventional",E01.370.350.850.855
23785141,2013-06-19T00:00:00,Animals,B01.050
23785141,2013-06-19T00:00:00,Circadian Rhythm,G07.180.562.190
23785141,2013-06-19T00:00:00,Color,G01.201.875.770.578.199
23785141,2013-06-19T00:00:00,Color,G01.590.540.199
23785141,2013-06-19T00:00:00,"Electrodes, Implanted",E07.305.250.319
23785141,2013-06-19T00:00:00,Electroencephalography,E01.370.376.300
23785141,2013-06-19T00:00:00,Electroencephalography,E01.370.405.245
23785141,2013-06-19T00:00:00,Hypothalamic Hormones,D06.472.699.327
23785141,2013-06-19T00:00:00,Hypothalamic Hormones,D12.644.400.400
23785141,2013-06-19T00:00:00,Hypothalamic Hormones,D12.644.548.365
23785141,2013-06-19T00:00:00,Hypothalamic Hormones,D12.776.641.650.405
23785141,2013-06-19T00:00:00,Hypothalamus,A08.186.211.464.482
23785141,2013-06-19T00:00:00,Hypothalamus,A08.186.211.730.317.357
23785141,2013-06-19T00:00:00,Melanins,D12.125.072.050.875.379
23785141,2013-06-19T00:00:00,Melanins,D23.767.620
23785141,2013-06-19T00:00:00,Neurons,A08.663
23785141,2013-06-19T00:00:00,Neurons,A11.671
23785141,2013-06-19T00:00:00,Patch-Clamp Techniques,E05.200.500.800
23785141,2013-06-19T00:00:00,Photic Stimulation,E05.723.729
23785141,2013-06-19T00:00:00,Pituitary Hormones,D06.472.699.631
23785141,2013-06-19T00:00:00,Pituitary Hormones,D12.644.548.691
23785141,2013-06-19T00:00:00,Plasmids,G05.360.600
23785141,2013-06-19T00:00:00,Rhodopsin,D12.776.543.750.100.955
23785141,2013-06-19T00:00:00,Rhodopsin,D23.767.930.750.500.500
23785141,2013-06-19T00:00:00,Sleep,F02.830.855
23785141,2013-06-19T00:00:00,Sleep,G11.561.600.815
23785141,2013-06-19T00:00:00,"Sleep, REM",F02.830.855.796.671
23785141,2013-06-19T00:00:00,"Sleep, REM",G11.561.600.815.754.671
23785141,2013-06-19T00:00:00,Wakefulness,F02.830.104.821
23785141,2013-06-19T00:00:00,Wakefulness,G11.561.600.042.738
23782182,2013-06-20T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23782182,2013-06-20T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23782182,2013-06-20T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23782182,2013-06-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23782182,2013-06-20T00:00:00,Stroke,C10.228.140.300.775
23782182,2013-06-20T00:00:00,Stroke,C14.907.253.855
23782182,2013-06-20T00:00:00,Thrombectomy,E04.100.814.842
23782182,2013-06-20T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23782182,2013-06-20T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23782182,2013-06-20T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23782182,2013-06-20T00:00:00,Tissue Plasminogen Activator,D23.119.970
23790499,2013-06-21T00:00:00,Adult,M01.060.116
23790499,2013-06-21T00:00:00,Aged,M01.060.116.100
23790499,2013-06-21T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
23790499,2013-06-21T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
23790499,2013-06-21T00:00:00,"Blood Loss, Surgical",C23.550.414.300
23790499,2013-06-21T00:00:00,"Blood Loss, Surgical",C23.550.505.300
23790499,2013-06-21T00:00:00,Blood Transfusion,E02.095.135
23790499,2013-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23790499,2013-06-21T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
23790499,2013-06-21T00:00:00,Middle Aged,M01.060.116.630
23790499,2013-06-21T00:00:00,Treatment Outcome,E01.789.800
23790499,2013-06-21T00:00:00,Treatment Outcome,N04.761.559.590.800
23790499,2013-06-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23790499,2013-06-21T00:00:00,Young Adult,M01.060.116.815
23791160,2013-06-21T00:00:00,Adult,M01.060.116
23791160,2013-06-21T00:00:00,Aged,M01.060.116.100
23791160,2013-06-21T00:00:00,Animals,B01.050
23791160,2013-06-21T00:00:00,Blood Flow Velocity,E01.370.370.130
23791160,2013-06-21T00:00:00,Blood Flow Velocity,G09.330.380.630.080
23791160,2013-06-21T00:00:00,Blood Vessel Prosthesis,E07.695.110
23791160,2013-06-21T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
23791160,2013-06-21T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
23791160,2013-06-21T00:00:00,Case-Control Studies,E05.318.760.500.500
23791160,2013-06-21T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23791160,2013-06-21T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23791160,2013-06-21T00:00:00,Cattle,B01.050.150.900.649.077.380.271
23791160,2013-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23791160,2013-06-21T00:00:00,Lung Neoplasms,C04.588.894.797.520
23791160,2013-06-21T00:00:00,Lung Neoplasms,C08.381.540
23791160,2013-06-21T00:00:00,Lung Neoplasms,C08.785.520
23791160,2013-06-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23791160,2013-06-21T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23791160,2013-06-21T00:00:00,Middle Aged,M01.060.116.630
23791160,2013-06-21T00:00:00,Neoplasm Invasiveness,C04.697.645
23791160,2013-06-21T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23791160,2013-06-21T00:00:00,Pneumonectomy,E04.928.600.600
23791160,2013-06-21T00:00:00,Prosthesis Failure,C23.550.767.865
23791160,2013-06-21T00:00:00,Prosthesis Failure,E05.325.771
23791160,2013-06-21T00:00:00,Reconstructive Surgical Procedures,E04.680
23791160,2013-06-21T00:00:00,Risk Assessment,E05.318.740.600.800.715
23791160,2013-06-21T00:00:00,Risk Assessment,N04.452.871.715
23791160,2013-06-21T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23791160,2013-06-21T00:00:00,Risk Assessment,N06.850.505.715
23791160,2013-06-21T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23791160,2013-06-21T00:00:00,Treatment Outcome,E01.789.800
23791160,2013-06-21T00:00:00,Treatment Outcome,N04.761.559.590.800
23791160,2013-06-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23791160,2013-06-21T00:00:00,Vascular Patency,G09.330.920
23791160,2013-06-21T00:00:00,"Vena Cava, Superior",A07.231.908.949.815
23796570,2013-06-21T00:00:00,Adult,M01.060.116
23796570,2013-06-21T00:00:00,Aged,M01.060.116.100
23796570,2013-06-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23796570,2013-06-21T00:00:00,Middle Aged,M01.060.116.630
23796570,2013-06-21T00:00:00,Pressure,G01.374.715
23796570,2013-06-21T00:00:00,Prosthesis Design,E05.320.550
23796570,2013-06-21T00:00:00,Prosthesis Design,E07.695.680
23796570,2013-06-21T00:00:00,"Urinary Incontinence, Stress",C12.777.934.852.249
23796570,2013-06-21T00:00:00,"Urinary Incontinence, Stress",C13.351.968.934.814.500
23796570,2013-06-21T00:00:00,"Urinary Incontinence, Stress",C23.888.942.800.500
23792241,2013-06-22T00:00:00,Aged,M01.060.116.100
23792241,2013-06-22T00:00:00,Diastole,G09.330.190.541.295
23792241,2013-06-22T00:00:00,Diastole,G11.427.590.540.554.250
23792241,2013-06-22T00:00:00,Diastole,G11.427.590.540.570.295
23792241,2013-06-22T00:00:00,Echocardiography,E01.370.350.850.220
23792241,2013-06-22T00:00:00,Echocardiography,E01.370.370.380.220
23792241,2013-06-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23792241,2013-06-22T00:00:00,Hypertension,C14.907.489
23792241,2013-06-22T00:00:00,Middle Aged,M01.060.116.630
23792241,2013-06-22T00:00:00,Peptide Fragments,D12.644.541
23792241,2013-06-22T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
23797978,2013-06-24T00:00:00,Adolescent,M01.060.057
23797978,2013-06-24T00:00:00,Adult,M01.060.116
23797978,2013-06-24T00:00:00,Aged,M01.060.116.100
23797978,2013-06-24T00:00:00,Child,M01.060.406
23797978,2013-06-24T00:00:00,"Child, Preschool",M01.060.406.448
23797978,2013-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23797978,2013-06-24T00:00:00,Incidence,E05.318.308.985.525.375
23797978,2013-06-24T00:00:00,Incidence,L01.280.975.525.375
23797978,2013-06-24T00:00:00,Incidence,N01.224.935.597.500
23797978,2013-06-24T00:00:00,Incidence,N06.850.505.400.975.525.375
23797978,2013-06-24T00:00:00,Incidence,N06.850.520.308.985.525.375
23797978,2013-06-24T00:00:00,Infant,M01.060.703
23797978,2013-06-24T00:00:00,Middle Aged,M01.060.116.630
23797978,2013-06-24T00:00:00,Risk Factors,E05.318.740.600.800.725
23797978,2013-06-24T00:00:00,Risk Factors,N05.715.350.200.700
23797978,2013-06-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23797978,2013-06-24T00:00:00,Risk Factors,N06.850.490.625.750
23797978,2013-06-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23797978,2013-06-24T00:00:00,Treatment Outcome,E01.789.800
23797978,2013-06-24T00:00:00,Treatment Outcome,N04.761.559.590.800
23797978,2013-06-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23797978,2013-06-24T00:00:00,United States,Z01.107.567.875
23797978,2013-06-24T00:00:00,Young Adult,M01.060.116.815
23806824,2013-06-24T00:00:00,Extremities,A01.378
23806824,2013-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23806824,2013-06-24T00:00:00,Middle Aged,M01.060.116.630
23806824,2013-06-24T00:00:00,Neoplasm Invasiveness,C04.697.645
23806824,2013-06-24T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23806824,2013-06-24T00:00:00,Sarcoma,C04.557.450.795
23806824,2013-06-24T00:00:00,United States,Z01.107.567.875
23806832,2013-06-24T00:00:00,Adolescent,M01.060.057
23806832,2013-06-24T00:00:00,Adult,M01.060.116
23806832,2013-06-24T00:00:00,Aged,M01.060.116.100
23806832,2013-06-24T00:00:00,Biological Markers,D23.101
23806832,2013-06-24T00:00:00,Depression,F01.145.126.350
23806832,2013-06-24T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23806832,2013-06-24T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23806832,2013-06-24T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23806832,2013-06-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23806832,2013-06-24T00:00:00,Hydrocortisone,D04.808.745.745.654.600
23806832,2013-06-24T00:00:00,Hydrocortisone,D06.472.040.585.353.476
23806832,2013-06-24T00:00:00,Hydrocortisone,D06.472.040.585.478.392
23806832,2013-06-24T00:00:00,Middle Aged,M01.060.116.630
23806832,2013-06-24T00:00:00,Rape,I01.198.240.748.640
23806832,2013-06-24T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23800882,2013-06-25T00:00:00,Animals,B01.050
23800882,2013-06-25T00:00:00,"Antigens, CD",D23.050.301.264.035
23800882,2013-06-25T00:00:00,"Antigens, CD",D23.101.100.110
23800882,2013-06-25T00:00:00,"Aorta, Thoracic",A07.231.114.056.372
23800882,2013-06-25T00:00:00,Cattle,B01.050.150.900.649.077.380.271
23800882,2013-06-25T00:00:00,Cell Adhesion,G04.299.117
23800882,2013-06-25T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
23800882,2013-06-25T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
23800882,2013-06-25T00:00:00,Cell Adhesion Molecules,D23.050.301.350
23800882,2013-06-25T00:00:00,"Endothelium, Vascular",A07.231.330
23800882,2013-06-25T00:00:00,"Endothelium, Vascular",A10.272.491.355
23800882,2013-06-25T00:00:00,Leukocytes,A11.118.637
23800882,2013-06-25T00:00:00,Leukocytes,A15.145.229.637
23800882,2013-06-25T00:00:00,Leukocytes,A15.382.490
23800882,2013-06-25T00:00:00,Macrophages,A11.329.372
23800882,2013-06-25T00:00:00,Macrophages,A11.627.482
23800882,2013-06-25T00:00:00,Macrophages,A11.733.397
23800882,2013-06-25T00:00:00,Macrophages,A15.382.680.397
23800882,2013-06-25T00:00:00,Macrophages,A15.382.812.522
23800882,2013-06-25T00:00:00,Nitric Oxide,D01.339.387
23800882,2013-06-25T00:00:00,Nitric Oxide,D01.625.550.500
23800882,2013-06-25T00:00:00,Nitric Oxide,D01.625.700.500
23800882,2013-06-25T00:00:00,Nitric Oxide,D01.650.550.587.600
23800882,2013-06-25T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
23800882,2013-06-25T00:00:00,Oxidative Stress,G03.495.710
23800882,2013-06-25T00:00:00,Oxidative Stress,G07.700.830.750
23800882,2013-06-25T00:00:00,RNA Interference,G05.355.315.203.374.790
23800882,2013-06-25T00:00:00,Signal Transduction,G02.111.087.800
23800882,2013-06-25T00:00:00,Signal Transduction,G02.149.115.800
23800882,2013-06-25T00:00:00,Signal Transduction,G04.299.880
23801650,2013-06-25T00:00:00,Chromosome Aberrations,C23.550.210
23801650,2013-06-25T00:00:00,Chromosome Aberrations,G05.365.590.175
23801650,2013-06-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23801650,2013-06-25T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.500.620.670.325.350
23801650,2013-06-25T00:00:00,"In Situ Hybridization, Fluorescence",E05.200.750.600.670.325.350
23801650,2013-06-25T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.285.350
23801650,2013-06-25T00:00:00,"In Situ Hybridization, Fluorescence",E05.393.661.475.350
23801650,2013-06-25T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23801650,2013-06-25T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23801650,2013-06-25T00:00:00,Sensitivity and Specificity,E05.318.740.872
23801650,2013-06-25T00:00:00,Sensitivity and Specificity,E05.318.780.800
23801650,2013-06-25T00:00:00,Sensitivity and Specificity,G17.800
23801650,2013-06-25T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23801650,2013-06-25T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23801650,2013-06-25T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23801650,2013-06-25T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
23801650,2013-06-25T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
23825688,2013-06-25T00:00:00,Animals,B01.050
23825688,2013-06-25T00:00:00,Complement C3,D12.776.124.050.140
23825688,2013-06-25T00:00:00,Complement C3,D12.776.124.486.274.250
23825688,2013-06-25T00:00:00,Complement System Proteins,D12.776.124.486.274
23825688,2013-06-25T00:00:00,Eye Diseases,C11
23825688,2013-06-25T00:00:00,Gene Expression Regulation,G05.355.315
23825688,2013-06-25T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23825688,2013-06-25T00:00:00,Mitochondria,A11.284.835.626
23825688,2013-06-25T00:00:00,Signal Transduction,G02.111.087.800
23825688,2013-06-25T00:00:00,Signal Transduction,G02.149.115.800
23825688,2013-06-25T00:00:00,Signal Transduction,G04.299.880
23825688,2013-06-25T00:00:00,Tobacco,B01.650.388.100.905.900
23804119,2013-06-26T00:00:00,Adolescent,M01.060.057
23804119,2013-06-26T00:00:00,Adult,M01.060.116
23804119,2013-06-26T00:00:00,Child,M01.060.406
23804119,2013-06-26T00:00:00,Child Abuse,I01.198.240.856.350.250
23804119,2013-06-26T00:00:00,Child Abuse,I01.880.735.900.350.250
23804119,2013-06-26T00:00:00,Child Abuse,I01.880.787.293.292
23804119,2013-06-26T00:00:00,Health Policy,I01.880.604.825.608.400
23804119,2013-06-26T00:00:00,Health Policy,N03.706.825.608.428
23804119,2013-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23804119,2013-06-26T00:00:00,Risk Factors,E05.318.740.600.800.725
23804119,2013-06-26T00:00:00,Risk Factors,N05.715.350.200.700
23804119,2013-06-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23804119,2013-06-26T00:00:00,Risk Factors,N06.850.490.625.750
23804119,2013-06-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23804395,2013-06-26T00:00:00,Adenoidectomy,E04.580.068
23804395,2013-06-26T00:00:00,Age Factors,N05.715.350.075
23804395,2013-06-26T00:00:00,Age Factors,N06.850.490.250
23804395,2013-06-26T00:00:00,"Child, Preschool",M01.060.406.448
23804395,2013-06-26T00:00:00,Continuous Positive Airway Pressure,E02.880.820.790.259
23804395,2013-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23804395,2013-06-26T00:00:00,Infant,M01.060.703
23804395,2013-06-26T00:00:00,"Monitoring, Physiologic",E01.370.520
23804395,2013-06-26T00:00:00,Oxygen Consumption,G03.730
23804395,2013-06-26T00:00:00,Polysomnography,E01.370.520.625
23804395,2013-06-26T00:00:00,Risk Assessment,E05.318.740.600.800.715
23804395,2013-06-26T00:00:00,Risk Assessment,N04.452.871.715
23804395,2013-06-26T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23804395,2013-06-26T00:00:00,Risk Assessment,N06.850.505.715
23804395,2013-06-26T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23804395,2013-06-26T00:00:00,"Sleep Apnea, Obstructive",C08.618.085.852.850
23804395,2013-06-26T00:00:00,"Sleep Apnea, Obstructive",C10.886.425.800.750.850
23804395,2013-06-26T00:00:00,Tonsillectomy,E04.580.848
23804395,2013-06-26T00:00:00,Tracheostomy,E04.579.935
23804395,2013-06-26T00:00:00,Tracheostomy,E04.580.900
23804395,2013-06-26T00:00:00,Tracheostomy,E04.928.780
23804395,2013-06-26T00:00:00,Treatment Outcome,E01.789.800
23804395,2013-06-26T00:00:00,Treatment Outcome,N04.761.559.590.800
23804395,2013-06-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23809463,2013-06-26T00:00:00,Adult,M01.060.116
23809463,2013-06-26T00:00:00,Anxiety Disorders,F03.080
23809463,2013-06-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23809463,2013-06-26T00:00:00,Middle Aged,M01.060.116.630
23809463,2013-06-26T00:00:00,"Models, Statistical",E05.318.740.500
23809463,2013-06-26T00:00:00,"Models, Statistical",E05.599.835
23809463,2013-06-26T00:00:00,"Models, Statistical",N05.715.360.750.530
23809463,2013-06-26T00:00:00,"Models, Statistical",N06.850.520.830.500
23809463,2013-06-26T00:00:00,Mood Disorders,F03.600
23809463,2013-06-26T00:00:00,Phobic Disorders,F03.080.725
23809463,2013-06-26T00:00:00,Psychiatric Status Rating Scales,F04.586
23809463,2013-06-26T00:00:00,Questionnaires,E05.318.308.750
23809463,2013-06-26T00:00:00,Questionnaires,L01.280.800
23809463,2013-06-26T00:00:00,Questionnaires,N05.715.360.300.695
23809463,2013-06-26T00:00:00,Questionnaires,N06.850.520.308.750
23811330,2013-06-26T00:00:00,Animals,B01.050
23811330,2013-06-26T00:00:00,Cell Survival,G04.299.316
23811330,2013-06-26T00:00:00,Environmental Pollutants,D27.888.284
23811330,2013-06-26T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
23811330,2013-06-26T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23811330,2013-06-26T00:00:00,Mitochondria,A11.284.835.626
23811330,2013-06-26T00:00:00,Oxygen Consumption,G03.730
23811330,2013-06-26T00:00:00,Rabbits,B01.050.150.900.649.521.700
23811330,2013-06-26T00:00:00,Small Molecule Libraries,D27.720.470.765
22707325,2013-06-27T00:00:00,Adolescent,M01.060.057
22707325,2013-06-27T00:00:00,Adult,M01.060.116
22707325,2013-06-27T00:00:00,Aged,M01.060.116.100
22707325,2013-06-27T00:00:00,"Foramen Ovale, Patent",C14.240.400.560.375.258
22707325,2013-06-27T00:00:00,"Foramen Ovale, Patent",C14.280.400.560.375.258
22707325,2013-06-27T00:00:00,"Foramen Ovale, Patent",C16.131.240.400.560.375.258
22707325,2013-06-27T00:00:00,Hemodynamics,G09.330.190.400
22707325,2013-06-27T00:00:00,Hemodynamics,G09.330.380
22707325,2013-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22707325,2013-06-27T00:00:00,Incidence,E05.318.308.985.525.375
22707325,2013-06-27T00:00:00,Incidence,L01.280.975.525.375
22707325,2013-06-27T00:00:00,Incidence,N01.224.935.597.500
22707325,2013-06-27T00:00:00,Incidence,N06.850.505.400.975.525.375
22707325,2013-06-27T00:00:00,Incidence,N06.850.520.308.985.525.375
22707325,2013-06-27T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
22707325,2013-06-27T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
22707325,2013-06-27T00:00:00,Middle Aged,M01.060.116.630
22707325,2013-06-27T00:00:00,Risk Factors,E05.318.740.600.800.725
22707325,2013-06-27T00:00:00,Risk Factors,N05.715.350.200.700
22707325,2013-06-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
22707325,2013-06-27T00:00:00,Risk Factors,N06.850.490.625.750
22707325,2013-06-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
22707325,2013-06-27T00:00:00,Secondary Prevention,N02.421.726.825
22707325,2013-06-27T00:00:00,Secondary Prevention,N06.850.780.750
22707325,2013-06-27T00:00:00,Stroke,C10.228.140.300.775
22707325,2013-06-27T00:00:00,Stroke,C14.907.253.855
22707325,2013-06-27T00:00:00,Treatment Outcome,E01.789.800
22707325,2013-06-27T00:00:00,Treatment Outcome,N04.761.559.590.800
22707325,2013-06-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
22707325,2013-06-27T00:00:00,Young Adult,M01.060.116.815
23803174,2013-06-27T00:00:00,Clinical Trials as Topic,E05.318.760.535
23803174,2013-06-27T00:00:00,Clinical Trials as Topic,E05.337.250
23803174,2013-06-27T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23803174,2013-06-27T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23803174,2013-06-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23803174,2013-06-27T00:00:00,Regression Analysis,E05.318.740.750
23803174,2013-06-27T00:00:00,Regression Analysis,N05.715.360.750.695
23803174,2013-06-27T00:00:00,Regression Analysis,N06.850.520.830.750
23803174,2013-06-27T00:00:00,Stroke,C10.228.140.300.775
23803174,2013-06-27T00:00:00,Stroke,C14.907.253.855
23803174,2013-06-27T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23803174,2013-06-27T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23803174,2013-06-27T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23803174,2013-06-27T00:00:00,Tissue Plasminogen Activator,D23.119.970
23803174,2013-06-27T00:00:00,Treatment Outcome,E01.789.800
23803174,2013-06-27T00:00:00,Treatment Outcome,N04.761.559.590.800
23803174,2013-06-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23803174,2013-06-27T00:00:00,United States,Z01.107.567.875
23872027,2013-06-27T00:00:00,Hot Temperature,G01.906.595.543
23872027,2013-06-27T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
23872027,2013-06-27T00:00:00,Hot Temperature,G16.500.750.775.710.380
23872027,2013-06-27T00:00:00,Hot Temperature,N06.230.300.100.725.232
23872027,2013-06-27T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
23872027,2013-06-27T00:00:00,"Hydrocarbons, Chlorinated",D02.455.526.439
23872027,2013-06-27T00:00:00,Volatile Organic Compounds,D02.974
23712592,2013-06-28T00:00:00,Adult,M01.060.116
23712592,2013-06-28T00:00:00,Aged,M01.060.116.100
23712592,2013-06-28T00:00:00,"Diagnosis, Differential",E01.171
23712592,2013-06-28T00:00:00,Endoscopy,E01.370.388.250
23712592,2013-06-28T00:00:00,Endoscopy,E04.800.250
23712592,2013-06-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23712592,2013-06-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23712592,2013-06-28T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23712592,2013-06-28T00:00:00,Middle Aged,M01.060.116.630
23712592,2013-06-28T00:00:00,Young Adult,M01.060.116.815
23816900,2013-06-28T00:00:00,Blood Pressure,E01.370.600.875.249
23816900,2013-06-28T00:00:00,Blood Pressure,G09.330.380.076
23816900,2013-06-28T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
23816900,2013-06-28T00:00:00,"Feedback, Physiological",G07.700.360.732
23816900,2013-06-28T00:00:00,"Feedback, Physiological",L01.143.283.425.311
23816900,2013-06-28T00:00:00,Hemodynamics,G09.330.190.400
23816900,2013-06-28T00:00:00,Hemodynamics,G09.330.380
23816900,2013-06-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23816900,2013-06-28T00:00:00,Manikins,J01.897.280.500.545.129.400
23816900,2013-06-28T00:00:00,Manikins,L01.178.820.090.545.129.400
23820626,2013-06-29T00:00:00,Cardiac Surgical Procedures,E04.100.376
23820626,2013-06-29T00:00:00,Cardiac Surgical Procedures,E04.928.220
23820626,2013-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23820626,2013-06-29T00:00:00,Stroke,C10.228.140.300.775
23820626,2013-06-29T00:00:00,Stroke,C14.907.253.855
23905932,2013-06-29T00:00:00,Emergencies,C23.550.291.781
23905932,2013-06-29T00:00:00,Emergencies,N06.230.100.083
23905932,2013-06-29T00:00:00,Emergencies,N06.850.376
23905932,2013-06-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23905932,2013-06-29T00:00:00,Interdisciplinary Communication,F01.145.209.381
23905932,2013-06-29T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
23905932,2013-06-29T00:00:00,Interdisciplinary Communication,L01.143.474
23905932,2013-06-29T00:00:00,Kidney,A05.810.453
23905932,2013-06-29T00:00:00,Multiple Trauma,C21.866.640
23905932,2013-06-29T00:00:00,Ureter,A05.810.776
23905932,2013-06-29T00:00:00,Urethra,A05.360.444.492.726
23905932,2013-06-29T00:00:00,Urethra,A05.810.876
23905932,2013-06-29T00:00:00,Urinary Bladder,A05.810.890
22751479,2013-07-01T00:00:00,Cartilage Diseases,C05.182
22751479,2013-07-01T00:00:00,Cartilage Diseases,C17.300.182
22751479,2013-07-01T00:00:00,"Child, Preschool",M01.060.406.448
22751479,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
22751479,2013-07-01T00:00:00,"Lower Extremity Deformities, Congenital",C05.660.585.512
22751479,2013-07-01T00:00:00,"Lower Extremity Deformities, Congenital",C16.131.621.585.512
23320737,2013-07-01T00:00:00,Animals,B01.050
23320737,2013-07-01T00:00:00,Cell Differentiation,G04.299.151
23320737,2013-07-01T00:00:00,Cell Line,A11.251.210
23320737,2013-07-01T00:00:00,Dendritic Cells,A11.066.270
23320737,2013-07-01T00:00:00,Dendritic Cells,A11.436.270
23320737,2013-07-01T00:00:00,Dendritic Cells,A15.382.066.270
23320737,2013-07-01T00:00:00,Dendritic Cells,A15.382.812.260
23320737,2013-07-01T00:00:00,Macrophages,A11.329.372
23320737,2013-07-01T00:00:00,Macrophages,A11.627.482
23320737,2013-07-01T00:00:00,Macrophages,A11.733.397
23320737,2013-07-01T00:00:00,Macrophages,A15.382.680.397
23320737,2013-07-01T00:00:00,Macrophages,A15.382.812.522
23320737,2013-07-01T00:00:00,Membrane Proteins,D12.776.543
23320737,2013-07-01T00:00:00,Monocytes,A11.118.637.555.652
23320737,2013-07-01T00:00:00,Monocytes,A11.148.580
23320737,2013-07-01T00:00:00,Monocytes,A11.627.624
23320737,2013-07-01T00:00:00,Monocytes,A11.733.547
23320737,2013-07-01T00:00:00,Monocytes,A15.145.229.637.555.652
23320737,2013-07-01T00:00:00,Monocytes,A15.378.316.580
23320737,2013-07-01T00:00:00,Monocytes,A15.382.490.555.652
23320737,2013-07-01T00:00:00,Monocytes,A15.382.680.547
23320737,2013-07-01T00:00:00,Monocytes,A15.382.812.547
23320737,2013-07-01T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.260.665.400
23320737,2013-07-01T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.624.664.700.175.400
23320737,2013-07-01T00:00:00,Proto-Oncogene Protein c-fli-1,D12.776.930.635.400
23381113,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23381113,2013-07-01T00:00:00,Neoplasms,C04
23381113,2013-07-01T00:00:00,Organizational Objectives,N04.452.615
23381113,2013-07-01T00:00:00,Outcome and Process Assessment (Health Care),N04.761.559
23381113,2013-07-01T00:00:00,Outcome and Process Assessment (Health Care),N05.715.360.575
23381113,2013-07-01T00:00:00,Program Evaluation,E05.337.820
23381113,2013-07-01T00:00:00,Program Evaluation,N04.761.685
23381113,2013-07-01T00:00:00,Program Evaluation,N05.715.360.650
23381113,2013-07-01T00:00:00,"Quality Indicators, Health Care",N04.761.789
23381113,2013-07-01T00:00:00,Resource Allocation,I01.261.750
23381113,2013-07-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23381113,2013-07-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23388845,2013-07-01T00:00:00,Drug-Induced Liver Injury,C06.552.195
23388845,2013-07-01T00:00:00,Drug-Induced Liver Injury,C21.613.260
23388845,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23388845,2013-07-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
23388845,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23539284,2013-07-01T00:00:00,Diabetes Mellitus,C18.452.394.750
23539284,2013-07-01T00:00:00,Diabetes Mellitus,C19.246
23539284,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23539284,2013-07-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
23539284,2013-07-01T00:00:00,Medication Adherence,F01.145.488.500.500
23539284,2013-07-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
23581848,2013-07-01T00:00:00,Animals,B01.050
23581848,2013-07-01T00:00:00,Antineoplastic Agents,D27.505.954.248
23581848,2013-07-01T00:00:00,Cell Proliferation,G04.299.233.750
23581848,2013-07-01T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23581848,2013-07-01T00:00:00,Drug Design,E05.295.500
23581848,2013-07-01T00:00:00,Drug Design,H01.158.703.007.675.500
23581848,2013-07-01T00:00:00,Drug Design,H01.181.466.675.500
23581848,2013-07-01T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
23581848,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23581848,2013-07-01T00:00:00,Neoplasms,C04
23586923,2013-07-01T00:00:00,Animals,B01.050
23586923,2013-07-01T00:00:00,Cell Differentiation,G04.299.151
23586923,2013-07-01T00:00:00,Central Nervous System,A08.186
23586923,2013-07-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.114.703.300
23586923,2013-07-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C10.314.350.250
23586923,2013-07-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",C20.111.258.625.300
23586923,2013-07-01T00:00:00,"Encephalomyelitis, Autoimmune, Experimental",E05.598.500.500.500
23586923,2013-07-01T00:00:00,Gene Expression Regulation,G05.355.315
23586923,2013-07-01T00:00:00,Immunologic Factors,D27.505.696.477
23586923,2013-07-01T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.260.698.209.715
23586923,2013-07-01T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.826.209.715
23586923,2013-07-01T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.930.662
23586923,2013-07-01T00:00:00,"Receptors, Aryl Hydrocarbon",D12.776.930.669.209.715
23586923,2013-07-01T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
23586923,2013-07-01T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
23586923,2013-07-01T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
23715884,2013-07-01T00:00:00,Central Nervous System Diseases,C10.228
23715884,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23715884,2013-07-01T00:00:00,Malnutrition,C18.654.521
23715884,2013-07-01T00:00:00,Mental Disorders,F03
23715884,2013-07-01T00:00:00,Peripheral Nervous System Diseases,C10.668.829
23715884,2013-07-01T00:00:00,Vision Disorders,C10.597.751.941
23715884,2013-07-01T00:00:00,Vision Disorders,C11.966
23715884,2013-07-01T00:00:00,Vision Disorders,C23.888.592.763.941
23719060,2013-07-01T00:00:00,Brain Ischemia,C10.228.140.300.150
23719060,2013-07-01T00:00:00,Brain Ischemia,C14.907.253.092
23719060,2013-07-01T00:00:00,Equipment Failure Analysis,E05.325.192
23719060,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23719060,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23719060,2013-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23719060,2013-07-01T00:00:00,Risk Factors,N05.715.350.200.700
23719060,2013-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23719060,2013-07-01T00:00:00,Risk Factors,N06.850.490.625.750
23719060,2013-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23719060,2013-07-01T00:00:00,Stents,E07.695.750
23719060,2013-07-01T00:00:00,Stroke,C10.228.140.300.775
23719060,2013-07-01T00:00:00,Stroke,C14.907.253.855
23719060,2013-07-01T00:00:00,Treatment Outcome,E01.789.800
23719060,2013-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23719060,2013-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23719060,2013-07-01T00:00:00,United States,Z01.107.567.875
23733664,2013-07-01T00:00:00,Agriculture,J01.040
23733664,2013-07-01T00:00:00,California,Z01.107.567.875.580.200
23733664,2013-07-01T00:00:00,California,Z01.107.567.875.760.200
23733664,2013-07-01T00:00:00,Environmental Monitoring,N06.850.460.350.080
23733664,2013-07-01T00:00:00,Environmental Monitoring,N06.850.780.375
23733664,2013-07-01T00:00:00,Environmental Pollutants,D27.888.284
23733664,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23739024,2013-07-01T00:00:00,Aged,M01.060.116.100
23739024,2013-07-01T00:00:00,Alcohol Drinking,F01.145.317.269
23739024,2013-07-01T00:00:00,Alcohol-Related Disorders,C21.739.100
23739024,2013-07-01T00:00:00,Alcohol-Related Disorders,F03.900.100
23739024,2013-07-01T00:00:00,Diabetes Mellitus,C18.452.394.750
23739024,2013-07-01T00:00:00,Diabetes Mellitus,C19.246
23739024,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23739024,2013-07-01T00:00:00,Hypertension,C14.907.489
23739024,2013-07-01T00:00:00,Mass Screening,E01.370.500
23739024,2013-07-01T00:00:00,Mass Screening,E05.318.308.250.580
23739024,2013-07-01T00:00:00,Mass Screening,N02.421.143.827.233.443
23739024,2013-07-01T00:00:00,Mass Screening,N02.421.726.233.443
23739024,2013-07-01T00:00:00,Mass Screening,N05.715.360.300.375.500
23739024,2013-07-01T00:00:00,Mass Screening,N06.850.520.308.250.580
23739024,2013-07-01T00:00:00,Mass Screening,N06.850.780.500
23739024,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23739024,2013-07-01T00:00:00,Physician's Practice Patterns,N04.590.748
23739024,2013-07-01T00:00:00,Physician's Practice Patterns,N05.300.625
23739024,2013-07-01T00:00:00,Primary Health Care,N04.590.233.727
23748650,2013-07-01T00:00:00,Evidence-Based Dentistry,H02.163.232
23748650,2013-07-01T00:00:00,Evidence-Based Dentistry,H02.249.500
23748650,2013-07-01T00:00:00,Fluorodeoxyglucose F18,D09.254.229.500
23748650,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23748650,2013-07-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
23748650,2013-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23748650,2013-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23748650,2013-07-01T00:00:00,Positron-Emission Tomography,E01.370.350.350.800.700
23748650,2013-07-01T00:00:00,Positron-Emission Tomography,E01.370.350.600.350.800.399
23748650,2013-07-01T00:00:00,Positron-Emission Tomography,E01.370.350.710.800.399
23748650,2013-07-01T00:00:00,Positron-Emission Tomography,E01.370.350.825.800.399
23748650,2013-07-01T00:00:00,Positron-Emission Tomography,E01.370.384.730.800.399
23748650,2013-07-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23748650,2013-07-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23748650,2013-07-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
23778441,2013-07-01T00:00:00,Adult,M01.060.116
23778441,2013-07-01T00:00:00,"Embolization, Therapeutic",E02.520.360
23778441,2013-07-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
23778441,2013-07-01T00:00:00,Hospital Mortality,L01.280.975.550.400
23778441,2013-07-01T00:00:00,Hospital Mortality,N01.224.935.698.400
23778441,2013-07-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
23778441,2013-07-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
23778441,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23778441,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23778441,2013-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
23778441,2013-07-01T00:00:00,Risk Assessment,N04.452.871.715
23778441,2013-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23778441,2013-07-01T00:00:00,Risk Assessment,N06.850.505.715
23778441,2013-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23778441,2013-07-01T00:00:00,Salvage Therapy,E02.186.800
23778441,2013-07-01T00:00:00,Salvage Therapy,E02.895
23778441,2013-07-01T00:00:00,Splenectomy,E04.726
23778441,2013-07-01T00:00:00,Trauma Centers,N02.278.354.422.336.500
23778441,2013-07-01T00:00:00,Trauma Centers,N02.421.297.195.480
23778441,2013-07-01T00:00:00,Trauma Centers,N04.452.442.422.336.400
23778441,2013-07-01T00:00:00,Treatment Outcome,E01.789.800
23778441,2013-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23778441,2013-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23778441,2013-07-01T00:00:00,"Wounds, Nonpenetrating",C21.866.974
23791135,2013-07-01T00:00:00,Anesthesiology,H02.403.066
23791135,2013-07-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
23791135,2013-07-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
23791135,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23791135,2013-07-01T00:00:00,Perioperative Care,E02.760.722
23791135,2013-07-01T00:00:00,Perioperative Care,E04.604
23791135,2013-07-01T00:00:00,Perioperative Care,N02.421.585.722
23791135,2013-07-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23791135,2013-07-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23791324,2013-07-01T00:00:00,Adult,M01.060.116
23791324,2013-07-01T00:00:00,African Americans,M01.686.508.100.100
23791324,2013-07-01T00:00:00,African Americans,M01.686.754.100
23791324,2013-07-01T00:00:00,Exercise,G11.427.590.237
23791324,2013-07-01T00:00:00,Exercise,I03.350
23791324,2013-07-01T00:00:00,Health Behavior,F01.145.488
23791324,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23791324,2013-07-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23791324,2013-07-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23791324,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23791324,2013-07-01T00:00:00,Patient Compliance,F01.145.488.500
23791324,2013-07-01T00:00:00,Patient Compliance,N05.300.150.600.600
23809281,2013-07-01T00:00:00,Attitude of Health Personnel,F01.100.050
23809281,2013-07-01T00:00:00,Attitude of Health Personnel,N05.300.100
23809281,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23809281,2013-07-01T00:00:00,Nephrology,H02.403.429.580
23809281,2013-07-01T00:00:00,Patient Education as Topic,I02.233.332.500
23809281,2013-07-01T00:00:00,Patient Education as Topic,N02.421.143.827.407.680
23809281,2013-07-01T00:00:00,Patient Education as Topic,N02.421.726.407.680
23809281,2013-07-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23809281,2013-07-01T00:00:00,Physician-Patient Relations,N05.300.660.625
23809281,2013-07-01T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
23809281,2013-07-01T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23809281,2013-07-01T00:00:00,United States,Z01.107.567.875
23815108,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23815108,2013-07-01T00:00:00,"Memory, Short-Term",F02.463.425.540.407
23815108,2013-07-01T00:00:00,Neuropsychological Tests,F04.711.513
23815108,2013-07-01T00:00:00,Young Adult,M01.060.116.815
23815999,2013-07-01T00:00:00,Adolescent,M01.060.057
23815999,2013-07-01T00:00:00,Adult,M01.060.116
23815999,2013-07-01T00:00:00,Aged,M01.060.116.100
23815999,2013-07-01T00:00:00,Chronic Disease,C23.550.291.500
23815999,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23815999,2013-07-01T00:00:00,Hyperglycemia,C18.452.394.952
23815999,2013-07-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
23815999,2013-07-01T00:00:00,Insulin,D06.472.699.587.740.625
23815999,2013-07-01T00:00:00,Insulin,D12.644.548.586.740.625
23815999,2013-07-01T00:00:00,Islets of Langerhans Transplantation,E04.270.550
23815999,2013-07-01T00:00:00,Islets of Langerhans Transplantation,E04.936.225.375
23815999,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23815999,2013-07-01T00:00:00,Pancreatectomy,E04.210.752
23815999,2013-07-01T00:00:00,Pancreatitis,C06.689.750
23815999,2013-07-01T00:00:00,Postoperative Complications,C23.550.767
23815999,2013-07-01T00:00:00,Quality of Life,I01.800
23815999,2013-07-01T00:00:00,Quality of Life,K01.752.400.750
23815999,2013-07-01T00:00:00,Questionnaires,E05.318.308.750
23815999,2013-07-01T00:00:00,Questionnaires,L01.280.800
23815999,2013-07-01T00:00:00,Questionnaires,N05.715.360.300.695
23815999,2013-07-01T00:00:00,Questionnaires,N06.850.520.308.750
23815999,2013-07-01T00:00:00,Treatment Outcome,E01.789.800
23815999,2013-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23815999,2013-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23816068,2013-07-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
23816068,2013-07-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
23816068,2013-07-01T00:00:00,"Efficiency, Organizational",N04.452.227
23816068,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23816068,2013-07-01T00:00:00,"Societies, Medical",N03.540.828.589
23816068,2013-07-01T00:00:00,Thoracic Surgery,H02.403.810.803
23816151,2013-07-01T00:00:00,Adult,M01.060.116
23816151,2013-07-01T00:00:00,Age Factors,N05.715.350.075
23816151,2013-07-01T00:00:00,Age Factors,N06.850.490.250
23816151,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23816151,2013-07-01T00:00:00,Military Personnel,M01.526.625
23816151,2013-07-01T00:00:00,Questionnaires,E05.318.308.750
23816151,2013-07-01T00:00:00,Questionnaires,L01.280.800
23816151,2013-07-01T00:00:00,Questionnaires,N05.715.360.300.695
23816151,2013-07-01T00:00:00,Questionnaires,N06.850.520.308.750
23816151,2013-07-01T00:00:00,Rape,I01.198.240.748.640
23816151,2013-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23816151,2013-07-01T00:00:00,Risk Factors,N05.715.350.200.700
23816151,2013-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23816151,2013-07-01T00:00:00,Risk Factors,N06.850.490.625.750
23816151,2013-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23816151,2013-07-01T00:00:00,"Stress, Psychological",F01.145.126.990
23816151,2013-07-01T00:00:00,"Stress, Psychological",F02.830.900
23816151,2013-07-01T00:00:00,Young Adult,M01.060.116.815
23817821,2013-07-01T00:00:00,Adult,M01.060.116
23817821,2013-07-01T00:00:00,Aged,M01.060.116.100
23817821,2013-07-01T00:00:00,Cardiovascular Diseases,C14
23817821,2013-07-01T00:00:00,Confidentiality,F04.096.544.335.240
23817821,2013-07-01T00:00:00,Confidentiality,I01.880.604.473.650.500
23817821,2013-07-01T00:00:00,Confidentiality,I01.880.604.583.080
23817821,2013-07-01T00:00:00,Confidentiality,N03.706.437.650.124
23817821,2013-07-01T00:00:00,Confidentiality,N03.706.535.230
23817821,2013-07-01T00:00:00,Critical Care,E02.760.190
23817821,2013-07-01T00:00:00,Critical Care,N02.421.585.190
23817821,2013-07-01T00:00:00,Genetic Research,H01.158.273.343.249
23817821,2013-07-01T00:00:00,Genetic Research,H01.770.644.145.350
23817821,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23817821,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23817821,2013-07-01T00:00:00,Qualitative Research,H01.770.644.241.850
23818434,2013-07-01T00:00:00,Algorithms,G17.035
23818434,2013-07-01T00:00:00,Algorithms,L01.224.050
23818434,2013-07-01T00:00:00,Bias (Epidemiology),N05.715.350.150
23818434,2013-07-01T00:00:00,Bias (Epidemiology),N06.850.490.500
23818434,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23818434,2013-07-01T00:00:00,"Models, Statistical",E05.318.740.500
23818434,2013-07-01T00:00:00,"Models, Statistical",E05.599.835
23818434,2013-07-01T00:00:00,"Models, Statistical",N05.715.360.750.530
23818434,2013-07-01T00:00:00,"Models, Statistical",N06.850.520.830.500
23818434,2013-07-01T00:00:00,Patient Dropouts,M01.643.673
23818434,2013-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23818434,2013-07-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23818434,2013-07-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23818434,2013-07-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23818462,2013-07-01T00:00:00,Adrenal Cortex Hormones,D06.472.040
23818462,2013-07-01T00:00:00,Anti-Asthmatic Agents,D27.505.954.796.050
23818462,2013-07-01T00:00:00,Asthma,C08.127.108
23818462,2013-07-01T00:00:00,Asthma,C08.381.495.108
23818462,2013-07-01T00:00:00,Asthma,C08.674.095
23818462,2013-07-01T00:00:00,Asthma,C20.543.480.680.095
23818462,2013-07-01T00:00:00,Chronic Disease,C23.550.291.500
23818462,2013-07-01T00:00:00,Endoscopy,E01.370.388.250
23818462,2013-07-01T00:00:00,Endoscopy,E04.800.250
23818462,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23818462,2013-07-01T00:00:00,Paranasal Sinuses,A04.531.621
23818462,2013-07-01T00:00:00,Rhinitis,C08.460.799
23818462,2013-07-01T00:00:00,Rhinitis,C08.730.674
23818462,2013-07-01T00:00:00,Rhinitis,C09.603.799
23818462,2013-07-01T00:00:00,Sinusitis,C08.460.692.752
23818462,2013-07-01T00:00:00,Sinusitis,C08.730.749
23818462,2013-07-01T00:00:00,Sinusitis,C09.603.692.752
23818462,2013-07-01T00:00:00,Treatment Outcome,E01.789.800
23818462,2013-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23818462,2013-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23820904,2013-07-01T00:00:00,"Education, Medical",I02.358.399
23820904,2013-07-01T00:00:00,"Faculty, Medical",I02.463.373
23820904,2013-07-01T00:00:00,"Faculty, Medical",M01.526.339.373
23820904,2013-07-01T00:00:00,"Faculty, Medical",M01.526.485.375
23820904,2013-07-01T00:00:00,"Faculty, Medical",N02.360.375
23820904,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23820904,2013-07-01T00:00:00,Research,H01.770.644
23823002,2013-07-01T00:00:00,Dietary Fats,D10.212.302
23823002,2013-07-01T00:00:00,Dietary Fats,J02.500.375
23823002,2013-07-01T00:00:00,Dietary Proteins,D12.776.256
23823002,2013-07-01T00:00:00,Dietary Proteins,J02.500.428
23823002,2013-07-01T00:00:00,Energy Intake,G07.610.240.340
23823002,2013-07-01T00:00:00,Enteral Nutrition,E02.421.360
23823002,2013-07-01T00:00:00,Enteral Nutrition,E02.642.500.360
23823002,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23823002,2013-07-01T00:00:00,Hyperglycemia,C18.452.394.952
23823002,2013-07-01T00:00:00,Intensive Care Units,N02.278.388.493
23823002,2013-07-01T00:00:00,Parenteral Nutrition,E02.421.505
23823002,2013-07-01T00:00:00,Parenteral Nutrition,E02.642.500.505
23835820,2013-07-01T00:00:00,Adult,M01.060.116
23835820,2013-07-01T00:00:00,Chronic Disease,C23.550.291.500
23835820,2013-07-01T00:00:00,Community-Based Participatory Research,N05.425.104
23835820,2013-07-01T00:00:00,Health Services Accessibility,N04.590.374.350
23835820,2013-07-01T00:00:00,Health Services Accessibility,N05.300.430
23835820,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23835820,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23835820,2013-07-01T00:00:00,Patient-Centered Care,N04.590.233.675
23835820,2013-07-01T00:00:00,Patient-Centered Care,N04.590.233.727.407
23835820,2013-07-01T00:00:00,Patient-Centered Care,N04.590.720
23835820,2013-07-01T00:00:00,Primary Health Care,N04.590.233.727
23835820,2013-07-01T00:00:00,Quality of Health Care,N04.761
23835820,2013-07-01T00:00:00,Quality of Health Care,N05.715
23835820,2013-07-01T00:00:00,United States,Z01.107.567.875
23835820,2013-07-01T00:00:00,Young Adult,M01.060.116.815
23840872,2013-07-01T00:00:00,Adult,M01.060.116
23840872,2013-07-01T00:00:00,Depression,F01.145.126.350
23840872,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23840872,2013-07-01T00:00:00,Questionnaires,E05.318.308.750
23840872,2013-07-01T00:00:00,Questionnaires,L01.280.800
23840872,2013-07-01T00:00:00,Questionnaires,N05.715.360.300.695
23840872,2013-07-01T00:00:00,Questionnaires,N06.850.520.308.750
23840872,2013-07-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23840872,2013-07-01T00:00:00,Risk Factors,N05.715.350.200.700
23840872,2013-07-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23840872,2013-07-01T00:00:00,Risk Factors,N06.850.490.625.750
23840872,2013-07-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23840872,2013-07-01T00:00:00,"Stress, Psychological",F01.145.126.990
23840872,2013-07-01T00:00:00,"Stress, Psychological",F02.830.900
23863529,2013-07-01T00:00:00,Adult,M01.060.116
23863529,2013-07-01T00:00:00,Aged,M01.060.116.100
23863529,2013-07-01T00:00:00,Body Burden,E05.799.638.231
23863529,2013-07-01T00:00:00,Body Burden,N06.850.460.200
23863529,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23863529,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
23863529,2013-07-01T00:00:00,Radiation Dosage,E05.799.513
23863529,2013-07-01T00:00:00,Radiation Dosage,G01.201.875.740
23863529,2013-07-01T00:00:00,Radiation Dosage,N06.850.810.250
23863529,2013-07-01T00:00:00,"Radiography, Abdominal",E01.370.350.700.715
23863529,2013-07-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.600.350.700.700
23863529,2013-07-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.700.700.700
23863529,2013-07-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.760.700
23863529,2013-07-01T00:00:00,"Radiography, Dual-Energy Scanned Projection",L01.224.308.380.800
23863529,2013-07-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
23863529,2013-07-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
23863529,2013-07-01T00:00:00,Sensitivity and Specificity,G17.800
23863529,2013-07-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23863529,2013-07-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23863529,2013-07-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23863529,2013-07-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23863529,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23863529,2013-07-01T00:00:00,Young Adult,M01.060.116.815
23868436,2013-07-01T00:00:00,"Child, Preschool",M01.060.406.448
23868436,2013-07-01T00:00:00,Chronic Disease,C23.550.291.500
23868436,2013-07-01T00:00:00,"Diagnosis, Differential",E01.171
23868436,2013-07-01T00:00:00,"Histiocytosis, Langerhans-Cell",C08.381.483.375
23868436,2013-07-01T00:00:00,"Histiocytosis, Langerhans-Cell",C15.604.250.400
23868436,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23868436,2013-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23868436,2013-07-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23868436,2013-07-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23928312,2013-07-01T00:00:00,Angiography,E01.370.350.700.060
23928312,2013-07-01T00:00:00,Angiography,E01.370.370.050
23928312,2013-07-01T00:00:00,Arteries,A07.231.114
23928312,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24145977,2013-07-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
24145977,2013-07-01T00:00:00,Coronary Angiography,E01.370.370.050.200
24145977,2013-07-01T00:00:00,Coronary Angiography,E01.370.370.380.200
24145977,2013-07-01T00:00:00,Coronary Artery Bypass,E04.100.376.719.332
24145977,2013-07-01T00:00:00,Coronary Artery Bypass,E04.928.220.520.220
24145977,2013-07-01T00:00:00,Coronary Stenosis,C14.280.647.250.285
24145977,2013-07-01T00:00:00,Coronary Stenosis,C14.907.585.250.285
24145977,2013-07-01T00:00:00,Critical Illness,C23.550.291.625
24145977,2013-07-01T00:00:00,Device Removal,E04.199
24145977,2013-07-01T00:00:00,Heart-Assist Devices,E04.050.430
24145977,2013-07-01T00:00:00,Heart-Assist Devices,E07.695.300.300
24145977,2013-07-01T00:00:00,Heart-Assist Devices,E07.858.082.374.300
24145977,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24145977,2013-07-01T00:00:00,Intensive Care Units,N02.278.388.493
24145977,2013-07-01T00:00:00,Middle Aged,M01.060.116.630
24145977,2013-07-01T00:00:00,Myocardial Infarction,C14.280.647.500
24145977,2013-07-01T00:00:00,Myocardial Infarction,C14.907.585.500
24145977,2013-07-01T00:00:00,Postoperative Care,E02.760.722.700
24145977,2013-07-01T00:00:00,Postoperative Care,E04.624
24145977,2013-07-01T00:00:00,Postoperative Care,N02.421.585.722.700
24145977,2013-07-01T00:00:00,Postoperative Complications,C23.550.767
24145977,2013-07-01T00:00:00,"Respiration, Artificial",E02.365.647.729
24145977,2013-07-01T00:00:00,"Respiration, Artificial",E02.880.820
24145977,2013-07-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
24145977,2013-07-01T00:00:00,Risk Assessment,N04.452.871.715
24145977,2013-07-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24145977,2013-07-01T00:00:00,Risk Assessment,N06.850.505.715
24145977,2013-07-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24145977,2013-07-01T00:00:00,"Shock, Cardiogenic",C14.280.647.500.750
24145977,2013-07-01T00:00:00,"Shock, Cardiogenic",C14.907.585.500.750
24145977,2013-07-01T00:00:00,"Shock, Cardiogenic",C23.550.835.550
24145977,2013-07-01T00:00:00,Thrombectomy,E04.100.814.842
24145977,2013-07-01T00:00:00,Tracheostomy,E04.579.935
24145977,2013-07-01T00:00:00,Tracheostomy,E04.580.900
24145977,2013-07-01T00:00:00,Tracheostomy,E04.928.780
24145977,2013-07-01T00:00:00,Treatment Outcome,E01.789.800
24145977,2013-07-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24145977,2013-07-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24145977,2013-07-01T00:00:00,Venous Thrombosis,C14.907.355.830.925
24152838,2013-07-01T00:00:00,Animals,B01.050
24152838,2013-07-01T00:00:00,"Diabetes Mellitus, Experimental",C18.452.394.750.074
24152838,2013-07-01T00:00:00,"Diabetes Mellitus, Experimental",C19.246.240
24152838,2013-07-01T00:00:00,"Diabetes Mellitus, Experimental",E05.598.500.374
24152838,2013-07-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
24152838,2013-07-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
24152838,2013-07-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
24152838,2013-07-01T00:00:00,Kidney,A05.810.453
24152838,2013-07-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24152838,2013-07-01T00:00:00,Reactive Oxygen Species,D01.339.431
24152838,2013-07-01T00:00:00,Reactive Oxygen Species,D01.650.775
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
24152838,2013-07-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
24218870,2013-07-01T00:00:00,Adolescent,M01.060.057
24218870,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24218870,2013-07-01T00:00:00,Parenting,F01.829.263.370.310
24218870,2013-07-01T00:00:00,Pregnancy,G08.686.785.760.769
24218870,2013-07-01T00:00:00,Pregnancy in Adolescence,G08.686.785.760.769.494
24218870,2013-07-01T00:00:00,Urban Population,N01.600.900
24313085,2013-07-01T00:00:00,Adolescent,M01.060.057
24313085,2013-07-01T00:00:00,"Catheterization, Peripheral",E02.148.224
24313085,2013-07-01T00:00:00,Child,M01.060.406
24313085,2013-07-01T00:00:00,"Child, Preschool",M01.060.406.448
24313085,2013-07-01T00:00:00,Health Resources,N03.349.340
24313085,2013-07-01T00:00:00,Health Resources,N05.300.420
24313085,2013-07-01T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
24313085,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24313085,2013-07-01T00:00:00,Infant,M01.060.703
24313085,2013-07-01T00:00:00,"Infant, Newborn",M01.060.703.520
24313085,2013-07-01T00:00:00,United States,Z01.107.567.875
24313097,2013-07-01T00:00:00,Adult,M01.060.116
24313097,2013-07-01T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
24313097,2013-07-01T00:00:00,Clinical Competence,I02.399.630.210
24313097,2013-07-01T00:00:00,Clinical Competence,N04.761.210
24313097,2013-07-01T00:00:00,Computer Simulation,L01.224.160
24313097,2013-07-01T00:00:00,Curriculum,I02.158
24313097,2013-07-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24313097,2013-07-01T00:00:00,Internship and Residency,I02.358.399.644
24313097,2013-07-01T00:00:00,Manikins,J01.897.280.500.545.129.400
24313097,2013-07-01T00:00:00,Manikins,L01.178.820.090.545.129.400
24313097,2013-07-01T00:00:00,Pediatrics,H02.403.670
23817481,2013-07-02T00:00:00,Adult,M01.060.116
23817481,2013-07-02T00:00:00,Aged,M01.060.116.100
23817481,2013-07-02T00:00:00,Blood Pressure,E01.370.600.875.249
23817481,2013-07-02T00:00:00,Blood Pressure,G09.330.380.076
23817481,2013-07-02T00:00:00,Cholesterol,D04.808.247.222.284
23817481,2013-07-02T00:00:00,Cholesterol,D04.808.247.808.197
23817481,2013-07-02T00:00:00,Cholesterol,D10.570.938.208
23817481,2013-07-02T00:00:00,Cholesterol,D10.851.208
23817481,2013-07-02T00:00:00,Coronary Artery Disease,C14.280.647.250.260
23817481,2013-07-02T00:00:00,Coronary Artery Disease,C14.907.137.126.339
23817481,2013-07-02T00:00:00,Coronary Artery Disease,C14.907.585.250.260
23817481,2013-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23817481,2013-07-02T00:00:00,Hypercholesterolemia,C18.452.584.500.500.396
23817481,2013-07-02T00:00:00,Hypertension,C14.907.489
23817481,2013-07-02T00:00:00,Middle Aged,M01.060.116.630
23817481,2013-07-02T00:00:00,Nutrition Surveys,E05.318.308.250.600
23817481,2013-07-02T00:00:00,Nutrition Surveys,E05.318.308.585.550
23817481,2013-07-02T00:00:00,Nutrition Surveys,N05.715.360.300.375.560
23817481,2013-07-02T00:00:00,Nutrition Surveys,N05.715.360.300.560.565
23817481,2013-07-02T00:00:00,Nutrition Surveys,N06.850.520.308.250.600
23817481,2013-07-02T00:00:00,Nutrition Surveys,N06.850.520.308.585.550
23817481,2013-07-02T00:00:00,Risk Factors,E05.318.740.600.800.725
23817481,2013-07-02T00:00:00,Risk Factors,N05.715.350.200.700
23817481,2013-07-02T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23817481,2013-07-02T00:00:00,Risk Factors,N06.850.490.625.750
23817481,2013-07-02T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23817481,2013-07-02T00:00:00,United States,Z01.107.567.875
23818126,2013-07-02T00:00:00,"Diagnosis, Differential",E01.171
23818126,2013-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23818126,2013-07-02T00:00:00,Treatment Outcome,E01.789.800
23818126,2013-07-02T00:00:00,Treatment Outcome,N04.761.559.590.800
23818126,2013-07-02T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23821232,2013-07-02T00:00:00,Disease Management,N04.590.607
23821232,2013-07-02T00:00:00,Forecasting,I01.320
23821232,2013-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23821232,2013-07-02T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
23821232,2013-07-02T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
23821232,2013-07-02T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
23821232,2013-07-02T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23821232,2013-07-02T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23821232,2013-07-02T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23821232,2013-07-02T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23830138,2013-07-02T00:00:00,Electromyography,E01.370.405.255
23830138,2013-07-02T00:00:00,Electromyography,E01.370.530.255
23830138,2013-07-02T00:00:00,Gait,E01.370.600.250
23830138,2013-07-02T00:00:00,Gait,G11.427.590.530.389
23830138,2013-07-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23830138,2013-07-02T00:00:00,Knee Joint,A02.835.583.475
23830138,2013-07-02T00:00:00,Leg,A01.378.610.500
23830138,2013-07-02T00:00:00,Middle Aged,M01.060.116.630
23830138,2013-07-02T00:00:00,"Models, Biological",E05.599.395
23830138,2013-07-02T00:00:00,"Muscle, Skeletal",A02.633.567
23830138,2013-07-02T00:00:00,"Muscle, Skeletal",A10.690.552.500
23830138,2013-07-02T00:00:00,Paresis,C10.597.636
23830138,2013-07-02T00:00:00,Paresis,C23.888.592.643
23830138,2013-07-02T00:00:00,Stroke,C10.228.140.300.775
23830138,2013-07-02T00:00:00,Stroke,C14.907.253.855
23830138,2013-07-02T00:00:00,Walking,G11.427.590.530.568.900
23830138,2013-07-02T00:00:00,Walking,G11.427.590.530.698.940
23830138,2013-07-02T00:00:00,Walking,I03.450.642.845.940
23820633,2013-07-03T00:00:00,Animals,B01.050
23820633,2013-07-03T00:00:00,Cell Cycle Proteins,D12.776.167
23820633,2013-07-03T00:00:00,Dietary Fats,D10.212.302
23820633,2013-07-03T00:00:00,Dietary Fats,J02.500.375
23820633,2013-07-03T00:00:00,Fatty Acids,D10.251
23820633,2013-07-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23820633,2013-07-03T00:00:00,Insulin Resistance,C18.452.394.968.500
23820633,2013-07-03T00:00:00,Insulin Resistance,G07.690.320.617
23820633,2013-07-03T00:00:00,Obesity,C18.654.726.500
23820633,2013-07-03T00:00:00,Obesity,C23.888.144.699.500
23820633,2013-07-03T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23820633,2013-07-03T00:00:00,Obesity,G07.100.100.160.120.699.500
23820633,2013-07-03T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23820633,2013-07-03T00:00:00,Repressor Proteins,D12.776.260.703
23820633,2013-07-03T00:00:00,Repressor Proteins,D12.776.930.700
23828629,2013-07-05T00:00:00,Contrast Media,D27.720.259
23828629,2013-07-05T00:00:00,Diagnostic Imaging,E01.370.350
23828629,2013-07-05T00:00:00,Luminescence,G01.201.875.770.578.665
23828629,2013-07-05T00:00:00,Luminescence,G01.590.540.665
23828629,2013-07-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23828629,2013-07-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23828629,2013-07-05T00:00:00,Nanoparticles,J01.637.512.600
23828629,2013-07-05T00:00:00,Polyethylene Glycols,D02.033.455.250.700
23828629,2013-07-05T00:00:00,Polyethylene Glycols,D05.750.741
23828629,2013-07-05T00:00:00,Polyethylene Glycols,D25.720.741
23828629,2013-07-05T00:00:00,Polyethylene Glycols,J01.637.051.720.741
23832869,2013-07-05T00:00:00,Biofilms,G06.120
23832869,2013-07-05T00:00:00,Biosensing Techniques,E05.601.123
23832869,2013-07-05T00:00:00,Luminescent Measurements,E05.196.712.516
23861849,2013-07-05T00:00:00,Aged,M01.060.116.100
23861849,2013-07-05T00:00:00,Gene Expression Regulation,G05.355.315
23861849,2013-07-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23861849,2013-07-05T00:00:00,Middle Aged,M01.060.116.630
23861849,2013-07-05T00:00:00,Muscle Contraction,G11.427.590.540
23861849,2013-07-05T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
23861849,2013-07-05T00:00:00,Peptides,D12.644
23861849,2013-07-05T00:00:00,"Urinary Bladder, Overactive",C12.777.829.866
23861849,2013-07-05T00:00:00,"Urinary Bladder, Overactive",C13.351.968.829.813
23861849,2013-07-05T00:00:00,"Urinary Bladder, Overactive",C23.888.942.775
23838851,2013-07-06T00:00:00,Awareness,F02.463.188.150
23838851,2013-07-06T00:00:00,Clinical Trials as Topic,E05.318.760.535
23838851,2013-07-06T00:00:00,Clinical Trials as Topic,E05.337.250
23838851,2013-07-06T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23838851,2013-07-06T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23838851,2013-07-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23838851,2013-07-06T00:00:00,Risk Factors,E05.318.740.600.800.725
23838851,2013-07-06T00:00:00,Risk Factors,N05.715.350.200.700
23838851,2013-07-06T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23838851,2013-07-06T00:00:00,Risk Factors,N06.850.490.625.750
23838851,2013-07-06T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23838851,2013-07-06T00:00:00,Secondary Prevention,N02.421.726.825
23838851,2013-07-06T00:00:00,Secondary Prevention,N06.850.780.750
23838851,2013-07-06T00:00:00,Stroke,C10.228.140.300.775
23838851,2013-07-06T00:00:00,Stroke,C14.907.253.855
23911762,2013-07-06T00:00:00,Animals,B01.050
23911762,2013-07-06T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23911762,2013-07-06T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23911762,2013-07-06T00:00:00,Ceramides,D02.065.313
23911762,2013-07-06T00:00:00,Ceramides,D09.400.410.420.525.200
23911762,2013-07-06T00:00:00,Ceramides,D10.390.470.675.200
23911762,2013-07-06T00:00:00,Ceramides,D10.570.877.360.612.200
23911762,2013-07-06T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
23911762,2013-07-06T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
23911762,2013-07-06T00:00:00,Oxidoreductases,D08.811.682
23911762,2013-07-06T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
23911762,2013-07-06T00:00:00,Photochemotherapy,E02.186.500
23911762,2013-07-06T00:00:00,Photochemotherapy,E02.319.685
23911762,2013-07-06T00:00:00,Photochemotherapy,E02.774.722
23911762,2013-07-06T00:00:00,Propanolamines,D02.033.100.624
23911762,2013-07-06T00:00:00,Propanolamines,D02.033.755.624
23911762,2013-07-06T00:00:00,Propanolamines,D02.092.063.624
23911762,2013-07-06T00:00:00,Sphingosine,D02.033.100.700
23911762,2013-07-06T00:00:00,Sphingosine,D02.033.455.843
23911762,2013-07-06T00:00:00,Sphingosine,D02.092.063.700
23911762,2013-07-06T00:00:00,Treatment Outcome,E01.789.800
23911762,2013-07-06T00:00:00,Treatment Outcome,N04.761.559.590.800
23911762,2013-07-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23835761,2013-07-08T00:00:00,Adult,M01.060.116
23835761,2013-07-08T00:00:00,Antioxidants,D27.505.519.217
23835761,2013-07-08T00:00:00,Antioxidants,D27.505.696.706.125
23835761,2013-07-08T00:00:00,Antioxidants,D27.720.799.047
23835761,2013-07-08T00:00:00,Flavonolignans,D02.455.426.559.389.140.450.388
23835761,2013-07-08T00:00:00,Flavonolignans,D03.438.150.266.450.268
23835761,2013-07-08T00:00:00,Flavonolignans,D03.830.219.266.450.268
23835761,2013-07-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23835761,2013-07-08T00:00:00,Young Adult,M01.060.116.815
23837992,2013-07-09T00:00:00,Delivery of Health Care,N04.590.374
23837992,2013-07-09T00:00:00,Delivery of Health Care,N05.300
23837992,2013-07-09T00:00:00,Internet,L01.224.230.110.500
23837992,2013-07-09T00:00:00,Telemedicine,H02.403.840
23837992,2013-07-09T00:00:00,Telemedicine,L01.178.847.652
23837992,2013-07-09T00:00:00,Telemedicine,N04.590.374.800
23837992,2013-07-09T00:00:00,United States,Z01.107.567.875
23838308,2013-07-09T00:00:00,Adult,M01.060.116
23838308,2013-07-09T00:00:00,Chronic Disease,C23.550.291.500
23838308,2013-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23838308,2013-07-09T00:00:00,Middle Aged,M01.060.116.630
23838308,2013-07-09T00:00:00,Reactive Oxygen Species,D01.339.431
23838308,2013-07-09T00:00:00,Reactive Oxygen Species,D01.650.775
23838308,2013-07-09T00:00:00,Rhinitis,C08.460.799
23838308,2013-07-09T00:00:00,Rhinitis,C08.730.674
23838308,2013-07-09T00:00:00,Rhinitis,C09.603.799
23838308,2013-07-09T00:00:00,Sinusitis,C08.460.692.752
23838308,2013-07-09T00:00:00,Sinusitis,C08.730.749
23838308,2013-07-09T00:00:00,Sinusitis,C09.603.692.752
23838308,2013-07-09T00:00:00,Tobacco Smoke Pollution,D20.633.937.680
23838308,2013-07-09T00:00:00,Tobacco Smoke Pollution,N06.850.460.100.555
23838935,2013-07-09T00:00:00,Animals,B01.050
23838935,2013-07-09T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
23838935,2013-07-09T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
23838935,2013-07-09T00:00:00,Apoptosis,G04.299.139.160
23838935,2013-07-09T00:00:00,Bone Marrow Cells,A11.148
23838935,2013-07-09T00:00:00,Bone Marrow Cells,A15.378.316
23838935,2013-07-09T00:00:00,Cell Differentiation,G04.299.151
23838935,2013-07-09T00:00:00,Cell Movement,G04.299.283
23838935,2013-07-09T00:00:00,Cell Movement,G07.700.560.500.180
23838935,2013-07-09T00:00:00,Cell Proliferation,G04.299.233.750
23838935,2013-07-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23838935,2013-07-09T00:00:00,Chromatin Immunoprecipitation,E05.393.170
23838935,2013-07-09T00:00:00,Chromatin Immunoprecipitation,E05.478.605.160
23838935,2013-07-09T00:00:00,Fibroblasts,A11.329.228
23838935,2013-07-09T00:00:00,Fibroblasts,A11.872.228
23838935,2013-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23838935,2013-07-09T00:00:00,"Mammary Neoplasms, Animal",C04.588.531
23838935,2013-07-09T00:00:00,"Mammary Neoplasms, Animal",C22.520
23838935,2013-07-09T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23838935,2013-07-09T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C04.588.322.455
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C19.344.410
23838935,2013-07-09T00:00:00,Ovarian Neoplasms,C19.391.630.705
23838935,2013-07-09T00:00:00,Phenotype,G05.695
23838935,2013-07-09T00:00:00,"RNA, Messenger",D13.444.735.544
23874466,2013-07-09T00:00:00,Brain Mapping,E01.370.350.086
23874466,2013-07-09T00:00:00,Brain Mapping,E01.370.376.149
23874466,2013-07-09T00:00:00,Brain Mapping,E05.132
23874466,2013-07-09T00:00:00,Corpus Striatum,A08.186.211.730.885.287.249.487
23874466,2013-07-09T00:00:00,Hippocampus,A08.186.211.464.405
23874466,2013-07-09T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
23874466,2013-07-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23874466,2013-07-09T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
23874466,2013-07-09T00:00:00,Limbic System,A08.186.211.464
23874466,2013-07-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23874466,2013-07-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23874466,2013-07-09T00:00:00,Pilot Projects,E05.318.760.750
23874466,2013-07-09T00:00:00,Pilot Projects,E05.337.737
23874466,2013-07-09T00:00:00,Pilot Projects,N05.715.360.775.625
23874466,2013-07-09T00:00:00,Pilot Projects,N06.850.520.450.720
23874466,2013-07-09T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
23874466,2013-07-09T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
23874466,2013-07-09T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
23839981,2013-07-10T00:00:00,Animals,B01.050
23839981,2013-07-10T00:00:00,"Animals, Newborn",B01.050.050.282
23839981,2013-07-10T00:00:00,Cell Survival,G04.299.316
23839981,2013-07-10T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
23839981,2013-07-10T00:00:00,Cytokines,D12.644.276.374
23839981,2013-07-10T00:00:00,Cytokines,D12.776.467.374
23839981,2013-07-10T00:00:00,Cytokines,D23.529.374
23839981,2013-07-10T00:00:00,Enzyme Inhibitors,D27.505.519.389
23839981,2013-07-10T00:00:00,Glutathione,D12.644.456.448
23839981,2013-07-10T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
23839981,2013-07-10T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
23839981,2013-07-10T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
23839981,2013-07-10T00:00:00,Lovastatin,D02.455.426.559.847.638.400
23839981,2013-07-10T00:00:00,Lovastatin,D04.615.638.400
23839981,2013-07-10T00:00:00,Neurons,A08.663
23839981,2013-07-10T00:00:00,Neurons,A11.671
23839981,2013-07-10T00:00:00,Oligodendroglia,A08.637.600
23839981,2013-07-10T00:00:00,Oligodendroglia,A11.650.600
23839981,2013-07-10T00:00:00,Pregnancy,G08.686.785.760.769
23839981,2013-07-10T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23839981,2013-07-10T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23839981,2013-07-10T00:00:00,Reactive Oxygen Species,D01.339.431
23839981,2013-07-10T00:00:00,Reactive Oxygen Species,D01.650.775
23839981,2013-07-10T00:00:00,Signal Transduction,G02.111.087.800
23839981,2013-07-10T00:00:00,Signal Transduction,G02.149.115.800
23839981,2013-07-10T00:00:00,Signal Transduction,G04.299.880
23839981,2013-07-10T00:00:00,rho GTP-Binding Proteins,D08.811.277.040.330.300.400.700
23839981,2013-07-10T00:00:00,rho GTP-Binding Proteins,D12.644.360.525.700
23839981,2013-07-10T00:00:00,rho GTP-Binding Proteins,D12.776.157.325.515.700
23839981,2013-07-10T00:00:00,rho GTP-Binding Proteins,D12.776.476.525.700
23841494,2013-07-10T00:00:00,Animals,B01.050
23841494,2013-07-10T00:00:00,Autoimmune Diseases,C20.111
23841494,2013-07-10T00:00:00,Gastrointestinal Tract,A03.556
23841494,2013-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23841494,2013-07-10T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
23841494,2013-07-10T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
23841494,2013-07-10T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
23936841,2013-07-10T00:00:00,Aged,M01.060.116.100
23936841,2013-07-10T00:00:00,Carcinoma,C04.557.470.200
23936841,2013-07-10T00:00:00,Diagnostic Imaging,E01.370.350
23936841,2013-07-10T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
23936841,2013-07-10T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
23936841,2013-07-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23936841,2013-07-10T00:00:00,Middle Aged,M01.060.116.630
23936841,2013-07-10T00:00:00,Treatment Outcome,E01.789.800
23936841,2013-07-10T00:00:00,Treatment Outcome,N04.761.559.590.800
23936841,2013-07-10T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23847251,2013-07-11T00:00:00,African Continental Ancestry Group,M01.686.508.100
23847251,2013-07-11T00:00:00,Aged,M01.060.116.100
23847251,2013-07-11T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23847251,2013-07-11T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23847251,2013-07-11T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23847251,2013-07-11T00:00:00,European Continental Ancestry Group,M01.686.508.400
23847251,2013-07-11T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
23847251,2013-07-11T00:00:00,Glomerular Filtration Rate,G08.852.357
23847251,2013-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23847251,2013-07-11T00:00:00,Middle Aged,M01.060.116.630
23847251,2013-07-11T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
23847251,2013-07-11T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23850191,2013-07-11T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
23850191,2013-07-11T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
23850191,2013-07-11T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
23850191,2013-07-11T00:00:00,Animals,B01.050
23850191,2013-07-11T00:00:00,Phosphoproteins,D12.776.744
23850191,2013-07-11T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
23850191,2013-07-11T00:00:00,Signal Transduction,G02.111.087.800
23850191,2013-07-11T00:00:00,Signal Transduction,G02.149.115.800
23850191,2013-07-11T00:00:00,Signal Transduction,G04.299.880
23850262,2013-07-11T00:00:00,Adult,M01.060.116
23850262,2013-07-11T00:00:00,Albuminuria,C12.777.934.734.269
23850262,2013-07-11T00:00:00,Albuminuria,C13.351.968.934.734.269
23850262,2013-07-11T00:00:00,Albuminuria,C23.888.942.750.269
23850262,2013-07-11T00:00:00,Clinical Trials as Topic,E05.318.760.535
23850262,2013-07-11T00:00:00,Clinical Trials as Topic,E05.337.250
23850262,2013-07-11T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23850262,2013-07-11T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23850262,2013-07-11T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
23850262,2013-07-11T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
23850262,2013-07-11T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
23850262,2013-07-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23850262,2013-07-11T00:00:00,Lipoproteins,D10.532
23850262,2013-07-11T00:00:00,Lipoproteins,D12.776.521
23850262,2013-07-11T00:00:00,Middle Aged,M01.060.116.630
23850262,2013-07-11T00:00:00,Prevalence,E05.318.308.985.525.750
23850262,2013-07-11T00:00:00,Prevalence,L01.280.975.525.750
23850262,2013-07-11T00:00:00,Prevalence,N01.224.935.597.750
23850262,2013-07-11T00:00:00,Prevalence,N06.850.505.400.975.525.750
23850262,2013-07-11T00:00:00,Prevalence,N06.850.520.308.985.525.750
23852826,2013-07-12T00:00:00,Adolescent,M01.060.057
23852826,2013-07-12T00:00:00,Adult,M01.060.116
23852826,2013-07-12T00:00:00,Aged,M01.060.116.100
23852826,2013-07-12T00:00:00,Cyclonic Storms,G16.500.240.135.500
23852826,2013-07-12T00:00:00,Depression,F01.145.126.350
23852826,2013-07-12T00:00:00,Disasters,N06.230.100
23852826,2013-07-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23852826,2013-07-12T00:00:00,Middle Aged,M01.060.116.630
23852826,2013-07-12T00:00:00,Risk Factors,E05.318.740.600.800.725
23852826,2013-07-12T00:00:00,Risk Factors,N05.715.350.200.700
23852826,2013-07-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23852826,2013-07-12T00:00:00,Risk Factors,N06.850.490.625.750
23852826,2013-07-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23852826,2013-07-12T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23852826,2013-07-12T00:00:00,Young Adult,M01.060.116.815
23911830,2013-07-13T00:00:00,Adsorption,G02.149.047
23911830,2013-07-13T00:00:00,Adsorption,G02.149.767.029
23911830,2013-07-13T00:00:00,Adsorption,G02.842.750.029
23911830,2013-07-13T00:00:00,Carbon,D01.268.150
23911830,2013-07-13T00:00:00,"Membranes, Artificial",D25.479
23911830,2013-07-13T00:00:00,"Membranes, Artificial",J01.637.051.479
23911830,2013-07-13T00:00:00,"Membranes, Artificial",J01.637.087.500
23911830,2013-07-13T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23911830,2013-07-13T00:00:00,Water Purification,N06.850.780.200.800.800.900.900
23911830,2013-07-13T00:00:00,Water Purification,N06.850.860.510.900.900
23911830,2013-07-13T00:00:00,Water Purification,N06.850.860.510.915.900
23856802,2013-07-15T00:00:00,Chronic Disease,C23.550.291.500
23856802,2013-07-15T00:00:00,Decision Making,F02.463.785.373
23856802,2013-07-15T00:00:00,Endoscopy,E01.370.388.250
23856802,2013-07-15T00:00:00,Endoscopy,E04.800.250
23856802,2013-07-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23856802,2013-07-15T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23856802,2013-07-15T00:00:00,Physician-Patient Relations,N05.300.660.625
23856802,2013-07-15T00:00:00,Quality of Life,I01.800
23856802,2013-07-15T00:00:00,Quality of Life,K01.752.400.750
23856802,2013-07-15T00:00:00,Rhinitis,C08.460.799
23856802,2013-07-15T00:00:00,Rhinitis,C08.730.674
23856802,2013-07-15T00:00:00,Rhinitis,C09.603.799
23856802,2013-07-15T00:00:00,Sinusitis,C08.460.692.752
23856802,2013-07-15T00:00:00,Sinusitis,C08.730.749
23856802,2013-07-15T00:00:00,Sinusitis,C09.603.692.752
23856802,2013-07-15T00:00:00,Social Support,I01.880.656.600
23856688,2013-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23856688,2013-07-16T00:00:00,Lung Neoplasms,C04.588.894.797.520
23856688,2013-07-16T00:00:00,Lung Neoplasms,C08.381.540
23856688,2013-07-16T00:00:00,Lung Neoplasms,C08.785.520
23856688,2013-07-16T00:00:00,Mass Screening,E01.370.500
23856688,2013-07-16T00:00:00,Mass Screening,E05.318.308.250.580
23856688,2013-07-16T00:00:00,Mass Screening,N02.421.143.827.233.443
23856688,2013-07-16T00:00:00,Mass Screening,N02.421.726.233.443
23856688,2013-07-16T00:00:00,Mass Screening,N05.715.360.300.375.500
23856688,2013-07-16T00:00:00,Mass Screening,N06.850.520.308.250.580
23856688,2013-07-16T00:00:00,Mass Screening,N06.850.780.500
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23856688,2013-07-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23861399,2013-07-16T00:00:00,Animals,B01.050
23861399,2013-07-16T00:00:00,Glutathione,D12.644.456.448
23861399,2013-07-16T00:00:00,Glutathione Transferase,D08.811.913.225.500
23861399,2013-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23861399,2013-07-16T00:00:00,Nitric Oxide,D01.339.387
23861399,2013-07-16T00:00:00,Nitric Oxide,D01.625.550.500
23861399,2013-07-16T00:00:00,Nitric Oxide,D01.625.700.500
23861399,2013-07-16T00:00:00,Nitric Oxide,D01.650.550.587.600
23861399,2013-07-16T00:00:00,Nitrogen,D01.268.604
23861399,2013-07-16T00:00:00,Nitrogen,D01.362.625
23861399,2013-07-16T00:00:00,Oxidative Stress,G03.495.710
23861399,2013-07-16T00:00:00,Oxidative Stress,G07.700.830.750
23861399,2013-07-16T00:00:00,Peroxidases,D08.811.682.732
23861399,2013-07-16T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
23861399,2013-07-16T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
23861399,2013-07-16T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
23861399,2013-07-16T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
23861399,2013-07-16T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
23861399,2013-07-16T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
23861399,2013-07-16T00:00:00,Reactive Oxygen Species,D01.339.431
23861399,2013-07-16T00:00:00,Reactive Oxygen Species,D01.650.775
23861399,2013-07-16T00:00:00,Serpins,D12.644.822.750
23861399,2013-07-16T00:00:00,Serpins,D12.644.861
23861399,2013-07-16T00:00:00,Serpins,D12.776.645.750
23861399,2013-07-16T00:00:00,Serpins,D12.776.872
23870160,2013-07-16T00:00:00,Biological Markers,D23.101
23870160,2013-07-16T00:00:00,Cardiac Surgical Procedures,E04.100.376
23870160,2013-07-16T00:00:00,Cardiac Surgical Procedures,E04.928.220
23870160,2013-07-16T00:00:00,Cardiopulmonary Bypass,E04.292.413
23870160,2013-07-16T00:00:00,Cytokines,D12.644.276.374
23870160,2013-07-16T00:00:00,Cytokines,D12.776.467.374
23870160,2013-07-16T00:00:00,Cytokines,D23.529.374
23870160,2013-07-16T00:00:00,Glucocorticoids,D06.472.040.543
23870160,2013-07-16T00:00:00,Glucocorticoids,D27.505.696.399.472.488
23870160,2013-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23870160,2013-07-16T00:00:00,"Infant, Newborn",M01.060.703.520
23870160,2013-07-16T00:00:00,Inflammation,C23.550.470
23870160,2013-07-16T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
23870160,2013-07-16T00:00:00,Length of Stay,E02.760.400.480
23870160,2013-07-16T00:00:00,Length of Stay,N02.421.585.400.480
23870160,2013-07-16T00:00:00,Preoperative Care,E02.760.795
23870160,2013-07-16T00:00:00,Preoperative Care,E04.641
23870160,2013-07-16T00:00:00,Preoperative Care,N02.421.585.795
23870160,2013-07-16T00:00:00,South Carolina,Z01.107.567.875.075.662
23870160,2013-07-16T00:00:00,South Carolina,Z01.107.567.875.750.700
23870160,2013-07-16T00:00:00,Treatment Outcome,E01.789.800
23870160,2013-07-16T00:00:00,Treatment Outcome,N04.761.559.590.800
23870160,2013-07-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23871686,2013-07-16T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23871686,2013-07-16T00:00:00,Genetic Predisposition to Disease,G05.380.355
23871686,2013-07-16T00:00:00,Genome-Wide Association Study,E05.318.416.249
23871686,2013-07-16T00:00:00,Genome-Wide Association Study,E05.318.780.392
23871686,2013-07-16T00:00:00,Genome-Wide Association Study,E05.393.385.500
23871686,2013-07-16T00:00:00,Genome-Wide Association Study,E05.393.522.500
23871686,2013-07-16T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23871686,2013-07-16T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23871686,2013-07-16T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23871686,2013-07-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23871686,2013-07-16T00:00:00,"Mutation, Missense",G05.365.590.650
23871686,2013-07-16T00:00:00,Proteins,D12.776
23863051,2013-07-18T00:00:00,Aged,M01.060.116.100
23863051,2013-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23863051,2013-07-18T00:00:00,Lung,A04.411
23863051,2013-07-18T00:00:00,Lung Neoplasms,C04.588.894.797.520
23863051,2013-07-18T00:00:00,Lung Neoplasms,C08.381.540
23863051,2013-07-18T00:00:00,Lung Neoplasms,C08.785.520
23863051,2013-07-18T00:00:00,Mass Screening,E01.370.500
23863051,2013-07-18T00:00:00,Mass Screening,E05.318.308.250.580
23863051,2013-07-18T00:00:00,Mass Screening,N02.421.143.827.233.443
23863051,2013-07-18T00:00:00,Mass Screening,N02.421.726.233.443
23863051,2013-07-18T00:00:00,Mass Screening,N05.715.360.300.375.500
23863051,2013-07-18T00:00:00,Mass Screening,N06.850.520.308.250.580
23863051,2013-07-18T00:00:00,Mass Screening,N06.850.780.500
23863051,2013-07-18T00:00:00,Middle Aged,M01.060.116.630
23863051,2013-07-18T00:00:00,Radiation Dosage,E05.799.513
23863051,2013-07-18T00:00:00,Radiation Dosage,G01.201.875.740
23863051,2013-07-18T00:00:00,Radiation Dosage,N06.850.810.250
23863051,2013-07-18T00:00:00,Smoking,F01.145.466.753
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23863051,2013-07-18T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23868899,2013-07-18T00:00:00,Animals,B01.050
23868899,2013-07-18T00:00:00,Biomedical Research,H01.770.644.145
23868899,2013-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23868899,2013-07-18T00:00:00,Risk Factors,E05.318.740.600.800.725
23868899,2013-07-18T00:00:00,Risk Factors,N05.715.350.200.700
23868899,2013-07-18T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23868899,2013-07-18T00:00:00,Risk Factors,N06.850.490.625.750
23868899,2013-07-18T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23868899,2013-07-18T00:00:00,United States,Z01.107.567.875
23868902,2013-07-18T00:00:00,African Continental Ancestry Group,M01.686.508.100
23868902,2013-07-18T00:00:00,Aged,M01.060.116.100
23868902,2013-07-18T00:00:00,Albuminuria,C12.777.934.734.269
23868902,2013-07-18T00:00:00,Albuminuria,C13.351.968.934.734.269
23868902,2013-07-18T00:00:00,Albuminuria,C23.888.942.750.269
23868902,2013-07-18T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23868902,2013-07-18T00:00:00,Blood Pressure,E01.370.600.875.249
23868902,2013-07-18T00:00:00,Blood Pressure,G09.330.380.076
23868902,2013-07-18T00:00:00,Creatinine,D03.383.129.308.207
23868902,2013-07-18T00:00:00,Diabetes Mellitus,C18.452.394.750
23868902,2013-07-18T00:00:00,Diabetes Mellitus,C19.246
23868902,2013-07-18T00:00:00,Drug Resistance,G07.690.320
23868902,2013-07-18T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
23868902,2013-07-18T00:00:00,Glomerular Filtration Rate,G08.852.357
23868902,2013-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23868902,2013-07-18T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
23868902,2013-07-18T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
23868902,2013-07-18T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
23868902,2013-07-18T00:00:00,Hypertension,C14.907.489
23868902,2013-07-18T00:00:00,Middle Aged,M01.060.116.630
23868902,2013-07-18T00:00:00,Myocardial Infarction,C14.280.647.500
23868902,2013-07-18T00:00:00,Myocardial Infarction,C14.907.585.500
23868902,2013-07-18T00:00:00,Prevalence,E05.318.308.985.525.750
23868902,2013-07-18T00:00:00,Prevalence,L01.280.975.525.750
23868902,2013-07-18T00:00:00,Prevalence,N01.224.935.597.750
23868902,2013-07-18T00:00:00,Prevalence,N06.850.505.400.975.525.750
23868902,2013-07-18T00:00:00,Prevalence,N06.850.520.308.985.525.750
23868902,2013-07-18T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
23868902,2013-07-18T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23868902,2013-07-18T00:00:00,Sex Factors,N05.715.350.675
23868902,2013-07-18T00:00:00,Sex Factors,N06.850.490.875
23868902,2013-07-18T00:00:00,Stroke,C10.228.140.300.775
23868902,2013-07-18T00:00:00,Stroke,C14.907.253.855
23868902,2013-07-18T00:00:00,United States,Z01.107.567.875
23870125,2013-07-18T00:00:00,Animals,B01.050
23870125,2013-07-18T00:00:00,Apoptosis Regulatory Proteins,D12.644.360.075
23870125,2013-07-18T00:00:00,Apoptosis Regulatory Proteins,D12.776.476.075
23870125,2013-07-18T00:00:00,Autophagy,G04.299.139.399
23870125,2013-07-18T00:00:00,Autophagy,G04.299.482.350.091
23870125,2013-07-18T00:00:00,Cattle,B01.050.150.900.649.077.380.271
23870125,2013-07-18T00:00:00,Microtubule-Associated Proteins,D12.776.220.600.450
23870125,2013-07-18T00:00:00,Microtubule-Associated Proteins,D12.776.641.560
23870125,2013-07-18T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23870125,2013-07-18T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23870125,2013-07-18T00:00:00,Retinoids,D02.455.326.271.665.202.495
23870125,2013-07-18T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
23870125,2013-07-18T00:00:00,Retinoids,D02.455.849.131.495
23870125,2013-07-18T00:00:00,Retinoids,D23.767.261.700
23870125,2013-07-18T00:00:00,"Vision, Ocular",F02.830.816.964
23870125,2013-07-18T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
23870125,2013-07-18T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
23870125,2013-07-18T00:00:00,"Vision, Ocular",G04.299.880.480.900
23870125,2013-07-18T00:00:00,"Vision, Ocular",G11.561.600.810.964
23870125,2013-07-18T00:00:00,"Vision, Ocular",G14.640.816
23872371,2013-07-18T00:00:00,Animals,B01.050
23872371,2013-07-18T00:00:00,Ethanol,D02.033.375
23872371,2013-07-18T00:00:00,Locomotion,G07.700.560.500
23872371,2013-07-18T00:00:00,Locomotion,G11.427.590.530.568
23874208,2013-07-18T00:00:00,African Americans,M01.686.508.100.100
23874208,2013-07-18T00:00:00,African Americans,M01.686.754.100
23874208,2013-07-18T00:00:00,Alleles,G05.360.340.024.340.030
23874208,2013-07-18T00:00:00,European Continental Ancestry Group,M01.686.508.400
23874208,2013-07-18T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23874208,2013-07-18T00:00:00,Genetic Predisposition to Disease,G05.380.355
23874208,2013-07-18T00:00:00,Genome-Wide Association Study,E05.318.416.249
23874208,2013-07-18T00:00:00,Genome-Wide Association Study,E05.318.780.392
23874208,2013-07-18T00:00:00,Genome-Wide Association Study,E05.393.385.500
23874208,2013-07-18T00:00:00,Genome-Wide Association Study,E05.393.522.500
23874208,2013-07-18T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23874208,2013-07-18T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23874208,2013-07-18T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23874208,2013-07-18T00:00:00,Hispanic Americans,M01.686.754.441
23874208,2013-07-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23874208,2013-07-18T00:00:00,Linkage Disequilibrium,G05.540.500
23874208,2013-07-18T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23874208,2013-07-18T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23874208,2013-07-18T00:00:00,Lymphocytes,A11.118.637.555.567
23874208,2013-07-18T00:00:00,Lymphocytes,A15.145.229.637.555.567
23874208,2013-07-18T00:00:00,Lymphocytes,A15.382.490.555.567
23874208,2013-07-18T00:00:00,NF-kappa B,D12.776.260.600
23874208,2013-07-18T00:00:00,NF-kappa B,D12.776.660.600
23874208,2013-07-18T00:00:00,NF-kappa B,D12.776.930.600
23874208,2013-07-18T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23865821,2013-07-19T00:00:00,Adult,M01.060.116
23865821,2013-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23865821,2013-07-19T00:00:00,Kidney,A05.810.453
23865821,2013-07-19T00:00:00,Kidney Transplantation,E02.870.500
23865821,2013-07-19T00:00:00,Kidney Transplantation,E04.936.450.485
23865821,2013-07-19T00:00:00,Kidney Transplantation,E04.950.774.400
23865821,2013-07-19T00:00:00,Living Donors,M01.898.656
23865821,2013-07-19T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23865821,2013-07-19T00:00:00,Metabolic Syndrome X,C18.452.625
23865821,2013-07-19T00:00:00,Middle Aged,M01.060.116.630
23865821,2013-07-19T00:00:00,Nephrectomy,E04.950.774.435
23865821,2013-07-19T00:00:00,Prevalence,E05.318.308.985.525.750
23865821,2013-07-19T00:00:00,Prevalence,L01.280.975.525.750
23865821,2013-07-19T00:00:00,Prevalence,N01.224.935.597.750
23865821,2013-07-19T00:00:00,Prevalence,N06.850.505.400.975.525.750
23865821,2013-07-19T00:00:00,Prevalence,N06.850.520.308.985.525.750
23865821,2013-07-19T00:00:00,Weight Loss,C23.888.144.243.963
23865821,2013-07-19T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23876704,2013-07-19T00:00:00,Adult,M01.060.116
23876704,2013-07-19T00:00:00,Age Factors,N05.715.350.075
23876704,2013-07-19T00:00:00,Age Factors,N06.850.490.250
23876704,2013-07-19T00:00:00,Blood Glucose,D09.546.359.448.500
23876704,2013-07-19T00:00:00,Enteral Nutrition,E02.421.360
23876704,2013-07-19T00:00:00,Enteral Nutrition,E02.642.500.360
23876704,2013-07-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23876704,2013-07-19T00:00:00,Hyperglycemia,C18.452.394.952
23876704,2013-07-19T00:00:00,Hypoglycemic Agents,D27.505.696.422
23876704,2013-07-19T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
23876704,2013-07-19T00:00:00,Insulin,D06.472.699.587.740.625
23876704,2013-07-19T00:00:00,Insulin,D12.644.548.586.740.625
23876704,2013-07-19T00:00:00,Intensive Care Units,N02.278.388.493
23876704,2013-07-19T00:00:00,Middle Aged,M01.060.116.630
23876704,2013-07-19T00:00:00,Risk Factors,E05.318.740.600.800.725
23876704,2013-07-19T00:00:00,Risk Factors,N05.715.350.200.700
23876704,2013-07-19T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23876704,2013-07-19T00:00:00,Risk Factors,N06.850.490.625.750
23876704,2013-07-19T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23876704,2013-07-19T00:00:00,Treatment Outcome,E01.789.800
23876704,2013-07-19T00:00:00,Treatment Outcome,N04.761.559.590.800
23876704,2013-07-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23869967,2013-07-22T00:00:00,Adolescent,M01.060.057
23869967,2013-07-22T00:00:00,Cognition,F02.463.188
23869967,2013-07-22T00:00:00,Emotions,F01.470
23869967,2013-07-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23869967,2013-07-22T00:00:00,Social Isolation,F01.145.813.781
23869967,2013-07-22T00:00:00,Social Isolation,I01.880.683
23878296,2013-07-22T00:00:00,Antineoplastic Agents,D27.505.954.248
23878296,2013-07-22T00:00:00,Clinical Trials as Topic,E05.318.760.535
23878296,2013-07-22T00:00:00,Clinical Trials as Topic,E05.337.250
23878296,2013-07-22T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23878296,2013-07-22T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23878296,2013-07-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23886031,2013-07-22T00:00:00,Adolescent,M01.060.057
23886031,2013-07-22T00:00:00,Adult,M01.060.116
23886031,2013-07-22T00:00:00,Cardiopulmonary Bypass,E04.292.413
23886031,2013-07-22T00:00:00,Child,M01.060.406
23886031,2013-07-22T00:00:00,"Child, Preschool",M01.060.406.448
23886031,2013-07-22T00:00:00,"Heart Defects, Congenital",C14.240.400
23886031,2013-07-22T00:00:00,"Heart Defects, Congenital",C14.280.400
23886031,2013-07-22T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23886031,2013-07-22T00:00:00,Heart Transplantation,E04.100.376.475
23886031,2013-07-22T00:00:00,Heart Transplantation,E04.928.220.390
23886031,2013-07-22T00:00:00,Heart Transplantation,E04.936.450.475
23886031,2013-07-22T00:00:00,Hospital Mortality,E05.318.308.985.550.400
23886031,2013-07-22T00:00:00,Hospital Mortality,L01.280.975.550.400
23886031,2013-07-22T00:00:00,Hospital Mortality,N01.224.935.698.400
23886031,2013-07-22T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
23886031,2013-07-22T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
23886031,2013-07-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23886031,2013-07-22T00:00:00,Infant,M01.060.703
23886031,2013-07-22T00:00:00,"Infant, Newborn",M01.060.703.520
23886031,2013-07-22T00:00:00,Renal Dialysis,E02.870.300
23886031,2013-07-22T00:00:00,Renal Dialysis,E02.912.800
23886031,2013-07-22T00:00:00,Renal Insufficiency,C12.777.419.780
23886031,2013-07-22T00:00:00,Renal Insufficiency,C13.351.968.419.780
23886031,2013-07-22T00:00:00,Risk Assessment,E05.318.740.600.800.715
23886031,2013-07-22T00:00:00,Risk Assessment,N04.452.871.715
23886031,2013-07-22T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23886031,2013-07-22T00:00:00,Risk Assessment,N06.850.505.715
23886031,2013-07-22T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23886031,2013-07-22T00:00:00,Risk Factors,E05.318.740.600.800.725
23886031,2013-07-22T00:00:00,Risk Factors,N05.715.350.200.700
23886031,2013-07-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23886031,2013-07-22T00:00:00,Risk Factors,N06.850.490.625.750
23886031,2013-07-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23886031,2013-07-22T00:00:00,South Carolina,Z01.107.567.875.075.662
23886031,2013-07-22T00:00:00,South Carolina,Z01.107.567.875.750.700
23886031,2013-07-22T00:00:00,Treatment Outcome,E01.789.800
23886031,2013-07-22T00:00:00,Treatment Outcome,N04.761.559.590.800
23886031,2013-07-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23886031,2013-07-22T00:00:00,Young Adult,M01.060.116.815
23877182,2013-07-23T00:00:00,"Analgesics, Non-Narcotic",D27.505.696.663.850.014.040
23877182,2013-07-23T00:00:00,"Analgesics, Non-Narcotic",D27.505.954.427.040.100
23877182,2013-07-23T00:00:00,Electrolytes,D01.248
23877182,2013-07-23T00:00:00,Ibuprofen,D02.241.223.701.430
23877182,2013-07-23T00:00:00,Plant Leaves,A18.024.812
23877182,2013-07-23T00:00:00,Tobacco,B01.650.388.100.905.900
23881643,2013-07-23T00:00:00,Adolescent,M01.060.057
23881643,2013-07-23T00:00:00,Ambulatory Care,E02.760.106
23881643,2013-07-23T00:00:00,Ambulatory Care,N02.421.585.106
23881643,2013-07-23T00:00:00,Bacteremia,C01.252.100
23881643,2013-07-23T00:00:00,Bacteremia,C01.539.757.100
23881643,2013-07-23T00:00:00,Bacteremia,C23.550.470.790.500.100
23881643,2013-07-23T00:00:00,Case-Control Studies,E05.318.760.500.500
23881643,2013-07-23T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23881643,2013-07-23T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23881643,2013-07-23T00:00:00,"Catheterization, Central Venous",E02.148.167
23881643,2013-07-23T00:00:00,Child,M01.060.406
23881643,2013-07-23T00:00:00,"Child, Preschool",M01.060.406.448
23881643,2013-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23881643,2013-07-23T00:00:00,Infant,M01.060.703
23881643,2013-07-23T00:00:00,Inpatients,M01.643.470
23881643,2013-07-23T00:00:00,Medical Oncology,H02.403.429.515
23881643,2013-07-23T00:00:00,Pediatrics,H02.403.670
23881643,2013-07-23T00:00:00,Risk Factors,E05.318.740.600.800.725
23881643,2013-07-23T00:00:00,Risk Factors,N05.715.350.200.700
23881643,2013-07-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23881643,2013-07-23T00:00:00,Risk Factors,N06.850.490.625.750
23881643,2013-07-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23886870,2013-07-23T00:00:00,Adenosine,D03.438.759.590.138
23886870,2013-07-23T00:00:00,Adenosine,D13.570.583.138
23886870,2013-07-23T00:00:00,Adenosine,D13.570.800.096
23886870,2013-07-23T00:00:00,Aged,M01.060.116.100
23886870,2013-07-23T00:00:00,Blood Flow Velocity,E01.370.370.130
23886870,2013-07-23T00:00:00,Blood Flow Velocity,G09.330.380.630.080
23886870,2013-07-23T00:00:00,Blood Pressure,E01.370.600.875.249
23886870,2013-07-23T00:00:00,Blood Pressure,G09.330.380.076
23886870,2013-07-23T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23886870,2013-07-23T00:00:00,Coronary Angiography,E01.370.370.050.200
23886870,2013-07-23T00:00:00,Coronary Angiography,E01.370.370.380.200
23886870,2013-07-23T00:00:00,Coronary Circulation,G09.330.190.163.324
23886870,2013-07-23T00:00:00,Coronary Vessels,A07.231.114.269
23886870,2013-07-23T00:00:00,Coronary Vessels,A07.231.908.194
23886870,2013-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23886870,2013-07-23T00:00:00,Middle Aged,M01.060.116.630
23890491,2013-07-23T00:00:00,Adolescent,M01.060.057
23890491,2013-07-23T00:00:00,Adult,M01.060.116
23890491,2013-07-23T00:00:00,Aged,M01.060.116.100
23890491,2013-07-23T00:00:00,Alcohol Drinking,F01.145.317.269
23890491,2013-07-23T00:00:00,Child,M01.060.406
23890491,2013-07-23T00:00:00,"Data Interpretation, Statistical",E05.245.380
23890491,2013-07-23T00:00:00,"Data Interpretation, Statistical",E05.318.740.300
23890491,2013-07-23T00:00:00,"Data Interpretation, Statistical",L01.700.508.190.380
23890491,2013-07-23T00:00:00,"Data Interpretation, Statistical",N05.715.360.750.300
23890491,2013-07-23T00:00:00,"Data Interpretation, Statistical",N06.850.520.830.300
23890491,2013-07-23T00:00:00,Ethnic Groups,M01.686.754
23890491,2013-07-23T00:00:00,Ethnic Groups,N01.224.317
23890491,2013-07-23T00:00:00,European Continental Ancestry Group,M01.686.508.400
23890491,2013-07-23T00:00:00,Health Behavior,F01.145.488
23890491,2013-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23890491,2013-07-23T00:00:00,Middle Aged,M01.060.116.630
23890491,2013-07-23T00:00:00,Opioid-Related Disorders,C21.739.675
23890491,2013-07-23T00:00:00,Opioid-Related Disorders,F03.900.675
23890491,2013-07-23T00:00:00,Prevalence,E05.318.308.985.525.750
23890491,2013-07-23T00:00:00,Prevalence,L01.280.975.525.750
23890491,2013-07-23T00:00:00,Prevalence,N01.224.935.597.750
23890491,2013-07-23T00:00:00,Prevalence,N06.850.505.400.975.525.750
23890491,2013-07-23T00:00:00,Prevalence,N06.850.520.308.985.525.750
23890491,2013-07-23T00:00:00,Smoking,F01.145.466.753
23890491,2013-07-23T00:00:00,Substance-Related Disorders,C21.739
23890491,2013-07-23T00:00:00,Substance-Related Disorders,F03.900
23890491,2013-07-23T00:00:00,United States,Z01.107.567.875
23890491,2013-07-23T00:00:00,Young Adult,M01.060.116.815
23910619,2013-07-23T00:00:00,Biological Markers,D23.101
23910619,2013-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23910619,2013-07-23T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23910619,2013-07-23T00:00:00,"Scleroderma, Diffuse",C17.300.799.602
23910619,2013-07-23T00:00:00,"Scleroderma, Diffuse",C17.800.784.602
23946824,2013-07-23T00:00:00,Biosensing Techniques,E05.601.123
23946824,2013-07-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23946824,2013-07-23T00:00:00,Nanoparticles,J01.637.512.600
23946824,2013-07-23T00:00:00,Nanotechnology,H01.603
23946824,2013-07-23T00:00:00,Nanotechnology,J01.897.520.600
23946824,2013-07-23T00:00:00,Risk Assessment,E05.318.740.600.800.715
23946824,2013-07-23T00:00:00,Risk Assessment,N04.452.871.715
23946824,2013-07-23T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23946824,2013-07-23T00:00:00,Risk Assessment,N06.850.505.715
23946824,2013-07-23T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23890780,2013-07-24T00:00:00,Adult,M01.060.116
23890780,2013-07-24T00:00:00,Body Mass Index,E01.370.600.115.100.125
23890780,2013-07-24T00:00:00,Body Mass Index,E05.041.124.125
23890780,2013-07-24T00:00:00,Body Mass Index,G07.100.100.125
23890780,2013-07-24T00:00:00,Body Mass Index,N06.850.505.200.100.175
23890780,2013-07-24T00:00:00,Breast Neoplasms,C04.588.180
23890780,2013-07-24T00:00:00,Breast Neoplasms,C17.800.090.500
23890780,2013-07-24T00:00:00,Cooperative Behavior,F01.145.813.115
23890780,2013-07-24T00:00:00,Gonadal Steroid Hormones,D06.472.334.851
23890780,2013-07-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23863716,2013-07-25T00:00:00,Animals,B01.050
23863716,2013-07-25T00:00:00,Apoptosis,G04.299.139.160
23863716,2013-07-25T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
23863716,2013-07-25T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
23863716,2013-07-25T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
23887844,2013-07-25T00:00:00,Aged,M01.060.116.100
23887844,2013-07-25T00:00:00,Brain Ischemia,C10.228.140.300.150
23887844,2013-07-25T00:00:00,Brain Ischemia,C14.907.253.092
23887844,2013-07-25T00:00:00,Clinical Trials as Topic,E05.318.760.535
23887844,2013-07-25T00:00:00,Clinical Trials as Topic,E05.337.250
23887844,2013-07-25T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23887844,2013-07-25T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23887844,2013-07-25T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
23887844,2013-07-25T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
23887844,2013-07-25T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
23887844,2013-07-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23887844,2013-07-25T00:00:00,Internet,L01.224.230.110.500
23887844,2013-07-25T00:00:00,Middle Aged,M01.060.116.630
23887844,2013-07-25T00:00:00,"Models, Biological",E05.599.395
23887844,2013-07-25T00:00:00,Risk Factors,E05.318.740.600.800.725
23887844,2013-07-25T00:00:00,Risk Factors,N05.715.350.200.700
23887844,2013-07-25T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23887844,2013-07-25T00:00:00,Risk Factors,N06.850.490.625.750
23887844,2013-07-25T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23887844,2013-07-25T00:00:00,Stroke,C10.228.140.300.775
23887844,2013-07-25T00:00:00,Stroke,C14.907.253.855
23887844,2013-07-25T00:00:00,Thrombolytic Therapy,E02.319.913
23887844,2013-07-25T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
23887844,2013-07-25T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
23887844,2013-07-25T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
23887844,2013-07-25T00:00:00,Tissue Plasminogen Activator,D23.119.970
23887844,2013-07-25T00:00:00,Treatment Outcome,E01.789.800
23887844,2013-07-25T00:00:00,Treatment Outcome,N04.761.559.590.800
23887844,2013-07-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23888049,2013-07-25T00:00:00,"Antigens, CD147",D12.776.395.550.045
23888049,2013-07-25T00:00:00,"Antigens, CD147",D12.776.543.550.188
23888049,2013-07-25T00:00:00,"Antigens, CD147",D23.050.285.040
23888049,2013-07-25T00:00:00,"Antigens, CD147",D23.050.301.264.035.247
23888049,2013-07-25T00:00:00,"Antigens, CD147",D23.101.100.110.247
23888049,2013-07-25T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
23888049,2013-07-25T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
23888049,2013-07-25T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
23888049,2013-07-25T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
23888049,2013-07-25T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
23888049,2013-07-25T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
23888049,2013-07-25T00:00:00,Breast Neoplasms,C04.588.180
23888049,2013-07-25T00:00:00,Breast Neoplasms,C17.800.090.500
23888049,2013-07-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23888049,2013-07-25T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
23888049,2013-07-25T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
23888049,2013-07-25T00:00:00,MAP Kinase Signaling System,G03.495.553.560
23888049,2013-07-25T00:00:00,MAP Kinase Signaling System,G04.299.880.560
23888049,2013-07-25T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
23888049,2013-07-25T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
23888049,2013-07-25T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
23888049,2013-07-25T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
23888049,2013-07-25T00:00:00,Multiprotein Complexes,D05.500
23888049,2013-07-25T00:00:00,Neoplasm Invasiveness,C04.697.645
23888049,2013-07-25T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23888049,2013-07-25T00:00:00,Neoplasm Proteins,D12.776.624
23888049,2013-07-25T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
23888049,2013-07-25T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
23888049,2013-07-25T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
23888049,2013-07-25T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
23891478,2013-07-25T00:00:00,Hepatectomy,E04.210.556
23891478,2013-07-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23891478,2013-07-25T00:00:00,Internship and Residency,I02.358.399.644
23891478,2013-07-25T00:00:00,Middle Aged,M01.060.116.630
23891478,2013-07-25T00:00:00,Surgical Wound Infection,C01.539.947.692
23891478,2013-07-25T00:00:00,Surgical Wound Infection,C23.550.767.925
23891478,2013-07-25T00:00:00,Treatment Outcome,E01.789.800
23891478,2013-07-25T00:00:00,Treatment Outcome,N04.761.559.590.800
23891478,2013-07-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23891478,2013-07-25T00:00:00,United States,Z01.107.567.875
23936091,2013-07-25T00:00:00,Carrier State,N06.850.160
23936091,2013-07-25T00:00:00,Genetic Variation,G05.365
23936091,2013-07-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23936091,2013-07-25T00:00:00,Membrane Transport Proteins,D12.776.157.530
23936091,2013-07-25T00:00:00,Membrane Transport Proteins,D12.776.543.585
23936091,2013-07-25T00:00:00,Meningococcal Infections,C01.252.400.625.549
23936091,2013-07-25T00:00:00,Neisseria meningitidis,B03.440.400.425.550.550.641
23936091,2013-07-25T00:00:00,Neisseria meningitidis,B03.660.075.525.520.500
23936091,2013-07-25T00:00:00,Phenotype,G05.695
23890664,2013-07-26T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
23890664,2013-07-26T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
23890664,2013-07-26T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
23890664,2013-07-26T00:00:00,Aged,M01.060.116.100
23890664,2013-07-26T00:00:00,Electric Stimulation,E05.723.402
23890664,2013-07-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23890664,2013-07-26T00:00:00,Middle Aged,M01.060.116.630
23890664,2013-07-26T00:00:00,Muscarinic Antagonists,D27.505.519.625.120.200.500
23890664,2013-07-26T00:00:00,Muscarinic Antagonists,D27.505.696.577.120.200.500
23890664,2013-07-26T00:00:00,Muscle Contraction,G11.427.590.540
23890664,2013-07-26T00:00:00,"Muscle, Smooth",A02.633.570
23890664,2013-07-26T00:00:00,"Muscle, Smooth",A10.690.467
23890664,2013-07-26T00:00:00,Peptides,D12.644
23890664,2013-07-26T00:00:00,Urinary Bladder,A05.810.890
23905549,2013-07-26T00:00:00,Central Nervous System Depressants,D27.505.696.277
23905549,2013-07-26T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
23905549,2013-07-26T00:00:00,Ethanol,D02.033.375
23905549,2013-07-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23905549,2013-07-26T00:00:00,Patch-Clamp Techniques,E05.200.500.800
23905549,2013-07-26T00:00:00,Piperidines,D03.383.621
23905549,2013-07-26T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
23923017,2013-07-26T00:00:00,Animals,B01.050
23923017,2013-07-26T00:00:00,Apoptosis,G04.299.139.160
23923017,2013-07-26T00:00:00,Fatty Acids,D10.251
23923017,2013-07-26T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
23923017,2013-07-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23923017,2013-07-26T00:00:00,Peroxisomes,A11.284.430.214.190.500.585.600
23923017,2013-07-26T00:00:00,Peroxisomes,A11.284.430.214.190.875.190.190.755.600
23923017,2013-07-26T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23897602,2013-07-29T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
23897602,2013-07-29T00:00:00,Drug Monitoring,E01.370.520.200
23897602,2013-07-29T00:00:00,Guideline Adherence,N04.761.337
23897602,2013-07-29T00:00:00,Guideline Adherence,N05.715.360.395
23897602,2013-07-29T00:00:00,Hospitals,N02.278.421
23897602,2013-07-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23897602,2013-07-29T00:00:00,Internet,L01.224.230.110.500
23897602,2013-07-29T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23897602,2013-07-29T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23897602,2013-07-29T00:00:00,United States,Z01.107.567.875
23897602,2013-07-29T00:00:00,Vancomycin,D09.400.420.925
23897602,2013-07-29T00:00:00,Vancomycin,D12.644.233.925
23897908,2013-07-29T00:00:00,Cooperative Behavior,F01.145.813.115
23897908,2013-07-29T00:00:00,"Education, Medical, Graduate",I02.358.337.350
23897908,2013-07-29T00:00:00,"Education, Medical, Graduate",I02.358.399.350
23897908,2013-07-29T00:00:00,Health Manpower,N02.350
23897908,2013-07-29T00:00:00,Health Manpower,N05.300.420.400
23897908,2013-07-29T00:00:00,Health Policy,I01.880.604.825.608.400
23897908,2013-07-29T00:00:00,Health Policy,N03.706.825.608.428
23897908,2013-07-29T00:00:00,Health Services Accessibility,N04.590.374.350
23897908,2013-07-29T00:00:00,Health Services Accessibility,N05.300.430
23897908,2013-07-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23897908,2013-07-29T00:00:00,Interdisciplinary Communication,F01.145.209.381
23897908,2013-07-29T00:00:00,Interdisciplinary Communication,F01.829.401.205.249
23897908,2013-07-29T00:00:00,Interdisciplinary Communication,L01.143.474
23897908,2013-07-29T00:00:00,Nurse Practitioners,M01.526.485.650.640
23897908,2013-07-29T00:00:00,Nurse Practitioners,N02.360.650.640
23897908,2013-07-29T00:00:00,Patient Care Team,N04.590.715
23897908,2013-07-29T00:00:00,Patient-Centered Care,N04.590.233.675
23897908,2013-07-29T00:00:00,Patient-Centered Care,N04.590.233.727.407
23897908,2013-07-29T00:00:00,Patient-Centered Care,N04.590.720
23897908,2013-07-29T00:00:00,Pediatrics,H02.403.670
23897908,2013-07-29T00:00:00,Physician Assistants,M01.526.485.067.740
23897908,2013-07-29T00:00:00,Physician Assistants,N02.360.067.740
23897908,2013-07-29T00:00:00,"Societies, Medical",N03.540.828.589
23897908,2013-07-29T00:00:00,United States,Z01.107.567.875
23900696,2013-07-29T00:00:00,Aged,M01.060.116.100
23900696,2013-07-29T00:00:00,Cause of Death,E05.318.308.985.550.250
23900696,2013-07-29T00:00:00,Cause of Death,L01.280.975.550.250
23900696,2013-07-29T00:00:00,Cause of Death,N01.224.935.698.100
23900696,2013-07-29T00:00:00,Cause of Death,N06.850.505.400.975.550.250
23900696,2013-07-29T00:00:00,Cause of Death,N06.850.520.308.985.550.250
23900696,2013-07-29T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23900696,2013-07-29T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23900696,2013-07-29T00:00:00,"Defibrillators, Implantable",E07.695.175
23900696,2013-07-29T00:00:00,Heart Failure,C14.280.434
23900696,2013-07-29T00:00:00,Hospitalization,E02.760.400
23900696,2013-07-29T00:00:00,Hospitalization,N02.421.585.400
23900696,2013-07-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23900696,2013-07-29T00:00:00,Middle Aged,M01.060.116.630
23900696,2013-07-29T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23900696,2013-07-29T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23900696,2013-07-29T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23900696,2013-07-29T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23900696,2013-07-29T00:00:00,Stroke Volume,E01.370.370.380.150.700
23900696,2013-07-29T00:00:00,Stroke Volume,G09.330.380.124.882
23900696,2013-07-29T00:00:00,Treatment Outcome,E01.789.800
23900696,2013-07-29T00:00:00,Treatment Outcome,N04.761.559.590.800
23900696,2013-07-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23900696,2013-07-29T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
23943904,2013-07-29T00:00:00,Data Collection,E05.318.308
23943904,2013-07-29T00:00:00,Data Collection,L01.280
23943904,2013-07-29T00:00:00,Data Collection,N05.715.360.300
23943904,2013-07-29T00:00:00,Data Collection,N06.850.520.308
23943904,2013-07-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23943904,2013-07-29T00:00:00,Medical Oncology,H02.403.429.515
23943904,2013-07-29T00:00:00,Neoplasms,C04
23943904,2013-07-29T00:00:00,Physician's Practice Patterns,N04.590.748
23943904,2013-07-29T00:00:00,Physician's Practice Patterns,N05.300.625
23943904,2013-07-29T00:00:00,Smoking Cessation,F01.145.940.700
23943904,2013-07-29T00:00:00,"Societies, Medical",N03.540.828.589
23936142,2013-07-30T00:00:00,Animals,B01.050
23936142,2013-07-30T00:00:00,Apoptosis,G04.299.139.160
23936142,2013-07-30T00:00:00,Cell Cycle,G04.299.134
23936142,2013-07-30T00:00:00,Cell Line,A11.251.210
23936142,2013-07-30T00:00:00,Cell Proliferation,G04.299.233.750
23936142,2013-07-30T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23936142,2013-07-30T00:00:00,DNA Damage,C21.111
23936142,2013-07-30T00:00:00,DNA Damage,G05.355.180
23936142,2013-07-30T00:00:00,Folic Acid,D03.438.733.631.400
23936142,2013-07-30T00:00:00,Gene Expression,G05.355.310
23936142,2013-07-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23936142,2013-07-30T00:00:00,"Models, Molecular",E05.599.595
23936142,2013-07-30T00:00:00,Molecular Conformation,G02.111.570.790
23936142,2013-07-30T00:00:00,Molecular Conformation,G02.575.500
23936142,2013-07-30T00:00:00,Molecular Conformation,G02.842.575.500
23936142,2013-07-30T00:00:00,Mutation,G05.365.590
23936142,2013-07-30T00:00:00,Protein Transport,G03.495.166.700
23936142,2013-07-30T00:00:00,Recombinant Proteins,D12.776.828
23936142,2013-07-30T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
23901810,2013-07-31T00:00:00,Calcinosis,C18.452.174.130
23901810,2013-07-31T00:00:00,Cervical Vertebrae,A02.835.232.834.151
23901810,2013-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23901810,2013-07-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23901810,2013-07-31T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23903826,2013-07-31T00:00:00,Animals,B01.050
23903826,2013-07-31T00:00:00,Apoptosis,G04.299.139.160
23903826,2013-07-31T00:00:00,"Carcinoma, Hepatocellular",C04.557.470.200.025.255
23903826,2013-07-31T00:00:00,"Carcinoma, Hepatocellular",C04.588.274.623.160
23903826,2013-07-31T00:00:00,"Carcinoma, Hepatocellular",C06.301.623.160
23903826,2013-07-31T00:00:00,"Carcinoma, Hepatocellular",C06.552.697.160
23903826,2013-07-31T00:00:00,Cell Movement,G04.299.283
23903826,2013-07-31T00:00:00,Cell Movement,G07.700.560.500.180
23903826,2013-07-31T00:00:00,Cell Proliferation,G04.299.233.750
23903826,2013-07-31T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23903826,2013-07-31T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
23903826,2013-07-31T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
23903826,2013-07-31T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
23903826,2013-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23903826,2013-07-31T00:00:00,Liver Neoplasms,C04.588.274.623
23903826,2013-07-31T00:00:00,Liver Neoplasms,C06.301.623
23903826,2013-07-31T00:00:00,Liver Neoplasms,C06.552.697
23903826,2013-07-31T00:00:00,Neoplasm Invasiveness,C04.697.645
23903826,2013-07-31T00:00:00,Neoplasm Invasiveness,C23.550.727.645
23954364,2013-07-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23954364,2013-07-31T00:00:00,Mitochondria,A11.284.430.214.190.875.564
23954364,2013-07-31T00:00:00,Mitochondria,A11.284.835.626
23954364,2013-07-31T00:00:00,"Models, Molecular",E05.599.595
23954364,2013-07-31T00:00:00,Molecular Structure,G02.111.570
23954364,2013-07-31T00:00:00,Molecular Structure,G02.575
23954364,2013-07-31T00:00:00,Molecular Structure,G02.842.575
23954364,2013-07-31T00:00:00,Phenotype,G05.695
23526211,2013-08-01T00:00:00,Animals,B01.050
23526211,2013-08-01T00:00:00,Antibodies,D12.776.124.486.485.114
23526211,2013-08-01T00:00:00,Antibodies,D12.776.124.790.651.114
23526211,2013-08-01T00:00:00,Antibodies,D12.776.377.715.548.114
23526211,2013-08-01T00:00:00,Complement Activation,G12.425.255
23526211,2013-08-01T00:00:00,Complement System Proteins,D12.776.124.486.274
23526211,2013-08-01T00:00:00,"Influenza A Virus, H5N1 Subtype",B04.820.545.405.400.500
23526211,2013-08-01T00:00:00,"Influenza A Virus, H5N1 Subtype",B04.909.777.545.405.400.500
23526211,2013-08-01T00:00:00,Lung,A04.411
23526211,2013-08-01T00:00:00,Orthomyxoviridae Infections,C02.782.620
23652277,2013-08-01T00:00:00,Aged,M01.060.116.100
23652277,2013-08-01T00:00:00,Antineoplastic Agents,D27.505.954.248
23652277,2013-08-01T00:00:00,Disease-Free Survival,E01.789.200
23652277,2013-08-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
23652277,2013-08-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
23652277,2013-08-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
23652277,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23652277,2013-08-01T00:00:00,Middle Aged,M01.060.116.630
23652277,2013-08-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
23652277,2013-08-01T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
23652277,2013-08-01T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
23652277,2013-08-01T00:00:00,Prostate-Specific Antigen,D23.050.285.625
23652277,2013-08-01T00:00:00,Prostate-Specific Antigen,D23.101.840.625
23652277,2013-08-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23652277,2013-08-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
23652277,2013-08-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
23652277,2013-08-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
23652277,2013-08-01T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23652277,2013-08-01T00:00:00,Pyrimidines,D03.383.742
23652277,2013-08-01T00:00:00,Testosterone,D04.808.054.079.429.824
23652277,2013-08-01T00:00:00,Testosterone,D06.472.334.851.968.984
23652277,2013-08-01T00:00:00,Treatment Outcome,E01.789.800
23652277,2013-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23652277,2013-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23722353,2013-08-01T00:00:00,Animals,B01.050
23722353,2013-08-01T00:00:00,Biomedical Engineering,H02.070
23722353,2013-08-01T00:00:00,Biomedical Engineering,J01.293.140
23722353,2013-08-01T00:00:00,Collagen,D05.750.078.280
23722353,2013-08-01T00:00:00,Collagen,D12.776.860.300.250
23722353,2013-08-01T00:00:00,Hemodynamics,G09.330.190.400
23722353,2013-08-01T00:00:00,Hemodynamics,G09.330.380
23722353,2013-08-01T00:00:00,"Models, Cardiovascular",E05.599.395.161
23722353,2013-08-01T00:00:00,"Stress, Mechanical",G01.374.676.830
23722353,2013-08-01T00:00:00,"Stress, Mechanical",G01.595.540.830
23785065,2013-08-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23785065,2013-08-01T00:00:00,Clinical Trials as Topic,E05.337.250
23785065,2013-08-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23785065,2013-08-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23785065,2013-08-01T00:00:00,Documentation,L01.453.245
23785065,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23785065,2013-08-01T00:00:00,Information Management,L01.399
23785065,2013-08-01T00:00:00,Informed Consent,I01.880.604.473.650.718
23785065,2013-08-01T00:00:00,Informed Consent,I01.880.604.583.427
23785065,2013-08-01T00:00:00,Informed Consent,N03.706.437.650.312
23785065,2013-08-01T00:00:00,Informed Consent,N03.706.535.489
23785065,2013-08-01T00:00:00,Patient Selection,E05.581.500.653
23785065,2013-08-01T00:00:00,Patient Selection,N04.590.731
23785065,2013-08-01T00:00:00,Pilot Projects,E05.318.760.750
23785065,2013-08-01T00:00:00,Pilot Projects,E05.337.737
23785065,2013-08-01T00:00:00,Pilot Projects,N05.715.360.775.625
23785065,2013-08-01T00:00:00,Pilot Projects,N06.850.520.450.720
23785065,2013-08-01T00:00:00,Software,L01.224.900
23785065,2013-08-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23785065,2013-08-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23785065,2013-08-01T00:00:00,User-Computer Interface,L01.224.900.910
23839700,2013-08-01T00:00:00,Activities of Daily Living,E02.831.067
23839700,2013-08-01T00:00:00,Activities of Daily Living,I03.050
23839700,2013-08-01T00:00:00,Activities of Daily Living,N02.421.784.110
23839700,2013-08-01T00:00:00,Adult,M01.060.116
23839700,2013-08-01T00:00:00,Aged,M01.060.116.100
23839700,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23839700,2013-08-01T00:00:00,Psychometrics,F04.711.780
23839700,2013-08-01T00:00:00,Quality of Life,I01.800
23839700,2013-08-01T00:00:00,Quality of Life,K01.752.400.750
23839700,2013-08-01T00:00:00,Questionnaires,E05.318.308.750
23839700,2013-08-01T00:00:00,Questionnaires,L01.280.800
23839700,2013-08-01T00:00:00,Questionnaires,N05.715.360.300.695
23839700,2013-08-01T00:00:00,Questionnaires,N06.850.520.308.750
23839700,2013-08-01T00:00:00,Vision Disorders,C10.597.751.941
23839700,2013-08-01T00:00:00,Vision Disorders,C11.966
23839700,2013-08-01T00:00:00,Vision Disorders,C23.888.592.763.941
23849147,2013-08-01T00:00:00,Adolescent,M01.060.057
23849147,2013-08-01T00:00:00,Adult,M01.060.116
23849147,2013-08-01T00:00:00,Aged,M01.060.116.100
23849147,2013-08-01T00:00:00,Anticonvulsants,D27.505.954.427.080
23849147,2013-08-01T00:00:00,Bayes Theorem,E05.318.740.600.200
23849147,2013-08-01T00:00:00,Bayes Theorem,N05.715.360.750.625.150
23849147,2013-08-01T00:00:00,Bayes Theorem,N06.850.520.830.600.200
23849147,2013-08-01T00:00:00,Child,M01.060.406
23849147,2013-08-01T00:00:00,"Child, Preschool",M01.060.406.448
23849147,2013-08-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23849147,2013-08-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23849147,2013-08-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23849147,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23849147,2013-08-01T00:00:00,Middle Aged,M01.060.116.630
23849147,2013-08-01T00:00:00,"Models, Statistical",E05.318.740.500
23849147,2013-08-01T00:00:00,"Models, Statistical",E05.599.835
23849147,2013-08-01T00:00:00,"Models, Statistical",N05.715.360.750.530
23849147,2013-08-01T00:00:00,"Models, Statistical",N06.850.520.830.500
23849147,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23849147,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23849147,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23849147,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23849147,2013-08-01T00:00:00,Research Design,E05.581.500
23849147,2013-08-01T00:00:00,Research Design,H01.770.644.728
23849147,2013-08-01T00:00:00,Status Epilepticus,C10.228.140.490.690
23849147,2013-08-01T00:00:00,Treatment Outcome,E01.789.800
23849147,2013-08-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23849147,2013-08-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23849147,2013-08-01T00:00:00,Valproic Acid,D02.241.081.944.509.900
23849147,2013-08-01T00:00:00,Valproic Acid,D10.251.400.895.593.900
23849147,2013-08-01T00:00:00,Young Adult,M01.060.116.815
23879752,2013-08-01T00:00:00,Adult,M01.060.116
23879752,2013-08-01T00:00:00,Aged,M01.060.116.100
23879752,2013-08-01T00:00:00,Blood Platelets,A11.118.188
23879752,2013-08-01T00:00:00,Blood Platelets,A15.145.229.188
23879752,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23879752,2013-08-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
23879752,2013-08-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
23879752,2013-08-01T00:00:00,Middle Aged,M01.060.116.630
23879752,2013-08-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
23879752,2013-08-01T00:00:00,Research Design,E05.581.500
23879752,2013-08-01T00:00:00,Research Design,H01.770.644.728
23879752,2013-08-01T00:00:00,Stroke,C10.228.140.300.775
23879752,2013-08-01T00:00:00,Stroke,C14.907.253.855
23879752,2013-08-01T00:00:00,Ticlopidine,D02.886.778.834
23879752,2013-08-01T00:00:00,Ticlopidine,D03.383.903.834
23879752,2013-08-01T00:00:00,Young Adult,M01.060.116.815
23886342,2013-08-01T00:00:00,Antineoplastic Agents,D27.505.954.248
23886342,2013-08-01T00:00:00,Autoimmune Diseases,C20.111
23886342,2013-08-01T00:00:00,B-Lymphocytes,A11.063.438
23886342,2013-08-01T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
23886342,2013-08-01T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
23886342,2013-08-01T00:00:00,B-Lymphocytes,A15.382.032.438
23886342,2013-08-01T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
23886342,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23886342,2013-08-01T00:00:00,Signal Transduction,G02.111.087.800
23886342,2013-08-01T00:00:00,Signal Transduction,G02.149.115.800
23886342,2013-08-01T00:00:00,Signal Transduction,G04.299.880
23907808,2013-08-01T00:00:00,Adolescent,M01.060.057
23907808,2013-08-01T00:00:00,Age Factors,N05.715.350.075
23907808,2013-08-01T00:00:00,Age Factors,N06.850.490.250
23907808,2013-08-01T00:00:00,Attention Deficit Disorder with Hyperactivity,F03.550.150.150
23907808,2013-08-01T00:00:00,Brain Mapping,E01.370.350.086
23907808,2013-08-01T00:00:00,Brain Mapping,E01.370.376.149
23907808,2013-08-01T00:00:00,Brain Mapping,E05.132
23907808,2013-08-01T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
23907808,2013-08-01T00:00:00,Child,M01.060.406
23907808,2013-08-01T00:00:00,Developmental Disabilities,F03.550.362
23907808,2013-08-01T00:00:00,Diffusion Tensor Imaging,E01.370.350.500.150.500
23907808,2013-08-01T00:00:00,Diffusion Tensor Imaging,E01.370.376.224
23907808,2013-08-01T00:00:00,Diffusion Tensor Imaging,E05.278
23907808,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23907808,2013-08-01T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
23907808,2013-08-01T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
23907808,2013-08-01T00:00:00,Psychiatric Status Rating Scales,F04.586
23908060,2013-08-01T00:00:00,Animals,B01.050
23908060,2013-08-01T00:00:00,Bibliometrics,L01.178.682.099.325
23908060,2013-08-01T00:00:00,Bibliometrics,L01.453.183.291
23908060,2013-08-01T00:00:00,Cerebrovascular Disorders,C10.228.140.300
23908060,2013-08-01T00:00:00,Cerebrovascular Disorders,C14.907.253
23908060,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23908060,2013-08-01T00:00:00,Peer Review,F01.829.316.549
23908060,2013-08-01T00:00:00,Peer Review,I01.880.604.640
23908060,2013-08-01T00:00:00,Peer Review,N03.706.700
23908060,2013-08-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
23910392,2013-08-01T00:00:00,Adult,M01.060.116
23910392,2013-08-01T00:00:00,Evidence-Based Medicine,H02.249.750
23910392,2013-08-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23910392,2013-08-01T00:00:00,Guideline Adherence,N04.761.337
23910392,2013-08-01T00:00:00,Guideline Adherence,N05.715.360.395
23910392,2013-08-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23910392,2013-08-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23910392,2013-08-01T00:00:00,Health Personnel,M01.526.485
23910392,2013-08-01T00:00:00,Health Personnel,N02.360
23910392,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23910392,2013-08-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23910392,2013-08-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23910392,2013-08-01T00:00:00,Substance-Related Disorders,C21.739
23910392,2013-08-01T00:00:00,Substance-Related Disorders,F03.900
23911535,2013-08-01T00:00:00,Aged,M01.060.116.100
23911535,2013-08-01T00:00:00,Blood Glucose,D09.546.359.448.500
23911535,2013-08-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23911535,2013-08-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23911535,2013-08-01T00:00:00,Hospitalization,E02.760.400
23911535,2013-08-01T00:00:00,Hospitalization,N02.421.585.400
23911535,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23911535,2013-08-01T00:00:00,Hypoglycemic Agents,D27.505.696.422
23911535,2013-08-01T00:00:00,Inpatients,M01.643.470
23911535,2013-08-01T00:00:00,Insulin,D06.472.699.587.740.625
23911535,2013-08-01T00:00:00,Insulin,D12.644.548.586.740.625
23911535,2013-08-01T00:00:00,Middle Aged,M01.060.116.630
23911535,2013-08-01T00:00:00,Perioperative Care,E02.760.722
23911535,2013-08-01T00:00:00,Perioperative Care,E04.604
23911535,2013-08-01T00:00:00,Perioperative Care,N02.421.585.722
23911536,2013-08-01T00:00:00,Aged,M01.060.116.100
23911536,2013-08-01T00:00:00,Cardiovascular Diseases,C14
23911536,2013-08-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23911536,2013-08-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23911536,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23911536,2013-08-01T00:00:00,Lipid Metabolism,G03.495.520
23911536,2013-08-01T00:00:00,Lipoproteins,D10.532
23911536,2013-08-01T00:00:00,Lipoproteins,D12.776.521
23911536,2013-08-01T00:00:00,Middle Aged,M01.060.116.630
23911536,2013-08-01T00:00:00,"Nuclear Magnetic Resonance, Biomolecular",E05.196.867.519.550
23911536,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23911536,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23911536,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23911536,2013-08-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23911536,2013-08-01T00:00:00,United States,Z01.107.567.875
23911536,2013-08-01T00:00:00,United States Department of Veterans Affairs,I01.409.137.500.700
23911536,2013-08-01T00:00:00,United States Department of Veterans Affairs,N03.540.348.500.500.700
23911536,2013-08-01T00:00:00,Veterans,M01.930
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
23912400,2013-08-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
23912400,2013-08-01T00:00:00,Fluoroscopy,E01.370.350.700.225
23912400,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23912400,2013-08-01T00:00:00,Physician's Practice Patterns,N04.590.748
23912400,2013-08-01T00:00:00,Physician's Practice Patterns,N05.300.625
23912400,2013-08-01T00:00:00,Regression Analysis,E05.318.740.750
23912400,2013-08-01T00:00:00,Regression Analysis,N05.715.360.750.695
23912400,2013-08-01T00:00:00,Regression Analysis,N06.850.520.830.750
23913833,2013-08-01T00:00:00,Animals,B01.050
23913833,2013-08-01T00:00:00,"Cartilage, Articular",A02.165.407.150
23913833,2013-08-01T00:00:00,"Cartilage, Articular",A02.835.583.192
23913833,2013-08-01T00:00:00,Glycosaminoglycans,D09.698.373
23913833,2013-08-01T00:00:00,Swine,B01.050.150.900.649.077.880
23913833,2013-08-01T00:00:00,X-Rays,G01.201.875.750.918
23974396,2013-08-01T00:00:00,Adult,M01.060.116
23974396,2013-08-01T00:00:00,Continental Population Groups,M01.686.508
23974396,2013-08-01T00:00:00,Health Status Disparities,I01.240.425.675
23974396,2013-08-01T00:00:00,Health Status Disparities,N01.224.425.437
23974396,2013-08-01T00:00:00,Health Status Disparities,N06.850.505.400.425.675
23974396,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23974396,2013-08-01T00:00:00,Middle Aged,M01.060.116.630
23974396,2013-08-01T00:00:00,Pain,C10.597.617
23974396,2013-08-01T00:00:00,Pain,C23.888.592.612
23974396,2013-08-01T00:00:00,Pain,C23.888.646
23974396,2013-08-01T00:00:00,Pain,F02.830.816.444
23974396,2013-08-01T00:00:00,Pain,G11.561.600.810.444
23974396,2013-08-01T00:00:00,Sex Factors,N05.715.350.675
23974396,2013-08-01T00:00:00,Sex Factors,N06.850.490.875
23974396,2013-08-01T00:00:00,Spinal Cord Injuries,C10.228.854.770
23974396,2013-08-01T00:00:00,Spinal Cord Injuries,C10.900.850
23974396,2013-08-01T00:00:00,Spinal Cord Injuries,C21.866.819
23991509,2013-08-01T00:00:00,Bacteremia,C01.252.100
23991509,2013-08-01T00:00:00,Bacteremia,C01.539.757.100
23991509,2013-08-01T00:00:00,Bacteremia,C23.550.470.790.500.100
23991509,2013-08-01T00:00:00,"Catheterization, Central Venous",E02.148.167
23991509,2013-08-01T00:00:00,Child,M01.060.406
23991509,2013-08-01T00:00:00,Guideline Adherence,N04.761.337
23991509,2013-08-01T00:00:00,Guideline Adherence,N05.715.360.395
23991509,2013-08-01T00:00:00,Health Services Research,N03.349.380
23991509,2013-08-01T00:00:00,Health Services Research,N05.425
23991509,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23991509,2013-08-01T00:00:00,Neoplasms,C04
23991509,2013-08-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23991509,2013-08-01T00:00:00,Risk Factors,N05.715.350.200.700
23991509,2013-08-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23991509,2013-08-01T00:00:00,Risk Factors,N06.850.490.625.750
23991509,2013-08-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23991509,2013-08-01T00:00:00,United States,Z01.107.567.875
24021498,2013-08-01T00:00:00,Aged,M01.060.116.100
24021498,2013-08-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
24021498,2013-08-01T00:00:00,Alzheimer Disease,C10.574.945.249
24021498,2013-08-01T00:00:00,Alzheimer Disease,F03.087.400.100
24021498,2013-08-01T00:00:00,Central Nervous System Stimulants,D27.505.696.282
24021498,2013-08-01T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
24021498,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24021498,2013-08-01T00:00:00,Methylphenidate,D02.241.223.601.600
24021498,2013-08-01T00:00:00,Methylphenidate,D03.383.621.460
24021498,2013-08-01T00:00:00,Neuropsychological Tests,F04.711.513
24021498,2013-08-01T00:00:00,Psychometrics,F04.711.780
24205574,2013-08-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24205574,2013-08-01T00:00:00,Specialization,H02.811
24205574,2013-08-01T00:00:00,"Specialties, Surgical",H02.403.810
24205574,2013-08-01T00:00:00,Thoracic Surgery,H02.403.810.803
24205574,2013-08-01T00:00:00,United States,Z01.107.567.875
24205574,2013-08-01T00:00:00,Vascular Surgical Procedures,E04.100.814
23936373,2013-08-02T00:00:00,Animals,B01.050
23936373,2013-08-02T00:00:00,Diabetic Nephropathies,C12.777.419.192
23936373,2013-08-02T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
23936373,2013-08-02T00:00:00,Diabetic Nephropathies,C19.246.099.875
23936373,2013-08-02T00:00:00,Glucose,D09.546.359.448
23936373,2013-08-02T00:00:00,"Kidney Tubules, Proximal",A05.810.453.736.560.570
23936373,2013-08-02T00:00:00,Oxidative Stress,G03.495.710
23936373,2013-08-02T00:00:00,Oxidative Stress,G07.700.830.750
23936373,2013-08-02T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23936373,2013-08-02T00:00:00,Reactive Oxygen Species,D01.339.431
23936373,2013-08-02T00:00:00,Reactive Oxygen Species,D01.650.775
23918255,2013-08-05T00:00:00,American Heart Association,N03.540.630.780.110
23918255,2013-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23918255,2013-08-05T00:00:00,Operating Rooms,N02.278.388.700
23918255,2013-08-05T00:00:00,Patient Care Team,N04.590.715
23918255,2013-08-05T00:00:00,United States,Z01.107.567.875
23918740,2013-08-05T00:00:00,Adult,M01.060.116
23918740,2013-08-05T00:00:00,Aged,M01.060.116.100
23918740,2013-08-05T00:00:00,Chronic Disease,C23.550.291.500
23918740,2013-08-05T00:00:00,Depression,F01.145.126.350
23918740,2013-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23918740,2013-08-05T00:00:00,Middle Aged,M01.060.116.630
23918740,2013-08-05T00:00:00,Quality of Life,I01.800
23918740,2013-08-05T00:00:00,Quality of Life,K01.752.400.750
23918740,2013-08-05T00:00:00,Rhinitis,C08.460.799
23918740,2013-08-05T00:00:00,Rhinitis,C08.730.674
23918740,2013-08-05T00:00:00,Rhinitis,C09.603.799
23918740,2013-08-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23918740,2013-08-05T00:00:00,Risk Factors,N05.715.350.200.700
23918740,2013-08-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23918740,2013-08-05T00:00:00,Risk Factors,N06.850.490.625.750
23918740,2013-08-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23918740,2013-08-05T00:00:00,Sinusitis,C08.460.692.752
23918740,2013-08-05T00:00:00,Sinusitis,C08.730.749
23918740,2013-08-05T00:00:00,Sinusitis,C09.603.692.752
23918740,2013-08-05T00:00:00,Sleep,F02.830.855
23918740,2013-08-05T00:00:00,Sleep,G11.561.600.815
23918740,2013-08-05T00:00:00,Sleep Disorders,C10.886
23918740,2013-08-05T00:00:00,Sleep Disorders,C23.888.592.796
23918740,2013-08-05T00:00:00,Sleep Disorders,F03.870
23918740,2013-08-05T00:00:00,Young Adult,M01.060.116.815
23918752,2013-08-05T00:00:00,African Americans,M01.686.508.100.100
23918752,2013-08-05T00:00:00,African Americans,M01.686.754.100
23918752,2013-08-05T00:00:00,Aged,M01.060.116.100
23918752,2013-08-05T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23918752,2013-08-05T00:00:00,Blood Pressure,E01.370.600.875.249
23918752,2013-08-05T00:00:00,Blood Pressure,G09.330.380.076
23918752,2013-08-05T00:00:00,Community Health Services,N02.421.143
23918752,2013-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23918752,2013-08-05T00:00:00,Hypertension,C14.907.489
23918752,2013-08-05T00:00:00,Medication Adherence,F01.145.488.500.500
23918752,2013-08-05T00:00:00,Medication Adherence,N05.300.150.600.600.500
23918752,2013-08-05T00:00:00,Middle Aged,M01.060.116.630
23918752,2013-08-05T00:00:00,Prevalence,E05.318.308.985.525.750
23918752,2013-08-05T00:00:00,Prevalence,L01.280.975.525.750
23918752,2013-08-05T00:00:00,Prevalence,N01.224.935.597.750
23918752,2013-08-05T00:00:00,Prevalence,N06.850.505.400.975.525.750
23918752,2013-08-05T00:00:00,Prevalence,N06.850.520.308.985.525.750
23918752,2013-08-05T00:00:00,Risk Factors,E05.318.740.600.800.725
23918752,2013-08-05T00:00:00,Risk Factors,N05.715.350.200.700
23918752,2013-08-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23918752,2013-08-05T00:00:00,Risk Factors,N06.850.490.625.750
23918752,2013-08-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23918752,2013-08-05T00:00:00,United States,Z01.107.567.875
23940584,2013-08-05T00:00:00,Cell Cycle,G04.299.134
23940584,2013-08-05T00:00:00,Cell Cycle Proteins,D12.776.167
23940584,2013-08-05T00:00:00,Cell Line,A11.251.210
23940584,2013-08-05T00:00:00,Endothelial Cells,A11.436.275
23940584,2013-08-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23940584,2013-08-05T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
23940584,2013-08-05T00:00:00,Nuclear Proteins,D12.776.660
23940584,2013-08-05T00:00:00,Oligonucleotide Array Sequence Analysis,E05.196.630.570.660
23940584,2013-08-05T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.525.640
23940584,2013-08-05T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.661.640
23940584,2013-08-05T00:00:00,Oligonucleotide Array Sequence Analysis,E05.393.760.640
23940584,2013-08-05T00:00:00,Oligonucleotide Array Sequence Analysis,E05.588.570.660
23940584,2013-08-05T00:00:00,Oligonucleotide Array Sequence Analysis,E05.601.640
23940622,2013-08-05T00:00:00,Animals,B01.050
23940622,2013-08-05T00:00:00,Cell Differentiation,G04.299.151
23940622,2013-08-05T00:00:00,Drosophila Proteins,D12.776.466.462
23940622,2013-08-05T00:00:00,Drosophila melanogaster,B01.050.500.131.617.289.310.250.500
23940622,2013-08-05T00:00:00,Epidermal Growth Factor,D06.472.317.350
23940622,2013-08-05T00:00:00,Epidermal Growth Factor,D12.644.276.561
23940622,2013-08-05T00:00:00,Epidermal Growth Factor,D12.776.467.561
23940622,2013-08-05T00:00:00,Epidermal Growth Factor,D23.529.561
23940622,2013-08-05T00:00:00,Gene Expression,G05.355.310
23940622,2013-08-05T00:00:00,"Receptor, Epidermal Growth Factor",D08.811.913.696.620.682.725.400.100
23940622,2013-08-05T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.060.249
23940622,2013-08-05T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.360.300
23940622,2013-08-05T00:00:00,"Receptor, Epidermal Growth Factor",D12.776.543.750.750.400.340
23940622,2013-08-05T00:00:00,Testis,A05.360.444.849
23940622,2013-08-05T00:00:00,Testis,A05.360.576.782
23940622,2013-08-05T00:00:00,Testis,A06.407.312.782
23852962,2013-08-06T00:00:00,Adult,M01.060.116
23852962,2013-08-06T00:00:00,Biological Markers,D23.101
23852962,2013-08-06T00:00:00,Chronic Disease,C23.550.291.500
23852962,2013-08-06T00:00:00,Cytokines,D12.644.276.374
23852962,2013-08-06T00:00:00,Cytokines,D12.776.467.374
23852962,2013-08-06T00:00:00,Cytokines,D23.529.374
23852962,2013-08-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23852962,2013-08-06T00:00:00,Middle Aged,M01.060.116.630
23852962,2013-08-06T00:00:00,Nasal Mucosa,A04.531.520
23852962,2013-08-06T00:00:00,Nasal Mucosa,A04.760.600
23852962,2013-08-06T00:00:00,Nasal Mucosa,A10.615.550.760.600
23852962,2013-08-06T00:00:00,Paranasal Sinuses,A04.531.621
23852962,2013-08-06T00:00:00,Rhinitis,C08.460.799
23852962,2013-08-06T00:00:00,Rhinitis,C08.730.674
23852962,2013-08-06T00:00:00,Rhinitis,C09.603.799
23852962,2013-08-06T00:00:00,Sinusitis,C08.460.692.752
23852962,2013-08-06T00:00:00,Sinusitis,C08.730.749
23852962,2013-08-06T00:00:00,Sinusitis,C09.603.692.752
23921144,2013-08-06T00:00:00,Animals,B01.050
23921144,2013-08-06T00:00:00,Cell Line,A11.251.210
23921144,2013-08-06T00:00:00,Inflammation,C23.550.470
23921144,2013-08-06T00:00:00,Interleukin-6,D12.644.276.374.465.506
23921144,2013-08-06T00:00:00,Interleukin-6,D12.776.467.374.465.506
23921144,2013-08-06T00:00:00,Interleukin-6,D23.529.374.465.506
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D09.400.500
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D09.698.718.450
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D10.494
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D23.050.161.616.525
23921144,2013-08-06T00:00:00,Lipopolysaccharides,D23.946.123.329.500
23921144,2013-08-06T00:00:00,Macrophages,A11.329.372
23921144,2013-08-06T00:00:00,Macrophages,A11.627.482
23921144,2013-08-06T00:00:00,Macrophages,A11.733.397
23921144,2013-08-06T00:00:00,Macrophages,A15.382.680.397
23921144,2013-08-06T00:00:00,Macrophages,A15.382.812.522
23921144,2013-08-06T00:00:00,NF-kappa B,D12.776.260.600
23921144,2013-08-06T00:00:00,NF-kappa B,D12.776.660.600
23921144,2013-08-06T00:00:00,NF-kappa B,D12.776.930.600
23921144,2013-08-06T00:00:00,Signal Transduction,G02.111.087.800
23921144,2013-08-06T00:00:00,Signal Transduction,G02.149.115.800
23921144,2013-08-06T00:00:00,Signal Transduction,G04.299.880
23921144,2013-08-06T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
23921144,2013-08-06T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
23921560,2013-08-07T00:00:00,Gold,D01.268.556.322
23921560,2013-08-07T00:00:00,Gold,D01.268.956.186
23921560,2013-08-07T00:00:00,Gold,D01.552.544.322
23921560,2013-08-07T00:00:00,Metal Nanoparticles,J01.637.512.600.500
23921560,2013-08-07T00:00:00,Nanoparticles,J01.637.512.600
23921560,2013-08-07T00:00:00,"Protein Structure, Secondary",G02.111.570.790.709.600
23921560,2013-08-07T00:00:00,Surface Properties,G02.842.850
23921560,2013-08-07T00:00:00,Ubiquitin,D12.776.947.500
23926298,2013-08-07T00:00:00,Animals,B01.050
23926298,2013-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23926298,2013-08-07T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23926298,2013-08-07T00:00:00,Janus Kinase 2,D08.811.913.696.620.682.725.124.200
23926298,2013-08-07T00:00:00,Janus Kinase 2,D12.776.476.393.200
23926298,2013-08-07T00:00:00,Janus Kinase 2,D12.776.624.664.700.117
23926298,2013-08-07T00:00:00,Mutation,G05.365.590
23926298,2013-08-07T00:00:00,Propylene Glycols,D02.033.455.706
23926298,2013-08-07T00:00:00,Protein Kinase C,D08.811.913.696.620.682.700.725
23926298,2013-08-07T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
23926298,2013-08-07T00:00:00,Protein Phosphatase 2,D12.644.360.583
23926298,2013-08-07T00:00:00,Protein Phosphatase 2,D12.776.476.561
23926298,2013-08-07T00:00:00,RNA Interference,G05.355.315.203.374.790
23926298,2013-08-07T00:00:00,Signal Transduction,G02.111.087.800
23926298,2013-08-07T00:00:00,Signal Transduction,G02.149.115.800
23926298,2013-08-07T00:00:00,Signal Transduction,G04.299.880
23926298,2013-08-07T00:00:00,Sphingosine,D02.033.100.700
23926298,2013-08-07T00:00:00,Sphingosine,D02.033.455.843
23926298,2013-08-07T00:00:00,Sphingosine,D02.092.063.700
23926298,2013-08-07T00:00:00,Treatment Outcome,E01.789.800
23926298,2013-08-07T00:00:00,Treatment Outcome,N04.761.559.590.800
23926298,2013-08-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23950893,2013-08-07T00:00:00,African Americans,M01.686.508.100.100
23950893,2013-08-07T00:00:00,African Americans,M01.686.754.100
23950893,2013-08-07T00:00:00,European Continental Ancestry Group,M01.686.508.400
23950893,2013-08-07T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23950893,2013-08-07T00:00:00,Genetic Predisposition to Disease,G05.380.355
23950893,2013-08-07T00:00:00,Hispanic Americans,M01.686.754.441
23950893,2013-08-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23950893,2013-08-07T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
23950893,2013-08-07T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
23950893,2013-08-07T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
23950893,2013-08-07T00:00:00,Linkage Disequilibrium,G05.540.500
23950893,2013-08-07T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
23950893,2013-08-07T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
23950893,2013-08-07T00:00:00,Phenotype,G05.695
23950893,2013-08-07T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23932018,2013-08-08T00:00:00,Animals,B01.050
23932018,2013-08-08T00:00:00,Graft Rejection,G12.425.901.545.328
23932018,2013-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23932018,2013-08-08T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23932018,2013-08-08T00:00:00,Kidney Transplantation,E02.870.500
23932018,2013-08-08T00:00:00,Kidney Transplantation,E04.936.450.485
23932018,2013-08-08T00:00:00,Kidney Transplantation,E04.950.774.400
23932491,2013-08-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23932491,2013-08-08T00:00:00,Learning,F02.463.425
23932491,2013-08-08T00:00:00,Learning,F02.784.629.529
23932491,2013-08-08T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
23932491,2013-08-08T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
23932491,2013-08-08T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
23932491,2013-08-08T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
23932491,2013-08-08T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
23932491,2013-08-08T00:00:00,Photic Stimulation,E05.723.729
23932491,2013-08-08T00:00:00,Visual Cortex,A08.186.211.730.885.287.500.571.735
23932491,2013-08-08T00:00:00,Visual Perception,F02.463.593.932
23761010,2013-08-09T00:00:00,Animals,B01.050
23761010,2013-08-09T00:00:00,Metal Nanoparticles,J01.637.512.600.500
23761010,2013-08-09T00:00:00,Rivers,G01.311.750
23761010,2013-08-09T00:00:00,Rivers,G16.500.275.280.500
23761010,2013-08-09T00:00:00,Rivers,N06.230.232.500
23761010,2013-08-09T00:00:00,Silver,D01.268.556.812
23761010,2013-08-09T00:00:00,Silver,D01.268.956.843
23761010,2013-08-09T00:00:00,Silver,D01.552.544.812
23761010,2013-08-09T00:00:00,United States,Z01.107.567.875
23761010,2013-08-09T00:00:00,"Water Pollutants, Chemical",D27.888.284.903.655
23931729,2013-08-09T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23931729,2013-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23931729,2013-08-09T00:00:00,Psychotherapy,F04.754
23931729,2013-08-09T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23931729,2013-08-09T00:00:00,Telemedicine,H02.403.840
23931729,2013-08-09T00:00:00,Telemedicine,L01.178.847.652
23931729,2013-08-09T00:00:00,Telemedicine,N04.590.374.800
23931729,2013-08-09T00:00:00,Veterans,M01.930
23939512,2013-08-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23939512,2013-08-09T00:00:00,Implosive Therapy,F04.754.137.506.325
23939512,2013-08-09T00:00:00,Psychiatric Status Rating Scales,F04.586
23939512,2013-08-09T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23939512,2013-08-09T00:00:00,Treatment Outcome,E01.789.800
23939512,2013-08-09T00:00:00,Treatment Outcome,N04.761.559.590.800
23939512,2013-08-09T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23939512,2013-08-09T00:00:00,United States,Z01.107.567.875
23939512,2013-08-09T00:00:00,Veterans,M01.930
23939512,2013-08-09T00:00:00,Yohimbine,D03.132.436.681.933
23939512,2013-08-09T00:00:00,Yohimbine,D03.438.473.402.681.933
23939036,2013-08-10T00:00:00,Adolescent,M01.060.057
23939036,2013-08-10T00:00:00,Child,M01.060.406
23939036,2013-08-10T00:00:00,Epilepsy,C10.228.140.490
23939036,2013-08-10T00:00:00,Health Promotion,N02.370
23939036,2013-08-10T00:00:00,Health Promotion,N02.421.726.507
23939036,2013-08-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23939036,2013-08-10T00:00:00,United States,Z01.107.567.875
23939036,2013-08-10T00:00:00,Young Adult,M01.060.116.815
23941992,2013-08-11T00:00:00,Antineoplastic Agents,D27.505.954.248
23941992,2013-08-11T00:00:00,Apoptosis,G04.299.139.160
23941992,2013-08-11T00:00:00,Cell Differentiation,G04.299.151
23941992,2013-08-11T00:00:00,Cell Movement,G04.299.283
23941992,2013-08-11T00:00:00,Cell Movement,G07.700.560.500.180
23941992,2013-08-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23941992,2013-08-11T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
23941992,2013-08-11T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
23941992,2013-08-11T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
23941992,2013-08-11T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.260.676
23941992,2013-08-11T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.624.664.700.189
23941992,2013-08-11T00:00:00,Proto-Oncogene Proteins c-myc,D12.776.660.765
23941992,2013-08-11T00:00:00,"RNA, Messenger",D13.444.735.544
23966720,2013-08-12T00:00:00,"Education, Pharmacy",I02.358.525
23966720,2013-08-12T00:00:00,Faculty,I02.463
23966720,2013-08-12T00:00:00,Faculty,M01.526.339
23966720,2013-08-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23966720,2013-08-12T00:00:00,Program Development,N04.452.760
23966720,2013-08-12T00:00:00,Program Evaluation,E05.337.820
23966720,2013-08-12T00:00:00,Program Evaluation,N04.761.685
23966720,2013-08-12T00:00:00,Program Evaluation,N05.715.360.650
23966720,2013-08-12T00:00:00,"Students, Pharmacy",I02.851.686.768
23966720,2013-08-12T00:00:00,"Students, Pharmacy",M01.848.769.768
23966720,2013-08-12T00:00:00,Universities,I02.783.850
23943804,2013-08-13T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
23943804,2013-08-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23943804,2013-08-13T00:00:00,Intracellular Signaling Peptides and Proteins,D12.644.360
23943804,2013-08-13T00:00:00,Intracellular Signaling Peptides and Proteins,D12.776.476
23943804,2013-08-13T00:00:00,Lung Neoplasms,C04.588.894.797.520
23943804,2013-08-13T00:00:00,Lung Neoplasms,C08.381.540
23943804,2013-08-13T00:00:00,Lung Neoplasms,C08.785.520
23943804,2013-08-13T00:00:00,MicroRNAs,D13.150.650.319
23943804,2013-08-13T00:00:00,MicroRNAs,D13.444.735.150.319
23943804,2013-08-13T00:00:00,MicroRNAs,D13.444.735.790.099
23943804,2013-08-13T00:00:00,Polyamines,D02.092.782
23943804,2013-08-13T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
23943804,2013-08-13T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
23943804,2013-08-13T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
23943804,2013-08-13T00:00:00,Spermine,D02.092.211.415.701.801.821
23943804,2013-08-13T00:00:00,Spermine,D02.092.782.802
23879743,2013-08-14T00:00:00,Allosteric Regulation,G02.111.087.040
23879743,2013-08-14T00:00:00,Allosteric Regulation,G02.149.115.040
23879743,2013-08-14T00:00:00,Catalytic Domain,G02.111.570.120.704
23879743,2013-08-14T00:00:00,Catalytic Domain,G02.111.570.790.709.610.189
23879743,2013-08-14T00:00:00,Crystallization,E05.196.300
23879743,2013-08-14T00:00:00,Crystallization,G02.149.767.505
23879743,2013-08-14T00:00:00,Crystallization,G02.842.750.505
23879743,2013-08-14T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
23879743,2013-08-14T00:00:00,"Models, Molecular",E05.599.595
23879743,2013-08-14T00:00:00,Potassium,D01.268.549.550
23879743,2013-08-14T00:00:00,Potassium,D01.552.528.652
23879743,2013-08-14T00:00:00,Sulfates,D01.248.497.158.845
23879743,2013-08-14T00:00:00,Sulfates,D01.875.800.800.850
23942418,2013-08-14T00:00:00,Animals,B01.050
23942418,2013-08-14T00:00:00,Association Learning,F02.463.425.069.296
23942418,2013-08-14T00:00:00,Conditioning (Psychology),F02.463.425.179
23942418,2013-08-14T00:00:00,Morphine,D03.132.577.249.547
23942418,2013-08-14T00:00:00,Morphine,D03.549.686.575
23942418,2013-08-14T00:00:00,Morphine,D03.605.497.575
23942418,2013-08-14T00:00:00,Morphine,D04.615.723.795.547
23942418,2013-08-14T00:00:00,Motivation,F01.658
23942418,2013-08-14T00:00:00,Motivation,F01.752.543.500.750
23942418,2013-08-14T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23942418,2013-08-14T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23942418,2013-08-14T00:00:00,Reinforcement (Psychology),F02.463.425.770
23942418,2013-08-14T00:00:00,Substance Withdrawal Syndrome,C21.739.835
23942418,2013-08-14T00:00:00,Substance Withdrawal Syndrome,F03.900.825
23943025,2013-08-14T00:00:00,Aged,M01.060.116.100
23943025,2013-08-14T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
23943025,2013-08-14T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
23943025,2013-08-14T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
23943025,2013-08-14T00:00:00,Esophageal Neoplasms,C04.588.443.353
23943025,2013-08-14T00:00:00,Esophageal Neoplasms,C06.301.371.205
23943025,2013-08-14T00:00:00,Esophageal Neoplasms,C06.405.117.430
23943025,2013-08-14T00:00:00,Esophageal Neoplasms,C06.405.249.205
23943025,2013-08-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23946297,2013-08-14T00:00:00,Adolescent,M01.060.057
23946297,2013-08-14T00:00:00,Adult,M01.060.116
23946297,2013-08-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23946297,2013-08-14T00:00:00,Prevalence,E05.318.308.985.525.750
23946297,2013-08-14T00:00:00,Prevalence,L01.280.975.525.750
23946297,2013-08-14T00:00:00,Prevalence,N01.224.935.597.750
23946297,2013-08-14T00:00:00,Prevalence,N06.850.505.400.975.525.750
23946297,2013-08-14T00:00:00,Prevalence,N06.850.520.308.985.525.750
23946297,2013-08-14T00:00:00,Risk Factors,E05.318.740.600.800.725
23946297,2013-08-14T00:00:00,Risk Factors,N05.715.350.200.700
23946297,2013-08-14T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23946297,2013-08-14T00:00:00,Risk Factors,N06.850.490.625.750
23946297,2013-08-14T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23946297,2013-08-14T00:00:00,Secondary Prevention,N02.421.726.825
23946297,2013-08-14T00:00:00,Secondary Prevention,N06.850.780.750
23946297,2013-08-14T00:00:00,Stroke,C10.228.140.300.775
23946297,2013-08-14T00:00:00,Stroke,C14.907.253.855
23946297,2013-08-14T00:00:00,Young Adult,M01.060.116.815
23847313,2013-08-15T00:00:00,Adolescent,M01.060.057
23847313,2013-08-15T00:00:00,Adult,M01.060.116
23847313,2013-08-15T00:00:00,Aged,M01.060.116.100
23847313,2013-08-15T00:00:00,Aging,G07.700.320.124
23847313,2013-08-15T00:00:00,Biological Markers,D23.101
23847313,2013-08-15T00:00:00,Child,M01.060.406
23847313,2013-08-15T00:00:00,"Child, Preschool",M01.060.406.448
23847313,2013-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23847313,2013-08-15T00:00:00,Infant,M01.060.703
23847313,2013-08-15T00:00:00,"Infant, Newborn",M01.060.703.520
23847313,2013-08-15T00:00:00,Lipofuscin,D10.460
23847313,2013-08-15T00:00:00,Lipofuscin,D23.767.550
23847313,2013-08-15T00:00:00,Middle Aged,M01.060.116.630
23847313,2013-08-15T00:00:00,Retinal Degeneration,C11.768.585
23847313,2013-08-15T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23847313,2013-08-15T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23847313,2013-08-15T00:00:00,Retinoids,D02.455.326.271.665.202.495
23847313,2013-08-15T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
23847313,2013-08-15T00:00:00,Retinoids,D02.455.849.131.495
23847313,2013-08-15T00:00:00,Retinoids,D23.767.261.700
23847313,2013-08-15T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
23847313,2013-08-15T00:00:00,Young Adult,M01.060.116.815
23950187,2013-08-15T00:00:00,Adult,M01.060.116
23950187,2013-08-15T00:00:00,African Americans,M01.686.508.100.100
23950187,2013-08-15T00:00:00,African Americans,M01.686.754.100
23950187,2013-08-15T00:00:00,Aged,M01.060.116.100
23950187,2013-08-15T00:00:00,"Arthritis, Rheumatoid",C05.550.114.154
23950187,2013-08-15T00:00:00,"Arthritis, Rheumatoid",C05.799.114
23950187,2013-08-15T00:00:00,"Arthritis, Rheumatoid",C17.300.775.099
23950187,2013-08-15T00:00:00,"Arthritis, Rheumatoid",C20.111.199
23950187,2013-08-15T00:00:00,C-Reactive Protein,D12.776.034.145
23950187,2013-08-15T00:00:00,C-Reactive Protein,D12.776.124.050.120
23950187,2013-08-15T00:00:00,C-Reactive Protein,D12.776.124.486.157
23950187,2013-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23950187,2013-08-15T00:00:00,Middle Aged,M01.060.116.630
23966867,2013-08-15T00:00:00,African Continental Ancestry Group,M01.686.508.100
23966867,2013-08-15T00:00:00,European Continental Ancestry Group,M01.686.508.400
23966867,2013-08-15T00:00:00,Genetic Loci,G05.360.340.024.380
23966867,2013-08-15T00:00:00,Genome-Wide Association Study,E05.318.416.249
23966867,2013-08-15T00:00:00,Genome-Wide Association Study,E05.318.780.392
23966867,2013-08-15T00:00:00,Genome-Wide Association Study,E05.393.385.500
23966867,2013-08-15T00:00:00,Genome-Wide Association Study,E05.393.522.500
23966867,2013-08-15T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23966867,2013-08-15T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23966867,2013-08-15T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23966867,2013-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23966867,2013-08-15T00:00:00,Obesity,C18.654.726.500
23966867,2013-08-15T00:00:00,Obesity,C23.888.144.699.500
23966867,2013-08-15T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23966867,2013-08-15T00:00:00,Obesity,G07.100.100.160.120.699.500
23966867,2013-08-15T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
24021441,2013-08-15T00:00:00,Bone Neoplasms,C04.588.149
24021441,2013-08-15T00:00:00,Bone Neoplasms,C05.116.231
24021441,2013-08-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
24021441,2013-08-15T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
24021441,2013-08-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24021441,2013-08-15T00:00:00,Incidental Findings,E01.410
24021441,2013-08-15T00:00:00,Mohs Surgery,E04.494.575
24021441,2013-08-15T00:00:00,Multiple Myeloma,C04.557.595.500
24021441,2013-08-15T00:00:00,Multiple Myeloma,C14.907.454.460
24021441,2013-08-15T00:00:00,Multiple Myeloma,C15.378.147.780.650
24021441,2013-08-15T00:00:00,Multiple Myeloma,C15.378.463.835.460
24021441,2013-08-15T00:00:00,Multiple Myeloma,C20.683.515.845
24021441,2013-08-15T00:00:00,Multiple Myeloma,C20.683.780.650
24021441,2013-08-15T00:00:00,Skin Neoplasms,C04.588.805
24021441,2013-08-15T00:00:00,Skin Neoplasms,C17.800.882
23958035,2013-08-16T00:00:00,Adolescent,M01.060.057
23958035,2013-08-16T00:00:00,Employment,N01.824.245
23958035,2013-08-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23958035,2013-08-16T00:00:00,Juvenile Delinquency,I01.880.735.479
23958035,2013-08-16T00:00:00,Program Development,N04.452.760
23958035,2013-08-16T00:00:00,Program Evaluation,E05.337.820
23958035,2013-08-16T00:00:00,Program Evaluation,N04.761.685
23958035,2013-08-16T00:00:00,Program Evaluation,N05.715.360.650
23958035,2013-08-16T00:00:00,Substance-Related Disorders,C21.739
23958035,2013-08-16T00:00:00,Substance-Related Disorders,F03.900
23955026,2013-08-17T00:00:00,Activities of Daily Living,E02.831.067
23955026,2013-08-17T00:00:00,Activities of Daily Living,I03.050
23955026,2013-08-17T00:00:00,Activities of Daily Living,N02.421.784.110
23955026,2013-08-17T00:00:00,Adult,M01.060.116
23955026,2013-08-17T00:00:00,Aged,M01.060.116.100
23955026,2013-08-17T00:00:00,Caregivers,M01.085
23955026,2013-08-17T00:00:00,Caregivers,M01.526.485.200
23955026,2013-08-17T00:00:00,Caregivers,N02.360.200
23955026,2013-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23955026,2013-08-17T00:00:00,Income,N01.824.417
23955026,2013-08-17T00:00:00,Middle Aged,M01.060.116.630
23955026,2013-08-17T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23955026,2013-08-17T00:00:00,Prostatic Neoplasms,C12.294.260.750
23955026,2013-08-17T00:00:00,Prostatic Neoplasms,C12.294.565.625
23955026,2013-08-17T00:00:00,Prostatic Neoplasms,C12.758.409.750
23955026,2013-08-17T00:00:00,Regression Analysis,E05.318.740.750
23955026,2013-08-17T00:00:00,Regression Analysis,N05.715.360.750.695
23955026,2013-08-17T00:00:00,Regression Analysis,N06.850.520.830.750
23955026,2013-08-17T00:00:00,Spouses,F01.829.263.500.660
23955026,2013-08-17T00:00:00,Spouses,I01.880.225.500.670
23955026,2013-08-17T00:00:00,Spouses,M01.816
23955026,2013-08-17T00:00:00,United States,Z01.107.567.875
23979022,2013-08-17T00:00:00,Animals,B01.050
23979022,2013-08-17T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23979022,2013-08-17T00:00:00,Spinal Cord Injuries,C10.228.854.770
23979022,2013-08-17T00:00:00,Spinal Cord Injuries,C10.900.850
23979022,2013-08-17T00:00:00,Spinal Cord Injuries,C21.866.819
24018226,2013-08-17T00:00:00,Adolescent,M01.060.057
24018226,2013-08-17T00:00:00,Adult,M01.060.116
24018226,2013-08-17T00:00:00,Benzazepines,D03.438.079
24018226,2013-08-17T00:00:00,Cues,F02.463.425.234
24018226,2013-08-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24018226,2013-08-17T00:00:00,Middle Aged,M01.060.116.630
24018226,2013-08-17T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
24018226,2013-08-17T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
24018226,2013-08-17T00:00:00,Smoking,F01.145.466.753
24018226,2013-08-17T00:00:00,Smoking Cessation,F01.145.940.700
24018226,2013-08-17T00:00:00,Treatment Outcome,E01.789.800
24018226,2013-08-17T00:00:00,Treatment Outcome,N04.761.559.590.800
24018226,2013-08-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24018226,2013-08-17T00:00:00,Young Adult,M01.060.116.815
23780824,2013-08-18T00:00:00,Adult,M01.060.116
23780824,2013-08-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23780824,2013-08-18T00:00:00,Mental Disorders,F03
23780824,2013-08-18T00:00:00,Middle Aged,M01.060.116.630
23780824,2013-08-18T00:00:00,Quality of Life,I01.800
23780824,2013-08-18T00:00:00,Quality of Life,K01.752.400.750
23780824,2013-08-18T00:00:00,Questionnaires,E05.318.308.750
23780824,2013-08-18T00:00:00,Questionnaires,L01.280.800
23780824,2013-08-18T00:00:00,Questionnaires,N05.715.360.300.695
23780824,2013-08-18T00:00:00,Questionnaires,N06.850.520.308.750
23780824,2013-08-18T00:00:00,Substance-Related Disorders,C21.739
23780824,2013-08-18T00:00:00,Substance-Related Disorders,F03.900
23780824,2013-08-18T00:00:00,United States,Z01.107.567.875
23831765,2013-08-18T00:00:00,Polymers,D05.750
23831765,2013-08-18T00:00:00,Polymers,D25.720
23831765,2013-08-18T00:00:00,Polymers,J01.637.051.720
23954847,2013-08-19T00:00:00,Animals,B01.050
23954847,2013-08-19T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
23954847,2013-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23954847,2013-08-19T00:00:00,Limbic System,A08.186.211.464
23954847,2013-08-19T00:00:00,Solvents,D27.720.844
23954847,2013-08-19T00:00:00,Substance-Related Disorders,C21.739
23954847,2013-08-19T00:00:00,Substance-Related Disorders,F03.900
23969078,2013-08-19T00:00:00,Animals,B01.050
23969078,2013-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23969078,2013-08-19T00:00:00,Lipofuscin,D10.460
23969078,2013-08-19T00:00:00,Lipofuscin,D23.767.550
23969078,2013-08-19T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
23969078,2013-08-19T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
23969078,2013-08-19T00:00:00,Retinoids,D02.455.326.271.665.202.495
23969078,2013-08-19T00:00:00,Retinoids,D02.455.426.392.368.367.379.249.700
23969078,2013-08-19T00:00:00,Retinoids,D02.455.849.131.495
23969078,2013-08-19T00:00:00,Retinoids,D23.767.261.700
23969078,2013-08-19T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
24018231,2013-08-19T00:00:00,Adolescent,M01.060.057
24018231,2013-08-19T00:00:00,Alcohol Drinking,F01.145.317.269
24018231,2013-08-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24018231,2013-08-19T00:00:00,Impulsive Behavior,F01.145.527
24018231,2013-08-19T00:00:00,Life Change Events,F01.829.458.410
24018231,2013-08-19T00:00:00,Motivation,F01.658
24018231,2013-08-19T00:00:00,Motivation,F01.752.543.500.750
24018231,2013-08-19T00:00:00,Students,I02.233.748
24018231,2013-08-19T00:00:00,Students,I02.851
24018231,2013-08-19T00:00:00,Students,M01.848
24018231,2013-08-19T00:00:00,Young Adult,M01.060.116.815
23875735,2013-08-20T00:00:00,Alzheimer Disease,C10.228.140.380.100
23875735,2013-08-20T00:00:00,Alzheimer Disease,C10.574.945.249
23875735,2013-08-20T00:00:00,Alzheimer Disease,F03.087.400.100
23875735,2013-08-20T00:00:00,Calcium-Binding Proteins,D12.776.157.125
23875735,2013-08-20T00:00:00,Calpain,D08.811.277.656.262.500.120
23875735,2013-08-20T00:00:00,Calpain,D08.811.277.656.300.200.120
23875735,2013-08-20T00:00:00,Case-Control Studies,E05.318.760.500.500
23875735,2013-08-20T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23875735,2013-08-20T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23875735,2013-08-20T00:00:00,Cell Death,G04.299.139
23875735,2013-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23875735,2013-08-20T00:00:00,Huntington Disease,C10.228.140.079.545
23875735,2013-08-20T00:00:00,Huntington Disease,C10.228.140.380.278
23875735,2013-08-20T00:00:00,Huntington Disease,C10.228.662.262.249.750
23875735,2013-08-20T00:00:00,Huntington Disease,C10.574.500.497
23875735,2013-08-20T00:00:00,Huntington Disease,C16.320.400.430
23875735,2013-08-20T00:00:00,Huntington Disease,F03.087.250.400
23875735,2013-08-20T00:00:00,Huntington Disease,F03.087.400.390
23875735,2013-08-20T00:00:00,Inflammation,C23.550.470
23875735,2013-08-20T00:00:00,Multiple Sclerosis,C10.114.375.500
23875735,2013-08-20T00:00:00,Multiple Sclerosis,C10.314.350.500
23875735,2013-08-20T00:00:00,Multiple Sclerosis,C20.111.258.250.500
23875735,2013-08-20T00:00:00,Neurons,A08.663
23875735,2013-08-20T00:00:00,Neurons,A11.671
23875735,2013-08-20T00:00:00,Parkinson Disease,C10.228.140.079.862.500
23875735,2013-08-20T00:00:00,Parkinson Disease,C10.228.662.600.400
23875735,2013-08-20T00:00:00,Parkinson Disease,C10.574.812
23875735,2013-08-20T00:00:00,Spinal Cord,A08.186.854
23875735,2013-08-20T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
23875735,2013-08-20T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
23875735,2013-08-20T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
23965492,2013-08-20T00:00:00,Antigen-Antibody Complex,D12.776.124.486.485.114.257
23965492,2013-08-20T00:00:00,Antigen-Antibody Complex,D12.776.124.790.651.114.257
23965492,2013-08-20T00:00:00,Antigen-Antibody Complex,D12.776.377.715.548.114.257
23965492,2013-08-20T00:00:00,Antigen-Antibody Complex,D23.050.101
23965492,2013-08-20T00:00:00,Atherosclerosis,C14.907.137.126.307
23965492,2013-08-20T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
23965492,2013-08-20T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
23965492,2013-08-20T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
23965492,2013-08-20T00:00:00,Cell Line,A11.251.210
23965492,2013-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23965492,2013-08-20T00:00:00,"Lipoproteins, LDL",D10.532.515
23965492,2013-08-20T00:00:00,"Lipoproteins, LDL",D12.776.521.550
23968766,2013-08-20T00:00:00,"Anastomosis, Surgical",E04.035
23968766,2013-08-20T00:00:00,Animals,B01.050
23968766,2013-08-20T00:00:00,Endothelial Cells,A11.436.275
23968766,2013-08-20T00:00:00,"Endothelium, Vascular",A07.231.330
23968766,2013-08-20T00:00:00,"Endothelium, Vascular",A10.272.491.355
23968766,2013-08-20T00:00:00,Phenotype,G05.695
23968766,2013-08-20T00:00:00,Pulmonary Artery,A07.231.114.715
23968766,2013-08-20T00:00:00,Swine,B01.050.150.900.649.077.880
23968766,2013-08-20T00:00:00,Vascular Surgical Procedures,E04.100.814
23968859,2013-08-20T00:00:00,Gene Regulatory Networks,G05.360.080.689.360
23968859,2013-08-20T00:00:00,Genetic Variation,G05.365
23968859,2013-08-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23968859,2013-08-20T00:00:00,Individualized Medicine,E02.574
23968859,2013-08-20T00:00:00,Individualized Medicine,H02.403.200.700
23966687,2013-08-21T00:00:00,Animals,B01.050
23966687,2013-08-21T00:00:00,Cocaine,D02.145.074.722.388
23966687,2013-08-21T00:00:00,Cocaine,D03.132.889.354
23966687,2013-08-21T00:00:00,Cocaine,D03.605.869.388
23966687,2013-08-21T00:00:00,Cocaine,D04.075.080.875.099.722.388
23966687,2013-08-21T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
23966687,2013-08-21T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
23966687,2013-08-21T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
23966687,2013-08-21T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
23966687,2013-08-21T00:00:00,Electric Stimulation,E05.723.402
23966687,2013-08-21T00:00:00,"Extinction, Psychological",F02.463.425.770.232
23966687,2013-08-21T00:00:00,Green Fluorescent Proteins,D12.776.532.265
23966687,2013-08-21T00:00:00,Neural Pathways,A08.612
23966687,2013-08-21T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23966687,2013-08-21T00:00:00,Patch-Clamp Techniques,E05.200.500.800
23966687,2013-08-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23966687,2013-08-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23966687,2013-08-21T00:00:00,Reinforcement (Psychology),F02.463.425.770
23966687,2013-08-21T00:00:00,Self Administration,E02.319.890
23966687,2013-08-21T00:00:00,Self Administration,E02.900.890
23970121,2013-08-22T00:00:00,Animals,B01.050
23970121,2013-08-22T00:00:00,DNA-Binding Proteins,D12.776.260
23970121,2013-08-22T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
23970121,2013-08-22T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
23970121,2013-08-22T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
23970121,2013-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23970121,2013-08-22T00:00:00,Kidney,A05.810.453
23970121,2013-08-22T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
23970121,2013-08-22T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
23970121,2013-08-22T00:00:00,Lupus Nephritis,C17.300.480.680
23970121,2013-08-22T00:00:00,Lupus Nephritis,C20.111.590.560
23970121,2013-08-22T00:00:00,NF-kappa B,D12.776.260.600
23970121,2013-08-22T00:00:00,NF-kappa B,D12.776.660.600
23970121,2013-08-22T00:00:00,NF-kappa B,D12.776.930.600
23970121,2013-08-22T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23970380,2013-08-22T00:00:00,Adult,M01.060.116
23970380,2013-08-22T00:00:00,Animals,B01.050
23970380,2013-08-22T00:00:00,Antineoplastic Agents,D27.505.954.248
23970380,2013-08-22T00:00:00,Apoptosis,G04.299.139.160
23970380,2013-08-22T00:00:00,Cell Proliferation,G04.299.233.750
23970380,2013-08-22T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23970380,2013-08-22T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
23970380,2013-08-22T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
23970380,2013-08-22T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
23970380,2013-08-22T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
23970380,2013-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23970380,2013-08-22T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
23970380,2013-08-22T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
23970380,2013-08-22T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23970380,2013-08-22T00:00:00,Protein Transport,G03.495.166.700
23970380,2013-08-22T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.260.698
23970380,2013-08-22T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.826
23970380,2013-08-22T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.930.669
23970380,2013-08-22T00:00:00,Ribonucleoproteins,D12.776.157.725.500
23970380,2013-08-22T00:00:00,Ribonucleoproteins,D12.776.664.962.500
23970380,2013-08-22T00:00:00,Transcription Factors,D12.776.930
23970794,2013-08-22T00:00:00,Adolescent,M01.060.057
23970794,2013-08-22T00:00:00,Adult,M01.060.116
23970794,2013-08-22T00:00:00,Data Collection,E05.318.308
23970794,2013-08-22T00:00:00,Data Collection,L01.280
23970794,2013-08-22T00:00:00,Data Collection,N05.715.360.300
23970794,2013-08-22T00:00:00,Data Collection,N06.850.520.308
23970794,2013-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23970794,2013-08-22T00:00:00,Prevalence,E05.318.308.985.525.750
23970794,2013-08-22T00:00:00,Prevalence,L01.280.975.525.750
23970794,2013-08-22T00:00:00,Prevalence,N01.224.935.597.750
23970794,2013-08-22T00:00:00,Prevalence,N06.850.505.400.975.525.750
23970794,2013-08-22T00:00:00,Prevalence,N06.850.520.308.985.525.750
23970794,2013-08-22T00:00:00,Smoking,F01.145.466.753
23970794,2013-08-22T00:00:00,United States,Z01.107.567.875
23970794,2013-08-22T00:00:00,Young Adult,M01.060.116.815
23972371,2013-08-22T00:00:00,African Continental Ancestry Group,M01.686.508.100
23972371,2013-08-22T00:00:00,Blood Pressure,E01.370.600.875.249
23972371,2013-08-22T00:00:00,Blood Pressure,G09.330.380.076
23972371,2013-08-22T00:00:00,"Databases, Genetic",L01.470.750.750.325
23972371,2013-08-22T00:00:00,"Databases, Genetic",L01.700.508.300.188.400.325
23972371,2013-08-22T00:00:00,Genetic Loci,G05.360.340.024.380
23972371,2013-08-22T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23972371,2013-08-22T00:00:00,Genetic Predisposition to Disease,G05.380.355
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.318.416.249
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.318.780.392
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.393.385.500
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.393.522.500
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
23972371,2013-08-22T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
23972371,2013-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23972371,2013-08-22T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
23972722,2013-08-22T00:00:00,Aged,M01.060.116.100
23972722,2013-08-22T00:00:00,Guideline Adherence,N04.761.337
23972722,2013-08-22T00:00:00,Guideline Adherence,N05.715.360.395
23972722,2013-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23972722,2013-08-22T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23972722,2013-08-22T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23972722,2013-08-22T00:00:00,"Phantoms, Imaging",E07.671
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D12.776.866.249.500
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D23.050.285.625
23972722,2013-08-22T00:00:00,Prostate-Specific Antigen,D23.101.840.625
23972722,2013-08-22T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23972722,2013-08-22T00:00:00,Prostatic Neoplasms,C12.294.260.750
23972722,2013-08-22T00:00:00,Prostatic Neoplasms,C12.294.565.625
23972722,2013-08-22T00:00:00,Prostatic Neoplasms,C12.758.409.750
23972722,2013-08-22T00:00:00,"Quality Assurance, Health Care",N04.761.700
23972722,2013-08-22T00:00:00,"Quality Assurance, Health Care",N05.700
23972722,2013-08-22T00:00:00,Questionnaires,E05.318.308.750
23972722,2013-08-22T00:00:00,Questionnaires,L01.280.800
23972722,2013-08-22T00:00:00,Questionnaires,N05.715.360.300.695
23972722,2013-08-22T00:00:00,Questionnaires,N06.850.520.308.750
23972722,2013-08-22T00:00:00,Radiotherapy Dosage,E02.815.639
23972722,2013-08-22T00:00:00,"Radiotherapy Planning, Computer-Assisted",E02.950.825
23972722,2013-08-22T00:00:00,"Radiotherapy Planning, Computer-Assisted",L01.700.508.100.710.600.608
23972722,2013-08-22T00:00:00,"Radiotherapy, Conformal",E02.815.635.700
23972722,2013-08-22T00:00:00,"Radiotherapy, Conformal",L01.700.508.100.710.600.550
23972722,2013-08-22T00:00:00,"Radiotherapy, Intensity-Modulated",E02.815.635.700.700
23972722,2013-08-22T00:00:00,"Radiotherapy, Intensity-Modulated",L01.700.508.100.710.600.550.700
23972722,2013-08-22T00:00:00,Salvage Therapy,E02.186.800
23972722,2013-08-22T00:00:00,Salvage Therapy,E02.895
23972722,2013-08-22T00:00:00,Urinary Bladder,A05.810.890
23975452,2013-08-22T00:00:00,Animals,B01.050
23975452,2013-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23975452,2013-08-22T00:00:00,Mutation,G05.365.590
24034708,2013-08-22T00:00:00,Adult,M01.060.116
24034708,2013-08-22T00:00:00,Aged,M01.060.116.100
24034708,2013-08-22T00:00:00,Community Health Services,N02.421.143
24034708,2013-08-22T00:00:00,Health Services Accessibility,N04.590.374.350
24034708,2013-08-22T00:00:00,Health Services Accessibility,N05.300.430
24034708,2013-08-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24034708,2013-08-22T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
24034708,2013-08-22T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
24034708,2013-08-22T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
24034708,2013-08-22T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
24034708,2013-08-22T00:00:00,Kidney Transplantation,E02.870.500
24034708,2013-08-22T00:00:00,Kidney Transplantation,E04.936.450.485
24034708,2013-08-22T00:00:00,Kidney Transplantation,E04.950.774.400
24034708,2013-08-22T00:00:00,Living Donors,M01.898.656
24034708,2013-08-22T00:00:00,Middle Aged,M01.060.116.630
24034708,2013-08-22T00:00:00,Risk Factors,E05.318.740.600.800.725
24034708,2013-08-22T00:00:00,Risk Factors,N05.715.350.200.700
24034708,2013-08-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24034708,2013-08-22T00:00:00,Risk Factors,N06.850.490.625.750
24034708,2013-08-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24034708,2013-08-22T00:00:00,Rural Population,N01.600.725
24034708,2013-08-22T00:00:00,Tissue Donors,M01.898
24034708,2013-08-22T00:00:00,Treatment Outcome,E01.789.800
24034708,2013-08-22T00:00:00,Treatment Outcome,N04.761.559.590.800
24034708,2013-08-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24034708,2013-08-22T00:00:00,Urban Population,N01.600.900
24034708,2013-08-22T00:00:00,Waiting Lists,N04.452.095.738
23869611,2013-08-23T00:00:00,Aging,G07.700.320.124
23869611,2013-08-23T00:00:00,Animals,B01.050
23869611,2013-08-23T00:00:00,Collagen,D05.750.078.280
23869611,2013-08-23T00:00:00,Collagen,D12.776.860.300.250
23869611,2013-08-23T00:00:00,Fetus,A16.378
23869611,2013-08-23T00:00:00,Mitral Valve,A07.541.510.507
24011306,2013-08-23T00:00:00,Animals,B01.050
24011306,2013-08-23T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
24011306,2013-08-23T00:00:00,Cytokines,D12.644.276.374
24011306,2013-08-23T00:00:00,Cytokines,D12.776.467.374
24011306,2013-08-23T00:00:00,Cytokines,D23.529.374
24011306,2013-08-23T00:00:00,"Immunity, Innate",G12.450.575
24011306,2013-08-23T00:00:00,Interleukin-6,D12.644.276.374.465.506
24011306,2013-08-23T00:00:00,Interleukin-6,D12.776.467.374.465.506
24011306,2013-08-23T00:00:00,Interleukin-6,D23.529.374.465.506
24011306,2013-08-23T00:00:00,Lipopolysaccharides,D09.400.500
24011306,2013-08-23T00:00:00,Lipopolysaccharides,D09.698.718.450
24011306,2013-08-23T00:00:00,Lipopolysaccharides,D10.494
24011306,2013-08-23T00:00:00,Lipopolysaccharides,D23.050.161.616.525
24011306,2013-08-23T00:00:00,Lipopolysaccharides,D23.946.123.329.500
24011306,2013-08-23T00:00:00,Macrophages,A11.329.372
24011306,2013-08-23T00:00:00,Macrophages,A11.627.482
24011306,2013-08-23T00:00:00,Macrophages,A11.733.397
24011306,2013-08-23T00:00:00,Macrophages,A15.382.680.397
24011306,2013-08-23T00:00:00,Macrophages,A15.382.812.522
24011306,2013-08-23T00:00:00,"RNA, Messenger",D13.444.735.544
24011306,2013-08-23T00:00:00,Signal Transduction,G02.111.087.800
24011306,2013-08-23T00:00:00,Signal Transduction,G02.149.115.800
24011306,2013-08-23T00:00:00,Signal Transduction,G04.299.880
24011306,2013-08-23T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.644.360.024.374
24011306,2013-08-23T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.157.057.249
24011306,2013-08-23T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.476.024.437
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
24011306,2013-08-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
24011306,2013-08-23T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
24011306,2013-08-23T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
24011306,2013-08-23T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
24011306,2013-08-23T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
24054945,2013-08-23T00:00:00,Alleles,G05.360.340.024.340.030
24054945,2013-08-23T00:00:00,Breast Neoplasms,C04.588.180
24054945,2013-08-23T00:00:00,Breast Neoplasms,C17.800.090.500
24054945,2013-08-23T00:00:00,Carcinoma,C04.557.470.200
24054945,2013-08-23T00:00:00,Case-Control Studies,E05.318.760.500.500
24054945,2013-08-23T00:00:00,Case-Control Studies,N05.715.360.775.175.200
24054945,2013-08-23T00:00:00,Case-Control Studies,N06.850.520.450.500.500
24054945,2013-08-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24054945,2013-08-23T00:00:00,"Immunity, Humoral",G12.450.050.420
24054945,2013-08-23T00:00:00,Immunoglobulin kappa-Chains,D12.776.124.486.485.705.750.530
24054945,2013-08-23T00:00:00,Immunoglobulin kappa-Chains,D12.776.124.790.651.705.750.530
24054945,2013-08-23T00:00:00,Immunoglobulin kappa-Chains,D12.776.377.715.548.705.750.530
24054945,2013-08-23T00:00:00,Linkage Disequilibrium,G05.540.500
24054945,2013-08-23T00:00:00,"Polymorphism, Genetic",G05.365.795
24054945,2013-08-23T00:00:00,"Receptor, erbB-2",D08.811.913.696.620.682.725.400.150
24054945,2013-08-23T00:00:00,"Receptor, erbB-2",D12.776.543.750.060.374
24054945,2013-08-23T00:00:00,"Receptor, erbB-2",D12.776.543.750.750.400.350
24054945,2013-08-23T00:00:00,"Receptor, erbB-2",D12.776.624.664.700.642
24054945,2013-08-23T00:00:00,"Receptor, erbB-2",D23.101.840.642
24054945,2013-08-23T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
24054945,2013-08-23T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
24054945,2013-08-23T00:00:00,"Receptors, IgG",D23.101.100.110.695
24054945,2013-08-23T00:00:00,Risk Factors,E05.318.740.600.800.725
24054945,2013-08-23T00:00:00,Risk Factors,N05.715.350.200.700
24054945,2013-08-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24054945,2013-08-23T00:00:00,Risk Factors,N06.850.490.625.750
24054945,2013-08-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23971871,2013-08-24T00:00:00,Animals,B01.050
23971871,2013-08-24T00:00:00,Apoptosis,G04.299.139.160
23971871,2013-08-24T00:00:00,Clinical Trials as Topic,E05.318.760.535
23971871,2013-08-24T00:00:00,Clinical Trials as Topic,E05.337.250
23971871,2013-08-24T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23971871,2013-08-24T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23971871,2013-08-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23971871,2013-08-24T00:00:00,Neurodegenerative Diseases,C10.574
23971871,2013-08-24T00:00:00,Neuroprotective Agents,D27.505.696.706.548
23971871,2013-08-24T00:00:00,Neuroprotective Agents,D27.505.954.427.575
23971871,2013-08-24T00:00:00,Oligopeptides,D12.644.456
23971871,2013-08-24T00:00:00,Treatment Outcome,E01.789.800
23971871,2013-08-24T00:00:00,Treatment Outcome,N04.761.559.590.800
23971871,2013-08-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23988286,2013-08-26T00:00:00,Adenocarcinoma,C04.557.470.200.025
23988286,2013-08-26T00:00:00,"Carcinoma, Signet Ring Cell",C04.557.470.200.025.415
23988286,2013-08-26T00:00:00,"Carcinoma, Signet Ring Cell",C04.557.470.590.415
23988286,2013-08-26T00:00:00,"Chemotherapy, Adjuvant",E02.186.170
23988286,2013-08-26T00:00:00,"Chemotherapy, Adjuvant",E02.319.170
23988286,2013-08-26T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
23988286,2013-08-26T00:00:00,Esophageal Neoplasms,C04.588.443.353
23988286,2013-08-26T00:00:00,Esophageal Neoplasms,C06.301.371.205
23988286,2013-08-26T00:00:00,Esophageal Neoplasms,C06.405.117.430
23988286,2013-08-26T00:00:00,Esophageal Neoplasms,C06.405.249.205
23988286,2013-08-26T00:00:00,Gastric Bypass,E02.065.062.249
23988286,2013-08-26T00:00:00,Gastric Bypass,E04.035.398.385
23988286,2013-08-26T00:00:00,Gastric Bypass,E04.062.249
23988286,2013-08-26T00:00:00,Gastric Bypass,E04.210.457.430
23988286,2013-08-26T00:00:00,Gastrostomy,E04.210.496
23988286,2013-08-26T00:00:00,Gastrostomy,E04.579.408
23988286,2013-08-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23988286,2013-08-26T00:00:00,Jejunostomy,E04.210.338.523
23988286,2013-08-26T00:00:00,Jejunostomy,E04.579.338.523
23988286,2013-08-26T00:00:00,Middle Aged,M01.060.116.630
23988286,2013-08-26T00:00:00,Reconstructive Surgical Procedures,E04.680
23988286,2013-08-26T00:00:00,Stomach Neoplasms,C04.588.274.476.767
23988286,2013-08-26T00:00:00,Stomach Neoplasms,C06.301.371.767
23988286,2013-08-26T00:00:00,Stomach Neoplasms,C06.405.249.767
23988286,2013-08-26T00:00:00,Stomach Neoplasms,C06.405.748.789
23988286,2013-08-26T00:00:00,Treatment Outcome,E01.789.800
23988286,2013-08-26T00:00:00,Treatment Outcome,N04.761.559.590.800
23988286,2013-08-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24028801,2013-08-26T00:00:00,Adult,M01.060.116
24028801,2013-08-26T00:00:00,Amphetamine-Related Disorders,C21.739.225
24028801,2013-08-26T00:00:00,Amphetamine-Related Disorders,F03.900.225
24028801,2013-08-26T00:00:00,Central Nervous System Stimulants,D27.505.696.282
24028801,2013-08-26T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
24028801,2013-08-26T00:00:00,Cues,F02.463.425.234
24028801,2013-08-26T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
24028801,2013-08-26T00:00:00,Functional Laterality,F02.830.297.425
24028801,2013-08-26T00:00:00,Functional Laterality,G11.561.225.425
24028801,2013-08-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24028801,2013-08-26T00:00:00,Methamphetamine,D02.092.471.683.152.619
24028801,2013-08-26T00:00:00,Movement,G07.700.560
24028801,2013-08-26T00:00:00,Movement,G11.427.590.530
24028801,2013-08-26T00:00:00,Photic Stimulation,E05.723.729
24028801,2013-08-26T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
24028801,2013-08-26T00:00:00,Seizures,C10.228.140.490.631
24028801,2013-08-26T00:00:00,Seizures,C10.597.742
24028801,2013-08-26T00:00:00,Seizures,C23.888.592.742
24028801,2013-08-26T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
24028801,2013-08-26T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
23979626,2013-08-27T00:00:00,Adult,M01.060.116
23979626,2013-08-27T00:00:00,Aged,M01.060.116.100
23979626,2013-08-27T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
23979626,2013-08-27T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
23979626,2013-08-27T00:00:00,"Defibrillators, Implantable",E07.695.175
23979626,2013-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23979626,2013-08-27T00:00:00,Middle Aged,M01.060.116.630
23979626,2013-08-27T00:00:00,"Tachycardia, Ventricular",C14.280.067.845.940
23979626,2013-08-27T00:00:00,"Tachycardia, Ventricular",C23.550.073.845.940
23979626,2013-08-27T00:00:00,Treatment Outcome,E01.789.800
23979626,2013-08-27T00:00:00,Treatment Outcome,N04.761.559.590.800
23979626,2013-08-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23987898,2013-08-27T00:00:00,Aged,M01.060.116.100
23987898,2013-08-27T00:00:00,"Carcinoma, Signet Ring Cell",C04.557.470.200.025.415
23987898,2013-08-27T00:00:00,"Carcinoma, Signet Ring Cell",C04.557.470.590.415
23987898,2013-08-27T00:00:00,Esophageal Neoplasms,C04.588.274.476.205
23987898,2013-08-27T00:00:00,Esophageal Neoplasms,C04.588.443.353
23987898,2013-08-27T00:00:00,Esophageal Neoplasms,C06.301.371.205
23987898,2013-08-27T00:00:00,Esophageal Neoplasms,C06.405.117.430
23987898,2013-08-27T00:00:00,Esophageal Neoplasms,C06.405.249.205
23987898,2013-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23987898,2013-08-27T00:00:00,Middle Aged,M01.060.116.630
23987898,2013-08-27T00:00:00,South Carolina,Z01.107.567.875.075.662
23987898,2013-08-27T00:00:00,South Carolina,Z01.107.567.875.750.700
23988192,2013-08-27T00:00:00,Adult,M01.060.116
23988192,2013-08-27T00:00:00,Ambulatory Care,E02.760.106
23988192,2013-08-27T00:00:00,Ambulatory Care,N02.421.585.106
23988192,2013-08-27T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23988192,2013-08-27T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23988192,2013-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23988192,2013-08-27T00:00:00,Middle Aged,M01.060.116.630
23988192,2013-08-27T00:00:00,Opioid-Related Disorders,C21.739.675
23988192,2013-08-27T00:00:00,Opioid-Related Disorders,F03.900.675
23988192,2013-08-27T00:00:00,Smoking,F01.145.466.753
23988192,2013-08-27T00:00:00,Smoking Cessation,F01.145.940.700
23988192,2013-08-27T00:00:00,Substance-Related Disorders,C21.739
23988192,2013-08-27T00:00:00,Substance-Related Disorders,F03.900
23988192,2013-08-27T00:00:00,Tobacco Use Disorder,C21.739.912
23988192,2013-08-27T00:00:00,Tobacco Use Disorder,F03.900.912
23994289,2013-08-27T00:00:00,Animals,B01.050
23994289,2013-08-27T00:00:00,Bone Marrow Cells,A11.148
23994289,2013-08-27T00:00:00,Bone Marrow Cells,A15.378.316
23994289,2013-08-27T00:00:00,Hematopoietic Stem Cell Transplantation,E04.936.225.687.500
23994289,2013-08-27T00:00:00,Hematopoietic Stem Cells,A11.148.378
23994289,2013-08-27T00:00:00,Hematopoietic Stem Cells,A11.872.378
23994289,2013-08-27T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
23994289,2013-08-27T00:00:00,Heterocyclic Compounds,D03
23994289,2013-08-27T00:00:00,Proteomics,H01.158.201.843
23994289,2013-08-27T00:00:00,Proteomics,H01.158.273.180.350.700
23994289,2013-08-27T00:00:00,Proteomics,H01.158.273.343.350.700
23994289,2013-08-27T00:00:00,Proteomics,H01.181.122.738
23994289,2013-08-27T00:00:00,Thioredoxins,D12.776.915
24007727,2013-08-27T00:00:00,Adolescent,M01.060.057
24007727,2013-08-27T00:00:00,Adult,M01.060.116
24007727,2013-08-27T00:00:00,Aged,M01.060.116.100
24007727,2013-08-27T00:00:00,Astrocytoma,C04.557.465.625.600.380.080
24007727,2013-08-27T00:00:00,Astrocytoma,C04.557.470.670.380.080
24007727,2013-08-27T00:00:00,Astrocytoma,C04.557.580.625.600.380.080
24007727,2013-08-27T00:00:00,Brain Neoplasms,C04.588.614.250.195
24007727,2013-08-27T00:00:00,Brain Neoplasms,C10.228.140.211
24007727,2013-08-27T00:00:00,Brain Neoplasms,C10.551.240.250
24007727,2013-08-27T00:00:00,Disease Progression,C23.550.291.656
24007727,2013-08-27T00:00:00,Disease-Free Survival,E01.789.200
24007727,2013-08-27T00:00:00,Disease-Free Survival,E05.318.740.998.300
24007727,2013-08-27T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
24007727,2013-08-27T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
24007727,2013-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24007727,2013-08-27T00:00:00,Magnetic Resonance Angiography,E01.370.350.500.500
24007727,2013-08-27T00:00:00,Magnetic Resonance Angiography,E01.370.350.825.500.500
24007727,2013-08-27T00:00:00,Magnetic Resonance Angiography,E01.370.370.050.500
24007727,2013-08-27T00:00:00,Middle Aged,M01.060.116.630
24007727,2013-08-27T00:00:00,Young Adult,M01.060.116.815
24077033,2013-08-27T00:00:00,Cyclonic Storms,G16.500.240.135.500
24077033,2013-08-27T00:00:00,Disasters,N06.230.100
24077033,2013-08-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24077033,2013-08-27T00:00:00,Hypothalamo-Hypophyseal System,A06.688.357
24077033,2013-08-27T00:00:00,Hypothalamo-Hypophyseal System,A08.186.211.730.317.357.352.435
24077033,2013-08-27T00:00:00,Hypothalamo-Hypophyseal System,A08.713.357
24077033,2013-08-27T00:00:00,Middle Aged,M01.060.116.630
24077033,2013-08-27T00:00:00,Pituitary-Adrenal System,A06.407.691
24077033,2013-08-27T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
24077033,2013-08-27T00:00:00,"Receptors, Corticotropin-Releasing Hormone",D12.776.543.750.100.180
24077033,2013-08-27T00:00:00,"Receptors, Corticotropin-Releasing Hormone",D12.776.543.750.720.600.290
24077033,2013-08-27T00:00:00,"Receptors, Corticotropin-Releasing Hormone",D12.776.543.750.750.555.290
24077033,2013-08-27T00:00:00,"Receptors, Corticotropin-Releasing Hormone",D12.776.543.750.750.700.150
24077033,2013-08-27T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23986503,2013-08-28T00:00:00,Adult,M01.060.116
23986503,2013-08-28T00:00:00,Aged,M01.060.116.100
23986503,2013-08-28T00:00:00,Agriculture,J01.040
23986503,2013-08-28T00:00:00,California,Z01.107.567.875.580.200
23986503,2013-08-28T00:00:00,California,Z01.107.567.875.760.200
23986503,2013-08-28T00:00:00,Communication,F01.145.209
23986503,2013-08-28T00:00:00,Communication,L01.143
23986503,2013-08-28T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
23986503,2013-08-28T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
23986503,2013-08-28T00:00:00,Government Regulation,I01.880.604.394
23986503,2013-08-28T00:00:00,Government Regulation,N03.706.358
23986503,2013-08-28T00:00:00,Health Behavior,F01.145.488
23986503,2013-08-28T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23986503,2013-08-28T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23986503,2013-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23986503,2013-08-28T00:00:00,Middle Aged,M01.060.116.630
23986503,2013-08-28T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23986503,2013-08-28T00:00:00,Physician-Patient Relations,N05.300.660.625
23986503,2013-08-28T00:00:00,Qualitative Research,H01.770.644.241.850
23994352,2013-08-28T00:00:00,Bacteriophages,B04.123
23994352,2013-08-28T00:00:00,"Genes, Reporter",G05.360.340.024.340.435
23994352,2013-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23994352,2013-08-28T00:00:00,Luminescent Measurements,E05.196.712.516
23994509,2013-08-28T00:00:00,Age Factors,N05.715.350.075
23994509,2013-08-28T00:00:00,Age Factors,N06.850.490.250
23994509,2013-08-28T00:00:00,Animals,B01.050
23994509,2013-08-28T00:00:00,Face,A01.456.505
23994509,2013-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23994509,2013-08-28T00:00:00,Infant,M01.060.703
23994509,2013-08-28T00:00:00,"Pattern Recognition, Visual",F02.463.593.524.500
23994509,2013-08-28T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.622
23994509,2013-08-28T00:00:00,"Pattern Recognition, Visual",F02.463.593.932.869.435.673
23994509,2013-08-28T00:00:00,Photic Stimulation,E05.723.729
23994509,2013-08-28T00:00:00,Sex Factors,N05.715.350.675
23994509,2013-08-28T00:00:00,Sex Factors,N06.850.490.875
24025359,2013-08-28T00:00:00,Adenoviridae,B04.280.030
24025359,2013-08-28T00:00:00,Adenoviridae,B04.909.204.097
24025359,2013-08-28T00:00:00,Animals,B01.050
24025359,2013-08-28T00:00:00,Antineoplastic Agents,D27.505.954.248
24025359,2013-08-28T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
24025359,2013-08-28T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
24025359,2013-08-28T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
24025359,2013-08-28T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
24025359,2013-08-28T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
24025359,2013-08-28T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
24025359,2013-08-28T00:00:00,Drug Interactions,G07.690.812.240
24025359,2013-08-28T00:00:00,Drug Interactions,G07.700.680.240
24025359,2013-08-28T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
24025359,2013-08-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24025359,2013-08-28T00:00:00,Kidney Neoplasms,C04.588.945.947.535
24025359,2013-08-28T00:00:00,Kidney Neoplasms,C12.758.820.750
24025359,2013-08-28T00:00:00,Kidney Neoplasms,C12.777.419.473
24025359,2013-08-28T00:00:00,Kidney Neoplasms,C13.351.937.820.535
24025359,2013-08-28T00:00:00,Kidney Neoplasms,C13.351.968.419.473
24025359,2013-08-28T00:00:00,Recombinant Proteins,D12.776.828
24025359,2013-08-28T00:00:00,Signal Transduction,G02.111.087.800
24025359,2013-08-28T00:00:00,Signal Transduction,G02.149.115.800
24025359,2013-08-28T00:00:00,Signal Transduction,G04.299.880
23985782,2013-08-29T00:00:00,Animals,B01.050
23985782,2013-08-29T00:00:00,"Behavior, Addictive",F01.145.527.100.120
23985782,2013-08-29T00:00:00,Cocaine,D02.145.074.722.388
23985782,2013-08-29T00:00:00,Cocaine,D03.132.889.354
23985782,2013-08-29T00:00:00,Cocaine,D03.605.869.388
23985782,2013-08-29T00:00:00,Cocaine,D04.075.080.875.099.722.388
23985782,2013-08-29T00:00:00,Neuroglia,A08.637
23985782,2013-08-29T00:00:00,Neuroglia,A11.650
23985782,2013-08-29T00:00:00,Neurons,A08.663
23985782,2013-08-29T00:00:00,Neurons,A11.671
23985782,2013-08-29T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
23985782,2013-08-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23985782,2013-08-29T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23988638,2013-08-29T00:00:00,Delivery of Health Care,N04.590.374
23988638,2013-08-29T00:00:00,Delivery of Health Care,N05.300
23988638,2013-08-29T00:00:00,Health Policy,I01.880.604.825.608.400
23988638,2013-08-29T00:00:00,Health Policy,N03.706.825.608.428
23988638,2013-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23988638,2013-08-29T00:00:00,Stroke,C10.228.140.300.775
23988638,2013-08-29T00:00:00,Stroke,C14.907.253.855
23988639,2013-08-29T00:00:00,Aged,M01.060.116.100
23988639,2013-08-29T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
23988639,2013-08-29T00:00:00,Benzimidazoles,D03.438.103
23988639,2013-08-29T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
23988639,2013-08-29T00:00:00,Glomerular Filtration Rate,G08.852.357
23988639,2013-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23988639,2013-08-29T00:00:00,Middle Aged,M01.060.116.630
23988639,2013-08-29T00:00:00,Renin-Angiotensin System,G03.495.805
23988639,2013-08-29T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
23988639,2013-08-29T00:00:00,Risk Factors,E05.318.740.600.800.725
23988639,2013-08-29T00:00:00,Risk Factors,N05.715.350.200.700
23988639,2013-08-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23988639,2013-08-29T00:00:00,Risk Factors,N06.850.490.625.750
23988639,2013-08-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23988639,2013-08-29T00:00:00,Stroke,C10.228.140.300.775
23988639,2013-08-29T00:00:00,Stroke,C14.907.253.855
23994584,2013-08-29T00:00:00,Adult,M01.060.116
23994584,2013-08-29T00:00:00,Aged,M01.060.116.100
23994584,2013-08-29T00:00:00,Alleles,G05.360.340.024.340.030
23994584,2013-08-29T00:00:00,Case-Control Studies,E05.318.760.500.500
23994584,2013-08-29T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23994584,2013-08-29T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23994584,2013-08-29T00:00:00,"Epistasis, Genetic",G05.355.315.207
23994584,2013-08-29T00:00:00,Genetic Loci,G05.360.340.024.380
23994584,2013-08-29T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
23994584,2013-08-29T00:00:00,Genetic Predisposition to Disease,G05.380.355
23994584,2013-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23994584,2013-08-29T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
23994584,2013-08-29T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
23994584,2013-08-29T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
23994584,2013-08-29T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
23994584,2013-08-29T00:00:00,Middle Aged,M01.060.116.630
23994584,2013-08-29T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
23994584,2013-08-29T00:00:00,Prostatic Neoplasms,C12.294.260.750
23994584,2013-08-29T00:00:00,Prostatic Neoplasms,C12.294.565.625
23994584,2013-08-29T00:00:00,Prostatic Neoplasms,C12.758.409.750
23994584,2013-08-29T00:00:00,"Receptors, IgG",D12.776.543.750.705.871.300
23994584,2013-08-29T00:00:00,"Receptors, IgG",D23.050.301.264.035.695
23994584,2013-08-29T00:00:00,"Receptors, IgG",D23.101.100.110.695
24035640,2013-08-29T00:00:00,Case-Control Studies,E05.318.760.500.500
24035640,2013-08-29T00:00:00,Case-Control Studies,N05.715.360.775.175.200
24035640,2013-08-29T00:00:00,Case-Control Studies,N06.850.520.450.500.500
24035640,2013-08-29T00:00:00,"Child, Preschool",M01.060.406.448
24035640,2013-08-29T00:00:00,"Constriction, Pathologic",C23.300.287
24035640,2013-08-29T00:00:00,Craniofacial Abnormalities,C05.660.207
24035640,2013-08-29T00:00:00,Craniofacial Abnormalities,C16.131.621.207
24035640,2013-08-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24035640,2013-08-29T00:00:00,Infant,M01.060.703
24035640,2013-08-29T00:00:00,"Infant, Newborn",M01.060.703.520
24035640,2013-08-29T00:00:00,Nasal Cavity,A04.531.449
24035640,2013-08-29T00:00:00,Nasal Obstruction,C08.460.525
24035640,2013-08-29T00:00:00,Nasal Obstruction,C08.618.846.185.525
24035640,2013-08-29T00:00:00,Nasal Obstruction,C09.603.525
24035640,2013-08-29T00:00:00,Rhinoplasty,E02.218.755
24035640,2013-08-29T00:00:00,Rhinoplasty,E04.580.677
24035640,2013-08-29T00:00:00,Rhinoplasty,E04.680.650
24035640,2013-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24035640,2013-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24035640,2013-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24035640,2013-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24035640,2013-08-29T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24035640,2013-08-29T00:00:00,Treatment Outcome,E01.789.800
24035640,2013-08-29T00:00:00,Treatment Outcome,N04.761.559.590.800
24035640,2013-08-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24054066,2013-08-29T00:00:00,Carbon Dioxide,D01.200.200
24054066,2013-08-29T00:00:00,Carbon Dioxide,D01.362.150
24054066,2013-08-29T00:00:00,Carbon Dioxide,D01.650.550.200
24054066,2013-08-29T00:00:00,Chemical Fractionation,E05.196.155
24054066,2013-08-29T00:00:00,Elements,D01.268
24054066,2013-08-29T00:00:00,Industrial Waste,D20.944.420
24054066,2013-08-29T00:00:00,Industrial Waste,D27.888.284.404
24054066,2013-08-29T00:00:00,Industrial Waste,N06.850.460.710.420
24054066,2013-08-29T00:00:00,Lignin,D05.750.078.562.180.515
24054066,2013-08-29T00:00:00,Lignin,D05.750.078.687
24054066,2013-08-29T00:00:00,Lignin,D09.698.365.180.515
24054066,2013-08-29T00:00:00,Lignin,D25.720.099.687
24054066,2013-08-29T00:00:00,Lignin,J01.637.051.720.099.687
24054066,2013-08-29T00:00:00,Paper,J01.576.154.600
24054066,2013-08-29T00:00:00,Paper,J01.637.650
24054066,2013-08-29T00:00:00,Solvents,D27.720.844
23828274,2013-08-30T00:00:00,Adult,M01.060.116
23828274,2013-08-30T00:00:00,Aged,M01.060.116.100
23828274,2013-08-30T00:00:00,Biological Markers,D23.101
23828274,2013-08-30T00:00:00,Ceramides,D02.065.313
23828274,2013-08-30T00:00:00,Ceramides,D09.400.410.420.525.200
23828274,2013-08-30T00:00:00,Ceramides,D10.390.470.675.200
23828274,2013-08-30T00:00:00,Ceramides,D10.570.877.360.612.200
23828274,2013-08-30T00:00:00,Child,M01.060.406
23828274,2013-08-30T00:00:00,"Child, Preschool",M01.060.406.448
23828274,2013-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23828274,2013-08-30T00:00:00,Infant,M01.060.703
23828274,2013-08-30T00:00:00,"Lymphohistiocytosis, Hemophagocytic",C15.604.250.410.575
23828274,2013-08-30T00:00:00,Middle Aged,M01.060.116.630
23828274,2013-08-30T00:00:00,Sphingolipids,D10.570.877
23828274,2013-08-30T00:00:00,Sphingolipids,D10.808
23828274,2013-08-30T00:00:00,Sphingomyelin Phosphodiesterase,D08.811.277.352.640.750
23828274,2013-08-30T00:00:00,Sphingosine,D02.033.100.700
23828274,2013-08-30T00:00:00,Sphingosine,D02.033.455.843
23828274,2013-08-30T00:00:00,Sphingosine,D02.092.063.700
23828274,2013-08-30T00:00:00,Young Adult,M01.060.116.815
23989715,2013-08-30T00:00:00,Animals,B01.050
23989715,2013-08-30T00:00:00,Biological Markers,D23.101
23989715,2013-08-30T00:00:00,Extracellular Matrix,A11.284.295.310
23989715,2013-08-30T00:00:00,Heart Failure,C14.280.434
23989715,2013-08-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23989715,2013-08-30T00:00:00,MicroRNAs,D13.150.650.319
23989715,2013-08-30T00:00:00,MicroRNAs,D13.444.735.150.319
23989715,2013-08-30T00:00:00,MicroRNAs,D13.444.735.790.099
23989715,2013-08-30T00:00:00,Myocardium,A02.633.580
23989715,2013-08-30T00:00:00,Myocardium,A07.541.704
23989715,2013-08-30T00:00:00,Myocardium,A10.690.552.750
23996472,2013-08-31T00:00:00,Cell Adhesion,G04.299.117
23996472,2013-08-31T00:00:00,Cell Movement,G04.299.283
23996472,2013-08-31T00:00:00,Cell Movement,G07.700.560.500.180
23996472,2013-08-31T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
23996472,2013-08-31T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
23996472,2013-08-31T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
23996472,2013-08-31T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
23996472,2013-08-31T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
23996472,2013-08-31T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
23996472,2013-08-31T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
23996472,2013-08-31T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
23996472,2013-08-31T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
23996472,2013-08-31T00:00:00,Gamma Rays,G01.201.875.750.400
23996472,2013-08-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23996472,2013-08-31T00:00:00,"RNA, Messenger",D13.444.735.544
23996472,2013-08-31T00:00:00,Radiation-Sensitizing Agents,D27.505.696.750
23996472,2013-08-31T00:00:00,Transcription Factors,D12.776.930
23295409,2013-09-01T00:00:00,Community Networks,I01.880.656.300
23295409,2013-09-01T00:00:00,Community Networks,L01.700.508.300.184
23295409,2013-09-01T00:00:00,Community Networks,N02.421.143.202
23295409,2013-09-01T00:00:00,Health Education,I02.233.332
23295409,2013-09-01T00:00:00,Health Education,N02.421.143.827.407
23295409,2013-09-01T00:00:00,Health Education,N02.421.726.407
23295409,2013-09-01T00:00:00,Health Promotion,N02.370
23295409,2013-09-01T00:00:00,Health Promotion,N02.421.726.507
23295409,2013-09-01T00:00:00,Hispanic Americans,M01.686.754.441
23295409,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23295409,2013-09-01T00:00:00,Obesity,C18.654.726.500
23295409,2013-09-01T00:00:00,Obesity,C23.888.144.699.500
23295409,2013-09-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23295409,2013-09-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23295409,2013-09-01T00:00:00,Program Evaluation,E05.337.820
23295409,2013-09-01T00:00:00,Program Evaluation,N04.761.685
23295409,2013-09-01T00:00:00,Program Evaluation,N05.715.360.650
23295409,2013-09-01T00:00:00,Qualitative Research,H01.770.644.241.850
23295409,2013-09-01T00:00:00,United States,Z01.107.567.875
23553658,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23553658,2013-09-01T00:00:00,Measles virus,B04.820.455.600.650.500.500
23553658,2013-09-01T00:00:00,Measles virus,B04.909.777.455.600.650.500.500
23553658,2013-09-01T00:00:00,Osteitis Deformans,C05.116.692
23553658,2013-09-01T00:00:00,Osteoclasts,A11.329.372.700
23553658,2013-09-01T00:00:00,Osteoclasts,A11.627.482.700
23553658,2013-09-01T00:00:00,RANK Ligand,D12.644.276.374.750.562
23553658,2013-09-01T00:00:00,RANK Ligand,D12.644.276.972.562
23553658,2013-09-01T00:00:00,RANK Ligand,D12.776.467.374.750.562
23553658,2013-09-01T00:00:00,RANK Ligand,D12.776.467.972.562
23553658,2013-09-01T00:00:00,RANK Ligand,D23.529.374.750.562
23553658,2013-09-01T00:00:00,RANK Ligand,D23.529.972.562
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.644.360.024.303.500.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.644.360.024.342.100
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.157.057.061.500.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.157.057.186.100
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.260.513.249.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.476.024.387.500.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.476.024.421.100
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.930.354.249.500
23553658,2013-09-01T00:00:00,STAT1 Transcription Factor,D12.776.930.840.100
23553658,2013-09-01T00:00:00,Stromal Cells,A11.329.830
23553658,2013-09-01T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.644.360.024.374
23553658,2013-09-01T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.157.057.249
23553658,2013-09-01T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.476.024.437
23645547,2013-09-01T00:00:00,Adult,M01.060.116
23645547,2013-09-01T00:00:00,Aged,M01.060.116.100
23645547,2013-09-01T00:00:00,Community Networks,I01.880.656.300
23645547,2013-09-01T00:00:00,Community Networks,L01.700.508.300.184
23645547,2013-09-01T00:00:00,Community Networks,N02.421.143.202
23645547,2013-09-01T00:00:00,Health Services Accessibility,N04.590.374.350
23645547,2013-09-01T00:00:00,Health Services Accessibility,N05.300.430
23645547,2013-09-01T00:00:00,Healthcare Disparities,N04.590.374.380
23645547,2013-09-01T00:00:00,Healthcare Disparities,N05.300.493
23645547,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23645547,2013-09-01T00:00:00,Intervention Studies,E05.318.760.565
23645547,2013-09-01T00:00:00,Intervention Studies,N05.715.360.775.390
23645547,2013-09-01T00:00:00,Intervention Studies,N06.850.520.450.565
23645547,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23645547,2013-09-01T00:00:00,Neoplasms,C04
23645547,2013-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23645547,2013-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23645547,2013-09-01T00:00:00,Young Adult,M01.060.116.815
23709270,2013-09-01T00:00:00,Adult,M01.060.116
23709270,2013-09-01T00:00:00,African Americans,M01.686.508.100.100
23709270,2013-09-01T00:00:00,African Americans,M01.686.754.100
23709270,2013-09-01T00:00:00,Aged,M01.060.116.100
23709270,2013-09-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
23709270,2013-09-01T00:00:00,Depressive Disorder,F03.600.300
23709270,2013-09-01T00:00:00,Disasters,N06.230.100
23709270,2013-09-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
23709270,2013-09-01T00:00:00,Hispanic Americans,M01.686.754.441
23709270,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23709270,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23709270,2013-09-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
23709270,2013-09-01T00:00:00,Young Adult,M01.060.116.815
23733527,2013-09-01T00:00:00,Adolescent,M01.060.057
23733527,2013-09-01T00:00:00,Adult,M01.060.116
23733527,2013-09-01T00:00:00,Age Factors,N05.715.350.075
23733527,2013-09-01T00:00:00,Age Factors,N06.850.490.250
23733527,2013-09-01T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
23733527,2013-09-01T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
23733527,2013-09-01T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
23733527,2013-09-01T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
23733527,2013-09-01T00:00:00,Blood Flow Velocity,E01.370.370.130
23733527,2013-09-01T00:00:00,Blood Flow Velocity,G09.330.380.630.080
23733527,2013-09-01T00:00:00,Child,M01.060.406
23733527,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23733527,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23733527,2013-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.700.560.260.850
23733527,2013-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.260.850
23733527,2013-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.350.850.850.870
23733527,2013-09-01T00:00:00,"Ultrasonography, Doppler, Transcranial",E01.370.376.560.260.850
23756744,2013-09-01T00:00:00,Adult,M01.060.116
23756744,2013-09-01T00:00:00,Aged,M01.060.116.100
23756744,2013-09-01T00:00:00,"Embolization, Therapeutic",E02.520.360
23756744,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23756744,2013-09-01T00:00:00,Intracranial Aneurysm,C10.228.140.300.510.600
23756744,2013-09-01T00:00:00,Intracranial Aneurysm,C14.907.055.635
23756744,2013-09-01T00:00:00,Intracranial Aneurysm,C14.907.253.560.300
23756744,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23756744,2013-09-01T00:00:00,Stents,E07.695.750
23756744,2013-09-01T00:00:00,Treatment Outcome,E01.789.800
23756744,2013-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23756744,2013-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23760764,2013-09-01T00:00:00,Adult,M01.060.116
23760764,2013-09-01T00:00:00,Blood Glucose,D09.546.359.448.500
23760764,2013-09-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
23760764,2013-09-01T00:00:00,Body Mass Index,E05.041.124.125
23760764,2013-09-01T00:00:00,Body Mass Index,G07.100.100.125
23760764,2013-09-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
23760764,2013-09-01T00:00:00,Device Removal,E04.199
23760764,2013-09-01T00:00:00,Gastroplasty,E02.065.062.750
23760764,2013-09-01T00:00:00,Gastroplasty,E04.062.750
23760764,2013-09-01T00:00:00,Gastroplasty,E04.210.485
23760764,2013-09-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
23760764,2013-09-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
23760764,2013-09-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
23760764,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23760764,2013-09-01T00:00:00,Insulin,D06.472.699.587.740.625
23760764,2013-09-01T00:00:00,Insulin,D12.644.548.586.740.625
23760764,2013-09-01T00:00:00,Laparoscopy,E01.370.388.250.520
23760764,2013-09-01T00:00:00,Laparoscopy,E04.800.250.520
23760764,2013-09-01T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
23760764,2013-09-01T00:00:00,Metabolic Syndrome X,C18.452.625
23760764,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23760764,2013-09-01T00:00:00,Obesity,C18.654.726.500
23760764,2013-09-01T00:00:00,Obesity,C23.888.144.699.500
23760764,2013-09-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
23760764,2013-09-01T00:00:00,Obesity,G07.100.100.160.120.699.500
23760764,2013-09-01T00:00:00,Postoperative Complications,C23.550.767
23760764,2013-09-01T00:00:00,Treatment Outcome,E01.789.800
23760764,2013-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23760764,2013-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23760764,2013-09-01T00:00:00,Weight Loss,C23.888.144.243.963
23760764,2013-09-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23846109,2013-09-01T00:00:00,Contrast Media,D27.720.259
23846109,2013-09-01T00:00:00,Diagnostic Imaging,E01.370.350
23846109,2013-09-01T00:00:00,Dyspnea,C08.618.326
23846109,2013-09-01T00:00:00,Dyspnea,C23.888.852.371
23846109,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23872681,2013-09-01T00:00:00,Aged,M01.060.116.100
23872681,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23872681,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23872681,2013-09-01T00:00:00,Paresis,C10.597.636
23872681,2013-09-01T00:00:00,Paresis,C23.888.592.643
23872681,2013-09-01T00:00:00,Psychomotor Performance,F02.808
23872681,2013-09-01T00:00:00,Psychomotor Performance,G11.427.700
23872681,2013-09-01T00:00:00,Psychomotor Performance,G11.561.623
23872681,2013-09-01T00:00:00,Recovery of Function,G16.757
23872681,2013-09-01T00:00:00,Stroke,C10.228.140.300.775
23872681,2013-09-01T00:00:00,Stroke,C14.907.253.855
23872681,2013-09-01T00:00:00,Treatment Outcome,E01.789.800
23872681,2013-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23872681,2013-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23872681,2013-09-01T00:00:00,User-Computer Interface,L01.224.900.910
23872681,2013-09-01T00:00:00,Video Games,I03.450.642.693.930
23872681,2013-09-01T00:00:00,Video Games,L01.224.900.930
23903770,2013-09-01T00:00:00,Acetylcysteine,D02.886.030.230.259
23903770,2013-09-01T00:00:00,Acetylcysteine,D12.125.166.230.259
23903770,2013-09-01T00:00:00,Animals,B01.050
23903770,2013-09-01T00:00:00,Brain,A08.186.211
23903770,2013-09-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
23903770,2013-09-01T00:00:00,Clinical Trials as Topic,E05.337.250
23903770,2013-09-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
23903770,2013-09-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
23903770,2013-09-01T00:00:00,Glutamic Acid,D12.125.067.750
23903770,2013-09-01T00:00:00,Glutamic Acid,D12.125.119.450
23903770,2013-09-01T00:00:00,Glutamic Acid,D12.125.427.300
23903770,2013-09-01T00:00:00,Substance-Related Disorders,C21.739
23903770,2013-09-01T00:00:00,Substance-Related Disorders,F03.900
23917920,2013-09-01T00:00:00,Copper,D01.268.556.195
23917920,2013-09-01T00:00:00,Copper,D01.268.956.170
23917920,2013-09-01T00:00:00,Copper,D01.552.544.195
23917920,2013-09-01T00:00:00,Cross Infection,C01.539.248
23917920,2013-09-01T00:00:00,Disinfectants,D27.505.954.122.425
23917920,2013-09-01T00:00:00,Disinfectants,D27.720.274
23917920,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23917920,2013-09-01T00:00:00,Intensive Care Units,N02.278.388.493
23917920,2013-09-01T00:00:00,Staphylococcal Infections,C01.252.410.868
23921866,2013-09-01T00:00:00,Cost-Benefit Analysis,N03.219.151.125
23921866,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23921866,2013-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
23921866,2013-09-01T00:00:00,Pregnancy,G08.686.785.760.769
23921866,2013-09-01T00:00:00,Unnecessary Procedures,N02.421.380.900
23921866,2013-09-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
23925471,2013-09-01T00:00:00,Biomedical Engineering,H02.070
23925471,2013-09-01T00:00:00,Biomedical Engineering,J01.293.140
23925471,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23931426,2013-09-01T00:00:00,Adult,M01.060.116
23931426,2013-09-01T00:00:00,Aged,M01.060.116.100
23931426,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
23931426,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
23931426,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
23931426,2013-09-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
23931426,2013-09-01T00:00:00,Cyclophosphamide,D02.705.670.243
23931426,2013-09-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
23931426,2013-09-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
23931426,2013-09-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
23931426,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23931426,2013-09-01T00:00:00,Magnetic Resonance Spectroscopy,E05.196.867.519
23931426,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23931426,2013-09-01T00:00:00,Phospholipids,D10.570.755
23931426,2013-09-01T00:00:00,Phospholipids,D10.695
23931426,2013-09-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
23931426,2013-09-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
23931426,2013-09-01T00:00:00,Sensitivity and Specificity,G17.800
23931426,2013-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23931426,2013-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23931426,2013-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23931426,2013-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23931426,2013-09-01T00:00:00,Treatment Outcome,E01.789.800
23931426,2013-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23931426,2013-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23931426,2013-09-01T00:00:00,"Tumor Markers, Biological",D23.101.840
23931426,2013-09-01T00:00:00,Young Adult,M01.060.116.815
23935169,2013-09-01T00:00:00,Evidence-Based Medicine,H02.249.750
23935169,2013-09-01T00:00:00,Evidence-Based Medicine,H02.403.200.400
23935169,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23935169,2013-09-01T00:00:00,Neurosurgical Procedures,E04.525
23935169,2013-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23935169,2013-09-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23935169,2013-09-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23935169,2013-09-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23935169,2013-09-01T00:00:00,Research Design,E05.581.500
23935169,2013-09-01T00:00:00,Research Design,H01.770.644.728
23957969,2013-09-01T00:00:00,Dermatology,H02.403.225
23957969,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23957969,2013-09-01T00:00:00,Internet,L01.224.230.110.500
23957969,2013-09-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
23957969,2013-09-01T00:00:00,Publishing,L01.737
23962940,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23962940,2013-09-01T00:00:00,"Intubation, Intratracheal",E05.497.578
23966095,2013-09-01T00:00:00,Chest Pain,C23.888.646.215
23966095,2013-09-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
23966095,2013-09-01T00:00:00,Coronary Angiography,E01.370.370.050.200
23966095,2013-09-01T00:00:00,Coronary Angiography,E01.370.370.380.200
23966095,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23966095,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23966095,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23966095,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23966095,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23966095,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23966648,2013-09-01T00:00:00,Anesthesia,E03.155
23966648,2013-09-01T00:00:00,Anesthesiology,H02.403.066
23966648,2013-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
23966648,2013-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
23966648,2013-09-01T00:00:00,Heart,A07.541
23966648,2013-09-01T00:00:00,"Heart Defects, Congenital",C14.240.400
23966648,2013-09-01T00:00:00,"Heart Defects, Congenital",C14.280.400
23966648,2013-09-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23966648,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23966648,2013-09-01T00:00:00,Neurosurgical Procedures,E04.525
23966648,2013-09-01T00:00:00,Perioperative Care,E02.760.722
23966648,2013-09-01T00:00:00,Perioperative Care,E04.604
23966648,2013-09-01T00:00:00,Perioperative Care,N02.421.585.722
23966648,2013-09-01T00:00:00,Pulmonary Embolism,C08.381.746
23966648,2013-09-01T00:00:00,Pulmonary Embolism,C14.907.355.350.700
23966648,2013-09-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
23966648,2013-09-01T00:00:00,"Quality Assurance, Health Care",N05.700
23966648,2013-09-01T00:00:00,"Societies, Medical",N03.540.828.589
23966648,2013-09-01T00:00:00,United States,Z01.107.567.875
23966648,2013-09-01T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
23971448,2013-09-01T00:00:00,Adult,M01.060.116
23971448,2013-09-01T00:00:00,Aged,M01.060.116.100
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Magnetic Resonance",E01.370.350.500.100
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Magnetic Resonance",E01.370.350.825.500.100
23971448,2013-09-01T00:00:00,"Cholangiopancreatography, Magnetic Resonance",E01.370.372.207
23971448,2013-09-01T00:00:00,Contrast Media,D27.720.259
23971448,2013-09-01T00:00:00,Endosonography,E01.370.350.850.280
23971448,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23971448,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23971448,2013-09-01T00:00:00,Physician's Practice Patterns,N04.590.748
23971448,2013-09-01T00:00:00,Physician's Practice Patterns,N05.300.625
23971448,2013-09-01T00:00:00,Referral and Consultation,N04.452.758.849
23974712,2013-09-01T00:00:00,Adult,M01.060.116
23974712,2013-09-01T00:00:00,Anti-Asthmatic Agents,D27.505.954.796.050
23974712,2013-09-01T00:00:00,Asthma,C08.127.108
23974712,2013-09-01T00:00:00,Asthma,C08.381.495.108
23974712,2013-09-01T00:00:00,Asthma,C08.674.095
23974712,2013-09-01T00:00:00,Asthma,C20.543.480.680.095
23974712,2013-09-01T00:00:00,Attitude of Health Personnel,F01.100.050
23974712,2013-09-01T00:00:00,Attitude of Health Personnel,N05.300.100
23974712,2013-09-01T00:00:00,Continuity of Patient Care,N04.590.233.727.210
23974712,2013-09-01T00:00:00,Drug Prescriptions,E02.319.307
23974712,2013-09-01T00:00:00,Drug Prescriptions,N02.421.668.778.500
23974712,2013-09-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
23974712,2013-09-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
23974712,2013-09-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
23974712,2013-09-01T00:00:00,Guideline Adherence,N04.761.337
23974712,2013-09-01T00:00:00,Guideline Adherence,N05.715.360.395
23974712,2013-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23974712,2013-09-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23974712,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23974712,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
23974712,2013-09-01T00:00:00,"Models, Theoretical",E05.599
23974712,2013-09-01T00:00:00,Pediatrics,H02.403.670
23974712,2013-09-01T00:00:00,Physician's Practice Patterns,N04.590.748
23974712,2013-09-01T00:00:00,Physician's Practice Patterns,N05.300.625
23974712,2013-09-01T00:00:00,Physicians,M01.526.485.810
23974712,2013-09-01T00:00:00,Physicians,N02.360.810
23974712,2013-09-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
23974712,2013-09-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
23974712,2013-09-01T00:00:00,United States,Z01.107.567.875
23998692,2013-09-01T00:00:00,Adult,M01.060.116
23998692,2013-09-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.400.200
23998692,2013-09-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.350.850.220.230
23998692,2013-09-01T00:00:00,"Echocardiography, Three-Dimensional",E01.370.370.380.220.230
23998692,2013-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
23998692,2013-09-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
23998692,2013-09-01T00:00:00,"Heart Defects, Congenital",C14.240.400
23998692,2013-09-01T00:00:00,"Heart Defects, Congenital",C14.280.400
23998692,2013-09-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
23998692,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23998692,2013-09-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
23998692,2013-09-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
23998692,2013-09-01T00:00:00,Sensitivity and Specificity,G17.800
23998692,2013-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
23998692,2013-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
23998692,2013-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
23998692,2013-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
23998692,2013-09-01T00:00:00,"Societies, Medical",N03.540.828.589
23998692,2013-09-01T00:00:00,United States,Z01.107.567.875
24001084,2013-09-01T00:00:00,Adolescent,M01.060.057
24001084,2013-09-01T00:00:00,Adult,M01.060.116
24001084,2013-09-01T00:00:00,Aged,M01.060.116.100
24001084,2013-09-01T00:00:00,Anticonvulsants,D27.505.954.427.080
24001084,2013-09-01T00:00:00,Child,M01.060.406
24001084,2013-09-01T00:00:00,"Child, Preschool",M01.060.406.448
24001084,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24001084,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24001084,2013-09-01T00:00:00,Research Design,E05.581.500
24001084,2013-09-01T00:00:00,Research Design,H01.770.644.728
24001084,2013-09-01T00:00:00,Status Epilepticus,C10.228.140.490.690
24001084,2013-09-01T00:00:00,Treatment Outcome,E01.789.800
24001084,2013-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24001084,2013-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24001084,2013-09-01T00:00:00,Valproic Acid,D02.241.081.944.509.900
24001084,2013-09-01T00:00:00,Valproic Acid,D10.251.400.895.593.900
24001084,2013-09-01T00:00:00,Young Adult,M01.060.116.815
24004038,2013-09-01T00:00:00,Academic Medical Centers,N02.278.020
24004038,2013-09-01T00:00:00,Cooperative Behavior,F01.145.813.115
24004038,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24004038,2013-09-01T00:00:00,Interprofessional Relations,F01.829.401.205
24004038,2013-09-01T00:00:00,Length of Stay,E02.760.400.480
24004038,2013-09-01T00:00:00,Length of Stay,N02.421.585.400.480
24004038,2013-09-01T00:00:00,"Pancreatitis, Chronic",C06.689.750.830
24004038,2013-09-01T00:00:00,Patient Readmission,E02.760.400.620
24004038,2013-09-01T00:00:00,Patient Readmission,N02.421.585.400.620
24004038,2013-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
24004038,2013-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
24004703,2013-09-01T00:00:00,Adolescent,M01.060.057
24004703,2013-09-01T00:00:00,Adult,M01.060.116
24004703,2013-09-01T00:00:00,Aged,M01.060.116.100
24004703,2013-09-01T00:00:00,Chronic Disease,C23.550.291.500
24004703,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24004703,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24004703,2013-09-01T00:00:00,Prevalence,E05.318.308.985.525.750
24004703,2013-09-01T00:00:00,Prevalence,L01.280.975.525.750
24004703,2013-09-01T00:00:00,Prevalence,N01.224.935.597.750
24004703,2013-09-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
24004703,2013-09-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
24004703,2013-09-01T00:00:00,Primary Health Care,N04.590.233.727
24004703,2013-09-01T00:00:00,United States,Z01.107.567.875
24004703,2013-09-01T00:00:00,Young Adult,M01.060.116.815
24020731,2013-09-01T00:00:00,Bacterial Infections,C01.252
24020731,2013-09-01T00:00:00,Cross Infection,C01.539.248
24020731,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24020731,2013-09-01T00:00:00,Infection Control,N06.850.780.200.450
24023328,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
24023328,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
24023328,2013-09-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
24023328,2013-09-01T00:00:00,Combined Modality Therapy,E02.186
24023328,2013-09-01T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
24023328,2013-09-01T00:00:00,Cyclophosphamide,D02.705.670.243
24023328,2013-09-01T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
24023328,2013-09-01T00:00:00,Doxorubicin,D04.615.562.050.200.175
24023328,2013-09-01T00:00:00,Doxorubicin,D09.408.051.059.200.175
24023328,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24023328,2013-09-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
24023328,2013-09-01T00:00:00,Lung Neoplasms,C08.381.540
24023328,2013-09-01T00:00:00,Lung Neoplasms,C08.785.520
24023328,2013-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24023328,2013-09-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24023328,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24023328,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24051744,2013-09-01T00:00:00,Aged,M01.060.116.100
24051744,2013-09-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
24051744,2013-09-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
24051744,2013-09-01T00:00:00,Dextrans,D05.750.078.562.272
24051744,2013-09-01T00:00:00,Dextrans,D09.698.365.272
24051744,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24051744,2013-09-01T00:00:00,Lymph Nodes,A10.549.400
24051744,2013-09-01T00:00:00,Lymph Nodes,A15.382.520.604.412
24051744,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24051744,2013-09-01T00:00:00,Mouth Neoplasms,C04.588.443.591
24051744,2013-09-01T00:00:00,Mouth Neoplasms,C07.465.565
24051744,2013-09-01T00:00:00,Neoplasm Invasiveness,C04.697.645
24051744,2013-09-01T00:00:00,Neoplasm Invasiveness,C23.550.727.645
24051744,2013-09-01T00:00:00,Radiopharmaceuticals,D27.720.470.410.650
24051744,2013-09-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
24051744,2013-09-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
24051744,2013-09-01T00:00:00,Sensitivity and Specificity,G17.800
24051744,2013-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
24051744,2013-09-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
24051744,2013-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
24051744,2013-09-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
24051744,2013-09-01T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24051744,2013-09-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24069979,2013-09-01T00:00:00,Animals,B01.050
24069979,2013-09-01T00:00:00,Appendectomy,E04.210.078
24069979,2013-09-01T00:00:00,Appendicitis,C06.405.205.099
24069979,2013-09-01T00:00:00,Appendicitis,C06.405.469.110.207
24069979,2013-09-01T00:00:00,Appendix,A03.556.124.526.209.290
24069979,2013-09-01T00:00:00,Appendix,A03.556.249.249.209.290
24069979,2013-09-01T00:00:00,"Child, Preschool",M01.060.406.448
24069979,2013-09-01T00:00:00,"Diagnosis, Differential",E01.171
24069979,2013-09-01T00:00:00,Enterobiasis,C03.335.508.700.550.550.375
24069979,2013-09-01T00:00:00,Enterobius,B01.050.500.500.294.700.500.500.308
24069979,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24069985,2013-09-01T00:00:00,"Child, Preschool",M01.060.406.448
24069985,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24069985,2013-09-01T00:00:00,"Radiography, Thoracic",E01.370.350.700.730
24069986,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24069986,2013-09-01T00:00:00,"Infant, Newborn",M01.060.703.520
24069986,2013-09-01T00:00:00,Pregnancy,G08.686.785.760.769
24069986,2013-09-01T00:00:00,Young Adult,M01.060.116.815
24070040,2013-09-01T00:00:00,Attitude,F01.100
24070040,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24070040,2013-09-01T00:00:00,Papillomavirus Vaccines,D20.215.894.899.498
24070040,2013-09-01T00:00:00,Parents,F01.829.263.500.320
24070040,2013-09-01T00:00:00,Parents,I01.880.225.500.340
24070040,2013-09-01T00:00:00,Parents,M01.620
24070040,2013-09-01T00:00:00,Patient Acceptance of Health Care,N05.300.150.600
24070040,2013-09-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
24070040,2013-09-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
24070040,2013-09-01T00:00:00,Vaccination,E02.095.465.425.400.530.890
24070040,2013-09-01T00:00:00,Vaccination,E05.478.550.600.890
24070040,2013-09-01T00:00:00,Vaccination,N02.421.726.758.310.890
24070040,2013-09-01T00:00:00,Vaccination,N06.850.780.200.425.900
24070040,2013-09-01T00:00:00,Vaccination,N06.850.780.680.310.890
24089040,2013-09-01T00:00:00,Adult,M01.060.116
24089040,2013-09-01T00:00:00,Ambulatory Care,E02.760.106
24089040,2013-09-01T00:00:00,Ambulatory Care,N02.421.585.106
24089040,2013-09-01T00:00:00,Demography,I01.240
24089040,2013-09-01T00:00:00,Demography,N01.224
24089040,2013-09-01T00:00:00,Demography,N06.850.505.400
24089040,2013-09-01T00:00:00,Health Status Disparities,I01.240.425.675
24089040,2013-09-01T00:00:00,Health Status Disparities,N01.224.425.437
24089040,2013-09-01T00:00:00,Health Status Disparities,N06.850.505.400.425.675
24089040,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24089040,2013-09-01T00:00:00,Mass Screening,E01.370.500
24089040,2013-09-01T00:00:00,Mass Screening,E05.318.308.250.580
24089040,2013-09-01T00:00:00,Mass Screening,N02.421.143.827.233.443
24089040,2013-09-01T00:00:00,Mass Screening,N02.421.726.233.443
24089040,2013-09-01T00:00:00,Mass Screening,N05.715.360.300.375.500
24089040,2013-09-01T00:00:00,Mass Screening,N06.850.520.308.250.580
24089040,2013-09-01T00:00:00,Mass Screening,N06.850.780.500
24089040,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24089040,2013-09-01T00:00:00,Outpatients,M01.643.630
24089040,2013-09-01T00:00:00,Psychiatric Status Rating Scales,F04.586
24089040,2013-09-01T00:00:00,Risk Factors,E05.318.740.600.800.725
24089040,2013-09-01T00:00:00,Risk Factors,N05.715.350.200.700
24089040,2013-09-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24089040,2013-09-01T00:00:00,Risk Factors,N06.850.490.625.750
24089040,2013-09-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24089040,2013-09-01T00:00:00,Social Support,I01.880.656.600
24089040,2013-09-01T00:00:00,Substance-Related Disorders,C21.739
24089040,2013-09-01T00:00:00,Substance-Related Disorders,F03.900
24089040,2013-09-01T00:00:00,United States,Z01.107.567.875
24119601,2013-09-01T00:00:00,Adolescent,M01.060.057
24119601,2013-09-01T00:00:00,Adult,M01.060.116
24119601,2013-09-01T00:00:00,Aged,M01.060.116.100
24119601,2013-09-01T00:00:00,Chronic Disease,C23.550.291.500
24119601,2013-09-01T00:00:00,Cytokines,D12.644.276.374
24119601,2013-09-01T00:00:00,Cytokines,D12.776.467.374
24119601,2013-09-01T00:00:00,Cytokines,D23.529.374
24119601,2013-09-01T00:00:00,Fibroblasts,A11.329.228
24119601,2013-09-01T00:00:00,Fibroblasts,A11.872.228
24119601,2013-09-01T00:00:00,Gene Expression Profiling,E05.393.332
24119601,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24119601,2013-09-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
24119601,2013-09-01T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
24119601,2013-09-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
24119601,2013-09-01T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
24119601,2013-09-01T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
24119601,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24119601,2013-09-01T00:00:00,Nasal Polyps,C08.460.572
24119601,2013-09-01T00:00:00,Nasal Polyps,C09.603.557
24119601,2013-09-01T00:00:00,Nasal Polyps,C23.300.825.557
24119601,2013-09-01T00:00:00,Paranasal Sinuses,A04.531.621
24119601,2013-09-01T00:00:00,Rhinitis,C08.460.799
24119601,2013-09-01T00:00:00,Rhinitis,C08.730.674
24119601,2013-09-01T00:00:00,Rhinitis,C09.603.799
24119601,2013-09-01T00:00:00,Sinusitis,C08.460.692.752
24119601,2013-09-01T00:00:00,Sinusitis,C08.730.749
24119601,2013-09-01T00:00:00,Sinusitis,C09.603.692.752
24119601,2013-09-01T00:00:00,Young Adult,M01.060.116.815
24119609,2013-09-01T00:00:00,Adult,M01.060.116
24119609,2013-09-01T00:00:00,Aged,M01.060.116.100
24119609,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24119609,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24119609,2013-09-01T00:00:00,"Neovascularization, Physiologic",G09.330.190.751
24119609,2013-09-01T00:00:00,Treatment Outcome,E01.789.800
24119609,2013-09-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24119609,2013-09-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24261154,2013-09-01T00:00:00,Adolescent,M01.060.057
24261154,2013-09-01T00:00:00,Adult,M01.060.116
24261154,2013-09-01T00:00:00,Aged,M01.060.116.100
24261154,2013-09-01T00:00:00,Demography,I01.240
24261154,2013-09-01T00:00:00,Demography,N01.224
24261154,2013-09-01T00:00:00,Demography,N06.850.505.400
24261154,2013-09-01T00:00:00,Electroencephalography,E01.370.376.300
24261154,2013-09-01T00:00:00,Electroencephalography,E01.370.405.245
24261154,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24261154,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24261154,2013-09-01T00:00:00,Seizures,C10.228.140.490.631
24261154,2013-09-01T00:00:00,Seizures,C10.597.742
24261154,2013-09-01T00:00:00,Seizures,C23.888.592.742
24261154,2013-09-01T00:00:00,South Carolina,Z01.107.567.875.075.662
24261154,2013-09-01T00:00:00,South Carolina,Z01.107.567.875.750.700
24261154,2013-09-01T00:00:00,"Stress, Psychological",F01.145.126.990
24261154,2013-09-01T00:00:00,"Stress, Psychological",F02.830.900
24261154,2013-09-01T00:00:00,Video Recording,L01.240.960
24261154,2013-09-01T00:00:00,Young Adult,M01.060.116.815
24261155,2013-09-01T00:00:00,"Communicable Diseases, Emerging",C01.539.221.500
24261155,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24261155,2013-09-01T00:00:00,Respiratory Tract Infections,C01.539.739
24261155,2013-09-01T00:00:00,Respiratory Tract Infections,C08.730
24261155,2013-09-01T00:00:00,Virus Diseases,C02
24386839,2013-09-01T00:00:00,Adolescent,M01.060.057
24386839,2013-09-01T00:00:00,Adult,M01.060.116
24386839,2013-09-01T00:00:00,Child,M01.060.406
24386839,2013-09-01T00:00:00,Genetic Variation,G05.365
24386839,2013-09-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24386839,2013-09-01T00:00:00,Middle Aged,M01.060.116.630
24386839,2013-09-01T00:00:00,Molecular Sequence Data,L01.453.245.667
24386839,2013-09-01T00:00:00,"Parainfluenza Virus 3, Human",B04.820.455.600.650.700.735
24386839,2013-09-01T00:00:00,"Parainfluenza Virus 3, Human",B04.909.777.455.600.650.700.735
24386839,2013-09-01T00:00:00,Phylogeny,G05.697
24386839,2013-09-01T00:00:00,Phylogeny,G16.100.275.605
24386839,2013-09-01T00:00:00,Phylogeny,L01.100.697
24386839,2013-09-01T00:00:00,Respirovirus Infections,C02.782.580.600.600
24386839,2013-09-01T00:00:00,Seasons,G01.910.645.661
24386839,2013-09-01T00:00:00,Seasons,G16.500.275.071.590
24386839,2013-09-01T00:00:00,Seasons,N06.230.300.100.250.525
24386839,2013-09-01T00:00:00,Young Adult,M01.060.116.815
23991646,2013-09-02T00:00:00,Adult,M01.060.116
23991646,2013-09-02T00:00:00,Algorithms,G17.035
23991646,2013-09-02T00:00:00,Algorithms,L01.224.050
23991646,2013-09-02T00:00:00,Fatty Liver,C06.552.241
23991646,2013-09-02T00:00:00,Graft Survival,G12.425.901.545.340
23991646,2013-09-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23991646,2013-09-02T00:00:00,Liver Transplantation,E04.210.650
23991646,2013-09-02T00:00:00,Liver Transplantation,E04.936.450.490
23991646,2013-09-02T00:00:00,Liver Transplantation,E04.936.580.490
23991646,2013-09-02T00:00:00,Middle Aged,M01.060.116.630
23991646,2013-09-02T00:00:00,Patient Selection,E05.581.500.653
23991646,2013-09-02T00:00:00,Patient Selection,N04.590.731
23991646,2013-09-02T00:00:00,Postoperative Complications,C23.550.767
23991646,2013-09-02T00:00:00,Reperfusion Injury,C14.907.725
23991646,2013-09-02T00:00:00,Reperfusion Injury,C23.550.767.877
23999433,2013-09-03T00:00:00,Animals,B01.050
23999433,2013-09-03T00:00:00,Antineoplastic Agents,D27.505.954.248
23999433,2013-09-03T00:00:00,Apoptosis,G04.299.139.160
23999433,2013-09-03T00:00:00,Cell Proliferation,G04.299.233.750
23999433,2013-09-03T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23999433,2013-09-03T00:00:00,Cell Survival,G04.299.316
23999433,2013-09-03T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
23999433,2013-09-03T00:00:00,"Fusion Proteins, bcr-abl",D08.811.913.696.620.682.725.500.500
23999433,2013-09-03T00:00:00,"Fusion Proteins, bcr-abl",D12.776.602.500.500.100
23999433,2013-09-03T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.100
23999433,2013-09-03T00:00:00,"Fusion Proteins, bcr-abl",D12.776.624.664.500.100
23999433,2013-09-03T00:00:00,Hematopoietic Stem Cells,A11.148.378
23999433,2013-09-03T00:00:00,Hematopoietic Stem Cells,A11.872.378
23999433,2013-09-03T00:00:00,Hematopoietic Stem Cells,A15.378.316.378
23999433,2013-09-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23999433,2013-09-03T00:00:00,Janus Kinase 2,D08.811.913.696.620.682.725.124.200
23999433,2013-09-03T00:00:00,Janus Kinase 2,D12.776.476.393.200
23999433,2013-09-03T00:00:00,Janus Kinase 2,D12.776.624.664.700.117
23999433,2013-09-03T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C04.557.337.539.250
23999433,2013-09-03T00:00:00,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive",C15.378.190.636.370
23999433,2013-09-03T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23999433,2013-09-03T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23999433,2013-09-03T00:00:00,Neoplastic Stem Cells,A11.872.650
23999433,2013-09-03T00:00:00,Propylene Glycols,D02.033.455.706
23999433,2013-09-03T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
23999433,2013-09-03T00:00:00,Protein Phosphatase 2,D08.811.277.352.650.625.706
23999433,2013-09-03T00:00:00,Protein Phosphatase 2,D12.644.360.583
23999433,2013-09-03T00:00:00,Protein Phosphatase 2,D12.776.476.561
23999433,2013-09-03T00:00:00,Sphingosine,D02.033.100.700
23999433,2013-09-03T00:00:00,Sphingosine,D02.033.455.843
23999433,2013-09-03T00:00:00,Sphingosine,D02.092.063.700
23999433,2013-09-03T00:00:00,beta Catenin,D12.776.091.249
23999433,2013-09-03T00:00:00,beta Catenin,D12.776.220.145.500
23999433,2013-09-03T00:00:00,beta Catenin,D12.776.930.130
24006963,2013-09-03T00:00:00,Adult,M01.060.116
24006963,2013-09-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24006963,2013-09-03T00:00:00,Pilot Projects,E05.318.760.750
24006963,2013-09-03T00:00:00,Pilot Projects,E05.337.737
24006963,2013-09-03T00:00:00,Pilot Projects,N05.715.360.775.625
24006963,2013-09-03T00:00:00,Pilot Projects,N06.850.520.450.720
24006963,2013-09-03T00:00:00,Smoking Cessation,F01.145.940.700
24006963,2013-09-03T00:00:00,Tobacco Use Disorder,C21.739.912
24006963,2013-09-03T00:00:00,Tobacco Use Disorder,F03.900.912
24006963,2013-09-03T00:00:00,Young Adult,M01.060.116.815
24005224,2013-09-04T00:00:00,Adult,M01.060.116
24005224,2013-09-04T00:00:00,Aged,M01.060.116.100
24005224,2013-09-04T00:00:00,Biological Markers,D23.101
24005224,2013-09-04T00:00:00,Cardiac Surgical Procedures,E04.100.376
24005224,2013-09-04T00:00:00,Cardiac Surgical Procedures,E04.928.220
24005224,2013-09-04T00:00:00,Disease Progression,C23.550.291.656
24005224,2013-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24005224,2013-09-04T00:00:00,Interleukin-18,D12.644.276.374.465.518
24005224,2013-09-04T00:00:00,Interleukin-18,D12.776.467.374.465.518
24005224,2013-09-04T00:00:00,Interleukin-18,D23.529.374.465.518
24005224,2013-09-04T00:00:00,Membrane Glycoproteins,D12.776.395.550
24005224,2013-09-04T00:00:00,Membrane Glycoproteins,D12.776.543.550
24005224,2013-09-04T00:00:00,Middle Aged,M01.060.116.630
24005224,2013-09-04T00:00:00,"Receptors, Virus",D12.776.543.750.925
24005224,2013-09-04T00:00:00,Risk Assessment,E05.318.740.600.800.715
24005224,2013-09-04T00:00:00,Risk Assessment,N04.452.871.715
24005224,2013-09-04T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24005224,2013-09-04T00:00:00,Risk Assessment,N06.850.505.715
24005224,2013-09-04T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24005224,2013-09-04T00:00:00,Risk Factors,E05.318.740.600.800.725
24005224,2013-09-04T00:00:00,Risk Factors,N05.715.350.200.700
24005224,2013-09-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24005224,2013-09-04T00:00:00,Risk Factors,N06.850.490.625.750
24005224,2013-09-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24005224,2013-09-04T00:00:00,United States,Z01.107.567.875
24005224,2013-09-04T00:00:00,Urinalysis,E01.370.390.810
24005224,2013-09-04T00:00:00,Urinalysis,E01.450.150.810
24005224,2013-09-04T00:00:00,Urinalysis,E01.450.890
24011524,2013-09-04T00:00:00,Biometry,E05.318.740.225
24011524,2013-09-04T00:00:00,Biometry,N06.850.505.200
24011524,2013-09-04T00:00:00,Cataract,C11.510.245
24011524,2013-09-04T00:00:00,Cataract Extraction,E04.540.825.249
24011524,2013-09-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24011524,2013-09-04T00:00:00,Infant,M01.060.703
24011524,2013-09-04T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
24011524,2013-09-04T00:00:00,"Lenses, Intraocular",E07.632.500.460
24011524,2013-09-04T00:00:00,"Lenses, Intraocular",E07.695.460
24011524,2013-09-04T00:00:00,Optics and Photonics,H01.671.617
24011524,2013-09-04T00:00:00,Optics and Photonics,J01.293.688
24011524,2013-09-04T00:00:00,"Refraction, Ocular",E01.370.380.850.700
24011524,2013-09-04T00:00:00,"Refraction, Ocular",G01.590.770.760
24011524,2013-09-04T00:00:00,"Refraction, Ocular",G01.595.640.760
24011524,2013-09-04T00:00:00,"Refraction, Ocular",G14.760
24011524,2013-09-04T00:00:00,Treatment Outcome,E01.789.800
24011524,2013-09-04T00:00:00,Treatment Outcome,N04.761.559.590.800
24011524,2013-09-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24011524,2013-09-04T00:00:00,Visual Acuity,E01.370.380.850.950
24011524,2013-09-04T00:00:00,Visual Acuity,F02.463.593.932.901
24011524,2013-09-04T00:00:00,Visual Acuity,G14.940
24006926,2013-09-05T00:00:00,Aged,M01.060.116.100
24006926,2013-09-05T00:00:00,Critical Pathways,N04.590.233.624.625
24006926,2013-09-05T00:00:00,Critical Pathways,N04.590.275
24006926,2013-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24006926,2013-09-05T00:00:00,Kidney Neoplasms,C04.588.945.947.535
24006926,2013-09-05T00:00:00,Kidney Neoplasms,C12.758.820.750
24006926,2013-09-05T00:00:00,Kidney Neoplasms,C12.777.419.473
24006926,2013-09-05T00:00:00,Kidney Neoplasms,C13.351.937.820.535
24006926,2013-09-05T00:00:00,Kidney Neoplasms,C13.351.968.419.473
24006926,2013-09-05T00:00:00,Laparoscopy,E01.370.388.250.520
24006926,2013-09-05T00:00:00,Laparoscopy,E04.800.250.520
24006926,2013-09-05T00:00:00,Length of Stay,E02.760.400.480
24006926,2013-09-05T00:00:00,Length of Stay,N02.421.585.400.480
24006926,2013-09-05T00:00:00,Middle Aged,M01.060.116.630
24006926,2013-09-05T00:00:00,Nephrectomy,E04.950.774.435
24006926,2013-09-05T00:00:00,Patient Discharge,E02.760.400.610
24006926,2013-09-05T00:00:00,Patient Discharge,N02.421.585.400.610
24006926,2013-09-05T00:00:00,Postoperative Care,E02.760.722.700
24006926,2013-09-05T00:00:00,Postoperative Care,E04.624
24006926,2013-09-05T00:00:00,Postoperative Care,N02.421.585.722.700
24006926,2013-09-05T00:00:00,Postoperative Complications,C23.550.767
24006926,2013-09-05T00:00:00,Robotics,H01.671.293.643
24006926,2013-09-05T00:00:00,Robotics,J01.897.104.834
24006926,2013-09-05T00:00:00,Robotics,L01.224.065.630
24006926,2013-09-05T00:00:00,Treatment Outcome,E01.789.800
24006926,2013-09-05T00:00:00,Treatment Outcome,N04.761.559.590.800
24006926,2013-09-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24007513,2013-09-05T00:00:00,Biological Markers,D23.101
24007513,2013-09-05T00:00:00,Graft Rejection,G12.425.901.545.328
24007513,2013-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24007513,2013-09-05T00:00:00,Kidney Transplantation,E02.870.500
24007513,2013-09-05T00:00:00,Kidney Transplantation,E04.936.450.485
24007513,2013-09-05T00:00:00,Kidney Transplantation,E04.950.774.400
24008491,2013-09-05T00:00:00,Alleles,G05.360.340.024.340.030
24008491,2013-09-05T00:00:00,Child,M01.060.406
24008491,2013-09-05T00:00:00,Cytomegalovirus,B04.280.382.150.150
24008491,2013-09-05T00:00:00,Cytomegalovirus,B04.909.204.382.150.150
24008491,2013-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.606.586
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.114.619.393.522.400
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.486.485.705.500.380.500
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.606.586
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.114.619.393.522.400
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,D12.776.124.790.651.705.500.380.500
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.606.586
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.114.619.393.522.400
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,D12.776.377.715.548.705.500.380.500
24008491,2013-09-05T00:00:00,Immunoglobulin Gm Allotypes,G12.500.400.586
24008491,2013-09-05T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
24008491,2013-09-05T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
24008491,2013-09-05T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
24008577,2013-09-05T00:00:00,Adolescent,M01.060.057
24008577,2013-09-05T00:00:00,Adult,M01.060.116
24008577,2013-09-05T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
24008577,2013-09-05T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
24008577,2013-09-05T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
24008577,2013-09-05T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
24008577,2013-09-05T00:00:00,Child,M01.060.406
24008577,2013-09-05T00:00:00,"Child, Preschool",M01.060.406.448
24008577,2013-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24008577,2013-09-05T00:00:00,Infant,M01.060.703
24008577,2013-09-05T00:00:00,"Infant, Newborn",M01.060.703.520
24008577,2013-09-05T00:00:00,Stroke,C10.228.140.300.775
24008577,2013-09-05T00:00:00,Stroke,C14.907.253.855
24009222,2013-09-05T00:00:00,Aged,M01.060.116.100
24009222,2013-09-05T00:00:00,Angiotensinogen,D12.644.456.073.070
24009222,2013-09-05T00:00:00,Angiotensinogen,D12.644.822.750.020
24009222,2013-09-05T00:00:00,Angiotensinogen,D12.644.861.020
24009222,2013-09-05T00:00:00,Angiotensinogen,D12.776.645.750.020
24009222,2013-09-05T00:00:00,Angiotensinogen,D12.776.811.070
24009222,2013-09-05T00:00:00,Angiotensinogen,D12.776.872.020
24009222,2013-09-05T00:00:00,Biological Markers,D23.101
24009222,2013-09-05T00:00:00,Cardiac Surgical Procedures,E04.100.376
24009222,2013-09-05T00:00:00,Cardiac Surgical Procedures,E04.928.220
24009222,2013-09-05T00:00:00,Creatinine,D03.383.129.308.207
24009222,2013-09-05T00:00:00,Disease Progression,C23.550.291.656
24009222,2013-09-05T00:00:00,Hospital Mortality,E05.318.308.985.550.400
24009222,2013-09-05T00:00:00,Hospital Mortality,L01.280.975.550.400
24009222,2013-09-05T00:00:00,Hospital Mortality,N01.224.935.698.400
24009222,2013-09-05T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
24009222,2013-09-05T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
24009222,2013-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24009222,2013-09-05T00:00:00,Middle Aged,M01.060.116.630
24009222,2013-09-05T00:00:00,Renin,D08.811.277.656.074.500.780
24009222,2013-09-05T00:00:00,Renin,D08.811.277.656.300.048.780
24009222,2013-09-05T00:00:00,Renin,D08.811.277.656.837.750
24009222,2013-09-05T00:00:00,Renin-Angiotensin System,G03.495.805
24009222,2013-09-05T00:00:00,Renin-Angiotensin System,G09.330.190.400.750
24009222,2013-09-05T00:00:00,Risk Factors,E05.318.740.600.800.725
24009222,2013-09-05T00:00:00,Risk Factors,N05.715.350.200.700
24009222,2013-09-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24009222,2013-09-05T00:00:00,Risk Factors,N06.850.490.625.750
24009222,2013-09-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24009222,2013-09-05T00:00:00,United States,Z01.107.567.875
24012766,2013-09-05T00:00:00,Animals,B01.050
24012766,2013-09-05T00:00:00,Anoxia,C23.888.852.079
24012766,2013-09-05T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
24012766,2013-09-05T00:00:00,Calcium,D01.268.552.100
24012766,2013-09-05T00:00:00,Calcium,D01.552.539.288
24012766,2013-09-05T00:00:00,Calcium,D23.119.100
24012766,2013-09-05T00:00:00,Calcium Channels,D12.776.157.530.400.150
24012766,2013-09-05T00:00:00,Calcium Channels,D12.776.543.550.425.150
24012766,2013-09-05T00:00:00,Calcium Channels,D12.776.543.585.400.150
24012766,2013-09-05T00:00:00,Hepatocytes,A11.436.348
24012766,2013-09-05T00:00:00,Iron,D01.268.556.412
24012766,2013-09-05T00:00:00,Iron,D01.268.956.287
24012766,2013-09-05T00:00:00,Iron,D01.552.544.412
24012766,2013-09-05T00:00:00,"Mitochondria, Liver",A11.284.430.214.190.875.564.461
24012766,2013-09-05T00:00:00,"Mitochondria, Liver",A11.284.835.626.461
24012766,2013-09-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24012766,2013-09-05T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
24012766,2013-09-05T00:00:00,Reperfusion Injury,C14.907.725
24012766,2013-09-05T00:00:00,Reperfusion Injury,C23.550.767.877
24039941,2013-09-05T00:00:00,Adolescent,M01.060.057
24039941,2013-09-05T00:00:00,Adult,M01.060.116
24039941,2013-09-05T00:00:00,African Continental Ancestry Group,M01.686.508.100
24039941,2013-09-05T00:00:00,Body Mass Index,E01.370.600.115.100.125
24039941,2013-09-05T00:00:00,Body Mass Index,E05.041.124.125
24039941,2013-09-05T00:00:00,Body Mass Index,G07.100.100.125
24039941,2013-09-05T00:00:00,Body Mass Index,N06.850.505.200.100.175
24039941,2013-09-05T00:00:00,"Diabetes, Gestational",C13.703.170
24039941,2013-09-05T00:00:00,"Diabetes, Gestational",C18.452.394.750.448
24039941,2013-09-05T00:00:00,"Diabetes, Gestational",C19.246.200
24039941,2013-09-05T00:00:00,European Continental Ancestry Group,M01.686.508.400
24039941,2013-09-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24039941,2013-09-05T00:00:00,"Models, Statistical",E05.318.740.500
24039941,2013-09-05T00:00:00,"Models, Statistical",E05.599.835
24039941,2013-09-05T00:00:00,"Models, Statistical",N05.715.360.750.530
24039941,2013-09-05T00:00:00,"Models, Statistical",N06.850.520.830.500
24039941,2013-09-05T00:00:00,Pregnancy,G08.686.785.760.769
24039941,2013-09-05T00:00:00,Prevalence,E05.318.308.985.525.750
24039941,2013-09-05T00:00:00,Prevalence,L01.280.975.525.750
24039941,2013-09-05T00:00:00,Prevalence,N01.224.935.597.750
24039941,2013-09-05T00:00:00,Prevalence,N06.850.505.400.975.525.750
24039941,2013-09-05T00:00:00,Prevalence,N06.850.520.308.985.525.750
24039941,2013-09-05T00:00:00,Risk Factors,E05.318.740.600.800.725
24039941,2013-09-05T00:00:00,Risk Factors,N05.715.350.200.700
24039941,2013-09-05T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24039941,2013-09-05T00:00:00,Risk Factors,N06.850.490.625.750
24039941,2013-09-05T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24039941,2013-09-05T00:00:00,United States,Z01.107.567.875
24039941,2013-09-05T00:00:00,Young Adult,M01.060.116.815
24010675,2013-09-06T00:00:00,Adult,M01.060.116
24010675,2013-09-06T00:00:00,Aged,M01.060.116.100
24010675,2013-09-06T00:00:00,Alcoholism,C21.739.100.250
24010675,2013-09-06T00:00:00,Alcoholism,F03.900.100.350
24010675,2013-09-06T00:00:00,Biological Markers,D23.101
24010675,2013-09-06T00:00:00,Body Weight,C23.888.144
24010675,2013-09-06T00:00:00,Body Weight,E01.370.600.115.100.160.120
24010675,2013-09-06T00:00:00,Body Weight,E05.041.124.160.750
24010675,2013-09-06T00:00:00,Body Weight,G07.100.100.160.120
24010675,2013-09-06T00:00:00,Body Weight,G07.700.320.249.314.120
24010675,2013-09-06T00:00:00,DNA,D13.444.308
24010675,2013-09-06T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
24010675,2013-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24010675,2013-09-06T00:00:00,Medication Adherence,F01.145.488.500.500
24010675,2013-09-06T00:00:00,Medication Adherence,N05.300.150.600.600.500
24010675,2013-09-06T00:00:00,Middle Aged,M01.060.116.630
24010675,2013-09-06T00:00:00,Narcotic Antagonists,D27.505.696.543
24010675,2013-09-06T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
24010675,2013-09-06T00:00:00,Narcotic Antagonists,D27.505.954.427.550
24010675,2013-09-06T00:00:00,Polymerase Chain Reaction,E05.393.620.500
24010675,2013-09-06T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
24010675,2013-09-06T00:00:00,Treatment Outcome,E01.789.800
24010675,2013-09-06T00:00:00,Treatment Outcome,N04.761.559.590.800
24010675,2013-09-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24010675,2013-09-06T00:00:00,Young Adult,M01.060.116.815
24012582,2013-09-06T00:00:00,"Child, Preschool",M01.060.406.448
24012582,2013-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24012582,2013-09-06T00:00:00,Infant,M01.060.703
24012582,2013-09-06T00:00:00,Postoperative Complications,C23.550.767
24012582,2013-09-06T00:00:00,Treatment Outcome,E01.789.800
24012582,2013-09-06T00:00:00,Treatment Outcome,N04.761.559.590.800
24012582,2013-09-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24012582,2013-09-06T00:00:00,Ureter,A05.810.776
24012582,2013-09-06T00:00:00,Urinary Tract Infections,C01.539.895
24012582,2013-09-06T00:00:00,Urinary Tract Infections,C12.777.892
24012582,2013-09-06T00:00:00,Urinary Tract Infections,C13.351.968.892
24012582,2013-09-06T00:00:00,Vesico-Ureteral Reflux,C12.777.829.920
24012582,2013-09-06T00:00:00,Vesico-Ureteral Reflux,C13.351.968.829.920
24013101,2013-09-06T00:00:00,Adult,M01.060.116
24013101,2013-09-06T00:00:00,Aged,M01.060.116.100
24013101,2013-09-06T00:00:00,Behavior Therapy,F04.754.137
24013101,2013-09-06T00:00:00,Body Mass Index,E01.370.600.115.100.125
24013101,2013-09-06T00:00:00,Body Mass Index,E05.041.124.125
24013101,2013-09-06T00:00:00,Body Mass Index,G07.100.100.125
24013101,2013-09-06T00:00:00,Body Mass Index,N06.850.505.200.100.175
24013101,2013-09-06T00:00:00,"Diet, Reducing",E02.642.249.285
24013101,2013-09-06T00:00:00,"Diet, Reducing",G07.610.240.285
24013101,2013-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24013101,2013-09-06T00:00:00,Hunger,F01.658.293.391
24013101,2013-09-06T00:00:00,Hunger,G07.610.390
24013101,2013-09-06T00:00:00,Hunger,G10.261.390
24013101,2013-09-06T00:00:00,Middle Aged,M01.060.116.630
24013101,2013-09-06T00:00:00,Obesity,C18.654.726.500
24013101,2013-09-06T00:00:00,Obesity,C23.888.144.699.500
24013101,2013-09-06T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
24013101,2013-09-06T00:00:00,Obesity,G07.100.100.160.120.699.500
24013101,2013-09-06T00:00:00,"Social Control, Informal",I01.880.630
24013101,2013-09-06T00:00:00,Treatment Outcome,E01.789.800
24013101,2013-09-06T00:00:00,Treatment Outcome,N04.761.559.590.800
24013101,2013-09-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24013101,2013-09-06T00:00:00,Weight Loss,C23.888.144.243.963
24013101,2013-09-06T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
24014540,2013-09-06T00:00:00,"Adaptation, Physiological",G07.700.062
24014540,2013-09-06T00:00:00,"Adaptation, Physiological",G16.100.057.500
24014540,2013-09-06T00:00:00,Animals,B01.050
24014540,2013-09-06T00:00:00,Chickens,B01.050.150.900.248.350.150
24014540,2013-09-06T00:00:00,Chickens,B01.050.150.900.248.617.192
24014540,2013-09-06T00:00:00,"Colony Count, Microbial",E05.200.875.220
24014540,2013-09-06T00:00:00,Food Contamination,N06.850.460.400
24014540,2013-09-06T00:00:00,Hot Temperature,G01.906.595.543
24014540,2013-09-06T00:00:00,Hot Temperature,G16.500.275.063.725.710.380
24014540,2013-09-06T00:00:00,Hot Temperature,G16.500.750.775.710.380
24014540,2013-09-06T00:00:00,Hot Temperature,N06.230.300.100.725.232
24014540,2013-09-06T00:00:00,Hot Temperature,N06.230.300.100.725.710.380
24014540,2013-09-06T00:00:00,Meat,J02.500.600
24014540,2013-09-06T00:00:00,Salmonella,B03.440.450.425.800
24014540,2013-09-06T00:00:00,Salmonella,B03.660.250.150.710
24014828,2013-09-06T00:00:00,Heart Failure,C14.280.434
24014828,2013-09-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24014828,2013-09-06T00:00:00,Middle Aged,M01.060.116.630
24014828,2013-09-06T00:00:00,North America,Z01.107.567
24014828,2013-09-06T00:00:00,Stroke Volume,E01.370.370.380.150.700
24014828,2013-09-06T00:00:00,Stroke Volume,G09.330.380.124.882
24014828,2013-09-06T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
24014828,2013-09-06T00:00:00,Ventricular Remodeling,C23.300.985
24014828,2013-09-06T00:00:00,Ventricular Remodeling,G09.330.190.962.975
24039848,2013-09-06T00:00:00,Adipocytes,A11.329.114
24039848,2013-09-06T00:00:00,Animals,B01.050
24039848,2013-09-06T00:00:00,Blood Glucose,D09.546.359.448.500
24039848,2013-09-06T00:00:00,Body Weight,C23.888.144
24039848,2013-09-06T00:00:00,Body Weight,E01.370.600.115.100.160.120
24039848,2013-09-06T00:00:00,Body Weight,E05.041.124.160.750
24039848,2013-09-06T00:00:00,Body Weight,G07.100.100.160.120
24039848,2013-09-06T00:00:00,Body Weight,G07.700.320.249.314.120
24039848,2013-09-06T00:00:00,Fibroblast Growth Factors,D12.644.276.624
24039848,2013-09-06T00:00:00,Fibroblast Growth Factors,D12.776.467.624
24039848,2013-09-06T00:00:00,Fibroblast Growth Factors,D23.529.624
24039848,2013-09-06T00:00:00,Gene Expression Profiling,E05.393.332
24039848,2013-09-06T00:00:00,Gene Expression Regulation,G05.355.315
24039848,2013-09-06T00:00:00,Insulin,D06.472.699.587.740.625
24039848,2013-09-06T00:00:00,Insulin,D12.644.548.586.740.625
24039848,2013-09-06T00:00:00,Phosphoproteins,D12.776.744
24039848,2013-09-06T00:00:00,Proteome,D12.776.817
24039848,2013-09-06T00:00:00,Signal Transduction,G02.111.087.800
24039848,2013-09-06T00:00:00,Signal Transduction,G02.149.115.800
24039848,2013-09-06T00:00:00,Signal Transduction,G04.299.880
24039848,2013-09-06T00:00:00,"Transcription, Genetic",G02.111.087.847
24039848,2013-09-06T00:00:00,"Transcription, Genetic",G02.149.115.847
24039848,2013-09-06T00:00:00,"Transcription, Genetic",G05.355.310.700
24121260,2013-09-07T00:00:00,Animals,B01.050
24121260,2013-09-07T00:00:00,Anticholesteremic Agents,D27.505.519.186.071.202
24121260,2013-09-07T00:00:00,Anticholesteremic Agents,D27.505.954.230.202
24121260,2013-09-07T00:00:00,Cell Line,A11.251.210
24121260,2013-09-07T00:00:00,Lipopolysaccharides,D09.400.500
24121260,2013-09-07T00:00:00,Lipopolysaccharides,D09.698.718.450
24121260,2013-09-07T00:00:00,Lipopolysaccharides,D10.494
24121260,2013-09-07T00:00:00,Lipopolysaccharides,D23.050.161.616.525
24121260,2013-09-07T00:00:00,Lipopolysaccharides,D23.946.123.329.500
24121260,2013-09-07T00:00:00,Macrophages,A11.329.372
24121260,2013-09-07T00:00:00,Macrophages,A11.627.482
24121260,2013-09-07T00:00:00,Macrophages,A11.733.397
24121260,2013-09-07T00:00:00,Macrophages,A15.382.680.397
24121260,2013-09-07T00:00:00,Macrophages,A15.382.812.522
24121260,2013-09-07T00:00:00,Myeloid Differentiation Factor 88,D12.644.360.024.305
24121260,2013-09-07T00:00:00,Myeloid Differentiation Factor 88,D12.776.157.057.064
24121260,2013-09-07T00:00:00,Myeloid Differentiation Factor 88,D12.776.476.024.390
24121260,2013-09-07T00:00:00,Signal Transduction,G02.111.087.800
24121260,2013-09-07T00:00:00,Signal Transduction,G02.149.115.800
24121260,2013-09-07T00:00:00,Signal Transduction,G04.299.880
24121260,2013-09-07T00:00:00,Sitosterols,D04.808.247.222.857
24121260,2013-09-07T00:00:00,Sitosterols,D04.808.247.808.756.669
24121260,2013-09-07T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.644.360.024.374
24121260,2013-09-07T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.157.057.249
24121260,2013-09-07T00:00:00,Suppressor of Cytokine Signaling Proteins,D12.776.476.024.437
24121260,2013-09-07T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
24011378,2013-09-08T00:00:00,Actins,D05.750.078.730.250
24011378,2013-09-08T00:00:00,Actins,D12.776.210.500.100
24011378,2013-09-08T00:00:00,Actins,D12.776.220.525.255
24011378,2013-09-08T00:00:00,Adolescent,M01.060.057
24011378,2013-09-08T00:00:00,Adult,M01.060.116
24011378,2013-09-08T00:00:00,Aged,M01.060.116.100
24011378,2013-09-08T00:00:00,Case-Control Studies,E05.318.760.500.500
24011378,2013-09-08T00:00:00,Case-Control Studies,N05.715.360.775.175.200
24011378,2013-09-08T00:00:00,Case-Control Studies,N06.850.520.450.500.500
24011378,2013-09-08T00:00:00,Caveolin 1,D12.644.360.024.264
24011378,2013-09-08T00:00:00,Caveolin 1,D12.776.157.057.010
24011378,2013-09-08T00:00:00,Caveolin 1,D12.776.476.024.280
24011378,2013-09-08T00:00:00,Caveolin 1,D12.776.543.990.100.500
24011378,2013-09-08T00:00:00,Caveolin 1,D12.776.744.287
24011378,2013-09-08T00:00:00,Cell Differentiation,G04.299.151
24011378,2013-09-08T00:00:00,Cell Movement,G04.299.283
24011378,2013-09-08T00:00:00,Cell Movement,G07.700.560.500.180
24011378,2013-09-08T00:00:00,Fibroblasts,A11.329.228
24011378,2013-09-08T00:00:00,Fibroblasts,A11.872.228
24011378,2013-09-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24011378,2013-09-08T00:00:00,Lung,A04.411
24011378,2013-09-08T00:00:00,Middle Aged,M01.060.116.630
24011378,2013-09-08T00:00:00,Monocytes,A11.118.637.555.652
24011378,2013-09-08T00:00:00,Monocytes,A11.148.580
24011378,2013-09-08T00:00:00,Monocytes,A11.627.624
24011378,2013-09-08T00:00:00,Monocytes,A11.733.547
24011378,2013-09-08T00:00:00,Monocytes,A15.145.229.637.555.652
24011378,2013-09-08T00:00:00,Monocytes,A15.378.316.580
24011378,2013-09-08T00:00:00,Monocytes,A15.382.490.555.652
24011378,2013-09-08T00:00:00,Monocytes,A15.382.680.547
24011378,2013-09-08T00:00:00,Monocytes,A15.382.812.547
24011378,2013-09-08T00:00:00,"Scleroderma, Systemic",C17.300.799
24011378,2013-09-08T00:00:00,"Scleroderma, Systemic",C17.800.784
24011378,2013-09-08T00:00:00,Young Adult,M01.060.116.815
24010993,2013-09-09T00:00:00,Adult,M01.060.116
24010993,2013-09-09T00:00:00,Aged,M01.060.116.100
24010993,2013-09-09T00:00:00,"Antibodies, Viral",D12.776.124.486.485.114.254
24010993,2013-09-09T00:00:00,"Antibodies, Viral",D12.776.124.790.651.114.254
24010993,2013-09-09T00:00:00,"Antibodies, Viral",D12.776.377.715.548.114.254
24010993,2013-09-09T00:00:00,Antilymphocyte Serum,A12.207.152.846.500.203
24010993,2013-09-09T00:00:00,Antilymphocyte Serum,D12.776.124.486.485.114.573.203
24010993,2013-09-09T00:00:00,Antilymphocyte Serum,D12.776.124.790.651.114.573.203
24010993,2013-09-09T00:00:00,Antilymphocyte Serum,D12.776.377.715.548.114.573.203
24010993,2013-09-09T00:00:00,Antilymphocyte Serum,D20.215.401.203
24010993,2013-09-09T00:00:00,Antiviral Agents,D27.505.954.122.388
24010993,2013-09-09T00:00:00,Body Weight,C23.888.144
24010993,2013-09-09T00:00:00,Body Weight,E01.370.600.115.100.160.120
24010993,2013-09-09T00:00:00,Body Weight,E05.041.124.160.750
24010993,2013-09-09T00:00:00,Body Weight,G07.100.100.160.120
24010993,2013-09-09T00:00:00,Body Weight,G07.700.320.249.314.120
24010993,2013-09-09T00:00:00,Creatinine,D03.383.129.308.207
24010993,2013-09-09T00:00:00,Cytomegalovirus,B04.280.382.150.150
24010993,2013-09-09T00:00:00,Cytomegalovirus,B04.909.204.382.150.150
24010993,2013-09-09T00:00:00,Disease-Free Survival,E01.789.200
24010993,2013-09-09T00:00:00,Disease-Free Survival,E05.318.740.998.300
24010993,2013-09-09T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
24010993,2013-09-09T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
24010993,2013-09-09T00:00:00,Ganciclovir,D03.438.759.758.399.454.250.300
24010993,2013-09-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24010993,2013-09-09T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
24010993,2013-09-09T00:00:00,Kidney,A05.810.453
24010993,2013-09-09T00:00:00,Kidney Transplantation,E02.870.500
24010993,2013-09-09T00:00:00,Kidney Transplantation,E04.936.450.485
24010993,2013-09-09T00:00:00,Kidney Transplantation,E04.950.774.400
24010993,2013-09-09T00:00:00,Middle Aged,M01.060.116.630
24011215,2013-09-09T00:00:00,Adolescent,M01.060.057
24011215,2013-09-09T00:00:00,Adult,M01.060.116
24011215,2013-09-09T00:00:00,Aged,M01.060.116.100
24011215,2013-09-09T00:00:00,Breast Diseases,C17.800.090
24011215,2013-09-09T00:00:00,Child,M01.060.406
24011215,2013-09-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24011215,2013-09-09T00:00:00,Mammography,E01.370.350.700.500
24011215,2013-09-09T00:00:00,Middle Aged,M01.060.116.630
24011215,2013-09-09T00:00:00,"Ultrasonography, Mammary",E01.370.350.850.860
24011215,2013-09-09T00:00:00,"Ultrasonography, Mammary",E01.370.378.850
24015804,2013-09-09T00:00:00,Animals,B01.050
24015804,2013-09-09T00:00:00,Anterior Cruciate Ligament,A02.513.514.100
24015804,2013-09-09T00:00:00,Anterior Cruciate Ligament,A02.835.583.512.100
24015804,2013-09-09T00:00:00,Cadaver,C23.550.260.224
24015804,2013-09-09T00:00:00,Dogs,B01.050.150.900.649.147.153.200
24015804,2013-09-09T00:00:00,Isometric Contraction,G11.427.590.540.472
24040012,2013-09-09T00:00:00,Actins,D05.750.078.730.250
24040012,2013-09-09T00:00:00,Actins,D12.776.210.500.100
24040012,2013-09-09T00:00:00,Actins,D12.776.220.525.255
24040012,2013-09-09T00:00:00,Animals,B01.050
24040012,2013-09-09T00:00:00,Collagen Type I,D05.750.078.280.300.100
24040012,2013-09-09T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
24040012,2013-09-09T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
24040012,2013-09-09T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
24040012,2013-09-09T00:00:00,Diabetic Nephropathies,C12.777.419.192
24040012,2013-09-09T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
24040012,2013-09-09T00:00:00,Diabetic Nephropathies,C19.246.099.875
24040012,2013-09-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24040012,2013-09-09T00:00:00,Intercellular Adhesion Molecule-1,D12.776.395.550.200.450
24040012,2013-09-09T00:00:00,Intercellular Adhesion Molecule-1,D12.776.543.550.200.450
24040012,2013-09-09T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.264.035.400
24040012,2013-09-09T00:00:00,Intercellular Adhesion Molecule-1,D23.050.301.350.450
24040012,2013-09-09T00:00:00,Intercellular Adhesion Molecule-1,D23.101.100.110.400
24040012,2013-09-09T00:00:00,Kidney,A05.810.453
24040012,2013-09-09T00:00:00,"Muscle, Smooth",A02.633.570
24040012,2013-09-09T00:00:00,"Muscle, Smooth",A10.690.467
24040012,2013-09-09T00:00:00,NF-kappa B,D12.776.260.600
24040012,2013-09-09T00:00:00,NF-kappa B,D12.776.660.600
24040012,2013-09-09T00:00:00,NF-kappa B,D12.776.930.600
24040012,2013-09-09T00:00:00,"Receptors, Leptin",D12.776.543.750.065.500
24040012,2013-09-09T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
24040012,2013-09-09T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
24040012,2013-09-09T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
24040012,2013-09-09T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
24040012,2013-09-09T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
24040012,2013-09-09T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
24040012,2013-09-09T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
24040012,2013-09-09T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
24040012,2013-09-09T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
23468366,2013-09-10T00:00:00,Aged,M01.060.116.100
23468366,2013-09-10T00:00:00,Brain Ischemia,C10.228.140.300.150
23468366,2013-09-10T00:00:00,Brain Ischemia,C14.907.253.092
23468366,2013-09-10T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23468366,2013-09-10T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23468366,2013-09-10T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23468366,2013-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23468366,2013-09-10T00:00:00,Middle Aged,M01.060.116.630
23468366,2013-09-10T00:00:00,Multicenter Studies as Topic,E05.318.760.535.500
23468366,2013-09-10T00:00:00,Multicenter Studies as Topic,E05.337.250.500
23468366,2013-09-10T00:00:00,Multicenter Studies as Topic,N05.715.360.775.235.545
23468366,2013-09-10T00:00:00,Multicenter Studies as Topic,N06.850.520.450.535.500
23468366,2013-09-10T00:00:00,"RNA, Messenger",D13.444.735.544
23468366,2013-09-10T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
23468366,2013-09-10T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
23468366,2013-09-10T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
23468366,2013-09-10T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
23468366,2013-09-10T00:00:00,Stroke,C10.228.140.300.775
23468366,2013-09-10T00:00:00,Stroke,C14.907.253.855
24026681,2013-09-10T00:00:00,Amino Acid Sequence,G02.111.570.060
24026681,2013-09-10T00:00:00,Amino Acid Sequence,L01.453.245.667.060
24026681,2013-09-10T00:00:00,Animals,B01.050
24026681,2013-09-10T00:00:00,Apoptosis,G04.299.139.160
24026681,2013-09-10T00:00:00,"Embryo, Nonmammalian",A13.350
24026681,2013-09-10T00:00:00,"Embryo, Nonmammalian",A16.331
24026681,2013-09-10T00:00:00,Gene Expression Profiling,E05.393.332
24026681,2013-09-10T00:00:00,Gene Expression Regulation,G05.355.315
24026681,2013-09-10T00:00:00,Genetic Variation,G05.365
24026681,2013-09-10T00:00:00,Glycoproteins,D09.400.430
24026681,2013-09-10T00:00:00,Glycoproteins,D12.776.395
24026681,2013-09-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24026681,2013-09-10T00:00:00,Molecular Sequence Data,L01.453.245.667
24026681,2013-09-10T00:00:00,Neurons,A08.663
24026681,2013-09-10T00:00:00,Neurons,A11.671
24026681,2013-09-10T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
24026681,2013-09-10T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
24030405,2013-09-10T00:00:00,Animals,B01.050
24030405,2013-09-10T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
24030405,2013-09-10T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
24030405,2013-09-10T00:00:00,Swine,B01.050.150.900.649.077.880
23824790,2013-09-11T00:00:00,Agriculture,J01.040
23824790,2013-09-11T00:00:00,Carbon Dioxide,D01.200.200
23824790,2013-09-11T00:00:00,Carbon Dioxide,D01.362.150
23824790,2013-09-11T00:00:00,Carbon Dioxide,D01.650.550.200
23824790,2013-09-11T00:00:00,"Models, Theoretical",E05.599
23824790,2013-09-11T00:00:00,North America,Z01.107.567
23824790,2013-09-11T00:00:00,Rivers,G01.311.750
23824790,2013-09-11T00:00:00,Rivers,G16.500.275.280.500
23824790,2013-09-11T00:00:00,Rivers,N06.230.232.500
24075226,2013-09-11T00:00:00,Adult,M01.060.116
24075226,2013-09-11T00:00:00,Amphetamine-Related Disorders,C21.739.225
24075226,2013-09-11T00:00:00,Amphetamine-Related Disorders,F03.900.225
24075226,2013-09-11T00:00:00,"Behavior, Addictive",F01.145.527.100.120
24075226,2013-09-11T00:00:00,Cocaine-Related Disorders,C21.739.300
24075226,2013-09-11T00:00:00,Cocaine-Related Disorders,F03.900.300
24075226,2013-09-11T00:00:00,European Continental Ancestry Group,M01.686.508.400
24075226,2013-09-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24075226,2013-09-11T00:00:00,Prevalence,E05.318.308.985.525.750
24075226,2013-09-11T00:00:00,Prevalence,L01.280.975.525.750
24075226,2013-09-11T00:00:00,Prevalence,N01.224.935.597.750
24075226,2013-09-11T00:00:00,Prevalence,N06.850.505.400.975.525.750
24075226,2013-09-11T00:00:00,Prevalence,N06.850.520.308.985.525.750
24075226,2013-09-11T00:00:00,Self Administration,E02.319.890
24075226,2013-09-11T00:00:00,Self Administration,E02.900.890
24075226,2013-09-11T00:00:00,Smoking,F01.145.466.753
24075226,2013-09-11T00:00:00,Smoking Cessation,F01.145.940.700
24075226,2013-09-11T00:00:00,Treatment Outcome,E01.789.800
24075226,2013-09-11T00:00:00,Treatment Outcome,N04.761.559.590.800
24075226,2013-09-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24075226,2013-09-11T00:00:00,Young Adult,M01.060.116.815
23987666,2013-09-12T00:00:00,Animals,B01.050
23987666,2013-09-12T00:00:00,Antineoplastic Agents,D27.505.954.248
23987666,2013-09-12T00:00:00,Apoptosis,G04.299.139.160
23987666,2013-09-12T00:00:00,Cell Proliferation,G04.299.233.750
23987666,2013-09-12T00:00:00,Cell Proliferation,G07.700.320.249.410.750
23987666,2013-09-12T00:00:00,Ceramides,D02.065.313
23987666,2013-09-12T00:00:00,Ceramides,D09.400.410.420.525.200
23987666,2013-09-12T00:00:00,Ceramides,D10.390.470.675.200
23987666,2013-09-12T00:00:00,Ceramides,D10.570.877.360.612.200
23987666,2013-09-12T00:00:00,Glioma,C04.557.465.625.600.380
23987666,2013-09-12T00:00:00,Glioma,C04.557.470.670.380
23987666,2013-09-12T00:00:00,Glioma,C04.557.580.625.600.380
23987666,2013-09-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23987666,2013-09-12T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
23987666,2013-09-12T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
23987666,2013-09-12T00:00:00,MAP Kinase Signaling System,G03.495.553.560
23987666,2013-09-12T00:00:00,MAP Kinase Signaling System,G04.299.880.560
23987666,2013-09-12T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567
23987666,2013-09-12T00:00:00,Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750
23987666,2013-09-12T00:00:00,Mitogen-Activated Protein Kinases,D12.644.360.450
23987666,2013-09-12T00:00:00,Mitogen-Activated Protein Kinases,D12.776.476.450
23987666,2013-09-12T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
23987666,2013-09-12T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
23987666,2013-09-12T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
23987666,2013-09-12T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
23987666,2013-09-12T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
23987666,2013-09-12T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
23987666,2013-09-12T00:00:00,Proteome,D12.776.817
23987666,2013-09-12T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
23987666,2013-09-12T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
23987666,2013-09-12T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
23987666,2013-09-12T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24029162,2013-09-12T00:00:00,Adult,M01.060.116
24029162,2013-09-12T00:00:00,African Continental Ancestry Group,M01.686.508.100
24029162,2013-09-12T00:00:00,Blood Pressure,E01.370.600.875.249
24029162,2013-09-12T00:00:00,Blood Pressure,G09.330.380.076
24029162,2013-09-12T00:00:00,Body Mass Index,E01.370.600.115.100.125
24029162,2013-09-12T00:00:00,Body Mass Index,E05.041.124.125
24029162,2013-09-12T00:00:00,Body Mass Index,G07.100.100.125
24029162,2013-09-12T00:00:00,Body Mass Index,N06.850.505.200.100.175
24029162,2013-09-12T00:00:00,European Continental Ancestry Group,M01.686.508.400
24029162,2013-09-12T00:00:00,Hispanic Americans,M01.686.754.441
24029162,2013-09-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24029162,2013-09-12T00:00:00,Middle Aged,M01.060.116.630
24029162,2013-09-12T00:00:00,Obesity,C18.654.726.500
24029162,2013-09-12T00:00:00,Obesity,C23.888.144.699.500
24029162,2013-09-12T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
24029162,2013-09-12T00:00:00,Obesity,G07.100.100.160.120.699.500
24032670,2013-09-13T00:00:00,Adult,M01.060.116
24032670,2013-09-13T00:00:00,Brain,A08.186.211
24032670,2013-09-13T00:00:00,Case-Control Studies,E05.318.760.500.500
24032670,2013-09-13T00:00:00,Case-Control Studies,N05.715.360.775.175.200
24032670,2013-09-13T00:00:00,Case-Control Studies,N06.850.520.450.500.500
24032670,2013-09-13T00:00:00,Diffusion Tensor Imaging,E01.370.350.500.150.500
24032670,2013-09-13T00:00:00,Diffusion Tensor Imaging,E01.370.376.224
24032670,2013-09-13T00:00:00,Diffusion Tensor Imaging,E05.278
24032670,2013-09-13T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
24032670,2013-09-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24032670,2013-09-13T00:00:00,"Nerve Fibers, Myelinated",A08.663.542.512
24032670,2013-09-13T00:00:00,"Nerve Fibers, Myelinated",A11.671.514
24058451,2013-09-13T00:00:00,Aged,M01.060.116.100
24058451,2013-09-13T00:00:00,Albuminuria,C12.777.934.734.269
24058451,2013-09-13T00:00:00,Albuminuria,C13.351.968.934.734.269
24058451,2013-09-13T00:00:00,Albuminuria,C23.888.942.750.269
24058451,2013-09-13T00:00:00,Biological Markers,D23.101
24058451,2013-09-13T00:00:00,Creatinine,D03.383.129.308.207
24058451,2013-09-13T00:00:00,Critical Illness,C23.550.291.625
24058451,2013-09-13T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
24058451,2013-09-13T00:00:00,Glomerular Filtration Rate,G08.852.357
24058451,2013-09-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24058451,2013-09-13T00:00:00,Intensive Care Units,N02.278.388.493
24058451,2013-09-13T00:00:00,Kidney,A05.810.453
24058451,2013-09-13T00:00:00,Middle Aged,M01.060.116.630
24058451,2013-09-13T00:00:00,Stroke,C10.228.140.300.775
24058451,2013-09-13T00:00:00,Stroke,C14.907.253.855
24041735,2013-09-14T00:00:00,Adult,M01.060.116
24041735,2013-09-14T00:00:00,Biological Markers,D23.101
24041735,2013-09-14T00:00:00,Creatinine,D03.383.129.308.207
24041735,2013-09-14T00:00:00,Environmental Exposure,N06.850.460.350
24041735,2013-09-14T00:00:00,Environmental Monitoring,N06.850.460.350.080
24041735,2013-09-14T00:00:00,Environmental Monitoring,N06.850.780.375
24041735,2013-09-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24041735,2013-09-14T00:00:00,Intervention Studies,E05.318.760.565
24041735,2013-09-14T00:00:00,Intervention Studies,N05.715.360.775.390
24041735,2013-09-14T00:00:00,Intervention Studies,N06.850.520.450.565
24041735,2013-09-14T00:00:00,Oxidative Stress,G03.495.710
24041735,2013-09-14T00:00:00,Oxidative Stress,G07.700.830.750
24044994,2013-09-14T00:00:00,Cell Survival,G04.299.316
24044994,2013-09-14T00:00:00,Doxorubicin,D02.455.426.559.847.562.050.200.175
24044994,2013-09-14T00:00:00,Doxorubicin,D04.615.562.050.200.175
24044994,2013-09-14T00:00:00,Doxorubicin,D09.408.051.059.200.175
24044994,2013-09-14T00:00:00,Drug Carriers,D26.255.260
24044994,2013-09-14T00:00:00,Drug Carriers,D27.720.280.260
24044994,2013-09-14T00:00:00,Drug Carriers,E02.319.300.380
24044994,2013-09-14T00:00:00,Drug Delivery Systems,E02.319.300
24044994,2013-09-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24042162,2013-09-16T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
24042162,2013-09-16T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
24042162,2013-09-16T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
24042162,2013-09-16T00:00:00,Animals,B01.050
24042162,2013-09-16T00:00:00,Folic Acid,D03.438.733.631.400
24042162,2013-09-16T00:00:00,Gene Expression,G05.355.310
24042162,2013-09-16T00:00:00,Mitochondria,A11.284.430.214.190.875.564
24042162,2013-09-16T00:00:00,Mitochondria,A11.284.835.626
24042162,2013-09-16T00:00:00,Oxygen Consumption,G03.730
24042162,2013-09-16T00:00:00,Piperazines,D03.383.606
24042162,2013-09-16T00:00:00,Rabbits,B01.050.150.900.649.521.700
24042699,2013-09-16T00:00:00,Adolescent,M01.060.057
24042699,2013-09-16T00:00:00,Adult,M01.060.116
24042699,2013-09-16T00:00:00,Affect,F01.470.047
24042699,2013-09-16T00:00:00,Alcohol Drinking,F01.145.317.269
24042699,2013-09-16T00:00:00,"Behavior, Addictive",F01.145.527.100.120
24042699,2013-09-16T00:00:00,Cues,F02.463.425.234
24042699,2013-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24042699,2013-09-16T00:00:00,Sex Factors,N05.715.350.675
24042699,2013-09-16T00:00:00,Sex Factors,N06.850.490.875
24042699,2013-09-16T00:00:00,Social Environment,I01.880.656
24042699,2013-09-16T00:00:00,South Carolina,Z01.107.567.875.075.662
24042699,2013-09-16T00:00:00,South Carolina,Z01.107.567.875.750.700
24042699,2013-09-16T00:00:00,Substance Withdrawal Syndrome,C21.739.835
24042699,2013-09-16T00:00:00,Substance Withdrawal Syndrome,F03.900.825
24042699,2013-09-16T00:00:00,Tobacco Use Disorder,C21.739.912
24042699,2013-09-16T00:00:00,Tobacco Use Disorder,F03.900.912
24042699,2013-09-16T00:00:00,Young Adult,M01.060.116.815
24091326,2013-09-16T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
24091326,2013-09-16T00:00:00,Amides,D02.065
24091326,2013-09-16T00:00:00,Animals,B01.050
24091326,2013-09-16T00:00:00,Gene Expression,G05.355.310
24091326,2013-09-16T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
24091326,2013-09-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24091326,2013-09-16T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
24091326,2013-09-16T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
24091326,2013-09-16T00:00:00,"Promoter Regions, Genetic",G02.111.570.080.689.675
24091326,2013-09-16T00:00:00,"Promoter Regions, Genetic",G05.360.080.689.675
24091326,2013-09-16T00:00:00,"Promoter Regions, Genetic",G05.360.340.024.340.137.750.680
24091326,2013-09-16T00:00:00,Propanolamines,D02.033.100.624
24091326,2013-09-16T00:00:00,Propanolamines,D02.033.755.624
24091326,2013-09-16T00:00:00,Propanolamines,D02.092.063.624
24091326,2013-09-16T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
24091326,2013-09-16T00:00:00,Prostatic Neoplasms,C12.294.260.750
24091326,2013-09-16T00:00:00,Prostatic Neoplasms,C12.294.565.625
24091326,2013-09-16T00:00:00,Prostatic Neoplasms,C12.758.409.750
24091326,2013-09-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.260.108.820
24091326,2013-09-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.624.664.700.182
24091326,2013-09-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.660.763
24091326,2013-09-16T00:00:00,Proto-Oncogene Proteins c-jun,D12.776.930.127.820
24091326,2013-09-16T00:00:00,Radiation-Sensitizing Agents,D27.505.696.750
24091326,2013-09-16T00:00:00,Sphingolipids,D10.570.877
24091326,2013-09-16T00:00:00,Sphingolipids,D10.808
24091326,2013-09-16T00:00:00,Transcriptional Activation,G05.355.315.800
24102418,2013-09-16T00:00:00,Color,G01.201.875.770.578.199
24102418,2013-09-16T00:00:00,Color,G01.590.540.199
24102418,2013-09-16T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.181.349.500
24102418,2013-09-16T00:00:00,Gas Chromatography-Mass Spectrometry,E05.196.566.500
24102418,2013-09-16T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
24102418,2013-09-16T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
24102418,2013-09-16T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
24102418,2013-09-16T00:00:00,Plant Extracts,D20.215.784.500
24102418,2013-09-16T00:00:00,Plant Extracts,D26.667
24102418,2013-09-16T00:00:00,Taste,F02.830.816.724
24102418,2013-09-16T00:00:00,Taste,G11.561.600.810.724
24102418,2013-09-16T00:00:00,Temperature,G01.906.595
24102418,2013-09-16T00:00:00,Temperature,G16.500.275.063.725.710
24102418,2013-09-16T00:00:00,Temperature,G16.500.750.775.710
24102418,2013-09-16T00:00:00,Temperature,N06.230.150.450
24102418,2013-09-16T00:00:00,Temperature,N06.230.300.100.725.710
24102418,2013-09-16T00:00:00,Volatile Organic Compounds,D02.974
24046275,2013-09-17T00:00:00,Adolescent,M01.060.057
24046275,2013-09-17T00:00:00,Adult,M01.060.116
24046275,2013-09-17T00:00:00,Cartilage,A02.165
24046275,2013-09-17T00:00:00,Cartilage,A10.165.382
24046275,2013-09-17T00:00:00,Child,M01.060.406
24046275,2013-09-17T00:00:00,"Child, Preschool",M01.060.406.448
24046275,2013-09-17T00:00:00,"Hospitals, Pediatric",N02.278.421.556.437
24046275,2013-09-17T00:00:00,"Hospitals, University",N02.278.020.300.310
24046275,2013-09-17T00:00:00,"Hospitals, University",N02.278.421.639.725
24046275,2013-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24046275,2013-09-17T00:00:00,Otologic Surgical Procedures,E04.580.450
24046275,2013-09-17T00:00:00,South Carolina,Z01.107.567.875.075.662
24046275,2013-09-17T00:00:00,South Carolina,Z01.107.567.875.750.700
24046275,2013-09-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24046275,2013-09-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24046275,2013-09-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24046275,2013-09-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24046275,2013-09-17T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24046275,2013-09-17T00:00:00,Treatment Outcome,E01.789.800
24046275,2013-09-17T00:00:00,Treatment Outcome,N04.761.559.590.800
24046275,2013-09-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24094920,2013-09-17T00:00:00,Adolescent,M01.060.057
24094920,2013-09-17T00:00:00,Adolescent Behavior,F01.145.022
24094920,2013-09-17T00:00:00,Drug Delivery Systems,E02.319.300
24094920,2013-09-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24094920,2013-09-17T00:00:00,Nicotine,D03.132.760.570
24094920,2013-09-17T00:00:00,Nicotine,D03.383.725.518
24094920,2013-09-17T00:00:00,Nicotinic Agonists,D27.505.519.625.120.140.700
24094920,2013-09-17T00:00:00,Nicotinic Agonists,D27.505.696.577.120.140.700
24094920,2013-09-17T00:00:00,Prevalence,E05.318.308.985.525.750
24094920,2013-09-17T00:00:00,Prevalence,L01.280.975.525.750
24094920,2013-09-17T00:00:00,Prevalence,N01.224.935.597.750
24094920,2013-09-17T00:00:00,Prevalence,N06.850.505.400.975.525.750
24094920,2013-09-17T00:00:00,Prevalence,N06.850.520.308.985.525.750
24094920,2013-09-17T00:00:00,Smoking,F01.145.466.753
24094920,2013-09-17T00:00:00,United States,Z01.107.567.875
24055515,2013-09-19T00:00:00,Aged,M01.060.116.100
24055515,2013-09-19T00:00:00,Blood Flow Velocity,E01.370.370.130
24055515,2013-09-19T00:00:00,Blood Flow Velocity,G09.330.380.630.080
24055515,2013-09-19T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
24055515,2013-09-19T00:00:00,Carotid Stenosis,C14.907.137.230
24055515,2013-09-19T00:00:00,Carotid Stenosis,C14.907.253.123.360
24055515,2013-09-19T00:00:00,"Endarterectomy, Carotid",E04.100.814.456.250
24055515,2013-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24055515,2013-09-19T00:00:00,Middle Aged,M01.060.116.630
24055515,2013-09-19T00:00:00,Stents,E07.695.750
24055515,2013-09-19T00:00:00,Treatment Outcome,E01.789.800
24055515,2013-09-19T00:00:00,Treatment Outcome,N04.761.559.590.800
24055515,2013-09-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24055889,2013-09-19T00:00:00,Animals,B01.050
24055889,2013-09-19T00:00:00,Autophagy,G04.299.139.399
24055889,2013-09-19T00:00:00,Autophagy,G04.299.482.350.091
24055889,2013-09-19T00:00:00,Ceramides,D02.065.313
24055889,2013-09-19T00:00:00,Ceramides,D09.400.410.420.525.200
24055889,2013-09-19T00:00:00,Ceramides,D10.390.470.675.200
24055889,2013-09-19T00:00:00,Ceramides,D10.570.877.360.612.200
24055889,2013-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24055889,2013-09-19T00:00:00,Signal Transduction,G02.111.087.800
24055889,2013-09-19T00:00:00,Signal Transduction,G02.149.115.800
24055889,2013-09-19T00:00:00,Signal Transduction,G04.299.880
24056391,2013-09-19T00:00:00,Advanced Cardiac Life Support,E02.365.647.110.500
24056391,2013-09-19T00:00:00,Computer Simulation,L01.224.160
24056391,2013-09-19T00:00:00,"Decision Making, Computer-Assisted",L01.700.508.100
24056391,2013-09-19T00:00:00,Decision Support Techniques,E05.245
24056391,2013-09-19T00:00:00,Decision Support Techniques,L01.700.508.190
24056391,2013-09-19T00:00:00,Heart Arrest,C14.280.383
24056391,2013-09-19T00:00:00,Hospitalization,E02.760.400
24056391,2013-09-19T00:00:00,Hospitalization,N02.421.585.400
24056391,2013-09-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24060276,2013-09-20T00:00:00,Adolescent,M01.060.057
24060276,2013-09-20T00:00:00,Adult,M01.060.116
24060276,2013-09-20T00:00:00,Athletic Injuries,C21.866.115
24060276,2013-09-20T00:00:00,Brain Injuries,C10.228.140.199
24060276,2013-09-20T00:00:00,Brain Injuries,C10.900.300.087
24060276,2013-09-20T00:00:00,Brain Injuries,C21.866.260.118
24060276,2013-09-20T00:00:00,Brain Injuries,C21.866.915.300.200
24060276,2013-09-20T00:00:00,Hospitalization,E02.760.400
24060276,2013-09-20T00:00:00,Hospitalization,N02.421.585.400
24060276,2013-09-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24060276,2013-09-20T00:00:00,Incidence,E05.318.308.985.525.375
24060276,2013-09-20T00:00:00,Incidence,L01.280.975.525.375
24060276,2013-09-20T00:00:00,Incidence,N01.224.935.597.500
24060276,2013-09-20T00:00:00,Incidence,N06.850.505.400.975.525.375
24060276,2013-09-20T00:00:00,Incidence,N06.850.520.308.985.525.375
24060276,2013-09-20T00:00:00,Population Surveillance,E05.318.308.250.700
24060276,2013-09-20T00:00:00,Population Surveillance,N05.715.360.300.375.625
24060276,2013-09-20T00:00:00,Population Surveillance,N06.850.520.308.250.700
24060276,2013-09-20T00:00:00,Population Surveillance,N06.850.780.675
24060276,2013-09-20T00:00:00,Risk Factors,E05.318.740.600.800.725
24060276,2013-09-20T00:00:00,Risk Factors,N05.715.350.200.700
24060276,2013-09-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24060276,2013-09-20T00:00:00,Risk Factors,N06.850.490.625.750
24060276,2013-09-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24060276,2013-09-20T00:00:00,South Carolina,Z01.107.567.875.075.662
24060276,2013-09-20T00:00:00,South Carolina,Z01.107.567.875.750.700
24060276,2013-09-20T00:00:00,Sports,I03.450.642.845
24060276,2013-09-20T00:00:00,Young Adult,M01.060.116.815
24061145,2013-09-21T00:00:00,Adult,M01.060.116
24061145,2013-09-21T00:00:00,Antihypertensive Agents,D27.505.954.411.162
24061145,2013-09-21T00:00:00,Blood Pressure,E01.370.600.875.249
24061145,2013-09-21T00:00:00,Blood Pressure,G09.330.380.076
24061145,2013-09-21T00:00:00,Diabetes Complications,C19.246.099
24061145,2013-09-21T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
24061145,2013-09-21T00:00:00,Glomerular Filtration Rate,G08.852.357
24061145,2013-09-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24061145,2013-09-21T00:00:00,Hypertension,C14.907.489
24061145,2013-09-21T00:00:00,Kidney Transplantation,E02.870.500
24061145,2013-09-21T00:00:00,Kidney Transplantation,E04.936.450.485
24061145,2013-09-21T00:00:00,Kidney Transplantation,E04.950.774.400
24061145,2013-09-21T00:00:00,Middle Aged,M01.060.116.630
24061145,2013-09-21T00:00:00,Patient Readmission,E02.760.400.620
24061145,2013-09-21T00:00:00,Patient Readmission,N02.421.585.400.620
24061145,2013-09-21T00:00:00,Potassium,D01.268.549.550
24061145,2013-09-21T00:00:00,Potassium,D01.552.528.652
24061145,2013-09-21T00:00:00,Renal Insufficiency,C12.777.419.780
24061145,2013-09-21T00:00:00,Renal Insufficiency,C13.351.968.419.780
24061145,2013-09-21T00:00:00,Treatment Outcome,E01.789.800
24061145,2013-09-21T00:00:00,Treatment Outcome,N04.761.559.590.800
24061145,2013-09-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24120952,2013-09-22T00:00:00,Adult,M01.060.116
24120952,2013-09-22T00:00:00,Cross-Over Studies,E05.318.780.150
24120952,2013-09-22T00:00:00,Cross-Over Studies,N05.715.360.780.150
24120952,2013-09-22T00:00:00,Cross-Over Studies,N06.850.520.445.150
24120952,2013-09-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24120952,2013-09-22T00:00:00,Movement Disorders,C10.228.662
24120952,2013-09-22T00:00:00,Somatoform Disorders,F03.875
24067296,2013-09-23T00:00:00,Aged,M01.060.116.100
24067296,2013-09-23T00:00:00,Cardiotonic Agents,D27.505.954.411.222
24067296,2013-09-23T00:00:00,Cardiotonic Agents,D27.720.799.080
24067296,2013-09-23T00:00:00,Cardiovascular Agents,D27.505.954.411
24067296,2013-09-23T00:00:00,Chronic Disease,C23.550.291.500
24067296,2013-09-23T00:00:00,Digoxin,D04.808.155.160.349
24067296,2013-09-23T00:00:00,Digoxin,D04.808.155.580.130.500.436
24067296,2013-09-23T00:00:00,Digoxin,D09.408.180.261.436
24067296,2013-09-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24067296,2013-09-23T00:00:00,Patient Admission,E02.760.400.600
24067296,2013-09-23T00:00:00,Patient Admission,N02.421.585.400.600
24067296,2013-09-23T00:00:00,Patient Readmission,E02.760.400.620
24067296,2013-09-23T00:00:00,Patient Readmission,N02.421.585.400.620
24067296,2013-09-23T00:00:00,Treatment Outcome,E01.789.800
24067296,2013-09-23T00:00:00,Treatment Outcome,N04.761.559.590.800
24067296,2013-09-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24067296,2013-09-23T00:00:00,United States,Z01.107.567.875
24071467,2013-09-23T00:00:00,Child,M01.060.406
24071467,2013-09-23T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.220.220.220
24071467,2013-09-23T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.220.220
24071467,2013-09-23T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.850.850.220
24071467,2013-09-23T00:00:00,"Echocardiography, Doppler, Color",E01.370.370.380.220.220.220
24071467,2013-09-23T00:00:00,Heart Failure,C14.280.434
24071467,2013-09-23T00:00:00,Heart Transplantation,E04.100.376.475
24071467,2013-09-23T00:00:00,Heart Transplantation,E04.928.220.390
24071467,2013-09-23T00:00:00,Heart Transplantation,E04.936.450.475
24071467,2013-09-23T00:00:00,Heart Valve Prosthesis,E07.695.310
24071467,2013-09-23T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
24071467,2013-09-23T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
24071467,2013-09-23T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
24071467,2013-09-23T00:00:00,Heart-Assist Devices,E04.050.430
24071467,2013-09-23T00:00:00,Heart-Assist Devices,E07.695.300.300
24071467,2013-09-23T00:00:00,Heart-Assist Devices,E07.858.082.374.300
24071467,2013-09-23T00:00:00,Hemodynamics,G09.330.190.400
24071467,2013-09-23T00:00:00,Hemodynamics,G09.330.380
24071467,2013-09-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24071467,2013-09-23T00:00:00,Mitral Valve Insufficiency,C14.280.484.461
24071467,2013-09-23T00:00:00,Prosthesis Design,E05.320.550
24071467,2013-09-23T00:00:00,Prosthesis Design,E07.695.680
24071467,2013-09-23T00:00:00,Treatment Outcome,E01.789.800
24071467,2013-09-23T00:00:00,Treatment Outcome,N04.761.559.590.800
24071467,2013-09-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24071033,2013-09-24T00:00:00,Adult,M01.060.116
24071033,2013-09-24T00:00:00,Attitude of Health Personnel,F01.100.050
24071033,2013-09-24T00:00:00,Attitude of Health Personnel,N05.300.100
24071033,2013-09-24T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
24071033,2013-09-24T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
24071033,2013-09-24T00:00:00,"Emergency Service, Hospital",N02.421.297.195
24071033,2013-09-24T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
24071033,2013-09-24T00:00:00,Health Care Costs,N03.219.151.400
24071033,2013-09-24T00:00:00,Health Care Costs,N05.300.375
24071033,2013-09-24T00:00:00,Hospital Costs,N03.219.151.400.687
24071033,2013-09-24T00:00:00,Hospital Costs,N03.219.262.500
24071033,2013-09-24T00:00:00,Hospital Costs,N05.300.375.500
24071033,2013-09-24T00:00:00,"Hospitals, Teaching",N02.278.020.300
24071033,2013-09-24T00:00:00,"Hospitals, Teaching",N02.278.421.639
24071033,2013-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24071033,2013-09-24T00:00:00,Length of Stay,E02.760.400.480
24071033,2013-09-24T00:00:00,Length of Stay,N02.421.585.400.480
24071033,2013-09-24T00:00:00,Pilot Projects,E05.318.760.750
24071033,2013-09-24T00:00:00,Pilot Projects,E05.337.737
24071033,2013-09-24T00:00:00,Pilot Projects,N05.715.360.775.625
24071033,2013-09-24T00:00:00,Pilot Projects,N06.850.520.450.720
24071033,2013-09-24T00:00:00,Quality of Health Care,N04.761
24071033,2013-09-24T00:00:00,Quality of Health Care,N05.715
24071033,2013-09-24T00:00:00,Questionnaires,E05.318.308.750
24071033,2013-09-24T00:00:00,Questionnaires,L01.280.800
24071033,2013-09-24T00:00:00,Questionnaires,N05.715.360.300.695
24071033,2013-09-24T00:00:00,Questionnaires,N06.850.520.308.750
24075300,2013-09-24T00:00:00,Adult,M01.060.116
24075300,2013-09-24T00:00:00,Age Factors,N05.715.350.075
24075300,2013-09-24T00:00:00,Age Factors,N06.850.490.250
24075300,2013-09-24T00:00:00,Aged,M01.060.116.100
24075300,2013-09-24T00:00:00,"Fracture Fixation, Internal",E04.555.300.300
24075300,2013-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24075300,2013-09-24T00:00:00,Intensive Care Units,N02.278.388.493
24075300,2013-09-24T00:00:00,Length of Stay,E02.760.400.480
24075300,2013-09-24T00:00:00,Length of Stay,N02.421.585.400.480
24075300,2013-09-24T00:00:00,Middle Aged,M01.060.116.630
24075300,2013-09-24T00:00:00,"Respiration, Artificial",E02.365.647.729
24075300,2013-09-24T00:00:00,"Respiration, Artificial",E02.880.820
24075300,2013-09-24T00:00:00,Trauma Centers,N02.278.354.422.336.500
24075300,2013-09-24T00:00:00,Trauma Centers,N02.421.297.195.480
24075300,2013-09-24T00:00:00,Trauma Centers,N04.452.442.422.336.400
24075300,2013-09-24T00:00:00,"Wounds, Nonpenetrating",C21.866.974
24075564,2013-09-24T00:00:00,"Heart Defects, Congenital",C14.240.400
24075564,2013-09-24T00:00:00,"Heart Defects, Congenital",C14.280.400
24075564,2013-09-24T00:00:00,"Heart Defects, Congenital",C16.131.240.400
24075564,2013-09-24T00:00:00,Heart Ventricles,A07.541.560
24075564,2013-09-24T00:00:00,Hospital Mortality,E05.318.308.985.550.400
24075564,2013-09-24T00:00:00,Hospital Mortality,L01.280.975.550.400
24075564,2013-09-24T00:00:00,Hospital Mortality,N01.224.935.698.400
24075564,2013-09-24T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
24075564,2013-09-24T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
24075564,2013-09-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24075564,2013-09-24T00:00:00,Infant,M01.060.703
24075564,2013-09-24T00:00:00,Intensive Care Units,N02.278.388.493
24075564,2013-09-24T00:00:00,Length of Stay,E02.760.400.480
24075564,2013-09-24T00:00:00,Length of Stay,N02.421.585.400.480
24075564,2013-09-24T00:00:00,North America,Z01.107.567
24075564,2013-09-24T00:00:00,Postoperative Complications,C23.550.767
24075564,2013-09-24T00:00:00,Risk Factors,E05.318.740.600.800.725
24075564,2013-09-24T00:00:00,Risk Factors,N05.715.350.200.700
24075564,2013-09-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24075564,2013-09-24T00:00:00,Risk Factors,N06.850.490.625.750
24075564,2013-09-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24075564,2013-09-24T00:00:00,Treatment Outcome,E01.789.800
24075564,2013-09-24T00:00:00,Treatment Outcome,N04.761.559.590.800
24075564,2013-09-24T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24060761,2013-09-25T00:00:00,Adolescent,M01.060.057
24060761,2013-09-25T00:00:00,Adult,M01.060.116
24060761,2013-09-25T00:00:00,Amino Acid Sequence,G02.111.570.060
24060761,2013-09-25T00:00:00,Amino Acid Sequence,L01.453.245.667.060
24060761,2013-09-25T00:00:00,Fruit,A18.024.500
24060761,2013-09-25T00:00:00,Fruit,J02.500.562
24060761,2013-09-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24060761,2013-09-25T00:00:00,Middle Aged,M01.060.116.630
24060761,2013-09-25T00:00:00,Molecular Sequence Data,L01.453.245.667
24060761,2013-09-25T00:00:00,Phylogeny,G05.697
24060761,2013-09-25T00:00:00,Phylogeny,G16.100.275.605
24060761,2013-09-25T00:00:00,Phylogeny,L01.100.697
24060761,2013-09-25T00:00:00,Plant Proteins,D12.776.765
24060761,2013-09-25T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
24060761,2013-09-25T00:00:00,Young Adult,M01.060.116.815
24067300,2013-09-26T00:00:00,Alcohol Drinking,F01.145.317.269
24067300,2013-09-26T00:00:00,Alcoholism,C21.739.100.250
24067300,2013-09-26T00:00:00,Alcoholism,F03.900.100.350
24067300,2013-09-26T00:00:00,Amino Acids,D12.125
24067300,2013-09-26T00:00:00,Animals,B01.050
24067300,2013-09-26T00:00:00,"Bicyclo Compounds, Heterocyclic",D02.455.426.100.080.085
24067300,2013-09-26T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.438.260
24067300,2013-09-26T00:00:00,"Bicyclo Compounds, Heterocyclic",D03.605.084
24067300,2013-09-26T00:00:00,"Bicyclo Compounds, Heterocyclic",D04.075.080.875
24067300,2013-09-26T00:00:00,Glutamic Acid,D12.125.067.750
24067300,2013-09-26T00:00:00,Glutamic Acid,D12.125.119.450
24067300,2013-09-26T00:00:00,Glutamic Acid,D12.125.427.300
24067300,2013-09-26T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
24121559,2013-09-26T00:00:00,Animals,B01.050
24121559,2013-09-26T00:00:00,CD4-Positive T-Lymphocytes,A11.118.637.555.567.569.200
24121559,2013-09-26T00:00:00,CD4-Positive T-Lymphocytes,A15.145.229.637.555.567.569.200
24121559,2013-09-26T00:00:00,CD4-Positive T-Lymphocytes,A15.382.490.555.567.569.200
24121559,2013-09-26T00:00:00,Cell Differentiation,G04.299.151
24121559,2013-09-26T00:00:00,Cytological Techniques,E05.200.500
24076337,2013-09-27T00:00:00,Adolescent,M01.060.057
24076337,2013-09-27T00:00:00,Adult,M01.060.116
24076337,2013-09-27T00:00:00,Aged,M01.060.116.100
24076337,2013-09-27T00:00:00,Brain Ischemia,C10.228.140.300.150
24076337,2013-09-27T00:00:00,Brain Ischemia,C14.907.253.092
24076337,2013-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24076337,2013-09-27T00:00:00,Middle Aged,M01.060.116.630
24076337,2013-09-27T00:00:00,Serum Albumin,D12.776.034.841
24076337,2013-09-27T00:00:00,Serum Albumin,D12.776.124.050.700
24076337,2013-09-27T00:00:00,Serum Albumin,D12.776.124.727
24076337,2013-09-27T00:00:00,Stroke,C10.228.140.300.775
24076337,2013-09-27T00:00:00,Stroke,C14.907.253.855
24076337,2013-09-27T00:00:00,Treatment Outcome,E01.789.800
24076337,2013-09-27T00:00:00,Treatment Outcome,N04.761.559.590.800
24076337,2013-09-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24076337,2013-09-27T00:00:00,Young Adult,M01.060.116.815
24077352,2013-09-27T00:00:00,Animals,B01.050
24077352,2013-09-27T00:00:00,Apoptosis,G04.299.139.160
24077352,2013-09-27T00:00:00,Cell Cycle,G04.299.134
24077352,2013-09-27T00:00:00,Cell Proliferation,G04.299.233.750
24077352,2013-09-27T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24077352,2013-09-27T00:00:00,Cell Survival,G04.299.316
24077352,2013-09-27T00:00:00,DNA-Binding Proteins,D12.776.260
24077352,2013-09-27T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
24077352,2013-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24077352,2013-09-27T00:00:00,Membrane Glycoproteins,D12.776.395.550
24077352,2013-09-27T00:00:00,Membrane Glycoproteins,D12.776.543.550
24077352,2013-09-27T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
24077352,2013-09-27T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
24077352,2013-09-27T00:00:00,Multiple Myeloma,C04.557.595.500
24077352,2013-09-27T00:00:00,Multiple Myeloma,C14.907.454.460
24077352,2013-09-27T00:00:00,Multiple Myeloma,C15.378.147.780.650
24077352,2013-09-27T00:00:00,Multiple Myeloma,C15.378.463.835.460
24077352,2013-09-27T00:00:00,Multiple Myeloma,C20.683.515.845
24077352,2013-09-27T00:00:00,Multiple Myeloma,C20.683.780.650
24077352,2013-09-27T00:00:00,RNA Interference,G05.355.315.203.374.790
24077352,2013-09-27T00:00:00,Repressor Proteins,D12.776.260.703
24077352,2013-09-27T00:00:00,Repressor Proteins,D12.776.930.700
24077352,2013-09-27T00:00:00,Transcription Factors,D12.776.930
24077352,2013-09-27T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
24077352,2013-09-27T00:00:00,Wnt Proteins,D12.644.276.984
24077352,2013-09-27T00:00:00,Wnt Proteins,D12.776.467.984
24077352,2013-09-27T00:00:00,Wnt Proteins,D23.529.984
24086674,2013-09-27T00:00:00,Animals,B01.050
24086674,2013-09-27T00:00:00,Body Weight,C23.888.144
24086674,2013-09-27T00:00:00,Body Weight,E01.370.600.115.100.160.120
24086674,2013-09-27T00:00:00,Body Weight,E05.041.124.160.750
24086674,2013-09-27T00:00:00,Body Weight,G07.100.100.160.120
24086674,2013-09-27T00:00:00,Body Weight,G07.700.320.249.314.120
24086674,2013-09-27T00:00:00,Fatty Liver,C06.552.241
24086674,2013-09-27T00:00:00,Gene Expression Profiling,E05.393.332
24086674,2013-09-27T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
24120858,2013-09-27T00:00:00,Animals,B01.050
24120858,2013-09-27T00:00:00,Brain,A08.186.211
24120858,2013-09-27T00:00:00,Gene Expression Regulation,G05.355.315
24120858,2013-09-27T00:00:00,Memory Disorders,C10.597.606.525
24120858,2013-09-27T00:00:00,Memory Disorders,C23.888.592.604.529
24120858,2013-09-27T00:00:00,Memory Disorders,F01.700.625
24120858,2013-09-27T00:00:00,Methamphetamine,D02.092.471.683.152.619
24120858,2013-09-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24120858,2013-09-27T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
24128815,2013-09-27T00:00:00,HIV Infections,C02.782.815.616.400
24128815,2013-09-27T00:00:00,HIV Infections,C02.800.801.400
24128815,2013-09-27T00:00:00,HIV Infections,C20.673.480
24128815,2013-09-27T00:00:00,HIV Protease,D08.811.277.656.074.500.340
24128815,2013-09-27T00:00:00,HIV Protease,D08.811.277.656.300.048.340
24128815,2013-09-27T00:00:00,HIV Protease,D12.776.964.775.375.545.750
24128815,2013-09-27T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
24128815,2013-09-27T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
24128815,2013-09-27T00:00:00,HIV-1,B04.820.650.589.650.350.400
24128815,2013-09-27T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
24128815,2013-09-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24128815,2013-09-27T00:00:00,"Models, Molecular",E05.599.595
24128815,2013-09-27T00:00:00,Protein Conformation,G02.111.570.790.709
24081905,2013-09-30T00:00:00,Animals,B01.050
24081905,2013-09-30T00:00:00,Autophagy,G04.299.139.399
24081905,2013-09-30T00:00:00,Autophagy,G04.299.482.350.091
24081905,2013-09-30T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
24081905,2013-09-30T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
24081905,2013-09-30T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
24081905,2013-09-30T00:00:00,Mitochondria,A11.284.430.214.190.875.564
24081905,2013-09-30T00:00:00,Mitochondria,A11.284.835.626
24081905,2013-09-30T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
24081905,2013-09-30T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
24081905,2013-09-30T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
24081905,2013-09-30T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.260.698
24081905,2013-09-30T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.826
24081905,2013-09-30T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.930.669
24114730,2013-09-30T00:00:00,Biomedical Research,H01.770.644.145
24114730,2013-09-30T00:00:00,Career Choice,F02.463.785.373.346.400
24114730,2013-09-30T00:00:00,Drug Therapy,E02.319
24114730,2013-09-30T00:00:00,"Education, Pharmacy",I02.358.525
24114730,2013-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24114730,2013-09-30T00:00:00,Pharmacists,M01.526.485.780
24114730,2013-09-30T00:00:00,Pharmacists,N02.360.780
24114730,2013-09-30T00:00:00,Professional Competence,I02.399.630
24114730,2013-09-30T00:00:00,Professional Role,F01.829.316.616.625
24114730,2013-09-30T00:00:00,United States,Z01.107.567.875
24114860,2013-09-30T00:00:00,Adolescent,M01.060.057
24114860,2013-09-30T00:00:00,Adult,M01.060.116
24114860,2013-09-30T00:00:00,Child,M01.060.406
24114860,2013-09-30T00:00:00,"Child Abuse, Sexual",I01.198.240.748.300
24114860,2013-09-30T00:00:00,"Child Abuse, Sexual",I01.198.240.856.350.250.255
24114860,2013-09-30T00:00:00,"Child Abuse, Sexual",I01.880.735.900.350.250.255
24114860,2013-09-30T00:00:00,"Child Abuse, Sexual",I01.880.787.293.292.325
24114860,2013-09-30T00:00:00,Crime Victims,M01.135
24114860,2013-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24114860,2013-09-30T00:00:00,Juvenile Delinquency,I01.880.735.479
24114860,2013-09-30T00:00:00,Middle Aged,M01.060.116.630
24114860,2013-09-30T00:00:00,Military Personnel,M01.526.625
24114860,2013-09-30T00:00:00,Parent-Child Relations,F01.829.263.370.290
24114860,2013-09-30T00:00:00,Risk Factors,E05.318.740.600.800.725
24114860,2013-09-30T00:00:00,Risk Factors,N05.715.350.200.700
24114860,2013-09-30T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24114860,2013-09-30T00:00:00,Risk Factors,N06.850.490.625.750
24114860,2013-09-30T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24114860,2013-09-30T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
24114860,2013-09-30T00:00:00,Substance-Related Disorders,C21.739
24114860,2013-09-30T00:00:00,Substance-Related Disorders,F03.900
24114860,2013-09-30T00:00:00,United States,Z01.107.567.875
24114860,2013-09-30T00:00:00,Young Adult,M01.060.116.815
24118980,2013-09-30T00:00:00,Aged,M01.060.116.100
24118980,2013-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24118980,2013-09-30T00:00:00,Interpersonal Relations,F01.829.401
24118980,2013-09-30T00:00:00,Middle Aged,M01.060.116.630
24118980,2013-09-30T00:00:00,Prostatectomy,E04.950.774.860.625
24118980,2013-09-30T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
24118980,2013-09-30T00:00:00,Prostatic Neoplasms,C12.294.260.750
24118980,2013-09-30T00:00:00,Prostatic Neoplasms,C12.294.565.625
24118980,2013-09-30T00:00:00,Prostatic Neoplasms,C12.758.409.750
24118980,2013-09-30T00:00:00,Questionnaires,E05.318.308.750
24118980,2013-09-30T00:00:00,Questionnaires,L01.280.800
24118980,2013-09-30T00:00:00,Questionnaires,N05.715.360.300.695
24118980,2013-09-30T00:00:00,Questionnaires,N06.850.520.308.750
24118980,2013-09-30T00:00:00,Sexual Behavior,F01.145.802
24118980,2013-09-30T00:00:00,Sexual Partners,M01.778
24119153,2013-09-30T00:00:00,Albuminuria,C12.777.934.734.269
24119153,2013-09-30T00:00:00,Albuminuria,C13.351.968.934.734.269
24119153,2013-09-30T00:00:00,Albuminuria,C23.888.942.750.269
24119153,2013-09-30T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
24119153,2013-09-30T00:00:00,Glomerular Filtration Rate,G08.852.357
24119153,2013-09-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24119153,2013-09-30T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
24119153,2013-09-30T00:00:00,Practice Guidelines as Topic,N05.700.350.650
24119153,2013-09-30T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
24119153,2013-09-30T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23389260,2013-10-01T00:00:00,Adult,M01.060.116
23389260,2013-10-01T00:00:00,Cross Infection,C01.539.248
23389260,2013-10-01T00:00:00,Evidence-Based Nursing,H02.249.875
23389260,2013-10-01T00:00:00,Evidence-Based Nursing,H02.478.197
23389260,2013-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
23389260,2013-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
23389260,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23389260,2013-10-01T00:00:00,Intervention Studies,E05.318.760.565
23389260,2013-10-01T00:00:00,Intervention Studies,N05.715.360.775.390
23389260,2013-10-01T00:00:00,Intervention Studies,N06.850.520.450.565
23389260,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
23389260,2013-10-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.680.490
23389260,2013-10-01T00:00:00,"Nursing Staff, Hospital",M01.526.485.740.523
23389260,2013-10-01T00:00:00,"Nursing Staff, Hospital",N02.360.680.490
23389260,2013-10-01T00:00:00,"Nursing Staff, Hospital",N02.360.740.523
23389260,2013-10-01T00:00:00,Pilot Projects,E05.318.760.750
23389260,2013-10-01T00:00:00,Pilot Projects,E05.337.737
23389260,2013-10-01T00:00:00,Pilot Projects,N05.715.360.775.625
23389260,2013-10-01T00:00:00,Pilot Projects,N06.850.520.450.720
23389260,2013-10-01T00:00:00,Questionnaires,E05.318.308.750
23389260,2013-10-01T00:00:00,Questionnaires,L01.280.800
23389260,2013-10-01T00:00:00,Questionnaires,N05.715.360.300.695
23389260,2013-10-01T00:00:00,Questionnaires,N06.850.520.308.750
23389260,2013-10-01T00:00:00,South Carolina,Z01.107.567.875.075.662
23389260,2013-10-01T00:00:00,South Carolina,Z01.107.567.875.750.700
23389260,2013-10-01T00:00:00,Urinary Catheterization,E01.370.390.820
23389260,2013-10-01T00:00:00,Urinary Catheterization,E02.148.947
23389260,2013-10-01T00:00:00,Urinary Tract Infections,C01.539.895
23389260,2013-10-01T00:00:00,Urinary Tract Infections,C12.777.892
23389260,2013-10-01T00:00:00,Urinary Tract Infections,C13.351.968.892
23608928,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23608928,2013-10-01T00:00:00,Hypercalcemia,C18.452.174.451
23608928,2013-10-01T00:00:00,Hypercalcemia,C18.452.950.340
23608928,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
23608928,2013-10-01T00:00:00,Thyroid Crisis,C19.874.397.685.905
23608928,2013-10-01T00:00:00,Thyroid Crisis,C19.874.902.905
23608928,2013-10-01T00:00:00,Treatment Outcome,E01.789.800
23608928,2013-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23608928,2013-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23609592,2013-10-01T00:00:00,Academic Medical Centers,N02.278.020
23609592,2013-10-01T00:00:00,Adult,M01.060.116
23609592,2013-10-01T00:00:00,Aged,M01.060.116.100
23609592,2013-10-01T00:00:00,Demography,I01.240
23609592,2013-10-01T00:00:00,Demography,N01.224
23609592,2013-10-01T00:00:00,Demography,N06.850.505.400
23609592,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23609592,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
23609592,2013-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23609592,2013-10-01T00:00:00,Risk Factors,N05.715.350.200.700
23609592,2013-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23609592,2013-10-01T00:00:00,Risk Factors,N06.850.490.625.750
23609592,2013-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23609592,2013-10-01T00:00:00,Treatment Outcome,E01.789.800
23609592,2013-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23609592,2013-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23636997,2013-10-01T00:00:00,Adolescent,M01.060.057
23636997,2013-10-01T00:00:00,Adult,M01.060.116
23636997,2013-10-01T00:00:00,Aged,M01.060.116.100
23636997,2013-10-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
23636997,2013-10-01T00:00:00,Body Mass Index,E05.041.124.125
23636997,2013-10-01T00:00:00,Body Mass Index,G07.100.100.125
23636997,2013-10-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
23636997,2013-10-01T00:00:00,Gastroplasty,E02.065.062.750
23636997,2013-10-01T00:00:00,Gastroplasty,E04.062.750
23636997,2013-10-01T00:00:00,Gastroplasty,E04.210.485
23636997,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23636997,2013-10-01T00:00:00,Laparoscopy,E01.370.388.250.520
23636997,2013-10-01T00:00:00,Laparoscopy,E04.800.250.520
23636997,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
23636997,2013-10-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
23636997,2013-10-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
23636997,2013-10-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
23636997,2013-10-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
23636997,2013-10-01T00:00:00,Treatment Outcome,E01.789.800
23636997,2013-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23636997,2013-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23636997,2013-10-01T00:00:00,Weight Loss,C23.888.144.243.963
23636997,2013-10-01T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
23797785,2013-10-01T00:00:00,Fibrinogen,D12.776.124.050.250
23797785,2013-10-01T00:00:00,Fibrinogen,D12.776.124.125.500
23797785,2013-10-01T00:00:00,Fibrinogen,D12.776.811.300
23797785,2013-10-01T00:00:00,Fibrinogen,D23.119.490
23797785,2013-10-01T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
23797785,2013-10-01T00:00:00,GTP-Binding Proteins,D12.776.157.325
23797785,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23797785,2013-10-01T00:00:00,Inflammation,C23.550.470
23797785,2013-10-01T00:00:00,Recombinant Proteins,D12.776.828
23797785,2013-10-01T00:00:00,Transglutaminases,D08.811.913.050.200.800
23816477,2013-10-01T00:00:00,Aged,M01.060.116.100
23816477,2013-10-01T00:00:00,Coronary Disease,C14.280.647.250
23816477,2013-10-01T00:00:00,Coronary Disease,C14.907.585.250
23816477,2013-10-01T00:00:00,Glomerular Filtration Rate,E01.370.390.400.300
23816477,2013-10-01T00:00:00,Glomerular Filtration Rate,G08.852.357
23816477,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23816477,2013-10-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
23816477,2013-10-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
23816477,2013-10-01T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
23816477,2013-10-01T00:00:00,Lipids,D10
23816477,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
23816477,2013-10-01T00:00:00,Patient Compliance,F01.145.488.500
23816477,2013-10-01T00:00:00,Patient Compliance,N05.300.150.600.600
23816477,2013-10-01T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
23816477,2013-10-01T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
23816477,2013-10-01T00:00:00,Treatment Outcome,E01.789.800
23816477,2013-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23816477,2013-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23816477,2013-10-01T00:00:00,United States,Z01.107.567.875
23897243,2013-10-01T00:00:00,Chemokines,D12.644.276.374.200
23897243,2013-10-01T00:00:00,Chemokines,D12.776.467.374.200
23897243,2013-10-01T00:00:00,Chemokines,D23.125.300
23897243,2013-10-01T00:00:00,Chemokines,D23.469.200
23897243,2013-10-01T00:00:00,Chemokines,D23.529.374.200
23897243,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23897243,2013-10-01T00:00:00,"Hypothermia, Induced",E02.258.750
23897243,2013-10-01T00:00:00,"Hypoxia-Ischemia, Brain",C10.228.140.300.150.716
23897243,2013-10-01T00:00:00,"Hypoxia-Ischemia, Brain",C10.228.140.624.500
23897243,2013-10-01T00:00:00,"Hypoxia-Ischemia, Brain",C14.907.253.092.716
23897243,2013-10-01T00:00:00,Infant,M01.060.703
23897243,2013-10-01T00:00:00,"Infant, Newborn",M01.060.703.520
23897243,2013-10-01T00:00:00,"Intensive Care Units, Neonatal",N02.278.388.493.390.380
23897243,2013-10-01T00:00:00,Leukocytes,A11.118.637
23897243,2013-10-01T00:00:00,Leukocytes,A15.145.229.637
23897243,2013-10-01T00:00:00,Leukocytes,A15.382.490
23897243,2013-10-01T00:00:00,Treatment Outcome,E01.789.800
23897243,2013-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23897243,2013-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23924348,2013-10-01T00:00:00,Animals,B01.050
23924348,2013-10-01T00:00:00,Apoptosis,G04.299.139.160
23924348,2013-10-01T00:00:00,Caveolin 1,D12.644.360.024.264
23924348,2013-10-01T00:00:00,Caveolin 1,D12.776.157.057.010
23924348,2013-10-01T00:00:00,Caveolin 1,D12.776.476.024.280
23924348,2013-10-01T00:00:00,Caveolin 1,D12.776.543.990.100.500
23924348,2013-10-01T00:00:00,Caveolin 1,D12.776.744.287
23924348,2013-10-01T00:00:00,Gene Expression Profiling,E05.393.332
23924348,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23924348,2013-10-01T00:00:00,Idiopathic Pulmonary Fibrosis,C08.381.483.487.500
23924348,2013-10-01T00:00:00,Idiopathic Pulmonary Fibrosis,C08.381.765.500
23924348,2013-10-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
23924348,2013-10-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
23924348,2013-10-01T00:00:00,Signal Transduction,G02.111.087.800
23924348,2013-10-01T00:00:00,Signal Transduction,G02.149.115.800
23924348,2013-10-01T00:00:00,Signal Transduction,G04.299.880
23924348,2013-10-01T00:00:00,Tissue Array Analysis,E05.196.630.570.850
23924348,2013-10-01T00:00:00,Tissue Array Analysis,E05.588.570.850
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
23924348,2013-10-01T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
23933793,2013-10-01T00:00:00,Animals,B01.050
23933793,2013-10-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
23933793,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23933793,2013-10-01T00:00:00,Hypertension,C14.907.489
23933793,2013-10-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
23933793,2013-10-01T00:00:00,Kidney Transplantation,E02.870.500
23933793,2013-10-01T00:00:00,Kidney Transplantation,E04.936.450.485
23933793,2013-10-01T00:00:00,Kidney Transplantation,E04.950.774.400
23933793,2013-10-01T00:00:00,Risk Factors,E05.318.740.600.800.725
23933793,2013-10-01T00:00:00,Risk Factors,N05.715.350.200.700
23933793,2013-10-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
23933793,2013-10-01T00:00:00,Risk Factors,N06.850.490.625.750
23933793,2013-10-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
23933793,2013-10-01T00:00:00,Treatment Outcome,E01.789.800
23933793,2013-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23933793,2013-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23943316,2013-10-01T00:00:00,Adolescent,M01.060.057
23943316,2013-10-01T00:00:00,Adult,M01.060.116
23943316,2013-10-01T00:00:00,Aged,M01.060.116.100
23943316,2013-10-01T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
23943316,2013-10-01T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
23943316,2013-10-01T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
23943316,2013-10-01T00:00:00,Critical Care,E02.760.190
23943316,2013-10-01T00:00:00,Critical Care,N02.421.585.190
23943316,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23943316,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
23943316,2013-10-01T00:00:00,Research Design,E05.581.500
23943316,2013-10-01T00:00:00,Research Design,H01.770.644.728
23943316,2013-10-01T00:00:00,Young Adult,M01.060.116.815
23969353,2013-10-01T00:00:00,Career Choice,F02.463.785.373.346.400
23969353,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23969353,2013-10-01T00:00:00,Primary Health Care,N04.590.233.727
23969353,2013-10-01T00:00:00,Questionnaires,E05.318.308.750
23969353,2013-10-01T00:00:00,Questionnaires,L01.280.800
23969353,2013-10-01T00:00:00,Questionnaires,N05.715.360.300.695
23969353,2013-10-01T00:00:00,Questionnaires,N06.850.520.308.750
23969353,2013-10-01T00:00:00,Specialization,H02.811
23969353,2013-10-01T00:00:00,"Students, Medical",I02.851.686.602
23969353,2013-10-01T00:00:00,"Students, Medical",M01.848.769.602
23969353,2013-10-01T00:00:00,United States,Z01.107.567.875
24033779,2013-10-01T00:00:00,Alcohol Drinking,F01.145.317.269
24033779,2013-10-01T00:00:00,Alcoholism,C21.739.100.250
24033779,2013-10-01T00:00:00,Alcoholism,F03.900.100.350
24033779,2013-10-01T00:00:00,Behavior Therapy,F04.754.137
24033779,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24033779,2013-10-01T00:00:00,Naltrexone,D03.132.577.249.706.550
24033779,2013-10-01T00:00:00,Naltrexone,D03.549.686.750.550
24033779,2013-10-01T00:00:00,Naltrexone,D03.605.497.750.550
24033779,2013-10-01T00:00:00,Naltrexone,D04.615.723.795.706.550
24033779,2013-10-01T00:00:00,Narcotic Antagonists,D27.505.696.543
24033779,2013-10-01T00:00:00,Narcotic Antagonists,D27.505.696.663.850.512
24033779,2013-10-01T00:00:00,Narcotic Antagonists,D27.505.954.427.550
24046400,2013-10-01T00:00:00,Animals,B01.050
24046400,2013-10-01T00:00:00,Chick Embryo,A13.350.150
24046400,2013-10-01T00:00:00,Chick Embryo,A16.331.200
24046400,2013-10-01T00:00:00,Chickens,B01.050.150.900.248.350.150
24046400,2013-10-01T00:00:00,Chickens,B01.050.150.900.248.617.192
24050419,2013-10-01T00:00:00,Adult,M01.060.116
24050419,2013-10-01T00:00:00,African Americans,M01.686.508.100.100
24050419,2013-10-01T00:00:00,African Americans,M01.686.754.100
24050419,2013-10-01T00:00:00,Body Mass Index,E01.370.600.115.100.125
24050419,2013-10-01T00:00:00,Body Mass Index,E05.041.124.125
24050419,2013-10-01T00:00:00,Body Mass Index,G07.100.100.125
24050419,2013-10-01T00:00:00,Body Mass Index,N06.850.505.200.100.175
24050419,2013-10-01T00:00:00,C-Reactive Protein,D12.776.034.145
24050419,2013-10-01T00:00:00,C-Reactive Protein,D12.776.124.050.120
24050419,2013-10-01T00:00:00,C-Reactive Protein,D12.776.124.486.157
24050419,2013-10-01T00:00:00,Diet,E05.272
24050419,2013-10-01T00:00:00,Diet,G07.610.240
24050419,2013-10-01T00:00:00,Health Behavior,F01.145.488
24050419,2013-10-01T00:00:00,Health Promotion,N02.370
24050419,2013-10-01T00:00:00,Health Promotion,N02.421.726.507
24050419,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24050419,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
24050419,2013-10-01T00:00:00,"Stress, Psychological",F01.145.126.990
24050419,2013-10-01T00:00:00,"Stress, Psychological",F02.830.900
24054098,2013-10-01T00:00:00,Ascitic Fluid,A12.207.119
24054098,2013-10-01T00:00:00,"Hernia, Umbilical",C16.614.378
24054098,2013-10-01T00:00:00,"Hernia, Umbilical",C23.300.707.374.937.500
24054098,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24054098,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
24054098,2013-10-01T00:00:00,Syndrome,C23.550.288.500
24054098,2013-10-01T00:00:00,Umbilicus,A01.047.849
24059877,2013-10-01T00:00:00,Adolescent,M01.060.057
24059877,2013-10-01T00:00:00,African Americans,M01.686.508.100.100
24059877,2013-10-01T00:00:00,African Americans,M01.686.754.100
24059877,2013-10-01T00:00:00,Condoms,E07.190.270.150
24059877,2013-10-01T00:00:00,HIV Infections,C02.782.815.616.400
24059877,2013-10-01T00:00:00,HIV Infections,C02.800.801.400
24059877,2013-10-01T00:00:00,HIV Infections,C20.673.480
24059877,2013-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
24059877,2013-10-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
24059877,2013-10-01T00:00:00,Health Promotion,N02.370
24059877,2013-10-01T00:00:00,Health Promotion,N02.421.726.507
24059877,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24059877,2013-10-01T00:00:00,Internet,L01.224.230.110.500
24059877,2013-10-01T00:00:00,Self Efficacy,F01.752.747.792.700
24059877,2013-10-01T00:00:00,Sexual Behavior,F01.145.802
24059877,2013-10-01T00:00:00,Sexually Transmitted Diseases,C01.539.778
24059877,2013-10-01T00:00:00,Sexually Transmitted Diseases,C02.800
24059877,2013-10-01T00:00:00,Sexually Transmitted Diseases,C12.294.668
24059877,2013-10-01T00:00:00,Sexually Transmitted Diseases,C13.351.500.711
24059877,2013-10-01T00:00:00,United States,Z01.107.567.875
24065790,2013-10-01T00:00:00,Atherosclerosis,C14.907.137.126.307
24065790,2013-10-01T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
24065790,2013-10-01T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
24065790,2013-10-01T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
24065790,2013-10-01T00:00:00,Diabetic Angiopathies,C14.907.320
24065790,2013-10-01T00:00:00,Diabetic Angiopathies,C19.246.099.500
24065790,2013-10-01T00:00:00,Diabetic Nephropathies,C12.777.419.192
24065790,2013-10-01T00:00:00,Diabetic Nephropathies,C13.351.968.419.192
24065790,2013-10-01T00:00:00,Diabetic Nephropathies,C19.246.099.875
24065790,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24065790,2013-10-01T00:00:00,Hyperglycemia,C18.452.394.952
24065790,2013-10-01T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
24074477,2013-10-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
24074477,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24081287,2013-10-01T00:00:00,Anticoagulants,D27.505.954.502.119
24081287,2013-10-01T00:00:00,Brain Ischemia,C10.228.140.300.150
24081287,2013-10-01T00:00:00,Brain Ischemia,C14.907.253.092
24081287,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24081287,2013-10-01T00:00:00,Intracranial Hemorrhages,C10.228.140.300.535
24081287,2013-10-01T00:00:00,Intracranial Hemorrhages,C14.907.253.573
24081287,2013-10-01T00:00:00,Intracranial Hemorrhages,C23.550.414.913
24081287,2013-10-01T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
24081287,2013-10-01T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
24081287,2013-10-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
24081287,2013-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
24081287,2013-10-01T00:00:00,Risk Assessment,N04.452.871.715
24081287,2013-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24081287,2013-10-01T00:00:00,Risk Assessment,N06.850.505.715
24081287,2013-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24081287,2013-10-01T00:00:00,Secondary Prevention,N02.421.726.825
24081287,2013-10-01T00:00:00,Secondary Prevention,N06.850.780.750
24081287,2013-10-01T00:00:00,Stroke,C10.228.140.300.775
24081287,2013-10-01T00:00:00,Stroke,C14.907.253.855
24081287,2013-10-01T00:00:00,Ticlopidine,D02.886.778.834
24081287,2013-10-01T00:00:00,Ticlopidine,D03.383.903.834
24083932,2013-10-01T00:00:00,Adult,M01.060.116
24083932,2013-10-01T00:00:00,Hand,A01.378.800.667
24083932,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24083932,2013-10-01T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.619.393.536
24083932,2013-10-01T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.486.485.114.632
24083932,2013-10-01T00:00:00,"Immunoglobulins, Intravenous",D12.776.124.790.651.114.632
24083932,2013-10-01T00:00:00,"Immunoglobulins, Intravenous",D12.776.377.715.548.114.632
24083932,2013-10-01T00:00:00,Immunologic Factors,D27.505.696.477
24083932,2013-10-01T00:00:00,Military Personnel,M01.526.625
24083932,2013-10-01T00:00:00,"Muscle, Skeletal",A02.633.567
24083932,2013-10-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
24083932,2013-10-01T00:00:00,United States,Z01.107.567.875
24084617,2013-10-01T00:00:00,Brain Neoplasms,C04.588.614.250.195
24084617,2013-10-01T00:00:00,Brain Neoplasms,C10.228.140.211
24084617,2013-10-01T00:00:00,Brain Neoplasms,C10.551.240.250
24084617,2013-10-01T00:00:00,Calcinosis,C18.452.174.130
24084617,2013-10-01T00:00:00,"Child, Preschool",M01.060.406.448
24084617,2013-10-01T00:00:00,Developing Countries,I01.615.500.300
24084617,2013-10-01T00:00:00,Diagnostic Errors,E01.354
24084617,2013-10-01T00:00:00,Diagnostic Errors,N02.421.450.280
24084617,2013-10-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
24084617,2013-10-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
24084617,2013-10-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
24084617,2013-10-01T00:00:00,Eye Neoplasms,C04.588.364
24084617,2013-10-01T00:00:00,Eye Neoplasms,C11.319
24084617,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24084617,2013-10-01T00:00:00,"Neoplasms, Multiple Primary",C04.651
24084617,2013-10-01T00:00:00,Point-of-Care Systems,N04.452.442.452.680
24084617,2013-10-01T00:00:00,Point-of-Care Systems,N04.452.515.360.652
24084617,2013-10-01T00:00:00,Point-of-Care Systems,N04.590.874
24084617,2013-10-01T00:00:00,Retinoblastoma,C04.557.465.625.600.725
24084617,2013-10-01T00:00:00,Retinoblastoma,C04.557.470.670.725
24084617,2013-10-01T00:00:00,Retinoblastoma,C04.557.580.625.600.725
24084617,2013-10-01T00:00:00,Retinoblastoma,C04.588.364.818.760
24084617,2013-10-01T00:00:00,Retinoblastoma,C11.319.475.760
24084617,2013-10-01T00:00:00,Retinoblastoma,C11.768.717.760
24084617,2013-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24084617,2013-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24084617,2013-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24084617,2013-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24084617,2013-10-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24085024,2013-10-01T00:00:00,Brain Ischemia,C10.228.140.300.150
24085024,2013-10-01T00:00:00,Brain Ischemia,C14.907.253.092
24085024,2013-10-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
24085024,2013-10-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
24085024,2013-10-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
24085024,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24085024,2013-10-01T00:00:00,Internet,L01.224.230.110.500
24085024,2013-10-01T00:00:00,"Models, Biological",E05.599.395
24085024,2013-10-01T00:00:00,Stroke,C10.228.140.300.775
24085024,2013-10-01T00:00:00,Stroke,C14.907.253.855
24085024,2013-10-01T00:00:00,Thrombolytic Therapy,E02.319.913
24085024,2013-10-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
24085024,2013-10-01T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
24085024,2013-10-01T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
24085024,2013-10-01T00:00:00,Tissue Plasminogen Activator,D23.119.970
24088440,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24088440,2013-10-01T00:00:00,Robotics,H01.671.293.643
24088440,2013-10-01T00:00:00,Robotics,J01.897.104.834
24088440,2013-10-01T00:00:00,Robotics,L01.224.065.630
24088440,2013-10-01T00:00:00,Thoracic Surgery,H02.403.810.803
24088440,2013-10-01T00:00:00,Thoracic Surgical Procedures,E04.928
24092499,2013-10-01T00:00:00,Government Regulation,I01.880.604.394
24092499,2013-10-01T00:00:00,Government Regulation,N03.706.358
24092499,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24092499,2013-10-01T00:00:00,United States,Z01.107.567.875
24098536,2013-10-01T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
24098536,2013-10-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
24098536,2013-10-01T00:00:00,Animals,B01.050
24098536,2013-10-01T00:00:00,Antineoplastic Agents,D27.505.954.248
24098536,2013-10-01T00:00:00,Apoptosis,G04.299.139.160
24098536,2013-10-01T00:00:00,Cell Cycle,G04.299.134
24098536,2013-10-01T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
24098536,2013-10-01T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
24098536,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24098536,2013-10-01T00:00:00,Lysophospholipids,D10.570.755.375.760.550
24098536,2013-10-01T00:00:00,PTEN Phosphohydrolase,D08.811.277.352.650.850
24098536,2013-10-01T00:00:00,PTEN Phosphohydrolase,D12.776.476.590
24098536,2013-10-01T00:00:00,PTEN Phosphohydrolase,D12.776.624.776.695
24098536,2013-10-01T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
24098536,2013-10-01T00:00:00,Prostatic Neoplasms,C12.294.260.750
24098536,2013-10-01T00:00:00,Prostatic Neoplasms,C12.294.565.625
24098536,2013-10-01T00:00:00,Prostatic Neoplasms,C12.758.409.750
24098536,2013-10-01T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
24098536,2013-10-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
24098536,2013-10-01T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
24098536,2013-10-01T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.260.698
24098536,2013-10-01T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.826
24098536,2013-10-01T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.930.669
24098536,2013-10-01T00:00:00,Signal Transduction,G02.111.087.800
24098536,2013-10-01T00:00:00,Signal Transduction,G02.149.115.800
24098536,2013-10-01T00:00:00,Signal Transduction,G04.299.880
24098536,2013-10-01T00:00:00,Sphingosine,D02.033.100.700
24098536,2013-10-01T00:00:00,Sphingosine,D02.033.455.843
24098536,2013-10-01T00:00:00,Sphingosine,D02.092.063.700
24116542,2013-10-01T00:00:00,Acoustic Stimulation,E02.037
24116542,2013-10-01T00:00:00,Acoustic Stimulation,E02.190.888.030
24116542,2013-10-01T00:00:00,Acoustic Stimulation,E05.723.136
24116542,2013-10-01T00:00:00,Adolescent,M01.060.057
24116542,2013-10-01T00:00:00,Adult,M01.060.116
24116542,2013-10-01T00:00:00,Auditory Threshold,F02.463.593.071.173
24116542,2013-10-01T00:00:00,Auditory Threshold,F02.463.593.710.190
24116542,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24116542,2013-10-01T00:00:00,Noise,G01.595.907.567
24116542,2013-10-01T00:00:00,Noise,G16.500.275.600
24116542,2013-10-01T00:00:00,Noise,N06.230.400
24116542,2013-10-01T00:00:00,Noise,N06.850.460.610
24116542,2013-10-01T00:00:00,"Pattern Recognition, Physiological",F02.463.593.524
24116542,2013-10-01T00:00:00,Perceptual Masking,F02.463.593.071.594
24116542,2013-10-01T00:00:00,Perceptual Masking,F02.463.593.932.733
24116542,2013-10-01T00:00:00,Speech Perception,F02.463.593.071.875
24116542,2013-10-01T00:00:00,Young Adult,M01.060.116.815
24145587,2013-10-01T00:00:00,Aged,M01.060.116.100
24145587,2013-10-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
24145587,2013-10-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
24145587,2013-10-01T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
24145587,2013-10-01T00:00:00,Disease Progression,C23.550.291.656
24145587,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24145587,2013-10-01T00:00:00,Interferon-alpha,D12.644.276.374.440.890.250
24145587,2013-10-01T00:00:00,Interferon-alpha,D12.644.276.718.500.250
24145587,2013-10-01T00:00:00,Interferon-alpha,D12.776.467.374.440.890.250
24145587,2013-10-01T00:00:00,Interferon-alpha,D12.776.467.718.500.250
24145587,2013-10-01T00:00:00,Interferon-alpha,D23.529.374.440.890.250
24145587,2013-10-01T00:00:00,Interferon-alpha,D23.529.718.500.250
24145587,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
24145587,2013-10-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
24145587,2013-10-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
24145587,2013-10-01T00:00:00,Salvage Therapy,E02.186.800
24145587,2013-10-01T00:00:00,Salvage Therapy,E02.895
24145587,2013-10-01T00:00:00,Treatment Outcome,E01.789.800
24145587,2013-10-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24145587,2013-10-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24145587,2013-10-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
24145587,2013-10-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
24145587,2013-10-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
24145587,2013-10-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
24145587,2013-10-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
24151000,2013-10-01T00:00:00,Adolescent,M01.060.057
24151000,2013-10-01T00:00:00,Adult,M01.060.116
24151000,2013-10-01T00:00:00,Aged,M01.060.116.100
24151000,2013-10-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
24151000,2013-10-01T00:00:00,Health Surveys,E05.318.308.250
24151000,2013-10-01T00:00:00,Health Surveys,N05.715.360.300.375
24151000,2013-10-01T00:00:00,Health Surveys,N06.850.520.308.250
24151000,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24151000,2013-10-01T00:00:00,Life Change Events,F01.829.458.410
24151000,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
24151000,2013-10-01T00:00:00,Prevalence,E05.318.308.985.525.750
24151000,2013-10-01T00:00:00,Prevalence,L01.280.975.525.750
24151000,2013-10-01T00:00:00,Prevalence,N01.224.935.597.750
24151000,2013-10-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
24151000,2013-10-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
24151000,2013-10-01T00:00:00,Sex Factors,N05.715.350.675
24151000,2013-10-01T00:00:00,Sex Factors,N06.850.490.875
24151000,2013-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
24151000,2013-10-01T00:00:00,United States,Z01.107.567.875
24151000,2013-10-01T00:00:00,Young Adult,M01.060.116.815
24151004,2013-10-01T00:00:00,Diagnostic and Statistical Manual of Mental Disorders,L01.453.245.945.200
24151004,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24151004,2013-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
24160982,2013-10-01T00:00:00,Adolescent,M01.060.057
24160982,2013-10-01T00:00:00,Corneal Stroma,A09.371.060.217.228
24160982,2013-10-01T00:00:00,Graft Rejection,G12.425.901.545.328
24160982,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24162125,2013-10-01T00:00:00,Bronchoscopy,E01.370.386.105
24162125,2013-10-01T00:00:00,Bronchoscopy,E01.370.388.250.100
24162125,2013-10-01T00:00:00,Bronchoscopy,E04.800.250.100
24162125,2013-10-01T00:00:00,Bronchoscopy,E04.928.600.080
24162125,2013-10-01T00:00:00,Fiber Optic Technology,H01.671.617.249
24162125,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24162125,2013-10-01T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
24162125,2013-10-01T00:00:00,"Signal Processing, Computer-Assisted",L01.224.800
24259698,2013-10-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
24259698,2013-10-01T00:00:00,Bacterial Infections,C01.252
24259698,2013-10-01T00:00:00,Daptomycin,D04.345.566.270
24259698,2013-10-01T00:00:00,Daptomycin,D10.477.500
24259698,2013-10-01T00:00:00,Daptomycin,D12.644.365.500
24259698,2013-10-01T00:00:00,Daptomycin,D12.644.641.270
24259698,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24259698,2013-10-01T00:00:00,Renal Dialysis,E02.870.300
24259698,2013-10-01T00:00:00,Renal Dialysis,E02.912.800
24274123,2013-10-01T00:00:00,"Adaptation, Psychological",F01.058
24274123,2013-10-01T00:00:00,Adult,M01.060.116
24274123,2013-10-01T00:00:00,Community Health Services,N02.421.143
24274123,2013-10-01T00:00:00,Cyclonic Storms,G16.500.240.135.500
24274123,2013-10-01T00:00:00,Disaster Planning,N06.230.100.035
24274123,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24274123,2013-10-01T00:00:00,Middle Aged,M01.060.116.630
24274123,2013-10-01T00:00:00,Questionnaires,E05.318.308.750
24274123,2013-10-01T00:00:00,Questionnaires,L01.280.800
24274123,2013-10-01T00:00:00,Questionnaires,N05.715.360.300.695
24274123,2013-10-01T00:00:00,Questionnaires,N06.850.520.308.750
24274123,2013-10-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
24274123,2013-10-01T00:00:00,Risk Assessment,N04.452.871.715
24274123,2013-10-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24274123,2013-10-01T00:00:00,Risk Assessment,N06.850.505.715
24274123,2013-10-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24274123,2013-10-01T00:00:00,Rural Population,N01.600.725
24274123,2013-10-01T00:00:00,Self-Help Groups,N03.540.782
24274123,2013-10-01T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
24274123,2013-10-01T00:00:00,Urban Population,N01.600.900
24274123,2013-10-01T00:00:00,Young Adult,M01.060.116.815
24279871,2013-10-01T00:00:00,Animals,B01.050
24279871,2013-10-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.486.485.114.224
24279871,2013-10-01T00:00:00,"Antibodies, Monoclonal",D12.776.124.790.651.114.224
24279871,2013-10-01T00:00:00,"Antibodies, Monoclonal",D12.776.377.715.548.114.224
24279871,2013-10-01T00:00:00,CD8-Positive T-Lymphocytes,A11.118.637.555.567.569.220
24279871,2013-10-01T00:00:00,CD8-Positive T-Lymphocytes,A15.145.229.637.555.567.569.220
24279871,2013-10-01T00:00:00,CD8-Positive T-Lymphocytes,A15.382.490.555.567.569.220
24279871,2013-10-01T00:00:00,Granulocyte Colony-Stimulating Factor,D12.644.276.374.410.240.350
24279871,2013-10-01T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.395.240.200
24279871,2013-10-01T00:00:00,Granulocyte Colony-Stimulating Factor,D12.776.467.374.410.240.350
24279871,2013-10-01T00:00:00,Granulocyte Colony-Stimulating Factor,D23.529.374.410.240.350
24279871,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24279871,2013-10-01T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
24279871,2013-10-01T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
24279871,2013-10-01T00:00:00,Myeloid Cells,A11.627
24327634,2013-10-01T00:00:00,Adolescent,M01.060.057
24327634,2013-10-01T00:00:00,Bioprosthesis,E07.695.100
24327634,2013-10-01T00:00:00,Device Removal,E04.199
24327634,2013-10-01T00:00:00,Heart Valve Prosthesis,E07.695.310
24327634,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24327634,2013-10-01T00:00:00,Prosthesis Failure,C23.550.767.865
24327634,2013-10-01T00:00:00,Prosthesis Failure,E05.325.771
24327634,2013-10-01T00:00:00,Reoperation,E04.690
24327634,2013-10-01T00:00:00,Young Adult,M01.060.116.815
24360490,2013-10-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
24360490,2013-10-01T00:00:00,"Arthroplasty, Replacement",E04.555.110.110
24360490,2013-10-01T00:00:00,"Arthroplasty, Replacement",E04.650.110
24360490,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24360490,2013-10-01T00:00:00,Joint Prosthesis,E07.695.400
24360490,2013-10-01T00:00:00,Reoperation,E04.690
24360497,2013-10-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
24360497,2013-10-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24360497,2013-10-01T00:00:00,Prosthesis-Related Infections,C01.539.685
24360497,2013-10-01T00:00:00,Prosthesis-Related Infections,C23.550.767.868
24502721,2013-10-01T00:00:00,Animals,B01.050
24502721,2013-10-01T00:00:00,New York,Z01.107.567.875.075.437
24502721,2013-10-01T00:00:00,New York,Z01.107.567.875.350.530
24502721,2013-10-01T00:00:00,New York,Z01.107.567.875.500.530
24502721,2013-10-01T00:00:00,Prevalence,E05.318.308.985.525.750
24502721,2013-10-01T00:00:00,Prevalence,L01.280.975.525.750
24502721,2013-10-01T00:00:00,Prevalence,N01.224.935.597.750
24502721,2013-10-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
24502721,2013-10-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
24502721,2013-10-01T00:00:00,Toxoplasma,B01.043.075.189.250.750.800
24502721,2013-10-01T00:00:00,"Toxoplasmosis, Animal",C03.701.688.817
24502721,2013-10-01T00:00:00,"Toxoplasmosis, Animal",C03.752.250.800.110
24502721,2013-10-01T00:00:00,"Toxoplasmosis, Animal",C03.752.625.817
24502721,2013-10-01T00:00:00,"Toxoplasmosis, Animal",C22.674.710.817
23881555,2013-10-02T00:00:00,Adolescent,M01.060.057
23881555,2013-10-02T00:00:00,Adult,M01.060.116
23881555,2013-10-02T00:00:00,Age Factors,N05.715.350.075
23881555,2013-10-02T00:00:00,Age Factors,N06.850.490.250
23881555,2013-10-02T00:00:00,Aged,M01.060.116.100
23881555,2013-10-02T00:00:00,Case-Control Studies,E05.318.760.500.500
23881555,2013-10-02T00:00:00,Case-Control Studies,N05.715.360.775.175.200
23881555,2013-10-02T00:00:00,Case-Control Studies,N06.850.520.450.500.500
23881555,2013-10-02T00:00:00,Child,M01.060.406
23881555,2013-10-02T00:00:00,"Child, Preschool",M01.060.406.448
23881555,2013-10-02T00:00:00,Head and Neck Neoplasms,C04.588.443
23881555,2013-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23881555,2013-10-02T00:00:00,Infant,M01.060.703
23881555,2013-10-02T00:00:00,Melanoma,C04.557.465.625.650.510
23881555,2013-10-02T00:00:00,Melanoma,C04.557.580.625.650.510
23881555,2013-10-02T00:00:00,Melanoma,C04.557.665.510
23881555,2013-10-02T00:00:00,Middle Aged,M01.060.116.630
23881555,2013-10-02T00:00:00,Skin Neoplasms,C04.588.805
23881555,2013-10-02T00:00:00,Skin Neoplasms,C17.800.882
23881555,2013-10-02T00:00:00,Young Adult,M01.060.116.815
24088981,2013-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24088981,2013-10-02T00:00:00,Spinal Fractures,C21.866.117.500.500
24088981,2013-10-02T00:00:00,Spinal Fractures,C21.866.404.812
24088981,2013-10-02T00:00:00,Spinal Fractures,C21.866.831.600
24267716,2013-10-02T00:00:00,Adolescent,M01.060.057
24267716,2013-10-02T00:00:00,Adult,M01.060.116
24267716,2013-10-02T00:00:00,Child,M01.060.406
24267716,2013-10-02T00:00:00,"Child, Preschool",M01.060.406.448
24267716,2013-10-02T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24267716,2013-10-02T00:00:00,Infant,M01.060.703
24267716,2013-10-02T00:00:00,"Infant, Newborn",M01.060.703.520
24267716,2013-10-02T00:00:00,Lung,A04.411
24267716,2013-10-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24267716,2013-10-02T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24267716,2013-10-02T00:00:00,Prenatal Diagnosis,E01.370.378.630
24267716,2013-10-02T00:00:00,Pulmonary Artery,A07.231.114.715
24267716,2013-10-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24267716,2013-10-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24267716,2013-10-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24267716,2013-10-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24267716,2013-10-02T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24490690,2013-10-02T00:00:00,Antioxidants,D27.505.519.217
24490690,2013-10-02T00:00:00,Antioxidants,D27.505.696.706.125
24490690,2013-10-02T00:00:00,Antioxidants,D27.720.799.047
24490690,2013-10-02T00:00:00,Copper,D01.268.556.195
24490690,2013-10-02T00:00:00,Copper,D01.268.956.170
24490690,2013-10-02T00:00:00,Copper,D01.552.544.195
24490690,2013-10-02T00:00:00,"Crystallography, X-Ray",E05.196.309.742.225
24490690,2013-10-02T00:00:00,Hydrogen Peroxide,D01.248.497.158.685.750.424
24490690,2013-10-02T00:00:00,Hydrogen Peroxide,D01.339.431.374.424
24490690,2013-10-02T00:00:00,Hydrogen Peroxide,D01.650.550.750.400
24490690,2013-10-02T00:00:00,"Models, Molecular",E05.599.595
24490690,2013-10-02T00:00:00,Molecular Structure,G02.111.570
24490690,2013-10-02T00:00:00,Molecular Structure,G02.575
24490690,2013-10-02T00:00:00,Molecular Structure,G02.842.575
24490690,2013-10-02T00:00:00,Organometallic Compounds,D01.632
24490690,2013-10-02T00:00:00,Organometallic Compounds,D02.691
24490690,2013-10-02T00:00:00,Selenium,D01.268.185.850
24490690,2013-10-02T00:00:00,Selenium,D01.578.700
24490690,2013-10-02T00:00:00,Sulfur,D01.268.185.900
24050758,2013-10-03T00:00:00,Animals,B01.050
24050758,2013-10-03T00:00:00,Brain,A08.186.211
24050758,2013-10-03T00:00:00,Gene Expression Regulation,G05.355.315
24050758,2013-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24050758,2013-10-03T00:00:00,Kidney,A05.810.453
24050758,2013-10-03T00:00:00,Polysaccharides,D09.698
24050758,2013-10-03T00:00:00,"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization",E05.196.566.755
24090055,2013-10-03T00:00:00,Clinical Trials as Topic,E05.318.760.535
24090055,2013-10-03T00:00:00,Clinical Trials as Topic,E05.337.250
24090055,2013-10-03T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
24090055,2013-10-03T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
24090055,2013-10-03T00:00:00,HIV Seropositivity,C02.782.815.616.400.500
24090055,2013-10-03T00:00:00,HIV Seropositivity,C02.800.801.400.500
24090055,2013-10-03T00:00:00,HIV Seropositivity,C20.673.480.500
24090055,2013-10-03T00:00:00,HIV-1,B04.820.650.589.650.350.400
24090055,2013-10-03T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
24090055,2013-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24090055,2013-10-03T00:00:00,Questionnaires,E05.318.308.750
24090055,2013-10-03T00:00:00,Questionnaires,L01.280.800
24090055,2013-10-03T00:00:00,Questionnaires,N05.715.360.300.695
24090055,2013-10-03T00:00:00,Questionnaires,N06.850.520.308.750
24090055,2013-10-03T00:00:00,Reverse Transcriptase Inhibitors,D27.505.519.389.675.850
24090055,2013-10-03T00:00:00,Reverse Transcriptase Inhibitors,D27.505.954.122.388.077.750
24092600,2013-10-03T00:00:00,Adolescent,M01.060.057
24092600,2013-10-03T00:00:00,Adult,M01.060.116
24092600,2013-10-03T00:00:00,Age Factors,N05.715.350.075
24092600,2013-10-03T00:00:00,Age Factors,N06.850.490.250
24092600,2013-10-03T00:00:00,Data Collection,E05.318.308
24092600,2013-10-03T00:00:00,Data Collection,L01.280
24092600,2013-10-03T00:00:00,Data Collection,N05.715.360.300
24092600,2013-10-03T00:00:00,Data Collection,N06.850.520.308
24092600,2013-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24092600,2013-10-03T00:00:00,Middle Aged,M01.060.116.630
24092600,2013-10-03T00:00:00,Smoking,F01.145.466.753
24092600,2013-10-03T00:00:00,United States,Z01.107.567.875
24092600,2013-10-03T00:00:00,Young Adult,M01.060.116.815
24094812,2013-10-03T00:00:00,Animals,B01.050
24094812,2013-10-03T00:00:00,Disease Progression,C23.550.291.656
24094812,2013-10-03T00:00:00,Gene Expression Profiling,E05.393.332
24094812,2013-10-03T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
24094812,2013-10-03T00:00:00,Glutamine,D12.125.068.330
24094812,2013-10-03T00:00:00,Glutamine,D12.125.095.461
24094812,2013-10-03T00:00:00,Glutamine,D12.125.154.424
24094812,2013-10-03T00:00:00,Glutathione,D12.644.456.448
24094812,2013-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24094812,2013-10-03T00:00:00,Reactive Oxygen Species,D01.339.431
24094812,2013-10-03T00:00:00,Reactive Oxygen Species,D01.650.775
24096033,2013-10-03T00:00:00,Animals,B01.050
24096033,2013-10-03T00:00:00,Homeostasis,G07.700.360
24096033,2013-10-03T00:00:00,Kidney,A05.810.453
24096033,2013-10-03T00:00:00,Kidney Tubules,A05.810.453.736.560
24096033,2013-10-03T00:00:00,Mitochondria,A11.284.430.214.190.875.564
24096033,2013-10-03T00:00:00,Mitochondria,A11.284.835.626
24096033,2013-10-03T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24096033,2013-10-03T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
24096033,2013-10-03T00:00:00,Recovery of Function,G16.757
24096033,2013-10-03T00:00:00,Reperfusion Injury,C14.907.725
24096033,2013-10-03T00:00:00,Reperfusion Injury,C23.550.767.877
24096033,2013-10-03T00:00:00,Transcription Factors,D12.776.930
24122180,2013-10-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24122180,2013-10-03T00:00:00,Rheumatology,H02.403.429.730
24122180,2013-10-03T00:00:00,"Scleroderma, Systemic",C17.300.799
24122180,2013-10-03T00:00:00,"Scleroderma, Systemic",C17.800.784
24122180,2013-10-03T00:00:00,Sensitivity and Specificity,E05.318.740.872
24122180,2013-10-03T00:00:00,Sensitivity and Specificity,E05.318.780.800
24122180,2013-10-03T00:00:00,Sensitivity and Specificity,G17.800
24122180,2013-10-03T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
24122180,2013-10-03T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
24122180,2013-10-03T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
24122180,2013-10-03T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24095648,2013-10-04T00:00:00,"Child, Preschool",M01.060.406.448
24095648,2013-10-04T00:00:00,Eye Diseases,C11
24095648,2013-10-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24095648,2013-10-04T00:00:00,Optic Disk,A08.800.800.120.680.660
24095648,2013-10-04T00:00:00,Optic Disk,A09.371.729.690
24095648,2013-10-04T00:00:00,Optic Nerve,A08.800.800.120.680
24092543,2013-10-05T00:00:00,Amino Acid Sequence,G02.111.570.060
24092543,2013-10-05T00:00:00,Amino Acid Sequence,L01.453.245.667.060
24092543,2013-10-05T00:00:00,Animals,B01.050
24092543,2013-10-05T00:00:00,Liver,A03.620
24092543,2013-10-05T00:00:00,Lysine,D12.125.068.555
24092543,2013-10-05T00:00:00,Lysine,D12.125.095.647
24092543,2013-10-05T00:00:00,Lysine,D12.125.142.497
24092543,2013-10-05T00:00:00,Molecular Sequence Data,L01.453.245.667
24092543,2013-10-05T00:00:00,Peroxisomes,A11.284.430.214.190.500.585.600
24092543,2013-10-05T00:00:00,Peroxisomes,A11.284.430.214.190.875.190.190.755.600
24092543,2013-10-05T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
24092543,2013-10-05T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
24092543,2013-10-05T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
24092543,2013-10-05T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
24092543,2013-10-05T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
24092543,2013-10-05T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
24092543,2013-10-05T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24092543,2013-10-05T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
24103233,2013-10-05T00:00:00,Advanced Cardiac Life Support,E02.365.647.110.500
24103233,2013-10-05T00:00:00,Guideline Adherence,N04.761.337
24103233,2013-10-05T00:00:00,Guideline Adherence,N05.715.360.395
24103233,2013-10-05T00:00:00,Heart Arrest,C14.280.383
24103233,2013-10-05T00:00:00,Hospitalization,E02.760.400
24103233,2013-10-05T00:00:00,Hospitalization,N02.421.585.400
24103233,2013-10-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24103233,2013-10-05T00:00:00,Middle Aged,M01.060.116.630
24097064,2013-10-06T00:00:00,"Cholesterol, HDL",D10.532.432.400
24097064,2013-10-06T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
24097064,2013-10-06T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
24097064,2013-10-06T00:00:00,"Cholesterol, LDL",D10.532.515.500
24097064,2013-10-06T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
24097064,2013-10-06T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
24097064,2013-10-06T00:00:00,Coronary Artery Disease,C14.280.647.250.260
24097064,2013-10-06T00:00:00,Coronary Artery Disease,C14.907.137.126.339
24097064,2013-10-06T00:00:00,Coronary Artery Disease,C14.907.585.250.260
24097064,2013-10-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24097064,2013-10-06T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
24097064,2013-10-06T00:00:00,Risk Factors,E05.318.740.600.800.725
24097064,2013-10-06T00:00:00,Risk Factors,N05.715.350.200.700
24097064,2013-10-06T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24097064,2013-10-06T00:00:00,Risk Factors,N06.850.490.625.750
24097064,2013-10-06T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24097068,2013-10-06T00:00:00,African Continental Ancestry Group,M01.686.508.100
24097068,2013-10-06T00:00:00,"Cholesterol, HDL",D10.532.432.400
24097068,2013-10-06T00:00:00,"Cholesterol, HDL",D10.570.938.208.270
24097068,2013-10-06T00:00:00,"Cholesterol, HDL",D12.776.521.479.470
24097068,2013-10-06T00:00:00,"Cholesterol, LDL",D10.532.515.500
24097068,2013-10-06T00:00:00,"Cholesterol, LDL",D10.570.938.208.275
24097068,2013-10-06T00:00:00,"Cholesterol, LDL",D12.776.521.550.500
24097068,2013-10-06T00:00:00,Coronary Artery Disease,C14.280.647.250.260
24097068,2013-10-06T00:00:00,Coronary Artery Disease,C14.907.137.126.339
24097068,2013-10-06T00:00:00,Coronary Artery Disease,C14.907.585.250.260
24097068,2013-10-06T00:00:00,European Continental Ancestry Group,M01.686.508.400
24097068,2013-10-06T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
24097068,2013-10-06T00:00:00,Genetic Predisposition to Disease,G05.380.355
24097068,2013-10-06T00:00:00,Genome-Wide Association Study,E05.318.416.249
24097068,2013-10-06T00:00:00,Genome-Wide Association Study,E05.318.780.392
24097068,2013-10-06T00:00:00,Genome-Wide Association Study,E05.393.385.500
24097068,2013-10-06T00:00:00,Genome-Wide Association Study,E05.393.522.500
24097068,2013-10-06T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
24097068,2013-10-06T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
24097068,2013-10-06T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
24097068,2013-10-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24097068,2013-10-06T00:00:00,Lipids,D10
24101764,2013-10-07T00:00:00,Adolescent,M01.060.057
24101764,2013-10-07T00:00:00,Ambulatory Care,E02.760.106
24101764,2013-10-07T00:00:00,Ambulatory Care,N02.421.585.106
24101764,2013-10-07T00:00:00,"Catheterization, Central Venous",E02.148.167
24101764,2013-10-07T00:00:00,Child,M01.060.406
24101764,2013-10-07T00:00:00,"Child, Preschool",M01.060.406.448
24101764,2013-10-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24101764,2013-10-07T00:00:00,Young Adult,M01.060.116.815
24106214,2013-10-08T00:00:00,Adult,M01.060.116
24106214,2013-10-08T00:00:00,Animals,B01.050
24106214,2013-10-08T00:00:00,Cell Proliferation,G04.299.233.750
24106214,2013-10-08T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24106214,2013-10-08T00:00:00,Enzyme Inhibitors,D27.505.519.389
24106214,2013-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24106214,2013-10-08T00:00:00,Lupus Nephritis,C12.777.419.570.363.680
24106214,2013-10-08T00:00:00,Lupus Nephritis,C13.351.968.419.570.363.680
24106214,2013-10-08T00:00:00,Lupus Nephritis,C17.300.480.680
24106214,2013-10-08T00:00:00,Lupus Nephritis,C20.111.590.560
24106214,2013-10-08T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.157.520.555
24106214,2013-10-08T00:00:00,"Mice, Inbred MRL lpr",B01.050.050.199.520.520.555
24106214,2013-10-08T00:00:00,"Mice, Inbred MRL lpr",B01.050.150.900.649.865.635.505.500.400.555
24106214,2013-10-08T00:00:00,Nitric Oxide Synthase Type III,D08.811.682.664.500.772.750
24106214,2013-10-08T00:00:00,Superoxides,D01.248.497.158.685.750.850
24106214,2013-10-08T00:00:00,Superoxides,D01.339.431.374.850
24106214,2013-10-08T00:00:00,Superoxides,D01.339.431.750
24106214,2013-10-08T00:00:00,Superoxides,D01.650.550.750.800
24106214,2013-10-08T00:00:00,Tyrosine,D12.125.072.050.875
24106214,2013-10-08T00:00:00,Young Adult,M01.060.116.815
24106283,2013-10-08T00:00:00,Animals,B01.050
24106283,2013-10-08T00:00:00,Dietary Supplements,J02.500.456
24106283,2013-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24106283,2013-10-08T00:00:00,Vitamin D,D04.808.812.768
24106283,2013-10-08T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
24113020,2013-10-08T00:00:00,Adult,M01.060.116
24113020,2013-10-08T00:00:00,Aged,M01.060.116.100
24113020,2013-10-08T00:00:00,Animals,B01.050
24113020,2013-10-08T00:00:00,"Blood Loss, Surgical",C23.550.414.300
24113020,2013-10-08T00:00:00,"Blood Loss, Surgical",C23.550.505.300
24113020,2013-10-08T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
24113020,2013-10-08T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
24113020,2013-10-08T00:00:00,Cattle,B01.050.150.900.649.077.380.271
24113020,2013-10-08T00:00:00,Hospital Mortality,E05.318.308.985.550.400
24113020,2013-10-08T00:00:00,Hospital Mortality,L01.280.975.550.400
24113020,2013-10-08T00:00:00,Hospital Mortality,N01.224.935.698.400
24113020,2013-10-08T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
24113020,2013-10-08T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
24113020,2013-10-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24113020,2013-10-08T00:00:00,Middle Aged,M01.060.116.630
24113020,2013-10-08T00:00:00,Pericardium,A07.541.795
24113020,2013-10-08T00:00:00,Pericardium,A10.615.789.470
24113020,2013-10-08T00:00:00,Risk Factors,E05.318.740.600.800.725
24113020,2013-10-08T00:00:00,Risk Factors,N05.715.350.200.700
24113020,2013-10-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24113020,2013-10-08T00:00:00,Risk Factors,N06.850.490.625.750
24113020,2013-10-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24113020,2013-10-08T00:00:00,Salvage Therapy,E02.186.800
24113020,2013-10-08T00:00:00,Salvage Therapy,E02.895
24113020,2013-10-08T00:00:00,Treatment Outcome,E01.789.800
24113020,2013-10-08T00:00:00,Treatment Outcome,N04.761.559.590.800
24113020,2013-10-08T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24113020,2013-10-08T00:00:00,Young Adult,M01.060.116.815
24024552,2013-10-09T00:00:00,Animals,B01.050
24024552,2013-10-09T00:00:00,Cell Line,A11.251.210
24024552,2013-10-09T00:00:00,Gene Expression Regulation,G05.355.315
24024552,2013-10-09T00:00:00,Melanins,D12.125.072.050.875.379
24024552,2013-10-09T00:00:00,Melanins,D23.767.620
24024552,2013-10-09T00:00:00,Melanosomes,A11.284.430.214.190.500.560
24024552,2013-10-09T00:00:00,Melanosomes,A11.284.430.214.190.875.190.190.560
24024552,2013-10-09T00:00:00,Melanosomes,A11.436.265.531.560
24024552,2013-10-09T00:00:00,Melanosomes,A11.436.613.560
24024552,2013-10-09T00:00:00,Membrane Glycoproteins,D12.776.395.550
24024552,2013-10-09T00:00:00,Membrane Glycoproteins,D12.776.543.550
24024552,2013-10-09T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
24024552,2013-10-09T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
24030463,2013-10-09T00:00:00,Astrocytes,A08.637.200
24030463,2013-10-09T00:00:00,Astrocytes,A11.650.200
24030463,2013-10-09T00:00:00,Enzyme Inhibitors,D27.505.519.389
24030463,2013-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.205.352
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.252.420
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.300.480.525.700.150
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.205.352
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.252.420
24030463,2013-10-09T00:00:00,Matrix Metalloproteinase 2,D08.811.277.656.675.374.525.700.150
24030463,2013-10-09T00:00:00,NF-kappa B,D12.776.260.600
24030463,2013-10-09T00:00:00,NF-kappa B,D12.776.660.600
24030463,2013-10-09T00:00:00,NF-kappa B,D12.776.930.600
24030463,2013-10-09T00:00:00,Optic Disk,A08.800.800.120.680.660
24030463,2013-10-09T00:00:00,Optic Disk,A09.371.729.690
24030463,2013-10-09T00:00:00,Piperazines,D03.383.606
24030463,2013-10-09T00:00:00,Sesquiterpenes,D02.455.849.765
24030463,2013-10-09T00:00:00,Signal Transduction,G02.111.087.800
24030463,2013-10-09T00:00:00,Signal Transduction,G02.149.115.800
24030463,2013-10-09T00:00:00,Signal Transduction,G04.299.880
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
24030463,2013-10-09T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
24030463,2013-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
24030463,2013-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
24030463,2013-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
24030463,2013-10-09T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
24107863,2013-10-09T00:00:00,Adult,M01.060.116
24107863,2013-10-09T00:00:00,Electroencephalography,E01.370.376.300
24107863,2013-10-09T00:00:00,Electroencephalography,E01.370.405.245
24107863,2013-10-09T00:00:00,"Epilepsy, Temporal Lobe",C10.228.140.490.360.290
24107863,2013-10-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24107863,2013-10-09T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
24107863,2013-10-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24107863,2013-10-09T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24107863,2013-10-09T00:00:00,Middle Aged,M01.060.116.630
24107863,2013-10-09T00:00:00,Neural Pathways,A08.612
24126464,2013-10-09T00:00:00,Acid Ceramidase,D08.811.277.087.250.100
24126464,2013-10-09T00:00:00,Animals,B01.050
24126464,2013-10-09T00:00:00,Apoptosis,G04.299.139.160
24126464,2013-10-09T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
24126464,2013-10-09T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
24126464,2013-10-09T00:00:00,Ceramides,D02.065.313
24126464,2013-10-09T00:00:00,Ceramides,D09.400.410.420.525.200
24126464,2013-10-09T00:00:00,Ceramides,D10.390.470.675.200
24126464,2013-10-09T00:00:00,Ceramides,D10.570.877.360.612.200
24126464,2013-10-09T00:00:00,Head and Neck Neoplasms,C04.588.443
24126464,2013-10-09T00:00:00,Mitochondria,A11.284.430.214.190.875.564
24126464,2013-10-09T00:00:00,Mitochondria,A11.284.835.626
24126464,2013-10-09T00:00:00,Oxidoreductases,D08.811.682
24126464,2013-10-09T00:00:00,Photochemotherapy,E02.186.500
24126464,2013-10-09T00:00:00,Photochemotherapy,E02.319.685
24126464,2013-10-09T00:00:00,Photochemotherapy,E02.774.722
24126464,2013-10-09T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
24126464,2013-10-09T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
24126464,2013-10-09T00:00:00,Pyrimidines,D03.383.742
24126464,2013-10-09T00:00:00,"RNA, Messenger",D13.444.735.544
24126464,2013-10-09T00:00:00,Sphingosine,D02.033.100.700
24126464,2013-10-09T00:00:00,Sphingosine,D02.033.455.843
24126464,2013-10-09T00:00:00,Sphingosine,D02.092.063.700
24111805,2013-10-10T00:00:00,HIV Infections,C02.782.815.616.400
24111805,2013-10-10T00:00:00,HIV Infections,C02.800.801.400
24111805,2013-10-10T00:00:00,HIV Infections,C20.673.480
24111805,2013-10-10T00:00:00,HIV-1,B04.820.650.589.650.350.400
24111805,2013-10-10T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
24111805,2013-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24111805,2013-10-10T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
24111805,2013-10-10T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
24111805,2013-10-10T00:00:00,Patient Satisfaction,N04.452.822.360.600
24111805,2013-10-10T00:00:00,Patient Satisfaction,N05.300.150.600.630
24111805,2013-10-10T00:00:00,Patient Satisfaction,N05.715.360.600
24111805,2013-10-10T00:00:00,Reverse Transcriptase Inhibitors,D27.505.519.389.675.850
24111805,2013-10-10T00:00:00,Reverse Transcriptase Inhibitors,D27.505.954.122.388.077.750
24112846,2013-10-10T00:00:00,Catheterization,E02.148
24112846,2013-10-10T00:00:00,Catheterization,E05.157
24112846,2013-10-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.350.700.715.200.200
24112846,2013-10-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.200.200
24112846,2013-10-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.372.250.200
24112846,2013-10-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E01.370.388.250.250.160
24112846,2013-10-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.210.240.160
24112846,2013-10-10T00:00:00,"Cholangiopancreatography, Endoscopic Retrograde",E04.800.250.250.160
24112846,2013-10-10T00:00:00,Hospitalization,E02.760.400
24112846,2013-10-10T00:00:00,Hospitalization,N02.421.585.400
24112846,2013-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24112846,2013-10-10T00:00:00,Pancreatitis,C06.689.750
24112846,2013-10-10T00:00:00,"Quality Assurance, Health Care",N04.761.700
24112846,2013-10-10T00:00:00,"Quality Assurance, Health Care",N05.700
24112846,2013-10-10T00:00:00,"Sphincterotomy, Endoscopic",E04.210.120.850
24112846,2013-10-10T00:00:00,"Sphincterotomy, Endoscopic",E04.210.240.250.840
24112846,2013-10-10T00:00:00,"Sphincterotomy, Endoscopic",E04.800.250.250.250.840
24113829,2013-10-10T00:00:00,Animals,B01.050
24113829,2013-10-10T00:00:00,Cochlea,A09.246.631.246
24113829,2013-10-10T00:00:00,Cochlear Nerve,A08.800.800.120.910.120
24113829,2013-10-10T00:00:00,Enzyme Inhibitors,D27.505.519.389
24113829,2013-10-10T00:00:00,"Mice, Inbred CBA",B01.050.050.157.520.440
24113829,2013-10-10T00:00:00,"Mice, Inbred CBA",B01.050.050.199.520.520.440
24113829,2013-10-10T00:00:00,"Mice, Inbred CBA",B01.050.150.900.649.865.635.505.500.400.440
24113829,2013-10-10T00:00:00,Neuronal Plasticity,G11.561.600.635
24113829,2013-10-10T00:00:00,Organ of Corti,A09.246.631.246.577
24113829,2013-10-10T00:00:00,Synapses,A08.850
24113829,2013-10-10T00:00:00,Synapses,A11.284.149.165.420.780
24130510,2013-10-10T00:00:00,Alleles,G05.360.340.024.340.030
24130510,2013-10-10T00:00:00,European Continental Ancestry Group,M01.686.508.400
24130510,2013-10-10T00:00:00,Gene Expression Regulation,G05.355.315
24130510,2013-10-10T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
24130510,2013-10-10T00:00:00,Genetic Predisposition to Disease,G05.380.355
24130510,2013-10-10T00:00:00,Genome-Wide Association Study,E05.318.416.249
24130510,2013-10-10T00:00:00,Genome-Wide Association Study,E05.318.780.392
24130510,2013-10-10T00:00:00,Genome-Wide Association Study,E05.393.385.500
24130510,2013-10-10T00:00:00,Genome-Wide Association Study,E05.393.522.500
24130510,2013-10-10T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
24130510,2013-10-10T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
24130510,2013-10-10T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
24130510,2013-10-10T00:00:00,Hispanic Americans,M01.686.754.441
24130510,2013-10-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24130510,2013-10-10T00:00:00,Interleukin-10,D12.644.276.374.465.510
24130510,2013-10-10T00:00:00,Interleukin-10,D12.776.467.374.465.510
24130510,2013-10-10T00:00:00,Interleukin-10,D23.529.374.465.510
24130510,2013-10-10T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
24130510,2013-10-10T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
24130510,2013-10-10T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
24030458,2013-10-11T00:00:00,Animals,B01.050
24030458,2013-10-11T00:00:00,Aqueous Humor,A09.371.060.067.070
24030458,2013-10-11T00:00:00,Aqueous Humor,A12.207.270.040
24030458,2013-10-11T00:00:00,Eye Proteins,D12.776.306
24030458,2013-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24030458,2013-10-11T00:00:00,Serpins,D12.644.822.750
24030458,2013-10-11T00:00:00,Serpins,D12.644.861
24030458,2013-10-11T00:00:00,Serpins,D12.776.645.750
24030458,2013-10-11T00:00:00,Serpins,D12.776.872
24030458,2013-10-11T00:00:00,Swine,B01.050.150.900.649.077.880
24030458,2013-10-11T00:00:00,Trabecular Meshwork,A09.371.060.932
24121493,2013-10-11T00:00:00,Animals,B01.050
24121493,2013-10-11T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
24121493,2013-10-11T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
24121493,2013-10-11T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
24121493,2013-10-11T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
24121493,2013-10-11T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
24121493,2013-10-11T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
24121493,2013-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24121493,2013-10-11T00:00:00,Lung Neoplasms,C04.588.894.797.520
24121493,2013-10-11T00:00:00,Lung Neoplasms,C08.381.540
24121493,2013-10-11T00:00:00,Lung Neoplasms,C08.785.520
24121493,2013-10-11T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
24121493,2013-10-11T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
24121493,2013-10-11T00:00:00,Neuropilin-2,D12.776.543.750.055.750
24121493,2013-10-11T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
24121493,2013-10-11T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
24121493,2013-10-11T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
24121493,2013-10-11T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
24121493,2013-10-11T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
24121493,2013-10-11T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
24121493,2013-10-11T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
24121493,2013-10-11T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
24121493,2013-10-11T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
24147033,2013-10-11T00:00:00,Animals,B01.050
24147033,2013-10-11T00:00:00,Bone Morphogenetic Protein 2,D12.644.276.954.200.200
24147033,2013-10-11T00:00:00,Bone Morphogenetic Protein 2,D12.776.467.942.200.200
24147033,2013-10-11T00:00:00,Bone Morphogenetic Protein 2,D23.529.942.200.200
24147033,2013-10-11T00:00:00,Cell Movement,G04.299.283
24147033,2013-10-11T00:00:00,Cell Movement,G07.700.560.500.180
24147033,2013-10-11T00:00:00,Chick Embryo,A13.350.150
24147033,2013-10-11T00:00:00,Chick Embryo,A16.331.200
24147033,2013-10-11T00:00:00,Endocardial Cushions,A07.541.459.374
24147033,2013-10-11T00:00:00,Endocardial Cushions,A16.378.303.662
24147033,2013-10-11T00:00:00,Gene Expression,G05.355.310
24147033,2013-10-11T00:00:00,Hyaluronic Acid,D09.698.373.475
24147033,2013-10-11T00:00:00,Mesoderm,A16.504.660
24147033,2013-10-11T00:00:00,RNA Interference,G05.355.315.203.374.790
24147033,2013-10-11T00:00:00,"RNA, Messenger",D13.444.735.544
24147033,2013-10-11T00:00:00,Versicans,D09.698.735.830.750
24147033,2013-10-11T00:00:00,Versicans,D12.776.395.650.750.750
24147033,2013-10-11T00:00:00,Versicans,D12.776.503.280.625
24267245,2013-10-11T00:00:00,Adolescent,M01.060.057
24267245,2013-10-11T00:00:00,Adult,M01.060.116
24267245,2013-10-11T00:00:00,Atherosclerosis,C14.907.137.126.307
24267245,2013-10-11T00:00:00,Blood Pressure,E01.370.600.875.249
24267245,2013-10-11T00:00:00,Blood Pressure,G09.330.380.076
24267245,2013-10-11T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
24267245,2013-10-11T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
24267245,2013-10-11T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
24267245,2013-10-11T00:00:00,Disease Progression,C23.550.291.656
24267245,2013-10-11T00:00:00,"Glycosylation End Products, Advanced",D02.415
24267245,2013-10-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24267245,2013-10-11T00:00:00,"Lipoproteins, LDL",D10.532.515
24267245,2013-10-11T00:00:00,"Lipoproteins, LDL",D12.776.521.550
24267245,2013-10-11T00:00:00,Prevalence,E05.318.308.985.525.750
24267245,2013-10-11T00:00:00,Prevalence,L01.280.975.525.750
24267245,2013-10-11T00:00:00,Prevalence,N01.224.935.597.750
24267245,2013-10-11T00:00:00,Prevalence,N06.850.505.400.975.525.750
24267245,2013-10-11T00:00:00,Prevalence,N06.850.520.308.985.525.750
24267245,2013-10-11T00:00:00,Regression Analysis,E05.318.740.750
24267245,2013-10-11T00:00:00,Regression Analysis,N05.715.360.750.695
24267245,2013-10-11T00:00:00,Regression Analysis,N06.850.520.830.750
24267245,2013-10-11T00:00:00,Young Adult,M01.060.116.815
24125796,2013-10-14T00:00:00,Aged,M01.060.116.100
24125796,2013-10-14T00:00:00,Combined Modality Therapy,E02.186
24125796,2013-10-14T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
24125796,2013-10-14T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
24125796,2013-10-14T00:00:00,"Defibrillators, Implantable",E07.695.175
24125796,2013-10-14T00:00:00,Heart Failure,C14.280.434
24125796,2013-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24125796,2013-10-14T00:00:00,Middle Aged,M01.060.116.630
24125796,2013-10-14T00:00:00,Quality of Life,I01.800
24125796,2013-10-14T00:00:00,Quality of Life,K01.752.400.750
24125796,2013-10-14T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
24125796,2013-10-14T00:00:00,Ventricular Remodeling,C23.300.985
24125796,2013-10-14T00:00:00,Ventricular Remodeling,G09.330.190.962.975
24135468,2013-10-14T00:00:00,Calcinosis,C18.452.174.130
24135468,2013-10-14T00:00:00,"Endoscopy, Digestive System",E01.370.372.250
24135468,2013-10-14T00:00:00,"Endoscopy, Digestive System",E01.370.388.250.250
24135468,2013-10-14T00:00:00,"Endoscopy, Digestive System",E04.210.240
24135468,2013-10-14T00:00:00,"Endoscopy, Digestive System",E04.800.250.250
24135468,2013-10-14T00:00:00,Gastric Mucosa,A03.556.875.875.440
24135468,2013-10-14T00:00:00,Gastric Mucosa,A10.615.550.291
24135468,2013-10-14T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
24135468,2013-10-14T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
24135468,2013-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24135468,2013-10-14T00:00:00,Intestinal Mucosa,A03.556.124.369
24135468,2013-10-14T00:00:00,Intestinal Mucosa,A10.615.550.444
24135468,2013-10-14T00:00:00,Middle Aged,M01.060.116.630
24159200,2013-10-14T00:00:00,"Education, Pharmacy",I02.358.525
24159200,2013-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24290522,2013-10-14T00:00:00,Cervical Vertebrae,A02.835.232.834.151
24290522,2013-10-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24290522,2013-10-14T00:00:00,Postoperative Care,E02.760.722.700
24290522,2013-10-14T00:00:00,Postoperative Care,E04.624
24290522,2013-10-14T00:00:00,Postoperative Care,N02.421.585.722.700
24290522,2013-10-14T00:00:00,Spinal Fusion,E04.555.100.700
24126660,2013-10-15T00:00:00,Anticonvulsants,D27.505.954.427.080
24126660,2013-10-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24126660,2013-10-15T00:00:00,Migraine Disorders,C10.228.140.546.399.750
24139952,2013-10-16T00:00:00,Brain,A08.186.211
24139952,2013-10-16T00:00:00,Headache,C10.597.617.470
24139952,2013-10-16T00:00:00,Headache,C23.888.592.612.441
24139952,2013-10-16T00:00:00,Headache,C23.888.646.487
24139952,2013-10-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24139952,2013-10-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24139952,2013-10-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24139952,2013-10-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24139952,2013-10-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24139952,2013-10-16T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24139952,2013-10-16T00:00:00,Young Adult,M01.060.116.815
24287126,2013-10-16T00:00:00,Activities of Daily Living,E02.831.067
24287126,2013-10-16T00:00:00,Activities of Daily Living,I03.050
24287126,2013-10-16T00:00:00,Activities of Daily Living,N02.421.784.110
24287126,2013-10-16T00:00:00,Adolescent,M01.060.057
24287126,2013-10-16T00:00:00,Adult,M01.060.116
24287126,2013-10-16T00:00:00,Aged,M01.060.116.100
24287126,2013-10-16T00:00:00,Child,M01.060.406
24287126,2013-10-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24287126,2013-10-16T00:00:00,Middle Aged,M01.060.116.630
24287126,2013-10-16T00:00:00,Musculoskeletal Diseases,C05
24287126,2013-10-16T00:00:00,Orthopedic Procedures,E02.718
24287126,2013-10-16T00:00:00,Orthopedic Procedures,E04.555
24287126,2013-10-16T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
24287126,2013-10-16T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
24287126,2013-10-16T00:00:00,Patient Satisfaction,N04.452.822.360.600
24287126,2013-10-16T00:00:00,Patient Satisfaction,N05.300.150.600.630
24287126,2013-10-16T00:00:00,Patient Satisfaction,N05.715.360.600
24287126,2013-10-16T00:00:00,Patient-Centered Care,N04.590.233.675
24287126,2013-10-16T00:00:00,Patient-Centered Care,N04.590.233.727.407
24287126,2013-10-16T00:00:00,Patient-Centered Care,N04.590.720
24287126,2013-10-16T00:00:00,Quality of Life,I01.800
24287126,2013-10-16T00:00:00,Quality of Life,K01.752.400.750
24287126,2013-10-16T00:00:00,Questionnaires,E05.318.308.750
24287126,2013-10-16T00:00:00,Questionnaires,L01.280.800
24287126,2013-10-16T00:00:00,Questionnaires,N05.715.360.300.695
24287126,2013-10-16T00:00:00,Questionnaires,N06.850.520.308.750
24287126,2013-10-16T00:00:00,United States,Z01.107.567.875
24287126,2013-10-16T00:00:00,Young Adult,M01.060.116.815
23737458,2013-10-17T00:00:00,Cardiology,H02.403.429.163
23737458,2013-10-17T00:00:00,Cardiovascular Diseases,C14
23737458,2013-10-17T00:00:00,Certification,N03.706.110.120
23737458,2013-10-17T00:00:00,Certification,N05.700.200.190
23737458,2013-10-17T00:00:00,Clinical Competence,I02.399.630.210
23737458,2013-10-17T00:00:00,Clinical Competence,N04.761.210
23737458,2013-10-17T00:00:00,Computer Simulation,L01.224.160
23737458,2013-10-17T00:00:00,Computer-Assisted Instruction,I02.903.573.208
23737458,2013-10-17T00:00:00,Diagnostic Imaging,E01.370.350
23737458,2013-10-17T00:00:00,"Education, Medical, Graduate",I02.358.337.350
23737458,2013-10-17T00:00:00,"Education, Medical, Graduate",I02.358.399.350
23737458,2013-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23737458,2013-10-17T00:00:00,Internship and Residency,I02.358.399.644
23737458,2013-10-17T00:00:00,"Models, Cardiovascular",E05.599.395.161
23737458,2013-10-17T00:00:00,"Societies, Medical",N03.540.828.589
23737458,2013-10-17T00:00:00,Teaching,I02.903
24131474,2013-10-17T00:00:00,Cardiac Surgical Procedures,E04.100.376
24131474,2013-10-17T00:00:00,Cardiac Surgical Procedures,E04.928.220
24131474,2013-10-17T00:00:00,"Child, Preschool",M01.060.406.448
24131474,2013-10-17T00:00:00,Echocardiography,E01.370.350.850.220
24131474,2013-10-17T00:00:00,Echocardiography,E01.370.370.380.220
24131474,2013-10-17T00:00:00,Heart Ventricles,A07.541.560
24131474,2013-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24131474,2013-10-17T00:00:00,Prosthesis Implantation,E04.650
24131474,2013-10-17T00:00:00,Septal Occluder Device,E07.695.715
24131474,2013-10-17T00:00:00,Treatment Outcome,E01.789.800
24131474,2013-10-17T00:00:00,Treatment Outcome,N04.761.559.590.800
24131474,2013-10-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24136618,2013-10-17T00:00:00,Adolescent,M01.060.057
24136618,2013-10-17T00:00:00,Child,M01.060.406
24136618,2013-10-17T00:00:00,"Child Development Disorders, Pervasive",F03.550.325
24136618,2013-10-17T00:00:00,"Child, Preschool",M01.060.406.448
24136618,2013-10-17T00:00:00,Chromosome Disorders,C16.131.260
24136618,2013-10-17T00:00:00,Chromosome Disorders,C16.320.180
24136618,2013-10-17T00:00:00,Developmental Disabilities,F03.550.362
24136618,2013-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24136618,2013-10-17T00:00:00,Infant,M01.060.703
24136618,2013-10-17T00:00:00,Nerve Tissue Proteins,D12.776.641
24136644,2013-10-17T00:00:00,Brain,A08.186.211
24136644,2013-10-17T00:00:00,Brain Mapping,E01.370.350.086
24136644,2013-10-17T00:00:00,Brain Mapping,E01.370.376.149
24136644,2013-10-17T00:00:00,Brain Mapping,E05.132
24136644,2013-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24136644,2013-10-17T00:00:00,Image Enhancement,E01.370.350.600.350
24136644,2013-10-17T00:00:00,Image Enhancement,L01.224.308.380
24136644,2013-10-17T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
24136644,2013-10-17T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
24136644,2013-10-17T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
24136644,2013-10-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24136644,2013-10-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24136926,2013-10-17T00:00:00,Adult,M01.060.116
24136926,2013-10-17T00:00:00,Aged,M01.060.116.100
24136926,2013-10-17T00:00:00,Executive Function,F02.463.217
24136926,2013-10-17T00:00:00,Gastric Bypass,E02.065.062.249
24136926,2013-10-17T00:00:00,Gastric Bypass,E04.035.398.385
24136926,2013-10-17T00:00:00,Gastric Bypass,E04.062.249
24136926,2013-10-17T00:00:00,Gastric Bypass,E04.210.457.430
24136926,2013-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24136926,2013-10-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24136926,2013-10-17T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24136926,2013-10-17T00:00:00,Middle Aged,M01.060.116.630
24136926,2013-10-17T00:00:00,Motivation,F01.658
24136926,2013-10-17T00:00:00,Motivation,F01.752.543.500.750
24136926,2013-10-17T00:00:00,"Obesity, Morbid",C18.654.726.500.700
24136926,2013-10-17T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
24136926,2013-10-17T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
24136926,2013-10-17T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
24136926,2013-10-17T00:00:00,Treatment Outcome,E01.789.800
24136926,2013-10-17T00:00:00,Treatment Outcome,N04.761.559.590.800
24136926,2013-10-17T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24136926,2013-10-17T00:00:00,Weight Loss,C23.888.144.243.963
24136926,2013-10-17T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
24136926,2013-10-17T00:00:00,Young Adult,M01.060.116.815
24138792,2013-10-17T00:00:00,Curriculum,I02.158
24138792,2013-10-17T00:00:00,"Education, Medical, Graduate",I02.358.337.350
24138792,2013-10-17T00:00:00,"Education, Medical, Graduate",I02.358.399.350
24138792,2013-10-17T00:00:00,"Faculty, Medical",I02.463.373
24138792,2013-10-17T00:00:00,"Faculty, Medical",M01.526.339.373
24138792,2013-10-17T00:00:00,"Faculty, Medical",M01.526.485.375
24138792,2013-10-17T00:00:00,"Faculty, Medical",N02.360.375
24138792,2013-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24138792,2013-10-17T00:00:00,Internship and Residency,I02.358.399.644
24138792,2013-10-17T00:00:00,Organizational Objectives,N04.452.615
24138792,2013-10-17T00:00:00,Personnel Staffing and Scheduling,N04.452.677.650
24138792,2013-10-17T00:00:00,Program Development,N04.452.760
24138792,2013-10-17T00:00:00,Program Evaluation,E05.337.820
24138792,2013-10-17T00:00:00,Program Evaluation,N04.761.685
24138792,2013-10-17T00:00:00,Program Evaluation,N05.715.360.650
24138792,2013-10-17T00:00:00,Teaching,I02.903
24138792,2013-10-17T00:00:00,Thoracic Surgical Procedures,E04.928
24138792,2013-10-17T00:00:00,Workload,N04.452.677.950
24141489,2013-10-17T00:00:00,Acetylcysteine,D02.886.030.230.259
24141489,2013-10-17T00:00:00,Acetylcysteine,D12.125.166.230.259
24141489,2013-10-17T00:00:00,Antioxidants,D27.505.519.217
24141489,2013-10-17T00:00:00,Antioxidants,D27.505.696.706.125
24141489,2013-10-17T00:00:00,Antioxidants,D27.720.799.047
24141489,2013-10-17T00:00:00,Apoptosis,G04.299.139.160
24141489,2013-10-17T00:00:00,"Carcinoma, Non-Small-Cell Lung",C04.588.894.797.520.109.220.249
24141489,2013-10-17T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.381.540.140.500
24141489,2013-10-17T00:00:00,"Carcinoma, Non-Small-Cell Lung",C08.785.520.100.220.500
24141489,2013-10-17T00:00:00,Cell Aging,G04.299.119
24141489,2013-10-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24141489,2013-10-17T00:00:00,Lung Neoplasms,C04.588.894.797.520
24141489,2013-10-17T00:00:00,Lung Neoplasms,C08.381.540
24141489,2013-10-17T00:00:00,Lung Neoplasms,C08.785.520
24141489,2013-10-17T00:00:00,Proto-Oncogene Proteins c-akt,D08.811.913.696.620.682.700.755
24141489,2013-10-17T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.476.565
24141489,2013-10-17T00:00:00,Proto-Oncogene Proteins c-akt,D12.776.624.664.700.168
24141489,2013-10-17T00:00:00,Radiation-Sensitizing Agents,D27.505.696.750
24141489,2013-10-17T00:00:00,Reactive Oxygen Species,D01.339.431
24141489,2013-10-17T00:00:00,Reactive Oxygen Species,D01.650.775
24141489,2013-10-17T00:00:00,Stilbenes,D02.455.426.559.389.150.700
24141489,2013-10-17T00:00:00,beta-Galactosidase,D08.811.277.450.410.100
24138447,2013-10-18T00:00:00,Adolescent,M01.060.057
24138447,2013-10-18T00:00:00,Brain,A08.186.211
24138447,2013-10-18T00:00:00,Brain Mapping,E01.370.350.086
24138447,2013-10-18T00:00:00,Brain Mapping,E01.370.376.149
24138447,2013-10-18T00:00:00,Brain Mapping,E05.132
24138447,2013-10-18T00:00:00,Empathy,F01.752.355
24138447,2013-10-18T00:00:00,Empathy,F01.752.543.500.500
24138447,2013-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24138447,2013-10-18T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
24138447,2013-10-18T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
24138447,2013-10-18T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
24138447,2013-10-18T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24138447,2013-10-18T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24138447,2013-10-18T00:00:00,Young Adult,M01.060.116.815
24140934,2013-10-18T00:00:00,Apoptosis,G04.299.139.160
24140934,2013-10-18T00:00:00,Cell Proliferation,G04.299.233.750
24140934,2013-10-18T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24140934,2013-10-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24140934,2013-10-18T00:00:00,Lysophospholipids,D10.570.755.375.760.550
24140934,2013-10-18T00:00:00,Phosphotransferases (Alcohol Group Acceptor),D08.811.913.696.620
24140934,2013-10-18T00:00:00,Signal Transduction,G02.111.087.800
24140934,2013-10-18T00:00:00,Signal Transduction,G02.149.115.800
24140934,2013-10-18T00:00:00,Signal Transduction,G04.299.880
24140934,2013-10-18T00:00:00,Sphingosine,D02.033.100.700
24140934,2013-10-18T00:00:00,Sphingosine,D02.033.455.843
24140934,2013-10-18T00:00:00,Sphingosine,D02.092.063.700
24252852,2013-10-18T00:00:00,"Anastomosis, Surgical",E04.035
24252852,2013-10-18T00:00:00,Animals,B01.050
24252852,2013-10-18T00:00:00,Blood Vessel Prosthesis,E07.695.110
24252852,2013-10-18T00:00:00,Liver,A03.620
24252852,2013-10-18T00:00:00,Liver Transplantation,E04.210.650
24252852,2013-10-18T00:00:00,Liver Transplantation,E04.936.450.490
24252852,2013-10-18T00:00:00,Liver Transplantation,E04.936.580.490
24252852,2013-10-18T00:00:00,"Models, Animal",E05.598
24252852,2013-10-18T00:00:00,Stents,E07.695.750
24252852,2013-10-18T00:00:00,Vascular Patency,G09.330.920
24252852,2013-10-18T00:00:00,Vascular Surgical Procedures,E04.100.814
24239836,2013-10-19T00:00:00,Alleles,G05.360.340.024.340.030
24239836,2013-10-19T00:00:00,Asthma,C08.127.108
24239836,2013-10-19T00:00:00,Asthma,C08.381.495.108
24239836,2013-10-19T00:00:00,Asthma,C08.674.095
24239836,2013-10-19T00:00:00,Asthma,C20.543.480.680.095
24239836,2013-10-19T00:00:00,Autoimmunity,G12.450.192
24239836,2013-10-19T00:00:00,B-Lymphocytes,A11.063.438
24239836,2013-10-19T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
24239836,2013-10-19T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
24239836,2013-10-19T00:00:00,B-Lymphocytes,A15.382.032.438
24239836,2013-10-19T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
24239836,2013-10-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24239836,2013-10-19T00:00:00,Immunoglobulin G,D12.776.124.486.485.114.619.393
24239836,2013-10-19T00:00:00,Immunoglobulin G,D12.776.124.790.651.114.619.393
24239836,2013-10-19T00:00:00,Immunoglobulin G,D12.776.377.715.548.114.619.393
24239836,2013-10-19T00:00:00,Neoplasms,C04
24239836,2013-10-19T00:00:00,Protein Isoforms,D12.776.800
24141716,2013-10-20T00:00:00,Heart,A07.541
24141716,2013-10-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24141716,2013-10-20T00:00:00,Iodine,D01.268.380.400
24141716,2013-10-20T00:00:00,Myocardium,A02.633.580
24141716,2013-10-20T00:00:00,Myocardium,A07.541.704
24141716,2013-10-20T00:00:00,Myocardium,A10.690.552.750
24141716,2013-10-20T00:00:00,"Phantoms, Imaging",E07.671
24141716,2013-10-20T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.600.350.700.700
24141716,2013-10-20T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.700.700.700
24141716,2013-10-20T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.760.700
24141716,2013-10-20T00:00:00,"Radiography, Dual-Energy Scanned Projection",L01.224.308.380.800
24141716,2013-10-20T00:00:00,Software,L01.224.900
24151141,2013-10-21T00:00:00,Adult,M01.060.116
24151141,2013-10-21T00:00:00,Disability Evaluation,E01.370.400
24151141,2013-10-21T00:00:00,Evidence-Based Medicine,H02.249.750
24151141,2013-10-21T00:00:00,Evidence-Based Medicine,H02.403.200.400
24151141,2013-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24151141,2013-10-21T00:00:00,Implosive Therapy,F04.754.137.506.325
24151141,2013-10-21T00:00:00,Patient Compliance,F01.145.488.500
24151141,2013-10-21T00:00:00,Patient Compliance,N05.300.150.600.600
24151141,2013-10-21T00:00:00,Patient Dropouts,M01.643.673
24151141,2013-10-21T00:00:00,Psychiatric Status Rating Scales,F04.586
24151141,2013-10-21T00:00:00,Social Support,I01.880.656.600
24151141,2013-10-21T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
24151141,2013-10-21T00:00:00,Veterans,M01.930
24151141,2013-10-21T00:00:00,Young Adult,M01.060.116.815
24411753,2013-10-21T00:00:00,Adult,M01.060.116
24411753,2013-10-21T00:00:00,Behavior Therapy,F04.754.137
24411753,2013-10-21T00:00:00,Blood Glucose,D09.546.359.448.500
24411753,2013-10-21T00:00:00,Blood Pressure,E01.370.600.875.249
24411753,2013-10-21T00:00:00,Blood Pressure,G09.330.380.076
24411753,2013-10-21T00:00:00,Cardiovascular Diseases,C14
24411753,2013-10-21T00:00:00,Cholesterol,D04.808.247.222.284
24411753,2013-10-21T00:00:00,Cholesterol,D04.808.247.808.197
24411753,2013-10-21T00:00:00,Cholesterol,D10.570.938.208
24411753,2013-10-21T00:00:00,Cholesterol,D10.851.208
24411753,2013-10-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24411753,2013-10-21T00:00:00,Middle Aged,M01.060.116.630
24411753,2013-10-21T00:00:00,Program Evaluation,E05.337.820
24411753,2013-10-21T00:00:00,Program Evaluation,N04.761.685
24411753,2013-10-21T00:00:00,Program Evaluation,N05.715.360.650
24411753,2013-10-21T00:00:00,Risk Factors,E05.318.740.600.800.725
24411753,2013-10-21T00:00:00,Risk Factors,N05.715.350.200.700
24411753,2013-10-21T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24411753,2013-10-21T00:00:00,Risk Factors,N06.850.490.625.750
24411753,2013-10-21T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24411753,2013-10-21T00:00:00,Treatment Outcome,E01.789.800
24411753,2013-10-21T00:00:00,Treatment Outcome,N04.761.559.590.800
24411753,2013-10-21T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24411753,2013-10-21T00:00:00,Weight Loss,C23.888.144.243.963
24411753,2013-10-21T00:00:00,Weight Loss,G07.700.320.249.314.120.200.963
24122763,2013-10-22T00:00:00,Catheter Ablation,E01.370.370.380.410.200
24122763,2013-10-22T00:00:00,Catheter Ablation,E02.148.110
24122763,2013-10-22T00:00:00,Catheter Ablation,E02.148.442.110
24122763,2013-10-22T00:00:00,Catheter Ablation,E02.154.402.110
24122763,2013-10-22T00:00:00,Catheter Ablation,E04.014.170.402.110
24122763,2013-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24146092,2013-10-22T00:00:00,Cell Adhesion Molecules,D12.776.395.550.200
24146092,2013-10-22T00:00:00,Cell Adhesion Molecules,D12.776.543.550.200
24146092,2013-10-22T00:00:00,Cell Adhesion Molecules,D23.050.301.350
24146092,2013-10-22T00:00:00,Cell Differentiation,G04.299.151
24146092,2013-10-22T00:00:00,Extracellular Matrix,A11.284.295.310
24146092,2013-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24146092,2013-10-22T00:00:00,Neoplasms,C04
24146092,2013-10-22T00:00:00,Regeneration,G16.100.856
24146092,2013-10-22T00:00:00,Wound Healing,G16.100.856.891
24157932,2013-10-22T00:00:00,Animals,B01.050
24157932,2013-10-22T00:00:00,Apoptosis,G04.299.139.160
24157932,2013-10-22T00:00:00,Cell Line,A11.251.210
24157932,2013-10-22T00:00:00,Gene Expression Regulation,G05.355.315
24157932,2013-10-22T00:00:00,MicroRNAs,D13.150.650.319
24157932,2013-10-22T00:00:00,MicroRNAs,D13.444.735.150.319
24157932,2013-10-22T00:00:00,MicroRNAs,D13.444.735.790.099
24157932,2013-10-22T00:00:00,Motor Neurons,A08.663.655.500
24157932,2013-10-22T00:00:00,Motor Neurons,A11.671.655.500
24157932,2013-10-22T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24157932,2013-10-22T00:00:00,"Receptors, Estrogen",D12.776.260.698.750.350
24157932,2013-10-22T00:00:00,"Receptors, Estrogen",D12.776.826.750.350
24157932,2013-10-22T00:00:00,"Receptors, Estrogen",D12.776.930.669.750.350
24157932,2013-10-22T00:00:00,Spinal Cord,A08.186.854
24296098,2013-10-22T00:00:00,Adult,M01.060.116
24296098,2013-10-22T00:00:00,Anticoagulants,D27.505.954.502.119
24296098,2013-10-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24296098,2013-10-22T00:00:00,Middle Aged,M01.060.116.630
24296098,2013-10-22T00:00:00,Risk Factors,E05.318.740.600.800.725
24296098,2013-10-22T00:00:00,Risk Factors,N05.715.350.200.700
24296098,2013-10-22T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24296098,2013-10-22T00:00:00,Risk Factors,N06.850.490.625.750
24296098,2013-10-22T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24296098,2013-10-22T00:00:00,Treatment Outcome,E01.789.800
24296098,2013-10-22T00:00:00,Treatment Outcome,N04.761.559.590.800
24296098,2013-10-22T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24296098,2013-10-22T00:00:00,Venous Thromboembolism,C14.907.355.590.700
24296098,2013-10-22T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
24296098,2013-10-22T00:00:00,Wounds and Injuries,C21.866
24147514,2013-10-23T00:00:00,Algorithms,G17.035
24147514,2013-10-23T00:00:00,Algorithms,L01.224.050
24147514,2013-10-23T00:00:00,Antihypertensive Agents,D27.505.954.411.162
24147514,2013-10-23T00:00:00,Blood Pressure,E01.370.600.875.249
24147514,2013-10-23T00:00:00,Blood Pressure,G09.330.380.076
24147514,2013-10-23T00:00:00,Drug Resistance,G07.690.320
24147514,2013-10-23T00:00:00,Evidence-Based Medicine,H02.249.750
24147514,2013-10-23T00:00:00,Evidence-Based Medicine,H02.403.200.400
24147514,2013-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24147514,2013-10-23T00:00:00,Hypertension,C14.907.489
24147514,2013-10-23T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
24147514,2013-10-23T00:00:00,Practice Guidelines as Topic,N05.700.350.650
24147514,2013-10-23T00:00:00,Treatment Outcome,E01.789.800
24147514,2013-10-23T00:00:00,Treatment Outcome,N04.761.559.590.800
24147514,2013-10-23T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24161272,2013-10-23T00:00:00,Adult,M01.060.116
24161272,2013-10-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24161272,2013-10-23T00:00:00,Risk Factors,E05.318.740.600.800.725
24161272,2013-10-23T00:00:00,Risk Factors,N05.715.350.200.700
24161272,2013-10-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24161272,2013-10-23T00:00:00,Risk Factors,N06.850.490.625.750
24161272,2013-10-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24161272,2013-10-23T00:00:00,Spinal Cord Injuries,C10.228.854.770
24161272,2013-10-23T00:00:00,Spinal Cord Injuries,C10.900.850
24161272,2013-10-23T00:00:00,Spinal Cord Injuries,C21.866.819
24161272,2013-10-23T00:00:00,Suicide,F01.145.126.980.875
24161272,2013-10-23T00:00:00,Suicide,I01.880.735.856
24161272,2013-10-23T00:00:00,United States,Z01.107.567.875
24157525,2013-10-24T00:00:00,Animals,B01.050
24157525,2013-10-24T00:00:00,Anoxia,C23.888.852.079
24157525,2013-10-24T00:00:00,"Calcium Channels, L-Type",D12.776.157.530.400.150.400
24157525,2013-10-24T00:00:00,"Calcium Channels, L-Type",D12.776.543.550.425.150.400
24157525,2013-10-24T00:00:00,"Calcium Channels, L-Type",D12.776.543.585.400.150.400
24157525,2013-10-24T00:00:00,"Myocytes, Cardiac",A07.541.704.570
24157525,2013-10-24T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
24157525,2013-10-24T00:00:00,"Myocytes, Cardiac",A11.620.500
24157525,2013-10-24T00:00:00,Oxygen,D01.268.185.550
24157525,2013-10-24T00:00:00,Oxygen,D01.362.670
24157525,2013-10-24T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24157525,2013-10-24T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
24156309,2013-10-25T00:00:00,African Americans,M01.686.508.100.100
24156309,2013-10-25T00:00:00,African Americans,M01.686.754.100
24156309,2013-10-25T00:00:00,Aged,M01.060.116.100
24156309,2013-10-25T00:00:00,Body Mass Index,E01.370.600.115.100.125
24156309,2013-10-25T00:00:00,Body Mass Index,E05.041.124.125
24156309,2013-10-25T00:00:00,Body Mass Index,G07.100.100.125
24156309,2013-10-25T00:00:00,Body Mass Index,N06.850.505.200.100.175
24156309,2013-10-25T00:00:00,European Continental Ancestry Group,M01.686.508.400
24156309,2013-10-25T00:00:00,Health Behavior,F01.145.488
24156309,2013-10-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24156309,2013-10-25T00:00:00,Middle Aged,M01.060.116.630
24156309,2013-10-25T00:00:00,Motor Activity,F01.145.632
24156309,2013-10-25T00:00:00,Motor Activity,G11.427.590.530.698
24156309,2013-10-25T00:00:00,Patient Compliance,F01.145.488.500
24156309,2013-10-25T00:00:00,Patient Compliance,N05.300.150.600.600
24156309,2013-10-25T00:00:00,Sedentary Lifestyle,F01.829.458.705
24163074,2013-10-25T00:00:00,Animals,B01.050
24163074,2013-10-25T00:00:00,Apoptosis,G04.299.139.160
24163074,2013-10-25T00:00:00,Cyclosporine,D04.345.566.235.300
24163074,2013-10-25T00:00:00,Cyclosporine,D12.644.641.235.300
24163074,2013-10-25T00:00:00,Myocardial Infarction,C14.280.647.500
24163074,2013-10-25T00:00:00,Myocardial Infarction,C14.907.585.500
24163074,2013-10-25T00:00:00,Stroke Volume,E01.370.370.380.150.700
24163074,2013-10-25T00:00:00,Stroke Volume,G09.330.380.124.882
24163074,2013-10-25T00:00:00,Ventricular Remodeling,C23.300.985
24163074,2013-10-25T00:00:00,Ventricular Remodeling,G09.330.190.962.975
24496870,2013-10-25T00:00:00,Counseling,F02.784.176
24496870,2013-10-25T00:00:00,Counseling,F04.408.413
24496870,2013-10-25T00:00:00,Counseling,N02.421.143.303
24496870,2013-10-25T00:00:00,Counseling,N02.421.461.363
24496870,2013-10-25T00:00:00,Electronic Health Records,E05.318.308.940.968.625.500
24496870,2013-10-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24496870,2013-10-25T00:00:00,Neoplasms,C04
24496870,2013-10-25T00:00:00,Questionnaires,E05.318.308.750
24496870,2013-10-25T00:00:00,Questionnaires,L01.280.800
24496870,2013-10-25T00:00:00,Questionnaires,N05.715.360.300.695
24496870,2013-10-25T00:00:00,Questionnaires,N06.850.520.308.750
24496870,2013-10-25T00:00:00,Smoking Cessation,F01.145.940.700
24168957,2013-10-26T00:00:00,Adult,M01.060.116
24168957,2013-10-26T00:00:00,Aged,M01.060.116.100
24168957,2013-10-26T00:00:00,Angioplasty,E02.148.050
24168957,2013-10-26T00:00:00,Angioplasty,E04.100.814.050
24168957,2013-10-26T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
24168957,2013-10-26T00:00:00,Carotid Stenosis,C14.907.137.230
24168957,2013-10-26T00:00:00,Carotid Stenosis,C14.907.253.123.360
24168957,2013-10-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24168957,2013-10-26T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
24168957,2013-10-26T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
24168957,2013-10-26T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
24168957,2013-10-26T00:00:00,"Ischemic Attack, Transient",C10.228.140.300.150.836
24168957,2013-10-26T00:00:00,"Ischemic Attack, Transient",C14.907.253.092.836
24168957,2013-10-26T00:00:00,Middle Aged,M01.060.116.630
24168957,2013-10-26T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
24168957,2013-10-26T00:00:00,Secondary Prevention,N02.421.726.825
24168957,2013-10-26T00:00:00,Secondary Prevention,N06.850.780.750
24168957,2013-10-26T00:00:00,Stents,E07.695.750
24168957,2013-10-26T00:00:00,Stroke,C10.228.140.300.775
24168957,2013-10-26T00:00:00,Stroke,C14.907.253.855
24168957,2013-10-26T00:00:00,Ticlopidine,D02.886.778.834
24168957,2013-10-26T00:00:00,Ticlopidine,D03.383.903.834
24168957,2013-10-26T00:00:00,Treatment Outcome,E01.789.800
24168957,2013-10-26T00:00:00,Treatment Outcome,N04.761.559.590.800
24168957,2013-10-26T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24164863,2013-10-27T00:00:00,Adult,M01.060.116
24164863,2013-10-27T00:00:00,Aged,M01.060.116.100
24164863,2013-10-27T00:00:00,"Arrhythmias, Cardiac",C14.280.067
24164863,2013-10-27T00:00:00,"Arrhythmias, Cardiac",C23.550.073
24164863,2013-10-27T00:00:00,Case-Control Studies,E05.318.760.500.500
24164863,2013-10-27T00:00:00,Case-Control Studies,N05.715.360.775.175.200
24164863,2013-10-27T00:00:00,Case-Control Studies,N06.850.520.450.500.500
24164863,2013-10-27T00:00:00,Clinical Trials as Topic,E05.318.760.535
24164863,2013-10-27T00:00:00,Clinical Trials as Topic,E05.337.250
24164863,2013-10-27T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
24164863,2013-10-27T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
24164863,2013-10-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24164863,2013-10-27T00:00:00,"Hypertrophy, Left Ventricular",C14.280.195.400
24164863,2013-10-27T00:00:00,"Hypertrophy, Left Ventricular",C23.300.775.250.400
24164863,2013-10-27T00:00:00,Middle Aged,M01.060.116.630
24164863,2013-10-27T00:00:00,Peptide Fragments,D12.644.541
24164863,2013-10-27T00:00:00,Stroke Volume,E01.370.370.380.150.700
24164863,2013-10-27T00:00:00,Stroke Volume,G09.330.380.124.882
24164863,2013-10-27T00:00:00,"Ventricular Dysfunction, Left",C14.280.945.900
23857456,2013-10-28T00:00:00,Colonoscopy,E01.370.372.250.250.200
23857456,2013-10-28T00:00:00,Colonoscopy,E01.370.388.250.250.250.160
23857456,2013-10-28T00:00:00,Colonoscopy,E04.210.240.250.160
23857456,2013-10-28T00:00:00,Colonoscopy,E04.800.250.250.250.160
23857456,2013-10-28T00:00:00,Early Detection of Cancer,E01.390.500
23857456,2013-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23857456,2013-10-28T00:00:00,Propofol,D02.755.773
24164441,2013-10-28T00:00:00,Aged,M01.060.116.100
24164441,2013-10-28T00:00:00,Chronic Disease,C23.550.291.500
24164441,2013-10-28T00:00:00,Disability Evaluation,E01.370.400
24164441,2013-10-28T00:00:00,Exercise Test,E01.370.370.380.250
24164441,2013-10-28T00:00:00,Exercise Test,E01.370.386.700.250
24164441,2013-10-28T00:00:00,Exercise Test,E05.333.250
24164441,2013-10-28T00:00:00,Gait,E01.370.600.250
24164441,2013-10-28T00:00:00,Gait,G11.427.590.530.389
24164441,2013-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24164441,2013-10-28T00:00:00,Middle Aged,M01.060.116.630
24164441,2013-10-28T00:00:00,Psychometrics,F04.711.780
24164441,2013-10-28T00:00:00,Stroke,C10.228.140.300.775
24164441,2013-10-28T00:00:00,Stroke,C14.907.253.855
24164441,2013-10-28T00:00:00,Walking,G11.427.590.530.568.900
24164441,2013-10-28T00:00:00,Walking,G11.427.590.530.698.940
24164441,2013-10-28T00:00:00,Walking,I03.450.642.845.940
24165813,2013-10-28T00:00:00,Adult,M01.060.116
24165813,2013-10-28T00:00:00,Aged,M01.060.116.100
24165813,2013-10-28T00:00:00,Bile Duct Neoplasms,C04.588.274.120.250
24165813,2013-10-28T00:00:00,Bile Duct Neoplasms,C06.130.120.120
24165813,2013-10-28T00:00:00,Bile Duct Neoplasms,C06.130.320.120
24165813,2013-10-28T00:00:00,Bile Duct Neoplasms,C06.301.120.250
24165813,2013-10-28T00:00:00,"Bile Ducts, Intrahepatic",A03.159.183.158
24165813,2013-10-28T00:00:00,"Bile Ducts, Intrahepatic",A03.620.150
24165813,2013-10-28T00:00:00,Cholangiocarcinoma,C04.557.470.200.025.450
24165813,2013-10-28T00:00:00,Hepatectomy,E04.210.556
24165813,2013-10-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24165813,2013-10-28T00:00:00,Liver Transplantation,E04.210.650
24165813,2013-10-28T00:00:00,Liver Transplantation,E04.936.450.490
24165813,2013-10-28T00:00:00,Liver Transplantation,E04.936.580.490
24165813,2013-10-28T00:00:00,Middle Aged,M01.060.116.630
24165813,2013-10-28T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
24165813,2013-10-28T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
24165813,2013-10-28T00:00:00,Pancreaticoduodenectomy,E04.210.760
24165813,2013-10-28T00:00:00,Preoperative Care,E02.760.795
24165813,2013-10-28T00:00:00,Preoperative Care,E04.641
24165813,2013-10-28T00:00:00,Preoperative Care,N02.421.585.795
24165813,2013-10-28T00:00:00,Treatment Outcome,E01.789.800
24165813,2013-10-28T00:00:00,Treatment Outcome,N04.761.559.590.800
24165813,2013-10-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24176725,2013-10-28T00:00:00,Animals,B01.050
24176725,2013-10-28T00:00:00,Cattle,B01.050.150.900.649.077.380.271
24176725,2013-10-28T00:00:00,Cell Survival,G04.299.316
24176725,2013-10-28T00:00:00,Iron,D01.268.556.412
24176725,2013-10-28T00:00:00,Iron,D01.268.956.287
24176725,2013-10-28T00:00:00,Iron,D01.552.544.412
24176725,2013-10-28T00:00:00,Oxides,D01.248.497.158.685
24176725,2013-10-28T00:00:00,Oxides,D01.650.550
24176725,2013-10-28T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24176725,2013-10-28T00:00:00,"Spheroids, Cellular",A11.251.800
24176725,2013-10-28T00:00:00,Tissue Engineering,E05.200.249.750
24165872,2013-10-29T00:00:00,Aged,M01.060.116.100
24165872,2013-10-29T00:00:00,Blood Transfusion,E02.095.135
24165872,2013-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24165872,2013-10-29T00:00:00,Length of Stay,E02.760.400.480
24165872,2013-10-29T00:00:00,Length of Stay,N02.421.585.400.480
24165872,2013-10-29T00:00:00,Pancreatectomy,E04.210.752
24165872,2013-10-29T00:00:00,Pancreatic Neoplasms,C04.588.274.761
24165872,2013-10-29T00:00:00,Pancreatic Neoplasms,C04.588.322.421
24165872,2013-10-29T00:00:00,Pancreatic Neoplasms,C06.301.761
24165872,2013-10-29T00:00:00,Pancreatic Neoplasms,C06.689.667
24165872,2013-10-29T00:00:00,Pancreatic Neoplasms,C19.344.421
24165872,2013-10-29T00:00:00,Pancreaticoduodenectomy,E04.210.760
24165872,2013-10-29T00:00:00,Surgical Wound Infection,C01.539.947.692
24165872,2013-10-29T00:00:00,Surgical Wound Infection,C23.550.767.925
24165872,2013-10-29T00:00:00,Treatment Outcome,E01.789.800
24165872,2013-10-29T00:00:00,Treatment Outcome,N04.761.559.590.800
24165872,2013-10-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24165872,2013-10-29T00:00:00,United States,Z01.107.567.875
24166409,2013-10-29T00:00:00,"Adaptor Proteins, Signal Transducing",D12.644.360.024
24166409,2013-10-29T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.157.057
24166409,2013-10-29T00:00:00,"Adaptor Proteins, Signal Transducing",D12.776.476.024
24166409,2013-10-29T00:00:00,African Americans,M01.686.508.100.100
24166409,2013-10-29T00:00:00,African Americans,M01.686.754.100
24166409,2013-10-29T00:00:00,Alcoholism,C21.739.100.250
24166409,2013-10-29T00:00:00,Alcoholism,F03.900.100.350
24166409,2013-10-29T00:00:00,Eukaryotic Initiation Factors,D12.776.835.725.868
24166409,2013-10-29T00:00:00,European Continental Ancestry Group,M01.686.508.400
24166409,2013-10-29T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
24166409,2013-10-29T00:00:00,Genetic Predisposition to Disease,G05.380.355
24166409,2013-10-29T00:00:00,Genome-Wide Association Study,E05.318.416.249
24166409,2013-10-29T00:00:00,Genome-Wide Association Study,E05.318.780.392
24166409,2013-10-29T00:00:00,Genome-Wide Association Study,E05.393.385.500
24166409,2013-10-29T00:00:00,Genome-Wide Association Study,E05.393.522.500
24166409,2013-10-29T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
24166409,2013-10-29T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
24166409,2013-10-29T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
24166409,2013-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24166409,2013-10-29T00:00:00,Mitochondrial Proteins,D12.776.575
24166409,2013-10-29T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
24166409,2013-10-29T00:00:00,Psychiatric Status Rating Scales,F04.586
24166409,2013-10-29T00:00:00,United States,Z01.107.567.875
24166409,2013-10-29T00:00:00,Vesicular Transport Proteins,D12.776.543.990
24169147,2013-10-29T00:00:00,Aged,M01.060.116.100
24169147,2013-10-29T00:00:00,Alzheimer Disease,C10.228.140.380.100
24169147,2013-10-29T00:00:00,Alzheimer Disease,C10.574.945.249
24169147,2013-10-29T00:00:00,Alzheimer Disease,F03.087.400.100
24169147,2013-10-29T00:00:00,Attention,F02.830.104.214
24169147,2013-10-29T00:00:00,Central Nervous System Stimulants,D27.505.696.282
24169147,2013-10-29T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
24169147,2013-10-29T00:00:00,Drug Monitoring,E01.370.520.200
24169147,2013-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24169147,2013-10-29T00:00:00,Methylphenidate,D02.241.223.601.600
24169147,2013-10-29T00:00:00,Methylphenidate,D03.383.621.460
24169147,2013-10-29T00:00:00,Neuropsychological Tests,F04.711.513
24169147,2013-10-29T00:00:00,Psychiatric Status Rating Scales,F04.586
24169147,2013-10-29T00:00:00,Treatment Outcome,E01.789.800
24169147,2013-10-29T00:00:00,Treatment Outcome,N04.761.559.590.800
24169147,2013-10-29T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24169812,2013-10-29T00:00:00,Alcohol Drinking,F01.145.317.269
24169812,2013-10-29T00:00:00,Health Behavior,F01.145.488
24169812,2013-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24169812,2013-10-29T00:00:00,Middle Aged,M01.060.116.630
24169812,2013-10-29T00:00:00,Pain,C10.597.617
24169812,2013-10-29T00:00:00,Pain,C23.888.592.612
24169812,2013-10-29T00:00:00,Pain,C23.888.646
24169812,2013-10-29T00:00:00,Pain,F02.830.816.444
24169812,2013-10-29T00:00:00,Pain,G11.561.600.810.444
24169812,2013-10-29T00:00:00,Questionnaires,E05.318.308.750
24169812,2013-10-29T00:00:00,Questionnaires,L01.280.800
24169812,2013-10-29T00:00:00,Questionnaires,N05.715.360.300.695
24169812,2013-10-29T00:00:00,Questionnaires,N06.850.520.308.750
24169812,2013-10-29T00:00:00,Risk Factors,E05.318.740.600.800.725
24169812,2013-10-29T00:00:00,Risk Factors,N05.715.350.200.700
24169812,2013-10-29T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24169812,2013-10-29T00:00:00,Risk Factors,N06.850.490.625.750
24169812,2013-10-29T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24169812,2013-10-29T00:00:00,Smoking,F01.145.466.753
24169812,2013-10-29T00:00:00,Smoking Cessation,F01.145.940.700
24169812,2013-10-29T00:00:00,Spinal Cord Injuries,C10.228.854.770
24169812,2013-10-29T00:00:00,Spinal Cord Injuries,C10.900.850
24169812,2013-10-29T00:00:00,Spinal Cord Injuries,C21.866.819
24169812,2013-10-29T00:00:00,Substance-Related Disorders,C21.739
24169812,2013-10-29T00:00:00,Substance-Related Disorders,F03.900
24170578,2013-10-29T00:00:00,Hospitals,N02.278.421
24170578,2013-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24170578,2013-10-29T00:00:00,Interprofessional Relations,F01.829.401.205
24170578,2013-10-29T00:00:00,Malnutrition,C18.654.521
24170578,2013-10-29T00:00:00,Nutritional Sciences,H02.533
24170578,2013-10-29T00:00:00,Patient Care Team,N04.590.715
24176601,2013-10-29T00:00:00,Attitude of Health Personnel,F01.100.050
24176601,2013-10-29T00:00:00,Attitude of Health Personnel,N05.300.100
24176601,2013-10-29T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
24176601,2013-10-29T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
24176601,2013-10-29T00:00:00,Health Personnel,M01.526.485
24176601,2013-10-29T00:00:00,Health Personnel,N02.360
24176601,2013-10-29T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24176601,2013-10-29T00:00:00,Influenza Vaccines,D20.215.894.899.302
24176601,2013-10-29T00:00:00,"Influenza, Human",C02.782.620.365
24176601,2013-10-29T00:00:00,"Influenza, Human",C08.730.310
24176601,2013-10-29T00:00:00,United States,Z01.107.567.875
24176601,2013-10-29T00:00:00,Vaccination,E02.095.465.425.400.530.890
24176601,2013-10-29T00:00:00,Vaccination,E05.478.550.600.890
24176601,2013-10-29T00:00:00,Vaccination,N02.421.726.758.310.890
24176601,2013-10-29T00:00:00,Vaccination,N06.850.780.200.425.900
24176601,2013-10-29T00:00:00,Vaccination,N06.850.780.680.310.890
24204762,2013-10-29T00:00:00,Actins,D05.750.078.730.250
24204762,2013-10-29T00:00:00,Actins,D12.776.210.500.100
24204762,2013-10-29T00:00:00,Actins,D12.776.220.525.255
24204762,2013-10-29T00:00:00,Animals,B01.050
24204762,2013-10-29T00:00:00,Cell Differentiation,G04.299.151
24204762,2013-10-29T00:00:00,Cell Movement,G04.299.283
24204762,2013-10-29T00:00:00,Cell Movement,G07.700.560.500.180
24204762,2013-10-29T00:00:00,Cell Proliferation,G04.299.233.750
24204762,2013-10-29T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24204762,2013-10-29T00:00:00,Drug-Induced Liver Injury,C06.552.195
24204762,2013-10-29T00:00:00,Drug-Induced Liver Injury,C21.613.260
24204762,2013-10-29T00:00:00,Gene Expression Regulation,G05.355.315
24204762,2013-10-29T00:00:00,Hepatic Stellate Cells,A11.561
24204762,2013-10-29T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
24204762,2013-10-29T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
24204762,2013-10-29T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
24204762,2013-10-29T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
24204762,2013-10-29T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
24204762,2013-10-29T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
24204762,2013-10-29T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
24204762,2013-10-29T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
24204762,2013-10-29T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24204762,2013-10-29T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
24204762,2013-10-29T00:00:00,Signal Transduction,G02.111.087.800
24204762,2013-10-29T00:00:00,Signal Transduction,G02.149.115.800
24204762,2013-10-29T00:00:00,Signal Transduction,G04.299.880
24204762,2013-10-29T00:00:00,Wound Healing,G16.100.856.891
24184245,2013-10-30T00:00:00,Aged,M01.060.116.100
24184245,2013-10-30T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.220.220.220
24184245,2013-10-30T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.220.220
24184245,2013-10-30T00:00:00,"Echocardiography, Doppler, Color",E01.370.350.850.850.850.850.220
24184245,2013-10-30T00:00:00,"Echocardiography, Doppler, Color",E01.370.370.380.220.220.220
24184245,2013-10-30T00:00:00,Heart Failure,C14.280.434
24184245,2013-10-30T00:00:00,Heart Ventricles,A07.541.560
24184245,2013-10-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24184245,2013-10-30T00:00:00,Middle Aged,M01.060.116.630
24184245,2013-10-30T00:00:00,Stroke Volume,E01.370.370.380.150.700
24184245,2013-10-30T00:00:00,Stroke Volume,G09.330.380.124.882
24184245,2013-10-30T00:00:00,"Ventricular Function, Left",G09.330.190.962.800
24183699,2013-10-31T00:00:00,Animals,B01.050
24183699,2013-10-31T00:00:00,Cell Survival,G04.299.316
24183699,2013-10-31T00:00:00,Fibroblasts,A11.329.228
24183699,2013-10-31T00:00:00,Fibroblasts,A11.872.228
24183699,2013-10-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24183699,2013-10-31T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
24183699,2013-10-31T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24183699,2013-10-31T00:00:00,"Spheroids, Cellular",A11.251.800
24183699,2013-10-31T00:00:00,Stem Cells,A11.872
24183699,2013-10-31T00:00:00,Tissue Engineering,E05.200.249.750
23370085,2013-11-01T00:00:00,Adolescent,M01.060.057
23370085,2013-11-01T00:00:00,Adult,M01.060.116
23370085,2013-11-01T00:00:00,Aged,M01.060.116.100
23370085,2013-11-01T00:00:00,"Analgesia, Patient-Controlled",E03.091.120
23370085,2013-11-01T00:00:00,"Analgesics, Opioid",D27.505.696.663.850.014.520
23370085,2013-11-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.040.325
23370085,2013-11-01T00:00:00,"Analgesics, Opioid",D27.505.954.427.210.049
23370085,2013-11-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
23370085,2013-11-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
23370085,2013-11-01T00:00:00,Electric Stimulation Therapy,E02.342
23370085,2013-11-01T00:00:00,Electric Stimulation Therapy,E02.779.468
23370085,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23370085,2013-11-01T00:00:00,Middle Aged,M01.060.116.630
23370085,2013-11-01T00:00:00,Pain Measurement,E01.370.376.550.600
23370085,2013-11-01T00:00:00,"Pain, Postoperative",C23.550.767.700
23370085,2013-11-01T00:00:00,"Pain, Postoperative",C23.888.646.530
23370085,2013-11-01T00:00:00,Treatment Outcome,E01.789.800
23370085,2013-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23370085,2013-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23370085,2013-11-01T00:00:00,Young Adult,M01.060.116.815
23686969,2013-11-01T00:00:00,Activities of Daily Living,E02.831.067
23686969,2013-11-01T00:00:00,Activities of Daily Living,I03.050
23686969,2013-11-01T00:00:00,Activities of Daily Living,N02.421.784.110
23686969,2013-11-01T00:00:00,Adolescent,M01.060.057
23686969,2013-11-01T00:00:00,Child,M01.060.406
23686969,2013-11-01T00:00:00,Cognitive Therapy,F04.754.137.428
23686969,2013-11-01T00:00:00,Fibromyalgia,C05.651.324
23686969,2013-11-01T00:00:00,Fibromyalgia,C05.799.321
23686969,2013-11-01T00:00:00,Fibromyalgia,C10.668.491.425
23686969,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23686969,2013-11-01T00:00:00,Pain Measurement,E01.370.376.550.600
23686969,2013-11-01T00:00:00,Psychometrics,F04.711.780
23686969,2013-11-01T00:00:00,"Quality Assurance, Health Care",N04.761.700
23686969,2013-11-01T00:00:00,"Quality Assurance, Health Care",N05.700
23686969,2013-11-01T00:00:00,Quality of Life,I01.800
23686969,2013-11-01T00:00:00,Quality of Life,K01.752.400.750
23686969,2013-11-01T00:00:00,Questionnaires,E05.318.308.750
23686969,2013-11-01T00:00:00,Questionnaires,L01.280.800
23686969,2013-11-01T00:00:00,Questionnaires,N05.715.360.300.695
23686969,2013-11-01T00:00:00,Questionnaires,N06.850.520.308.750
23686969,2013-11-01T00:00:00,Treatment Outcome,E01.789.800
23686969,2013-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23686969,2013-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23749555,2013-11-01T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
23749555,2013-11-01T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
23749555,2013-11-01T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
23749555,2013-11-01T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
23749555,2013-11-01T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
23749555,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23749555,2013-11-01T00:00:00,Medicine in Literature,K01.517.584
23749555,2013-11-01T00:00:00,Patient Care,E02.760
23749555,2013-11-01T00:00:00,Patient Care,N02.421.585
23749555,2013-11-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
23749555,2013-11-01T00:00:00,Physician-Patient Relations,N05.300.660.625
23749555,2013-11-01T00:00:00,Young Adult,M01.060.116.815
23795648,2013-11-01T00:00:00,Animals,B01.050
23795648,2013-11-01T00:00:00,Cytokines,D12.644.276.374
23795648,2013-11-01T00:00:00,Cytokines,D12.776.467.374
23795648,2013-11-01T00:00:00,Cytokines,D23.529.374
23795648,2013-11-01T00:00:00,Endotoxins,D23.946.123.329
23795648,2013-11-01T00:00:00,Gene Expression Regulation,G05.355.315
23795648,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23795648,2013-11-01T00:00:00,"Immunity, Innate",G12.450.575
23795648,2013-11-01T00:00:00,Lung,A04.411
23795648,2013-11-01T00:00:00,Peptides,D12.644
23795648,2013-11-01T00:00:00,Pneumocytes,A04.411.715.512
23795648,2013-11-01T00:00:00,Pneumocytes,A11.436.714
23795648,2013-11-01T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.260.665
23795648,2013-11-01T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.624.664.700.175
23795648,2013-11-01T00:00:00,Proto-Oncogene Proteins c-ets,D12.776.930.635
23795648,2013-11-01T00:00:00,Signal Transduction,G02.111.087.800
23795648,2013-11-01T00:00:00,Signal Transduction,G02.149.115.800
23795648,2013-11-01T00:00:00,Signal Transduction,G04.299.880
23795648,2013-11-01T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
23800176,2013-11-01T00:00:00,Animals,B01.050
23800176,2013-11-01T00:00:00,Atherosclerosis,C14.907.137.126.307
23800176,2013-11-01T00:00:00,Gene Expression Regulation,G05.355.315
23800176,2013-11-01T00:00:00,Glucose,D09.546.359.448
23800176,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.644.276.374.440.893
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.644.276.718.550
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.776.467.374.440.893
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D12.776.467.718.550
23800176,2013-11-01T00:00:00,Interferon-gamma,D23.529.374.440.893
23800176,2013-11-01T00:00:00,Interferon-gamma,D23.529.374.480.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D23.529.374.480.615.350
23800176,2013-11-01T00:00:00,Interferon-gamma,D23.529.718.550
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D09.400.500
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D09.698.718.450
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D10.494
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D23.050.161.616.525
23800176,2013-11-01T00:00:00,Lipopolysaccharides,D23.946.123.329.500
23800176,2013-11-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.205.351
23800176,2013-11-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.300.480.525.700.100
23800176,2013-11-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.205.351
23800176,2013-11-01T00:00:00,Matrix Metalloproteinase 1,D08.811.277.656.675.374.525.700.100
23800176,2013-11-01T00:00:00,Monocytes,A11.118.637.555.652
23800176,2013-11-01T00:00:00,Monocytes,A11.148.580
23800176,2013-11-01T00:00:00,Monocytes,A11.627.624
23800176,2013-11-01T00:00:00,Monocytes,A11.733.547
23800176,2013-11-01T00:00:00,Monocytes,A15.145.229.637.555.652
23800176,2013-11-01T00:00:00,Monocytes,A15.378.316.580
23800176,2013-11-01T00:00:00,Monocytes,A15.382.490.555.652
23800176,2013-11-01T00:00:00,Monocytes,A15.382.680.547
23800176,2013-11-01T00:00:00,Monocytes,A15.382.812.547
23800176,2013-11-01T00:00:00,Signal Transduction,G02.111.087.800
23800176,2013-11-01T00:00:00,Signal Transduction,G02.149.115.800
23800176,2013-11-01T00:00:00,Signal Transduction,G04.299.880
23800176,2013-11-01T00:00:00,Toll-Like Receptor 4,D12.776.543.750.705.910.500.400
23811697,2013-11-01T00:00:00,Communication,F01.145.209
23811697,2013-11-01T00:00:00,Communication,L01.143
23811697,2013-11-01T00:00:00,Environment Design,I01.283
23811697,2013-11-01T00:00:00,Environment Design,I01.880.709.359
23811697,2013-11-01T00:00:00,Environment Design,N06.230.200
23811697,2013-11-01T00:00:00,Equipment Failure,E05.325
23811697,2013-11-01T00:00:00,Facility Design and Construction,J01.086.339
23811697,2013-11-01T00:00:00,Facility Design and Construction,N02.278.200
23811697,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23811697,2013-11-01T00:00:00,Nurses,M01.526.485.650
23811697,2013-11-01T00:00:00,Nurses,N02.360.650
23811697,2013-11-01T00:00:00,Operating Rooms,N02.278.388.700
23811697,2013-11-01T00:00:00,Physicians,M01.526.485.810
23811697,2013-11-01T00:00:00,Physicians,N02.360.810
23811697,2013-11-01T00:00:00,Terminology as Topic,L01.143.506.598.400
23811697,2013-11-01T00:00:00,Thoracic Surgery,H02.403.810.803
23828481,2013-11-01T00:00:00,Aged,M01.060.116.100
23828481,2013-11-01T00:00:00,Bronchoscopy,E01.370.386.105
23828481,2013-11-01T00:00:00,Bronchoscopy,E01.370.388.250.100
23828481,2013-11-01T00:00:00,Bronchoscopy,E04.800.250.100
23828481,2013-11-01T00:00:00,Bronchoscopy,E04.928.600.080
23828481,2013-11-01T00:00:00,Exercise Tolerance,G11.427.680.270
23828481,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23828481,2013-11-01T00:00:00,Middle Aged,M01.060.116.630
23828481,2013-11-01T00:00:00,Pneumonectomy,E04.928.600.600
23828481,2013-11-01T00:00:00,Pulmonary Emphysema,C08.381.748
23828481,2013-11-01T00:00:00,Quality of Life,I01.800
23828481,2013-11-01T00:00:00,Quality of Life,K01.752.400.750
23828481,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23828481,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23828481,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23828481,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23828481,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23828481,2013-11-01T00:00:00,Treatment Outcome,E01.789.800
23828481,2013-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23828481,2013-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23963635,2013-11-01T00:00:00,Aged,M01.060.116.100
23963635,2013-11-01T00:00:00,Animals,B01.050
23963635,2013-11-01T00:00:00,Aortic Diseases,C14.907.109
23963635,2013-11-01T00:00:00,Calcium,D01.268.552.100
23963635,2013-11-01T00:00:00,Calcium,D01.552.539.288
23963635,2013-11-01T00:00:00,Calcium,D23.119.100
23963635,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23963635,2013-11-01T00:00:00,Middle Aged,M01.060.116.630
23963635,2013-11-01T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
23963635,2013-11-01T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
23963635,2013-11-01T00:00:00,Swine,B01.050.150.900.649.077.880
23963635,2013-11-01T00:00:00,Treatment Outcome,E01.789.800
23963635,2013-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23963635,2013-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24092682,2013-11-01T00:00:00,Adult,M01.060.116
24092682,2013-11-01T00:00:00,Aged,M01.060.116.100
24092682,2013-11-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
24092682,2013-11-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
24092682,2013-11-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
24092682,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24092682,2013-11-01T00:00:00,"Hypertension, Pulmonary",C08.381.423
24092682,2013-11-01T00:00:00,"Lung Diseases, Interstitial",C08.381.483
24092682,2013-11-01T00:00:00,Middle Aged,M01.060.116.630
24092682,2013-11-01T00:00:00,"Scleroderma, Systemic",C17.300.799
24092682,2013-11-01T00:00:00,"Scleroderma, Systemic",C17.800.784
24092682,2013-11-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
24092682,2013-11-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
24092682,2013-11-01T00:00:00,Sensitivity and Specificity,G17.800
24092682,2013-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
24092682,2013-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
24092682,2013-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
24092682,2013-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24092682,2013-11-01T00:00:00,United States,Z01.107.567.875
24135208,2013-11-01T00:00:00,Cerebral Arterial Diseases,C10.228.140.300.510.200
24135208,2013-11-01T00:00:00,Cerebral Arterial Diseases,C14.907.253.560.200
24135208,2013-11-01T00:00:00,"Constriction, Pathologic",C23.300.287
24135208,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24135208,2013-11-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
24135208,2013-11-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
24135208,2013-11-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
24147470,2013-11-01T00:00:00,Adult,M01.060.116
24147470,2013-11-01T00:00:00,Aged,M01.060.116.100
24147470,2013-11-01T00:00:00,Chronic Disease,C23.550.291.500
24147470,2013-11-01T00:00:00,Contrast Media,D27.720.259
24147470,2013-11-01T00:00:00,"Diagnosis, Differential",E01.171
24147470,2013-11-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
24147470,2013-11-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
24147470,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24147470,2013-11-01T00:00:00,Middle Aged,M01.060.116.630
24147470,2013-11-01T00:00:00,Organometallic Compounds,D01.632
24147470,2013-11-01T00:00:00,Organometallic Compounds,D02.691
24147470,2013-11-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
24147470,2013-11-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
24147470,2013-11-01T00:00:00,Pancreatic Neoplasms,C06.301.761
24147470,2013-11-01T00:00:00,Pancreatic Neoplasms,C06.689.667
24147470,2013-11-01T00:00:00,Pancreatic Neoplasms,C19.344.421
24147470,2013-11-01T00:00:00,Pancreatitis,C06.689.750
24166793,2013-11-01T00:00:00,Adult,M01.060.116
24166793,2013-11-01T00:00:00,Autoantibodies,D12.776.124.486.485.114.323
24166793,2013-11-01T00:00:00,Autoantibodies,D12.776.124.790.651.114.323
24166793,2013-11-01T00:00:00,Autoantibodies,D12.776.377.715.548.114.323
24166793,2013-11-01T00:00:00,Headache,C10.597.617.470
24166793,2013-11-01T00:00:00,Headache,C23.888.592.612.441
24166793,2013-11-01T00:00:00,Headache,C23.888.646.487
24166793,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24166793,2013-11-01T00:00:00,Internationality,I01.615
24166793,2013-11-01T00:00:00,Intracranial Hypertension,C10.228.140.631
24166793,2013-11-01T00:00:00,"Lupus Erythematosus, Systemic",C17.300.480
24166793,2013-11-01T00:00:00,"Lupus Erythematosus, Systemic",C20.111.590
24166793,2013-11-01T00:00:00,Middle Aged,M01.060.116.630
24166793,2013-11-01T00:00:00,Migraine Disorders,C10.228.140.546.399.750
24166793,2013-11-01T00:00:00,Quality of Life,I01.800
24166793,2013-11-01T00:00:00,Quality of Life,K01.752.400.750
24166793,2013-11-01T00:00:00,Young Adult,M01.060.116.815
24189058,2013-11-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.200.400
24189058,2013-11-01T00:00:00,"Carcinoma, Squamous Cell",C04.557.470.700.400
24189058,2013-11-01T00:00:00,Head and Neck Neoplasms,C04.588.443
24189058,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24189058,2013-11-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
24189058,2013-11-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
24189058,2013-11-01T00:00:00,Patient Satisfaction,N05.715.360.600
24189058,2013-11-01T00:00:00,Radiation Injuries,C21.866.733
24189058,2013-11-01T00:00:00,Radiation Injuries,N06.850.810.300.360
24189058,2013-11-01T00:00:00,Treatment Outcome,E01.789.800
24189058,2013-11-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24189058,2013-11-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24191093,2013-11-01T00:00:00,Demography,I01.240
24191093,2013-11-01T00:00:00,Demography,N01.224
24191093,2013-11-01T00:00:00,Demography,N06.850.505.400
24191093,2013-11-01T00:00:00,Federal Government,I01.409.137
24191093,2013-11-01T00:00:00,Federal Government,N03.540.348.500
24191093,2013-11-01T00:00:00,Health Occupations,H02
24191093,2013-11-01T00:00:00,Health Policy,I01.880.604.825.608.400
24191093,2013-11-01T00:00:00,Health Policy,N03.706.825.608.428
24191093,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24191093,2013-11-01T00:00:00,Mental Disorders,F03
24191093,2013-11-01T00:00:00,Mental Health Services,F04.408
24191093,2013-11-01T00:00:00,Mental Health Services,N02.421.461
24191093,2013-11-01T00:00:00,Organizational Objectives,N04.452.615
24191093,2013-11-01T00:00:00,Professional Competence,I02.399.630
24191093,2013-11-01T00:00:00,Substance-Related Disorders,C21.739
24191093,2013-11-01T00:00:00,Substance-Related Disorders,F03.900
24191093,2013-11-01T00:00:00,United States,Z01.107.567.875
24196093,2013-11-01T00:00:00,Animals,B01.050
24196093,2013-11-01T00:00:00,Child,M01.060.406
24196093,2013-11-01T00:00:00,Combined Modality Therapy,E02.186
24196093,2013-11-01T00:00:00,Crotalid Venoms,D20.888.850.960.200
24196093,2013-11-01T00:00:00,Crotalid Venoms,D23.946.833.850.960.200
24196093,2013-11-01T00:00:00,Crotalus,B01.050.150.900.833.672.875.280
24196093,2013-11-01T00:00:00,Emergencies,C23.550.291.781
24196093,2013-11-01T00:00:00,Emergencies,N06.230.100.083
24196093,2013-11-01T00:00:00,Emergencies,N06.850.376
24196093,2013-11-01T00:00:00,Facial Paralysis,C07.465.327
24196093,2013-11-01T00:00:00,Facial Paralysis,C10.597.622.214
24196093,2013-11-01T00:00:00,Facial Paralysis,C23.888.592.636.214
24196093,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24196093,2013-11-01T00:00:00,Multiple Organ Failure,C23.550.835.525
24196093,2013-11-01T00:00:00,Ophthalmoplegia,C10.292.562.750
24196093,2013-11-01T00:00:00,Ophthalmoplegia,C10.597.622.447
24196093,2013-11-01T00:00:00,Ophthalmoplegia,C11.590.472
24196093,2013-11-01T00:00:00,Ophthalmoplegia,C23.888.592.636.447
24196093,2013-11-01T00:00:00,Paralysis,C10.597.622
24196093,2013-11-01T00:00:00,Paralysis,C23.888.592.636
24196093,2013-11-01T00:00:00,"Respiration, Artificial",E02.365.647.729
24196093,2013-11-01T00:00:00,"Respiration, Artificial",E02.880.820
24196093,2013-11-01T00:00:00,Rhabdomyolysis,C05.651.807
24196093,2013-11-01T00:00:00,Snake Bites,C21.613.127.722
24210445,2013-11-01T00:00:00,"Diagnosis, Differential",E01.171
24210445,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24210445,2013-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24210445,2013-11-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24210445,2013-11-01T00:00:00,Ovarian Cysts,C04.182.612
24210445,2013-11-01T00:00:00,Ovarian Cysts,C13.351.500.056.630.580
24210445,2013-11-01T00:00:00,Ovarian Cysts,C19.391.630.580
24210445,2013-11-01T00:00:00,Ovarian Neoplasms,C04.588.322.455
24210445,2013-11-01T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
24210445,2013-11-01T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
24210445,2013-11-01T00:00:00,Ovarian Neoplasms,C19.344.410
24210445,2013-11-01T00:00:00,Ovarian Neoplasms,C19.391.630.705
24210445,2013-11-01T00:00:00,Ovary,A05.360.319.114.630
24210445,2013-11-01T00:00:00,Ovary,A05.360.576.497
24210445,2013-11-01T00:00:00,Ovary,A06.407.312.497
24210445,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24210445,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24210445,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24210445,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24210445,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24210445,2013-11-01T00:00:00,"Ultrasonography, Doppler, Color",E01.370.350.850.850.850.850
24224585,2013-11-01T00:00:00,Adult,M01.060.116
24224585,2013-11-01T00:00:00,Aged,M01.060.116.100
24224585,2013-11-01T00:00:00,"Cholangiopancreatography, Magnetic Resonance",E01.370.350.500.100
24224585,2013-11-01T00:00:00,"Cholangiopancreatography, Magnetic Resonance",E01.370.350.825.500.100
24224585,2013-11-01T00:00:00,"Cholangiopancreatography, Magnetic Resonance",E01.370.372.207
24224585,2013-11-01T00:00:00,Contrast Media,D27.720.259
24224585,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24224585,2013-11-01T00:00:00,Image Enhancement,E01.370.350.600.350
24224585,2013-11-01T00:00:00,Image Enhancement,L01.224.308.380
24224585,2013-11-01T00:00:00,Middle Aged,M01.060.116.630
24270115,2013-11-01T00:00:00,Adult,M01.060.116
24270115,2013-11-01T00:00:00,Aged,M01.060.116.100
24270115,2013-11-01T00:00:00,Algorithms,G17.035
24270115,2013-11-01T00:00:00,Algorithms,L01.224.050
24270115,2013-11-01T00:00:00,Attitude of Health Personnel,F01.100.050
24270115,2013-11-01T00:00:00,Attitude of Health Personnel,N05.300.100
24270115,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24270115,2013-11-01T00:00:00,Middle Aged,M01.060.116.630
24270115,2013-11-01T00:00:00,Professional Competence,I02.399.630
24270115,2013-11-01T00:00:00,Radiation Dosage,E05.799.513
24270115,2013-11-01T00:00:00,Radiation Dosage,G01.201.875.740
24270115,2013-11-01T00:00:00,Radiation Dosage,N06.850.810.250
24270115,2013-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.600.350.700
24270115,2013-11-01T00:00:00,Radiographic Image Enhancement,E01.370.350.700.700
24270115,2013-11-01T00:00:00,Radiographic Image Enhancement,L01.224.308.380.600
24270115,2013-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
24270115,2013-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
24270115,2013-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
24270115,2013-11-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
24270115,2013-11-01T00:00:00,"Radiography, Abdominal",E01.370.350.700.715
24270115,2013-11-01T00:00:00,Sensitivity and Specificity,E05.318.740.872
24270115,2013-11-01T00:00:00,Sensitivity and Specificity,E05.318.780.800
24270115,2013-11-01T00:00:00,Sensitivity and Specificity,G17.800
24270115,2013-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
24270115,2013-11-01T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
24270115,2013-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
24270115,2013-11-01T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24270115,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24270115,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24270115,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24270115,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24270115,2013-11-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24274220,2013-11-01T00:00:00,Chronic Disease,C23.550.291.500
24274220,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24274220,2013-11-01T00:00:00,Nasal Polyps,C08.460.572
24274220,2013-11-01T00:00:00,Nasal Polyps,C09.603.557
24274220,2013-11-01T00:00:00,Nasal Polyps,C23.300.825.557
24274220,2013-11-01T00:00:00,Rhinitis,C08.460.799
24274220,2013-11-01T00:00:00,Rhinitis,C08.730.674
24274220,2013-11-01T00:00:00,Rhinitis,C09.603.799
24274220,2013-11-01T00:00:00,Sinusitis,C08.460.692.752
24274220,2013-11-01T00:00:00,Sinusitis,C08.730.749
24274220,2013-11-01T00:00:00,Sinusitis,C09.603.692.752
24274224,2013-11-01T00:00:00,Adrenal Cortex Hormones,D06.472.040
24274224,2013-11-01T00:00:00,Chronic Disease,C23.550.291.500
24274224,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24274224,2013-11-01T00:00:00,Nasal Polyps,C08.460.572
24274224,2013-11-01T00:00:00,Nasal Polyps,C09.603.557
24274224,2013-11-01T00:00:00,Nasal Polyps,C23.300.825.557
24274224,2013-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.318.760.535.365.500
24274224,2013-11-01T00:00:00,Randomized Controlled Trials as Topic,E05.337.250.365.500
24274224,2013-11-01T00:00:00,Randomized Controlled Trials as Topic,N05.715.360.775.235.387.500
24274224,2013-11-01T00:00:00,Randomized Controlled Trials as Topic,N06.850.520.450.535.365.500
24274224,2013-11-01T00:00:00,Rhinitis,C08.460.799
24274224,2013-11-01T00:00:00,Rhinitis,C08.730.674
24274224,2013-11-01T00:00:00,Rhinitis,C09.603.799
24274224,2013-11-01T00:00:00,Sinusitis,C08.460.692.752
24274224,2013-11-01T00:00:00,Sinusitis,C08.730.749
24274224,2013-11-01T00:00:00,Sinusitis,C09.603.692.752
24291501,2013-11-01T00:00:00,HIV Protease,D08.811.277.656.074.500.340
24291501,2013-11-01T00:00:00,HIV Protease,D08.811.277.656.300.048.340
24291501,2013-11-01T00:00:00,HIV Protease,D12.776.964.775.375.545.750
24291501,2013-11-01T00:00:00,HIV Protease Inhibitors,D27.505.519.389.745.420
24291501,2013-11-01T00:00:00,HIV Protease Inhibitors,D27.505.954.122.388.077.088.420
24291501,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24291501,2013-11-01T00:00:00,Hydrogen Bonding,G02.149.767.620
24291501,2013-11-01T00:00:00,Hydrogen Bonding,G02.842.750.620
24291501,2013-11-01T00:00:00,"Models, Molecular",E05.599.595
24291501,2013-11-01T00:00:00,Protein Conformation,G02.111.570.790.709
24313139,2013-11-01T00:00:00,"Education, Medical, Continuing",I02.358.212.350
24313139,2013-11-01T00:00:00,"Education, Medical, Continuing",I02.358.399.250
24313139,2013-11-01T00:00:00,General Surgery,H02.403.810.300
24313139,2013-11-01T00:00:00,"History, 20th Century",K01.400.504.968
24313139,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24313139,2013-11-01T00:00:00,"Medical Staff, Hospital",M01.526.485.630.490
24313139,2013-11-01T00:00:00,"Medical Staff, Hospital",M01.526.485.740.422
24313139,2013-11-01T00:00:00,"Medical Staff, Hospital",N02.360.630.490
24313139,2013-11-01T00:00:00,"Medical Staff, Hospital",N02.360.740.422
24313139,2013-11-01T00:00:00,"Societies, Medical",N03.540.828.589
24313139,2013-11-01T00:00:00,United States,Z01.107.567.875
24347187,2013-11-01T00:00:00,Adult,M01.060.116
24347187,2013-11-01T00:00:00,"Contraceptive Agents, Female",D27.505.696.875.360.276
24347187,2013-11-01T00:00:00,"Contraceptive Agents, Female",D27.505.954.705.360.276
24347187,2013-11-01T00:00:00,Depression,F01.145.126.350
24347187,2013-11-01T00:00:00,Drug Implants,D26.255.210.315
24347187,2013-11-01T00:00:00,Drug Implants,D27.720.280.210.315
24347187,2013-11-01T00:00:00,Headache,C10.597.617.470
24347187,2013-11-01T00:00:00,Headache,C23.888.592.612.441
24347187,2013-11-01T00:00:00,Headache,C23.888.646.487
24347187,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24347187,2013-11-01T00:00:00,Pain,C10.597.617
24347187,2013-11-01T00:00:00,Pain,C23.888.592.612
24347187,2013-11-01T00:00:00,Pain,C23.888.646
24347187,2013-11-01T00:00:00,Pain,F02.830.816.444
24347187,2013-11-01T00:00:00,Pain,G11.561.600.810.444
24347187,2013-11-01T00:00:00,Patient Satisfaction,N04.452.822.360.600
24347187,2013-11-01T00:00:00,Patient Satisfaction,N05.300.150.600.630
24347187,2013-11-01T00:00:00,Patient Satisfaction,N05.715.360.600
24347187,2013-11-01T00:00:00,South Carolina,Z01.107.567.875.075.662
24347187,2013-11-01T00:00:00,South Carolina,Z01.107.567.875.750.700
24347187,2013-11-01T00:00:00,Weight Gain,C23.888.144.243.926
24347187,2013-11-01T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
24347187,2013-11-01T00:00:00,Young Adult,M01.060.116.815
24383098,2013-11-01T00:00:00,Brain,A08.186.211
24383098,2013-11-01T00:00:00,Cognition,F02.463.188
24383098,2013-11-01T00:00:00,Electric Stimulation,E05.723.402
24383098,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24383098,2013-11-01T00:00:00,Thinking,F02.463.785
24383098,2013-11-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
24383098,2013-11-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
24423078,2013-11-01T00:00:00,Communication,F01.145.209
24423078,2013-11-01T00:00:00,Communication,L01.143
24423078,2013-11-01T00:00:00,Delivery of Health Care,N04.590.374
24423078,2013-11-01T00:00:00,Delivery of Health Care,N05.300
24423078,2013-11-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24423078,2013-11-01T00:00:00,Information Dissemination,F01.145.209.364
24423078,2013-11-01T00:00:00,Information Dissemination,L01.143.443
24423078,2013-11-01T00:00:00,Physicians,M01.526.485.810
24423078,2013-11-01T00:00:00,Physicians,N02.360.810
24188082,2013-11-04T00:00:00,Adolescent,M01.060.057
24188082,2013-11-04T00:00:00,Family Therapy,F04.754.864.581.273
24188082,2013-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24188082,2013-11-04T00:00:00,Juvenile Delinquency,I01.880.735.479
24188082,2013-11-04T00:00:00,Psychotherapy,F04.754
24188082,2013-11-04T00:00:00,Sex Offenses,I01.198.240.748
24188082,2013-11-04T00:00:00,Treatment Outcome,E01.789.800
24188082,2013-11-04T00:00:00,Treatment Outcome,N04.761.559.590.800
24188082,2013-11-04T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24190905,2013-11-04T00:00:00,African Continental Ancestry Group,M01.686.508.100
24190905,2013-11-04T00:00:00,Aged,M01.060.116.100
24190905,2013-11-04T00:00:00,Blood Pressure,E01.370.600.875.249
24190905,2013-11-04T00:00:00,Blood Pressure,G09.330.380.076
24190905,2013-11-04T00:00:00,Cardiovascular Diseases,C14
24190905,2013-11-04T00:00:00,Coronary Artery Disease,C14.280.647.250.260
24190905,2013-11-04T00:00:00,Coronary Artery Disease,C14.907.137.126.339
24190905,2013-11-04T00:00:00,Coronary Artery Disease,C14.907.585.250.260
24190905,2013-11-04T00:00:00,Coronary Disease,C14.280.647.250
24190905,2013-11-04T00:00:00,Coronary Disease,C14.907.585.250
24190905,2013-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24190905,2013-11-04T00:00:00,Hypertension,C14.907.489
24190905,2013-11-04T00:00:00,Middle Aged,M01.060.116.630
24190905,2013-11-04T00:00:00,Myocardial Infarction,C14.280.647.500
24190905,2013-11-04T00:00:00,Myocardial Infarction,C14.907.585.500
24190905,2013-11-04T00:00:00,Risk Factors,E05.318.740.600.800.725
24190905,2013-11-04T00:00:00,Risk Factors,N05.715.350.200.700
24190905,2013-11-04T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24190905,2013-11-04T00:00:00,Risk Factors,N06.850.490.625.750
24190905,2013-11-04T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24190905,2013-11-04T00:00:00,Stroke,C10.228.140.300.775
24190905,2013-11-04T00:00:00,Stroke,C14.907.253.855
24190905,2013-11-04T00:00:00,United States,Z01.107.567.875
24200678,2013-11-04T00:00:00,Cell Adhesion,G04.299.117
24200678,2013-11-04T00:00:00,Cell Movement,G04.299.283
24200678,2013-11-04T00:00:00,Cell Movement,G07.700.560.500.180
24200678,2013-11-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24200678,2013-11-04T00:00:00,Mesoderm,A16.504.660
24200678,2013-11-04T00:00:00,Mutation,G05.365.590
24200678,2013-11-04T00:00:00,rac GTP-Binding Proteins,D08.811.277.040.330.300.400.700.100
24200678,2013-11-04T00:00:00,rac GTP-Binding Proteins,D12.644.360.525.700.100
24200678,2013-11-04T00:00:00,rac GTP-Binding Proteins,D12.776.157.325.515.700.100
24200678,2013-11-04T00:00:00,rac GTP-Binding Proteins,D12.776.476.525.700.100
24216846,2013-11-04T00:00:00,Algorithms,G17.035
24216846,2013-11-04T00:00:00,Algorithms,L01.224.050
24216846,2013-11-04T00:00:00,Image Enhancement,E01.370.350.600.350
24216846,2013-11-04T00:00:00,Image Enhancement,L01.224.308.380
24216846,2013-11-04T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
24216846,2013-11-04T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
24216846,2013-11-04T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
24216846,2013-11-04T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
24216846,2013-11-04T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
24216846,2013-11-04T00:00:00,Materials Testing,E05.570
24216846,2013-11-04T00:00:00,Nanoparticles,J01.637.512.600
24216846,2013-11-04T00:00:00,"Pattern Recognition, Automated",L01.725
24216846,2013-11-04T00:00:00,Sensitivity and Specificity,E05.318.740.872
24216846,2013-11-04T00:00:00,Sensitivity and Specificity,E05.318.780.800
24216846,2013-11-04T00:00:00,Sensitivity and Specificity,G17.800
24216846,2013-11-04T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
24216846,2013-11-04T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
24216846,2013-11-04T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
24216846,2013-11-04T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24193798,2013-11-05T00:00:00,Adolescent,M01.060.057
24193798,2013-11-05T00:00:00,Adult,M01.060.116
24193798,2013-11-05T00:00:00,Aged,M01.060.116.100
24193798,2013-11-05T00:00:00,Blood Glucose,D09.546.359.448.500
24193798,2013-11-05T00:00:00,Brain Ischemia,C10.228.140.300.150
24193798,2013-11-05T00:00:00,Brain Ischemia,C14.907.253.092
24193798,2013-11-05T00:00:00,European Continental Ancestry Group,M01.686.508.400
24193798,2013-11-05T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
24193798,2013-11-05T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
24193798,2013-11-05T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
24193798,2013-11-05T00:00:00,Glyburide,D02.886.590.795.575
24193798,2013-11-05T00:00:00,Glyburide,D02.948.828.575
24193798,2013-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24193798,2013-11-05T00:00:00,Hypoglycemic Agents,D27.505.696.422
24193798,2013-11-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24193798,2013-11-05T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24193798,2013-11-05T00:00:00,Middle Aged,M01.060.116.630
24193798,2013-11-05T00:00:00,Pilot Projects,E05.318.760.750
24193798,2013-11-05T00:00:00,Pilot Projects,E05.337.737
24193798,2013-11-05T00:00:00,Pilot Projects,N05.715.360.775.625
24193798,2013-11-05T00:00:00,Pilot Projects,N06.850.520.450.720
24193798,2013-11-05T00:00:00,Stroke,C10.228.140.300.775
24193798,2013-11-05T00:00:00,Stroke,C14.907.253.855
24193798,2013-11-05T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
24193798,2013-11-05T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
24193798,2013-11-05T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
24193798,2013-11-05T00:00:00,Tissue Plasminogen Activator,D23.119.970
24193798,2013-11-05T00:00:00,Treatment Outcome,E01.789.800
24193798,2013-11-05T00:00:00,Treatment Outcome,N04.761.559.590.800
24193798,2013-11-05T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24193798,2013-11-05T00:00:00,Young Adult,M01.060.116.815
24193804,2013-11-05T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
24193804,2013-11-05T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
24193804,2013-11-05T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
24193804,2013-11-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24193804,2013-11-05T00:00:00,"Renal Insufficiency, Chronic",C12.777.419.780.750
24193804,2013-11-05T00:00:00,"Renal Insufficiency, Chronic",C13.351.968.419.780.750
24194504,2013-11-05T00:00:00,Aging,G07.700.320.124
24194504,2013-11-05T00:00:00,Animals,B01.050
24194504,2013-11-05T00:00:00,Bacteria,B03
24194504,2013-11-05T00:00:00,Cytokines,D12.644.276.374
24194504,2013-11-05T00:00:00,Cytokines,D12.776.467.374
24194504,2013-11-05T00:00:00,Cytokines,D23.529.374
24194504,2013-11-05T00:00:00,"Diabetes Mellitus, Type 1",C18.452.394.750.124
24194504,2013-11-05T00:00:00,"Diabetes Mellitus, Type 1",C19.246.267
24194504,2013-11-05T00:00:00,"Diabetes Mellitus, Type 1",C20.111.327
24194504,2013-11-05T00:00:00,Gastrointestinal Tract,A03.556
24194504,2013-11-05T00:00:00,T-Lymphocytes,A11.118.637.555.567.569
24194504,2013-11-05T00:00:00,T-Lymphocytes,A15.145.229.637.555.567.569
24194504,2013-11-05T00:00:00,T-Lymphocytes,A15.382.490.555.567.569
24194504,2013-11-05T00:00:00,Transcription Factors,D12.776.930
24192980,2013-11-06T00:00:00,Coronary Angiography,E01.370.350.700.060.200
24192980,2013-11-06T00:00:00,Coronary Angiography,E01.370.370.050.200
24192980,2013-11-06T00:00:00,Coronary Angiography,E01.370.370.380.200
24192980,2013-11-06T00:00:00,Coronary Artery Disease,C14.280.647.250.260
24192980,2013-11-06T00:00:00,Coronary Artery Disease,C14.907.137.126.339
24192980,2013-11-06T00:00:00,Coronary Artery Disease,C14.907.585.250.260
24192980,2013-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24192980,2013-11-06T00:00:00,"Imaging, Three-Dimensional",E01.370.350.400
24192980,2013-11-06T00:00:00,"Imaging, Three-Dimensional",L01.224.308.410
24192980,2013-11-06T00:00:00,Middle Aged,M01.060.116.630
24192980,2013-11-06T00:00:00,Pericardium,A07.541.795
24192980,2013-11-06T00:00:00,Pericardium,A10.615.789.470
24192980,2013-11-06T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
24192980,2013-11-06T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
24192980,2013-11-06T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
24192980,2013-11-06T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
24192980,2013-11-06T00:00:00,Software,L01.224.900
24192980,2013-11-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24192980,2013-11-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24192980,2013-11-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24192980,2013-11-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24192980,2013-11-06T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24196832,2013-11-06T00:00:00,Antifungal Agents,D27.505.954.122.136
24196832,2013-11-06T00:00:00,Ceramides,D02.065.313
24196832,2013-11-06T00:00:00,Ceramides,D09.400.410.420.525.200
24196832,2013-11-06T00:00:00,Ceramides,D10.390.470.675.200
24196832,2013-11-06T00:00:00,Ceramides,D10.570.877.360.612.200
24196832,2013-11-06T00:00:00,"Fatty Acids, Monounsaturated",D10.251.355.325
24196832,2013-11-06T00:00:00,"Gene Expression Regulation, Fungal",G05.355.315.330
24196832,2013-11-06T00:00:00,Microbial Sensitivity Tests,E05.200.875.595
24196832,2013-11-06T00:00:00,Microbial Sensitivity Tests,E05.337.550.400
24196832,2013-11-06T00:00:00,Protein Transport,G03.495.166.700
24196832,2013-11-06T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
24196832,2013-11-06T00:00:00,Saccharomyces cerevisiae,B01.300.107.795.785.800
24196832,2013-11-06T00:00:00,Saccharomyces cerevisiae,B01.300.930.705.655
24196832,2013-11-06T00:00:00,Saccharomyces cerevisiae Proteins,D12.776.354.750
24196832,2013-11-06T00:00:00,Sphingolipids,D10.570.877
24196832,2013-11-06T00:00:00,Sphingolipids,D10.808
24196832,2013-11-06T00:00:00,Sphingosine,D02.033.100.700
24196832,2013-11-06T00:00:00,Sphingosine,D02.033.455.843
24196832,2013-11-06T00:00:00,Sphingosine,D02.092.063.700
24196832,2013-11-06T00:00:00,"Transcription, Genetic",G02.111.087.847
24196832,2013-11-06T00:00:00,"Transcription, Genetic",G02.149.115.847
24196832,2013-11-06T00:00:00,"Transcription, Genetic",G05.355.310.700
24197886,2013-11-06T00:00:00,Adolescent,M01.060.057
24197886,2013-11-06T00:00:00,Adult,M01.060.116
24197886,2013-11-06T00:00:00,Aged,M01.060.116.100
24197886,2013-11-06T00:00:00,Child,M01.060.406
24197886,2013-11-06T00:00:00,"Child, Preschool",M01.060.406.448
24197886,2013-11-06T00:00:00,Clostridium Infections,C01.252.410.222
24197886,2013-11-06T00:00:00,Clostridium difficile,B03.300.390.400.200.250
24197886,2013-11-06T00:00:00,Clostridium difficile,B03.510.415.400.200.250
24197886,2013-11-06T00:00:00,Diarrhea,C23.888.821.214
24197886,2013-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24197886,2013-11-06T00:00:00,Infant,M01.060.703
24197886,2013-11-06T00:00:00,Middle Aged,M01.060.116.630
24197886,2013-11-06T00:00:00,Molecular Diagnostic Techniques,E05.200.880
24197886,2013-11-06T00:00:00,Molecular Diagnostic Techniques,E05.393.520
24197886,2013-11-06T00:00:00,Young Adult,M01.060.116.815
24210923,2013-11-06T00:00:00,Enteral Nutrition,E02.421.360
24210923,2013-11-06T00:00:00,Enteral Nutrition,E02.642.500.360
24210923,2013-11-06T00:00:00,Gastrostomy,E04.210.496
24210923,2013-11-06T00:00:00,Gastrostomy,E04.579.408
24210923,2013-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24210923,2013-11-06T00:00:00,Hypoplastic Left Heart Syndrome,C14.240.400.625
24210923,2013-11-06T00:00:00,Hypoplastic Left Heart Syndrome,C14.280.400.625
24210923,2013-11-06T00:00:00,Hypoplastic Left Heart Syndrome,C16.131.240.400.625
24210923,2013-11-06T00:00:00,"Infant, Newborn",M01.060.703.520
24210923,2013-11-06T00:00:00,Length of Stay,E02.760.400.480
24210923,2013-11-06T00:00:00,Length of Stay,N02.421.585.400.480
24210923,2013-11-06T00:00:00,Patient Discharge,E02.760.400.610
24210923,2013-11-06T00:00:00,Patient Discharge,N02.421.585.400.610
24210923,2013-11-06T00:00:00,Treatment Outcome,E01.789.800
24210923,2013-11-06T00:00:00,Treatment Outcome,N04.761.559.590.800
24210923,2013-11-06T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24210923,2013-11-06T00:00:00,Weight Gain,C23.888.144.243.926
24210923,2013-11-06T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
24211319,2013-11-06T00:00:00,Adult,M01.060.116
24211319,2013-11-06T00:00:00,Aged,M01.060.116.100
24211319,2013-11-06T00:00:00,Hematopoietic Stem Cell Mobilization,E02.095.410
24211319,2013-11-06T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24211319,2013-11-06T00:00:00,Middle Aged,M01.060.116.630
24211319,2013-11-06T00:00:00,Multiple Myeloma,C04.557.595.500
24211319,2013-11-06T00:00:00,Multiple Myeloma,C14.907.454.460
24211319,2013-11-06T00:00:00,Multiple Myeloma,C15.378.147.780.650
24211319,2013-11-06T00:00:00,Multiple Myeloma,C15.378.463.835.460
24211319,2013-11-06T00:00:00,Multiple Myeloma,C20.683.515.845
24211319,2013-11-06T00:00:00,Multiple Myeloma,C20.683.780.650
24223185,2013-11-06T00:00:00,Aging,G07.700.320.124
24223185,2013-11-06T00:00:00,Animals,B01.050
24223185,2013-11-06T00:00:00,Cell Culture Techniques,E05.200.249.249
24223185,2013-11-06T00:00:00,Collagen Type I,D05.750.078.280.300.100
24223185,2013-11-06T00:00:00,Collagen Type I,D12.776.860.300.250.300.100
24223185,2013-11-06T00:00:00,Extracellular Matrix,A11.284.295.310
24223185,2013-11-06T00:00:00,Fibroblasts,A11.329.228
24223185,2013-11-06T00:00:00,Fibroblasts,A11.872.228
24223185,2013-11-06T00:00:00,Gene Expression Regulation,G05.355.315
24223185,2013-11-06T00:00:00,Myocardium,A02.633.580
24223185,2013-11-06T00:00:00,Myocardium,A07.541.704
24223185,2013-11-06T00:00:00,Myocardium,A10.690.552.750
24223185,2013-11-06T00:00:00,Osteonectin,D12.776.157.125.715
24223185,2013-11-06T00:00:00,Osteonectin,D12.776.395.600
24223185,2013-11-06T00:00:00,Procollagen,D12.776.811.690
24223185,2013-11-06T00:00:00,Procollagen,D12.776.860.300.250.600
24122966,2013-11-07T00:00:00,Adolescent,M01.060.057
24122966,2013-11-07T00:00:00,Adult,M01.060.116
24122966,2013-11-07T00:00:00,Age Factors,N05.715.350.075
24122966,2013-11-07T00:00:00,Age Factors,N06.850.490.250
24122966,2013-11-07T00:00:00,Aged,M01.060.116.100
24122966,2013-11-07T00:00:00,Cause of Death,E05.318.308.985.550.250
24122966,2013-11-07T00:00:00,Cause of Death,L01.280.975.550.250
24122966,2013-11-07T00:00:00,Cause of Death,N01.224.935.698.100
24122966,2013-11-07T00:00:00,Cause of Death,N06.850.505.400.975.550.250
24122966,2013-11-07T00:00:00,Cause of Death,N06.850.520.308.985.550.250
24122966,2013-11-07T00:00:00,Combined Modality Therapy,E02.186
24122966,2013-11-07T00:00:00,Disease-Free Survival,E01.789.200
24122966,2013-11-07T00:00:00,Disease-Free Survival,E05.318.740.998.300
24122966,2013-11-07T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
24122966,2013-11-07T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
24122966,2013-11-07T00:00:00,Head and Neck Neoplasms,C04.588.443
24122966,2013-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24122966,2013-11-07T00:00:00,Melanoma,C04.557.465.625.650.510
24122966,2013-11-07T00:00:00,Melanoma,C04.557.580.625.650.510
24122966,2013-11-07T00:00:00,Melanoma,C04.557.665.510
24122966,2013-11-07T00:00:00,Middle Aged,M01.060.116.630
24122966,2013-11-07T00:00:00,Neoplasm Invasiveness,C04.697.645
24122966,2013-11-07T00:00:00,Neoplasm Invasiveness,C23.550.727.645
24122966,2013-11-07T00:00:00,Risk Assessment,E05.318.740.600.800.715
24122966,2013-11-07T00:00:00,Risk Assessment,N04.452.871.715
24122966,2013-11-07T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24122966,2013-11-07T00:00:00,Risk Assessment,N06.850.505.715
24122966,2013-11-07T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24122966,2013-11-07T00:00:00,Sex Factors,N05.715.350.675
24122966,2013-11-07T00:00:00,Sex Factors,N06.850.490.875
24122966,2013-11-07T00:00:00,Skin Neoplasms,C04.588.805
24122966,2013-11-07T00:00:00,Skin Neoplasms,C17.800.882
24122966,2013-11-07T00:00:00,Treatment Outcome,E01.789.800
24122966,2013-11-07T00:00:00,Treatment Outcome,N04.761.559.590.800
24122966,2013-11-07T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24122966,2013-11-07T00:00:00,Young Adult,M01.060.116.815
24200968,2013-11-07T00:00:00,Cell Movement,G04.299.283
24200968,2013-11-07T00:00:00,Cell Movement,G07.700.560.500.180
24200968,2013-11-07T00:00:00,Cell Proliferation,G04.299.233.750
24200968,2013-11-07T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24200968,2013-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24200968,2013-11-07T00:00:00,MicroRNAs,D13.150.650.319
24200968,2013-11-07T00:00:00,MicroRNAs,D13.444.735.150.319
24200968,2013-11-07T00:00:00,MicroRNAs,D13.444.735.790.099
24200968,2013-11-07T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
24200968,2013-11-07T00:00:00,Prostatic Neoplasms,C12.294.260.750
24200968,2013-11-07T00:00:00,Prostatic Neoplasms,C12.294.565.625
24200968,2013-11-07T00:00:00,Prostatic Neoplasms,C12.758.409.750
24200968,2013-11-07T00:00:00,"Tumor Markers, Biological",D23.101.840
24202177,2013-11-07T00:00:00,"Analgesics, Non-Narcotic",D27.505.696.663.850.014.040
24202177,2013-11-07T00:00:00,"Analgesics, Non-Narcotic",D27.505.954.427.040.100
24202177,2013-11-07T00:00:00,Animals,B01.050
24202177,2013-11-07T00:00:00,Bone Marrow Cells,A11.148
24202177,2013-11-07T00:00:00,Bone Marrow Cells,A15.378.316
24202177,2013-11-07T00:00:00,Gene Expression Regulation,G05.355.315
24202177,2013-11-07T00:00:00,Immune Tolerance,G12.425.746.425
24202177,2013-11-07T00:00:00,Myeloid Cells,A11.627
24204002,2013-11-07T00:00:00,3T3 Cells,A11.251.210.700
24204002,2013-11-07T00:00:00,3T3 Cells,A11.329.228.900
24204002,2013-11-07T00:00:00,Adult,M01.060.116
24204002,2013-11-07T00:00:00,Animals,B01.050
24204002,2013-11-07T00:00:00,Antimicrobial Cationic Peptides,D12.644.050
24204002,2013-11-07T00:00:00,Antimicrobial Cationic Peptides,D12.776.543.695.054
24204002,2013-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24204002,2013-11-07T00:00:00,Middle Aged,M01.060.116.630
24204002,2013-11-07T00:00:00,Pilot Projects,E05.318.760.750
24204002,2013-11-07T00:00:00,Pilot Projects,E05.337.737
24204002,2013-11-07T00:00:00,Pilot Projects,N05.715.360.775.625
24204002,2013-11-07T00:00:00,Pilot Projects,N06.850.520.450.720
24204002,2013-11-07T00:00:00,Vitamin D,D04.808.812.768
24268011,2013-11-07T00:00:00,Heart Diseases,C14.280
24268011,2013-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24268011,2013-11-07T00:00:00,"Scleroderma, Systemic",C17.300.799
24268011,2013-11-07T00:00:00,"Scleroderma, Systemic",C17.800.784
24331932,2013-11-07T00:00:00,"Abnormalities, Multiple",C16.131.077
24331932,2013-11-07T00:00:00,Coronary Angiography,E01.370.350.700.060.200
24331932,2013-11-07T00:00:00,Coronary Angiography,E01.370.370.050.200
24331932,2013-11-07T00:00:00,Coronary Angiography,E01.370.370.380.200
24331932,2013-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24331932,2013-11-07T00:00:00,Infant,M01.060.703
24331932,2013-11-07T00:00:00,"Infant, Newborn",M01.060.703.520
24331932,2013-11-07T00:00:00,Pulmonary Artery,A07.231.114.715
24331932,2013-11-07T00:00:00,Sensitivity and Specificity,E05.318.740.872
24331932,2013-11-07T00:00:00,Sensitivity and Specificity,E05.318.780.800
24331932,2013-11-07T00:00:00,Sensitivity and Specificity,G17.800
24331932,2013-11-07T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
24331932,2013-11-07T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
24331932,2013-11-07T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
24331932,2013-11-07T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24331932,2013-11-07T00:00:00,Tetralogy of Fallot,C14.240.400.849
24331932,2013-11-07T00:00:00,Tetralogy of Fallot,C14.280.400.849
24331932,2013-11-07T00:00:00,Tetralogy of Fallot,C16.131.240.400.849
24331932,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24331932,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24331932,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24331932,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24331932,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24331936,2013-11-07T00:00:00,Child,M01.060.406
24331936,2013-11-07T00:00:00,"Child, Preschool",M01.060.406.448
24331936,2013-11-07T00:00:00,Coronary Angiography,E01.370.350.700.060.200
24331936,2013-11-07T00:00:00,Coronary Angiography,E01.370.370.050.200
24331936,2013-11-07T00:00:00,Coronary Angiography,E01.370.370.380.200
24331936,2013-11-07T00:00:00,"Heart Defects, Congenital",C14.240.400
24331936,2013-11-07T00:00:00,"Heart Defects, Congenital",C14.280.400
24331936,2013-11-07T00:00:00,"Heart Defects, Congenital",C16.131.240.400
24331936,2013-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24331936,2013-11-07T00:00:00,Infant,M01.060.703
24331936,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24331936,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24331936,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24331936,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24331936,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24331937,2013-11-07T00:00:00,"Abnormalities, Multiple",C16.131.077
24331937,2013-11-07T00:00:00,Child,M01.060.406
24331937,2013-11-07T00:00:00,Coronary Angiography,E01.370.350.700.060.200
24331937,2013-11-07T00:00:00,Coronary Angiography,E01.370.370.050.200
24331937,2013-11-07T00:00:00,Coronary Angiography,E01.370.370.380.200
24331937,2013-11-07T00:00:00,"Heart Defects, Congenital",C14.240.400
24331937,2013-11-07T00:00:00,"Heart Defects, Congenital",C14.280.400
24331937,2013-11-07T00:00:00,"Heart Defects, Congenital",C16.131.240.400
24331937,2013-11-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24331937,2013-11-07T00:00:00,"Infant, Newborn",M01.060.703.520
24331937,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24331937,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24331937,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24331937,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24331937,2013-11-07T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24213915,2013-11-08T00:00:00,Animals,B01.050
24213915,2013-11-08T00:00:00,Bronchial Hyperreactivity,C08.127.210
24213915,2013-11-08T00:00:00,Bronchiectasis,C08.127.384
24213915,2013-11-08T00:00:00,Cilia,A11.284.180.165
24213915,2013-11-08T00:00:00,Ciliary Motility Disorders,C08.200
24213915,2013-11-08T00:00:00,Ciliary Motility Disorders,C09.150
24213915,2013-11-08T00:00:00,Tumor Suppressor Proteins,D12.776.624.776
24331934,2013-11-08T00:00:00,"Abnormalities, Multiple",C16.131.077
24331934,2013-11-08T00:00:00,Adolescent,M01.060.057
24331934,2013-11-08T00:00:00,Adult,M01.060.116
24331934,2013-11-08T00:00:00,Aged,M01.060.116.100
24331934,2013-11-08T00:00:00,Child,M01.060.406
24331934,2013-11-08T00:00:00,"Child, Preschool",M01.060.406.448
24331934,2013-11-08T00:00:00,Coronary Angiography,E01.370.350.700.060.200
24331934,2013-11-08T00:00:00,Coronary Angiography,E01.370.370.050.200
24331934,2013-11-08T00:00:00,Coronary Angiography,E01.370.370.380.200
24331934,2013-11-08T00:00:00,Coronary Vessel Anomalies,C14.240.400.210
24331934,2013-11-08T00:00:00,Coronary Vessel Anomalies,C14.280.400.210
24331934,2013-11-08T00:00:00,Coronary Vessel Anomalies,C16.131.240.400.210
24331934,2013-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24331934,2013-11-08T00:00:00,Incidence,E05.318.308.985.525.375
24331934,2013-11-08T00:00:00,Incidence,L01.280.975.525.375
24331934,2013-11-08T00:00:00,Incidence,N01.224.935.597.500
24331934,2013-11-08T00:00:00,Incidence,N06.850.505.400.975.525.375
24331934,2013-11-08T00:00:00,Incidence,N06.850.520.308.985.525.375
24331934,2013-11-08T00:00:00,Infant,M01.060.703
24331934,2013-11-08T00:00:00,"Infant, Newborn",M01.060.703.520
24331934,2013-11-08T00:00:00,Middle Aged,M01.060.116.630
24331934,2013-11-08T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.600.350.700.700
24331934,2013-11-08T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.700.700.700
24331934,2013-11-08T00:00:00,"Radiography, Dual-Energy Scanned Projection",E01.370.350.760.700
24331934,2013-11-08T00:00:00,"Radiography, Dual-Energy Scanned Projection",L01.224.308.380.800
24331934,2013-11-08T00:00:00,Risk Factors,E05.318.740.600.800.725
24331934,2013-11-08T00:00:00,Risk Factors,N05.715.350.200.700
24331934,2013-11-08T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24331934,2013-11-08T00:00:00,Risk Factors,N06.850.490.625.750
24331934,2013-11-08T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24331934,2013-11-08T00:00:00,Sensitivity and Specificity,E05.318.740.872
24331934,2013-11-08T00:00:00,Sensitivity and Specificity,E05.318.780.800
24331934,2013-11-08T00:00:00,Sensitivity and Specificity,G17.800
24331934,2013-11-08T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
24331934,2013-11-08T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
24331934,2013-11-08T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
24331934,2013-11-08T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24331934,2013-11-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24331934,2013-11-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24331934,2013-11-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24331934,2013-11-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24331934,2013-11-08T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24331934,2013-11-08T00:00:00,Young Adult,M01.060.116.815
24399661,2013-11-08T00:00:00,Adult,M01.060.116
24399661,2013-11-08T00:00:00,Disease Management,N04.590.607
24399661,2013-11-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24399661,2013-11-08T00:00:00,Parenteral Nutrition,E02.421.505
24399661,2013-11-08T00:00:00,Parenteral Nutrition,E02.642.500.505
24399661,2013-11-08T00:00:00,Pharmaceutical Preparations,D26
24215451,2013-11-11T00:00:00,Adult,M01.060.116
24215451,2013-11-11T00:00:00,Data Collection,E05.318.308
24215451,2013-11-11T00:00:00,Data Collection,L01.280
24215451,2013-11-11T00:00:00,Data Collection,N05.715.360.300
24215451,2013-11-11T00:00:00,Data Collection,N06.850.520.308
24215451,2013-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24215451,2013-11-11T00:00:00,Middle Aged,M01.060.116.630
24215451,2013-11-11T00:00:00,Neuropsychology,F04.096.795.600
24215451,2013-11-11T00:00:00,Neuropsychology,H01.158.782.795.110
24215451,2013-11-11T00:00:00,United States,Z01.107.567.875
24524588,2013-11-11T00:00:00,"Adaptation, Psychological",F01.058
24524588,2013-11-11T00:00:00,Adult,M01.060.116
24524588,2013-11-11T00:00:00,Bereavement,F01.470.142
24524588,2013-11-11T00:00:00,Depression,F01.145.126.350
24524588,2013-11-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24524588,2013-11-11T00:00:00,Middle Aged,M01.060.116.630
24524588,2013-11-11T00:00:00,Treatment Outcome,E01.789.800
24524588,2013-11-11T00:00:00,Treatment Outcome,N04.761.559.590.800
24524588,2013-11-11T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24524588,2013-11-11T00:00:00,Violence,I01.198.240.856
24524588,2013-11-11T00:00:00,Violence,I01.880.735.900
24222018,2013-11-12T00:00:00,American Heart Association,N03.540.630.780.110
24222018,2013-11-12T00:00:00,Cardiovascular Diseases,C14
24222018,2013-11-12T00:00:00,Continental Population Groups,M01.686.508
24222018,2013-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24222018,2013-11-12T00:00:00,Risk Assessment,E05.318.740.600.800.715
24222018,2013-11-12T00:00:00,Risk Assessment,N04.452.871.715
24222018,2013-11-12T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24222018,2013-11-12T00:00:00,Risk Assessment,N06.850.505.715
24222018,2013-11-12T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24222018,2013-11-12T00:00:00,Sex Factors,N05.715.350.675
24222018,2013-11-12T00:00:00,Sex Factors,N06.850.490.875
24222018,2013-11-12T00:00:00,United States,Z01.107.567.875
24227760,2013-11-12T00:00:00,Antineoplastic Agents,D27.505.954.248
24227760,2013-11-12T00:00:00,Cell Proliferation,G04.299.233.750
24227760,2013-11-12T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24227760,2013-11-12T00:00:00,Hela Cells,A11.251.210.190.400
24227760,2013-11-12T00:00:00,Hela Cells,A11.251.860.180.400
24227760,2013-11-12T00:00:00,Hela Cells,A11.436.340
24227760,2013-11-12T00:00:00,Histone Deacetylase Inhibitors,D27.505.519.389.360
24227760,2013-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24227760,2013-11-12T00:00:00,"Models, Molecular",E05.599.595
24227760,2013-11-12T00:00:00,Molecular Conformation,G02.111.570.790
24227760,2013-11-12T00:00:00,Molecular Conformation,G02.575.500
24227760,2013-11-12T00:00:00,Molecular Conformation,G02.842.575.500
24227760,2013-11-12T00:00:00,Small Molecule Libraries,D27.720.470.765
24238571,2013-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24238571,2013-11-12T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
24238571,2013-11-12T00:00:00,Prostatic Neoplasms,C12.294.260.750
24238571,2013-11-12T00:00:00,Prostatic Neoplasms,C12.294.565.625
24238571,2013-11-12T00:00:00,Prostatic Neoplasms,C12.758.409.750
24239921,2013-11-12T00:00:00,American Heart Association,N03.540.630.780.110
24239921,2013-11-12T00:00:00,Blood Pressure,E01.370.600.875.249
24239921,2013-11-12T00:00:00,Blood Pressure,G09.330.380.076
24239921,2013-11-12T00:00:00,Cardiology,H02.403.429.163
24239921,2013-11-12T00:00:00,Cardiovascular Diseases,C14
24239921,2013-11-12T00:00:00,Diet,E05.272
24239921,2013-11-12T00:00:00,Diet,G07.610.240
24239921,2013-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24239921,2013-11-12T00:00:00,Risk Assessment,E05.318.740.600.800.715
24239921,2013-11-12T00:00:00,Risk Assessment,N04.452.871.715
24239921,2013-11-12T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24239921,2013-11-12T00:00:00,Risk Assessment,N06.850.505.715
24239921,2013-11-12T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24239921,2013-11-12T00:00:00,Risk Factors,E05.318.740.600.800.725
24239921,2013-11-12T00:00:00,Risk Factors,N05.715.350.200.700
24239921,2013-11-12T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24239921,2013-11-12T00:00:00,Risk Factors,N06.850.490.625.750
24239921,2013-11-12T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24239921,2013-11-12T00:00:00,"Societies, Medical",N03.540.828.589
24239921,2013-11-12T00:00:00,United States,Z01.107.567.875
24249870,2013-11-12T00:00:00,"Education, Pharmacy",I02.358.525
24249870,2013-11-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24249870,2013-11-12T00:00:00,"Schools, Pharmacy",I02.783.660.694
24249870,2013-11-12T00:00:00,United States,Z01.107.567.875
24446171,2013-11-12T00:00:00,Animals,B01.050
24446171,2013-11-12T00:00:00,Carrier Proteins,D12.776.157
24446171,2013-11-12T00:00:00,Conditioning (Psychology),F02.463.425.179
24446171,2013-11-12T00:00:00,Electric Stimulation,E05.723.402
24446171,2013-11-12T00:00:00,Fear,F01.470.361
24446171,2013-11-12T00:00:00,Hippocampus,A08.186.211.464.405
24446171,2013-11-12T00:00:00,Hippocampus,A08.186.211.730.885.287.500.345
24446171,2013-11-12T00:00:00,Long-Term Potentiation,G11.561.600.635.350
24446171,2013-11-12T00:00:00,"Mice, Inbred DBA",B01.050.050.157.520.460
24446171,2013-11-12T00:00:00,"Mice, Inbred DBA",B01.050.050.199.520.520.460
24446171,2013-11-12T00:00:00,"Mice, Inbred DBA",B01.050.150.900.649.865.635.505.500.400.460
24446171,2013-11-12T00:00:00,"Receptors, N-Methyl-D-Aspartate",D12.776.543.750.720.200.450.580
24446171,2013-11-12T00:00:00,Synapses,A08.850
24446171,2013-11-12T00:00:00,Synapses,A11.284.149.165.420.780
24236058,2013-11-13T00:00:00,Animals,B01.050
24236058,2013-11-13T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
24236058,2013-11-13T00:00:00,"Polymorphism, Single Nucleotide",G05.365.795.598
24236058,2013-11-13T00:00:00,Weight Gain,C23.888.144.243.926
24236058,2013-11-13T00:00:00,Weight Gain,G07.700.320.249.314.120.200.926
24238838,2013-11-13T00:00:00,Adsorption,G02.149.047
24238838,2013-11-13T00:00:00,Adsorption,G02.149.767.029
24238838,2013-11-13T00:00:00,Adsorption,G02.842.750.029
24238838,2013-11-13T00:00:00,Geologic Sediments,G01.311.500
24238838,2013-11-13T00:00:00,Geologic Sediments,G16.500.320
24238838,2013-11-13T00:00:00,"Models, Theoretical",E05.599
24238838,2013-11-13T00:00:00,Plutonium,D01.268.033.700
24238838,2013-11-13T00:00:00,Plutonium,D01.268.271.100.700
24238838,2013-11-13T00:00:00,Plutonium,D01.268.556.700
24238838,2013-11-13T00:00:00,Plutonium,D01.552.020.734
24238838,2013-11-13T00:00:00,Plutonium,D01.552.544.700
24238838,2013-11-13T00:00:00,Radioactive Waste,D20.693.638
24238838,2013-11-13T00:00:00,Radioactive Waste,D20.944.380.638
24238838,2013-11-13T00:00:00,Radioactive Waste,N06.850.460.710.380.638
24238838,2013-11-13T00:00:00,Radioactive Waste,N06.850.810.485
24238838,2013-11-13T00:00:00,South Carolina,Z01.107.567.875.075.662
24238838,2013-11-13T00:00:00,South Carolina,Z01.107.567.875.750.700
24238838,2013-11-13T00:00:00,"Water Pollutants, Radioactive",D20.693.903
24238838,2013-11-13T00:00:00,"Water Pollutants, Radioactive",D27.888.284.903.821
24266976,2013-11-13T00:00:00,Adult,M01.060.116
24266976,2013-11-13T00:00:00,Fibrosis,C23.550.355
24266976,2013-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24266976,2013-11-13T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
24266976,2013-11-13T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
24266976,2013-11-13T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
24266976,2013-11-13T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
24266976,2013-11-13T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
24266976,2013-11-13T00:00:00,Kidney Transplantation,E02.870.500
24266976,2013-11-13T00:00:00,Kidney Transplantation,E04.936.450.485
24266976,2013-11-13T00:00:00,Kidney Transplantation,E04.950.774.400
24266976,2013-11-13T00:00:00,Living Donors,M01.898.656
24266976,2013-11-13T00:00:00,Renal Dialysis,E02.870.300
24266976,2013-11-13T00:00:00,Renal Dialysis,E02.912.800
24266976,2013-11-13T00:00:00,Treatment Outcome,E01.789.800
24266976,2013-11-13T00:00:00,Treatment Outcome,N04.761.559.590.800
24266976,2013-11-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24300735,2013-11-13T00:00:00,Animals,B01.050
24300735,2013-11-13T00:00:00,Drug Design,E05.295.500
24300735,2013-11-13T00:00:00,Drug Design,H01.158.703.007.675.500
24300735,2013-11-13T00:00:00,Drug Design,H01.181.466.675.500
24300735,2013-11-13T00:00:00,Enzyme Inhibitors,D27.505.519.389
24300735,2013-11-13T00:00:00,Histone Demethylases,D08.811.682.662.582.475
24300735,2013-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24300735,2013-11-13T00:00:00,Molecular Structure,G02.111.570
24300735,2013-11-13T00:00:00,Molecular Structure,G02.575
24300735,2013-11-13T00:00:00,Molecular Structure,G02.842.575
24378335,2013-11-13T00:00:00,Adenocarcinoma,C04.557.470.200.025
24378335,2013-11-13T00:00:00,Aged,M01.060.116.100
24378335,2013-11-13T00:00:00,Anilides,D02.065.199
24378335,2013-11-13T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.183.750.500
24378335,2013-11-13T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.077.500
24378335,2013-11-13T00:00:00,Antineoplastic Combined Chemotherapy Protocols,E02.319.310.037
24378335,2013-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24378335,2013-11-13T00:00:00,Middle Aged,M01.060.116.630
24378335,2013-11-13T00:00:00,Prostatic Neoplasms,C04.588.945.440.770
24378335,2013-11-13T00:00:00,Prostatic Neoplasms,C12.294.260.750
24378335,2013-11-13T00:00:00,Prostatic Neoplasms,C12.294.565.625
24378335,2013-11-13T00:00:00,Prostatic Neoplasms,C12.758.409.750
24378335,2013-11-13T00:00:00,"Radiotherapy, Intensity-Modulated",E02.815.635.700.700
24378335,2013-11-13T00:00:00,"Radiotherapy, Intensity-Modulated",L01.700.508.100.710.600.550.700
24378335,2013-11-13T00:00:00,Treatment Outcome,E01.789.800
24378335,2013-11-13T00:00:00,Treatment Outcome,N04.761.559.590.800
24378335,2013-11-13T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24475833,2013-11-13T00:00:00,Adenosine,D03.438.759.590.138
24475833,2013-11-13T00:00:00,Adenosine,D13.570.583.138
24475833,2013-11-13T00:00:00,Adenosine,D13.570.800.096
24475833,2013-11-13T00:00:00,Contrast Media,D27.720.259
24475833,2013-11-13T00:00:00,Coronary Artery Disease,C14.280.647.250.260
24475833,2013-11-13T00:00:00,Coronary Artery Disease,C14.907.137.126.339
24475833,2013-11-13T00:00:00,Coronary Artery Disease,C14.907.585.250.260
24475833,2013-11-13T00:00:00,Exercise Test,E01.370.370.380.250
24475833,2013-11-13T00:00:00,Exercise Test,E01.370.386.700.250
24475833,2013-11-13T00:00:00,Exercise Test,E05.333.250
24475833,2013-11-13T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24475833,2013-11-13T00:00:00,Middle Aged,M01.060.116.630
24475833,2013-11-13T00:00:00,Radiation Dosage,E05.799.513
24475833,2013-11-13T00:00:00,Radiation Dosage,G01.201.875.740
24475833,2013-11-13T00:00:00,Radiation Dosage,N06.850.810.250
24475833,2013-11-13T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
24475833,2013-11-13T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
24475833,2013-11-13T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
24475833,2013-11-13T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
24475833,2013-11-13T00:00:00,Sensitivity and Specificity,E05.318.740.872
24475833,2013-11-13T00:00:00,Sensitivity and Specificity,E05.318.780.800
24475833,2013-11-13T00:00:00,Sensitivity and Specificity,G17.800
24475833,2013-11-13T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
24475833,2013-11-13T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
24475833,2013-11-13T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
24475833,2013-11-13T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24475833,2013-11-13T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.350.800.800
24475833,2013-11-13T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.600.350.800.800
24475833,2013-11-13T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.710.800.800
24475833,2013-11-13T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.350.825.800.800
24475833,2013-11-13T00:00:00,"Tomography, Emission-Computed, Single-Photon",E01.370.384.730.800.800
24475833,2013-11-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24475833,2013-11-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24475833,2013-11-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24475833,2013-11-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24475833,2013-11-13T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24231848,2013-11-14T00:00:00,Brain,A08.186.211
24231848,2013-11-14T00:00:00,Brain Mapping,E01.370.350.086
24231848,2013-11-14T00:00:00,Brain Mapping,E01.370.376.149
24231848,2013-11-14T00:00:00,Brain Mapping,E05.132
24231848,2013-11-14T00:00:00,"Child, Preschool",M01.060.406.448
24231848,2013-11-14T00:00:00,Diffusion Tensor Imaging,E01.370.350.500.150.500
24231848,2013-11-14T00:00:00,Diffusion Tensor Imaging,E01.370.376.224
24231848,2013-11-14T00:00:00,Diffusion Tensor Imaging,E05.278
24231848,2013-11-14T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24231848,2013-11-14T00:00:00,Infant,M01.060.703
24231848,2013-11-14T00:00:00,"Infant, Newborn",M01.060.703.520
24231848,2013-11-14T00:00:00,"Models, Neurological",E05.599.395.642
24232172,2013-11-15T00:00:00,Animals,B01.050
24232172,2013-11-15T00:00:00,Cocaine,D02.145.074.722.388
24232172,2013-11-15T00:00:00,Cocaine,D03.132.889.354
24232172,2013-11-15T00:00:00,Cocaine,D03.605.869.388
24232172,2013-11-15T00:00:00,Cocaine,D04.075.080.875.099.722.388
24232172,2013-11-15T00:00:00,Cocaine-Related Disorders,C21.739.300
24232172,2013-11-15T00:00:00,Cocaine-Related Disorders,F03.900.300
24232172,2013-11-15T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.150.800
24232172,2013-11-15T00:00:00,Dopamine Uptake Inhibitors,D27.505.519.625.600.220
24232172,2013-11-15T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.150.800
24232172,2013-11-15T00:00:00,Dopamine Uptake Inhibitors,D27.505.696.577.600.220
24232172,2013-11-15T00:00:00,"Extinction, Psychological",F02.463.425.770.232
24232172,2013-11-15T00:00:00,Glutamic Acid,D12.125.067.750
24232172,2013-11-15T00:00:00,Glutamic Acid,D12.125.119.450
24232172,2013-11-15T00:00:00,Glutamic Acid,D12.125.427.300
24232172,2013-11-15T00:00:00,Neural Pathways,A08.612
24232172,2013-11-15T00:00:00,Neuronal Plasticity,G11.561.600.635
24232172,2013-11-15T00:00:00,Nucleus Accumbens,A08.186.211.730.885.287.249.683
24232172,2013-11-15T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
24232172,2013-11-15T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24232172,2013-11-15T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
24232172,2013-11-15T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.070.300.400.500
24232172,2013-11-15T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.100.150.400.500
24232172,2013-11-15T00:00:00,"Receptors, Dopamine D2",D12.776.543.750.720.300.300.400.500
24232172,2013-11-15T00:00:00,Synapses,A08.850
24232172,2013-11-15T00:00:00,Synapses,A11.284.149.165.420.780
24232172,2013-11-15T00:00:00,Ventral Tegmental Area,A08.186.211.132.659.822.820
24232172,2013-11-15T00:00:00,Ventral Tegmental Area,A08.186.211.653.822.820
24243871,2013-11-15T00:00:00,Adult,M01.060.116
24243871,2013-11-15T00:00:00,Attitude of Health Personnel,F01.100.050
24243871,2013-11-15T00:00:00,Attitude of Health Personnel,N05.300.100
24243871,2013-11-15T00:00:00,Chronic Disease,C23.550.291.500
24243871,2013-11-15T00:00:00,Clinical Competence,I02.399.630.210
24243871,2013-11-15T00:00:00,Clinical Competence,N04.761.210
24243871,2013-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24243871,2013-11-15T00:00:00,Middle Aged,M01.060.116.630
24243871,2013-11-15T00:00:00,Nurse Practitioners,M01.526.485.650.640
24243871,2013-11-15T00:00:00,Nurse Practitioners,N02.360.650.640
24243871,2013-11-15T00:00:00,Questionnaires,E05.318.308.750
24243871,2013-11-15T00:00:00,Questionnaires,L01.280.800
24243871,2013-11-15T00:00:00,Questionnaires,N05.715.360.300.695
24243871,2013-11-15T00:00:00,Questionnaires,N06.850.520.308.750
24246152,2013-11-15T00:00:00,Environmental Exposure,N06.850.460.350
24246152,2013-11-15T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24246152,2013-11-15T00:00:00,Metals,D01.552
24246152,2013-11-15T00:00:00,Risk Assessment,E05.318.740.600.800.715
24246152,2013-11-15T00:00:00,Risk Assessment,N04.452.871.715
24246152,2013-11-15T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24246152,2013-11-15T00:00:00,Risk Assessment,N06.850.505.715
24246152,2013-11-15T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24246152,2013-11-15T00:00:00,Soil Pollutants,D27.888.284.756
24242861,2013-11-16T00:00:00,Adult,M01.060.116
24242861,2013-11-16T00:00:00,Aged,M01.060.116.100
24242861,2013-11-16T00:00:00,"Carcinoma, Renal Cell",C04.557.470.200.025.390
24242861,2013-11-16T00:00:00,"Carcinoma, Renal Cell",C04.588.945.947.535.160
24242861,2013-11-16T00:00:00,"Carcinoma, Renal Cell",C12.758.820.750.160
24242861,2013-11-16T00:00:00,"Carcinoma, Renal Cell",C12.777.419.473.160
24242861,2013-11-16T00:00:00,"Carcinoma, Renal Cell",C13.351.937.820.535.160
24242861,2013-11-16T00:00:00,"Carcinoma, Renal Cell",C13.351.968.419.473.160
24242861,2013-11-16T00:00:00,Demography,I01.240
24242861,2013-11-16T00:00:00,Demography,N01.224
24242861,2013-11-16T00:00:00,Demography,N06.850.505.400
24242861,2013-11-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24242861,2013-11-16T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
24242861,2013-11-16T00:00:00,Kidney Neoplasms,C04.588.945.947.535
24242861,2013-11-16T00:00:00,Kidney Neoplasms,C12.758.820.750
24242861,2013-11-16T00:00:00,Kidney Neoplasms,C12.777.419.473
24242861,2013-11-16T00:00:00,Kidney Neoplasms,C13.351.937.820.535
24242861,2013-11-16T00:00:00,Kidney Neoplasms,C13.351.968.419.473
24242861,2013-11-16T00:00:00,Middle Aged,M01.060.116.630
24242861,2013-11-16T00:00:00,"Models, Molecular",E05.599.595
24242861,2013-11-16T00:00:00,Phosphoproteins,D12.776.744
24242861,2013-11-16T00:00:00,RNA-Binding Proteins,D12.776.157.725
24242861,2013-11-16T00:00:00,RNA-Binding Proteins,D12.776.664.962
24242861,2013-11-16T00:00:00,"Sequence Analysis, DNA",E05.393.760.700
24242861,2013-11-16T00:00:00,Treatment Outcome,E01.789.800
24242861,2013-11-16T00:00:00,Treatment Outcome,N04.761.559.590.800
24242861,2013-11-16T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24241791,2013-11-17T00:00:00,Alcohol-Related Disorders,C21.739.100
24241791,2013-11-17T00:00:00,Alcohol-Related Disorders,F03.900.100
24241791,2013-11-17T00:00:00,Animals,B01.050
24241791,2013-11-17T00:00:00,Cell Culture Techniques,E05.200.249.249
24241791,2013-11-17T00:00:00,Central Nervous System Depressants,D27.505.696.277
24241791,2013-11-17T00:00:00,Central Nervous System Depressants,D27.505.954.427.210
24241791,2013-11-17T00:00:00,Down-Regulation,G02.111.087.225
24241791,2013-11-17T00:00:00,Down-Regulation,G02.149.115.225
24241791,2013-11-17T00:00:00,Down-Regulation,G05.355.315.200
24241791,2013-11-17T00:00:00,Down-Regulation,G07.690.812.230
24241791,2013-11-17T00:00:00,Down-Regulation,G07.700.680.230
24241791,2013-11-17T00:00:00,Ethanol,D02.033.375
24241791,2013-11-17T00:00:00,Neurons,A08.663
24241791,2013-11-17T00:00:00,Neurons,A11.671
24241791,2013-11-17T00:00:00,Patch-Clamp Techniques,E05.200.500.800
24241791,2013-11-17T00:00:00,Potassium,D01.268.549.550
24241791,2013-11-17T00:00:00,Potassium,D01.552.528.652
24241791,2013-11-17T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
24241791,2013-11-17T00:00:00,Substance Withdrawal Syndrome,C21.739.835
24241791,2013-11-17T00:00:00,Substance Withdrawal Syndrome,F03.900.825
24295787,2013-11-17T00:00:00,Antineoplastic Agents,D27.505.954.248
24295787,2013-11-17T00:00:00,Arachidonate 5-Lipoxygenase,D08.811.682.690.416.444.050.055
24295787,2013-11-17T00:00:00,Arachidonate 5-Lipoxygenase,D12.776.556.579.374.450.025.020
24295787,2013-11-17T00:00:00,Cell Proliferation,G04.299.233.750
24295787,2013-11-17T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24295787,2013-11-17T00:00:00,Cell Survival,G04.299.316
24295787,2013-11-17T00:00:00,Cyclooxygenase 2,D08.811.600.720.750
24295787,2013-11-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24295787,2013-11-17T00:00:00,"Models, Molecular",E05.599.595
24295787,2013-11-17T00:00:00,Molecular Structure,G02.111.570
24295787,2013-11-17T00:00:00,Molecular Structure,G02.575
24295787,2013-11-17T00:00:00,Molecular Structure,G02.842.575
24224861,2013-11-18T00:00:00,Carbon,D01.268.150
24224861,2013-11-18T00:00:00,Graphite,D01.268.150.300
24224861,2013-11-18T00:00:00,Graphite,D01.578.300
24224861,2013-11-18T00:00:00,Nanostructures,J01.637.512
24224861,2013-11-18T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
24224861,2013-11-18T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
24224861,2013-11-18T00:00:00,Optics and Photonics,H01.671.617
24224861,2013-11-18T00:00:00,Optics and Photonics,J01.293.688
24257675,2013-11-20T00:00:00,Aged,M01.060.116.100
24257675,2013-11-20T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
24257675,2013-11-20T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
24257675,2013-11-20T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
24257675,2013-11-20T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
24257675,2013-11-20T00:00:00,Hospitalization,E02.760.400
24257675,2013-11-20T00:00:00,Hospitalization,N02.421.585.400
24257675,2013-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24257675,2013-11-20T00:00:00,Incidence,E05.318.308.985.525.375
24257675,2013-11-20T00:00:00,Incidence,L01.280.975.525.375
24257675,2013-11-20T00:00:00,Incidence,N01.224.935.597.500
24257675,2013-11-20T00:00:00,Incidence,N06.850.505.400.975.525.375
24257675,2013-11-20T00:00:00,Incidence,N06.850.520.308.985.525.375
24257675,2013-11-20T00:00:00,Pulmonary Embolism,C08.381.746
24257675,2013-11-20T00:00:00,Pulmonary Embolism,C14.907.355.350.700
24257675,2013-11-20T00:00:00,Risk Factors,E05.318.740.600.800.725
24257675,2013-11-20T00:00:00,Risk Factors,N05.715.350.200.700
24257675,2013-11-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24257675,2013-11-20T00:00:00,Risk Factors,N06.850.490.625.750
24257675,2013-11-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24257675,2013-11-20T00:00:00,United States,Z01.107.567.875
24258566,2013-11-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24258566,2013-11-20T00:00:00,Lung Diseases,C08.381
24258566,2013-11-20T00:00:00,Lung Neoplasms,C04.588.894.797.520
24258566,2013-11-20T00:00:00,Lung Neoplasms,C08.381.540
24258566,2013-11-20T00:00:00,Lung Neoplasms,C08.785.520
24258566,2013-11-20T00:00:00,Mass Screening,E01.370.500
24258566,2013-11-20T00:00:00,Mass Screening,E05.318.308.250.580
24258566,2013-11-20T00:00:00,Mass Screening,N02.421.143.827.233.443
24258566,2013-11-20T00:00:00,Mass Screening,N02.421.726.233.443
24258566,2013-11-20T00:00:00,Mass Screening,N05.715.360.300.375.500
24258566,2013-11-20T00:00:00,Mass Screening,N06.850.520.308.250.580
24258566,2013-11-20T00:00:00,Mass Screening,N06.850.780.500
24258566,2013-11-20T00:00:00,Patient Preference,N04.452.822.360.600.500
24258566,2013-11-20T00:00:00,Patient Preference,N05.300.150.600.630.500
24258566,2013-11-20T00:00:00,Probability,E05.318.740.600
24258566,2013-11-20T00:00:00,Probability,G17.680
24258566,2013-11-20T00:00:00,Probability,N05.715.360.750.625
24258566,2013-11-20T00:00:00,Probability,N06.850.520.830.600
24258566,2013-11-20T00:00:00,Risk Factors,E05.318.740.600.800.725
24258566,2013-11-20T00:00:00,Risk Factors,N05.715.350.200.700
24258566,2013-11-20T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24258566,2013-11-20T00:00:00,Risk Factors,N06.850.490.625.750
24258566,2013-11-20T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24258566,2013-11-20T00:00:00,Solitary Pulmonary Nodule,C04.588.894.797.520.966
24258566,2013-11-20T00:00:00,Solitary Pulmonary Nodule,C08.381.540.933
24258566,2013-11-20T00:00:00,Solitary Pulmonary Nodule,C08.381.884
24258566,2013-11-20T00:00:00,Solitary Pulmonary Nodule,C08.785.520.933
24269279,2013-11-20T00:00:00,Animals,B01.050
24269279,2013-11-20T00:00:00,Biological Markers,D23.101
24269279,2013-11-20T00:00:00,Cell Lineage,G04.172
24269279,2013-11-20T00:00:00,Cell Lineage,G07.700.320.500.325.180.500
24269279,2013-11-20T00:00:00,Cell Lineage,G08.686.155
24269279,2013-11-20T00:00:00,Cell Lineage,G08.686.785.760.170.104.249
24269279,2013-11-20T00:00:00,Cell Membrane,A11.284.149
24269279,2013-11-20T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.587.200
24269279,2013-11-20T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.625.225.200
24269279,2013-11-20T00:00:00,Dual Specificity Phosphatase 1,D08.811.277.352.650.775.250.200
24269279,2013-11-20T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.268.200
24269279,2013-11-20T00:00:00,Dual Specificity Phosphatase 1,D12.644.360.445.100
24269279,2013-11-20T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.268.200
24269279,2013-11-20T00:00:00,Dual Specificity Phosphatase 1,D12.776.476.445.200
24269279,2013-11-20T00:00:00,Gene Expression Regulation,G05.355.315
24269279,2013-11-20T00:00:00,NFATC Transcription Factors,D12.776.930.608
24269279,2013-11-20T00:00:00,Osteoclasts,A11.329.372.700
24269279,2013-11-20T00:00:00,Osteoclasts,A11.627.482.700
24269279,2013-11-20T00:00:00,Osteogenesis,G07.700.320.500.325.377.625.100.729
24269279,2013-11-20T00:00:00,Osteogenesis,G11.427.590.560.100.729
24269279,2013-11-20T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
24269279,2013-11-20T00:00:00,Protein Transport,G03.495.166.700
24269279,2013-11-20T00:00:00,RANK Ligand,D12.644.276.374.750.562
24269279,2013-11-20T00:00:00,RANK Ligand,D12.644.276.972.562
24269279,2013-11-20T00:00:00,RANK Ligand,D12.776.467.374.750.562
24269279,2013-11-20T00:00:00,RANK Ligand,D12.776.467.972.562
24269279,2013-11-20T00:00:00,RANK Ligand,D23.529.374.750.562
24269279,2013-11-20T00:00:00,RANK Ligand,D23.529.972.562
24269279,2013-11-20T00:00:00,Signal Transduction,G02.111.087.800
24269279,2013-11-20T00:00:00,Signal Transduction,G02.149.115.800
24269279,2013-11-20T00:00:00,Signal Transduction,G04.299.880
24269279,2013-11-20T00:00:00,Stem Cells,A11.872
24269279,2013-11-20T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.567.878
24269279,2013-11-20T00:00:00,p38 Mitogen-Activated Protein Kinases,D08.811.913.696.620.682.700.646.750.843
24269279,2013-11-20T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.644.360.450.835
24269279,2013-11-20T00:00:00,p38 Mitogen-Activated Protein Kinases,D12.776.476.450.835
24188160,2013-11-21T00:00:00,Animals,B01.050
24188160,2013-11-21T00:00:00,Astrocytes,A08.637.200
24188160,2013-11-21T00:00:00,Astrocytes,A11.650.200
24188160,2013-11-21T00:00:00,Gene Expression,G05.355.310
24188160,2013-11-21T00:00:00,Lipopolysaccharides,D09.400.500
24188160,2013-11-21T00:00:00,Lipopolysaccharides,D09.698.718.450
24188160,2013-11-21T00:00:00,Lipopolysaccharides,D10.494
24188160,2013-11-21T00:00:00,Lipopolysaccharides,D23.050.161.616.525
24188160,2013-11-21T00:00:00,Lipopolysaccharides,D23.946.123.329.500
24188160,2013-11-21T00:00:00,MAP Kinase Signaling System,G02.111.087.800.560
24188160,2013-11-21T00:00:00,MAP Kinase Signaling System,G02.149.115.800.560
24188160,2013-11-21T00:00:00,MAP Kinase Signaling System,G03.495.553.560
24188160,2013-11-21T00:00:00,MAP Kinase Signaling System,G04.299.880.560
24188160,2013-11-21T00:00:00,Microglia,A08.637.400
24188160,2013-11-21T00:00:00,Microglia,A11.650.400
24188160,2013-11-21T00:00:00,Nitric Oxide,D01.339.387
24188160,2013-11-21T00:00:00,Nitric Oxide,D01.625.550.500
24188160,2013-11-21T00:00:00,Nitric Oxide,D01.625.700.500
24188160,2013-11-21T00:00:00,Nitric Oxide,D01.650.550.587.600
24188160,2013-11-21T00:00:00,Nitric Oxide Synthase Type II,D08.811.682.664.500.772.500
24188160,2013-11-21T00:00:00,Pregnancy,G08.686.785.760.769
24188160,2013-11-21T00:00:00,Proto-Oncogene Proteins,D12.776.624.664.700
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
24188160,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
24261661,2013-11-21T00:00:00,Animals,B01.050
24261661,2013-11-21T00:00:00,Central Nervous System Stimulants,D27.505.696.282
24261661,2013-11-21T00:00:00,Central Nervous System Stimulants,D27.505.954.427.220
24261661,2013-11-21T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.124
24261661,2013-11-21T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.500
24261661,2013-11-21T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.124
24261661,2013-11-21T00:00:00,Dopamine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.500
24261661,2013-11-21T00:00:00,Methylphenidate,D02.241.223.601.600
24261661,2013-11-21T00:00:00,Methylphenidate,D03.383.621.460
24261661,2013-11-21T00:00:00,Motor Activity,F01.145.632
24261661,2013-11-21T00:00:00,Motor Activity,G11.427.590.530.698
24261661,2013-11-21T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.450.625.186
24261661,2013-11-21T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.157.530.562.374.500.750
24261661,2013-11-21T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.450.625.186
24261661,2013-11-21T00:00:00,Norepinephrine Plasma Membrane Transport Proteins,D12.776.543.585.562.374.500.750
24261661,2013-11-21T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24261661,2013-11-21T00:00:00,"Rats, Sprague-Dawley",B01.050.150.900.649.865.635.505.700.750
24261661,2013-11-21T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.450.625.311
24261661,2013-11-21T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.157.530.562.374.875
24261661,2013-11-21T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.450.625.374
24261661,2013-11-21T00:00:00,Serotonin Plasma Membrane Transport Proteins,D12.776.543.585.562.374.875
24278169,2013-11-21T00:00:00,Animals,B01.050
24278169,2013-11-21T00:00:00,Antibodies,D12.776.124.486.485.114
24278169,2013-11-21T00:00:00,Antibodies,D12.776.124.790.651.114
24278169,2013-11-21T00:00:00,Antibodies,D12.776.377.715.548.114
24278169,2013-11-21T00:00:00,Interferon-gamma,D12.644.276.374.440.893
24278169,2013-11-21T00:00:00,Interferon-gamma,D12.644.276.374.480.350
24278169,2013-11-21T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
24278169,2013-11-21T00:00:00,Interferon-gamma,D12.644.276.718.550
24278169,2013-11-21T00:00:00,Interferon-gamma,D12.776.467.374.440.893
24278169,2013-11-21T00:00:00,Interferon-gamma,D12.776.467.374.480.350
24278169,2013-11-21T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
24278169,2013-11-21T00:00:00,Interferon-gamma,D12.776.467.718.550
24278169,2013-11-21T00:00:00,Interferon-gamma,D23.529.374.440.893
24278169,2013-11-21T00:00:00,Interferon-gamma,D23.529.374.480.350
24278169,2013-11-21T00:00:00,Interferon-gamma,D23.529.374.480.615.350
24278169,2013-11-21T00:00:00,Interferon-gamma,D23.529.718.550
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
24278169,2013-11-21T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
24264999,2013-11-22T00:00:00,Adolescent,M01.060.057
24264999,2013-11-22T00:00:00,Child,M01.060.406
24264999,2013-11-22T00:00:00,"Child, Preschool",M01.060.406.448
24264999,2013-11-22T00:00:00,Echocardiography,E01.370.350.850.220
24264999,2013-11-22T00:00:00,Echocardiography,E01.370.370.380.220
24264999,2013-11-22T00:00:00,Exercise Test,E01.370.370.380.250
24264999,2013-11-22T00:00:00,Exercise Test,E01.370.386.700.250
24264999,2013-11-22T00:00:00,Exercise Test,E05.333.250
24264999,2013-11-22T00:00:00,Fontan Procedure,E04.035.410.295
24264999,2013-11-22T00:00:00,Fontan Procedure,E04.100.376.410.295
24264999,2013-11-22T00:00:00,Fontan Procedure,E04.928.220.370.295
24264999,2013-11-22T00:00:00,Health Status,I01.240.425
24264999,2013-11-22T00:00:00,Health Status,N01.224.425
24264999,2013-11-22T00:00:00,Health Status,N06.850.505.400.425
24264999,2013-11-22T00:00:00,"Heart Defects, Congenital",C14.240.400
24264999,2013-11-22T00:00:00,"Heart Defects, Congenital",C14.280.400
24264999,2013-11-22T00:00:00,"Heart Defects, Congenital",C16.131.240.400
24264999,2013-11-22T00:00:00,Heart Ventricles,A07.541.560
24264999,2013-11-22T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24264999,2013-11-22T00:00:00,Quality of Life,I01.800
24264999,2013-11-22T00:00:00,Quality of Life,K01.752.400.750
24264999,2013-11-22T00:00:00,Questionnaires,E05.318.308.750
24264999,2013-11-22T00:00:00,Questionnaires,L01.280.800
24264999,2013-11-22T00:00:00,Questionnaires,N05.715.360.300.695
24264999,2013-11-22T00:00:00,Questionnaires,N06.850.520.308.750
24264999,2013-11-22T00:00:00,United States,Z01.107.567.875
24264999,2013-11-22T00:00:00,Young Adult,M01.060.116.815
24275386,2013-11-22T00:00:00,Actins,D05.750.078.730.250
24275386,2013-11-22T00:00:00,Actins,D12.776.210.500.100
24275386,2013-11-22T00:00:00,Actins,D12.776.220.525.255
24275386,2013-11-22T00:00:00,Animals,B01.050
24275386,2013-11-22T00:00:00,Collagen,D05.750.078.280
24275386,2013-11-22T00:00:00,Collagen,D12.776.860.300.250
24275386,2013-11-22T00:00:00,Creatinine,D03.383.129.308.207
24275386,2013-11-22T00:00:00,DNA,D13.444.308
24275386,2013-11-22T00:00:00,Fibrosis,C23.550.355
24275386,2013-11-22T00:00:00,Folic Acid,D03.438.733.631.400
24275386,2013-11-22T00:00:00,Homeostasis,G07.700.360
24275386,2013-11-22T00:00:00,Mitochondria,A11.284.430.214.190.875.564
24275386,2013-11-22T00:00:00,Mitochondria,A11.284.835.626
24275386,2013-11-22T00:00:00,Mitochondrial Diseases,C18.452.660
24275386,2013-11-22T00:00:00,"RNA, Messenger",D13.444.735.544
24277940,2013-11-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24277940,2013-11-25T00:00:00,"Protein Processing, Post-Translational",G02.111.087.675.871.790.600
24277940,2013-11-25T00:00:00,"Protein Processing, Post-Translational",G02.111.087.693.600
24277940,2013-11-25T00:00:00,"Protein Processing, Post-Translational",G02.149.115.675.871.790.600
24277940,2013-11-25T00:00:00,"Protein Processing, Post-Translational",G02.149.115.693.600
24277940,2013-11-25T00:00:00,"Protein Processing, Post-Translational",G03.495.770.871.790.600
24277940,2013-11-25T00:00:00,"Protein Processing, Post-Translational",G05.355.315.670.600
24277940,2013-11-25T00:00:00,Proteomics,H01.158.201.843
24277940,2013-11-25T00:00:00,Proteomics,H01.158.273.180.350.700
24277940,2013-11-25T00:00:00,Proteomics,H01.158.273.343.350.700
24277940,2013-11-25T00:00:00,Proteomics,H01.181.122.738
24215280,2013-11-26T00:00:00,Antineoplastic Agents,D27.505.954.248
24215280,2013-11-26T00:00:00,Drug Carriers,D26.255.260
24215280,2013-11-26T00:00:00,Drug Carriers,D27.720.280.260
24215280,2013-11-26T00:00:00,Drug Carriers,E02.319.300.380
24215280,2013-11-26T00:00:00,Drug Delivery Systems,E02.319.300
24215280,2013-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24215280,2013-11-26T00:00:00,Nanomedicine,H01.603.600
24215280,2013-11-26T00:00:00,Nanomedicine,J01.897.115.625
24215280,2013-11-26T00:00:00,Nanomedicine,J01.897.520.600.600
24215280,2013-11-26T00:00:00,Nanoparticles,J01.637.512.600
24215280,2013-11-26T00:00:00,Nanotechnology,H01.603
24215280,2013-11-26T00:00:00,Nanotechnology,J01.897.520.600
24215280,2013-11-26T00:00:00,Neoplasms,C04
24281227,2013-11-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24281227,2013-11-26T00:00:00,Research,H01.770.644
24281227,2013-11-26T00:00:00,Stroke,C10.228.140.300.775
24281227,2013-11-26T00:00:00,Stroke,C14.907.253.855
24281227,2013-11-26T00:00:00,United States,Z01.107.567.875
24281852,2013-11-27T00:00:00,Aged,M01.060.116.100
24281852,2013-11-27T00:00:00,Bayes Theorem,E05.318.740.600.200
24281852,2013-11-27T00:00:00,Bayes Theorem,N05.715.360.750.625.150
24281852,2013-11-27T00:00:00,Bayes Theorem,N06.850.520.830.600.200
24281852,2013-11-27T00:00:00,Breast Neoplasms,C04.588.180
24281852,2013-11-27T00:00:00,Breast Neoplasms,C17.800.090.500
24281852,2013-11-27T00:00:00,Case-Control Studies,E05.318.760.500.500
24281852,2013-11-27T00:00:00,Case-Control Studies,N05.715.360.775.175.200
24281852,2013-11-27T00:00:00,Case-Control Studies,N06.850.520.450.500.500
24281852,2013-11-27T00:00:00,Genetic Predisposition to Disease,C23.550.291.687.500
24281852,2013-11-27T00:00:00,Genetic Predisposition to Disease,G05.380.355
24281852,2013-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24281852,2013-11-27T00:00:00,Middle Aged,M01.060.116.630
24281852,2013-11-27T00:00:00,"Polymorphism, Genetic",G05.365.795
24281852,2013-11-27T00:00:00,Questionnaires,E05.318.308.750
24281852,2013-11-27T00:00:00,Questionnaires,L01.280.800
24281852,2013-11-27T00:00:00,Questionnaires,N05.715.360.300.695
24281852,2013-11-27T00:00:00,Questionnaires,N06.850.520.308.750
24281852,2013-11-27T00:00:00,Risk Factors,E05.318.740.600.800.725
24281852,2013-11-27T00:00:00,Risk Factors,N05.715.350.200.700
24281852,2013-11-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24281852,2013-11-27T00:00:00,Risk Factors,N06.850.490.625.750
24281852,2013-11-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24281852,2013-11-27T00:00:00,United States,Z01.107.567.875
24285486,2013-11-27T00:00:00,Animals,B01.050
24285486,2013-11-27T00:00:00,Intestinal Mucosa,A03.556.124.369
24285486,2013-11-27T00:00:00,Intestinal Mucosa,A10.615.550.444
24285486,2013-11-27T00:00:00,Nanoparticles,J01.637.512.600
24285499,2013-11-27T00:00:00,Animals,B01.050
24285499,2013-11-27T00:00:00,Cyclophosphamide,D02.455.526.728.650.730.243
24285499,2013-11-27T00:00:00,Cyclophosphamide,D02.705.670.243
24285499,2013-11-27T00:00:00,Glyburide,D02.886.590.795.575
24285499,2013-11-27T00:00:00,Glyburide,D02.948.828.575
24285499,2013-11-27T00:00:00,"Immunity, Innate",G12.450.575
24285499,2013-11-27T00:00:00,Neuronal Apoptosis-Inhibitory Protein,D12.644.360.075.437.500
24285499,2013-11-27T00:00:00,Neuronal Apoptosis-Inhibitory Protein,D12.776.476.075.437.500
24285499,2013-11-27T00:00:00,Neuronal Apoptosis-Inhibitory Protein,D12.776.641.642
24285499,2013-11-27T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24285499,2013-11-27T00:00:00,"Receptors, Cell Surface",D12.776.543.750
24285499,2013-11-27T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.260.698
24285499,2013-11-27T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.826
24285499,2013-11-27T00:00:00,"Receptors, Cytoplasmic and Nuclear",D12.776.930.669
24285499,2013-11-27T00:00:00,Toll-Like Receptors,D12.776.543.750.705.910.500
24285499,2013-11-27T00:00:00,Urinary Bladder,A05.810.890
24285902,2013-11-27T00:00:00,Adult,M01.060.116
24285902,2013-11-27T00:00:00,Brain Mapping,E01.370.350.086
24285902,2013-11-27T00:00:00,Brain Mapping,E01.370.376.149
24285902,2013-11-27T00:00:00,Brain Mapping,E05.132
24285902,2013-11-27T00:00:00,Frontal Lobe,A08.186.211.730.885.287.500.270
24285902,2013-11-27T00:00:00,Gyrus Cinguli,A08.186.211.464.330
24285902,2013-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24285902,2013-11-27T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
24285902,2013-11-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24285902,2013-11-27T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24285902,2013-11-27T00:00:00,Neural Pathways,A08.612
24285902,2013-11-27T00:00:00,Oxygen,D01.268.185.550
24285902,2013-11-27T00:00:00,Oxygen,D01.362.670
24285902,2013-11-27T00:00:00,Psychomotor Performance,F02.808
24285902,2013-11-27T00:00:00,Psychomotor Performance,G11.427.700
24285902,2013-11-27T00:00:00,Psychomotor Performance,G11.561.623
24285902,2013-11-27T00:00:00,Speech Perception,F02.463.593.071.875
24285902,2013-11-27T00:00:00,Young Adult,M01.060.116.815
24290708,2013-11-27T00:00:00,Aortic Valve,A07.541.510.110
24290708,2013-11-27T00:00:00,Heart Valve Prosthesis,E07.695.310
24290708,2013-11-27T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
24290708,2013-11-27T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
24290708,2013-11-27T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
24290708,2013-11-27T00:00:00,Hemodynamics,G09.330.190.400
24290708,2013-11-27T00:00:00,Hemodynamics,G09.330.380
24290708,2013-11-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24290708,2013-11-27T00:00:00,Prosthesis Design,E05.320.550
24290708,2013-11-27T00:00:00,Prosthesis Design,E07.695.680
24290708,2013-11-27T00:00:00,Treatment Outcome,E01.789.800
24290708,2013-11-27T00:00:00,Treatment Outcome,N04.761.559.590.800
24290708,2013-11-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23996496,2013-11-28T00:00:00,Adolescent,M01.060.057
23996496,2013-11-28T00:00:00,"Anemia, Sickle Cell",C15.378.071.141.150.150
23996496,2013-11-28T00:00:00,"Anemia, Sickle Cell",C15.378.420.155
23996496,2013-11-28T00:00:00,"Anemia, Sickle Cell",C16.320.070.150
23996496,2013-11-28T00:00:00,"Anemia, Sickle Cell",C16.320.365.155
23996496,2013-11-28T00:00:00,Biological Markers,D23.101
23996496,2013-11-28T00:00:00,Child,M01.060.406
23996496,2013-11-28T00:00:00,"Child, Preschool",M01.060.406.448
23996496,2013-11-28T00:00:00,"Endothelium, Vascular",A07.231.330
23996496,2013-11-28T00:00:00,"Endothelium, Vascular",A10.272.491.355
23996496,2013-11-28T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23996496,2013-11-28T00:00:00,Stroke,C10.228.140.300.775
23996496,2013-11-28T00:00:00,Stroke,C14.907.253.855
23996496,2013-11-28T00:00:00,Thrombosis,C14.907.355.830
23996496,2013-11-28T00:00:00,Treatment Outcome,E01.789.800
23996496,2013-11-28T00:00:00,Treatment Outcome,N04.761.559.590.800
23996496,2013-11-28T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24312373,2013-11-28T00:00:00,Animals,B01.050
24312373,2013-11-28T00:00:00,Autophagy,G04.299.139.399
24312373,2013-11-28T00:00:00,Autophagy,G04.299.482.350.091
24312373,2013-11-28T00:00:00,Carrier Proteins,D12.776.157
24312373,2013-11-28T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
24312373,2013-11-28T00:00:00,Flow Cytometry,E05.200.500.386.350
24312373,2013-11-28T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D08.811.277.040.330.300.200.100.200
24312373,2013-11-28T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.644.360.375.100.200
24312373,2013-11-28T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.157.325.332.100.200
24312373,2013-11-28T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.476.375.100.200
24312373,2013-11-28T00:00:00,"GTP-Binding Protein alpha Subunits, Gi-Go",D12.776.543.325.100.200
24312373,2013-11-28T00:00:00,Macrophages,A11.329.372
24312373,2013-11-28T00:00:00,Macrophages,A11.627.482
24312373,2013-11-28T00:00:00,Macrophages,A11.733.397
24312373,2013-11-28T00:00:00,Macrophages,A15.382.680.397
24312373,2013-11-28T00:00:00,Macrophages,A15.382.812.522
24312373,2013-11-28T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
24312373,2013-11-28T00:00:00,"Microscopy, Confocal",E05.595.395
24312373,2013-11-28T00:00:00,RGS Proteins,D12.644.360.325.150.750
24312373,2013-11-28T00:00:00,RGS Proteins,D12.776.402.150.750
24312373,2013-11-28T00:00:00,RGS Proteins,D12.776.476.325.150.750
24295524,2013-11-30T00:00:00,Attitude of Health Personnel,F01.100.050
24295524,2013-11-30T00:00:00,Attitude of Health Personnel,N05.300.100
24295524,2013-11-30T00:00:00,Combined Modality Therapy,E02.186
24295524,2013-11-30T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
24295524,2013-11-30T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
24295524,2013-11-30T00:00:00,"Hospitals, Community",N02.278.421.306
24295524,2013-11-30T00:00:00,"Hospitals, University",N02.278.020.300.310
24295524,2013-11-30T00:00:00,"Hospitals, University",N02.278.421.639.725
24295524,2013-11-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24295524,2013-11-30T00:00:00,Internationality,I01.615
24295524,2013-11-30T00:00:00,Liver Cirrhosis,C06.552.630
23657083,2013-12-01T00:00:00,Adult,M01.060.116
23657083,2013-12-01T00:00:00,Aged,M01.060.116.100
23657083,2013-12-01T00:00:00,Cancer Vaccines,D20.215.894.200
23657083,2013-12-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
23657083,2013-12-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
23657083,2013-12-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
23657083,2013-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
23657083,2013-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
23657083,2013-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
23657083,2013-12-01T00:00:00,Dendritic Cells,A11.066.270
23657083,2013-12-01T00:00:00,Dendritic Cells,A11.436.270
23657083,2013-12-01T00:00:00,Dendritic Cells,A15.382.066.270
23657083,2013-12-01T00:00:00,Dendritic Cells,A15.382.812.260
23657083,2013-12-01T00:00:00,Disease-Free Survival,E01.789.200
23657083,2013-12-01T00:00:00,Disease-Free Survival,E05.318.740.998.300
23657083,2013-12-01T00:00:00,Disease-Free Survival,N05.715.360.750.795.300
23657083,2013-12-01T00:00:00,Disease-Free Survival,N06.850.520.830.998.300
23657083,2013-12-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.644.276.374.410.240.375
23657083,2013-12-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.395.240.300
23657083,2013-12-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.467.374.410.240.375
23657083,2013-12-01T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D23.529.374.410.240.375
23657083,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23657083,2013-12-01T00:00:00,Immunization,E02.095.465.425.400
23657083,2013-12-01T00:00:00,Immunization,E05.478.550
23657083,2013-12-01T00:00:00,Immunization,N02.421.726.758.310
23657083,2013-12-01T00:00:00,Immunization,N06.850.780.200.425
23657083,2013-12-01T00:00:00,Immunization,N06.850.780.680.310
23657083,2013-12-01T00:00:00,Membrane Glycoproteins,D12.776.395.550
23657083,2013-12-01T00:00:00,Membrane Glycoproteins,D12.776.543.550
23657083,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
23657083,2013-12-01T00:00:00,"Neoplasm Recurrence, Local",C04.697.655
23657083,2013-12-01T00:00:00,"Neoplasm Recurrence, Local",C23.550.727.655
23754240,2013-12-01T00:00:00,Adult,M01.060.116
23754240,2013-12-01T00:00:00,Gastroesophageal Reflux,C06.405.117.119.500.484
23754240,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23754240,2013-12-01T00:00:00,Laparoscopy,E01.370.388.250.520
23754240,2013-12-01T00:00:00,Laparoscopy,E04.800.250.520
23754240,2013-12-01T00:00:00,"Obesity, Morbid",C18.654.726.500.700
23754240,2013-12-01T00:00:00,"Obesity, Morbid",C23.888.144.699.500.500
23754240,2013-12-01T00:00:00,"Obesity, Morbid",E01.370.600.115.100.160.120.699.500.500
23754240,2013-12-01T00:00:00,"Obesity, Morbid",G07.100.100.160.120.699.500.500
23754240,2013-12-01T00:00:00,Preoperative Care,E02.760.795
23754240,2013-12-01T00:00:00,Preoperative Care,E04.641
23754240,2013-12-01T00:00:00,Preoperative Care,N02.421.585.795
23754240,2013-12-01T00:00:00,Questionnaires,E05.318.308.750
23754240,2013-12-01T00:00:00,Questionnaires,L01.280.800
23754240,2013-12-01T00:00:00,Questionnaires,N05.715.360.300.695
23754240,2013-12-01T00:00:00,Questionnaires,N06.850.520.308.750
23754240,2013-12-01T00:00:00,Reoperation,E04.690
23754240,2013-12-01T00:00:00,Treatment Outcome,E01.789.800
23754240,2013-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23754240,2013-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
23757569,2013-12-01T00:00:00,"Adaptation, Physiological",G07.700.062
23757569,2013-12-01T00:00:00,"Adaptation, Physiological",G16.100.057.500
23757569,2013-12-01T00:00:00,Adult,M01.060.116
23757569,2013-12-01T00:00:00,Algorithms,G17.035
23757569,2013-12-01T00:00:00,Algorithms,L01.224.050
23757569,2013-12-01T00:00:00,"Biofeedback, Psychology",E02.190.525.123
23757569,2013-12-01T00:00:00,"Biofeedback, Psychology",F02.830.131
23757569,2013-12-01T00:00:00,"Biofeedback, Psychology",F04.754.137.301
23757569,2013-12-01T00:00:00,"Biofeedback, Psychology",F04.754.308.500
23757569,2013-12-01T00:00:00,"Biofeedback, Psychology",L01.143.283.425.624.500
23757569,2013-12-01T00:00:00,Electric Stimulation Therapy,E02.342
23757569,2013-12-01T00:00:00,Electric Stimulation Therapy,E02.779.468
23757569,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23757569,2013-12-01T00:00:00,Knee Joint,A02.835.583.475
23757569,2013-12-01T00:00:00,Muscle Contraction,G11.427.590.540
23757569,2013-12-01T00:00:00,"Muscle, Skeletal",A02.633.567
23757569,2013-12-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
23757569,2013-12-01T00:00:00,"Therapy, Computer-Assisted",E02.950
23757569,2013-12-01T00:00:00,"Therapy, Computer-Assisted",L01.700.508.100.710
23764896,2013-12-01T00:00:00,Adult,M01.060.116
23764896,2013-12-01T00:00:00,Aged,M01.060.116.100
23764896,2013-12-01T00:00:00,Attitude to Health,F01.100.150
23764896,2013-12-01T00:00:00,Attitude to Health,N05.300.150
23764896,2013-12-01T00:00:00,Culture,I01.076.201.450
23764896,2013-12-01T00:00:00,Culture,I01.880.143
23764896,2013-12-01T00:00:00,Data Collection,E05.318.308
23764896,2013-12-01T00:00:00,Data Collection,L01.280
23764896,2013-12-01T00:00:00,Data Collection,N05.715.360.300
23764896,2013-12-01T00:00:00,Data Collection,N06.850.520.308
23764896,2013-12-01T00:00:00,Early Detection of Cancer,E01.390.500
23764896,2013-12-01T00:00:00,Health Status,I01.240.425
23764896,2013-12-01T00:00:00,Health Status,N01.224.425
23764896,2013-12-01T00:00:00,Health Status,N06.850.505.400.425
23764896,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23764896,2013-12-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
23764896,2013-12-01T00:00:00,Lung Neoplasms,C08.381.540
23764896,2013-12-01T00:00:00,Lung Neoplasms,C08.785.520
23764896,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
23764896,2013-12-01T00:00:00,Questionnaires,E05.318.308.750
23764896,2013-12-01T00:00:00,Questionnaires,L01.280.800
23764896,2013-12-01T00:00:00,Questionnaires,N05.715.360.300.695
23764896,2013-12-01T00:00:00,Questionnaires,N06.850.520.308.750
23764896,2013-12-01T00:00:00,Smoking,F01.145.466.753
23764896,2013-12-01T00:00:00,United States,Z01.107.567.875
23764896,2013-12-01T00:00:00,Veterans,M01.930
24061443,2013-12-01T00:00:00,Adult,M01.060.116
24061443,2013-12-01T00:00:00,African Americans,M01.686.508.100.100
24061443,2013-12-01T00:00:00,African Americans,M01.686.754.100
24061443,2013-12-01T00:00:00,Aged,M01.060.116.100
24061443,2013-12-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
24061443,2013-12-01T00:00:00,Graft Rejection,G12.425.901.545.328
24061443,2013-12-01T00:00:00,Graft Survival,G12.425.901.545.340
24061443,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24061443,2013-12-01T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
24061443,2013-12-01T00:00:00,Kidney Transplantation,E02.870.500
24061443,2013-12-01T00:00:00,Kidney Transplantation,E04.936.450.485
24061443,2013-12-01T00:00:00,Kidney Transplantation,E04.950.774.400
24061443,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
24063427,2013-12-01T00:00:00,Clinical Competence,I02.399.630.210
24063427,2013-12-01T00:00:00,Clinical Competence,N04.761.210
24063427,2013-12-01T00:00:00,Decision Support Techniques,E05.245
24063427,2013-12-01T00:00:00,Decision Support Techniques,L01.700.508.190
24063427,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24063427,2013-12-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
24063427,2013-12-01T00:00:00,Lung Neoplasms,C08.381.540
24063427,2013-12-01T00:00:00,Lung Neoplasms,C08.785.520
24063427,2013-12-01T00:00:00,Probability,E05.318.740.600
24063427,2013-12-01T00:00:00,Probability,G17.680
24063427,2013-12-01T00:00:00,Probability,N05.715.360.750.625
24063427,2013-12-01T00:00:00,Probability,N06.850.520.830.600
24063427,2013-12-01T00:00:00,Pulmonary Medicine,H02.403.429.675
24063427,2013-12-01T00:00:00,Solitary Pulmonary Nodule,C04.588.894.797.520.966
24063427,2013-12-01T00:00:00,Solitary Pulmonary Nodule,C08.381.540.933
24063427,2013-12-01T00:00:00,Solitary Pulmonary Nodule,C08.381.884
24063427,2013-12-01T00:00:00,Solitary Pulmonary Nodule,C08.785.520.933
24105641,2013-12-01T00:00:00,Carotid Stenosis,C10.228.140.300.200.360
24105641,2013-12-01T00:00:00,Carotid Stenosis,C14.907.137.230
24105641,2013-12-01T00:00:00,Carotid Stenosis,C14.907.253.123.360
24105641,2013-12-01T00:00:00,"Constriction, Pathologic",C23.300.287
24105641,2013-12-01T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
24105641,2013-12-01T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
24105641,2013-12-01T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
24105641,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24105641,2013-12-01T00:00:00,Intracranial Arteriosclerosis,C10.228.140.300.510.800
24105641,2013-12-01T00:00:00,Intracranial Arteriosclerosis,C14.907.137.126.372
24105641,2013-12-01T00:00:00,Intracranial Arteriosclerosis,C14.907.253.560.350
24105641,2013-12-01T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
24105641,2013-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
24105641,2013-12-01T00:00:00,Risk Factors,N05.715.350.200.700
24105641,2013-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24105641,2013-12-01T00:00:00,Risk Factors,N06.850.490.625.750
24105641,2013-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24105641,2013-12-01T00:00:00,Secondary Prevention,N02.421.726.825
24105641,2013-12-01T00:00:00,Secondary Prevention,N06.850.780.750
24105641,2013-12-01T00:00:00,Stroke,C10.228.140.300.775
24105641,2013-12-01T00:00:00,Stroke,C14.907.253.855
24105641,2013-12-01T00:00:00,Ticlopidine,D02.886.778.834
24105641,2013-12-01T00:00:00,Ticlopidine,D03.383.903.834
24105641,2013-12-01T00:00:00,Treatment Outcome,E01.789.800
24105641,2013-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24105641,2013-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24105641,2013-12-01T00:00:00,United States,Z01.107.567.875
24105641,2013-12-01T00:00:00,Warfarin,D03.438.150.446.520.914
24105641,2013-12-01T00:00:00,Warfarin,D03.830.219.446.520.914
24113732,2013-12-01T00:00:00,Adult,M01.060.116
24113732,2013-12-01T00:00:00,Clinical Competence,I02.399.630.210
24113732,2013-12-01T00:00:00,Clinical Competence,N04.761.210
24113732,2013-12-01T00:00:00,"Emergency Service, Hospital",N02.278.354.422.336
24113732,2013-12-01T00:00:00,"Emergency Service, Hospital",N02.421.297.195
24113732,2013-12-01T00:00:00,"Emergency Service, Hospital",N04.452.442.422.336
24113732,2013-12-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.372.250.250
24113732,2013-12-01T00:00:00,"Endoscopy, Gastrointestinal",E01.370.388.250.250.250
24113732,2013-12-01T00:00:00,"Endoscopy, Gastrointestinal",E04.210.240.250
24113732,2013-12-01T00:00:00,"Endoscopy, Gastrointestinal",E04.800.250.250.250
24113732,2013-12-01T00:00:00,Gastrointestinal Hemorrhage,C06.405.227
24113732,2013-12-01T00:00:00,Gastrointestinal Hemorrhage,C23.550.414.788
24113732,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24113732,2013-12-01T00:00:00,Judgment,F02.463.785.626
24113732,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
24113732,2013-12-01T00:00:00,Physicians,M01.526.485.810
24113732,2013-12-01T00:00:00,Physicians,N02.360.810
24128629,2013-12-01T00:00:00,Career Choice,F02.463.785.373.346.400
24128629,2013-12-01T00:00:00,"Education, Professional",I02.358
24128629,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24128629,2013-12-01T00:00:00,Physician Assistants,M01.526.485.067.740
24128629,2013-12-01T00:00:00,Physician Assistants,N02.360.067.740
24128629,2013-12-01T00:00:00,Primary Health Care,N04.590.233.727
24128629,2013-12-01T00:00:00,United States,Z01.107.567.875
24128629,2013-12-01T00:00:00,Veterans,M01.930
24142744,2013-12-01T00:00:00,Animals,B01.050
24142744,2013-12-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
24142744,2013-12-01T00:00:00,Heart Diseases,C14.280
24142744,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24142744,2013-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
24142744,2013-12-01T00:00:00,Risk Factors,N05.715.350.200.700
24142744,2013-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24142744,2013-12-01T00:00:00,Risk Factors,N06.850.490.625.750
24142744,2013-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24177412,2013-12-01T00:00:00,Bandages,E07.101
24177412,2013-12-01T00:00:00,Chronic Disease,C23.550.291.500
24177412,2013-12-01T00:00:00,Endoscopy,E01.370.388.250
24177412,2013-12-01T00:00:00,Endoscopy,E04.800.250
24177412,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24177412,2013-12-01T00:00:00,Nasal Cavity,A04.531.449
24177412,2013-12-01T00:00:00,Pain Measurement,E01.370.376.550.600
24177412,2013-12-01T00:00:00,Rhinitis,C08.460.799
24177412,2013-12-01T00:00:00,Rhinitis,C08.730.674
24177412,2013-12-01T00:00:00,Rhinitis,C09.603.799
24177412,2013-12-01T00:00:00,Sinusitis,C08.460.692.752
24177412,2013-12-01T00:00:00,Sinusitis,C08.730.749
24177412,2013-12-01T00:00:00,Sinusitis,C09.603.692.752
24177412,2013-12-01T00:00:00,Treatment Outcome,E01.789.800
24177412,2013-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24177412,2013-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24188687,2013-12-01T00:00:00,Adult,M01.060.116
24188687,2013-12-01T00:00:00,African Americans,M01.686.508.100.100
24188687,2013-12-01T00:00:00,African Americans,M01.686.754.100
24188687,2013-12-01T00:00:00,Age Factors,N05.715.350.075
24188687,2013-12-01T00:00:00,Age Factors,N06.850.490.250
24188687,2013-12-01T00:00:00,Aged,M01.060.116.100
24188687,2013-12-01T00:00:00,Colorectal Neoplasms,C04.588.274.476.411.307
24188687,2013-12-01T00:00:00,Colorectal Neoplasms,C06.301.371.411.307
24188687,2013-12-01T00:00:00,Colorectal Neoplasms,C06.405.249.411.307
24188687,2013-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.158.356
24188687,2013-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.491.307
24188687,2013-12-01T00:00:00,Colorectal Neoplasms,C06.405.469.860.180
24188687,2013-12-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
24188687,2013-12-01T00:00:00,Health Status Disparities,I01.240.425.675
24188687,2013-12-01T00:00:00,Health Status Disparities,N01.224.425.437
24188687,2013-12-01T00:00:00,Health Status Disparities,N06.850.505.400.425.675
24188687,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24188687,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
24212204,2013-12-01T00:00:00,Adolescent,M01.060.057
24212204,2013-12-01T00:00:00,Child,M01.060.406
24212204,2013-12-01T00:00:00,"Child, Preschool",M01.060.406.448
24212204,2013-12-01T00:00:00,Cornea,A09.371.060.217
24212204,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24212204,2013-12-01T00:00:00,Optic Disk,A08.800.800.120.680.660
24212204,2013-12-01T00:00:00,Optic Disk,A09.371.729.690
24212204,2013-12-01T00:00:00,Retinal Ganglion Cells,A08.663.650.850.875
24212204,2013-12-01T00:00:00,Retinal Ganglion Cells,A09.371.729.831.875
24212204,2013-12-01T00:00:00,Retinal Ganglion Cells,A11.671.650.850.875
24219550,2013-12-01T00:00:00,Anticoagulants,D27.505.954.502.119
24219550,2013-12-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.555.110.110.110
24219550,2013-12-01T00:00:00,"Arthroplasty, Replacement, Hip",E04.650.110.110
24219550,2013-12-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.555.110.110.115
24219550,2013-12-01T00:00:00,"Arthroplasty, Replacement, Knee",E04.650.110.115
24219550,2013-12-01T00:00:00,Benzimidazoles,D03.438.103
24219550,2013-12-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
24219550,2013-12-01T00:00:00,Clinical Trials as Topic,E05.337.250
24219550,2013-12-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
24219550,2013-12-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
24219550,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24219550,2013-12-01T00:00:00,Postoperative Complications,C23.550.767
24219550,2013-12-01T00:00:00,Pyrazoles,D03.383.129.539
24219550,2013-12-01T00:00:00,Pyridones,D03.383.725.791
24219550,2013-12-01T00:00:00,Thiophenes,D02.886.778
24219550,2013-12-01T00:00:00,Thiophenes,D03.383.903
24219550,2013-12-01T00:00:00,Venous Thromboembolism,C14.907.355.590.700
24219550,2013-12-01T00:00:00,Venous Thromboembolism,C14.907.355.830.850.700
24219550,2013-12-01T00:00:00,beta-Alanine,D12.125.042.070
24240819,2013-12-01T00:00:00,Albumins,D12.776.034
24240819,2013-12-01T00:00:00,Colloids,D20.280
24240819,2013-12-01T00:00:00,Colloids,D26.255.165
24240819,2013-12-01T00:00:00,Colloids,D27.720.280.165
24240819,2013-12-01T00:00:00,Critical Care,E02.760.190
24240819,2013-12-01T00:00:00,Critical Care,N02.421.585.190
24240819,2013-12-01T00:00:00,Fluid Therapy,E02.319.360
24240819,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24240819,2013-12-01T00:00:00,"Infusions, Intravenous",E02.319.267.510.590
24240819,2013-12-01T00:00:00,Isotonic Solutions,D26.776.498
24240819,2013-12-01T00:00:00,Patient Selection,E05.581.500.653
24240819,2013-12-01T00:00:00,Patient Selection,N04.590.731
24240819,2013-12-01T00:00:00,Resuscitation,E02.365.647
24240819,2013-12-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
24240819,2013-12-01T00:00:00,Risk Assessment,N04.452.871.715
24240819,2013-12-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24240819,2013-12-01T00:00:00,Risk Assessment,N06.850.505.715
24240819,2013-12-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24240819,2013-12-01T00:00:00,Sepsis,C01.539.757
24240819,2013-12-01T00:00:00,Sepsis,C23.550.470.790.500
24246622,2013-12-01T00:00:00,Adolescent,M01.060.057
24246622,2013-12-01T00:00:00,Body Image,F02.463.593.112
24246622,2013-12-01T00:00:00,Child,M01.060.406
24246622,2013-12-01T00:00:00,Exercise Test,E01.370.370.380.250
24246622,2013-12-01T00:00:00,Exercise Test,E01.370.386.700.250
24246622,2013-12-01T00:00:00,Exercise Test,E05.333.250
24246622,2013-12-01T00:00:00,Funnel Chest,C05.116.099.386
24246622,2013-12-01T00:00:00,Funnel Chest,C05.660.386
24246622,2013-12-01T00:00:00,Funnel Chest,C16.131.621.386
24246622,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24246622,2013-12-01T00:00:00,Orthopedic Procedures,E02.718
24246622,2013-12-01T00:00:00,Orthopedic Procedures,E04.555
24246622,2013-12-01T00:00:00,Postoperative Complications,C23.550.767
24246622,2013-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24246622,2013-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24246622,2013-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24246622,2013-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24246622,2013-12-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24246622,2013-12-01T00:00:00,Treatment Outcome,E01.789.800
24246622,2013-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24246622,2013-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24257420,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24257420,2013-12-01T00:00:00,"Infant, Newborn",M01.060.703.520
24257420,2013-12-01T00:00:00,"Infectious Disease Transmission, Vertical",N06.850.310.425
24257420,2013-12-01T00:00:00,Pregnancy,G08.686.785.760.769
24257420,2013-12-01T00:00:00,"Pregnancy Complications, Infectious",C01.539.674
24257420,2013-12-01T00:00:00,"Pregnancy Complications, Infectious",C13.703.700
24257420,2013-12-01T00:00:00,Prenatal Diagnosis,E01.370.378.630
24261364,2013-12-01T00:00:00,Aged,M01.060.116.100
24261364,2013-12-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.500.150
24261364,2013-12-01T00:00:00,Diffusion Magnetic Resonance Imaging,E01.370.350.825.500.150
24261364,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24261364,2013-12-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.158.600
24261364,2013-12-01T00:00:00,"Image Interpretation, Computer-Assisted",E01.370.350.350
24261364,2013-12-01T00:00:00,"Image Interpretation, Computer-Assisted",L01.700.508.100.158.600
24261364,2013-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24261364,2013-12-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24261364,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
24261364,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
24261364,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
24261364,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
24261364,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
24261364,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
24263022,2013-12-01T00:00:00,Adult,M01.060.116
24263022,2013-12-01T00:00:00,Algorithms,G17.035
24263022,2013-12-01T00:00:00,Algorithms,L01.224.050
24263022,2013-12-01T00:00:00,Heart Transplantation,E04.100.376.475
24263022,2013-12-01T00:00:00,Heart Transplantation,E04.928.220.390
24263022,2013-12-01T00:00:00,Heart Transplantation,E04.936.450.475
24263022,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24263022,2013-12-01T00:00:00,"Medical Staff, Hospital",M01.526.485.630.490
24263022,2013-12-01T00:00:00,"Medical Staff, Hospital",M01.526.485.740.422
24263022,2013-12-01T00:00:00,"Medical Staff, Hospital",N02.360.630.490
24263022,2013-12-01T00:00:00,"Medical Staff, Hospital",N02.360.740.422
24263022,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
24263022,2013-12-01T00:00:00,"Models, Statistical",E05.318.740.500
24263022,2013-12-01T00:00:00,"Models, Statistical",E05.599.835
24263022,2013-12-01T00:00:00,"Models, Statistical",N05.715.360.750.530
24263022,2013-12-01T00:00:00,"Models, Statistical",N06.850.520.830.500
24263022,2013-12-01T00:00:00,Physician's Practice Patterns,N04.590.748
24263022,2013-12-01T00:00:00,Physician's Practice Patterns,N05.300.625
24263022,2013-12-01T00:00:00,Regression Analysis,E05.318.740.750
24263022,2013-12-01T00:00:00,Regression Analysis,N05.715.360.750.695
24263022,2013-12-01T00:00:00,Regression Analysis,N06.850.520.830.750
24263022,2013-12-01T00:00:00,Risk Factors,E05.318.740.600.800.725
24263022,2013-12-01T00:00:00,Risk Factors,N05.715.350.200.700
24263022,2013-12-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24263022,2013-12-01T00:00:00,Risk Factors,N06.850.490.625.750
24263022,2013-12-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24263022,2013-12-01T00:00:00,Treatment Outcome,E01.789.800
24263022,2013-12-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24263022,2013-12-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24263079,2013-12-01T00:00:00,Brain,A08.186.211
24263079,2013-12-01T00:00:00,Carotid Arteries,A07.231.114.186
24263079,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24264706,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24264706,2013-12-01T00:00:00,Pregnancy,G08.686.785.760.769
24264706,2013-12-01T00:00:00,Unnecessary Procedures,N02.421.380.900
24264706,2013-12-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
24291671,2013-12-01T00:00:00,Adenosine Triphosphate,D03.438.759.646.138.236
24291671,2013-12-01T00:00:00,Adenosine Triphosphate,D13.695.667.138.236
24291671,2013-12-01T00:00:00,Adenosine Triphosphate,D13.695.827.068.236
24291671,2013-12-01T00:00:00,Animals,B01.050
24291671,2013-12-01T00:00:00,Anticonvulsants,D27.505.954.427.080
24291671,2013-12-01T00:00:00,Cell Line,A11.251.210
24291671,2013-12-01T00:00:00,Drug Interactions,G07.690.812.240
24291671,2013-12-01T00:00:00,Drug Interactions,G07.700.680.240
24291671,2013-12-01T00:00:00,Enzyme Inhibitors,D27.505.519.389
24291671,2013-12-01T00:00:00,Epilepsy,C10.228.140.490
24291671,2013-12-01T00:00:00,Oxygen Consumption,G03.730
24291671,2013-12-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.260.108.765
24291671,2013-12-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.624.664.700.179
24291671,2013-12-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.660.760
24291671,2013-12-01T00:00:00,Proto-Oncogene Proteins c-fos,D12.776.930.127.765
24291671,2013-12-01T00:00:00,Zebrafish,B01.050.150.900.493.200.244.828
24293750,2013-12-01T00:00:00,Animals,B01.050
24293750,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24293750,2013-12-01T00:00:00,Hypothalamic Hormones,D06.472.699.327
24293750,2013-12-01T00:00:00,Hypothalamic Hormones,D12.644.400.400
24293750,2013-12-01T00:00:00,Hypothalamic Hormones,D12.644.548.365
24293750,2013-12-01T00:00:00,Hypothalamic Hormones,D12.776.641.650.405
24293750,2013-12-01T00:00:00,Melanins,D12.125.072.050.875.379
24293750,2013-12-01T00:00:00,Melanins,D23.767.620
24293750,2013-12-01T00:00:00,Neurons,A08.663
24293750,2013-12-01T00:00:00,Neurons,A11.671
24293750,2013-12-01T00:00:00,Pituitary Hormones,D06.472.699.631
24293750,2013-12-01T00:00:00,Pituitary Hormones,D12.644.548.691
24293750,2013-12-01T00:00:00,Sleep,F02.830.855
24293750,2013-12-01T00:00:00,Sleep,G11.561.600.815
24294618,2013-12-01T00:00:00,Aged,M01.060.116.100
24294618,2013-12-01T00:00:00,Body Weight,C23.888.144
24294618,2013-12-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
24294618,2013-12-01T00:00:00,Body Weight,E05.041.124.160.750
24294618,2013-12-01T00:00:00,Body Weight,G07.100.100.160.120
24294618,2013-12-01T00:00:00,Body Weight,G07.700.320.249.314.120
24294618,2013-12-01T00:00:00,Counseling,F02.784.176
24294618,2013-12-01T00:00:00,Counseling,F04.408.413
24294618,2013-12-01T00:00:00,Counseling,N02.421.143.303
24294618,2013-12-01T00:00:00,Counseling,N02.421.461.363
24294618,2013-12-01T00:00:00,Diet,E05.272
24294618,2013-12-01T00:00:00,Diet,G07.610.240
24294618,2013-12-01T00:00:00,Exercise,G11.427.590.237
24294618,2013-12-01T00:00:00,Exercise,I03.350
24294618,2013-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
24294618,2013-12-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
24294618,2013-12-01T00:00:00,Health Status,I01.240.425
24294618,2013-12-01T00:00:00,Health Status,N01.224.425
24294618,2013-12-01T00:00:00,Health Status,N06.850.505.400.425
24294618,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24294618,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
24294618,2013-12-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
24294618,2013-12-01T00:00:00,Physician-Patient Relations,N05.300.660.625
24294618,2013-12-01T00:00:00,Qualitative Research,H01.770.644.241.850
24297115,2013-12-01T00:00:00,Guideline Adherence,N04.761.337
24297115,2013-12-01T00:00:00,Guideline Adherence,N05.715.360.395
24297115,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24297115,2013-12-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
24297115,2013-12-01T00:00:00,Lung Neoplasms,C08.381.540
24297115,2013-12-01T00:00:00,Lung Neoplasms,C08.785.520
24297115,2013-12-01T00:00:00,Quality of Health Care,N04.761
24297115,2013-12-01T00:00:00,Quality of Health Care,N05.715
24302198,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24302198,2013-12-01T00:00:00,Obesity,C18.654.726.500
24302198,2013-12-01T00:00:00,Obesity,C23.888.144.699.500
24302198,2013-12-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
24302198,2013-12-01T00:00:00,Obesity,G07.100.100.160.120.699.500
24321427,2013-12-01T00:00:00,Adolescent,M01.060.057
24321427,2013-12-01T00:00:00,Adult,M01.060.116
24321427,2013-12-01T00:00:00,Cataract Extraction,E04.540.825.249
24321427,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24321427,2013-12-01T00:00:00,"Lens Implantation, Intraocular",E04.540.825.600
24321427,2013-12-01T00:00:00,"Refraction, Ocular",E01.370.380.850.700
24321427,2013-12-01T00:00:00,"Refraction, Ocular",G01.590.770.760
24321427,2013-12-01T00:00:00,"Refraction, Ocular",G01.595.640.760
24321427,2013-12-01T00:00:00,"Refraction, Ocular",G14.760
24321427,2013-12-01T00:00:00,"Vision, Ocular",F02.830.816.964
24321427,2013-12-01T00:00:00,"Vision, Ocular",G02.111.087.800.480.900
24321427,2013-12-01T00:00:00,"Vision, Ocular",G02.149.115.800.480.900
24321427,2013-12-01T00:00:00,"Vision, Ocular",G04.299.880.480.900
24321427,2013-12-01T00:00:00,"Vision, Ocular",G11.561.600.810.964
24321427,2013-12-01T00:00:00,"Vision, Ocular",G14.640.816
24321427,2013-12-01T00:00:00,Visual Acuity,E01.370.380.850.950
24321427,2013-12-01T00:00:00,Visual Acuity,F02.463.593.932.901
24321427,2013-12-01T00:00:00,Visual Acuity,G14.940
24321427,2013-12-01T00:00:00,Young Adult,M01.060.116.815
24326612,2013-12-01T00:00:00,Adenoviridae,B04.280.030
24326612,2013-12-01T00:00:00,Adenoviridae,B04.909.204.097
24326612,2013-12-01T00:00:00,Animals,B01.050
24326612,2013-12-01T00:00:00,Gene Transfer Techniques,E05.393.350
24326612,2013-12-01T00:00:00,Genetic Vectors,G05.360.337
24326612,2013-12-01T00:00:00,Luminescent Measurements,E05.196.712.516
24326612,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
24326612,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
24326612,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
24326612,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
24326612,2013-12-01T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
24326612,2013-12-01T00:00:00,Urinary Catheterization,E01.370.390.820
24326612,2013-12-01T00:00:00,Urinary Catheterization,E02.148.947
24342767,2013-12-01T00:00:00,Adolescent,M01.060.057
24342767,2013-12-01T00:00:00,Adult,M01.060.116
24342767,2013-12-01T00:00:00,African Americans,M01.686.508.100.100
24342767,2013-12-01T00:00:00,African Americans,M01.686.754.100
24342767,2013-12-01T00:00:00,Age Factors,N05.715.350.075
24342767,2013-12-01T00:00:00,Age Factors,N06.850.490.250
24342767,2013-12-01T00:00:00,Aged,M01.060.116.100
24342767,2013-12-01T00:00:00,Child,M01.060.406
24342767,2013-12-01T00:00:00,Continental Population Groups,M01.686.508
24342767,2013-12-01T00:00:00,Ethnic Groups,M01.686.754
24342767,2013-12-01T00:00:00,Ethnic Groups,N01.224.317
24342767,2013-12-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
24342767,2013-12-01T00:00:00,Hispanic Americans,M01.686.754.441
24342767,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24342767,2013-12-01T00:00:00,Marijuana Abuse,C21.739.635
24342767,2013-12-01T00:00:00,Marijuana Abuse,F03.900.635
24342767,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
24342767,2013-12-01T00:00:00,Prevalence,E05.318.308.985.525.750
24342767,2013-12-01T00:00:00,Prevalence,L01.280.975.525.750
24342767,2013-12-01T00:00:00,Prevalence,N01.224.935.597.750
24342767,2013-12-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
24342767,2013-12-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
24342767,2013-12-01T00:00:00,United States,Z01.107.567.875
24342767,2013-12-01T00:00:00,Young Adult,M01.060.116.815
24347599,2013-12-01T00:00:00,"Arrhythmias, Cardiac",C14.280.067
24347599,2013-12-01T00:00:00,"Arrhythmias, Cardiac",C23.550.073
24347599,2013-12-01T00:00:00,"Cardiac Pacing, Artificial",E02.145
24347599,2013-12-01T00:00:00,"Death, Sudden, Cardiac",C14.280.383.220
24347599,2013-12-01T00:00:00,"Death, Sudden, Cardiac",C23.550.260.322.250
24347599,2013-12-01T00:00:00,"Defibrillators, Implantable",E07.305.250.159.175
24347599,2013-12-01T00:00:00,"Defibrillators, Implantable",E07.305.250.319.175
24347599,2013-12-01T00:00:00,"Defibrillators, Implantable",E07.695.175
24347599,2013-12-01T00:00:00,Heart Failure,C14.280.434
24347599,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24347599,2013-12-01T00:00:00,Patient Selection,E05.581.500.653
24347599,2013-12-01T00:00:00,Patient Selection,N04.590.731
24347599,2013-12-01T00:00:00,Primary Prevention,N02.421.726.758
24347599,2013-12-01T00:00:00,Primary Prevention,N06.850.780.680
24347599,2013-12-01T00:00:00,Prosthesis Implantation,E04.650
24908911,2013-12-01T00:00:00,Aortic Valve,A07.541.510.110
24908911,2013-12-01T00:00:00,Aortic Valve Stenosis,C14.280.484.150
24908911,2013-12-01T00:00:00,Aortic Valve Stenosis,C14.280.955.249
24908911,2013-12-01T00:00:00,Heart Valve Prosthesis Implantation,E04.100.376.485
24908911,2013-12-01T00:00:00,Heart Valve Prosthesis Implantation,E04.650.410
24908911,2013-12-01T00:00:00,Heart Valve Prosthesis Implantation,E04.928.220.410
24908911,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24908911,2013-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
24908911,2013-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
24908912,2013-12-01T00:00:00,Adolescent,M01.060.057
24908912,2013-12-01T00:00:00,Adult,M01.060.116
24908912,2013-12-01T00:00:00,Aged,M01.060.116.100
24908912,2013-12-01T00:00:00,Ambulatory Care,E02.760.106
24908912,2013-12-01T00:00:00,Ambulatory Care,N02.421.585.106
24908912,2013-12-01T00:00:00,Child,M01.060.406
24908912,2013-12-01T00:00:00,Diabetes Mellitus,C18.452.394.750
24908912,2013-12-01T00:00:00,Diabetes Mellitus,C19.246
24908912,2013-12-01T00:00:00,Disease Management,N04.590.607
24908912,2013-12-01T00:00:00,Guideline Adherence,N04.761.337
24908912,2013-12-01T00:00:00,Guideline Adherence,N05.715.360.395
24908912,2013-12-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
24908912,2013-12-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
24908912,2013-12-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
24908912,2013-12-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24908912,2013-12-01T00:00:00,Middle Aged,M01.060.116.630
24908912,2013-12-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
24908912,2013-12-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
24908912,2013-12-01T00:00:00,South Carolina,Z01.107.567.875.075.662
24908912,2013-12-01T00:00:00,South Carolina,Z01.107.567.875.750.700
24908912,2013-12-01T00:00:00,Young Adult,M01.060.116.815
24053691,2013-12-02T00:00:00,Animals,B01.050
24053691,2013-12-02T00:00:00,Laparoscopy,E01.370.388.250.520
24053691,2013-12-02T00:00:00,Laparoscopy,E04.800.250.520
24053691,2013-12-02T00:00:00,Peritoneal Diseases,C06.844
24053691,2013-12-02T00:00:00,Robotics,H01.671.293.643
24053691,2013-12-02T00:00:00,Robotics,J01.897.104.834
24053691,2013-12-02T00:00:00,Robotics,L01.224.065.630
24053691,2013-12-02T00:00:00,Swine,B01.050.150.900.649.077.880
24053691,2013-12-02T00:00:00,Urinary Bladder,A05.810.890
24296805,2013-12-03T00:00:00,Adult,M01.060.116
24296805,2013-12-03T00:00:00,African Americans,M01.686.508.100.100
24296805,2013-12-03T00:00:00,African Americans,M01.686.754.100
24296805,2013-12-03T00:00:00,Age Factors,N05.715.350.075
24296805,2013-12-03T00:00:00,Age Factors,N06.850.490.250
24296805,2013-12-03T00:00:00,Continental Population Groups,M01.686.508
24296805,2013-12-03T00:00:00,Employment,N01.824.245
24296805,2013-12-03T00:00:00,European Continental Ancestry Group,M01.686.508.400
24296805,2013-12-03T00:00:00,Hispanic Americans,M01.686.754.441
24296805,2013-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24296805,2013-12-03T00:00:00,Middle Aged,M01.060.116.630
24296805,2013-12-03T00:00:00,Spinal Cord Injuries,C10.228.854.770
24296805,2013-12-03T00:00:00,Spinal Cord Injuries,C10.900.850
24296805,2013-12-03T00:00:00,Spinal Cord Injuries,C21.866.819
24296805,2013-12-03T00:00:00,Young Adult,M01.060.116.815
24302560,2013-12-03T00:00:00,Animals,B01.050
24302560,2013-12-03T00:00:00,GTP-Binding Protein Regulators,D12.644.360.325
24302560,2013-12-03T00:00:00,GTP-Binding Protein Regulators,D12.776.402
24302560,2013-12-03T00:00:00,GTP-Binding Protein Regulators,D12.776.476.325
24302560,2013-12-03T00:00:00,GTP-Binding Proteins,D08.811.277.040.330.300
24302560,2013-12-03T00:00:00,GTP-Binding Proteins,D12.776.157.325
24302560,2013-12-03T00:00:00,"Receptors, Cell Surface",D12.776.543.750
24302560,2013-12-03T00:00:00,Signal Transduction,G02.111.087.800
24302560,2013-12-03T00:00:00,Signal Transduction,G02.149.115.800
24302560,2013-12-03T00:00:00,Signal Transduction,G04.299.880
24323565,2013-12-03T00:00:00,Adult,M01.060.116
24323565,2013-12-03T00:00:00,Aged,M01.060.116.100
24323565,2013-12-03T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24323565,2013-12-03T00:00:00,Incidence,E05.318.308.985.525.375
24323565,2013-12-03T00:00:00,Incidence,L01.280.975.525.375
24323565,2013-12-03T00:00:00,Incidence,N01.224.935.597.500
24323565,2013-12-03T00:00:00,Incidence,N06.850.505.400.975.525.375
24323565,2013-12-03T00:00:00,Incidence,N06.850.520.308.985.525.375
24323565,2013-12-03T00:00:00,Melanoma,C04.557.465.625.650.510
24323565,2013-12-03T00:00:00,Melanoma,C04.557.580.625.650.510
24323565,2013-12-03T00:00:00,Melanoma,C04.557.665.510
24323565,2013-12-03T00:00:00,Middle Aged,M01.060.116.630
24323565,2013-12-03T00:00:00,National Institutes of Health (U.S.),I01.409.137.500.600.480
24323565,2013-12-03T00:00:00,National Institutes of Health (U.S.),N03.540.348.500.500.600.480
24323565,2013-12-03T00:00:00,Neuroprotective Agents,D27.505.696.706.548
24323565,2013-12-03T00:00:00,Neuroprotective Agents,D27.505.954.427.575
24323565,2013-12-03T00:00:00,Parkinson Disease,C10.228.140.079.862.500
24323565,2013-12-03T00:00:00,Parkinson Disease,C10.228.662.600.400
24323565,2013-12-03T00:00:00,Parkinson Disease,C10.574.812
24323565,2013-12-03T00:00:00,Skin Neoplasms,C04.588.805
24323565,2013-12-03T00:00:00,Skin Neoplasms,C17.800.882
24323565,2013-12-03T00:00:00,United States,Z01.107.567.875
24323565,2013-12-03T00:00:00,Young Adult,M01.060.116.815
24188094,2013-12-04T00:00:00,Animals,B01.050
24188094,2013-12-04T00:00:00,Apoptosis,G04.299.139.160
24188094,2013-12-04T00:00:00,Calpain,D08.811.277.656.262.500.120
24188094,2013-12-04T00:00:00,Calpain,D08.811.277.656.300.200.120
24188094,2013-12-04T00:00:00,Cell Line,A11.251.210
24188094,2013-12-04T00:00:00,Cell Survival,G04.299.316
24188094,2013-12-04T00:00:00,Estrogen Receptor alpha,D12.776.260.698.750.350.174
24188094,2013-12-04T00:00:00,Estrogen Receptor alpha,D12.776.826.750.350.174
24188094,2013-12-04T00:00:00,Estrogen Receptor alpha,D12.776.930.669.750.350.174
24188094,2013-12-04T00:00:00,Insulin-Like Growth Factor I,D12.644.276.937.400
24188094,2013-12-04T00:00:00,Insulin-Like Growth Factor I,D12.776.124.862.400
24188094,2013-12-04T00:00:00,Insulin-Like Growth Factor I,D12.776.467.937.400
24188094,2013-12-04T00:00:00,Insulin-Like Growth Factor I,D23.529.937.400
24188094,2013-12-04T00:00:00,Interferon-gamma,D12.644.276.374.440.893
24188094,2013-12-04T00:00:00,Interferon-gamma,D12.644.276.374.480.350
24188094,2013-12-04T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
24188094,2013-12-04T00:00:00,Interferon-gamma,D12.644.276.718.550
24188094,2013-12-04T00:00:00,Interferon-gamma,D12.776.467.374.440.893
24188094,2013-12-04T00:00:00,Interferon-gamma,D12.776.467.374.480.350
24188094,2013-12-04T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
24188094,2013-12-04T00:00:00,Interferon-gamma,D12.776.467.718.550
24188094,2013-12-04T00:00:00,Interferon-gamma,D23.529.374.440.893
24188094,2013-12-04T00:00:00,Interferon-gamma,D23.529.374.480.350
24188094,2013-12-04T00:00:00,Interferon-gamma,D23.529.374.480.615.350
24188094,2013-12-04T00:00:00,Interferon-gamma,D23.529.718.550
24188094,2013-12-04T00:00:00,Motor Neurons,A08.663.655.500
24188094,2013-12-04T00:00:00,Motor Neurons,A11.671.655.500
24188094,2013-12-04T00:00:00,Neuroblastoma,C04.557.465.625.600.590.650.550
24188094,2013-12-04T00:00:00,Neuroblastoma,C04.557.470.670.590.650.550
24188094,2013-12-04T00:00:00,Neuroblastoma,C04.557.580.625.600.590.650.550
24188094,2013-12-04T00:00:00,Neuroprotective Agents,D27.505.696.706.548
24188094,2013-12-04T00:00:00,Neuroprotective Agents,D27.505.954.427.575
24188094,2013-12-04T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24188094,2013-12-04T00:00:00,Spinal Cord,A08.186.854
24302090,2013-12-04T00:00:00,Adult,M01.060.116
24302090,2013-12-04T00:00:00,Clinical Competence,I02.399.630.210
24302090,2013-12-04T00:00:00,Clinical Competence,N04.761.210
24302090,2013-12-04T00:00:00,Communication,F01.145.209
24302090,2013-12-04T00:00:00,Communication,L01.143
24302090,2013-12-04T00:00:00,Depression,F01.145.126.350
24302090,2013-12-04T00:00:00,Education,I02
24302090,2013-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24302090,2013-12-04T00:00:00,Internal Medicine,H02.403.429
24302090,2013-12-04T00:00:00,Internship and Residency,I02.358.399.644
24302090,2013-12-04T00:00:00,Nurse Practitioners,M01.526.485.650.640
24302090,2013-12-04T00:00:00,Nurse Practitioners,N02.360.650.640
24302090,2013-12-04T00:00:00,Patient Care,E02.760
24302090,2013-12-04T00:00:00,Patient Care,N02.421.585
24302090,2013-12-04T00:00:00,Patient Satisfaction,N04.452.822.360.600
24302090,2013-12-04T00:00:00,Patient Satisfaction,N05.300.150.600.630
24302090,2013-12-04T00:00:00,Patient Satisfaction,N05.715.360.600
24302090,2013-12-04T00:00:00,Physician-Patient Relations,F01.829.401.650.675
24302090,2013-12-04T00:00:00,Physician-Patient Relations,N05.300.660.625
24302090,2013-12-04T00:00:00,Quality of Health Care,N04.761
24302090,2013-12-04T00:00:00,Quality of Health Care,N05.715
24302090,2013-12-04T00:00:00,Terminal Care,E02.760.905
24302090,2013-12-04T00:00:00,Terminal Care,N02.421.585.905
24302090,2013-12-04T00:00:00,Young Adult,M01.060.116.815
24304712,2013-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24304712,2013-12-04T00:00:00,Incidence,E05.318.308.985.525.375
24304712,2013-12-04T00:00:00,Incidence,L01.280.975.525.375
24304712,2013-12-04T00:00:00,Incidence,N01.224.935.597.500
24304712,2013-12-04T00:00:00,Incidence,N06.850.505.400.975.525.375
24304712,2013-12-04T00:00:00,Incidence,N06.850.520.308.985.525.375
24304712,2013-12-04T00:00:00,Neoplasms,C04
24304712,2013-12-04T00:00:00,Smoking,F01.145.466.753
24304712,2013-12-04T00:00:00,Smoking Cessation,F01.145.940.700
24304712,2013-12-04T00:00:00,Tobacco,B01.650.388.100.905.900
24304712,2013-12-04T00:00:00,United States,Z01.107.567.875
24305817,2013-12-04T00:00:00,Acoustic Stimulation,E02.037
24305817,2013-12-04T00:00:00,Acoustic Stimulation,E02.190.888.030
24305817,2013-12-04T00:00:00,Acoustic Stimulation,E05.723.136
24305817,2013-12-04T00:00:00,Adult,M01.060.116
24305817,2013-12-04T00:00:00,Algorithms,G17.035
24305817,2013-12-04T00:00:00,Algorithms,L01.224.050
24305817,2013-12-04T00:00:00,Attention,F02.830.104.214
24305817,2013-12-04T00:00:00,Cerebral Cortex,A08.186.211.730.885.287.500
24305817,2013-12-04T00:00:00,Electroencephalography,E01.370.376.300
24305817,2013-12-04T00:00:00,Electroencephalography,E01.370.405.245
24305817,2013-12-04T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24305817,2013-12-04T00:00:00,"Image Processing, Computer-Assisted",L01.224.308
24305817,2013-12-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24305817,2013-12-04T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24305817,2013-12-04T00:00:00,Oxygen,D01.268.185.550
24305817,2013-12-04T00:00:00,Oxygen,D01.362.670
24305817,2013-12-04T00:00:00,Photic Stimulation,E05.723.729
24305817,2013-12-04T00:00:00,Reaction Time,F02.830.650
24305817,2013-12-04T00:00:00,Reaction Time,F04.669.817
24305817,2013-12-04T00:00:00,Reaction Time,G11.561.677
24305817,2013-12-04T00:00:00,Young Adult,M01.060.116.815
24309587,2013-12-05T00:00:00,Adolescent,M01.060.057
24309587,2013-12-05T00:00:00,Adult,M01.060.116
24309587,2013-12-05T00:00:00,Age Factors,N05.715.350.075
24309587,2013-12-05T00:00:00,Age Factors,N06.850.490.250
24309587,2013-12-05T00:00:00,Aged,M01.060.116.100
24309587,2013-12-05T00:00:00,American Heart Association,N03.540.630.780.110
24309587,2013-12-05T00:00:00,Atrial Fibrillation,C14.280.067.198
24309587,2013-12-05T00:00:00,Atrial Fibrillation,C23.550.073.198
24309587,2013-12-05T00:00:00,Blood Pressure,E01.370.600.875.249
24309587,2013-12-05T00:00:00,Blood Pressure,G09.330.380.076
24309587,2013-12-05T00:00:00,Clinical Trials as Topic,E05.318.760.535
24309587,2013-12-05T00:00:00,Clinical Trials as Topic,E05.337.250
24309587,2013-12-05T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
24309587,2013-12-05T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
24309587,2013-12-05T00:00:00,Diabetes Mellitus,C18.452.394.750
24309587,2013-12-05T00:00:00,Diabetes Mellitus,C19.246
24309587,2013-12-05T00:00:00,Exercise,G11.427.590.237
24309587,2013-12-05T00:00:00,Exercise,I03.350
24309587,2013-12-05T00:00:00,Heart Diseases,C14.280
24309587,2013-12-05T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24309587,2013-12-05T00:00:00,Hypertension,C14.907.489
24309587,2013-12-05T00:00:00,Incidence,E05.318.308.985.525.375
24309587,2013-12-05T00:00:00,Incidence,L01.280.975.525.375
24309587,2013-12-05T00:00:00,Incidence,N01.224.935.597.500
24309587,2013-12-05T00:00:00,Incidence,N06.850.505.400.975.525.375
24309587,2013-12-05T00:00:00,Incidence,N06.850.520.308.985.525.375
24309587,2013-12-05T00:00:00,Middle Aged,M01.060.116.630
24309587,2013-12-05T00:00:00,Obesity,C18.654.726.500
24309587,2013-12-05T00:00:00,Obesity,C23.888.144.699.500
24309587,2013-12-05T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
24309587,2013-12-05T00:00:00,Obesity,G07.100.100.160.120.699.500
24309587,2013-12-05T00:00:00,Platelet Aggregation Inhibitors,D27.505.954.502.780
24309587,2013-12-05T00:00:00,Prevalence,E05.318.308.985.525.750
24309587,2013-12-05T00:00:00,Prevalence,L01.280.975.525.750
24309587,2013-12-05T00:00:00,Prevalence,N01.224.935.597.750
24309587,2013-12-05T00:00:00,Prevalence,N06.850.505.400.975.525.750
24309587,2013-12-05T00:00:00,Prevalence,N06.850.520.308.985.525.750
24309587,2013-12-05T00:00:00,Secondary Prevention,N02.421.726.825
24309587,2013-12-05T00:00:00,Secondary Prevention,N06.850.780.750
24309587,2013-12-05T00:00:00,Sex Factors,N05.715.350.675
24309587,2013-12-05T00:00:00,Sex Factors,N06.850.490.875
24309587,2013-12-05T00:00:00,Smoking,F01.145.466.753
24309587,2013-12-05T00:00:00,Stroke,C10.228.140.300.775
24309587,2013-12-05T00:00:00,Stroke,C14.907.253.855
24309587,2013-12-05T00:00:00,Thrombolytic Therapy,E02.319.913
24309587,2013-12-05T00:00:00,United States,Z01.107.567.875
24309587,2013-12-05T00:00:00,Young Adult,M01.060.116.815
24319288,2013-12-06T00:00:00,Animals,B01.050
24319288,2013-12-06T00:00:00,Arachidonic Acids,D10.251.355.096
24319288,2013-12-06T00:00:00,Arachidonic Acids,D10.251.355.255.100
24319288,2013-12-06T00:00:00,Arachidonic Acids,D10.251.355.310.166
24319288,2013-12-06T00:00:00,Myeloid Cells,A11.627
24319288,2013-12-06T00:00:00,Polyunsaturated Alkamides,D02.065.160
24319288,2013-12-06T00:00:00,Polyunsaturated Alkamides,D02.455.326.271.060
24319288,2013-12-06T00:00:00,Polyunsaturated Alkamides,D02.455.326.397.675
24314019,2013-12-07T00:00:00,Animals,B01.050
24314019,2013-12-07T00:00:00,Disease Progression,C23.550.291.656
24314019,2013-12-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24314019,2013-12-07T00:00:00,Multiple Myeloma,C04.557.595.500
24314019,2013-12-07T00:00:00,Multiple Myeloma,C14.907.454.460
24314019,2013-12-07T00:00:00,Multiple Myeloma,C15.378.147.780.650
24314019,2013-12-07T00:00:00,Multiple Myeloma,C15.378.463.835.460
24314019,2013-12-07T00:00:00,Multiple Myeloma,C20.683.515.845
24314019,2013-12-07T00:00:00,Multiple Myeloma,C20.683.780.650
24314019,2013-12-07T00:00:00,Neoplastic Stem Cells,A11.872.650
24318083,2013-12-07T00:00:00,Case-Control Studies,E05.318.760.500.500
24318083,2013-12-07T00:00:00,Case-Control Studies,N05.715.360.775.175.200
24318083,2013-12-07T00:00:00,Case-Control Studies,N06.850.520.450.500.500
24318083,2013-12-07T00:00:00,Combat Disorders,F03.080.931.249
24318083,2013-12-07T00:00:00,Health Surveys,E05.318.308.250
24318083,2013-12-07T00:00:00,Health Surveys,N05.715.360.300.375
24318083,2013-12-07T00:00:00,Health Surveys,N06.850.520.308.250
24318083,2013-12-07T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24318083,2013-12-07T00:00:00,"Interview, Psychological",F04.669.599
24318083,2013-12-07T00:00:00,Middle Aged,M01.060.116.630
24318083,2013-12-07T00:00:00,Psychiatric Status Rating Scales,F04.586
24318083,2013-12-07T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
24318083,2013-12-07T00:00:00,Veterans,M01.930
24316865,2013-12-08T00:00:00,"Angioedemas, Hereditary",C14.907.079.500
24316865,2013-12-08T00:00:00,"Angioedemas, Hereditary",C16.320.078
24316865,2013-12-08T00:00:00,"Angioedemas, Hereditary",C17.800.862.945.066.500
24316865,2013-12-08T00:00:00,"Angioedemas, Hereditary",C20.543.480.904.066.500
24316865,2013-12-08T00:00:00,Angiotensin-Converting Enzyme Inhibitors,D27.505.519.389.745.085
24316865,2013-12-08T00:00:00,Animals,B01.050
24316865,2013-12-08T00:00:00,Bradykinin,D12.644.276.812.169
24316865,2013-12-08T00:00:00,Bradykinin,D12.644.400.090
24316865,2013-12-08T00:00:00,Bradykinin,D12.644.456.193
24316865,2013-12-08T00:00:00,Bradykinin,D12.776.467.812.169
24316865,2013-12-08T00:00:00,Bradykinin,D12.776.641.650.090
24316865,2013-12-08T00:00:00,Bradykinin,D23.469.050.375.110
24316865,2013-12-08T00:00:00,Bradykinin,D23.529.812.169
24316865,2013-12-08T00:00:00,Factor XII,D12.776.124.125.450
24316865,2013-12-08T00:00:00,Factor XII,D23.119.450
24316865,2013-12-08T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24316865,2013-12-08T00:00:00,Nitric Oxide,D01.339.387
24316865,2013-12-08T00:00:00,Nitric Oxide,D01.625.550.500
24316865,2013-12-08T00:00:00,Nitric Oxide,D01.625.700.500
24316865,2013-12-08T00:00:00,Nitric Oxide,D01.650.550.587.600
24326067,2013-12-08T00:00:00,Biomimetic Materials,J01.637.087
24326067,2013-12-08T00:00:00,Biosensing Techniques,E05.601.123
24326067,2013-12-08T00:00:00,Polysaccharides,D09.698
24326067,2013-12-08T00:00:00,"Serum Albumin, Bovine",D12.776.034.841.540
24326067,2013-12-08T00:00:00,"Serum Albumin, Bovine",D12.776.124.727.540
24326067,2013-12-08T00:00:00,Surface Plasmon Resonance,E05.196.890
24326067,2013-12-08T00:00:00,Surface Plasmon Resonance,E05.601.123.700
24294824,2013-12-09T00:00:00,Cell Proliferation,G04.299.233.750
24294824,2013-12-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24294824,2013-12-09T00:00:00,Drug Delivery Systems,E02.319.300
24294824,2013-12-09T00:00:00,Glioblastoma,C04.557.465.625.600.380.080.335
24294824,2013-12-09T00:00:00,Glioblastoma,C04.557.470.670.380.080.335
24294824,2013-12-09T00:00:00,Glioblastoma,C04.557.580.625.600.380.080.335
24294824,2013-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24294824,2013-12-09T00:00:00,Lactic Acid,D02.241.511.459.450
24294824,2013-12-09T00:00:00,Nanoparticles,J01.637.512.600
24294824,2013-12-09T00:00:00,"Nanotubes, Carbon",D01.268.150.250.500
24294824,2013-12-09T00:00:00,"Nanotubes, Carbon",J01.637.512.850.500
24294824,2013-12-09T00:00:00,Polyglycolic Acid,D05.750.728.780
24294824,2013-12-09T00:00:00,Polyglycolic Acid,D25.720.728.780
24294824,2013-12-09T00:00:00,Polyglycolic Acid,J01.637.051.720.728.780
24294824,2013-12-09T00:00:00,Protein Kinase Inhibitors,D27.505.519.389.755
24294824,2013-12-09T00:00:00,Protein-Tyrosine Kinases,D08.811.913.696.620.682.725
24294824,2013-12-09T00:00:00,Pyrimidines,D03.383.742
24320727,2013-12-09T00:00:00,Animals,B01.050
24320727,2013-12-09T00:00:00,Cell Cycle,G04.299.134
24320727,2013-12-09T00:00:00,Cell Death,G04.299.139
24320727,2013-12-09T00:00:00,Cell Proliferation,G04.299.233.750
24320727,2013-12-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24320727,2013-12-09T00:00:00,Fatty Liver,C06.552.241
24320727,2013-12-09T00:00:00,Gene Expression Profiling,E05.393.332
24320727,2013-12-09T00:00:00,Hela Cells,A11.251.210.190.400
24320727,2013-12-09T00:00:00,Hela Cells,A11.251.860.180.400
24320727,2013-12-09T00:00:00,Hela Cells,A11.436.340
24320727,2013-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24320727,2013-12-09T00:00:00,Ion Channels,D12.776.157.530.400
24320727,2013-12-09T00:00:00,Ion Channels,D12.776.543.550.425
24320727,2013-12-09T00:00:00,Ion Channels,D12.776.543.585.400
24320727,2013-12-09T00:00:00,Liver,A03.620
24320727,2013-12-09T00:00:00,Liver Regeneration,G10.261.326.520
24320727,2013-12-09T00:00:00,Liver Regeneration,G16.100.856.468
24320727,2013-12-09T00:00:00,Mitochondrial Proteins,D12.776.575
24322981,2013-12-09T00:00:00,Animals,B01.050
24322981,2013-12-09T00:00:00,Bone Marrow Cells,A11.148
24322981,2013-12-09T00:00:00,Bone Marrow Cells,A15.378.316
24322981,2013-12-09T00:00:00,"Cell Transformation, Neoplastic",C04.697.152
24322981,2013-12-09T00:00:00,"Cell Transformation, Neoplastic",C23.550.727.152
24322981,2013-12-09T00:00:00,Colitis,C06.405.205.265
24322981,2013-12-09T00:00:00,Colitis,C06.405.469.158.188
24322981,2013-12-09T00:00:00,Colon,A03.556.124.526.356
24322981,2013-12-09T00:00:00,Colon,A03.556.249.249.356
24322981,2013-12-09T00:00:00,Colonic Neoplasms,C04.588.274.476.411.307.180
24322981,2013-12-09T00:00:00,Colonic Neoplasms,C06.301.371.411.307.180
24322981,2013-12-09T00:00:00,Colonic Neoplasms,C06.405.249.411.307.180
24322981,2013-12-09T00:00:00,Colonic Neoplasms,C06.405.469.158.356.180
24322981,2013-12-09T00:00:00,Colonic Neoplasms,C06.405.469.491.307.180
24322981,2013-12-09T00:00:00,Cytokines,D12.644.276.374
24322981,2013-12-09T00:00:00,Cytokines,D12.776.467.374
24322981,2013-12-09T00:00:00,Cytokines,D23.529.374
24322981,2013-12-09T00:00:00,DNA Repair,G02.111.087.219
24322981,2013-12-09T00:00:00,DNA Repair,G02.149.115.219
24322981,2013-12-09T00:00:00,DNA Repair,G05.355.195
24322981,2013-12-09T00:00:00,Disease Progression,C23.550.291.656
24322981,2013-12-09T00:00:00,Gene Deletion,G05.355.600.800.320
24322981,2013-12-09T00:00:00,Gene Deletion,G05.365.590.762.320
24322981,2013-12-09T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
24322981,2013-12-09T00:00:00,Inflammation,C23.550.470
24322981,2013-12-09T00:00:00,Macrophages,A11.329.372
24322981,2013-12-09T00:00:00,Macrophages,A11.627.482
24322981,2013-12-09T00:00:00,Macrophages,A11.733.397
24322981,2013-12-09T00:00:00,Macrophages,A15.382.680.397
24322981,2013-12-09T00:00:00,Macrophages,A15.382.812.522
24322981,2013-12-09T00:00:00,Membrane Glycoproteins,D12.776.395.550
24322981,2013-12-09T00:00:00,Membrane Glycoproteins,D12.776.543.550
24324035,2013-12-09T00:00:00,Aged,M01.060.116.100
24324035,2013-12-09T00:00:00,Antihypertensive Agents,D27.505.954.411.162
24324035,2013-12-09T00:00:00,Blood Pressure,E01.370.600.875.249
24324035,2013-12-09T00:00:00,Blood Pressure,G09.330.380.076
24324035,2013-12-09T00:00:00,Coronary Artery Disease,C14.280.647.250.260
24324035,2013-12-09T00:00:00,Coronary Artery Disease,C14.907.137.126.339
24324035,2013-12-09T00:00:00,Coronary Artery Disease,C14.907.585.250.260
24324035,2013-12-09T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
24324035,2013-12-09T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
24324035,2013-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24324035,2013-12-09T00:00:00,Hypertension,C14.907.489
24324035,2013-12-09T00:00:00,Population Surveillance,E05.318.308.250.700
24324035,2013-12-09T00:00:00,Population Surveillance,N05.715.360.300.375.625
24324035,2013-12-09T00:00:00,Population Surveillance,N06.850.520.308.250.700
24324035,2013-12-09T00:00:00,Population Surveillance,N06.850.780.675
24324035,2013-12-09T00:00:00,Prevalence,E05.318.308.985.525.750
24324035,2013-12-09T00:00:00,Prevalence,L01.280.975.525.750
24324035,2013-12-09T00:00:00,Prevalence,N01.224.935.597.750
24324035,2013-12-09T00:00:00,Prevalence,N06.850.505.400.975.525.750
24324035,2013-12-09T00:00:00,Prevalence,N06.850.520.308.985.525.750
24324035,2013-12-09T00:00:00,Risk Factors,E05.318.740.600.800.725
24324035,2013-12-09T00:00:00,Risk Factors,N05.715.350.200.700
24324035,2013-12-09T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24324035,2013-12-09T00:00:00,Risk Factors,N06.850.490.625.750
24324035,2013-12-09T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24324035,2013-12-09T00:00:00,Stroke,C10.228.140.300.775
24324035,2013-12-09T00:00:00,Stroke,C14.907.253.855
24324035,2013-12-09T00:00:00,United States,Z01.107.567.875
24324260,2013-12-09T00:00:00,Animals,B01.050
24324260,2013-12-09T00:00:00,"Antigens, CD44",D12.776.395.550.200.625.144
24324260,2013-12-09T00:00:00,"Antigens, CD44",D12.776.543.550.200.625.144
24324260,2013-12-09T00:00:00,"Antigens, CD44",D12.776.543.750.705.877.144
24324260,2013-12-09T00:00:00,"Antigens, CD44",D23.050.301.264.035.850.144
24324260,2013-12-09T00:00:00,"Antigens, CD44",D23.050.301.350.625.144
24324260,2013-12-09T00:00:00,"Antigens, CD44",D23.101.100.110.850.144
24324260,2013-12-09T00:00:00,Cell Proliferation,G04.299.233.750
24324260,2013-12-09T00:00:00,Cell Proliferation,G07.700.320.249.410.750
24324260,2013-12-09T00:00:00,Fibroblasts,A11.329.228
24324260,2013-12-09T00:00:00,Fibroblasts,A11.872.228
24324260,2013-12-09T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
24324260,2013-12-09T00:00:00,Flow Cytometry,E05.200.500.386.350
24324260,2013-12-09T00:00:00,Gene Expression Regulation,G05.355.315
24324260,2013-12-09T00:00:00,Hepatocyte Growth Factor,D12.644.276.374.420
24324260,2013-12-09T00:00:00,Hepatocyte Growth Factor,D12.776.467.374.420
24324260,2013-12-09T00:00:00,Hepatocyte Growth Factor,D23.529.374.420
24324260,2013-12-09T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24324260,2013-12-09T00:00:00,Lung,A04.411
24324260,2013-12-09T00:00:00,"Lung Diseases, Interstitial",C08.381.483
24324260,2013-12-09T00:00:00,Proto-Oncogene Proteins c-met,D08.811.913.696.620.682.725.400.075
24324260,2013-12-09T00:00:00,Proto-Oncogene Proteins c-met,D12.776.543.750.060.186
24324260,2013-12-09T00:00:00,Proto-Oncogene Proteins c-met,D12.776.543.750.750.400.100
24324260,2013-12-09T00:00:00,Proto-Oncogene Proteins c-met,D12.776.624.664.700.186
24324260,2013-12-09T00:00:00,Pulmonary Fibrosis,C08.381.765
24324260,2013-12-09T00:00:00,"RNA, Messenger",D13.444.735.544
24324260,2013-12-09T00:00:00,Signal Transduction,G02.111.087.800
24324260,2013-12-09T00:00:00,Signal Transduction,G02.149.115.800
24324260,2013-12-09T00:00:00,Signal Transduction,G04.299.880
24324260,2013-12-09T00:00:00,Transforming Growth Factor beta1,D12.644.276.374.687.100
24324260,2013-12-09T00:00:00,Transforming Growth Factor beta1,D12.644.276.954.800.720.100
24324260,2013-12-09T00:00:00,Transforming Growth Factor beta1,D12.644.276.963.720.100
24324260,2013-12-09T00:00:00,Transforming Growth Factor beta1,D12.776.467.374.687.100
24324260,2013-12-09T00:00:00,Transforming Growth Factor beta1,D12.776.467.942.800.720.100
24324260,2013-12-09T00:00:00,Transforming Growth Factor beta1,D12.776.467.960.720.100
24324260,2013-12-09T00:00:00,Transforming Growth Factor beta1,D23.529.374.687.100
24324260,2013-12-09T00:00:00,Transforming Growth Factor beta1,D23.529.942.800.720.100
24324260,2013-12-09T00:00:00,Transforming Growth Factor beta1,D23.529.960.720.100
24327720,2013-12-10T00:00:00,Adult,M01.060.116
24327720,2013-12-10T00:00:00,African Americans,M01.686.508.100.100
24327720,2013-12-10T00:00:00,African Americans,M01.686.754.100
24327720,2013-12-10T00:00:00,Biological Markers,D23.101
24327720,2013-12-10T00:00:00,Cholecalciferol,D04.808.247.222.159
24327720,2013-12-10T00:00:00,Cholecalciferol,D04.808.247.808.146
24327720,2013-12-10T00:00:00,Cholecalciferol,D04.808.812.768.196
24327720,2013-12-10T00:00:00,Cholecalciferol,D10.570.938.146
24327720,2013-12-10T00:00:00,Dietary Supplements,J02.500.456
24327720,2013-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24327720,2013-12-10T00:00:00,Inflammation,C23.550.470
24327720,2013-12-10T00:00:00,Middle Aged,M01.060.116.630
24327720,2013-12-10T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
24332101,2013-12-10T00:00:00,Cardiopulmonary Bypass,E04.292.413
24332101,2013-12-10T00:00:00,"Education, Medical",I02.358.399
24332101,2013-12-10T00:00:00,"History, 20th Century",K01.400.504.968
24332101,2013-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24332101,2013-12-10T00:00:00,Internship and Residency,I02.358.399.644
24332101,2013-12-10T00:00:00,"Societies, Medical",N03.540.828.589
24332101,2013-12-10T00:00:00,Thoracic Surgery,H02.403.810.803
24332101,2013-12-10T00:00:00,Thoracic Surgical Procedures,E04.928
24332101,2013-12-10T00:00:00,United States,Z01.107.567.875
24370205,2013-12-10T00:00:00,Adolescent,M01.060.057
24370205,2013-12-10T00:00:00,Adult,M01.060.116
24370205,2013-12-10T00:00:00,Alcohol Drinking,F01.145.317.269
24370205,2013-12-10T00:00:00,Child,M01.060.406
24370205,2013-12-10T00:00:00,Crime Victims,M01.135
24370205,2013-12-10T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24370205,2013-12-10T00:00:00,Middle Aged,M01.060.116.630
24370205,2013-12-10T00:00:00,Prevalence,E05.318.308.985.525.750
24370205,2013-12-10T00:00:00,Prevalence,L01.280.975.525.750
24370205,2013-12-10T00:00:00,Prevalence,N01.224.935.597.750
24370205,2013-12-10T00:00:00,Prevalence,N06.850.505.400.975.525.750
24370205,2013-12-10T00:00:00,Prevalence,N06.850.520.308.985.525.750
24370205,2013-12-10T00:00:00,Rape,I01.198.240.748.640
24370205,2013-12-10T00:00:00,Risk Factors,E05.318.740.600.800.725
24370205,2013-12-10T00:00:00,Risk Factors,N05.715.350.200.700
24370205,2013-12-10T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24370205,2013-12-10T00:00:00,Risk Factors,N06.850.490.625.750
24370205,2013-12-10T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24370205,2013-12-10T00:00:00,Sex Offenses,I01.198.240.748
24370205,2013-12-10T00:00:00,"Stress Disorders, Post-Traumatic",F03.080.931.500
24370205,2013-12-10T00:00:00,Students,I02.233.748
24370205,2013-12-10T00:00:00,Students,I02.851
24370205,2013-12-10T00:00:00,Students,M01.848
24370205,2013-12-10T00:00:00,Substance-Related Disorders,C21.739
24370205,2013-12-10T00:00:00,Substance-Related Disorders,F03.900
24370205,2013-12-10T00:00:00,United States,Z01.107.567.875
24370205,2013-12-10T00:00:00,Universities,I02.783.850
24370205,2013-12-10T00:00:00,Young Adult,M01.060.116.815
24325638,2013-12-11T00:00:00,Antihypertensive Agents,D27.505.954.411.162
24325638,2013-12-11T00:00:00,Cerebral Hemorrhage,C10.228.140.300.535.200
24325638,2013-12-11T00:00:00,Cerebral Hemorrhage,C14.907.253.573.200
24325638,2013-12-11T00:00:00,Cerebral Hemorrhage,C23.550.414.913.100
24325638,2013-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24325638,2013-12-11T00:00:00,Hypertension,C14.907.489
24336983,2013-12-11T00:00:00,Adult,M01.060.116
24336983,2013-12-11T00:00:00,Age Factors,N05.715.350.075
24336983,2013-12-11T00:00:00,Age Factors,N06.850.490.250
24336983,2013-12-11T00:00:00,Aged,M01.060.116.100
24336983,2013-12-11T00:00:00,Coronary Angiography,E01.370.350.700.060.200
24336983,2013-12-11T00:00:00,Coronary Angiography,E01.370.370.050.200
24336983,2013-12-11T00:00:00,Coronary Angiography,E01.370.370.380.200
24336983,2013-12-11T00:00:00,Coronary Artery Disease,C14.280.647.250.260
24336983,2013-12-11T00:00:00,Coronary Artery Disease,C14.907.137.126.339
24336983,2013-12-11T00:00:00,Coronary Artery Disease,C14.907.585.250.260
24336983,2013-12-11T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24336983,2013-12-11T00:00:00,Middle Aged,M01.060.116.630
24336983,2013-12-11T00:00:00,Prevalence,E05.318.308.985.525.750
24336983,2013-12-11T00:00:00,Prevalence,L01.280.975.525.750
24336983,2013-12-11T00:00:00,Prevalence,N01.224.935.597.750
24336983,2013-12-11T00:00:00,Prevalence,N06.850.505.400.975.525.750
24336983,2013-12-11T00:00:00,Prevalence,N06.850.520.308.985.525.750
24336983,2013-12-11T00:00:00,Risk Factors,E05.318.740.600.800.725
24336983,2013-12-11T00:00:00,Risk Factors,N05.715.350.200.700
24336983,2013-12-11T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24336983,2013-12-11T00:00:00,Risk Factors,N06.850.490.625.750
24336983,2013-12-11T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24336983,2013-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24336983,2013-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24336983,2013-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24336983,2013-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24336983,2013-12-11T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24336983,2013-12-11T00:00:00,United States,Z01.107.567.875
24335227,2013-12-12T00:00:00,Aged,M01.060.116.100
24335227,2013-12-12T00:00:00,Arterial Occlusive Diseases,C14.907.137
24335227,2013-12-12T00:00:00,Brain Ischemia,C10.228.140.300.150
24335227,2013-12-12T00:00:00,Brain Ischemia,C14.907.253.092
24335227,2013-12-12T00:00:00,Fibrinolytic Agents,D27.505.519.421.750
24335227,2013-12-12T00:00:00,Fibrinolytic Agents,D27.505.954.411.320
24335227,2013-12-12T00:00:00,Fibrinolytic Agents,D27.505.954.502.427
24335227,2013-12-12T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24335227,2013-12-12T00:00:00,Middle Aged,M01.060.116.630
24335227,2013-12-12T00:00:00,Patient Selection,E05.581.500.653
24335227,2013-12-12T00:00:00,Patient Selection,N04.590.731
24335227,2013-12-12T00:00:00,Stroke,C10.228.140.300.775
24335227,2013-12-12T00:00:00,Stroke,C14.907.253.855
24335227,2013-12-12T00:00:00,Thrombolytic Therapy,E02.319.913
24335227,2013-12-12T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.300.760.875
24335227,2013-12-12T00:00:00,Tissue Plasminogen Activator,D08.811.277.656.959.350.875
24335227,2013-12-12T00:00:00,Tissue Plasminogen Activator,D12.776.124.125.662.768
24335227,2013-12-12T00:00:00,Tissue Plasminogen Activator,D23.119.970
24335227,2013-12-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24335227,2013-12-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24335227,2013-12-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24335227,2013-12-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24335227,2013-12-12T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24335227,2013-12-12T00:00:00,Treatment Outcome,E01.789.800
24335227,2013-12-12T00:00:00,Treatment Outcome,N04.761.559.590.800
24335227,2013-12-12T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24341912,2013-12-16T00:00:00,Calcium,D01.268.552.100
24341912,2013-12-16T00:00:00,Calcium,D01.552.539.288
24341912,2013-12-16T00:00:00,Calcium,D23.119.100
24341912,2013-12-16T00:00:00,Calpain,D08.811.277.656.262.500.120
24341912,2013-12-16T00:00:00,Calpain,D08.811.277.656.300.200.120
24341912,2013-12-16T00:00:00,Carbamates,D02.241.081.251
24341912,2013-12-16T00:00:00,Cell Survival,G04.299.316
24341912,2013-12-16T00:00:00,Dopamine Agents,D27.505.519.625.150
24341912,2013-12-16T00:00:00,Dopamine Agents,D27.505.696.577.150
24341912,2013-12-16T00:00:00,Fluorescent Antibody Technique,E01.450.495.435.375
24341912,2013-12-16T00:00:00,Fluorescent Antibody Technique,E05.200.750.551.512.240
24341912,2013-12-16T00:00:00,Fluorescent Antibody Technique,E05.478.594.430.375
24341912,2013-12-16T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24341912,2013-12-16T00:00:00,Neuroprotective Agents,D27.505.696.706.548
24341912,2013-12-16T00:00:00,Neuroprotective Agents,D27.505.954.427.575
24341912,2013-12-16T00:00:00,Reactive Oxygen Species,D01.339.431
24341912,2013-12-16T00:00:00,Reactive Oxygen Species,D01.650.775
24371356,2013-12-16T00:00:00,"Education, Pharmacy",I02.358.525
24371356,2013-12-16T00:00:00,United States,Z01.107.567.875
24379052,2013-12-16T00:00:00,Nanoparticles,J01.637.512.600
24379052,2013-12-16T00:00:00,Nanotechnology,H01.603
24379052,2013-12-16T00:00:00,Nanotechnology,J01.897.520.600
24379052,2013-12-16T00:00:00,Silicon Dioxide,D01.578.750
24379052,2013-12-16T00:00:00,Silicon Dioxide,D01.650.550.825
24379052,2013-12-16T00:00:00,Silicon Dioxide,D01.837.725
24379052,2013-12-16T00:00:00,Surface Properties,G02.842.850
24343162,2013-12-17T00:00:00,Adult,M01.060.116
24343162,2013-12-17T00:00:00,Attitude,F01.100
24343162,2013-12-17T00:00:00,Child,M01.060.406
24343162,2013-12-17T00:00:00,Culture,I01.076.201.450
24343162,2013-12-17T00:00:00,Culture,I01.880.143
24343162,2013-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24343162,2013-12-17T00:00:00,Parent-Child Relations,F01.829.263.370.290
24343162,2013-12-17T00:00:00,Parents,F01.829.263.500.320
24343162,2013-12-17T00:00:00,Parents,I01.880.225.500.340
24343162,2013-12-17T00:00:00,Parents,M01.620
24343162,2013-12-17T00:00:00,Qualitative Research,H01.770.644.241.850
24343162,2013-12-17T00:00:00,Sexual Behavior,F01.145.802
24343162,2013-12-17T00:00:00,Socialization,I01.880.813
24345880,2013-12-17T00:00:00,Ablation Techniques,E04.014
24345880,2013-12-17T00:00:00,Animals,B01.050
24345880,2013-12-17T00:00:00,Liver,A03.620
24345880,2013-12-17T00:00:00,"Models, Biological",E05.599.395
24345880,2013-12-17T00:00:00,Swine,B01.050.150.900.649.077.880
24345880,2013-12-17T00:00:00,Temperature,G01.906.595
24345880,2013-12-17T00:00:00,Temperature,G16.500.275.063.725.710
24345880,2013-12-17T00:00:00,Temperature,G16.500.750.775.710
24345880,2013-12-17T00:00:00,Temperature,N06.230.150.450
24345880,2013-12-17T00:00:00,Temperature,N06.230.300.100.725.710
24358285,2013-12-17T00:00:00,Aged,M01.060.116.100
24358285,2013-12-17T00:00:00,Ethnic Groups,M01.686.754
24358285,2013-12-17T00:00:00,Ethnic Groups,N01.224.317
24358285,2013-12-17T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24358285,2013-12-17T00:00:00,Kidney,A05.810.453
24358285,2013-12-17T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
24358285,2013-12-17T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
24358285,2013-12-17T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
24358285,2013-12-17T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
24358285,2013-12-17T00:00:00,Medicare,N03.219.521.346.506.564.663
24358285,2013-12-17T00:00:00,Medicare,N03.219.521.576.343.840
24358285,2013-12-17T00:00:00,Medicare,N03.706.615.696
24358285,2013-12-17T00:00:00,Middle Aged,M01.060.116.630
24358285,2013-12-17T00:00:00,Recovery of Function,G16.757
24358285,2013-12-17T00:00:00,Renal Dialysis,E02.870.300
24358285,2013-12-17T00:00:00,Renal Dialysis,E02.912.800
24358285,2013-12-17T00:00:00,United States,Z01.107.567.875
24350642,2013-12-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24350642,2013-12-18T00:00:00,"Hyperthermia, Induced",E02.565
24350642,2013-12-18T00:00:00,"Hyperthermia, Induced",E02.779.496
24350642,2013-12-18T00:00:00,"Monitoring, Physiologic",E01.370.520
24350642,2013-12-18T00:00:00,Physicians,M01.526.485.810
24350642,2013-12-18T00:00:00,Physicians,N02.360.810
24352501,2013-12-18T00:00:00,Alveolar Bone Loss,C05.116.264.150
24352501,2013-12-18T00:00:00,Alveolar Bone Loss,C07.465.714.354.500
24352501,2013-12-18T00:00:00,Animals,B01.050
24352501,2013-12-18T00:00:00,Blood Glucose,D09.546.359.448.500
24352501,2013-12-18T00:00:00,Cholesterol,D04.808.247.222.284
24352501,2013-12-18T00:00:00,Cholesterol,D04.808.247.808.197
24352501,2013-12-18T00:00:00,Cholesterol,D10.570.938.208
24352501,2013-12-18T00:00:00,Cholesterol,D10.851.208
24352501,2013-12-18T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.644.276.374.410.240.375
24352501,2013-12-18T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.395.240.300
24352501,2013-12-18T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D12.776.467.374.410.240.375
24352501,2013-12-18T00:00:00,Granulocyte-Macrophage Colony-Stimulating Factor,D23.529.374.410.240.375
24352501,2013-12-18T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370
24352501,2013-12-18T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370
24352501,2013-12-18T00:00:00,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.230.202.370
24352501,2013-12-18T00:00:00,Insulin,D06.472.699.587.740.625
24352501,2013-12-18T00:00:00,Insulin,D12.644.548.586.740.625
24352501,2013-12-18T00:00:00,Insulin Resistance,C18.452.394.968.500
24352501,2013-12-18T00:00:00,Insulin Resistance,G07.690.320.617
24352501,2013-12-18T00:00:00,Interleukin-6,D12.644.276.374.465.506
24352501,2013-12-18T00:00:00,Interleukin-6,D12.776.467.374.465.506
24352501,2013-12-18T00:00:00,Interleukin-6,D23.529.374.465.506
24352501,2013-12-18T00:00:00,Leukocytes,A11.118.637
24352501,2013-12-18T00:00:00,Leukocytes,A15.145.229.637
24352501,2013-12-18T00:00:00,Leukocytes,A15.382.490
24352501,2013-12-18T00:00:00,Lipopolysaccharides,D09.400.500
24352501,2013-12-18T00:00:00,Lipopolysaccharides,D09.698.718.450
24352501,2013-12-18T00:00:00,Lipopolysaccharides,D10.494
24352501,2013-12-18T00:00:00,Lipopolysaccharides,D23.050.161.616.525
24352501,2013-12-18T00:00:00,Lipopolysaccharides,D23.946.123.329.500
24352501,2013-12-18T00:00:00,Metabolic Syndrome X,C18.452.394.968.500.570
24352501,2013-12-18T00:00:00,Metabolic Syndrome X,C18.452.625
24352501,2013-12-18T00:00:00,Osteoclasts,A11.329.372.700
24352501,2013-12-18T00:00:00,Osteoclasts,A11.627.482.700
24352501,2013-12-18T00:00:00,Periodontitis,C07.465.714.533
24352501,2013-12-18T00:00:00,RANK Ligand,D12.644.276.374.750.562
24352501,2013-12-18T00:00:00,RANK Ligand,D12.644.276.972.562
24352501,2013-12-18T00:00:00,RANK Ligand,D12.776.467.374.750.562
24352501,2013-12-18T00:00:00,RANK Ligand,D12.776.467.972.562
24352501,2013-12-18T00:00:00,RANK Ligand,D23.529.374.750.562
24352501,2013-12-18T00:00:00,RANK Ligand,D23.529.972.562
24352501,2013-12-18T00:00:00,Rats,B01.050.150.900.649.865.635.505.700
24352519,2013-12-18T00:00:00,American Heart Association,N03.540.630.780.110
24352519,2013-12-18T00:00:00,Cardiology,H02.403.429.163
24352519,2013-12-18T00:00:00,Heart Diseases,C14.280
24352519,2013-12-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24352519,2013-12-18T00:00:00,Stroke,C10.228.140.300.775
24352519,2013-12-18T00:00:00,Stroke,C14.907.253.855
24352519,2013-12-18T00:00:00,United States,Z01.107.567.875
24405940,2013-12-18T00:00:00,Adolescent,M01.060.057
24405940,2013-12-18T00:00:00,Adult,M01.060.116
24405940,2013-12-18T00:00:00,Aged,M01.060.116.100
24405940,2013-12-18T00:00:00,Case-Control Studies,E05.318.760.500.500
24405940,2013-12-18T00:00:00,Case-Control Studies,N05.715.360.775.175.200
24405940,2013-12-18T00:00:00,Case-Control Studies,N06.850.520.450.500.500
24405940,2013-12-18T00:00:00,Child,M01.060.406
24405940,2013-12-18T00:00:00,"Child, Preschool",M01.060.406.448
24405940,2013-12-18T00:00:00,Epilepsy,C10.228.140.490
24405940,2013-12-18T00:00:00,Health Surveys,E05.318.308.250
24405940,2013-12-18T00:00:00,Health Surveys,N05.715.360.300.375
24405940,2013-12-18T00:00:00,Health Surveys,N06.850.520.308.250
24405940,2013-12-18T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24405940,2013-12-18T00:00:00,Infant,M01.060.703
24405940,2013-12-18T00:00:00,"Infant, Newborn",M01.060.703.520
24405940,2013-12-18T00:00:00,Mental Disorders,F03
24405940,2013-12-18T00:00:00,Middle Aged,M01.060.116.630
24405940,2013-12-18T00:00:00,Population Surveillance,E05.318.308.250.700
24405940,2013-12-18T00:00:00,Population Surveillance,N05.715.360.300.375.625
24405940,2013-12-18T00:00:00,Population Surveillance,N06.850.520.308.250.700
24405940,2013-12-18T00:00:00,Population Surveillance,N06.850.780.675
24405940,2013-12-18T00:00:00,Seizures,C10.228.140.490.631
24405940,2013-12-18T00:00:00,Seizures,C10.597.742
24405940,2013-12-18T00:00:00,Seizures,C23.888.592.742
24405940,2013-12-18T00:00:00,Young Adult,M01.060.116.815
24357674,2013-12-19T00:00:00,Albumins,D12.776.034
24357674,2013-12-19T00:00:00,Albuminuria,C12.777.934.734.269
24357674,2013-12-19T00:00:00,Albuminuria,C13.351.968.934.734.269
24357674,2013-12-19T00:00:00,Albuminuria,C23.888.942.750.269
24357674,2013-12-19T00:00:00,Animals,B01.050
24357674,2013-12-19T00:00:00,Gene Deletion,G05.355.600.800.320
24357674,2013-12-19T00:00:00,Gene Deletion,G05.365.590.762.320
24357674,2013-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24357674,2013-12-19T00:00:00,Kidney Glomerulus,A05.810.453.324.359
24357674,2013-12-19T00:00:00,Kidney Glomerulus,A05.810.453.736.520
24357674,2013-12-19T00:00:00,"Lipoproteins, HDL",D10.532.432
24357674,2013-12-19T00:00:00,"Lipoproteins, HDL",D12.776.521.479
24357674,2013-12-19T00:00:00,"Receptors, Cell Surface",D12.776.543.750
24360581,2013-12-19T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.055.239.075
24360581,2013-12-19T00:00:00,"Aortic Aneurysm, Abdominal",C14.907.109.139.075
24360581,2013-12-19T00:00:00,Blood Vessel Prosthesis,E07.695.110
24360581,2013-12-19T00:00:00,Blood Vessel Prosthesis Implantation,E04.100.814.200
24360581,2013-12-19T00:00:00,Blood Vessel Prosthesis Implantation,E04.650.200
24360581,2013-12-19T00:00:00,Diffusion of Innovation,L01.143.320
24360581,2013-12-19T00:00:00,"History, 20th Century",K01.400.504.968
24360581,2013-12-19T00:00:00,Hospitals,N02.278.421
24360581,2013-12-19T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24360581,2013-12-19T00:00:00,New York,Z01.107.567.875.075.437
24360581,2013-12-19T00:00:00,New York,Z01.107.567.875.350.530
24360581,2013-12-19T00:00:00,New York,Z01.107.567.875.500.530
24360581,2013-12-19T00:00:00,Program Development,N04.452.760
24360581,2013-12-19T00:00:00,Prosthesis Design,E05.320.550
24360581,2013-12-19T00:00:00,Prosthesis Design,E07.695.680
24360581,2013-12-19T00:00:00,Stents,E07.695.750
24360581,2013-12-19T00:00:00,Treatment Outcome,E01.789.800
24360581,2013-12-19T00:00:00,Treatment Outcome,N04.761.559.590.800
24360581,2013-12-19T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24355923,2013-12-20T00:00:00,Angiotensin II,D06.472.699.094.078
24355923,2013-12-20T00:00:00,Angiotensin II,D12.644.400.070.078
24355923,2013-12-20T00:00:00,Angiotensin II,D12.644.456.073.041
24355923,2013-12-20T00:00:00,Angiotensin II,D12.644.548.058.078
24355923,2013-12-20T00:00:00,Angiotensin II,D12.776.641.650.070.078
24355923,2013-12-20T00:00:00,Angiotensin II,D23.469.050.050.050
24355923,2013-12-20T00:00:00,Animals,B01.050
24355923,2013-12-20T00:00:00,Disease Progression,C23.550.291.656
24355923,2013-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24355923,2013-12-20T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
24355923,2013-12-20T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
24355923,2013-12-20T00:00:00,"Mutation, Missense",G05.365.590.650
24355923,2013-12-20T00:00:00,"Myocytes, Smooth Muscle",A11.620.520
24355923,2013-12-20T00:00:00,Phenotype,G05.695
24355923,2013-12-20T00:00:00,Protein-Serine-Threonine Kinases,D08.811.913.696.620.682.700
24355923,2013-12-20T00:00:00,Signal Transduction,G02.111.087.800
24355923,2013-12-20T00:00:00,Signal Transduction,G02.149.115.800
24355923,2013-12-20T00:00:00,Signal Transduction,G04.299.880
24355923,2013-12-20T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
24355923,2013-12-20T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
24355923,2013-12-20T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
24355923,2013-12-20T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
24355923,2013-12-20T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
24355923,2013-12-20T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
24355923,2013-12-20T00:00:00,Transforming Growth Factor beta,D23.529.374.687
24355923,2013-12-20T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
24355923,2013-12-20T00:00:00,Transforming Growth Factor beta,D23.529.960.720
24356423,2013-12-20T00:00:00,Animals,B01.050
24356423,2013-12-20T00:00:00,Aortic Valve,A07.541.510.110
24356423,2013-12-20T00:00:00,Aortic Valve Stenosis,C14.280.484.150
24356423,2013-12-20T00:00:00,Aortic Valve Stenosis,C14.280.955.249
24356423,2013-12-20T00:00:00,Calcinosis,C18.452.174.130
24356423,2013-12-20T00:00:00,Cell Differentiation,G04.299.151
24356423,2013-12-20T00:00:00,Cell Movement,G04.299.283
24356423,2013-12-20T00:00:00,Cell Movement,G07.700.560.500.180
24356423,2013-12-20T00:00:00,Chick Embryo,A13.350.150
24356423,2013-12-20T00:00:00,Chick Embryo,A16.331.200
24356423,2013-12-20T00:00:00,Gene Expression,G05.355.310
24356423,2013-12-20T00:00:00,Heart Valves,A07.541.510
24356423,2013-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24356423,2013-12-20T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
24356423,2013-12-20T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
24356423,2013-12-20T00:00:00,"RNA, Messenger",D13.444.735.544
24356423,2013-12-20T00:00:00,Signal Transduction,G02.111.087.800
24356423,2013-12-20T00:00:00,Signal Transduction,G02.149.115.800
24356423,2013-12-20T00:00:00,Signal Transduction,G04.299.880
24360902,2013-12-20T00:00:00,"Financing, Personal",N03.219.559
24360902,2013-12-20T00:00:00,Internship and Residency,I02.358.399.644
24360902,2013-12-20T00:00:00,"Models, Economic",E05.318.740.500.600
24360902,2013-12-20T00:00:00,"Models, Economic",E05.599.835.890
24360902,2013-12-20T00:00:00,"Models, Economic",N05.715.360.750.530.500
24360902,2013-12-20T00:00:00,"Models, Economic",N06.850.520.830.500.600
24360902,2013-12-20T00:00:00,Radiology,H02.403.740
24360902,2013-12-20T00:00:00,United States,Z01.107.567.875
24362034,2013-12-20T00:00:00,Animals,B01.050
24362034,2013-12-20T00:00:00,Apoptosis,G04.299.139.160
24362034,2013-12-20T00:00:00,Cell Line,A11.251.210
24362034,2013-12-20T00:00:00,Gamma Rays,G01.201.875.750.400
24362034,2013-12-20T00:00:00,Hu Paraneoplastic Encephalomyelitis Antigens,D12.776.157.725.092
24362034,2013-12-20T00:00:00,Hu Paraneoplastic Encephalomyelitis Antigens,D12.776.641.520
24362034,2013-12-20T00:00:00,Hu Paraneoplastic Encephalomyelitis Antigens,D12.776.664.962.311
24362034,2013-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24362034,2013-12-20T00:00:00,Keratinocytes,A11.436.397
24362034,2013-12-20T00:00:00,Mouth Mucosa,A10.615.550.599
24362034,2013-12-20T00:00:00,Mouth Mucosa,A14.549.512
24362034,2013-12-20T00:00:00,"RNA, Messenger",D13.444.735.544
24362034,2013-12-20T00:00:00,"Radiation Injuries, Experimental",C21.866.733.720
24362034,2013-12-20T00:00:00,"Radiation Injuries, Experimental",E05.598.500.750
24362034,2013-12-20T00:00:00,"Radiation Injuries, Experimental",N06.850.810.300.360.285
24362034,2013-12-20T00:00:00,Stomatitis,C07.465.864
24362034,2013-12-20T00:00:00,bcl-2-Associated X Protein,D12.644.360.075.718.400
24362034,2013-12-20T00:00:00,bcl-2-Associated X Protein,D12.776.476.075.718.400
24452255,2013-12-20T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24452255,2013-12-20T00:00:00,Regression Analysis,E05.318.740.750
24452255,2013-12-20T00:00:00,Regression Analysis,N05.715.360.750.695
24452255,2013-12-20T00:00:00,Regression Analysis,N06.850.520.830.750
24452255,2013-12-20T00:00:00,United States,Z01.107.567.875
24365661,2013-12-21T00:00:00,Adult,M01.060.116
24365661,2013-12-21T00:00:00,Aged,M01.060.116.100
24365661,2013-12-21T00:00:00,Aging,G07.700.320.124
24365661,2013-12-21T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24365661,2013-12-21T00:00:00,Middle Aged,M01.060.116.630
24365661,2013-12-21T00:00:00,Sex Factors,N05.715.350.675
24365661,2013-12-21T00:00:00,Sex Factors,N06.850.490.875
24362705,2013-12-22T00:00:00,Animals,B01.050
24362705,2013-12-22T00:00:00,Diabetes Mellitus,C18.452.394.750
24362705,2013-12-22T00:00:00,Diabetes Mellitus,C19.246
24362705,2013-12-22T00:00:00,Drug Delivery Systems,E02.319.300
24362705,2013-12-22T00:00:00,Obesity,C18.654.726.500
24362705,2013-12-22T00:00:00,Obesity,C23.888.144.699.500
24362705,2013-12-22T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
24362705,2013-12-22T00:00:00,Obesity,G07.100.100.160.120.699.500
24362705,2013-12-22T00:00:00,Phenotype,G05.695
24362705,2013-12-22T00:00:00,Proteomics,H01.158.201.843
24362705,2013-12-22T00:00:00,Proteomics,H01.158.273.180.350.700
24362705,2013-12-22T00:00:00,Proteomics,H01.158.273.343.350.700
24362705,2013-12-22T00:00:00,Proteomics,H01.181.122.738
24362705,2013-12-22T00:00:00,Small Molecule Libraries,D27.720.470.765
24366614,2013-12-23T00:00:00,Animals,B01.050
24366614,2013-12-23T00:00:00,Autoimmunity,G12.450.192
24366614,2013-12-23T00:00:00,Disease Progression,C23.550.291.656
24366614,2013-12-23T00:00:00,Epidermis,A10.272.497
24366614,2013-12-23T00:00:00,Epidermis,A17.815.250
24366614,2013-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24366614,2013-12-23T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
24366614,2013-12-23T00:00:00,Interferon-gamma,D12.644.276.374.440.893
24366614,2013-12-23T00:00:00,Interferon-gamma,D12.644.276.374.480.350
24366614,2013-12-23T00:00:00,Interferon-gamma,D12.644.276.374.480.615.350
24366614,2013-12-23T00:00:00,Interferon-gamma,D12.644.276.718.550
24366614,2013-12-23T00:00:00,Interferon-gamma,D12.776.467.374.440.893
24366614,2013-12-23T00:00:00,Interferon-gamma,D12.776.467.374.480.350
24366614,2013-12-23T00:00:00,Interferon-gamma,D12.776.467.374.480.615.350
24366614,2013-12-23T00:00:00,Interferon-gamma,D12.776.467.718.550
24366614,2013-12-23T00:00:00,Interferon-gamma,D23.529.374.440.893
24366614,2013-12-23T00:00:00,Interferon-gamma,D23.529.374.480.350
24366614,2013-12-23T00:00:00,Interferon-gamma,D23.529.374.480.615.350
24366614,2013-12-23T00:00:00,Interferon-gamma,D23.529.718.550
24366614,2013-12-23T00:00:00,Melanocytes,A11.436.613
24366614,2013-12-23T00:00:00,"Mice, Transgenic",B01.050.050.680.136.500
24366614,2013-12-23T00:00:00,"Mice, Transgenic",B01.050.150.900.649.865.635.505.500.800
24366614,2013-12-23T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.550.500
24366614,2013-12-23T00:00:00,T-Lymphocyte Subsets,A11.118.637.555.567.569.500
24366614,2013-12-23T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.550.500
24366614,2013-12-23T00:00:00,T-Lymphocyte Subsets,A15.145.229.637.555.567.569.500
24366614,2013-12-23T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.550.500
24366614,2013-12-23T00:00:00,T-Lymphocyte Subsets,A15.382.490.555.567.569.500
24366614,2013-12-23T00:00:00,"T-Lymphocytes, Regulatory",A11.118.637.555.567.569.200.700
24366614,2013-12-23T00:00:00,"T-Lymphocytes, Regulatory",A15.145.229.637.555.567.569.200.700
24366614,2013-12-23T00:00:00,"T-Lymphocytes, Regulatory",A15.382.490.555.567.569.200.700
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.500.800
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.374.750.626
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D12.644.276.972.626
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.124.900
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.395.930
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.500.800
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.374.750.626
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D12.776.467.972.626
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.500.800
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.374.750.626
24366614,2013-12-23T00:00:00,Tumor Necrosis Factor-alpha,D23.529.972.626
24366614,2013-12-23T00:00:00,Vitiligo,C17.800.621.440.895
24366853,2013-12-23T00:00:00,Animals,B01.050
24366853,2013-12-23T00:00:00,Diagnostic Imaging,E01.370.350
24366853,2013-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24366853,2013-12-23T00:00:00,Myocardial Infarction,C14.280.647.500
24366853,2013-12-23T00:00:00,Myocardial Infarction,C14.907.585.500
24366853,2013-12-23T00:00:00,Myocardium,A02.633.580
24366853,2013-12-23T00:00:00,Myocardium,A07.541.704
24366853,2013-12-23T00:00:00,Myocardium,A10.690.552.750
24366853,2013-12-23T00:00:00,Risk Assessment,E05.318.740.600.800.715
24366853,2013-12-23T00:00:00,Risk Assessment,N04.452.871.715
24366853,2013-12-23T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24366853,2013-12-23T00:00:00,Risk Assessment,N06.850.505.715
24366853,2013-12-23T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24366853,2013-12-23T00:00:00,Risk Factors,E05.318.740.600.800.725
24366853,2013-12-23T00:00:00,Risk Factors,N05.715.350.200.700
24366853,2013-12-23T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24366853,2013-12-23T00:00:00,Risk Factors,N06.850.490.625.750
24366853,2013-12-23T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24367004,2013-12-23T00:00:00,Animals,B01.050
24367004,2013-12-23T00:00:00,B-Lymphocytes,A11.063.438
24367004,2013-12-23T00:00:00,B-Lymphocytes,A11.118.637.555.567.562
24367004,2013-12-23T00:00:00,B-Lymphocytes,A15.145.229.637.555.567.562
24367004,2013-12-23T00:00:00,B-Lymphocytes,A15.382.032.438
24367004,2013-12-23T00:00:00,B-Lymphocytes,A15.382.490.555.567.562
24367004,2013-12-23T00:00:00,Flow Cytometry,E05.196.712.516.600.240.350
24367004,2013-12-23T00:00:00,Flow Cytometry,E05.200.500.386.350
24367004,2013-12-23T00:00:00,Gene Expression Regulation,G05.355.315
24367004,2013-12-23T00:00:00,"T-Lymphocytes, Helper-Inducer",A11.118.637.555.567.569.200.400
24367004,2013-12-23T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.145.229.637.555.567.569.200.400
24367004,2013-12-23T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.382.490.555.567.569.200.400
24367054,2013-12-23T00:00:00,Adolescent,M01.060.057
24367054,2013-12-23T00:00:00,Adult,M01.060.116
24367054,2013-12-23T00:00:00,Aged,M01.060.116.100
24367054,2013-12-23T00:00:00,Chronic Disease,C23.550.291.500
24367054,2013-12-23T00:00:00,Dendritic Cells,A11.066.270
24367054,2013-12-23T00:00:00,Dendritic Cells,A11.436.270
24367054,2013-12-23T00:00:00,Dendritic Cells,A15.382.066.270
24367054,2013-12-23T00:00:00,Dendritic Cells,A15.382.812.260
24367054,2013-12-23T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24367054,2013-12-23T00:00:00,Middle Aged,M01.060.116.630
24367054,2013-12-23T00:00:00,Quality of Life,I01.800
24367054,2013-12-23T00:00:00,Quality of Life,K01.752.400.750
24367054,2013-12-23T00:00:00,Rhinitis,C08.460.799
24367054,2013-12-23T00:00:00,Rhinitis,C08.730.674
24367054,2013-12-23T00:00:00,Rhinitis,C09.603.799
24367054,2013-12-23T00:00:00,Sinusitis,C08.460.692.752
24367054,2013-12-23T00:00:00,Sinusitis,C08.730.749
24367054,2013-12-23T00:00:00,Sinusitis,C09.603.692.752
24367054,2013-12-23T00:00:00,"T-Lymphocytes, Helper-Inducer",A11.118.637.555.567.569.200.400
24367054,2013-12-23T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.145.229.637.555.567.569.200.400
24367054,2013-12-23T00:00:00,"T-Lymphocytes, Helper-Inducer",A15.382.490.555.567.569.200.400
24367054,2013-12-23T00:00:00,Young Adult,M01.060.116.815
24368437,2013-12-24T00:00:00,Adult,M01.060.116
24368437,2013-12-24T00:00:00,African Americans,M01.686.508.100.100
24368437,2013-12-24T00:00:00,African Americans,M01.686.754.100
24368437,2013-12-24T00:00:00,Aged,M01.060.116.100
24368437,2013-12-24T00:00:00,Cardiovascular Diseases,C14
24368437,2013-12-24T00:00:00,Cholecalciferol,D04.808.247.222.159
24368437,2013-12-24T00:00:00,Cholecalciferol,D04.808.247.808.146
24368437,2013-12-24T00:00:00,Cholecalciferol,D04.808.812.768.196
24368437,2013-12-24T00:00:00,Cholecalciferol,D10.570.938.146
24368437,2013-12-24T00:00:00,Dietary Supplements,J02.500.456
24368437,2013-12-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24368437,2013-12-24T00:00:00,Middle Aged,M01.060.116.630
24368437,2013-12-24T00:00:00,Neoplasms,C04
24368437,2013-12-24T00:00:00,Patient Dropouts,M01.643.673
24368437,2013-12-24T00:00:00,Risk Factors,E05.318.740.600.800.725
24368437,2013-12-24T00:00:00,Risk Factors,N05.715.350.200.700
24368437,2013-12-24T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24368437,2013-12-24T00:00:00,Risk Factors,N06.850.490.625.750
24368437,2013-12-24T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24368437,2013-12-24T00:00:00,Seasons,G01.910.645.661
24368437,2013-12-24T00:00:00,Seasons,G16.500.275.071.590
24368437,2013-12-24T00:00:00,Seasons,N06.230.300.100.250.525
24368437,2013-12-24T00:00:00,Vitamin D Deficiency,C18.654.521.500.133.770
24370892,2013-12-24T00:00:00,Adenoviridae,B04.280.030
24370892,2013-12-24T00:00:00,Adenoviridae,B04.909.204.097
24370892,2013-12-24T00:00:00,Aminoglycosides,D09.408.051
24370892,2013-12-24T00:00:00,Animals,B01.050
24370892,2013-12-24T00:00:00,Gene Expression,G05.355.310
24370892,2013-12-24T00:00:00,Gene Transfer Techniques,E05.393.350
24370892,2013-12-24T00:00:00,Green Fluorescent Proteins,D12.776.532.265
24370892,2013-12-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24370892,2013-12-24T00:00:00,Polymers,D05.750
24370892,2013-12-24T00:00:00,Polymers,D25.720
24370892,2013-12-24T00:00:00,Polymers,J01.637.051.720
24370892,2013-12-24T00:00:00,Urinary Bladder Neoplasms,C04.588.945.947.960
24370892,2013-12-24T00:00:00,Urinary Bladder Neoplasms,C12.758.820.968
24370892,2013-12-24T00:00:00,Urinary Bladder Neoplasms,C12.777.829.813
24370892,2013-12-24T00:00:00,Urinary Bladder Neoplasms,C13.351.937.820.945
24370892,2013-12-24T00:00:00,Urinary Bladder Neoplasms,C13.351.968.829.707
24491243,2013-12-24T00:00:00,Adolescent,M01.060.057
24491243,2013-12-24T00:00:00,Adult,M01.060.116
24491243,2013-12-24T00:00:00,Aged,M01.060.116.100
24491243,2013-12-24T00:00:00,Child,M01.060.406
24491243,2013-12-24T00:00:00,"Child, Preschool",M01.060.406.448
24491243,2013-12-24T00:00:00,Graft Survival,G12.425.901.545.340
24491243,2013-12-24T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24491243,2013-12-24T00:00:00,Kidney Transplantation,E02.870.500
24491243,2013-12-24T00:00:00,Kidney Transplantation,E04.936.450.485
24491243,2013-12-24T00:00:00,Kidney Transplantation,E04.950.774.400
24491243,2013-12-24T00:00:00,Length of Stay,E02.760.400.480
24491243,2013-12-24T00:00:00,Length of Stay,N02.421.585.400.480
24491243,2013-12-24T00:00:00,Middle Aged,M01.060.116.630
24491243,2013-12-24T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
24491243,2013-12-24T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
24491243,2013-12-24T00:00:00,Patient Readmission,E02.760.400.620
24491243,2013-12-24T00:00:00,Patient Readmission,N02.421.585.400.620
24491243,2013-12-24T00:00:00,Postoperative Complications,C23.550.767
24491243,2013-12-24T00:00:00,"Quality Indicators, Health Care",N04.761.789
24491243,2013-12-24T00:00:00,United States,Z01.107.567.875
24491243,2013-12-24T00:00:00,Young Adult,M01.060.116.815
24370344,2013-12-25T00:00:00,Adolescent,M01.060.057
24370344,2013-12-25T00:00:00,Asthma,C08.127.108
24370344,2013-12-25T00:00:00,Asthma,C08.381.495.108
24370344,2013-12-25T00:00:00,Asthma,C08.674.095
24370344,2013-12-25T00:00:00,Asthma,C20.543.480.680.095
24370344,2013-12-25T00:00:00,Child,M01.060.406
24370344,2013-12-25T00:00:00,"Child, Preschool",M01.060.406.448
24370344,2013-12-25T00:00:00,Forecasting,I01.320
24370344,2013-12-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24524390,2013-12-25T00:00:00,Adult,M01.060.116
24524390,2013-12-25T00:00:00,Aged,M01.060.116.100
24524390,2013-12-25T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24524390,2013-12-25T00:00:00,Middle Aged,M01.060.116.630
24524390,2013-12-25T00:00:00,Nephrectomy,E04.950.774.435
24524390,2013-12-25T00:00:00,Pancreatic Neoplasms,C04.588.274.761
24524390,2013-12-25T00:00:00,Pancreatic Neoplasms,C04.588.322.421
24524390,2013-12-25T00:00:00,Pancreatic Neoplasms,C06.301.761
24524390,2013-12-25T00:00:00,Pancreatic Neoplasms,C06.689.667
24524390,2013-12-25T00:00:00,Pancreatic Neoplasms,C19.344.421
24524390,2013-12-25T00:00:00,Pancreaticoduodenectomy,E04.210.760
24524390,2013-12-25T00:00:00,Postoperative Complications,C23.550.767
24524390,2013-12-25T00:00:00,Treatment Outcome,E01.789.800
24524390,2013-12-25T00:00:00,Treatment Outcome,N04.761.559.590.800
24524390,2013-12-25T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24524390,2013-12-25T00:00:00,United States,Z01.107.567.875
24371062,2013-12-26T00:00:00,Adult,M01.060.116
24371062,2013-12-26T00:00:00,Aged,M01.060.116.100
24371062,2013-12-26T00:00:00,Algorithms,G17.035
24371062,2013-12-26T00:00:00,Algorithms,L01.224.050
24371062,2013-12-26T00:00:00,CD4 Lymphocyte Count,E01.450.375.107.595.500.150
24371062,2013-12-26T00:00:00,CD4 Lymphocyte Count,E05.200.500.195.107.595.500.150
24371062,2013-12-26T00:00:00,CD4 Lymphocyte Count,G04.170.107.595.500.150
24371062,2013-12-26T00:00:00,CD4 Lymphocyte Count,G09.188.105.595.500.150
24371062,2013-12-26T00:00:00,HIV Infections,C02.782.815.616.400
24371062,2013-12-26T00:00:00,HIV Infections,C02.800.801.400
24371062,2013-12-26T00:00:00,HIV Infections,C20.673.480
24371062,2013-12-26T00:00:00,HIV-1,B04.820.650.589.650.350.400
24371062,2013-12-26T00:00:00,HIV-1,B04.909.777.731.589.650.350.400
24371062,2013-12-26T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24371062,2013-12-26T00:00:00,Incidence,E05.318.308.985.525.375
24371062,2013-12-26T00:00:00,Incidence,L01.280.975.525.375
24371062,2013-12-26T00:00:00,Incidence,N01.224.935.597.500
24371062,2013-12-26T00:00:00,Incidence,N06.850.505.400.975.525.375
24371062,2013-12-26T00:00:00,Incidence,N06.850.520.308.985.525.375
24371062,2013-12-26T00:00:00,Middle Aged,M01.060.116.630
24371062,2013-12-26T00:00:00,"Models, Statistical",E05.318.740.500
24371062,2013-12-26T00:00:00,"Models, Statistical",E05.599.835
24371062,2013-12-26T00:00:00,"Models, Statistical",N05.715.360.750.530
24371062,2013-12-26T00:00:00,"Models, Statistical",N06.850.520.830.500
24371062,2013-12-26T00:00:00,Molecular Sequence Data,L01.453.245.667
24371062,2013-12-26T00:00:00,Risk Factors,E05.318.740.600.800.725
24371062,2013-12-26T00:00:00,Risk Factors,N05.715.350.200.700
24371062,2013-12-26T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24371062,2013-12-26T00:00:00,Risk Factors,N06.850.490.625.750
24371062,2013-12-26T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24371062,2013-12-26T00:00:00,Sensitivity and Specificity,E05.318.740.872
24371062,2013-12-26T00:00:00,Sensitivity and Specificity,E05.318.780.800
24371062,2013-12-26T00:00:00,Sensitivity and Specificity,G17.800
24371062,2013-12-26T00:00:00,Sensitivity and Specificity,N05.715.360.750.725
24371062,2013-12-26T00:00:00,Sensitivity and Specificity,N05.715.360.780.700
24371062,2013-12-26T00:00:00,Sensitivity and Specificity,N06.850.520.445.800
24371062,2013-12-26T00:00:00,Sensitivity and Specificity,N06.850.520.830.872
24371062,2013-12-26T00:00:00,Young Adult,M01.060.116.815
24056621,2013-12-27T00:00:00,Adolescent,M01.060.057
24056621,2013-12-27T00:00:00,Adult,M01.060.116
24056621,2013-12-27T00:00:00,Aged,M01.060.116.100
24056621,2013-12-27T00:00:00,Cytomegalovirus,B04.280.382.150.150
24056621,2013-12-27T00:00:00,Cytomegalovirus,B04.909.204.382.150.150
24056621,2013-12-27T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24056621,2013-12-27T00:00:00,Immunosuppressive Agents,D27.505.696.477.656
24056621,2013-12-27T00:00:00,Incidence,E05.318.308.985.525.375
24056621,2013-12-27T00:00:00,Incidence,L01.280.975.525.375
24056621,2013-12-27T00:00:00,Incidence,N01.224.935.597.500
24056621,2013-12-27T00:00:00,Incidence,N06.850.505.400.975.525.375
24056621,2013-12-27T00:00:00,Incidence,N06.850.520.308.985.525.375
24056621,2013-12-27T00:00:00,Kidney Transplantation,E02.870.500
24056621,2013-12-27T00:00:00,Kidney Transplantation,E04.936.450.485
24056621,2013-12-27T00:00:00,Kidney Transplantation,E04.950.774.400
24056621,2013-12-27T00:00:00,Middle Aged,M01.060.116.630
24056621,2013-12-27T00:00:00,Pancreas Transplantation,E04.210.725
24056621,2013-12-27T00:00:00,Pancreas Transplantation,E04.936.450.650
24056621,2013-12-27T00:00:00,Polymerase Chain Reaction,E05.393.620.500
24056621,2013-12-27T00:00:00,Renal Insufficiency,C12.777.419.780
24056621,2013-12-27T00:00:00,Renal Insufficiency,C13.351.968.419.780
24056621,2013-12-27T00:00:00,Risk Factors,E05.318.740.600.800.725
24056621,2013-12-27T00:00:00,Risk Factors,N05.715.350.200.700
24056621,2013-12-27T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24056621,2013-12-27T00:00:00,Risk Factors,N06.850.490.625.750
24056621,2013-12-27T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24056621,2013-12-27T00:00:00,Treatment Outcome,E01.789.800
24056621,2013-12-27T00:00:00,Treatment Outcome,N04.761.559.590.800
24056621,2013-12-27T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24056621,2013-12-27T00:00:00,Young Adult,M01.060.116.815
24379240,2013-12-30T00:00:00,Animals,B01.050
24379240,2013-12-30T00:00:00,Antineoplastic Agents,D27.505.954.248
24379240,2013-12-30T00:00:00,Apoptosis,G04.299.139.160
24379240,2013-12-30T00:00:00,Cell Line,A11.251.210
24379240,2013-12-30T00:00:00,Cell Survival,G04.299.316
24379240,2013-12-30T00:00:00,Cisplatin,D01.210.375
24379240,2013-12-30T00:00:00,Cisplatin,D01.625.125
24379240,2013-12-30T00:00:00,Cisplatin,D01.710.100
24379240,2013-12-30T00:00:00,"Drug Resistance, Neoplasm",G07.690.320.395
24379240,2013-12-30T00:00:00,Gene Expression,G05.355.310
24379240,2013-12-30T00:00:00,"Gene Expression Regulation, Neoplastic",G05.355.315.370
24379240,2013-12-30T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24379240,2013-12-30T00:00:00,"Neoplasms, Glandular and Epithelial",C04.557.470
24379240,2013-12-30T00:00:00,Ovarian Neoplasms,C04.588.322.455
24379240,2013-12-30T00:00:00,Ovarian Neoplasms,C13.351.500.056.630.705
24379240,2013-12-30T00:00:00,Ovarian Neoplasms,C13.351.937.418.685
24379240,2013-12-30T00:00:00,Ovarian Neoplasms,C19.344.410
24379240,2013-12-30T00:00:00,Ovarian Neoplasms,C19.391.630.705
24379240,2013-12-30T00:00:00,"Transcription, Genetic",G02.111.087.847
24379240,2013-12-30T00:00:00,"Transcription, Genetic",G02.149.115.847
24379240,2013-12-30T00:00:00,"Transcription, Genetic",G05.355.310.700
24379240,2013-12-30T00:00:00,Ubiquitin-Protein Ligases,D08.811.464.938.750
24388322,2013-12-31T00:00:00,"Arrhythmias, Cardiac",C14.280.067
24388322,2013-12-31T00:00:00,"Arrhythmias, Cardiac",C23.550.073
24388322,2013-12-31T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24388322,2013-12-31T00:00:00,"Infant, Newborn",M01.060.703.520
23666496,2014-01-01T00:00:00,Antithrombins,D12.644.822.750.060
23666496,2014-01-01T00:00:00,Antithrombins,D12.644.861.060
23666496,2014-01-01T00:00:00,Antithrombins,D12.776.645.750.060
23666496,2014-01-01T00:00:00,Antithrombins,D12.776.872.060
23666496,2014-01-01T00:00:00,Benzimidazoles,D03.438.103
23666496,2014-01-01T00:00:00,Decision Making,F02.463.785.373
23666496,2014-01-01T00:00:00,"Hematoma, Subdural",C10.228.140.300.535.450.400
23666496,2014-01-01T00:00:00,"Hematoma, Subdural",C10.900.300.837.600
23666496,2014-01-01T00:00:00,"Hematoma, Subdural",C14.907.253.573.400.450
23666496,2014-01-01T00:00:00,"Hematoma, Subdural",C21.866.260.616.600
23666496,2014-01-01T00:00:00,"Hematoma, Subdural",C21.866.915.300.490.450
23666496,2014-01-01T00:00:00,"Hematoma, Subdural",C23.550.414.838.700
23666496,2014-01-01T00:00:00,"Hematoma, Subdural",C23.550.414.913.700
23666496,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23666496,2014-01-01T00:00:00,beta-Alanine,D12.125.042.070
23912908,2014-01-01T00:00:00,Adolescent,M01.060.057
23912908,2014-01-01T00:00:00,Bone Screws,E07.695.130
23912908,2014-01-01T00:00:00,Bone Screws,E07.858.442.660.115
23912908,2014-01-01T00:00:00,Bone Screws,E07.858.690.650.115
23912908,2014-01-01T00:00:00,Child,M01.060.406
23912908,2014-01-01T00:00:00,Device Removal,E04.199
23912908,2014-01-01T00:00:00,Equipment Failure,E05.325
23912908,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
23912908,2014-01-01T00:00:00,Orthopedic Procedures,E02.718
23912908,2014-01-01T00:00:00,Orthopedic Procedures,E04.555
23912908,2014-01-01T00:00:00,Recovery of Function,G16.757
23912908,2014-01-01T00:00:00,Reoperation,E04.690
23912908,2014-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
23912908,2014-01-01T00:00:00,Risk Assessment,N04.452.871.715
23912908,2014-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
23912908,2014-01-01T00:00:00,Risk Assessment,N06.850.505.715
23912908,2014-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
23912908,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
23912908,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
23912908,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
23912908,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
23912908,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
23912908,2014-01-01T00:00:00,Treatment Outcome,E01.789.800
23912908,2014-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
23912908,2014-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24034685,2014-01-01T00:00:00,Adolescent,M01.060.057
24034685,2014-01-01T00:00:00,Adult,M01.060.116
24034685,2014-01-01T00:00:00,Aged,M01.060.116.100
24034685,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24034685,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
24034685,2014-01-01T00:00:00,Smoking Cessation,F01.145.940.700
24034685,2014-01-01T00:00:00,Young Adult,M01.060.116.815
24048933,2014-01-01T00:00:00,Animals,B01.050
24048933,2014-01-01T00:00:00,Brain,A08.186.211
24048933,2014-01-01T00:00:00,Electroporation,E05.200.500.410
24048933,2014-01-01T00:00:00,Electroporation,E05.301.500
24048933,2014-01-01T00:00:00,Larva,B05.500.500
24048933,2014-01-01T00:00:00,Larva,G07.700.320.500.550.500.500
24048933,2014-01-01T00:00:00,Phenotype,G05.695
24048933,2014-01-01T00:00:00,Plasmids,G05.360.600
24048933,2014-01-01T00:00:00,Retinal Ganglion Cells,A08.663.650.850.875
24048933,2014-01-01T00:00:00,Retinal Ganglion Cells,A09.371.729.831.875
24048933,2014-01-01T00:00:00,Retinal Ganglion Cells,A11.671.650.850.875
24048933,2014-01-01T00:00:00,Superior Colliculi,A08.186.211.132.659.727.816
24048933,2014-01-01T00:00:00,Superior Colliculi,A08.186.211.653.727.500
24048933,2014-01-01T00:00:00,Xenopus laevis,B01.050.150.900.090.180.610.500.562
24052352,2014-01-01T00:00:00,Actins,D05.750.078.730.250
24052352,2014-01-01T00:00:00,Actins,D12.776.210.500.100
24052352,2014-01-01T00:00:00,Actins,D12.776.220.525.255
24052352,2014-01-01T00:00:00,Adult,M01.060.116
24052352,2014-01-01T00:00:00,Animals,B01.050
24052352,2014-01-01T00:00:00,Cell Differentiation,G04.299.151
24052352,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24052352,2014-01-01T00:00:00,"Microscopy, Confocal",E01.370.350.515.395
24052352,2014-01-01T00:00:00,"Microscopy, Confocal",E05.595.395
24052352,2014-01-01T00:00:00,"Myocytes, Cardiac",A07.541.704.570
24052352,2014-01-01T00:00:00,"Myocytes, Cardiac",A10.690.552.750.570
24052352,2014-01-01T00:00:00,"Myocytes, Cardiac",A11.620.500
24121648,2014-01-01T00:00:00,Adult,M01.060.116
24121648,2014-01-01T00:00:00,Age Factors,N05.715.350.075
24121648,2014-01-01T00:00:00,Age Factors,N06.850.490.250
24121648,2014-01-01T00:00:00,Aged,M01.060.116.100
24121648,2014-01-01T00:00:00,Auditory Threshold,F02.463.593.071.173
24121648,2014-01-01T00:00:00,Auditory Threshold,F02.463.593.710.190
24121648,2014-01-01T00:00:00,Hearing Aids,E07.814.458
24121648,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24121648,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
24121648,2014-01-01T00:00:00,Noise,G01.595.907.567
24121648,2014-01-01T00:00:00,Noise,G16.500.275.600
24121648,2014-01-01T00:00:00,Noise,N06.230.400
24121648,2014-01-01T00:00:00,Noise,N06.850.460.610
24121648,2014-01-01T00:00:00,Speech Perception,F02.463.593.071.875
24121648,2014-01-01T00:00:00,Young Adult,M01.060.116.815
24121961,2014-01-01T00:00:00,Adult,M01.060.116
24121961,2014-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
24121961,2014-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
24121961,2014-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
24121961,2014-01-01T00:00:00,Amino Acid Sequence,G02.111.570.060
24121961,2014-01-01T00:00:00,Amino Acid Sequence,L01.453.245.667.060
24121961,2014-01-01T00:00:00,Computer Simulation,L01.224.160
24121961,2014-01-01T00:00:00,Dementia,C10.228.140.380
24121961,2014-01-01T00:00:00,Dementia,F03.087.400
24121961,2014-01-01T00:00:00,"Diagnosis, Differential",E01.171
24121961,2014-01-01T00:00:00,Disease Progression,C23.550.291.656
24121961,2014-01-01T00:00:00,Fibroblasts,A11.329.228
24121961,2014-01-01T00:00:00,Fibroblasts,A11.872.228
24121961,2014-01-01T00:00:00,Genome-Wide Association Study,E05.318.416.249
24121961,2014-01-01T00:00:00,Genome-Wide Association Study,E05.318.780.392
24121961,2014-01-01T00:00:00,Genome-Wide Association Study,E05.393.385.500
24121961,2014-01-01T00:00:00,Genome-Wide Association Study,E05.393.522.500
24121961,2014-01-01T00:00:00,Genome-Wide Association Study,E05.393.760.640.500
24121961,2014-01-01T00:00:00,Genome-Wide Association Study,N06.850.520.445.392
24121961,2014-01-01T00:00:00,Genome-Wide Association Study,N06.850.520.470.500
24121961,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24121961,2014-01-01T00:00:00,"Models, Genetic",E05.599.395.397
24121961,2014-01-01T00:00:00,Mutation,G05.365.590
24200079,2014-01-01T00:00:00,Animals,B01.050
24200079,2014-01-01T00:00:00,Antineoplastic Agents,D27.505.954.248
24200079,2014-01-01T00:00:00,Drug Carriers,D26.255.260
24200079,2014-01-01T00:00:00,Drug Carriers,D27.720.280.260
24200079,2014-01-01T00:00:00,Drug Carriers,E02.319.300.380
24200079,2014-01-01T00:00:00,Drug Delivery Systems,E02.319.300
24200079,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24200079,2014-01-01T00:00:00,Pancreatic Neoplasms,C04.588.274.761
24200079,2014-01-01T00:00:00,Pancreatic Neoplasms,C04.588.322.421
24200079,2014-01-01T00:00:00,Pancreatic Neoplasms,C06.301.761
24200079,2014-01-01T00:00:00,Pancreatic Neoplasms,C06.689.667
24200079,2014-01-01T00:00:00,Pancreatic Neoplasms,C19.344.421
24200079,2014-01-01T00:00:00,Polyethylene Glycols,D02.033.455.250.700
24200079,2014-01-01T00:00:00,Polyethylene Glycols,D05.750.741
24200079,2014-01-01T00:00:00,Polyethylene Glycols,D25.720.741
24200079,2014-01-01T00:00:00,Polyethylene Glycols,J01.637.051.720.741
24282121,2014-01-01T00:00:00,Clinical Trials as Topic,E05.318.760.535
24282121,2014-01-01T00:00:00,Clinical Trials as Topic,E05.337.250
24282121,2014-01-01T00:00:00,Clinical Trials as Topic,N05.715.360.775.235
24282121,2014-01-01T00:00:00,Clinical Trials as Topic,N06.850.520.450.535
24282121,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24282121,2014-01-01T00:00:00,Outcome Assessment (Health Care),N04.761.559.590
24282121,2014-01-01T00:00:00,Outcome Assessment (Health Care),N05.715.360.575.575
24282121,2014-01-01T00:00:00,Research Design,E05.581.500
24282121,2014-01-01T00:00:00,Research Design,H01.770.644.728
24292833,2014-01-01T00:00:00,Arrestins,D12.776.306.090
24292833,2014-01-01T00:00:00,Arrestins,D12.776.543.090
24292833,2014-01-01T00:00:00,Cell Membrane,A11.284.149
24292833,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24292833,2014-01-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.567.342.500
24292833,2014-01-01T00:00:00,Mitogen-Activated Protein Kinase 1,D08.811.913.696.620.682.700.646.750.249.500
24292833,2014-01-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.644.360.450.169.500
24292833,2014-01-01T00:00:00,Mitogen-Activated Protein Kinase 1,D12.776.476.450.169.500
24292833,2014-01-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.567.342.750
24292833,2014-01-01T00:00:00,Mitogen-Activated Protein Kinase 3,D08.811.913.696.620.682.700.646.750.249.750
24292833,2014-01-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.644.360.450.169.750
24292833,2014-01-01T00:00:00,Mitogen-Activated Protein Kinase 3,D12.776.476.450.169.750
24292833,2014-01-01T00:00:00,"Receptors, G-Protein-Coupled",D12.776.543.750.100
24292833,2014-01-01T00:00:00,Signal Transduction,G02.111.087.800
24292833,2014-01-01T00:00:00,Signal Transduction,G02.149.115.800
24292833,2014-01-01T00:00:00,Signal Transduction,G04.299.880
24292833,2014-01-01T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
24346518,2014-01-01T00:00:00,Age Factors,N05.715.350.075
24346518,2014-01-01T00:00:00,Age Factors,N06.850.490.250
24346518,2014-01-01T00:00:00,Aged,M01.060.116.100
24346518,2014-01-01T00:00:00,Cardiopulmonary Resuscitation,E02.365.647.110
24346518,2014-01-01T00:00:00,Hospital Mortality,E05.318.308.985.550.400
24346518,2014-01-01T00:00:00,Hospital Mortality,L01.280.975.550.400
24346518,2014-01-01T00:00:00,Hospital Mortality,N01.224.935.698.400
24346518,2014-01-01T00:00:00,Hospital Mortality,N06.850.505.400.975.550.400
24346518,2014-01-01T00:00:00,Hospital Mortality,N06.850.520.308.985.550.400
24346518,2014-01-01T00:00:00,Hospitalization,E02.760.400
24346518,2014-01-01T00:00:00,Hospitalization,N02.421.585.400
24346518,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24346518,2014-01-01T00:00:00,Inpatients,M01.643.470
24346518,2014-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
24346518,2014-01-01T00:00:00,Risk Factors,N05.715.350.200.700
24346518,2014-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24346518,2014-01-01T00:00:00,Risk Factors,N06.850.490.625.750
24346518,2014-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24354332,2014-01-01T00:00:00,Activities of Daily Living,E02.831.067
24354332,2014-01-01T00:00:00,Activities of Daily Living,I03.050
24354332,2014-01-01T00:00:00,Activities of Daily Living,N02.421.784.110
24354332,2014-01-01T00:00:00,Alzheimer Disease,C10.228.140.380.100
24354332,2014-01-01T00:00:00,Alzheimer Disease,C10.574.945.249
24354332,2014-01-01T00:00:00,Alzheimer Disease,F03.087.400.100
24354332,2014-01-01T00:00:00,Caregivers,M01.085
24354332,2014-01-01T00:00:00,Caregivers,M01.526.485.200
24354332,2014-01-01T00:00:00,Caregivers,N02.360.200
24354332,2014-01-01T00:00:00,Cognition Disorders,F03.087.250
24354332,2014-01-01T00:00:00,Culture,I01.076.201.450
24354332,2014-01-01T00:00:00,Culture,I01.880.143
24354332,2014-01-01T00:00:00,Dementia,C10.228.140.380
24354332,2014-01-01T00:00:00,Dementia,F03.087.400
24354332,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24354332,2014-01-01T00:00:00,Occupational Therapy,E02.831.489
24354332,2014-01-01T00:00:00,Occupational Therapy,H02.010.500
24356157,2014-01-01T00:00:00,Anesthesiology,H02.403.066
24356157,2014-01-01T00:00:00,Cardiovascular Diseases,C14
24356157,2014-01-01T00:00:00,Echocardiography,E01.370.350.850.220
24356157,2014-01-01T00:00:00,Echocardiography,E01.370.370.380.220
24356157,2014-01-01T00:00:00,"Echocardiography, Transesophageal",E01.370.350.850.220.235
24356157,2014-01-01T00:00:00,"Echocardiography, Transesophageal",E01.370.370.380.220.235
24356157,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24356157,2014-01-01T00:00:00,"Societies, Medical",N03.540.828.589
24356157,2014-01-01T00:00:00,United States,Z01.107.567.875
24366224,2014-01-01T00:00:00,Adolescent,M01.060.057
24366224,2014-01-01T00:00:00,Brain,A08.186.211
24366224,2014-01-01T00:00:00,Demyelinating Diseases,C10.314
24366224,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24366224,2014-01-01T00:00:00,Hyperemesis Gravidarum,C13.703.407.500
24366224,2014-01-01T00:00:00,Hyperemesis Gravidarum,C23.888.821.937.049.500
24366224,2014-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.500
24366224,2014-01-01T00:00:00,Magnetic Resonance Imaging,E01.370.350.825.500
24366224,2014-01-01T00:00:00,Malnutrition,C18.654.521
24366224,2014-01-01T00:00:00,Optic Nerve Diseases,C10.292.700
24366224,2014-01-01T00:00:00,Optic Nerve Diseases,C11.640
24366224,2014-01-01T00:00:00,Pregnancy,G08.686.785.760.769
24366224,2014-01-01T00:00:00,Pregnancy Complications,C13.703
24366224,2014-01-01T00:00:00,Pregnancy Outcome,E01.789.700
24366224,2014-01-01T00:00:00,Pregnancy Outcome,G08.686.785.760.769.530
24370164,2014-01-01T00:00:00,Contrast Media,D27.720.259
24370164,2014-01-01T00:00:00,Coronary Angiography,E01.370.350.700.060.200
24370164,2014-01-01T00:00:00,Coronary Angiography,E01.370.370.050.200
24370164,2014-01-01T00:00:00,Coronary Angiography,E01.370.370.380.200
24370164,2014-01-01T00:00:00,Coronary Disease,C14.280.647.250
24370164,2014-01-01T00:00:00,Coronary Disease,C14.907.585.250
24370164,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24370164,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
24370164,2014-01-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.158.600.680
24370164,2014-01-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.350.700
24370164,2014-01-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",E01.370.350.700.705
24370164,2014-01-01T00:00:00,"Radiographic Image Interpretation, Computer-Assisted",L01.700.508.100.158.600.680
24370164,2014-01-01T00:00:00,Software,L01.224.900
24370164,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24370164,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24370164,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24370164,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24370164,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24371208,2014-01-01T00:00:00,Bioprosthesis,E07.695.100
24371208,2014-01-01T00:00:00,Calcinosis,C18.452.174.130
24371208,2014-01-01T00:00:00,Elastin,D05.750.078.421
24371208,2014-01-01T00:00:00,Elastin,D12.776.860.300.350
24371208,2014-01-01T00:00:00,Glycosaminoglycans,D09.698.373
24371208,2014-01-01T00:00:00,Heart Valve Prosthesis,E07.695.310
24371208,2014-01-01T00:00:00,Hydrolyzable Tannins,D02.241.223.100.380.350.299
24371208,2014-01-01T00:00:00,Hydrolyzable Tannins,D02.241.511.390.350.299
24371208,2014-01-01T00:00:00,Hydrolyzable Tannins,D02.755.410.350.299
24371208,2014-01-01T00:00:00,Hydrolyzable Tannins,D05.750.078.937.214
24371208,2014-01-01T00:00:00,Neomycin,D09.408.051.623
24371208,2014-01-01T00:00:00,Protein Denaturation,G02.111.087.685
24371208,2014-01-01T00:00:00,Protein Denaturation,G02.149.115.685
24384190,2014-01-01T00:00:00,Adenocarcinoma,C04.557.470.200.025
24384190,2014-01-01T00:00:00,"Biopsy, Needle",E01.370.388.100.100
24384190,2014-01-01T00:00:00,"Biopsy, Needle",E01.450.230.100.100
24384190,2014-01-01T00:00:00,"Biopsy, Needle",E01.450.865.100.100
24384190,2014-01-01T00:00:00,"Biopsy, Needle",E01.450.865.632.100
24384190,2014-01-01T00:00:00,"Biopsy, Needle",E04.074.119
24384190,2014-01-01T00:00:00,Carcinoid Tumor,C04.557.465.625.650.200
24384190,2014-01-01T00:00:00,Carcinoid Tumor,C04.557.470.200.025.200
24384190,2014-01-01T00:00:00,Carcinoid Tumor,C04.557.580.625.650.200
24384190,2014-01-01T00:00:00,"Carcinoma, Neuroendocrine",C04.557.465.625.650.240
24384190,2014-01-01T00:00:00,"Carcinoma, Neuroendocrine",C04.557.470.200.025.370
24384190,2014-01-01T00:00:00,"Carcinoma, Neuroendocrine",C04.557.580.625.650.240
24384190,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24384190,2014-01-01T00:00:00,Incidental Findings,E01.410
24384190,2014-01-01T00:00:00,Lung Neoplasms,C04.588.894.797.520
24384190,2014-01-01T00:00:00,Lung Neoplasms,C08.381.540
24384190,2014-01-01T00:00:00,Lung Neoplasms,C08.785.520
24384190,2014-01-01T00:00:00,Neuroendocrine Cells,A11.382.944
24384190,2014-01-01T00:00:00,Pneumonectomy,E04.928.600.600
24384190,2014-01-01T00:00:00,Risk Assessment,E05.318.740.600.800.715
24384190,2014-01-01T00:00:00,Risk Assessment,N04.452.871.715
24384190,2014-01-01T00:00:00,Risk Assessment,N05.715.360.750.625.700.690
24384190,2014-01-01T00:00:00,Risk Assessment,N06.850.505.715
24384190,2014-01-01T00:00:00,Risk Assessment,N06.850.520.830.600.800.715
24384190,2014-01-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.840.830
24384190,2014-01-01T00:00:00,"Thoracic Surgery, Video-Assisted",E01.370.388.250.950.830
24384190,2014-01-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.840.830
24384190,2014-01-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.800.250.950.830
24384190,2014-01-01T00:00:00,"Thoracic Surgery, Video-Assisted",E04.928.752.830
24384190,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
24384190,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
24384190,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
24384190,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
24384190,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
24384190,2014-01-01T00:00:00,Treatment Outcome,E01.789.800
24384190,2014-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24384190,2014-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24384249,2014-01-01T00:00:00,"Education, Medical",I02.358.399
24384249,2014-01-01T00:00:00,"Ethics, Medical",K01.316.333.132.750
24384249,2014-01-01T00:00:00,"Ethics, Medical",N05.350.340.162.500
24384249,2014-01-01T00:00:00,"History, 20th Century",K01.400.504.968
24384249,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24384249,2014-01-01T00:00:00,"Societies, Medical",N03.540.828.589
24384249,2014-01-01T00:00:00,Thoracic Surgery,H02.403.810.803
24384249,2014-01-01T00:00:00,United States,Z01.107.567.875
24385520,2014-01-01T00:00:00,Alcohol Drinking,F01.145.317.269
24385520,2014-01-01T00:00:00,Behavior Therapy,F04.754.137
24385520,2014-01-01T00:00:00,Computer-Assisted Instruction,I02.903.573.208
24385520,2014-01-01T00:00:00,Curriculum,I02.158
24385520,2014-01-01T00:00:00,"Education, Dental",I02.358.274
24385520,2014-01-01T00:00:00,Educational Measurement,I02.399
24385520,2014-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
24385520,2014-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
24385520,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24385520,2014-01-01T00:00:00,Mass Screening,E01.370.500
24385520,2014-01-01T00:00:00,Mass Screening,E05.318.308.250.580
24385520,2014-01-01T00:00:00,Mass Screening,N02.421.143.827.233.443
24385520,2014-01-01T00:00:00,Mass Screening,N02.421.726.233.443
24385520,2014-01-01T00:00:00,Mass Screening,N05.715.360.300.375.500
24385520,2014-01-01T00:00:00,Mass Screening,N06.850.520.308.250.580
24385520,2014-01-01T00:00:00,Mass Screening,N06.850.780.500
24385520,2014-01-01T00:00:00,Professional Competence,I02.399.630
24388119,2014-01-01T00:00:00,Aged,M01.060.116.100
24388119,2014-01-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
24388119,2014-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
24388119,2014-01-01T00:00:00,Blood Pressure,G09.330.380.076
24388119,2014-01-01T00:00:00,Continental Population Groups,M01.686.508
24388119,2014-01-01T00:00:00,Drug Resistance,G07.690.320
24388119,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24388119,2014-01-01T00:00:00,Hypertension,C14.907.489
24388119,2014-01-01T00:00:00,Incidence,E05.318.308.985.525.375
24388119,2014-01-01T00:00:00,Incidence,L01.280.975.525.375
24388119,2014-01-01T00:00:00,Incidence,N01.224.935.597.500
24388119,2014-01-01T00:00:00,Incidence,N06.850.505.400.975.525.375
24388119,2014-01-01T00:00:00,Incidence,N06.850.520.308.985.525.375
24388119,2014-01-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.500.602
24388119,2014-01-01T00:00:00,"Kidney Failure, Chronic",C12.777.419.780.750.500
24388119,2014-01-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.500.602
24388119,2014-01-01T00:00:00,"Kidney Failure, Chronic",C13.351.968.419.780.750.500
24388119,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
24388119,2014-01-01T00:00:00,Prevalence,E05.318.308.985.525.750
24388119,2014-01-01T00:00:00,Prevalence,L01.280.975.525.750
24388119,2014-01-01T00:00:00,Prevalence,N01.224.935.597.750
24388119,2014-01-01T00:00:00,Prevalence,N06.850.505.400.975.525.750
24388119,2014-01-01T00:00:00,Prevalence,N06.850.520.308.985.525.750
24388119,2014-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
24388119,2014-01-01T00:00:00,Risk Factors,N05.715.350.200.700
24388119,2014-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24388119,2014-01-01T00:00:00,Risk Factors,N06.850.490.625.750
24388119,2014-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24388119,2014-01-01T00:00:00,Stroke,C10.228.140.300.775
24388119,2014-01-01T00:00:00,Stroke,C14.907.253.855
24388119,2014-01-01T00:00:00,United States,Z01.107.567.875
24388213,2014-01-01T00:00:00,"Angioedemas, Hereditary",C14.907.079.500
24388213,2014-01-01T00:00:00,"Angioedemas, Hereditary",C16.320.078
24388213,2014-01-01T00:00:00,"Angioedemas, Hereditary",C17.800.862.945.066.500
24388213,2014-01-01T00:00:00,"Angioedemas, Hereditary",C20.543.480.904.066.500
24388213,2014-01-01T00:00:00,Animals,B01.050
24388213,2014-01-01T00:00:00,Bradykinin,D12.644.276.812.169
24388213,2014-01-01T00:00:00,Bradykinin,D12.644.400.090
24388213,2014-01-01T00:00:00,Bradykinin,D12.644.456.193
24388213,2014-01-01T00:00:00,Bradykinin,D12.776.467.812.169
24388213,2014-01-01T00:00:00,Bradykinin,D12.776.641.650.090
24388213,2014-01-01T00:00:00,Bradykinin,D23.469.050.375.110
24388213,2014-01-01T00:00:00,Bradykinin,D23.529.812.169
24388213,2014-01-01T00:00:00,"Endothelium, Vascular",A07.231.330
24388213,2014-01-01T00:00:00,"Endothelium, Vascular",A10.272.491.355
24388213,2014-01-01T00:00:00,Factor XII,D12.776.124.125.450
24388213,2014-01-01T00:00:00,Factor XII,D23.119.450
24388213,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24388213,2014-01-01T00:00:00,"Immunity, Innate",G12.450.575
24388213,2014-01-01T00:00:00,Inflammation,C23.550.470
24388213,2014-01-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.644.276.812.654.350
24388213,2014-01-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.124.125.635.480
24388213,2014-01-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.467.812.654.350
24388213,2014-01-01T00:00:00,"Kininogen, High-Molecular-Weight",D12.776.811.420.350
24388213,2014-01-01T00:00:00,"Kininogen, High-Molecular-Weight",D23.119.630.480
24388213,2014-01-01T00:00:00,"Kininogen, High-Molecular-Weight",D23.469.050.375.425.350
24388213,2014-01-01T00:00:00,"Kininogen, High-Molecular-Weight",D23.529.812.654.350
24388213,2014-01-01T00:00:00,Prekallikrein,D08.811.277.656.300.760.442.725
24388213,2014-01-01T00:00:00,Prekallikrein,D08.811.277.656.959.350.442.725
24388213,2014-01-01T00:00:00,Prekallikrein,D12.776.124.125.597.712
24388213,2014-01-01T00:00:00,Prekallikrein,D23.119.597.712
24388213,2014-01-01T00:00:00,Signal Transduction,G02.111.087.800
24388213,2014-01-01T00:00:00,Signal Transduction,G02.149.115.800
24388213,2014-01-01T00:00:00,Signal Transduction,G04.299.880
24401493,2014-01-01T00:00:00,Anesthesiology,H02.403.066
24401493,2014-01-01T00:00:00,General Surgery,H02.403.810.300
24401493,2014-01-01T00:00:00,"History, 19th Century",K01.400.504.937
24403375,2014-01-01T00:00:00,Anesthesia,E03.155
24403375,2014-01-01T00:00:00,Biomedical Research,H01.770.644.145
24403375,2014-01-01T00:00:00,Cardiac Surgical Procedures,E04.100.376
24403375,2014-01-01T00:00:00,Cardiac Surgical Procedures,E04.928.220
24403375,2014-01-01T00:00:00,Cardiology,H02.403.429.163
24403375,2014-01-01T00:00:00,Child,M01.060.406
24403375,2014-01-01T00:00:00,Critical Care,E02.760.190
24403375,2014-01-01T00:00:00,Critical Care,N02.421.585.190
24403375,2014-01-01T00:00:00,"Heart Defects, Congenital",C14.240.400
24403375,2014-01-01T00:00:00,"Heart Defects, Congenital",C14.280.400
24403375,2014-01-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
24403375,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24403375,2014-01-01T00:00:00,Leadership,F01.752.609
24403375,2014-01-01T00:00:00,Pediatrics,H02.403.670
24417784,2014-01-01T00:00:00,Adult,M01.060.116
24417784,2014-01-01T00:00:00,Chlamydia trachomatis,B03.440.190.190.190.750
24417784,2014-01-01T00:00:00,Early Detection of Cancer,E01.390.500
24417784,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24417784,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
24417784,2014-01-01T00:00:00,Neisseria gonorrhoeae,B03.440.400.425.550.550.474
24417784,2014-01-01T00:00:00,Neisseria gonorrhoeae,B03.660.075.525.520.400
24417784,2014-01-01T00:00:00,Papillomavirus Infections,C02.256.650
24417784,2014-01-01T00:00:00,Papillomavirus Infections,C02.928.725
24417784,2014-01-01T00:00:00,Risk Factors,E05.318.740.600.800.725
24417784,2014-01-01T00:00:00,Risk Factors,N05.715.350.200.700
24417784,2014-01-01T00:00:00,Risk Factors,N05.715.360.750.625.700.700
24417784,2014-01-01T00:00:00,Risk Factors,N06.850.490.625.750
24417784,2014-01-01T00:00:00,Risk Factors,N06.850.520.830.600.800.725
24417784,2014-01-01T00:00:00,Rural Population,N01.600.725
24417784,2014-01-01T00:00:00,Trichomonas Vaginitis,C03.752.890.633
24417784,2014-01-01T00:00:00,Trichomonas Vaginitis,C13.351.500.894.906.633
24417784,2014-01-01T00:00:00,Trichomonas vaginalis,B01.630.800.808.717
24417784,2014-01-01T00:00:00,Uterine Cervical Neoplasms,C04.588.945.418.948.850
24417784,2014-01-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.593.131
24417784,2014-01-01T00:00:00,Uterine Cervical Neoplasms,C13.351.500.852.762.850
24417784,2014-01-01T00:00:00,Uterine Cervical Neoplasms,C13.351.937.418.875.850
24420982,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24420982,2014-01-01T00:00:00,Neoplasms,C04
24420984,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24420984,2014-01-01T00:00:00,Smoking,F01.145.466.753
24420984,2014-01-01T00:00:00,United States,Z01.107.567.875
24424052,2014-01-01T00:00:00,Animals,B01.050
24424052,2014-01-01T00:00:00,Bilirubin,D03.383.129.578.840.249.184
24424052,2014-01-01T00:00:00,Bilirubin,D03.549.909.249.184
24424052,2014-01-01T00:00:00,Bilirubin,D04.345.783.249.184
24424052,2014-01-01T00:00:00,Bilirubin,D23.767.193.184
24424052,2014-01-01T00:00:00,Body Weight,C23.888.144
24424052,2014-01-01T00:00:00,Body Weight,E01.370.600.115.100.160.120
24424052,2014-01-01T00:00:00,Body Weight,E05.041.124.160.750
24424052,2014-01-01T00:00:00,Body Weight,G07.100.100.160.120
24424052,2014-01-01T00:00:00,Body Weight,G07.700.320.249.314.120
24424052,2014-01-01T00:00:00,Endoplasmic Reticulum,A11.284.430.214.190.875.248
24424052,2014-01-01T00:00:00,Inflammation,C23.550.470
24424052,2014-01-01T00:00:00,Insulin,D06.472.699.587.740.625
24424052,2014-01-01T00:00:00,Insulin,D12.644.548.586.740.625
24424052,2014-01-01T00:00:00,Insulin Resistance,C18.452.394.968.500
24424052,2014-01-01T00:00:00,Insulin Resistance,G07.690.320.617
24424052,2014-01-01T00:00:00,Liver,A03.620
24424052,2014-01-01T00:00:00,Membrane Proteins,D12.776.543
24424052,2014-01-01T00:00:00,"Mice, Obese",B01.050.150.900.649.865.635.505.500.550.530
24424052,2014-01-01T00:00:00,"Muscle, Skeletal",A02.633.567
24424052,2014-01-01T00:00:00,"Muscle, Skeletal",A10.690.552.500
24424052,2014-01-01T00:00:00,Obesity,C18.654.726.500
24424052,2014-01-01T00:00:00,Obesity,C23.888.144.699.500
24424052,2014-01-01T00:00:00,Obesity,E01.370.600.115.100.160.120.699.500
24424052,2014-01-01T00:00:00,Obesity,G07.100.100.160.120.699.500
24424052,2014-01-01T00:00:00,Protein Denaturation,G02.111.087.685
24424052,2014-01-01T00:00:00,Protein Denaturation,G02.149.115.685
24424052,2014-01-01T00:00:00,"Receptors, Leptin",D12.776.543.750.065.500
24443024,2014-01-01T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.055.239.125
24443024,2014-01-01T00:00:00,"Aortic Aneurysm, Thoracic",C14.907.109.139.125
24443024,2014-01-01T00:00:00,Aortic Valve,A07.541.510.110
24443024,2014-01-01T00:00:00,Gene Expression Regulation,G05.355.315
24443024,2014-01-01T00:00:00,"Heart Defects, Congenital",C14.240.400
24443024,2014-01-01T00:00:00,"Heart Defects, Congenital",C14.280.400
24443024,2014-01-01T00:00:00,"Heart Defects, Congenital",C16.131.240.400
24443024,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24443024,2014-01-01T00:00:00,Marfan Syndrome,C05.116.099.674
24443024,2014-01-01T00:00:00,Marfan Syndrome,C14.240.400.725
24443024,2014-01-01T00:00:00,Marfan Syndrome,C14.280.400.725
24443024,2014-01-01T00:00:00,Marfan Syndrome,C16.131.077.550
24443024,2014-01-01T00:00:00,Marfan Syndrome,C16.131.240.400.720
24443024,2014-01-01T00:00:00,Marfan Syndrome,C16.320.540
24443024,2014-01-01T00:00:00,Marfan Syndrome,C17.300.500
24443024,2014-01-01T00:00:00,Mutation,G05.365.590
24443024,2014-01-01T00:00:00,Signal Transduction,G02.111.087.800
24443024,2014-01-01T00:00:00,Signal Transduction,G02.149.115.800
24443024,2014-01-01T00:00:00,Signal Transduction,G04.299.880
24443024,2014-01-01T00:00:00,Transforming Growth Factor beta,D12.644.276.374.687
24443024,2014-01-01T00:00:00,Transforming Growth Factor beta,D12.644.276.954.800.720
24443024,2014-01-01T00:00:00,Transforming Growth Factor beta,D12.644.276.963.720
24443024,2014-01-01T00:00:00,Transforming Growth Factor beta,D12.776.467.374.687
24443024,2014-01-01T00:00:00,Transforming Growth Factor beta,D12.776.467.942.800.720
24443024,2014-01-01T00:00:00,Transforming Growth Factor beta,D12.776.467.960.720
24443024,2014-01-01T00:00:00,Transforming Growth Factor beta,D23.529.374.687
24443024,2014-01-01T00:00:00,Transforming Growth Factor beta,D23.529.942.800.720
24443024,2014-01-01T00:00:00,Transforming Growth Factor beta,D23.529.960.720
24445095,2014-01-01T00:00:00,Delivery of Health Care,N04.590.374
24445095,2014-01-01T00:00:00,Delivery of Health Care,N05.300
24445095,2014-01-01T00:00:00,Family Practice,H02.403.280
24445095,2014-01-01T00:00:00,Health Care Costs,N03.219.151.400
24445095,2014-01-01T00:00:00,Health Care Costs,N05.300.375
24445095,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24445106,2014-01-01T00:00:00,Attitude of Health Personnel,F01.100.050
24445106,2014-01-01T00:00:00,Attitude of Health Personnel,N05.300.100
24445106,2014-01-01T00:00:00,Delivery of Health Care,N04.590.374
24445106,2014-01-01T00:00:00,Delivery of Health Care,N05.300
24445106,2014-01-01T00:00:00,"Education, Medical",I02.358.399
24445106,2014-01-01T00:00:00,Family Practice,H02.403.280
24445106,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24445106,2014-01-01T00:00:00,Physician-Patient Relations,F01.829.401.650.675
24445106,2014-01-01T00:00:00,Physician-Patient Relations,N05.300.660.625
24475476,2014-01-01T00:00:00,American Heart Association,N03.540.630.780.110
24475476,2014-01-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
24475476,2014-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
24475476,2014-01-01T00:00:00,Blood Pressure,G09.330.380.076
24475476,2014-01-01T00:00:00,Disease Management,N04.590.607
24475476,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24475476,2014-01-01T00:00:00,Hypertension,C14.907.489
24475476,2014-01-01T00:00:00,Practice Guidelines as Topic,N04.761.700.350.650
24475476,2014-01-01T00:00:00,Practice Guidelines as Topic,N05.700.350.650
24527503,2014-01-01T00:00:00,Adult,M01.060.116
24527503,2014-01-01T00:00:00,Analgesia,E03.091
24527503,2014-01-01T00:00:00,Gastric Bypass,E02.065.062.249
24527503,2014-01-01T00:00:00,Gastric Bypass,E04.035.398.385
24527503,2014-01-01T00:00:00,Gastric Bypass,E04.062.249
24527503,2014-01-01T00:00:00,Gastric Bypass,E04.210.457.430
24527503,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24527503,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
24527503,2014-01-01T00:00:00,"Pain, Postoperative",C23.550.767.700
24527503,2014-01-01T00:00:00,"Pain, Postoperative",C23.888.646.530
24527503,2014-01-01T00:00:00,Prefrontal Cortex,A08.186.211.730.885.287.500.270.700
24527503,2014-01-01T00:00:00,Transcranial Magnetic Stimulation,E01.370.376.850
24527503,2014-01-01T00:00:00,Transcranial Magnetic Stimulation,E02.621.820
24551889,2014-01-01T00:00:00,Baclofen,D02.241.081.160.050.350.100
24551889,2014-01-01T00:00:00,Benzodiazepines,D03.438.079.080
24551889,2014-01-01T00:00:00,Hiccup,C23.888.821.578
24551889,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24551889,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
24551889,2014-01-01T00:00:00,Treatment Outcome,E01.789.800
24551889,2014-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24551889,2014-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24570435,2014-01-01T00:00:00,Animals,B01.050
24570435,2014-01-01T00:00:00,Chick Embryo,A13.350.150
24570435,2014-01-01T00:00:00,Chick Embryo,A16.331.200
24570435,2014-01-01T00:00:00,Chickens,B01.050.150.900.248.350.150
24570435,2014-01-01T00:00:00,Chickens,B01.050.150.900.248.617.192
24592609,2014-01-01T00:00:00,Christianity,K01.844.188
24592609,2014-01-01T00:00:00,"Education, Nursing, Baccalaureate",I02.358.462.316
24592609,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24592609,2014-01-01T00:00:00,"Students, Nursing",I02.851.686.685
24592609,2014-01-01T00:00:00,"Students, Nursing",M01.848.769.685
24592609,2014-01-01T00:00:00,Young Adult,M01.060.116.815
24664702,2014-01-01T00:00:00,"Calcium Channels, L-Type",D12.776.157.530.400.150.400
24664702,2014-01-01T00:00:00,"Calcium Channels, L-Type",D12.776.543.550.425.150.400
24664702,2014-01-01T00:00:00,"Calcium Channels, L-Type",D12.776.543.585.400.150.400
24664702,2014-01-01T00:00:00,Complement Activation,G12.425.255
24664702,2014-01-01T00:00:00,Complement System Proteins,D12.776.124.486.274
24664702,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24664702,2014-01-01T00:00:00,Macular Degeneration,C11.768.585.439
24664702,2014-01-01T00:00:00,Oxidative Stress,G03.495.710
24664702,2014-01-01T00:00:00,Oxidative Stress,G07.700.830.750
24664702,2014-01-01T00:00:00,Retinal Pigment Epithelium,A09.371.670.500
24664702,2014-01-01T00:00:00,Retinal Pigment Epithelium,A09.371.729.887
24664702,2014-01-01T00:00:00,src-Family Kinases,D08.811.913.696.620.682.725.800
24664728,2014-01-01T00:00:00,Animals,B01.050
24664728,2014-01-01T00:00:00,"Antigens, CD59",D12.776.395.550.035
24664728,2014-01-01T00:00:00,"Antigens, CD59",D12.776.543.550.159
24664728,2014-01-01T00:00:00,"Antigens, CD59",D23.050.301.264.035.159
24664728,2014-01-01T00:00:00,"Antigens, CD59",D23.101.100.110.159
24664728,2014-01-01T00:00:00,Choroidal Neovascularization,C11.941.160.244
24664728,2014-01-01T00:00:00,Choroidal Neovascularization,C23.550.589.500.145
24664728,2014-01-01T00:00:00,Complement Membrane Attack Complex,D12.776.124.486.274.930
24664728,2014-01-01T00:00:00,Complement System Proteins,D12.776.124.486.274
24664728,2014-01-01T00:00:00,Macular Degeneration,C11.768.585.439
24804365,2014-01-01T00:00:00,African Americans,M01.686.508.100.100
24804365,2014-01-01T00:00:00,African Americans,M01.686.754.100
24804365,2014-01-01T00:00:00,Aged,M01.060.116.100
24804365,2014-01-01T00:00:00,Blood Pressure,E01.370.600.875.249
24804365,2014-01-01T00:00:00,Blood Pressure,G09.330.380.076
24804365,2014-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
24804365,2014-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
24804365,2014-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
24804365,2014-01-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
24804365,2014-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
24804365,2014-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
24804365,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24804365,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
24804365,2014-01-01T00:00:00,Regression Analysis,E05.318.740.750
24804365,2014-01-01T00:00:00,Regression Analysis,N05.715.360.750.695
24804365,2014-01-01T00:00:00,Regression Analysis,N06.850.520.830.750
24804365,2014-01-01T00:00:00,Treatment Outcome,E01.789.800
24804365,2014-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
24804365,2014-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
24956914,2014-01-01T00:00:00,Adolescent,M01.060.057
24956914,2014-01-01T00:00:00,Adult,M01.060.116
24956914,2014-01-01T00:00:00,Aged,M01.060.116.100
24956914,2014-01-01T00:00:00,Anti-Bacterial Agents,D27.505.954.122.085
24956914,2014-01-01T00:00:00,"Hospitals, Psychiatric",N02.278.421.556.508
24956914,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
24956914,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
24956914,2014-01-01T00:00:00,South Carolina,Z01.107.567.875.075.662
24956914,2014-01-01T00:00:00,South Carolina,Z01.107.567.875.750.700
24956914,2014-01-01T00:00:00,Unnecessary Procedures,N02.421.380.900
24956914,2014-01-01T00:00:00,Unnecessary Procedures,N05.300.150.395.900
24956914,2014-01-01T00:00:00,Urinalysis,E01.370.390.810
24956914,2014-01-01T00:00:00,Urinalysis,E01.450.150.810
24956914,2014-01-01T00:00:00,Urinalysis,E01.450.890
24956914,2014-01-01T00:00:00,Urinary Tract Infections,C01.539.895
24956914,2014-01-01T00:00:00,Urinary Tract Infections,C12.777.892
24956914,2014-01-01T00:00:00,Urinary Tract Infections,C13.351.968.892
24956914,2014-01-01T00:00:00,Young Adult,M01.060.116.815
25065078,2014-01-01T00:00:00,Adolescent,M01.060.057
25065078,2014-01-01T00:00:00,Adult,M01.060.116
25065078,2014-01-01T00:00:00,African Americans,M01.686.508.100.100
25065078,2014-01-01T00:00:00,African Americans,M01.686.754.100
25065078,2014-01-01T00:00:00,Aged,M01.060.116.100
25065078,2014-01-01T00:00:00,"Diabetes Mellitus, Type 2",C18.452.394.750.149
25065078,2014-01-01T00:00:00,"Diabetes Mellitus, Type 2",C19.246.300
25065078,2014-01-01T00:00:00,European Continental Ancestry Group,M01.686.508.400
25065078,2014-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",F01.100.150.500
25065078,2014-01-01T00:00:00,"Health Knowledge, Attitudes, Practice",N05.300.150.410
25065078,2014-01-01T00:00:00,"Hemoglobin A, Glycosylated",D09.408.375
25065078,2014-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.124.400.405.440
25065078,2014-01-01T00:00:00,"Hemoglobin A, Glycosylated",D12.776.422.316.762.380.440
25065078,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
25065078,2014-01-01T00:00:00,Medication Adherence,F01.145.488.500.500
25065078,2014-01-01T00:00:00,Medication Adherence,N05.300.150.600.600.500
25065078,2014-01-01T00:00:00,Middle Aged,M01.060.116.630
25065078,2014-01-01T00:00:00,Minority Groups,I01.880.371
25065078,2014-01-01T00:00:00,Quality of Life,I01.800
25065078,2014-01-01T00:00:00,Quality of Life,K01.752.400.750
25065078,2014-01-01T00:00:00,Self Care,E02.900
25065078,2014-01-01T00:00:00,Self Care,N02.421.784.680
25065078,2014-01-01T00:00:00,Self Efficacy,F01.752.747.792.700
25065078,2014-01-01T00:00:00,Young Adult,M01.060.116.815
25068943,2014-01-01T00:00:00,Algorithms,G17.035
25068943,2014-01-01T00:00:00,Algorithms,L01.224.050
25068943,2014-01-01T00:00:00,Chemical Hazard Release,N06.850.135.195
25068943,2014-01-01T00:00:00,Environmental Exposure,N06.850.460.350
25068943,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
25068943,2014-01-01T00:00:00,Mass Casualty Incidents,I01.198.240.856.800.537
25068943,2014-01-01T00:00:00,Mass Casualty Incidents,I01.880.735.900.800.575
25068943,2014-01-01T00:00:00,Mass Casualty Incidents,N06.230.100.160
25068943,2014-01-01T00:00:00,Triage,N02.421.297.900
25070233,2014-01-01T00:00:00,Age Factors,N05.715.350.075
25070233,2014-01-01T00:00:00,Age Factors,N06.850.490.250
25070233,2014-01-01T00:00:00,Bone Neoplasms,C04.588.149
25070233,2014-01-01T00:00:00,Bone Neoplasms,C05.116.231
25070233,2014-01-01T00:00:00,Chondrosarcoma,C04.557.450.565.280
25070233,2014-01-01T00:00:00,Chondrosarcoma,C04.557.450.795.300
25070233,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
25070233,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.350.810
25070233,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.600.350.700.810
25070233,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.700.810
25070233,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.700.810.810
25070233,2014-01-01T00:00:00,"Tomography, X-Ray Computed",E01.370.350.825.810.810
25070233,2014-01-01T00:00:00,Treatment Outcome,E01.789.800
25070233,2014-01-01T00:00:00,Treatment Outcome,N04.761.559.590.800
25070233,2014-01-01T00:00:00,Treatment Outcome,N05.715.360.575.575.800
25070233,2014-01-01T00:00:00,X-Rays,G01.201.875.750.918
25084816,2014-01-01T00:00:00,"History, 20th Century",K01.400.504.968
25084816,2014-01-01T00:00:00,Primary Health Care,N04.590.233.727
25084849,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
25084849,2014-01-01T00:00:00,Primary Health Care,N04.590.233.727
25084849,2014-01-01T00:00:00,Psychiatry,F04.096.544
25084849,2014-01-01T00:00:00,Psychiatry,H02.403.690
25084851,2014-01-01T00:00:00,Behavioral Medicine,F04.096.080
25084851,2014-01-01T00:00:00,Behavioral Medicine,H02.403.090
25084851,2014-01-01T00:00:00,Faculty,I02.463
25084851,2014-01-01T00:00:00,Faculty,M01.526.339
25084851,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
25084851,2014-01-01T00:00:00,Periodicals as Topic,L01.178.682.829.678
25130039,2014-01-01T00:00:00,Animals,B01.050
25130039,2014-01-01T00:00:00,Antihypertensive Agents,D27.505.954.411.162
25130039,2014-01-01T00:00:00,Diabetes Mellitus,C18.452.394.750
25130039,2014-01-01T00:00:00,Diabetes Mellitus,C19.246
25130039,2014-01-01T00:00:00,Heart Diseases,C14.280
25130039,2014-01-01T00:00:00,Humans,B01.050.150.900.649.801.400.112.400.400
25130039,2014-01-01T00:00:00,Hypertension,C14.907.489
25130039,2014-01-01T00:00:00,Kidney Diseases,C12.777.419
25130039,2014-01-01T00:00:00,Kidney Diseases,C13.351.968.419
25130039,2014-01-01T00:00:00,Kinins,D12.644.276.812
25130039,2014-01-01T00:00:00,Kinins,D12.776.467.812
25130039,2014-01-01T00:00:00,Kinins,D23.469.050.375
25130039,2014-01-01T00:00:00,Kinins,D23.529.812
25130039,2014-01-01T00:00:00,Signal Transduction,G02.111.087.800
25130039,2014-01-01T00:00:00,Signal Transduction,G02.149.115.800
25130039,2014-01-01T00:00:00,Signal Transduction,G04.299.880
25130039,2014-01-01T00:00:00,Tissue Kallikreins,D08.811.277.656.300.760.442.875
25130039,2014-01-01T00:00:00,Tissue Kallikreins,D08.811.277.656.959.350.442.875
25130039,2014-01-01T00:00:00,Tissue Kallikreins,D23.101.840.870
